data_1x57_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1x57 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 . . . . . 0 C--O 1.225 -0.199 0 CA-C-O 119.149 -0.453 . . . . 0.0 111.322 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.8 t -57.51 -54.73 27.26 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.253 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 171.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.4 -44.18 93.65 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-N 118.388 0.54 . . . . 0.0 112.372 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -59.68 -56.93 15.76 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 117.631 -1.176 . . . . 0.0 109.636 175.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 69.3 t -58.84 -36.07 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 120.357 1.435 . . . . 0.0 110.375 -178.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.6 mt -57.3 -59.24 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 174.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -57.11 -48.31 78.94 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.753 1.221 . . . . 0.0 110.784 -178.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -62.87 -46.38 88.13 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 125.123 1.369 . . . . 0.0 111.636 -176.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.39 -35.73 63.28 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-O 118.816 -0.991 . . . . 0.0 111.493 178.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 13.1 mtm105 -54.82 -61.61 2.2 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 118.049 0.924 . . . . 0.0 109.211 170.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -62.39 -30.82 71.47 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.131 0.972 . . . . 0.0 111.663 -172.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.8 m -63.88 -16.87 62.43 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 118.92 -0.562 . . . . 0.0 112.422 175.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -124.22 11.42 8.78 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.891 2.076 . . . . 0.0 110.314 -176.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.33 13.97 31.66 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.514 1.054 . . . . 0.0 114.678 -176.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 44.4 mt -78.36 119.95 22.42 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 119.945 1.873 . . . . 0.0 108.845 -170.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 62.1 p -64.67 168.9 5.5 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.557 0.694 . . . . 0.0 110.362 172.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -62.91 -34.51 77.58 Favored 'General case' 0 N--CA 1.464 0.258 0 O-C-N 120.424 -1.422 . . . . 0.0 110.428 174.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.93 -33.02 63.79 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.186 0.594 . . . . 0.0 109.73 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -63.65 -39.44 94.35 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.641 1.11 . . . . 0.0 109.557 171.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.89 -52.81 54.51 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 123.917 0.887 . . . . 0.0 110.312 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.93 -43.24 63.35 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 124.679 1.192 . . . . 0.0 110.403 177.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 60.7 m -60.11 -52.39 65.57 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.998 0.919 . . . . 0.0 110.379 174.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.3 mttm -57.23 -25.28 58.84 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 119.24 0.927 . . . . 0.0 113.196 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.3 pt -113.81 5.16 7.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 118.972 0.806 . . . . 0.0 112.227 -176.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.9 m120 54.5 54.94 8.62 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.524 1.529 . . . . 0.0 109.537 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -128.59 -178.6 4.65 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 126.922 2.089 . . . . 0.0 109.168 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 51.7 mmtt -81.02 149.73 67.22 Favored Pre-proline 0 C--N 1.333 -0.148 0 C-N-CA 123.853 0.861 . . . . 0.0 109.546 167.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.48 -11.5 26.46 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.668 2.245 . . . . 0.0 112.115 167.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -59.49 -57.94 10.77 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.952 1.301 . . . . 0.0 109.448 169.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.9 m -63.92 -33.27 61.02 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.556 0 CA-C-O 118.128 -0.939 . . . . 0.0 110.689 -173.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 42.8 mm -60.5 -46.51 95.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 120.166 1.348 . . . . 0.0 110.044 176.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.08 -28.91 69.95 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.169 0.587 . . . . 0.0 112.356 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -85.23 -38.46 18.9 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.846 0.858 . . . . 0.0 110.61 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -54.98 -40.98 70.64 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 126.328 1.851 . . . . 0.0 110.537 173.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -58.68 -42.94 89.66 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.82 0.848 . . . . 0.0 112.084 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 9.0 m -75.41 -35.32 61.02 Favored 'General case' 0 C--N 1.331 -0.207 0 O-C-N 122.097 -0.377 . . . . 0.0 110.222 175.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.85 46.34 3.17 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 -168.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 21.2 mtm-85 -128.42 -0.35 5.63 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 125.272 1.429 . . . . 0.0 113.309 -177.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -89.48 175.76 7.17 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 161.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 48.8 mm -93.8 112.66 57.87 Favored Pre-proline 0 C--O 1.239 0.541 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 171.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -77.49 115.51 3.91 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 123.138 2.558 . . . . 0.0 108.064 -177.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -113.84 142.5 46.01 Favored 'General case' 0 CA--C 1.517 -0.317 0 O-C-N 121.695 -0.628 . . . . 0.0 109.674 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -58.24 -26.23 62.64 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.791 0.836 . . . . 0.0 113.146 -171.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -62.91 -57.61 10.21 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.98 0.912 . . . . 0.0 110.528 173.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.2 t -68.68 -43.75 82.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 118.409 -0.805 . . . . 0.0 109.573 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 54.5 mt -49.48 -46.84 48.65 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.08 0.855 . . . . 0.0 110.337 171.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.99 -43.2 95.12 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 123.998 0.809 . . . . 0.0 112.722 176.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -61.8 -45.65 92.92 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 118.373 1.087 . . . . 0.0 110.796 174.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.0 mt -61.47 -33.69 58.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 C-N-CA 123.939 0.896 . . . . 0.0 110.324 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -56.8 -51.3 69.49 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 119.538 1.063 . . . . 0.0 110.419 176.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 52.5 mtt180 -54.12 -42.03 69.02 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.27 0.628 . . . . 0.0 109.874 177.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.04 -42.22 68.94 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.72 1.608 . . . . 0.0 113.09 -173.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 45.7 pt -114.74 -16.94 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 123.593 0.757 . . . . 0.0 112.167 -174.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.57 25.18 54.61 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 125.09 1.328 . . . . 0.0 113.052 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 61.6 mt -130.59 162.95 28.18 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.081 1.352 . . . . 0.0 109.434 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 47.6 mttm -77.16 146.3 37.17 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 127.16 2.184 . . . . 0.0 110.312 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -121.32 5.03 10.24 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.512 1.525 . . . . 0.0 112.223 -175.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 66.3 mtm180 -139.59 163.5 32.39 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.681 1.592 . . . . 0.0 109.909 171.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.38 167.76 43.78 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 125.831 1.681 . . . . 0.0 109.538 -171.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -71.36 -9.76 58.67 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.455 -1.027 . . . . 0.0 110.137 163.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -75.09 8.17 2.78 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.547 1.939 . . . . 0.0 110.791 170.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.4 tt -52.54 141.46 6.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 O-C-N 120.275 -1.516 . . . . 0.0 110.279 175.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.3 -4.61 54.58 Favored Glycine 0 CA--C 1.537 1.428 0 CA-C-O 119.04 -0.867 . . . . 0.0 113.838 -177.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.5 mmtt -66.29 146.79 99.05 Favored Pre-proline 0 N--CA 1.454 -0.267 0 CA-C-N 119.877 1.839 . . . . 0.0 107.934 159.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -70.43 162.11 43.59 Favored 'Trans proline' 0 N--CA 1.447 -1.262 0 C-N-CA 123.441 2.76 . . . . 0.0 111.222 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.1 pt . . . . . 0 C--N 1.332 -0.155 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 172.459 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 . . . . . 0 C--O 1.226 -0.144 0 CA-C-O 119.875 -0.107 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.5 t -55.68 -58.38 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 123.575 0.75 . . . . 0.0 109.389 173.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.31 -40.02 95.42 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 118.891 0.769 . . . . 0.0 112.666 -178.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.36 -54.44 45.66 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.563 1.145 . . . . 0.0 110.242 176.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.4 t -63.25 -38.24 81.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 C-N-CA 123.618 0.767 . . . . 0.0 110.268 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 52.0 mt -56.81 -56.71 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.065 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 175.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -52.61 -55.28 23.44 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.194 0.598 . . . . 0.0 110.115 -178.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.23 -41.94 98.87 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.138 0.575 . . . . 0.0 111.468 -174.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.34 -41.61 45.05 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-O 119.204 -0.775 . . . . 0.0 111.396 -176.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.1 mtm105 -52.5 -60.11 3.64 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 117.669 0.734 . . . . 0.0 109.514 171.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.72 -31.33 72.47 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 123.702 0.626 . . . . 0.0 110.953 -171.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.8 t -64.2 -25.03 67.89 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.029 0.532 . . . . 0.0 111.77 176.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -112.98 13.08 19.44 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.913 1.285 . . . . 0.0 111.226 178.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.31 13.4 43.16 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.221 0.915 . . . . 0.0 113.446 -178.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 54.4 mt -74.04 118.89 17.52 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -171.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 27.0 p -65.72 174.3 2.4 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.626 0.726 . . . . 0.0 109.564 171.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -68.6 -37.16 79.58 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 120.747 -1.22 . . . . 0.0 110.137 174.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -64.86 -35.3 80.67 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 119.246 0.93 . . . . 0.0 111.612 172.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.63 -51.54 69.35 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 118.973 0.806 . . . . 0.0 109.048 176.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.81 -50.76 72.15 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 124.332 1.053 . . . . 0.0 109.888 -177.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -49.64 -52.36 31.28 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.092 1.357 . . . . 0.0 110.2 175.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.0 m -58.25 -44.54 88.38 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.857 0.863 . . . . 0.0 112.439 175.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.3 mttp -59.71 -16.29 26.02 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.445 1.02 . . . . 0.0 112.764 176.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.9 pt -117.69 8.97 7.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 124.808 1.243 . . . . 0.0 111.886 173.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.6 t30 55.12 6.78 0.15 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 128.494 2.718 . . . . 0.0 115.609 -174.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -102.64 -171.0 1.88 Allowed 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 124.537 1.135 . . . . 0.0 109.216 -171.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -95.87 141.36 23.05 Favored Pre-proline 0 N--CA 1.464 0.263 0 O-C-N 120.743 -1.223 . . . . 0.0 113.359 -168.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.09 -20.82 43.59 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.175 2.583 . . . . 0.0 112.585 -177.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.4 tp60 -56.82 -44.0 81.59 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 117.74 -1.124 . . . . 0.0 110.696 167.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . 0.273 12.1 m -67.15 -36.1 75.99 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.345 0 CA-C-N 120.116 1.325 . . . . 0.0 109.917 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 42.1 mm -59.3 -49.01 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 119.827 1.194 . . . . 0.0 109.931 177.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.34 -36.59 71.36 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.24 -41.61 48.63 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.738 1.615 . . . . 0.0 111.827 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -57.94 -45.96 85.81 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.103 1.361 . . . . 0.0 108.81 175.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -55.17 -38.22 68.02 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.479 0.711 . . . . 0.0 111.392 175.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.52 2.24 56.49 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -179.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.15 13.21 77.65 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-N 120.27 1.396 . . . . 0.0 113.026 174.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -87.98 -57.52 2.9 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.671 1.588 . . . . 0.0 108.082 -169.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.52 142.62 48.42 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.76 0.824 . . . . 0.0 110.136 -177.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.8 mt -69.47 119.51 71.14 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 168.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.54 135.41 24.11 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.257 1.971 . . . . 0.0 109.149 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -133.8 132.78 40.88 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.008 0.923 . . . . 0.0 109.136 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -40.39 -46.18 2.33 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.647 1.979 . . . . 0.0 112.358 176.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -51.01 -48.88 61.32 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.377 0.671 . . . . 0.0 111.22 -178.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.455 ' HA ' ' HD3' ' A' ' 60' ' ' LYS . 58.2 t -79.73 -48.05 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 125.819 1.648 . . . . 0.0 108.636 -178.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 88.6 mt -50.46 -40.01 49.59 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.497 1.044 . . . . 0.0 111.742 177.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.17 -28.75 72.49 Favored Glycine 0 CA--C 1.526 0.768 0 O-C-N 121.036 -1.04 . . . . 0.0 112.47 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.455 ' HD3' ' HA ' ' A' ' 57' ' ' VAL . 18.9 mtpp -73.51 -47.51 40.53 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 124.619 1.168 . . . . 0.0 108.213 173.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.9 mt -58.1 -39.34 72.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 123.704 0.801 . . . . 0.0 110.32 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -60.32 -42.66 96.04 Favored 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 118.869 -1.132 . . . . 0.0 110.644 -178.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -66.78 -37.04 83.8 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 118.84 0.746 . . . . 0.0 111.447 174.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.66 -36.25 64.4 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.941 1.696 . . . . 0.0 111.946 -177.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 24.5 pt -113.25 -19.1 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 118.999 0.818 . . . . 0.0 112.029 176.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.74 30.08 60.29 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 125.506 1.526 . . . . 0.0 113.061 -176.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.9 mt -132.56 161.45 33.79 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 124.839 1.256 . . . . 0.0 108.3 173.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -71.32 141.12 50.47 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 125.499 1.52 . . . . 0.0 109.408 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -115.88 -1.34 12.6 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.721 1.608 . . . . 0.0 109.506 175.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.4 mtm105 -132.76 142.05 48.82 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.537 1.535 . . . . 0.0 108.491 -177.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.59 167.49 36.62 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 125.135 1.35 . . . . 0.0 111.104 -178.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -70.59 -12.14 61.38 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 121.687 -0.89 . . . . 0.0 111.396 172.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -82.04 16.91 1.73 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.106 2.162 . . . . 0.0 111.267 171.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.2 tt -52.06 141.88 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 O-C-N 120.613 -1.305 . . . . 0.0 110.161 176.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.97 -10.06 10.23 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-O 118.762 -1.021 . . . . 0.0 114.065 -177.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.3 mmtt -70.78 151.06 95.29 Favored Pre-proline 0 N--CA 1.453 -0.294 0 CA-C-N 120.843 2.321 . . . . 0.0 106.016 161.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -67.96 157.02 63.66 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.863 2.376 . . . . 0.0 111.246 -174.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 25.9 pt . . . . . 0 C--O 1.234 0.242 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 161.198 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 . . . . . 0 CA--C 1.533 0.32 0 CA-C-O 119.091 -0.48 . . . . 0.0 110.737 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 63.4 t -58.62 -66.38 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 125.028 1.331 . . . . 0.0 109.695 174.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.59 -29.41 40.07 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 119.182 0.901 . . . . 0.0 113.498 -177.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.7 tttt -72.58 -55.51 6.79 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 117.654 -1.165 . . . . 0.0 110.701 175.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.3 t -58.84 -39.26 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 120.101 1.319 . . . . 0.0 110.28 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 86.4 mt -54.96 -61.21 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 175.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -63.35 -39.9 95.81 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 -172.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -58.25 -46.82 85.26 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.688 1.595 . . . . 0.0 111.381 176.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.94 -43.74 81.46 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -178.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.9 mtm105 -54.89 -59.55 4.57 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 117.341 0.57 . . . . 0.0 110.54 173.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -58.89 -33.05 70.07 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.636 0.775 . . . . 0.0 110.885 -176.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.0 t -68.31 -8.45 39.82 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 118.23 -0.891 . . . . 0.0 113.395 177.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -132.37 7.88 4.25 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 120.363 1.438 . . . . 0.0 111.505 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 57.19 32.15 63.01 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-N 118.793 0.724 . . . . 0.0 112.174 -173.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 44.8 mt -85.38 119.78 26.13 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.7 t -73.88 171.71 12.9 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.143 0.883 . . . . 0.0 109.964 176.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -61.68 -37.64 84.87 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 120.364 -1.46 . . . . 0.0 110.841 176.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.4 mttp -59.28 -32.6 70.18 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.078 0.854 . . . . 0.0 112.684 170.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -70.32 -39.25 74.87 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 119.422 1.01 . . . . 0.0 108.604 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.68 -48.02 76.28 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -50.89 -51.2 54.15 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 126.221 1.808 . . . . 0.0 109.455 177.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 60.1 m -61.49 -47.29 86.3 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.985 1.314 . . . . 0.0 111.037 177.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.6 mttm -64.21 -20.49 66.06 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 26.6 pt -111.34 -2.33 10.25 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.356 0 CA-C-N 120.179 1.354 . . . . 0.0 111.214 174.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 53.5 t30 44.92 71.5 0.26 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.695 1.598 . . . . 0.0 112.466 -167.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -140.26 177.65 7.84 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 127.36 2.264 . . . . 0.0 109.179 166.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 28.2 mtmt -79.38 141.48 57.18 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 124.061 0.944 . . . . 0.0 111.916 177.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -66.51 -11.13 30.4 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.41 2.74 . . . . 0.0 115.227 -178.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 42.4 tp60 -75.89 -27.79 57.85 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 120.699 1.591 . . . . 0.0 111.379 169.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 m -68.1 -35.8 72.93 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.413 0 CA-C-N 120.832 1.651 . . . . 0.0 108.293 173.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 33.6 mm -59.67 -50.44 79.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 C-N-CA 124.207 1.003 . . . . 0.0 110.078 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.4 -32.11 73.45 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.928 -0.483 . . . . 0.0 112.089 176.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.82 -27.98 61.39 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 120.798 -1.189 . . . . 0.0 110.97 175.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -69.46 -37.7 77.43 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.653 1.581 . . . . 0.0 110.87 175.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -55.29 -56.8 15.93 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 167.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.5 m -66.58 -19.88 65.88 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.22 1.008 . . . . 0.0 113.46 -172.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.34 -10.31 73.37 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 123.773 0.702 . . . . 0.0 114.5 -175.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 28.9 mtt-85 -77.23 -21.21 54.13 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 118.199 1.0 . . . . 0.0 112.39 -174.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.14 115.22 19.58 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 105.264 -2.125 . . . . 0.0 105.264 168.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.2 mm -69.1 113.73 18.49 Favored Pre-proline 0 C--O 1.238 0.47 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 -171.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -77.33 114.57 3.77 Favored 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 121.783 1.655 . . . . 0.0 110.563 -163.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -110.5 144.23 39.65 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.945 0.898 . . . . 0.0 109.539 -174.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -53.41 -40.46 65.12 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -171.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -52.51 -60.63 3.0 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.052 0.941 . . . . 0.0 109.662 177.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.433 ' HA ' ' HD3' ' A' ' 60' ' ' LYS . 70.9 t -65.96 -44.8 92.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-O 118.328 -0.844 . . . . 0.0 109.49 -175.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.7 mt -51.3 -44.79 61.98 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.783 0.72 . . . . 0.0 110.2 176.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.82 -43.96 94.46 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.024 0.821 . . . . 0.0 113.068 175.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.433 ' HD3' ' HA ' ' A' ' 57' ' ' VAL . 15.8 mtpp -65.23 -42.88 92.94 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 121.304 -1.115 . . . . 0.0 109.651 178.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.2 mt -60.81 -32.99 53.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 123.563 0.745 . . . . 0.0 109.271 176.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -58.49 -49.03 78.84 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 120.078 1.308 . . . . 0.0 110.212 178.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 48.5 mtt85 -68.6 -20.91 64.52 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.606 -0.684 . . . . 0.0 112.496 175.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.27 -54.81 41.31 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 50.2 pt -100.22 -18.07 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -176.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.19 20.87 58.25 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 125.871 1.701 . . . . 0.0 113.533 -177.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 60.8 mt -125.47 161.73 26.46 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 125.14 1.376 . . . . 0.0 108.913 178.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -72.18 139.78 48.41 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 125.244 1.418 . . . . 0.0 109.226 177.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -119.72 -1.39 10.57 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.218 1.807 . . . . 0.0 110.961 177.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.3 mmm180 -125.46 155.14 40.95 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 119.496 1.044 . . . . 0.0 108.68 170.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.13 159.93 6.63 Favored Glycine 0 N--CA 1.447 -0.613 0 O-C-N 124.843 1.339 . . . . 0.0 110.573 -178.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -73.18 -4.24 31.66 Favored 'General case' 0 N--CA 1.464 0.273 0 O-C-N 121.001 -1.293 . . . . 0.0 112.131 -176.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -73.32 12.4 0.59 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.849 0.749 . . . . 0.0 110.572 162.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.7 tt -48.56 134.03 5.96 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 CA-C-N 120.269 1.395 . . . . 0.0 109.125 176.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.32 -4.76 66.15 Favored Glycine 0 CA--C 1.538 1.521 0 CA-C-O 119.155 -0.803 . . . . 0.0 114.15 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 40.9 mmtt -72.57 151.39 91.54 Favored Pre-proline 0 N--CA 1.455 -0.206 0 CA-C-N 119.989 1.895 . . . . 0.0 106.794 159.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -72.47 160.75 46.02 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 123.423 2.749 . . . . 0.0 111.489 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 36.8 pt . . . . . 0 C--O 1.235 0.294 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 173.518 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 69.5 mt-10 . . . . . 0 N--CA 1.462 0.155 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.5 t -57.97 -51.22 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 176.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.45 -36.5 84.63 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 118.771 -1.016 . . . . 0.0 112.895 175.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -63.19 -55.92 21.04 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 119.024 1.412 . . . . 0.0 109.235 176.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.4 t -64.12 -34.55 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-N 119.311 0.96 . . . . 0.0 110.573 -178.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.4 mt -59.18 -59.49 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 171.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -56.69 -41.28 77.09 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 118.836 0.744 . . . . 0.0 110.75 -174.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -62.79 -57.13 11.98 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.405 1.882 . . . . 0.0 110.822 176.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.69 -32.66 83.76 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 118.205 0.457 . . . . 0.0 111.995 -175.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.418 HH21 ' CD ' ' A' ' 47' ' ' GLU . 25.3 mtm105 -53.51 -61.41 2.32 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 166.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -50.55 -46.56 57.6 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.713 1.205 . . . . 0.0 111.69 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.2 m -71.11 -6.79 41.97 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.42 1.088 . . . . 0.0 113.409 -176.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.423 ' HE3' HD12 ' A' ' 27' ' ' LEU . 26.5 mtpp -120.06 8.12 10.94 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.899 1.68 . . . . 0.0 111.535 167.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.09 19.58 51.71 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.777 1.179 . . . . 0.0 113.015 -176.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.423 HD12 ' HE3' ' A' ' 25' ' ' LYS . 79.6 mt -84.34 131.87 34.66 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 118.804 1.302 . . . . 0.0 108.552 -171.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.4 p -75.75 176.57 7.61 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 171.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -68.07 -37.58 81.41 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.179 -0.951 . . . . 0.0 110.73 172.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.6 tmtp? -63.26 -39.23 94.01 Favored 'General case' 0 N--CA 1.462 0.125 0 C-N-CA 123.107 0.563 . . . . 0.0 110.873 174.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.55 -42.22 83.01 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 177.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.04 -50.67 72.65 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 123.744 0.817 . . . . 0.0 110.089 176.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -48.54 -53.47 18.1 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 125.269 1.428 . . . . 0.0 109.978 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 35.1 m -63.09 -40.74 98.56 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.647 0.779 . . . . 0.0 111.933 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.7 mttp -61.81 -12.19 16.08 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 119.719 1.145 . . . . 0.0 113.81 174.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 24.8 pt -123.6 10.38 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 119.99 1.268 . . . . 0.0 111.583 175.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 37.09 68.85 0.25 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 128.453 2.701 . . . . 0.0 112.067 -168.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -131.35 -178.67 4.95 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 127.44 2.296 . . . . 0.0 107.437 173.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -93.67 151.57 40.11 Favored Pre-proline 0 CA--C 1.531 0.233 0 C-N-CA 124.362 1.065 . . . . 0.0 110.595 171.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -67.03 -17.27 51.03 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 123.676 2.917 . . . . 0.0 113.697 -178.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 -65.51 -52.24 54.08 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 118.502 0.592 . . . . 0.0 110.398 177.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.1 m -63.55 -27.61 43.33 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 C-N-CA 120.5 -0.48 . . . . 0.0 109.965 -175.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 38.0 mm -61.38 -53.32 50.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 123.084 0.554 . . . . 0.0 110.574 174.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.17 -39.9 73.07 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 118.957 0.798 . . . . 0.0 111.485 177.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.88 -31.15 67.72 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 118.678 -0.677 . . . . 0.0 111.086 -178.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -63.06 -45.63 91.28 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 125.288 1.435 . . . . 0.0 111.342 172.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.418 ' CD ' HH21 ' A' ' 22' ' ' ARG . 4.7 mt-10 -58.86 -32.96 69.92 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.292 0.637 . . . . 0.0 111.328 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 43.7 m -82.8 -23.15 33.96 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 174.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.2 0.15 80.72 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 119.624 1.102 . . . . 0.0 114.218 -169.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.8 mtt85 -69.49 -47.12 64.9 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 117.867 0.834 . . . . 0.0 109.561 -177.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.39 134.82 57.35 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 171.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 34.0 mm -68.95 120.39 76.02 Favored Pre-proline 0 C--O 1.237 0.416 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -71.44 115.54 4.33 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.503 2.135 . . . . 0.0 110.5 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -106.2 122.2 45.74 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 126.509 1.923 . . . . 0.0 107.697 -178.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -55.73 -24.8 37.08 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 119.813 1.188 . . . . 0.0 113.221 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -61.55 -55.93 25.53 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.491 0.716 . . . . 0.0 109.284 174.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.0 t -71.26 -38.76 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.4 -177.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.4 mt -50.44 -46.39 56.53 Favored 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 169.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.61 -46.89 91.6 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 124.138 0.875 . . . . 0.0 112.036 177.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -57.85 -43.7 86.05 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 117.935 0.867 . . . . 0.0 110.828 175.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.0 mt -65.24 -35.77 76.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 124.685 1.194 . . . . 0.0 110.325 178.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -59.93 -49.91 75.82 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 119.495 1.043 . . . . 0.0 108.616 176.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.8 mtm105 -57.59 -31.32 66.06 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 122.871 0.468 . . . . 0.0 111.288 175.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.47 -53.7 26.55 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.011 0.924 . . . . 0.0 112.227 -177.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 35.6 pt -90.05 -16.5 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 122.418 0.287 . . . . 0.0 111.269 -177.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.92 27.28 58.77 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 125.871 1.701 . . . . 0.0 113.186 -175.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.2 mt -143.37 161.38 38.51 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.727 1.764 . . . . 0.0 109.887 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -68.28 142.83 55.46 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 126.163 1.785 . . . . 0.0 110.746 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -118.17 10.33 12.89 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.467 1.107 . . . . 0.0 110.398 173.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 25.1 mtm105 -139.8 157.27 46.0 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 121.32 -0.863 . . . . 0.0 109.711 -178.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.96 167.91 21.04 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -170.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 43.2 tttp -68.94 -14.08 62.82 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.363 -1.08 . . . . 0.0 110.642 172.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -64.93 8.23 0.13 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.695 1.998 . . . . 0.0 112.426 168.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.7 tt -50.24 135.9 8.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-N 120.552 1.524 . . . . 0.0 110.283 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.28 -4.68 62.18 Favored Glycine 0 CA--C 1.533 1.204 0 CA-C-O 119.045 -0.864 . . . . 0.0 114.406 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 44.7 mmtt -70.07 153.14 95.57 Favored Pre-proline 0 N--CA 1.453 -0.314 0 CA-C-N 119.808 1.804 . . . . 0.0 107.101 161.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -67.18 168.78 16.67 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.062 2.508 . . . . 0.0 112.53 -176.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 34.4 pt . . . . . 0 N--CA 1.453 -0.302 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 175.546 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 . . . . . 0 CA--C 1.54 0.596 0 CA-C-O 119.238 -0.41 . . . . 0.0 111.235 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.0 t -57.58 -57.37 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 125.742 1.617 . . . . 0.0 109.8 178.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -49.12 -46.7 33.79 Favored Glycine 0 C--O 1.223 -0.537 0 C-N-CA 124.849 1.214 . . . . 0.0 112.246 177.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -62.1 -49.08 77.36 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 119.008 1.404 . . . . 0.0 110.958 178.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 63.6 t -60.63 -41.99 90.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-N 119.482 1.037 . . . . 0.0 110.983 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 21.2 mt -54.15 -68.19 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 106.209 -1.775 . . . . 0.0 106.209 173.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -57.87 -30.37 65.77 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 125.079 1.352 . . . . 0.0 110.413 -167.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -64.55 -69.38 0.29 Allowed 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.715 1.606 . . . . 0.0 110.924 171.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.58 -29.34 74.62 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-N 119.413 1.006 . . . . 0.0 111.765 -171.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.4 ttp85 -53.74 -60.45 3.3 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 126.218 1.807 . . . . 0.0 108.76 168.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -67.42 -28.94 68.33 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 119.809 1.186 . . . . 0.0 113.334 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 59.0 m -61.03 -20.42 62.5 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.187 0.903 . . . . 0.0 111.99 172.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -109.67 5.9 23.29 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.915 1.686 . . . . 0.0 111.073 175.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.06 9.75 54.66 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 126.442 1.972 . . . . 0.0 113.68 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 34.7 mt -74.15 130.78 40.43 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 118.559 1.179 . . . . 0.0 109.231 -163.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 32.1 p -66.02 162.35 19.61 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 166.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -55.19 -37.24 66.8 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 121.469 -0.77 . . . . 0.0 109.863 169.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -63.85 -43.46 96.05 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.05 0.54 . . . . 0.0 111.298 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -70.02 -35.55 74.41 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 118.853 -0.594 . . . . 0.0 110.628 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.63 -46.05 90.15 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.747 0.703 . . . . 0.0 109.937 173.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.61 -54.44 45.98 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 124.722 1.209 . . . . 0.0 108.978 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 52.0 m -68.01 -31.4 71.06 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 117.962 -1.018 . . . . 0.0 111.608 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.1 mttp -52.75 -50.58 63.19 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 119.945 1.248 . . . . 0.0 110.47 173.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.9 pt -88.13 2.42 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 123.174 0.59 . . . . 0.0 112.383 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 62.3 t-20 45.02 74.21 0.14 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 128.973 2.909 . . . . 0.0 111.716 -170.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -139.35 173.6 11.37 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 128.612 2.765 . . . . 0.0 109.906 178.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.8 mmpt? -81.44 144.21 52.93 Favored Pre-proline 0 CA--C 1.534 0.341 0 O-C-N 121.505 -0.747 . . . . 0.0 109.882 173.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.32 -16.52 13.64 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.334 2.022 . . . . 0.0 114.452 -172.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 -68.04 -34.16 75.95 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 120.331 1.423 . . . . 0.0 110.782 173.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.6 m -72.22 -27.81 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 119.686 1.13 . . . . 0.0 110.155 177.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 36.3 mm -63.92 -50.51 77.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 C-N-CA 123.221 0.609 . . . . 0.0 109.414 172.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.17 -35.58 71.77 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.126 0.489 . . . . 0.0 110.462 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -72.94 -31.03 64.33 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 117.974 -1.012 . . . . 0.0 112.462 176.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -57.08 -50.84 71.54 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-N 120.019 1.281 . . . . 0.0 109.958 170.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -67.55 -29.68 69.12 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 119.188 -0.434 . . . . 0.0 110.965 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.6 m -71.11 -37.1 72.37 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.299 0.954 . . . . 0.0 111.716 176.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 113.85 9.37 16.45 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 124.943 1.259 . . . . 0.0 113.441 -176.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.5 mmt85 -101.29 -42.63 6.24 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 124.546 1.138 . . . . 0.0 110.955 -163.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.85 130.02 42.45 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 174.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 30.1 mm -68.3 124.9 90.89 Favored Pre-proline 0 C--O 1.238 0.456 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 -177.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -76.58 111.81 3.33 Favored 'Trans proline' 0 N--CA 1.442 -1.525 0 N-CA-C 106.836 -2.024 . . . . 0.0 106.836 -175.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -104.9 130.65 53.01 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 -174.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -50.54 -31.51 15.85 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 117.85 -1.071 . . . . 0.0 113.64 -178.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -65.24 -59.55 3.95 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 120.838 1.654 . . . . 0.0 110.673 172.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.1 t -59.7 -47.46 91.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 124.143 0.977 . . . . 0.0 110.034 -176.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 78.8 mt -47.68 -51.03 23.23 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 124.432 1.093 . . . . 0.0 109.538 169.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.72 -43.44 69.32 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 123.718 0.675 . . . . 0.0 112.576 177.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt -66.45 -44.04 83.88 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.14 0.97 . . . . 0.0 109.946 177.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.3 mt -60.01 -37.22 71.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 124.76 1.224 . . . . 0.0 109.903 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -58.35 -47.37 84.01 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 119.229 0.922 . . . . 0.0 109.564 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 26.1 mtt-85 -69.75 -27.22 64.76 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 118.296 -0.859 . . . . 0.0 112.326 176.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.75 -40.15 79.02 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.818 0.847 . . . . 0.0 112.056 176.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 22.1 pt -117.2 -16.07 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -174.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.1 30.88 62.4 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 125.225 1.393 . . . . 0.0 112.813 -176.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 69.7 mt -124.11 164.32 19.68 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 118.631 1.216 . . . . 0.0 109.489 169.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -78.76 140.85 38.2 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 126.033 1.733 . . . . 0.0 108.22 176.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -120.07 7.84 10.9 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.563 1.145 . . . . 0.0 108.985 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 22.8 mtm105 -141.63 168.61 19.35 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 127.208 2.203 . . . . 0.0 108.461 177.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 68.91 158.26 1.45 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -162.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 24.3 mtmt -64.63 -15.6 61.46 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 120.876 -1.367 . . . . 0.0 111.387 164.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -66.62 11.69 0.09 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.323 2.249 . . . . 0.0 111.906 168.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.1 tt -51.84 144.52 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 O-C-N 120.485 -1.384 . . . . 0.0 110.532 177.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.79 -4.03 24.29 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-O 118.911 -0.938 . . . . 0.0 113.152 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 39.6 mmtt -69.51 150.79 96.87 Favored Pre-proline 0 N--CA 1.446 -0.667 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 157.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -69.33 158.5 57.28 Favored 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 122.448 2.099 . . . . 0.0 111.365 -177.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 27.8 pt . . . . . 0 C--O 1.238 0.474 0 N-CA-C 105.796 -1.928 . . . . 0.0 105.796 158.876 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 . . . . . 0 CA--C 1.532 0.254 0 N-CA-C 111.132 0.049 . . . . 0.0 111.132 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.5 t -57.9 -56.94 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 124.07 0.948 . . . . 0.0 109.094 177.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -55.21 -39.82 72.68 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-O 118.947 -0.918 . . . . 0.0 112.745 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 48.8 tptt -60.2 -57.7 11.69 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.633 1.216 . . . . 0.0 109.733 176.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.4 t -61.81 -31.9 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 118.662 0.665 . . . . 0.0 110.029 -177.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.1 mt -65.76 -56.41 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 CA-C-N 119.809 1.186 . . . . 0.0 109.061 176.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -51.88 -49.38 63.09 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.599 1.16 . . . . 0.0 110.404 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -66.39 -53.06 40.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.104 1.762 . . . . 0.0 111.958 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.23 -34.24 89.39 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 124.413 1.006 . . . . 0.0 111.519 -174.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.9 mtm105 -64.69 -51.31 63.13 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 118.531 -0.747 . . . . 0.0 111.28 168.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -51.8 -37.76 52.92 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.751 0.82 . . . . 0.0 111.399 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.2 m -73.92 -2.39 23.72 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.621 1.968 . . . . 0.0 112.493 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 21.0 mtpp -136.54 6.72 3.0 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.448 2.299 . . . . 0.0 111.314 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.26 21.04 69.9 Favored Glycine 0 CA--C 1.536 1.399 0 CA-C-O 118.681 -1.066 . . . . 0.0 114.742 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 20.8 mt -93.44 135.4 34.72 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.271 1.536 . . . . 0.0 110.964 -169.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 61.7 p -74.98 170.52 15.82 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.262 -0.899 . . . . 0.0 109.515 163.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -63.44 -29.01 70.37 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.237 -0.914 . . . . 0.0 111.568 166.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.53 -36.81 73.92 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.836 0.855 . . . . 0.0 110.8 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -66.13 -37.39 85.59 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 171.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.9 -48.42 66.08 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 118.207 0.458 . . . . 0.0 111.267 -175.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -48.24 -48.85 34.97 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 125.43 1.492 . . . . 0.0 109.209 172.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 63.0 m -60.91 -48.74 80.44 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.796 0.838 . . . . 0.0 111.528 175.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.3 mttm -58.4 -11.68 3.08 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 127.175 2.19 . . . . 0.0 114.233 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.9 pt -128.64 0.07 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 119.26 0.937 . . . . 0.0 112.273 177.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 53.2 t30 42.27 76.31 0.08 Allowed 'General case' 0 C--O 1.235 0.301 0 C-N-CA 126.768 2.027 . . . . 0.0 112.103 -163.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -137.6 -179.51 5.79 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 128.03 2.532 . . . . 0.0 107.567 168.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -88.01 141.71 31.54 Favored Pre-proline 0 C--N 1.335 -0.05 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 175.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -64.36 -18.82 64.47 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.587 2.192 . . . . 0.0 112.029 170.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.5 tp60 -62.23 -52.19 64.76 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 123.93 0.892 . . . . 0.0 110.429 171.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.1 m -69.88 -34.68 61.36 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.431 0 CA-C-N 119.36 0.982 . . . . 0.0 110.094 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 42.1 mm -56.57 -48.96 79.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 O-C-N 121.227 -0.921 . . . . 0.0 110.244 174.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.81 -20.91 66.65 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 178.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.16 -54.05 12.38 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 118.822 -0.608 . . . . 0.0 110.45 167.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -42.81 -50.65 5.62 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 124.535 1.134 . . . . 0.0 112.35 176.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.79 -29.35 68.51 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 120.897 1.68 . . . . 0.0 113.223 -171.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 12.8 m -69.85 -37.16 76.06 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.874 166.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.63 28.58 18.69 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -177.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -79.16 -50.8 10.42 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 117.494 0.647 . . . . 0.0 109.373 -174.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.35 167.32 18.38 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 127.366 2.266 . . . . 0.0 110.433 171.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 23.9 mm -89.73 127.34 54.61 Favored Pre-proline 0 C--O 1.235 0.333 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 174.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -72.75 115.07 4.2 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 N-CA-C 108.645 -1.329 . . . . 0.0 108.645 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -99.14 135.99 39.75 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.664 0.786 . . . . 0.0 110.795 -169.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -52.4 -36.95 55.4 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.365 1.066 . . . . 0.0 113.275 -170.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -57.59 -64.91 0.74 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.072 0.949 . . . . 0.0 109.226 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 92.4 t -63.3 -40.44 89.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 125.574 1.549 . . . . 0.0 109.844 -178.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.6 mt -49.61 -52.82 27.75 Favored 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 124.354 1.062 . . . . 0.0 110.223 175.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.76 -31.5 78.34 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-N 118.679 0.672 . . . . 0.0 112.523 -178.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -67.59 -43.55 80.27 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 121.401 -1.058 . . . . 0.0 110.371 173.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.0 mt -63.51 -37.12 78.74 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.091 0 C-N-CA 124.337 1.055 . . . . 0.0 109.843 176.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -56.39 -50.86 70.37 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.386 0.994 . . . . 0.0 109.227 176.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 23.2 mtm180 -64.95 -19.04 65.75 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 175.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.59 -44.76 73.67 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 118.426 -0.797 . . . . 0.0 111.264 177.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 21.5 pt -114.45 -10.13 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -173.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.51 23.36 78.13 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 127.561 2.505 . . . . 0.0 114.031 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.0 mt -121.94 161.59 22.59 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 118.453 1.126 . . . . 0.0 108.793 172.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -74.36 140.26 44.68 Favored 'General case' 0 CA--C 1.512 -0.51 0 C-N-CA 124.984 1.314 . . . . 0.0 108.753 176.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -119.56 9.92 11.64 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 125.087 1.355 . . . . 0.0 111.201 176.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.5 mtm180 -130.85 166.79 20.12 Favored 'General case' 0 C--O 1.233 0.209 0 O-C-N 121.023 -1.048 . . . . 0.0 109.04 174.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.63 176.91 43.56 Favored Glycine 0 N--CA 1.449 -0.495 0 O-C-N 124.233 0.958 . . . . 0.0 110.89 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -83.2 11.74 6.13 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.643 0.777 . . . . 0.0 111.114 171.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -102.91 16.25 27.14 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.381 1.472 . . . . 0.0 110.359 177.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.5 tt -54.68 142.98 7.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 O-C-N 121.219 -0.925 . . . . 0.0 110.545 -168.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.55 -4.48 59.9 Favored Glycine 0 CA--C 1.536 1.4 0 CA-C-O 119.307 -0.718 . . . . 0.0 114.257 -178.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -71.74 149.15 92.9 Favored Pre-proline 0 C--N 1.341 0.212 0 CA-C-N 119.938 1.869 . . . . 0.0 107.974 163.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.34 151.22 29.43 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 123.896 3.064 . . . . 0.0 112.85 -171.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.0 pt . . . . . 0 N--CA 1.454 -0.232 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 175.541 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 . . . . . 0 N--CA 1.456 -0.154 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 53.5 t -57.31 -64.53 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.098 0 C-N-CA 125.41 1.484 . . . . 0.0 109.287 -178.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -49.16 -42.99 32.58 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-N 119.425 1.011 . . . . 0.0 112.998 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -67.44 -52.6 37.6 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 117.843 -1.075 . . . . 0.0 112.564 177.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 66.7 t -59.27 -31.34 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 119.805 1.184 . . . . 0.0 110.242 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 52.9 mt -61.32 -58.38 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 175.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -60.03 -47.0 87.65 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 123.608 0.568 . . . . 0.0 110.47 -177.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -60.3 -49.75 76.36 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.841 1.256 . . . . 0.0 110.734 178.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.17 -32.14 75.9 Favored Glycine 0 CA--C 1.52 0.377 0 O-C-N 120.535 -1.353 . . . . 0.0 112.663 -177.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 15.1 mtm105 -59.6 -61.42 2.63 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 118.145 0.973 . . . . 0.0 110.777 167.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.27 -22.95 67.2 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.169 0.988 . . . . 0.0 112.692 -174.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.4 t -61.4 -16.59 48.05 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.662 1.585 . . . . 0.0 111.303 171.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -126.98 2.12 6.57 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.413 1.885 . . . . 0.0 110.986 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 71.67 0.24 39.29 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 126.022 1.772 . . . . 0.0 113.024 -175.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.6 mt -78.63 145.32 34.74 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 119.034 1.417 . . . . 0.0 110.619 -162.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.1 p -83.86 174.61 10.25 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.656 0.782 . . . . 0.0 110.013 -173.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -69.09 -38.49 78.99 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 121.432 -0.793 . . . . 0.0 109.743 171.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.3 mtpm? -58.91 -41.99 88.57 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.82 0.848 . . . . 0.0 110.911 171.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -63.43 -43.46 97.4 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 118.832 0.742 . . . . 0.0 109.388 177.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.32 -49.3 77.56 Favored 'General case' 0 C--O 1.228 -0.069 0 C-N-CA 124.205 1.002 . . . . 0.0 110.091 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.15 -45.24 71.98 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.856 0.862 . . . . 0.0 109.919 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.7 m -61.82 -48.45 80.53 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.287 1.035 . . . . 0.0 110.576 177.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.2 mttm -54.48 -27.66 39.21 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.764 1.226 . . . . 0.0 113.274 176.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.6 pt -111.93 10.05 8.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 123.928 0.891 . . . . 0.0 112.13 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.5 m120 45.25 48.68 10.2 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.594 2.358 . . . . 0.0 111.421 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -132.27 -171.49 2.65 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.241 1.416 . . . . 0.0 109.224 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.6 mmmm -91.61 142.0 26.36 Favored Pre-proline 0 N--CA 1.466 0.355 0 O-C-N 121.015 -1.053 . . . . 0.0 109.713 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.52 -10.18 28.24 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.715 2.277 . . . . 0.0 112.123 169.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 30.0 tp60 -50.92 -61.68 2.07 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.901 1.28 . . . . 0.0 109.361 163.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.4 m -66.42 -29.5 46.77 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.677 0 C-N-CA 119.741 -0.783 . . . . 0.0 110.419 -175.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 51.4 mm -62.77 -45.08 99.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 119.686 1.13 . . . . 0.0 109.952 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.82 -39.64 92.48 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 121.496 -0.082 . . . . 0.0 111.09 172.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -63.62 -40.28 96.51 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.512 0.725 . . . . 0.0 110.68 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -63.25 -44.73 94.34 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 126.183 1.793 . . . . 0.0 108.867 176.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -60.73 -30.41 69.97 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.277 1.031 . . . . 0.0 113.164 176.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.7 m -90.49 -19.64 23.61 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 177.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.97 42.45 7.62 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 119.56 1.073 . . . . 0.0 111.188 -173.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -114.36 -47.83 2.91 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 124.941 1.297 . . . . 0.0 108.856 -176.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.21 150.11 11.5 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.31 0.644 . . . . 0.0 109.874 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 36.3 mm -68.98 117.32 50.51 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 167.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -69.76 115.6 4.17 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 N-CA-C 106.892 -2.003 . . . . 0.0 106.892 171.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -127.67 123.91 36.64 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 -172.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.2 p-10 -51.74 -29.59 19.25 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.909 1.684 . . . . 0.0 112.998 -174.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -58.54 -47.6 83.67 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.741 1.616 . . . . 0.0 111.205 173.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.2 t -91.66 -36.5 7.99 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-O 117.778 -1.106 . . . . 0.0 109.971 -175.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 14.1 mt -47.8 -45.63 29.83 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.56 1.073 . . . . 0.0 109.518 170.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.65 -40.31 94.57 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-O 119.492 -0.616 . . . . 0.0 112.813 176.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -64.99 -47.63 76.86 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 118.836 1.318 . . . . 0.0 109.683 177.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.3 mt -61.41 -36.1 70.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 123.226 0.611 . . . . 0.0 110.117 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -58.3 -50.19 74.49 Favored 'General case' 0 C--N 1.33 -0.255 0 O-C-N 121.583 -0.698 . . . . 0.0 109.862 176.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 36.5 mtt180 -65.91 -24.77 66.9 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.301 -0.874 . . . . 0.0 112.807 174.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.85 -55.88 28.73 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 118.771 0.714 . . . . 0.0 109.525 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 45.9 pt -93.34 -15.92 7.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 123.548 0.739 . . . . 0.0 112.002 -177.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.18 39.67 92.48 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 125.337 1.446 . . . . 0.0 111.682 -173.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 47.5 mt -135.45 166.14 23.88 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.4 1.08 . . . . 0.0 109.057 169.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -73.54 141.52 46.7 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 126.336 1.854 . . . . 0.0 109.52 176.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -119.36 5.25 11.18 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.425 1.89 . . . . 0.0 110.302 176.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 56.1 mtm180 -142.1 147.08 36.16 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.924 0.783 . . . . 0.0 110.009 -172.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.25 167.58 21.4 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 125.193 1.378 . . . . 0.0 109.931 -170.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.2 mttp -68.84 -11.57 60.62 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.119 -1.224 . . . . 0.0 111.667 176.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.98 13.74 0.49 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.924 1.69 . . . . 0.0 110.704 172.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.8 tt -52.65 150.45 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 O-C-N 120.843 -1.161 . . . . 0.0 110.761 176.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.53 -12.49 7.78 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-O 118.871 -0.96 . . . . 0.0 113.749 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 33.9 mmtt -70.77 150.57 95.27 Favored Pre-proline 0 N--CA 1.449 -0.515 0 CA-C-N 119.671 1.736 . . . . 0.0 107.784 166.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -73.16 162.44 40.67 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 123.575 2.85 . . . . 0.0 110.856 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 42.3 pt . . . . . 0 N--CA 1.465 0.296 0 C-N-CA 124.364 1.065 . . . . 0.0 108.535 -178.858 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 . . . . . 0 N--CA 1.465 0.31 0 CA-C-O 119.616 -0.23 . . . . 0.0 111.066 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.1 t -56.13 -61.7 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 123.506 0.722 . . . . 0.0 109.464 176.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -56.67 -38.08 80.15 Favored Glycine 0 C--N 1.335 0.527 0 CA-C-N 119.523 1.056 . . . . 0.0 112.523 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.4 -56.35 21.24 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.276 1.038 . . . . 0.0 109.86 177.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.3 t -60.13 -37.88 74.87 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.128 0 C-N-CA 123.808 0.843 . . . . 0.0 110.298 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 64.4 mt -59.98 -57.74 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 176.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -55.68 -49.0 74.11 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.142 0.577 . . . . 0.0 110.125 -176.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -56.67 -60.61 3.3 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 123.362 0.665 . . . . 0.0 110.801 176.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.38 -30.84 78.96 Favored Glycine 0 CA--C 1.521 0.442 0 CA-C-N 119.914 1.234 . . . . 0.0 112.719 -171.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 16.7 mtm105 -57.12 -65.72 0.57 Allowed 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 118.272 1.036 . . . . 0.0 109.782 166.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -61.52 -29.88 70.28 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.806 1.242 . . . . 0.0 112.161 -173.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.7 m -72.6 -4.73 32.58 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.984 1.314 . . . . 0.0 112.295 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp -127.72 12.35 6.82 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.465 1.906 . . . . 0.0 110.16 176.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.21 17.56 66.11 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.297 0.951 . . . . 0.0 113.725 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 59.4 mt -88.62 144.77 26.08 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 118.652 1.226 . . . . 0.0 111.505 -168.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 81.9 p -84.18 168.75 15.48 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.305 173.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -58.91 -43.38 91.04 Favored 'General case' 0 N--CA 1.464 0.267 0 O-C-N 121.321 -0.862 . . . . 0.0 110.216 166.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.5 mttt -57.1 -36.27 70.43 Favored 'General case' 0 CA--C 1.521 -0.136 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 176.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -64.13 -38.37 90.83 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 118.244 0.474 . . . . 0.0 110.232 176.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.59 -48.68 71.5 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 123.34 0.656 . . . . 0.0 109.256 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -50.16 -56.42 11.05 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.48 1.512 . . . . 0.0 108.643 178.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 95.9 m -59.59 -44.14 93.47 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.491 0.717 . . . . 0.0 112.299 177.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -58.86 -32.83 69.81 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 119.595 1.089 . . . . 0.0 112.137 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.2 pt -103.39 1.44 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 119.12 0.873 . . . . 0.0 112.073 176.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 63.3 t30 54.11 44.38 29.3 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 128.236 2.614 . . . . 0.0 113.709 -175.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -113.76 177.85 4.49 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.788 2.035 . . . . 0.0 110.907 176.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -75.93 147.99 81.26 Favored Pre-proline 0 C--N 1.342 0.26 0 CA-C-N 118.991 0.814 . . . . 0.0 109.542 168.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.0 -7.48 20.94 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 123.023 2.482 . . . . 0.0 112.616 170.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.4 tp60 -55.63 -63.44 1.17 Allowed 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 123.278 0.631 . . . . 0.0 109.551 166.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.8 m -67.98 -22.92 28.39 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.339 0 C-N-CA 119.954 -0.698 . . . . 0.0 111.014 -169.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 44.1 mm -61.63 -46.93 95.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 123.98 0.912 . . . . 0.0 110.298 171.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.31 -27.13 68.39 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 123.259 0.623 . . . . 0.0 112.287 177.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -79.75 -39.11 31.79 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.214 1.006 . . . . 0.0 110.789 176.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -55.0 -40.15 69.82 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 125.92 1.688 . . . . 0.0 111.054 175.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -61.14 -39.9 91.81 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 119.177 -0.44 . . . . 0.0 111.895 -177.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.5 m -80.87 -23.89 38.73 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 118.478 -0.772 . . . . 0.0 112.954 172.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.05 7.2 62.65 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-O 119.286 -0.73 . . . . 0.0 112.8 -171.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 45.8 mtt180 -67.44 -37.55 83.17 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.062 1.431 . . . . 0.0 110.195 177.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.63 115.1 7.62 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 167.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.6 mm -70.04 117.42 53.91 Favored Pre-proline 0 C--O 1.236 0.364 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 170.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -80.75 154.48 20.31 Favored 'Trans proline' 0 N--CA 1.446 -1.28 0 C-N-CA 122.188 1.925 . . . . 0.0 110.238 -173.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -127.47 153.92 45.72 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.526 1.13 . . . . 0.0 108.506 174.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 72.9 m-80 -62.12 -31.84 72.35 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.883 0.765 . . . . 0.0 112.309 -172.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -56.61 -61.37 2.47 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.004 0.922 . . . . 0.0 109.381 174.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.0 t -66.15 -48.94 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-O 118.087 -0.959 . . . . 0.0 109.69 -176.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 51.9 mt -44.91 -48.4 11.27 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 119.366 0.985 . . . . 0.0 110.164 170.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.14 -47.45 73.83 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 125.236 1.398 . . . . 0.0 112.562 176.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -61.73 -41.95 98.32 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 121.732 -0.863 . . . . 0.0 110.425 175.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 77.5 mt -63.68 -34.63 69.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 118.755 0.707 . . . . 0.0 109.651 176.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -62.11 -43.5 98.69 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 120.957 -1.089 . . . . 0.0 109.873 174.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 84.8 mtt-85 -59.22 -39.01 81.36 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.453 -0.78 . . . . 0.0 111.004 173.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.74 -55.36 31.1 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.619 1.568 . . . . 0.0 111.453 -175.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.0 pt -91.02 -26.51 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 118.673 0.669 . . . . 0.0 110.942 -178.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.59 28.08 36.82 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 125.614 1.578 . . . . 0.0 112.215 -178.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.6 mt -133.65 165.09 25.74 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.542 1.537 . . . . 0.0 108.572 173.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.2 mttm -69.41 140.96 54.19 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 126.236 1.814 . . . . 0.0 109.947 176.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -119.75 8.02 11.11 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.429 1.892 . . . . 0.0 109.791 174.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -133.42 154.93 50.36 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.578 1.551 . . . . 0.0 108.082 -175.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 65.51 174.18 4.7 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.627 1.584 . . . . 0.0 112.624 -178.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 72.1 mttt -69.15 -16.83 63.73 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 121.883 -0.775 . . . . 0.0 111.867 178.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -76.82 16.04 0.58 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.391 0.996 . . . . 0.0 111.362 176.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.6 tt -52.15 139.51 8.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 O-C-N 120.718 -1.239 . . . . 0.0 110.78 -176.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.27 -8.05 41.96 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 118.79 -1.006 . . . . 0.0 113.386 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 16.5 mmtt -72.55 154.38 91.57 Favored Pre-proline 0 N--CA 1.451 -0.411 0 CA-C-N 120.546 2.173 . . . . 0.0 106.672 161.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -67.8 170.67 13.57 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 123.388 2.725 . . . . 0.0 112.204 -175.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 25.2 pt . . . . . 0 C--O 1.236 0.353 0 C-N-CA 124.637 1.175 . . . . 0.0 108.679 171.822 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 . . . . . 0 CA--C 1.536 0.411 0 CA-C-O 118.906 -0.568 . . . . 0.0 110.034 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 37.1 t -60.95 -57.44 12.12 Favored 'Isoleucine or valine' 0 C--N 1.344 0.329 0 CA-C-N 119.372 0.987 . . . . 0.0 109.14 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.91 -40.9 66.38 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 119.677 -0.513 . . . . 0.0 112.1 177.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.8 tptt -57.85 -61.22 2.68 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 117.827 0.814 . . . . 0.0 110.826 173.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 78.6 t -58.49 -31.85 44.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 118.994 0.816 . . . . 0.0 110.068 -176.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 52.3 mt -64.74 -59.19 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-O 117.799 -1.096 . . . . 0.0 108.753 175.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -54.23 -50.03 68.1 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.706 0.803 . . . . 0.0 109.839 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.85 -52.22 63.96 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 123.786 0.835 . . . . 0.0 110.394 -177.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.99 -33.87 88.4 Favored Glycine 0 CA--C 1.524 0.618 0 CA-C-O 118.862 -0.966 . . . . 0.0 112.098 -177.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.438 HH21 ' CD ' ' A' ' 47' ' ' GLU . 17.3 mtm105 -59.68 -58.14 9.89 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 118.321 1.061 . . . . 0.0 109.7 170.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.9 mm100 -64.36 -17.68 63.95 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.753 1.621 . . . . 0.0 113.216 -176.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 65.3 m -72.15 -11.33 60.69 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.144 0.978 . . . . 0.0 112.941 168.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -135.66 23.06 3.38 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 120.399 1.454 . . . . 0.0 111.993 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 61.2 14.19 38.92 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.477 1.037 . . . . 0.0 113.924 -178.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 44.5 mt -73.09 125.27 27.28 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 118.67 1.235 . . . . 0.0 108.898 -167.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 67.2 p -66.7 170.42 6.44 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 165.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -63.04 -32.39 73.75 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.098 -1.001 . . . . 0.0 110.399 169.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -72.15 -36.32 69.3 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.481 0.712 . . . . 0.0 111.058 178.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -59.91 -40.54 89.19 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.96 0.8 . . . . 0.0 109.129 174.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.82 -47.5 74.81 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.406 0.682 . . . . 0.0 110.803 177.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.64 -47.4 67.1 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.485 1.114 . . . . 0.0 110.487 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 95.3 m -58.89 -49.12 78.98 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 125.03 1.332 . . . . 0.0 111.081 172.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.6 mttp -57.88 -22.55 48.86 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 117.837 -1.078 . . . . 0.0 113.563 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.6 pt -115.3 8.15 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 120.021 1.282 . . . . 0.0 112.096 173.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 42.1 t30 36.74 72.15 0.12 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.424 1.889 . . . . 0.0 112.015 -170.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.77 -179.69 6.48 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.691 1.596 . . . . 0.0 109.706 171.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -68.54 143.51 95.33 Favored Pre-proline 0 N--CA 1.455 -0.203 0 O-C-N 121.347 -0.846 . . . . 0.0 109.797 172.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -69.72 -10.33 28.34 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 122.599 2.199 . . . . 0.0 112.123 170.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -61.29 -42.22 98.28 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.897 1.279 . . . . 0.0 110.73 170.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.3 m -76.39 -27.27 17.35 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.382 0 C-N-CA 119.687 -0.805 . . . . 0.0 110.294 -176.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.3 mm -62.99 -47.47 92.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 119.44 1.018 . . . . 0.0 109.226 176.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.68 -42.38 71.32 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 122.885 0.474 . . . . 0.0 110.834 175.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -78.58 -32.9 47.87 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 118.608 -0.71 . . . . 0.0 111.263 -173.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -58.8 -43.72 90.59 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.33 1.052 . . . . 0.0 109.533 168.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.438 ' CD ' HH21 ' A' ' 22' ' ' ARG . 7.0 mt-10 -62.43 -40.55 96.93 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 118.44 -0.79 . . . . 0.0 112.501 -178.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.3 m -82.11 -25.62 34.29 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 119.145 0.884 . . . . 0.0 112.657 175.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 108.84 3.33 32.07 Favored Glycine 0 CA--C 1.523 0.538 0 C-N-CA 123.464 0.554 . . . . 0.0 113.052 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 55.0 mmt-85 -67.3 -58.34 4.98 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.32 1.448 . . . . 0.0 109.416 -175.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.11 142.71 53.75 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.438 0.563 . . . . 0.0 109.894 -175.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 mt -68.43 126.86 93.15 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 174.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.15 116.86 4.79 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 122.72 2.28 . . . . 0.0 108.192 175.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -114.67 126.72 55.2 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 178.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -44.69 -38.19 4.2 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.767 1.627 . . . . 0.0 114.103 175.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -58.18 -33.15 68.94 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 123.245 0.618 . . . . 0.0 111.979 177.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 75.3 t -94.19 -46.8 13.58 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 C-N-CA 124.898 1.279 . . . . 0.0 109.425 176.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 78.0 mt -47.97 -49.35 30.91 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 120.463 1.483 . . . . 0.0 111.115 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.78 -31.47 71.75 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 118.459 0.572 . . . . 0.0 113.131 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.9 mtpp -74.31 -43.39 56.95 Favored 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 125.071 1.348 . . . . 0.0 109.419 175.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.0 mt -59.17 -36.79 64.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 175.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -59.12 -46.16 89.05 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.426 1.012 . . . . 0.0 109.995 176.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 48.0 mtt180 -67.57 -23.31 65.39 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.329 -0.857 . . . . 0.0 112.713 174.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.95 -37.09 81.16 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.614 1.166 . . . . 0.0 111.893 -178.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 29.7 pt -119.25 -20.38 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.021 0.929 . . . . 0.0 112.544 -177.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.61 29.43 52.43 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 125.476 1.512 . . . . 0.0 113.345 -177.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 81.1 mt -124.92 166.09 16.92 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 118.267 1.033 . . . . 0.0 108.569 170.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.7 mttm -74.59 143.27 44.48 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 125.357 1.463 . . . . 0.0 109.738 175.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -121.26 9.71 10.47 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.56 1.544 . . . . 0.0 110.387 176.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 33.9 mtt-85 -137.64 163.06 32.16 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 119.371 0.987 . . . . 0.0 110.951 175.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.82 177.95 49.94 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 125.413 1.483 . . . . 0.0 110.811 -174.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -69.75 -20.91 63.49 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 121.694 -0.886 . . . . 0.0 110.741 163.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.34 15.71 0.09 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 128.755 2.822 . . . . 0.0 111.382 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.3 tt -56.86 150.89 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 O-C-N 121.106 -0.997 . . . . 0.0 109.334 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.73 -7.15 7.42 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-O 118.533 -1.148 . . . . 0.0 114.13 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.9 mmmt -61.47 149.79 82.65 Favored Pre-proline 0 C--N 1.342 0.242 0 CA-C-N 120.04 1.92 . . . . 0.0 107.137 158.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -67.73 154.79 72.28 Favored 'Trans proline' 0 N--CA 1.445 -1.337 0 C-N-CA 123.139 2.56 . . . . 0.0 110.462 170.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.7 pt . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 164.489 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 . . . . . 0 N--CA 1.466 0.334 0 N-CA-C 111.207 0.077 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.1 t -56.3 -53.88 34.59 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.15 0 C-N-CA 124.044 0.938 . . . . 0.0 109.498 173.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -56.63 -39.7 86.32 Favored Glycine 0 CA--C 1.529 0.924 0 CA-C-N 119.363 0.983 . . . . 0.0 112.719 178.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -63.63 -55.44 23.58 Favored 'General case' 0 N--CA 1.46 0.048 0 CA-C-N 118.51 1.155 . . . . 0.0 109.943 176.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.3 t -58.71 -38.47 72.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 123.465 0.706 . . . . 0.0 110.443 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 57.0 mt -58.64 -59.48 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 176.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -61.93 -37.15 83.6 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 118.073 0.397 . . . . 0.0 111.229 -173.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.88 -53.98 50.66 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 121.418 -0.801 . . . . 0.0 111.914 171.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.64 -37.12 93.24 Favored Glycine 0 CA--C 1.521 0.457 0 CA-C-O 119.177 -0.79 . . . . 0.0 111.899 -173.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 17.6 mtm105 -57.3 -61.33 2.55 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 117.69 0.745 . . . . 0.0 109.407 173.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -60.74 -29.91 69.68 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.132 0.973 . . . . 0.0 112.347 -177.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.4 m -65.05 -12.95 56.27 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.285 0.948 . . . . 0.0 112.959 177.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 41.6 mttm -121.69 8.83 10.07 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.484 1.513 . . . . 0.0 110.295 171.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.12 24.86 61.42 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 126.014 1.769 . . . . 0.0 113.249 -177.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 57.6 mt -87.55 139.89 30.08 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.264 1.532 . . . . 0.0 111.536 -171.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.1 t -78.88 163.68 25.09 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.613 1.165 . . . . 0.0 110.156 177.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -59.21 -40.84 87.08 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 121.015 -1.053 . . . . 0.0 110.086 175.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.47 -34.85 76.15 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 118.512 -0.756 . . . . 0.0 111.972 178.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.39 -36.53 81.51 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.354 0.979 . . . . 0.0 110.787 175.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.78 -47.21 84.49 Favored 'General case' 0 C--N 1.338 0.108 0 O-C-N 121.896 -0.503 . . . . 0.0 109.875 178.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.23 -53.31 36.38 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 125.859 1.664 . . . . 0.0 108.738 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 29.3 m -58.09 -49.58 76.44 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.851 0.861 . . . . 0.0 111.55 174.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 49.1 mttm -57.53 -20.52 32.29 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.6 pt -116.6 5.2 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 119.399 1.0 . . . . 0.0 112.009 176.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 46.6 t30 48.01 64.42 1.65 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 127.04 2.136 . . . . 0.0 110.821 -175.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -137.9 174.88 10.11 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 127.38 2.272 . . . . 0.0 109.862 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.1 mmmm -73.72 143.07 81.22 Favored Pre-proline 0 CA--C 1.53 0.175 0 C-N-CA 124.448 1.099 . . . . 0.0 109.647 172.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -71.99 -12.22 28.07 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.678 2.252 . . . . 0.0 112.829 175.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 44.4 tp60 -73.83 -28.24 61.51 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 117.626 -1.178 . . . . 0.0 111.752 173.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.0 m -75.71 -34.29 28.24 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 CA-C-N 120.544 1.52 . . . . 0.0 109.984 174.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 35.9 mm -59.96 -52.72 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 119.579 1.081 . . . . 0.0 109.893 178.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.67 -31.78 71.92 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.252 -177.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -78.32 -36.26 46.65 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.769 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -54.73 -46.79 74.31 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 126.087 1.755 . . . . 0.0 110.147 173.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -59.65 -48.61 80.97 Favored 'General case' 0 C--N 1.34 0.152 0 C-N-CA 124.011 0.924 . . . . 0.0 110.854 177.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.9 -19.88 61.19 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 107.75 -3.21 34.07 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 125.1 1.333 . . . . 0.0 113.723 176.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 13.0 mmt180 -71.77 -52.87 15.41 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.895 1.347 . . . . 0.0 111.896 -170.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.56 129.23 40.92 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -175.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 35.4 mm -70.11 120.1 75.97 Favored Pre-proline 0 C--O 1.236 0.375 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 174.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -84.39 113.6 1.74 Allowed 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 121.093 1.195 . . . . 0.0 110.216 -171.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -81.24 142.12 33.47 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 177.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -55.54 -38.59 69.46 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.899 0.88 . . . . 0.0 111.849 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -67.19 -50.76 59.82 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.288 0.635 . . . . 0.0 111.351 174.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.6 t -64.42 -43.62 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 119.543 1.065 . . . . 0.0 109.962 -176.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 22.4 mt -45.36 -51.95 10.52 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 125.172 1.389 . . . . 0.0 109.447 165.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.98 -32.66 76.07 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 123.683 0.659 . . . . 0.0 114.105 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -71.71 -48.07 49.74 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 118.984 1.392 . . . . 0.0 109.522 174.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.1 mt -54.8 -36.12 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.104 0 C-N-CA 124.128 0.971 . . . . 0.0 109.923 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -56.27 -50.82 70.28 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 121.884 -0.51 . . . . 0.0 111.081 176.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 65.9 mtt85 -65.58 -24.9 67.19 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.678 0.672 . . . . 0.0 111.954 177.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.36 -33.96 77.2 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.97 0.908 . . . . 0.0 112.95 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 44.6 pt -117.41 -11.78 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.815 0.846 . . . . 0.0 112.174 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.0 36.18 72.64 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 126.078 1.799 . . . . 0.0 113.294 -175.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 48.7 mt -134.88 164.58 27.27 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 118.589 1.195 . . . . 0.0 109.894 171.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -69.99 141.29 52.98 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 127.404 2.281 . . . . 0.0 109.086 172.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -118.64 6.12 11.62 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.874 1.67 . . . . 0.0 110.005 176.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -138.88 162.23 35.32 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 125.01 1.324 . . . . 0.0 108.647 -175.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 67.27 170.65 4.7 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 -165.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -69.38 -15.72 63.37 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 123.472 0.709 . . . . 0.0 110.774 168.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -69.91 16.73 0.06 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.635 1.574 . . . . 0.0 111.71 172.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.0 tt -55.66 146.76 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 O-C-N 120.699 -1.251 . . . . 0.0 110.108 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.69 -1.4 53.11 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-O 119.664 -0.52 . . . . 0.0 113.63 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 20.1 mmtm -85.6 151.03 55.08 Favored Pre-proline 0 N--CA 1.45 -0.455 0 CA-C-N 119.447 1.624 . . . . 0.0 108.469 171.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -70.31 161.65 45.22 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 124.271 3.314 . . . . 0.0 113.191 -173.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 32.7 pt . . . . . 0 C--O 1.234 0.247 0 C-N-CA 125.56 1.544 . . . . 0.0 110.961 -175.55 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.0 mp0 . . . . . 0 N--CA 1.451 -0.424 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.6 t -53.8 -62.32 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 C-N-CA 125.299 1.44 . . . . 0.0 109.949 -178.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -52.36 -51.47 42.25 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-N 119.759 1.163 . . . . 0.0 112.678 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.03 -41.01 86.78 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 118.352 1.076 . . . . 0.0 111.923 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 68.1 t -70.99 -37.72 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 119.358 0.981 . . . . 0.0 110.913 176.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 40.5 mt -57.34 -56.98 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 176.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -54.17 -54.63 37.14 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 125.191 1.396 . . . . 0.0 109.512 -176.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -51.61 -60.72 2.83 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.788 1.235 . . . . 0.0 111.137 177.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.84 -27.35 72.44 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-O 118.692 -1.06 . . . . 0.0 113.042 -170.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.433 HH21 ' CD ' ' A' ' 47' ' ' GLU . 18.9 mtm105 -59.39 -59.42 5.48 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 118.314 1.057 . . . . 0.0 108.324 167.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -57.19 -39.55 75.61 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 125.547 1.539 . . . . 0.0 112.5 -175.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 56.7 m -58.91 -40.41 84.42 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 120.004 1.274 . . . . 0.0 110.529 177.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -81.27 -2.89 50.7 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.042 0.937 . . . . 0.0 111.568 176.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.31 7.9 69.11 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 126.393 1.949 . . . . 0.0 113.207 -176.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.2 mt -83.99 147.13 27.61 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 118.033 0.917 . . . . 0.0 110.408 -165.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 62.7 p -80.43 176.16 10.02 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.265 0.626 . . . . 0.0 110.344 177.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -63.6 -42.19 98.28 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 118.799 -0.62 . . . . 0.0 110.081 168.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -55.63 -42.35 74.84 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.245 1.018 . . . . 0.0 111.661 174.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -65.34 -40.08 93.21 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.52 -49.5 75.08 Favored 'General case' 0 C--N 1.344 0.336 0 C-N-CA 123.578 0.751 . . . . 0.0 109.105 176.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.83 -57.25 10.84 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 124.947 1.299 . . . . 0.0 108.363 -177.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 85.7 m -61.71 -34.16 75.3 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.466 0.707 . . . . 0.0 112.229 176.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.5 mttm -63.35 -15.31 57.02 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 120.832 1.651 . . . . 0.0 112.817 173.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.0 pt -120.41 6.4 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 124.731 1.212 . . . . 0.0 111.072 175.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 40.8 t30 55.65 31.09 16.64 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 128.131 2.573 . . . . 0.0 114.53 -173.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -105.68 -177.01 3.24 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 125.424 1.49 . . . . 0.0 110.918 177.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -84.81 145.66 44.49 Favored Pre-proline 0 C--O 1.228 -0.059 0 C-N-CA 126.458 1.903 . . . . 0.0 111.359 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.03 -19.76 63.69 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.798 2.332 . . . . 0.0 111.961 171.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 28.5 tp60 -64.45 -46.93 81.0 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.87 175.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.6 m -69.6 -31.56 49.3 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.731 0 O-C-N 123.766 0.666 . . . . 0.0 110.244 -173.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 23.7 mm -64.8 -44.44 96.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 O-C-N 119.953 -1.717 . . . . 0.0 110.241 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.59 -32.52 72.62 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 174.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.43 -57.32 10.64 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.765 170.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -52.02 -35.61 47.5 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 126.236 1.815 . . . . 0.0 112.48 -178.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.433 ' CD ' HH21 ' A' ' 22' ' ' ARG . 22.6 mt-10 -67.89 -24.47 65.23 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.076 0.853 . . . . 0.0 112.036 176.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.42 -32.84 28.87 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.874 1.27 . . . . 0.0 110.419 164.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.95 33.74 32.43 Favored Glycine 0 CA--C 1.525 0.694 0 O-C-N 121.185 -0.947 . . . . 0.0 112.573 -173.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.5 mtt85 -71.69 -60.02 2.45 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 118.29 1.045 . . . . 0.0 109.56 177.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.71 137.87 43.19 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 128.081 2.553 . . . . 0.0 108.918 173.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.9 mt -73.53 116.77 54.69 Favored Pre-proline 0 C--O 1.236 0.386 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 175.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -67.35 115.64 3.79 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 122.489 2.126 . . . . 0.0 107.29 -172.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -97.13 142.6 28.86 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -173.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -60.72 -39.26 87.94 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 119.039 -0.505 . . . . 0.0 110.357 -171.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -59.91 -26.55 66.02 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 175.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 73.2 t -93.44 -43.92 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 119.997 1.271 . . . . 0.0 109.085 177.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 26.9 mt -50.0 -46.73 53.0 Favored 'General case' 0 C--O 1.227 -0.086 0 C-N-CA 124.244 1.018 . . . . 0.0 110.105 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.98 -40.1 95.03 Favored Glycine 0 CA--C 1.535 1.336 0 CA-C-N 118.207 0.458 . . . . 0.0 113.009 176.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.6 mtmm -60.67 -42.78 97.76 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 118.794 1.297 . . . . 0.0 110.803 175.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.8 mt -67.31 -35.79 74.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 123.759 0.824 . . . . 0.0 109.515 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -58.77 -47.66 83.94 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 119.43 1.014 . . . . 0.0 109.519 175.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 16.5 mtm-85 -64.4 -20.69 66.3 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 175.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.92 -52.41 24.78 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.872 0.869 . . . . 0.0 111.478 -179.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 47.8 pt -99.96 -15.7 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.762 0.825 . . . . 0.0 111.828 -177.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.38 27.77 61.02 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 126.011 1.767 . . . . 0.0 113.563 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 58.9 mt -129.38 165.42 21.55 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.883 0.873 . . . . 0.0 108.973 173.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -70.32 145.05 51.48 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 125.326 1.451 . . . . 0.0 109.382 175.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -118.83 16.39 13.49 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.255 1.822 . . . . 0.0 109.462 175.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -144.92 162.18 37.5 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 125.364 1.466 . . . . 0.0 108.826 -171.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 70.44 171.63 10.27 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 124.633 1.111 . . . . 0.0 110.855 -174.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -67.54 -24.7 65.57 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.351 -1.088 . . . . 0.0 109.447 165.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -73.52 21.33 0.08 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.729 2.012 . . . . 0.0 112.126 175.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.7 tt -53.54 151.68 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 O-C-N 120.734 -1.229 . . . . 0.0 110.233 172.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.61 -6.83 10.31 Favored Glycine 0 CA--C 1.536 1.397 0 O-C-N 121.118 -0.989 . . . . 0.0 114.108 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 52.9 mmtt -71.01 148.5 94.47 Favored Pre-proline 0 N--CA 1.453 -0.313 0 CA-C-N 120.022 1.911 . . . . 0.0 107.529 163.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -71.05 158.78 54.3 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.419 2.746 . . . . 0.0 111.609 -175.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 17.8 pt . . . . . 0 C--O 1.234 0.25 0 C-N-CA 123.589 0.756 . . . . 0.0 109.187 177.069 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 . . . . . 0 C--O 1.235 0.318 0 N-CA-C 111.385 0.143 . . . . 0.0 111.385 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.7 t -52.23 -63.84 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 C-N-CA 126.433 1.893 . . . . 0.0 109.141 176.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -51.56 -41.26 49.07 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-N 118.493 0.588 . . . . 0.0 112.998 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -64.94 -51.02 64.1 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 117.287 0.544 . . . . 0.0 110.299 -178.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.7 t -66.83 -33.77 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.104 0 C-N-CA 123.299 0.639 . . . . 0.0 110.149 -178.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 59.0 mt -56.03 -58.0 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 173.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -58.61 -47.61 83.76 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 123.898 0.879 . . . . 0.0 110.806 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -60.17 -53.29 59.5 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 118.899 0.772 . . . . 0.0 111.827 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.1 -25.45 74.62 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-O 118.48 -1.178 . . . . 0.0 112.966 -174.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.8 mtm105 -54.54 -67.71 0.24 Allowed 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 119.214 1.507 . . . . 0.0 110.482 160.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -61.46 -34.2 75.04 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 123.933 0.77 . . . . 0.0 110.527 -167.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.2 t -69.7 -10.39 58.1 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.031 0.932 . . . . 0.0 111.546 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -118.46 7.41 11.88 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.933 1.693 . . . . 0.0 110.308 173.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.15 2.44 40.05 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 126.308 1.908 . . . . 0.0 114.148 -177.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 21.4 mt -67.09 119.69 12.45 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 124.779 1.231 . . . . 0.0 107.71 -176.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.2 t -71.53 173.5 7.91 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.911 168.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -53.07 -55.33 24.69 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.51 -0.744 . . . . 0.0 109.754 174.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -58.58 -27.28 64.48 Favored 'General case' 0 C--O 1.227 -0.103 0 CA-C-N 118.515 0.598 . . . . 0.0 112.239 178.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -69.13 -36.07 77.07 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.125 -0.984 . . . . 0.0 111.109 173.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.77 -48.72 62.96 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.526 0.731 . . . . 0.0 110.943 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.56 -51.95 57.28 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.854 0.862 . . . . 0.0 109.664 174.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 83.5 m -67.6 -30.07 69.57 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 118.734 -0.65 . . . . 0.0 111.592 -179.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.8 mttm -59.98 -49.55 77.24 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 120.279 1.399 . . . . 0.0 111.138 170.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.7 pt -86.53 -6.03 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 119.302 0.955 . . . . 0.0 112.731 -176.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.7 t30 59.15 65.16 1.24 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 128.851 2.861 . . . . 0.0 112.561 -171.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -133.86 178.78 6.68 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 126.913 2.085 . . . . 0.0 110.089 176.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -79.29 151.93 75.69 Favored Pre-proline 0 N--CA 1.463 0.18 0 C-N-CA 124.73 1.212 . . . . 0.0 109.116 169.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -79.78 -11.96 13.74 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.192 1.928 . . . . 0.0 115.306 -179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -71.82 -43.85 64.89 Favored 'General case' 0 CA--C 1.515 -0.368 0 O-C-N 120.981 -1.075 . . . . 0.0 110.075 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.6 m -67.32 -38.22 80.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 -172.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 27.6 mm -55.82 -50.66 66.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 125.796 1.639 . . . . 0.0 110.821 170.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.11 -30.73 68.33 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 122.244 -0.285 . . . . 0.0 111.36 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.2 -30.93 49.19 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 118.418 -0.801 . . . . 0.0 111.382 177.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -59.11 -43.97 91.96 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 120.026 1.285 . . . . 0.0 110.231 169.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -56.23 -40.84 74.73 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -171.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.2 m -105.2 9.27 34.14 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.66 -0.92 58.14 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.144 -1.027 . . . . 0.0 114.258 163.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 19.5 mtm180 -91.91 -21.52 20.54 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 118.941 1.371 . . . . 0.0 114.367 -174.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.72 145.81 55.56 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 166.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 26.9 mm -72.79 116.77 53.47 Favored Pre-proline 0 C--O 1.238 0.49 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 171.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.42 123.26 9.37 Favored 'Trans proline' 0 N--CA 1.445 -1.324 0 N-CA-C 108.21 -1.496 . . . . 0.0 108.21 -178.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 63.3 t-20 -131.8 122.46 25.82 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 -171.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -48.99 -34.09 12.35 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.842 1.257 . . . . 0.0 113.522 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -57.27 -35.19 69.45 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 65.6 t -93.98 -41.97 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 126.968 2.107 . . . . 0.0 109.937 176.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 76.9 mt -56.81 -39.73 74.7 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 120.457 1.48 . . . . 0.0 110.753 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.02 -38.66 93.26 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-N 118.922 0.783 . . . . 0.0 112.573 175.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 24.0 mtmm -65.39 -47.54 75.97 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 117.627 0.714 . . . . 0.0 110.574 173.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 78.1 mt -60.64 -34.6 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 123.86 0.864 . . . . 0.0 110.331 -178.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -56.57 -50.31 72.31 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.654 -0.654 . . . . 0.0 110.396 175.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.4 mtt85 -59.42 -35.37 73.87 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 118.763 0.71 . . . . 0.0 110.72 176.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.72 -32.86 70.94 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.006 1.323 . . . . 0.0 112.929 -174.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 44.4 pt -115.57 -12.15 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 123.755 0.822 . . . . 0.0 112.172 177.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.79 40.0 98.0 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 126.516 2.008 . . . . 0.0 112.648 -174.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 41.0 mt -142.78 164.31 30.44 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.711 1.256 . . . . 0.0 109.33 173.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -68.72 142.99 54.85 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 126.442 1.897 . . . . 0.0 110.902 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -117.54 4.28 12.41 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.865 2.066 . . . . 0.0 111.226 177.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 37.1 mtt-85 -138.44 163.29 32.31 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.258 1.023 . . . . 0.0 110.804 176.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.76 166.56 16.94 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 125.581 1.562 . . . . 0.0 110.09 -170.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -73.63 -7.41 51.84 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.036 -1.273 . . . . 0.0 110.296 168.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -67.53 6.94 0.54 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.729 1.612 . . . . 0.0 112.286 164.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.7 tt -51.36 142.4 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 120.151 1.342 . . . . 0.0 110.983 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.14 3.6 53.02 Favored Glycine 0 CA--C 1.537 1.452 0 O-C-N 121.637 -0.664 . . . . 0.0 114.002 -178.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 20.3 mmtt -81.46 155.09 71.67 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 120.709 2.255 . . . . 0.0 105.959 159.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -70.92 158.25 55.93 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.803 2.335 . . . . 0.0 113.072 -171.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 28.5 pt . . . . . 0 C--N 1.332 -0.184 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 171.273 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.465 0.276 0 CA-C-O 118.979 -0.534 . . . . 0.0 111.934 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.0 t -53.89 -58.52 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 123.844 0.858 . . . . 0.0 108.728 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -51.47 -46.12 53.05 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-O 118.571 -1.127 . . . . 0.0 112.929 176.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 36.1 tttm -59.06 -53.04 62.83 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 118.874 1.337 . . . . 0.0 109.244 -178.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 92.6 t -62.67 -33.59 60.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 118.707 -0.663 . . . . 0.0 110.548 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 70.1 mt -66.16 -59.19 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 119.913 1.233 . . . . 0.0 108.634 176.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -51.59 -47.33 63.59 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 126.545 1.938 . . . . 0.0 110.209 -178.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -60.4 -66.34 0.54 Allowed 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.726 1.61 . . . . 0.0 109.994 174.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.16 -26.19 69.0 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-O 118.736 -1.036 . . . . 0.0 113.303 -169.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 19.2 mtm105 -58.13 -64.28 0.97 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.546 1.173 . . . . 0.0 109.045 165.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -69.41 -8.43 46.53 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.562 1.545 . . . . 0.0 113.571 -175.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.8 m -69.24 -13.77 62.59 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.877 1.271 . . . . 0.0 112.201 162.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -133.86 12.71 4.01 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.484 1.914 . . . . 0.0 111.475 172.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.41 4.43 17.58 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 125.292 1.425 . . . . 0.0 114.758 -175.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 25.3 mt -66.69 125.85 27.13 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 119.635 1.717 . . . . 0.0 109.431 -165.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 52.1 p -65.88 168.98 7.2 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.754 0.788 . . . . 0.0 110.248 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -64.42 -34.6 78.55 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.459 -0.776 . . . . 0.0 110.733 172.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.2 mtpt -61.33 -44.44 97.19 Favored 'General case' 0 CA--C 1.518 -0.271 0 O-C-N 121.737 -0.602 . . . . 0.0 110.976 171.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -66.23 -37.85 86.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 118.312 0.506 . . . . 0.0 110.419 -177.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.11 -51.95 67.81 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 171.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.76 -48.55 69.6 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.283 1.033 . . . . 0.0 110.151 -177.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.7 m -57.76 -46.1 84.99 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.282 1.033 . . . . 0.0 111.369 175.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.2 mttm -59.03 -22.28 60.43 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.41 1.004 . . . . 0.0 113.681 178.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 26.9 pt -113.41 6.05 7.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 119.534 1.061 . . . . 0.0 111.992 178.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 49.88 48.33 21.92 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.234 1.814 . . . . 0.0 111.156 -174.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.468 ' HG3' ' H ' ' A' ' 39' ' ' LYS . 3.1 tp10 -127.68 -171.06 2.35 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.618 1.967 . . . . 0.0 109.007 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.468 ' H ' ' HG3' ' A' ' 38' ' ' GLU . 11.0 mmpt? -103.87 146.18 32.04 Favored Pre-proline 0 CA--C 1.531 0.242 0 O-C-N 120.655 -1.278 . . . . 0.0 111.169 -174.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -73.19 -19.2 22.88 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.46 2.106 . . . . 0.0 114.161 -178.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -58.47 -52.31 66.18 Favored 'General case' 0 C--N 1.339 0.127 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 167.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.4 m -66.1 -29.04 45.49 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.532 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.808 -175.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 49.1 mm -61.62 -50.16 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 120.421 1.464 . . . . 0.0 110.251 174.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.24 -31.85 73.11 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 122.396 0.279 . . . . 0.0 111.589 178.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -77.08 -33.45 57.08 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 122.943 0.497 . . . . 0.0 110.405 177.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -57.69 -43.63 85.27 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 125.657 1.583 . . . . 0.0 110.016 170.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -60.06 -58.31 9.08 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.014 0.926 . . . . 0.0 109.451 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.46 -9.42 34.13 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 178.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.1 0.15 77.86 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-N 120.061 1.301 . . . . 0.0 113.457 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 72.4 mtt-85 -70.82 -43.9 67.63 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.896 1.279 . . . . 0.0 111.125 -176.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.19 139.25 58.75 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 173.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 50.3 mm -74.45 117.13 59.57 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 105.669 -1.975 . . . . 0.0 105.669 168.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -77.04 115.01 3.92 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 C-N-CA 121.223 1.282 . . . . 0.0 109.072 -171.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -81.38 131.18 35.27 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.892 1.677 . . . . 0.0 107.77 -174.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -54.8 -33.5 61.6 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.33 1.052 . . . . 0.0 113.137 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -60.97 -64.02 1.1 Allowed 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 122.1 0.952 . . . . 0.0 108.577 174.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.414 ' HA ' ' HD3' ' A' ' 60' ' ' LYS . 77.5 t -60.6 -41.11 86.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.816 1.247 . . . . 0.0 110.272 -174.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.2 mt -48.23 -46.22 35.11 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.047 0.939 . . . . 0.0 110.551 177.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.02 -33.56 62.41 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 118.6 0.637 . . . . 0.0 113.561 178.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.414 ' HD3' ' HA ' ' A' ' 57' ' ' VAL . 37.3 mtpt -64.46 -40.19 95.25 Favored 'General case' 0 N--CA 1.463 0.205 0 O-C-N 121.305 -1.115 . . . . 0.0 109.541 174.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.9 mt -63.64 -36.77 77.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 124.681 1.192 . . . . 0.0 108.746 174.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -57.19 -51.23 70.16 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 119.739 1.154 . . . . 0.0 110.241 174.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 60.6 mtt85 -63.18 -27.48 69.39 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.188 0.449 . . . . 0.0 111.545 175.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.1 -38.11 87.61 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.948 0.899 . . . . 0.0 112.187 179.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 22.9 pt -118.6 -9.04 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 119.134 0.879 . . . . 0.0 113.256 -176.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.44 36.36 93.28 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 126.555 2.026 . . . . 0.0 113.343 -176.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 84.7 mt -133.37 165.51 24.67 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.345 1.458 . . . . 0.0 108.156 169.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 53.3 mttm -76.25 141.88 41.57 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.615 1.566 . . . . 0.0 109.565 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -118.6 11.07 12.73 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 126.267 1.827 . . . . 0.0 110.968 178.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 5.8 mtt85 -140.22 167.9 21.06 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.254 1.422 . . . . 0.0 108.255 176.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 73.4 171.04 21.25 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.543 1.544 . . . . 0.0 111.158 -173.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.75 -13.08 60.06 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.359 -1.083 . . . . 0.0 110.163 165.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -75.01 18.5 0.18 Allowed 'General case' 0 CA--C 1.549 0.921 0 O-C-N 120.577 -1.327 . . . . 0.0 110.146 168.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.9 tt -53.85 148.04 2.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 O-C-N 120.301 -1.499 . . . . 0.0 110.62 173.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 67.62 -1.43 7.45 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 123.781 0.705 . . . . 0.0 113.504 -178.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 12.3 mmtp -73.69 155.12 89.28 Favored Pre-proline 0 N--CA 1.452 -0.367 0 CA-C-N 119.634 1.717 . . . . 0.0 106.968 160.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -57.22 156.64 24.32 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 122.792 2.328 . . . . 0.0 112.559 177.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 30.7 pt . . . . . 0 C--O 1.236 0.369 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 154.134 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 . . . . . 0 C--O 1.221 -0.4 0 CA-C-O 119.422 -0.323 . . . . 0.0 110.473 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.2 t -56.71 -58.26 6.27 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.316 0 C-N-CA 123.668 0.787 . . . . 0.0 109.67 177.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -56.57 -38.59 81.95 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 119.571 1.078 . . . . 0.0 112.363 178.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -62.05 -59.3 5.29 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.257 1.028 . . . . 0.0 110.096 175.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.4 t -61.35 -37.57 77.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 125.308 1.443 . . . . 0.0 110.347 -175.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 51.4 mt -53.47 -68.67 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 170.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -58.4 -34.05 70.32 Favored 'General case' 0 N--CA 1.445 -0.697 0 O-C-N 123.882 0.739 . . . . 0.0 110.8 -168.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -57.22 -69.69 0.15 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.093 1.757 . . . . 0.0 109.906 174.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.95 -32.1 73.14 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.776 -0.529 . . . . 0.0 111.776 -172.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -54.58 -62.01 1.93 Allowed 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 125.392 1.477 . . . . 0.0 108.798 172.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -63.19 -38.21 90.27 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 119.14 0.882 . . . . 0.0 111.449 -177.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 43.5 m -76.26 -2.31 30.79 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.377 0.99 . . . . 0.0 112.561 -177.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -115.55 12.86 16.25 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.256 1.022 . . . . 0.0 111.229 165.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.79 3.15 66.76 Favored Glycine 0 C--N 1.34 0.769 0 C-N-CA 128.03 2.729 . . . . 0.0 114.676 175.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 33.6 mt -72.95 130.16 39.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 118.781 1.29 . . . . 0.0 109.087 -159.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.0 p -68.51 170.75 8.52 Favored 'General case' 0 C--O 1.239 0.507 0 O-C-N 121.328 -0.858 . . . . 0.0 109.143 169.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -61.73 -30.1 70.55 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.64 -0.663 . . . . 0.0 110.408 168.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.4 mttt -71.24 -39.09 71.88 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.645 1.111 . . . . 0.0 112.3 175.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -64.65 -48.76 73.62 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.23 -47.63 78.08 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.789 0.836 . . . . 0.0 110.772 176.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.41 -50.39 73.86 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.536 0.734 . . . . 0.0 111.269 178.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.7 m -55.13 -47.72 74.67 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.068 1.347 . . . . 0.0 109.712 177.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 51.0 mttm -59.88 -15.45 21.47 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 125.453 1.501 . . . . 0.0 113.981 178.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.4 pt -122.35 15.43 5.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 118.998 0.817 . . . . 0.0 111.348 175.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.8 t30 57.53 13.14 1.75 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.166 1.386 . . . . 0.0 113.686 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -107.29 -170.87 1.77 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.762 2.025 . . . . 0.0 108.89 -173.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -102.51 149.65 36.9 Favored Pre-proline 0 N--CA 1.466 0.327 0 CA-C-N 120.024 1.284 . . . . 0.0 112.783 -175.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.71 -13.98 35.6 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 123.39 2.727 . . . . 0.0 112.919 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.9 tp60 -54.81 -60.15 3.76 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 123.588 0.755 . . . . 0.0 109.343 165.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.0 m -60.68 -41.09 86.93 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.52 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -172.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 44.0 mm -54.23 -47.28 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 119.252 0.933 . . . . 0.0 110.726 -178.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.8 -35.72 73.28 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.121 0.486 . . . . 0.0 112.134 176.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -79.18 -38.31 36.17 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.369 1.068 . . . . 0.0 110.992 -177.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -58.37 -39.7 80.28 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.216 1.407 . . . . 0.0 109.026 170.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -70.12 -33.09 71.41 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -178.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.2 t -73.85 -29.48 62.14 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.958 1.253 . . . . 0.0 109.41 167.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.55 10.84 49.48 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 124.002 0.81 . . . . 0.0 111.364 -174.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.7 mmt-85 -64.62 -60.93 2.55 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.258 1.023 . . . . 0.0 109.666 176.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.89 141.28 49.8 Favored 'General case' 0 C--O 1.239 0.543 0 O-C-N 124.787 1.304 . . . . 0.0 110.073 -172.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 mp -74.14 123.99 89.66 Favored Pre-proline 0 CA--C 1.533 0.31 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 -177.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -67.18 114.86 3.37 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 121.561 1.508 . . . . 0.0 110.215 -178.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 -103.94 116.86 33.02 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 125.039 1.336 . . . . 0.0 108.418 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -47.27 -39.24 14.05 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.23 1.412 . . . . 0.0 113.472 -175.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -63.08 -52.97 60.59 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 118.416 0.553 . . . . 0.0 110.356 -178.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.457 ' HA ' ' HD3' ' A' ' 60' ' ' LYS . 23.9 t -63.66 -43.24 98.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 124.391 1.076 . . . . 0.0 108.36 -178.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 81.6 mt -53.7 -48.88 69.13 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-O 118.528 -0.748 . . . . 0.0 110.257 176.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.5 -34.4 69.0 Favored Glycine 0 CA--C 1.534 1.266 0 CA-C-N 119.24 0.927 . . . . 0.0 113.309 177.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.457 ' HD3' ' HA ' ' A' ' 57' ' ' VAL . 17.9 mtpp -70.57 -44.86 66.5 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.493 -1.004 . . . . 0.0 109.5 175.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.8 mt -59.62 -35.4 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.114 0 C-N-CA 124.862 1.265 . . . . 0.0 109.792 178.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -54.28 -51.76 63.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 119.039 0.836 . . . . 0.0 110.245 177.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 58.1 mtt180 -71.81 -8.4 54.05 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.493 -0.755 . . . . 0.0 112.804 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.37 -38.46 63.18 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.436 0.694 . . . . 0.0 110.719 173.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 25.7 pt -120.25 -10.51 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -172.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.26 33.69 83.38 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 126.628 2.061 . . . . 0.0 113.027 -178.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 67.8 mt -128.8 164.82 22.2 Favored 'General case' 0 CA--C 1.527 0.076 0 CA-C-N 118.126 0.963 . . . . 0.0 109.635 170.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -78.84 140.68 38.13 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 126.055 1.742 . . . . 0.0 108.738 174.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -120.01 -2.18 10.29 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 127.897 2.479 . . . . 0.0 110.462 -177.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.435 HH11 ' HG2' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -141.02 169.67 17.17 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.673 1.189 . . . . 0.0 109.136 176.935 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.53 164.51 18.96 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -169.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.9 ttmt -78.06 3.21 15.49 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.884 -0.774 . . . . 0.0 111.061 175.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -96.69 23.11 7.3 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.827 2.051 . . . . 0.0 110.499 171.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.3 tt -52.96 151.94 1.04 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-N 120.238 1.381 . . . . 0.0 110.763 177.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.83 -6.03 14.71 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 119.058 -0.857 . . . . 0.0 113.36 178.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 40.1 mmtt -76.02 150.97 83.85 Favored Pre-proline 0 N--CA 1.45 -0.441 0 CA-C-N 119.83 1.815 . . . . 0.0 107.744 166.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -69.99 157.15 60.87 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 123.253 2.636 . . . . 0.0 111.64 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.0 pt . . . . . 0 N--CA 1.461 0.093 0 C-N-CA 123.959 0.904 . . . . 0.0 108.775 177.069 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 . . . . . 0 N--CA 1.471 0.616 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.2 t -56.91 -61.33 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 C-N-CA 123.473 0.709 . . . . 0.0 109.227 -178.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.37 -33.1 65.06 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-N 119.325 0.966 . . . . 0.0 113.562 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 59.2 tptt -65.31 -55.09 20.22 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 125.421 1.488 . . . . 0.0 109.768 176.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 76.8 t -63.3 -39.16 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 CA-C-N 118.586 0.63 . . . . 0.0 110.573 178.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 83.3 mt -58.6 -56.31 17.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -51.47 -53.48 36.78 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.15 0.98 . . . . 0.0 109.662 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -58.98 -54.92 41.75 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 123.21 0.319 . . . . 0.0 110.977 -178.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.28 -25.01 76.32 Favored Glycine 0 CA--C 1.523 0.556 0 O-C-N 120.701 -1.249 . . . . 0.0 113.033 -172.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 20.0 mtm105 -60.07 -60.6 3.57 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 119.2 1.5 . . . . 0.0 109.511 162.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -64.6 -29.67 70.68 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.96 0.904 . . . . 0.0 111.916 -169.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.2 m -57.3 -20.97 31.73 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.485 1.114 . . . . 0.0 111.831 171.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -120.12 9.89 11.26 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.446 1.899 . . . . 0.0 109.462 -176.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 73.34 -4.75 24.47 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 126.565 2.031 . . . . 0.0 114.739 -177.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 52.1 mt -70.61 152.95 43.36 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 118.815 1.307 . . . . 0.0 111.539 -159.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.43 HG22 ' H ' ' A' ' 31' ' ' ASP . 0.5 OUTLIER -93.53 167.75 11.49 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.72 1.208 . . . . 0.0 110.393 172.056 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 9.3 mp0 -50.48 -39.72 48.98 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.64 0.776 . . . . 0.0 111.852 163.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 43.4 mttt -62.25 -38.61 89.89 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 118.502 0.592 . . . . 0.0 110.884 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.43 ' H ' HG22 ' A' ' 28' ' ' THR . 81.4 m-20 -66.65 -40.8 88.84 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 122.753 0.421 . . . . 0.0 110.089 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.84 -53.9 49.48 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 125.258 1.423 . . . . 0.0 109.161 177.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -48.83 -57.22 6.74 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.652 1.581 . . . . 0.0 109.739 178.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 18.5 m -57.93 -39.12 77.24 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.237 1.015 . . . . 0.0 112.803 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.9 mttm -58.68 -39.67 81.38 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 119.457 1.026 . . . . 0.0 112.36 176.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.7 pt -103.3 10.61 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 123.624 0.77 . . . . 0.0 111.376 -173.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.8 t30 65.32 42.68 3.81 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.925 2.09 . . . . 0.0 113.674 176.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -135.64 -177.44 4.68 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.032 0.933 . . . . 0.0 113.149 -174.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -92.43 145.23 30.17 Favored Pre-proline 0 C--N 1.339 0.135 0 C-N-CA 125.314 1.445 . . . . 0.0 110.345 178.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.1 -6.07 18.39 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.73 2.287 . . . . 0.0 112.951 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.3 tp60 -61.35 -51.39 69.04 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 118.501 -0.761 . . . . 0.0 110.684 169.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.7 m -68.79 -29.97 45.41 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.305 0 CA-C-N 118.906 0.775 . . . . 0.0 109.468 -176.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.7 mm -64.84 -46.64 91.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 124.048 0.939 . . . . 0.0 109.942 177.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.33 -35.91 74.7 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.061 0.544 . . . . 0.0 111.112 175.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.94 -40.94 62.72 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 121.731 -0.606 . . . . 0.0 110.978 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.42 ' HH ' ' HG ' ' A' ' 58' ' ' LEU . 0.9 OUTLIER -53.91 -47.43 71.17 Favored 'General case' 0 C--N 1.334 -0.081 0 C-N-CA 125.066 1.346 . . . . 0.0 110.331 172.129 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -57.41 -42.69 82.81 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.572 0.749 . . . . 0.0 112.03 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.1 t -78.45 -25.41 45.91 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.825 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.72 44.89 2.58 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 -174.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 15.9 mmt85 -129.76 -21.65 3.05 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 125.171 1.388 . . . . 0.0 112.793 -171.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.28 133.48 49.78 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 169.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 41.0 mm -68.91 109.18 3.83 Favored Pre-proline 0 C--O 1.237 0.432 0 N-CA-C 104.779 -2.304 . . . . 0.0 104.779 169.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -84.19 114.2 1.85 Allowed 'Trans proline' 0 N--CA 1.445 -1.359 0 N-CA-C 108.568 -1.358 . . . . 0.0 108.568 -159.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -80.84 140.31 35.48 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -63.02 -29.26 70.68 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.077 0.853 . . . . 0.0 110.798 173.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -57.88 -60.85 3.07 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.522 1.129 . . . . 0.0 109.593 173.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.438 ' HA ' ' HE3' ' A' ' 60' ' ' LYS . 59.8 t -64.68 -46.19 93.04 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.259 0 CA-C-O 118.38 -0.819 . . . . 0.0 110.098 -177.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.42 ' HG ' ' HH ' ' A' ' 46' ' ' TYR . 25.1 mt -48.88 -48.43 42.17 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 123.894 0.878 . . . . 0.0 109.501 172.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.56 -44.15 85.82 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 125.721 1.629 . . . . 0.0 113.687 176.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.438 ' HE3' ' HA ' ' A' ' 57' ' ' VAL . 44.6 mtmt -65.66 -42.47 91.33 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 117.762 0.781 . . . . 0.0 110.753 175.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.1 mt -60.75 -33.32 54.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.743 0.817 . . . . 0.0 109.307 175.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -59.36 -46.38 88.81 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.775 1.17 . . . . 0.0 110.656 174.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 40.4 mtt-85 -58.13 -40.24 80.76 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 118.698 0.681 . . . . 0.0 110.367 173.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.0 -25.18 67.49 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.523 1.529 . . . . 0.0 114.627 -171.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 26.3 pt -125.41 -12.98 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-N 119.264 0.938 . . . . 0.0 112.086 176.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.9 29.89 64.34 Favored Glycine 0 C--N 1.336 0.577 0 C-N-CA 126.369 1.938 . . . . 0.0 113.165 -178.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.2 mt -130.05 163.32 26.78 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.397 1.479 . . . . 0.0 109.35 174.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -73.45 143.55 46.63 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 125.198 1.399 . . . . 0.0 108.946 175.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -119.03 8.81 11.67 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.105 1.362 . . . . 0.0 110.472 178.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 34.6 mtm105 -141.03 127.61 20.11 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 121.549 -0.72 . . . . 0.0 109.272 -166.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.01 179.22 48.83 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 125.168 1.366 . . . . 0.0 112.038 176.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -64.41 -13.17 49.67 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -93.51 22.81 5.03 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.094 0.861 . . . . 0.0 109.745 177.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.1 tt -55.2 149.24 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 O-C-N 120.95 -1.093 . . . . 0.0 110.368 178.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.57 -14.22 7.26 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-O 117.681 -1.622 . . . . 0.0 113.148 178.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 32.4 mmtt -68.19 144.36 96.74 Favored Pre-proline 0 N--CA 1.452 -0.373 0 CA-C-N 120.459 2.13 . . . . 0.0 107.882 173.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -69.27 150.75 71.57 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.613 2.875 . . . . 0.0 111.648 -177.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.4 pt . . . . . 0 C--O 1.235 0.298 0 C-N-CA 124.146 0.978 . . . . 0.0 109.663 -178.153 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 . . . . . 0 N--CA 1.465 0.283 0 CA-C-O 119.357 -0.354 . . . . 0.0 111.404 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.7 t -58.18 -62.06 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 124.24 1.016 . . . . 0.0 108.479 172.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.37 -40.13 60.52 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-N 119.394 0.997 . . . . 0.0 111.968 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -61.52 -58.14 9.33 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.098 0.949 . . . . 0.0 111.27 177.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.2 t -60.04 -36.98 70.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 123.955 0.902 . . . . 0.0 109.774 -178.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 75.4 mt -57.94 -62.27 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 174.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -56.14 -40.68 74.19 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 118.654 0.661 . . . . 0.0 111.411 -175.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -62.03 -43.93 97.79 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.511 1.524 . . . . 0.0 112.117 175.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -75.02 -33.29 55.21 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 124.742 1.163 . . . . 0.0 112.226 -176.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 15.4 mtm105 -65.71 -48.65 71.28 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 117.687 0.744 . . . . 0.0 110.216 169.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -55.5 -33.82 64.06 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.914 0.886 . . . . 0.0 112.485 175.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.1 t -64.08 -19.06 64.97 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.143 0.977 . . . . 0.0 111.701 -178.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.401 ' HE3' ' HA ' ' A' ' 65' ' ' ILE . 5.7 mtmm -130.57 7.22 4.85 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.785 1.234 . . . . 0.0 110.811 -175.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 48.58 47.31 29.79 Favored Glycine 0 C--N 1.337 0.614 0 C-N-CA 126.068 1.794 . . . . 0.0 113.127 -173.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.506 ' CD1' ' HE3' ' A' ' 35' ' ' LYS . 61.1 mt -101.81 119.52 38.91 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -177.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.479 HG22 ' H ' ' A' ' 31' ' ' ASP . 13.3 t -68.01 169.26 10.35 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.627 0.727 . . . . 0.0 109.462 176.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -64.38 -36.72 85.06 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.389 0.676 . . . . 0.0 109.842 178.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.4 mttt -57.4 -44.65 84.7 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.191 0.997 . . . . 0.0 113.434 167.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.479 ' H ' HG22 ' A' ' 28' ' ' THR . 2.3 m-20 -65.9 -43.53 87.93 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -176.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.87 -50.48 73.6 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.082 1.353 . . . . 0.0 111.387 176.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.23 -48.5 65.13 Favored 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 125.485 1.514 . . . . 0.0 109.981 177.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 20.5 m -61.42 -47.87 83.78 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.932 0.787 . . . . 0.0 111.508 175.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.506 ' HE3' ' CD1' ' A' ' 27' ' ' LEU . 50.5 mttm -55.56 -40.33 71.79 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 119.282 0.946 . . . . 0.0 111.98 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.3 pt -98.28 6.16 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 123.438 0.695 . . . . 0.0 112.256 -178.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 52.4 t30 44.46 63.94 1.5 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.488 2.315 . . . . 0.0 113.383 -173.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -138.93 -173.32 3.54 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.835 2.054 . . . . 0.0 110.114 174.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -82.55 148.16 57.78 Favored Pre-proline 0 N--CA 1.467 0.412 0 O-C-N 120.791 -1.193 . . . . 0.0 110.594 177.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -66.39 -28.02 46.9 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.608 2.205 . . . . 0.0 111.872 169.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -67.67 -43.54 79.98 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 118.56 -0.733 . . . . 0.0 109.97 -178.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.9 m -68.37 -31.64 52.23 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.373 0 CA-C-O 117.827 -1.082 . . . . 0.0 110.69 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 41.5 mm -57.92 -49.82 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 120.093 1.315 . . . . 0.0 109.367 170.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.09 -22.92 65.08 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 121.541 -0.724 . . . . 0.0 112.622 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.67 -26.53 27.71 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 118.177 -0.916 . . . . 0.0 112.015 172.072 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -62.22 -59.09 5.54 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.395 1.452 . . . . 0.0 108.585 173.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -52.66 -42.82 65.06 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 123.69 0.796 . . . . 0.0 112.859 176.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 27.3 m -66.68 -24.04 66.22 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 117.841 -1.076 . . . . 0.0 113.634 177.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.42 24.84 11.67 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 119.97 1.259 . . . . 0.0 113.732 -177.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -122.98 -30.85 3.72 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.015 1.407 . . . . 0.0 113.457 -170.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.7 132.94 49.19 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 170.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 39.4 mm -69.25 113.56 17.57 Favored Pre-proline 0 C--O 1.24 0.582 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 179.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.57 115.36 3.38 Favored 'Trans proline' 0 N--CA 1.445 -1.36 0 C-N-CA 122.648 2.232 . . . . 0.0 108.426 -175.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -95.77 147.8 23.25 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 174.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 59.6 t-20 -54.07 -45.02 71.62 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.913 1.285 . . . . 0.0 110.782 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -57.6 -52.01 67.17 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.513 0.725 . . . . 0.0 111.106 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.1 t -68.66 -40.48 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 O-C-N 121.748 -0.595 . . . . 0.0 110.635 -178.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 31.5 mt -51.49 -43.37 62.18 Favored 'General case' 0 C--O 1.22 -0.469 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 171.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.13 -39.59 97.35 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-N 119.169 0.895 . . . . 0.0 112.841 175.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -63.85 -44.48 93.03 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 119.185 1.492 . . . . 0.0 110.046 175.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.3 mt -64.34 -35.46 74.24 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.095 0 C-N-CA 124.984 1.314 . . . . 0.0 110.162 178.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -58.63 -51.0 71.76 Favored 'General case' 0 CA--C 1.512 -0.497 0 O-C-N 121.509 -0.744 . . . . 0.0 109.524 177.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -58.64 -40.1 82.44 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-O 118.789 -0.624 . . . . 0.0 110.804 176.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.18 -26.43 60.61 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.507 1.523 . . . . 0.0 113.895 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.401 ' HA ' ' HE3' ' A' ' 25' ' ' LYS . 16.9 pt -114.55 -15.02 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 119.74 1.155 . . . . 0.0 112.353 173.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.74 27.83 70.15 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 127.847 2.642 . . . . 0.0 113.597 -174.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.9 mt -136.56 158.58 44.11 Favored 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 124.842 1.257 . . . . 0.0 109.36 -179.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -66.65 139.99 57.89 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 125.598 1.559 . . . . 0.0 109.572 176.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -114.54 0.87 14.13 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.472 1.509 . . . . 0.0 109.972 171.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 53.2 mtm180 -135.42 142.39 45.61 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.863 1.265 . . . . 0.0 108.161 -169.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.62 163.03 12.34 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -173.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -73.41 -1.77 19.63 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.564 -0.962 . . . . 0.0 113.379 -175.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -77.44 16.07 0.68 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.883 0.765 . . . . 0.0 111.174 165.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.1 tt -50.3 135.54 9.3 Favored 'Isoleucine or valine' 0 C--O 1.242 0.706 0 CA-C-N 120.091 1.314 . . . . 0.0 110.699 -175.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.46 -3.85 71.29 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-O 119.541 -0.588 . . . . 0.0 113.537 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 20.0 mmtm -74.86 150.13 85.95 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 120.655 2.227 . . . . 0.0 107.202 163.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -66.14 157.96 57.04 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.951 2.434 . . . . 0.0 111.992 -174.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 17.8 pt . . . . . 0 N--CA 1.466 0.325 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 168.165 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 118.369 -0.824 . . . . 0.0 110.416 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 49.7 t -54.26 -56.73 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 120.054 1.297 . . . . 0.0 110.669 -173.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -54.71 -42.37 77.75 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-O 119.129 -0.817 . . . . 0.0 113.041 176.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.406 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 1.8 tpmt? -62.5 -48.5 79.3 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 118.599 1.199 . . . . 0.0 110.177 177.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 74.9 t -61.43 -43.09 96.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 124.536 1.134 . . . . 0.0 109.589 -179.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.5 mt -59.51 -52.98 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 C-N-CA 124.324 1.05 . . . . 0.0 108.624 177.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -54.79 -50.18 69.13 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.267 1.427 . . . . 0.0 110.262 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -58.74 -56.2 25.32 Favored 'General case' 0 C--O 1.227 -0.109 0 C-N-CA 124.915 1.286 . . . . 0.0 111.31 178.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.5 -23.18 76.07 Favored Glycine 0 CA--C 1.52 0.403 0 CA-C-O 118.678 -1.068 . . . . 0.0 112.395 -171.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.4 mtm105 -60.6 -64.36 0.98 Allowed 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 119.178 1.489 . . . . 0.0 108.805 164.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -56.71 -37.74 71.34 Favored 'General case' 0 CA--C 1.52 -0.196 0 O-C-N 124.199 0.937 . . . . 0.0 111.098 -171.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.3 t -65.96 -13.84 60.5 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.812 -0.555 . . . . 0.0 111.52 -175.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -126.91 8.37 6.78 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.143 2.177 . . . . 0.0 110.212 -173.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.83 5.13 50.69 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 125.506 1.527 . . . . 0.0 114.221 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 19.7 mt -71.36 120.39 16.87 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 119.258 1.529 . . . . 0.0 108.882 -168.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.404 ' HG1' ' CG ' ' A' ' 31' ' ' ASP . 69.4 p -66.01 174.35 2.54 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.661 -0.65 . . . . 0.0 109.778 170.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -66.81 -41.35 87.67 Favored 'General case' 0 C--O 1.231 0.127 0 O-C-N 120.217 -1.552 . . . . 0.0 109.849 174.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.1 tttp -64.67 -25.33 67.9 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.11 0.564 . . . . 0.0 111.589 177.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.404 ' CG ' ' HG1' ' A' ' 28' ' ' THR . 83.0 m-20 -72.07 -45.37 60.98 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.437 0.695 . . . . 0.0 109.97 172.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.16 -46.85 88.27 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.374 0.534 . . . . 0.0 109.807 176.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.34 -50.37 65.15 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 125.232 1.413 . . . . 0.0 109.788 175.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.2 m -56.21 -49.63 73.56 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.367 1.067 . . . . 0.0 110.55 175.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -59.94 -16.12 27.38 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 124.935 1.294 . . . . 0.0 114.432 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.8 pt -126.82 9.39 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 119.807 1.185 . . . . 0.0 110.997 177.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.1 m120 54.88 30.7 14.34 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.042 1.737 . . . . 0.0 112.282 179.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -102.45 178.89 4.46 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.487 1.515 . . . . 0.0 110.318 -176.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -77.35 137.3 64.21 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 173.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -67.93 -22.47 42.21 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.488 2.125 . . . . 0.0 111.971 176.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 48.5 tp60 -61.65 -43.18 99.35 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.547 -0.721 . . . . 0.0 110.923 173.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.0 m -73.87 -28.16 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 119.013 0.824 . . . . 0.0 110.737 -176.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.4 mm -56.67 -48.21 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 119.298 0.954 . . . . 0.0 109.691 169.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.5 -35.53 70.34 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 123.43 0.457 . . . . 0.0 111.179 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -83.21 -23.18 32.91 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.551 0.741 . . . . 0.0 112.605 -177.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -62.23 -35.89 80.29 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.901 0.773 . . . . 0.0 109.801 166.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -70.48 -36.67 73.98 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.302 0.956 . . . . 0.0 111.627 175.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.4 m -66.73 -32.29 73.49 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.36 0.527 . . . . 0.0 111.876 173.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.46 7.28 57.05 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 124.82 1.2 . . . . 0.0 112.518 -172.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -78.52 -57.09 3.95 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.76 1.624 . . . . 0.0 110.822 -173.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.29 146.86 42.41 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 124.012 0.82 . . . . 0.0 109.078 -175.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 25.6 mm -68.84 122.06 83.62 Favored Pre-proline 0 C--O 1.237 0.406 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 -178.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.91 113.3 3.73 Favored 'Trans proline' 0 N--CA 1.444 -1.409 0 N-CA-C 106.148 -2.289 . . . . 0.0 106.148 171.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -125.56 138.78 53.96 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 118.878 -0.582 . . . . 0.0 109.721 -171.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -52.25 -46.28 65.7 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.999 1.32 . . . . 0.0 112.99 -165.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -55.39 -50.89 68.55 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -178.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.467 ' HA ' ' HD3' ' A' ' 60' ' ' LYS . 94.3 t -74.38 -47.87 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 124.785 1.234 . . . . 0.0 109.891 -174.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 42.5 mt -45.33 -49.65 12.69 Favored 'General case' 0 C--O 1.225 -0.218 0 C-N-CA 125.126 1.37 . . . . 0.0 110.378 175.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.76 -44.49 80.52 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 123.646 0.641 . . . . 0.0 113.184 176.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.467 ' HD3' ' HA ' ' A' ' 57' ' ' VAL . 17.6 mtpp -68.69 -38.24 80.16 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 121.771 -0.841 . . . . 0.0 109.125 -178.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.5 mt -62.4 -39.72 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 C-N-CA 123.777 0.831 . . . . 0.0 109.471 174.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -59.36 -48.99 79.55 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 119.649 1.113 . . . . 0.0 109.299 176.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 26.4 mtm105 -64.15 -18.58 64.58 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.371 0.668 . . . . 0.0 112.408 176.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.25 -55.74 5.7 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.727 1.211 . . . . 0.0 109.941 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.1 pt -91.76 -24.18 5.56 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 123.111 0.565 . . . . 0.0 110.746 -176.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.38 32.6 34.13 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 125.284 1.421 . . . . 0.0 112.593 -174.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.0 mt -135.72 163.41 30.25 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.057 1.743 . . . . 0.0 109.161 175.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 71.8 mttt -74.93 144.47 43.24 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 125.314 1.445 . . . . 0.0 110.776 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -118.69 16.95 13.63 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 127.323 2.249 . . . . 0.0 109.494 174.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -135.95 163.91 29.19 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 126.678 1.991 . . . . 0.0 109.449 -178.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 66.62 177.11 8.03 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 124.971 1.272 . . . . 0.0 112.11 176.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.8 tptt -72.89 -10.17 59.51 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.447 -1.031 . . . . 0.0 111.149 168.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -78.92 11.96 2.41 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.767 1.627 . . . . 0.0 111.616 172.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.3 tt -53.66 140.02 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 119.736 1.153 . . . . 0.0 110.704 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.24 -10.79 40.46 Favored Glycine 0 CA--C 1.533 1.178 0 CA-C-O 117.743 -1.587 . . . . 0.0 114.078 -176.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 33.2 mmtt -66.53 151.76 95.82 Favored Pre-proline 0 C--N 1.345 0.373 0 CA-C-N 120.608 2.204 . . . . 0.0 107.768 166.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -58.04 158.93 19.76 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 123.76 2.973 . . . . 0.0 112.549 175.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 24.7 pt . . . . . 0 N--CA 1.466 0.332 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 165.841 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 56.1 mp0 . . . . . 0 CA--C 1.53 0.193 0 CA-C-O 118.288 -0.863 . . . . 0.0 112.192 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 55.8 t -59.12 -59.59 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 119.384 0.993 . . . . 0.0 110.138 179.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -55.52 -45.65 83.6 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-N 119.994 1.27 . . . . 0.0 113.267 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 49.7 tttp -56.75 -54.65 43.78 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 118.846 1.323 . . . . 0.0 109.462 175.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.2 t -61.94 -37.53 78.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 123.207 0.603 . . . . 0.0 110.586 -177.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 69.5 mt -61.16 -61.67 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 175.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -53.01 -45.56 67.99 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.209 1.404 . . . . 0.0 110.076 -175.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -59.9 -58.78 7.09 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.884 1.674 . . . . 0.0 111.749 175.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -52.48 -51.38 43.46 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.9 mtm105 -48.38 -61.86 1.79 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.179 0.992 . . . . 0.0 109.742 175.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -57.56 -33.39 68.09 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 124.344 1.057 . . . . 0.0 112.22 -177.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.89 -28.93 64.91 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.851 1.205 . . . . 0.0 111.703 -172.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -94.73 2.69 55.55 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.177 0.898 . . . . 0.0 111.832 167.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 61.51 43.7 98.96 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 110.816 -0.913 . . . . 0.0 110.816 -176.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 68.3 mt -109.97 159.58 17.15 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.163 1.385 . . . . 0.0 108.324 178.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.9 t -116.38 169.32 9.4 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.787 1.235 . . . . 0.0 110.046 -170.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -55.24 -44.25 75.34 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.527 1.131 . . . . 0.0 110.739 174.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.25 -39.67 72.95 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 118.347 -0.835 . . . . 0.0 111.769 173.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -75.76 -37.28 59.42 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 119.558 1.072 . . . . 0.0 111.158 -176.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.67 -49.05 79.23 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.78 1.232 . . . . 0.0 108.744 173.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.7 -49.33 73.29 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.15 1.38 . . . . 0.0 109.656 178.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.8 m -58.66 -44.87 90.27 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.812 0.733 . . . . 0.0 110.928 174.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.8 mttm -62.2 -27.29 68.87 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 117.295 -1.336 . . . . 0.0 113.263 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.0 pt -107.95 6.19 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 120.461 1.482 . . . . 0.0 112.578 176.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 56.5 t30 48.63 62.21 2.68 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.101 1.76 . . . . 0.0 112.738 -172.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -133.42 179.88 5.93 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 126.982 2.113 . . . . 0.0 109.242 176.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 25.0 mmtp -87.01 153.24 54.35 Favored Pre-proline 0 N--CA 1.47 0.551 0 C-N-CA 124.692 1.197 . . . . 0.0 109.796 169.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.68 -26.64 39.1 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.26 1.974 . . . . 0.0 111.391 176.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.0 tp60 -60.5 -29.81 69.31 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.01 0.924 . . . . 0.0 112.514 178.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.6 m -79.72 -35.35 16.38 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.37 0 CA-C-N 119.439 1.018 . . . . 0.0 109.81 174.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 29.8 mm -60.72 -44.74 97.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 120.273 1.397 . . . . 0.0 110.056 179.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.58 -30.36 65.2 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 176.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -89.09 -24.93 22.16 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.98 0.912 . . . . 0.0 111.854 178.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -62.9 -44.39 96.23 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 120.029 1.286 . . . . 0.0 108.917 166.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -59.92 -43.57 94.84 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.22 0.608 . . . . 0.0 110.582 172.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.2 m -66.3 -37.45 85.44 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.636 0.653 . . . . 0.0 111.815 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.74 29.37 8.21 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -169.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -111.11 -29.21 7.97 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.409 1.483 . . . . 0.0 111.477 -171.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.42 178.36 2.95 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.655 0.782 . . . . 0.0 110.082 170.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.4 mm -109.75 113.69 57.38 Favored Pre-proline 0 C--O 1.237 0.423 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -78.31 115.61 3.74 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 123.375 2.716 . . . . 0.0 109.298 -175.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -118.92 144.61 46.34 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.296 1.439 . . . . 0.0 108.958 -175.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.4 m-20 -48.33 -45.42 35.27 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.6 1.56 . . . . 0.0 111.942 -171.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -63.87 -52.15 61.32 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -173.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.414 ' HA ' ' HD3' ' A' ' 60' ' ' LYS . 8.9 t -64.1 -47.74 88.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-O 117.834 -1.079 . . . . 0.0 108.931 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 25.7 mt -46.6 -56.46 6.03 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 125.405 1.482 . . . . 0.0 109.625 174.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.13 -33.68 70.61 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 123.627 0.632 . . . . 0.0 113.559 178.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.414 ' HD3' ' HA ' ' A' ' 57' ' ' VAL . 23.8 mtpp -71.11 -46.67 61.23 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 118.746 1.273 . . . . 0.0 109.228 177.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.7 mt -61.82 -35.9 70.55 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.08 0 C-N-CA 124.542 1.137 . . . . 0.0 109.414 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -57.13 -50.52 72.55 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 176.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 61.0 mtt180 -58.48 -38.31 77.33 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 120.832 -1.168 . . . . 0.0 111.449 173.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.46 -25.91 60.42 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.229 1.012 . . . . 0.0 113.713 -176.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 45.5 pt -120.87 -10.73 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 124.323 1.049 . . . . 0.0 111.984 175.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.39 28.56 72.4 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 126.891 2.186 . . . . 0.0 113.337 -176.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 69.3 mt -138.27 163.18 32.42 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.419 1.488 . . . . 0.0 107.752 -178.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -86.41 143.13 27.96 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 126.778 2.031 . . . . 0.0 112.335 -170.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -118.98 6.53 11.35 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.756 1.622 . . . . 0.0 111.004 -176.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -141.8 156.92 45.55 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.789 1.236 . . . . 0.0 109.454 -177.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 73.98 172.39 26.3 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.505 1.05 . . . . 0.0 111.823 -174.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -65.4 -16.11 63.28 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.9 -0.765 . . . . 0.0 110.896 171.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.44 9.31 0.48 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.313 1.445 . . . . 0.0 111.913 173.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.5 tt -54.11 129.87 15.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 121.42 1.918 . . . . 0.0 110.009 -177.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.97 -15.44 59.39 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-O 118.743 -1.032 . . . . 0.0 114.404 -177.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.3 mtmt -68.24 152.4 96.55 Favored Pre-proline 0 N--CA 1.444 -0.748 0 CA-C-N 119.235 1.518 . . . . 0.0 107.765 170.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -71.91 157.96 53.78 Favored 'Trans proline' 0 N--CA 1.447 -1.228 0 C-N-CA 122.724 2.283 . . . . 0.0 111.082 -174.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.5 pt . . . . . 0 C--O 1.235 0.322 0 N-CA-C 105.512 -2.032 . . . . 0.0 105.512 165.012 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 . . . . . 0 C--O 1.227 -0.122 0 CA-C-O 118.371 -0.823 . . . . 0.0 112.797 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.9 t -55.8 -61.12 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 171.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.56 -34.23 49.25 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-O 118.379 -1.234 . . . . 0.0 113.369 177.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -73.07 -48.38 36.45 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 119.405 1.603 . . . . 0.0 110.89 178.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 79.1 t -59.77 -40.01 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 118.945 0.793 . . . . 0.0 109.006 176.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 53.1 mt -58.17 -59.17 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 174.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -54.15 -45.9 72.14 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.151 0.58 . . . . 0.0 110.467 -177.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -54.94 -63.74 1.06 Allowed 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.071 1.349 . . . . 0.0 110.55 174.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.48 -34.95 87.67 Favored Glycine 0 CA--C 1.519 0.308 0 CA-C-N 119.002 0.819 . . . . 0.0 112.714 -172.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.462 HH21 ' HG2' ' A' ' 47' ' ' GLU . 27.1 mtm105 -62.74 -56.25 19.31 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 117.881 0.841 . . . . 0.0 109.125 173.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -54.97 -40.9 70.53 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.094 1.358 . . . . 0.0 111.467 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.7 m -66.63 -41.2 88.71 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.985 0.811 . . . . 0.0 109.484 -176.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 37.8 mtpt -84.21 -1.12 54.58 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.027 0.931 . . . . 0.0 112.682 177.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.39 16.38 64.95 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.503 1.049 . . . . 0.0 113.216 -175.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 43.1 mt -79.25 154.89 28.84 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 119.105 1.452 . . . . 0.0 109.694 -176.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 82.8 p -92.99 170.21 9.83 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.847 0.859 . . . . 0.0 110.718 175.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -60.45 -38.57 84.58 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.326 -0.859 . . . . 0.0 110.407 165.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.06 -38.59 83.27 Favored 'General case' 0 C--O 1.231 0.129 0 O-C-N 121.67 -0.644 . . . . 0.0 111.252 175.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -67.09 -35.1 79.07 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 117.968 0.349 . . . . 0.0 110.469 176.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.24 -49.78 68.33 Favored 'General case' 0 CA--C 1.529 0.14 0 O-C-N 121.545 -0.722 . . . . 0.0 109.172 178.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.93 -44.9 64.09 Favored 'General case' 0 CA--C 1.522 -0.117 0 C-N-CA 124.701 1.2 . . . . 0.0 109.9 176.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 43.9 m -62.85 -52.22 63.96 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.619 1.167 . . . . 0.0 109.927 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -58.68 -20.78 51.44 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.203 1.401 . . . . 0.0 114.297 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.4 pt -115.15 2.66 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 123.809 0.844 . . . . 0.0 111.937 177.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.8 t30 50.97 55.6 9.3 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.275 1.83 . . . . 0.0 112.878 -175.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -128.11 -175.69 3.57 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 127.344 2.258 . . . . 0.0 109.725 175.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.75 146.55 37.25 Favored Pre-proline 0 N--CA 1.464 0.226 0 O-C-N 120.81 -1.181 . . . . 0.0 110.223 174.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -66.34 -16.86 52.93 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.57 2.18 . . . . 0.0 114.242 178.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -61.55 -43.21 99.27 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 119.413 1.006 . . . . 0.0 110.829 172.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.4 m -63.71 -32.6 57.53 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.412 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.132 -176.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 25.2 mm -63.28 -46.51 95.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 124.754 1.221 . . . . 0.0 109.648 177.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.21 -40.1 67.32 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.928 -0.483 . . . . 0.0 111.146 174.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -79.7 -28.45 40.65 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.392 0.677 . . . . 0.0 112.566 -178.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -62.91 -52.28 63.66 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.405 1.082 . . . . 0.0 108.918 171.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.462 ' HG2' HH21 ' A' ' 22' ' ' ARG . 0.7 OUTLIER -60.07 -42.71 95.15 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 175.563 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.6 t -66.97 -37.82 84.94 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 124.043 0.839 . . . . 0.0 110.713 -177.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.94 3.12 20.11 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 118.596 -1.113 . . . . 0.0 114.269 -175.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 49.4 mtm180 -102.86 -14.28 16.63 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.453 1.626 . . . . 0.0 113.764 -170.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.72 151.66 41.39 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 119.665 1.12 . . . . 0.0 108.458 174.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.2 mm -79.6 116.17 58.84 Favored Pre-proline 0 C--O 1.236 0.354 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 165.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -70.78 141.92 42.22 Favored 'Trans proline' 0 N--CA 1.448 -1.175 0 N-CA-C 108.897 -1.232 . . . . 0.0 108.897 175.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -136.34 150.33 48.8 Favored 'General case' 0 CA--C 1.513 -0.445 0 O-C-N 121.472 -0.767 . . . . 0.0 110.064 169.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -55.29 -41.65 72.59 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 125.106 1.362 . . . . 0.0 111.149 -175.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -52.98 -60.06 3.75 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.412 1.085 . . . . 0.0 110.051 175.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.475 ' HA ' ' HD3' ' A' ' 60' ' ' LYS . 41.1 t -64.87 -51.08 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-O 118.285 -0.864 . . . . 0.0 109.713 -176.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 71.9 mt -44.38 -50.69 9.07 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 124.922 1.289 . . . . 0.0 110.804 175.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.77 -36.07 92.19 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 118.691 0.678 . . . . 0.0 113.126 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.475 ' HD3' ' HA ' ' A' ' 57' ' ' VAL . 16.2 mtpp -68.67 -44.25 74.48 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 118.7 1.25 . . . . 0.0 108.96 175.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.5 mt -59.1 -35.73 58.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 123.493 0.717 . . . . 0.0 109.362 177.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -57.45 -44.45 84.76 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 119.642 1.11 . . . . 0.0 109.859 176.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -73.01 -13.89 61.31 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.541 1.136 . . . . 0.0 113.199 178.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.33 -41.61 63.29 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.294 1.038 . . . . 0.0 111.455 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 36.0 pt -116.56 -16.69 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.293 1.037 . . . . 0.0 111.552 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.44 30.22 46.08 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 125.793 1.663 . . . . 0.0 113.091 -178.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 74.5 mt -123.72 163.12 21.75 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 118.486 1.143 . . . . 0.0 109.427 173.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.0 mttm -72.09 131.91 43.48 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 127.411 2.284 . . . . 0.0 108.252 172.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -112.67 7.98 18.87 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 126.666 1.986 . . . . 0.0 110.206 176.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.47 161.69 39.89 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 126.832 2.053 . . . . 0.0 107.634 -175.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 70.17 160.49 3.03 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.165 0.888 . . . . 0.0 111.166 -168.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -63.73 -11.99 30.94 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 120.929 -1.336 . . . . 0.0 111.203 173.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.22 6.46 1.68 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.04 1.736 . . . . 0.0 111.35 173.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.9 tt -48.98 136.27 5.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-N 121.241 1.837 . . . . 0.0 110.909 -173.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.06 -11.62 66.67 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 124.001 0.81 . . . . 0.0 113.992 -177.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 49.7 mmtt -74.4 150.32 87.09 Favored Pre-proline 0 N--CA 1.452 -0.35 0 CA-C-N 119.271 1.536 . . . . 0.0 108.477 169.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -70.8 161.99 44.15 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.309 2.672 . . . . 0.0 111.733 -177.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.7 pt . . . . . 0 C--N 1.339 0.148 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 178.464 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 . . . . . 0 CA--C 1.531 0.221 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 52.5 t -58.37 -57.06 12.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -178.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.14 -35.39 77.1 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 118.885 0.766 . . . . 0.0 113.191 -178.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.2 tptt -68.59 -52.75 28.24 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 124.001 0.92 . . . . 0.0 110.011 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 67.0 t -61.61 -36.52 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 49.1 mt -57.98 -60.12 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-O 118.161 -0.923 . . . . 0.0 108.924 173.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -53.8 -50.99 64.89 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.976 0.807 . . . . 0.0 109.905 -177.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -56.45 -48.47 76.98 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 126.345 1.858 . . . . 0.0 112.283 -178.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.99 -36.73 45.79 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-O 118.668 -1.073 . . . . 0.0 111.175 -175.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 15.4 mtm105 -56.77 -55.85 29.07 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 118.571 1.185 . . . . 0.0 109.763 170.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -50.78 -49.45 58.27 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 126.284 1.833 . . . . 0.0 110.883 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.6 m -63.63 -5.75 4.43 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.562 0.745 . . . . 0.0 112.412 -174.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -130.93 4.53 4.49 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.698 1.999 . . . . 0.0 110.638 -175.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.81 15.67 60.37 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.134 1.349 . . . . 0.0 113.546 -175.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 42.1 mt -73.73 127.08 31.84 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 119.086 1.443 . . . . 0.0 109.042 -170.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.4 p -67.57 169.54 9.12 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.697 0.761 . . . . 0.0 109.79 168.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -61.68 -34.55 75.93 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 120.999 -1.063 . . . . 0.0 110.086 166.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.89 -34.53 71.67 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-O 117.485 -1.245 . . . . 0.0 111.696 176.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -57.66 -51.76 68.19 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 119.787 1.176 . . . . 0.0 108.013 176.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.88 -48.23 80.44 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.882 0.873 . . . . 0.0 110.019 -176.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.07 -49.71 65.83 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.157 1.383 . . . . 0.0 110.202 177.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.1 m -60.66 -44.78 96.04 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.156 0.982 . . . . 0.0 111.174 175.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.8 mttm -53.19 -28.68 27.78 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.453 1.101 . . . . 0.0 112.208 175.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.3 pt -112.66 7.71 8.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 124.202 1.001 . . . . 0.0 113.079 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.16 21.77 5.49 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 127.027 2.131 . . . . 0.0 113.311 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.78 173.23 6.66 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.547 1.139 . . . . 0.0 109.853 -173.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -71.43 139.56 84.22 Favored Pre-proline 0 CA--C 1.53 0.204 0 C-N-CA 124.182 0.993 . . . . 0.0 110.93 -173.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -74.78 -10.73 21.73 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.451 2.767 . . . . 0.0 112.373 177.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.2 tp60 -58.84 -57.64 12.16 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 163.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.0 m -67.14 -24.32 31.9 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 CA-C-O 119.077 -0.487 . . . . 0.0 111.102 -169.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 43.6 mm -63.22 -47.68 91.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 124.489 1.116 . . . . 0.0 111.475 171.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.06 -36.62 84.92 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 122.562 0.345 . . . . 0.0 110.574 176.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.45 -31.69 65.66 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.201 0.6 . . . . 0.0 111.363 177.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -58.82 -38.32 78.38 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 125.341 1.456 . . . . 0.0 111.82 170.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -60.81 -58.83 6.8 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.019 0.528 . . . . 0.0 110.361 178.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.3 p -66.63 -27.11 67.43 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -176.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.21 8.11 56.75 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-O 119.856 -0.414 . . . . 0.0 112.281 -170.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 21.0 mtm180 -69.17 -38.12 78.54 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 118.288 1.044 . . . . 0.0 110.369 172.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.67 138.29 48.5 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.8 mm -76.62 126.25 86.28 Favored Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 168.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -68.76 158.83 56.23 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 121.645 1.563 . . . . 0.0 109.851 177.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 -136.51 137.26 40.12 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 171.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -54.51 -34.42 61.66 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.446 1.099 . . . . 0.0 110.925 -179.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -61.95 -58.26 8.58 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.566 0.746 . . . . 0.0 109.773 178.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 83.9 t -66.97 -46.15 85.51 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.453 0 CA-C-O 117.402 -1.285 . . . . 0.0 109.151 -176.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 62.3 mt -44.72 -56.17 4.67 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 120.794 1.634 . . . . 0.0 110.895 169.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.18 -14.19 52.36 Favored Glycine 0 CA--C 1.536 1.39 0 CA-C-N 118.566 0.621 . . . . 0.0 114.007 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 22.7 mtpp -89.39 -46.74 8.5 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 125.557 1.543 . . . . 0.0 110.444 171.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.0 mt -53.47 -37.5 30.26 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.191 0 C-N-CA 124.532 1.133 . . . . 0.0 108.698 175.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -55.95 -54.47 44.38 Favored 'General case' 0 C--O 1.223 -0.327 0 C-N-CA 119.65 -0.82 . . . . 0.0 111.343 175.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 23.6 mtm180 -69.35 -7.58 38.63 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.977 0.808 . . . . 0.0 112.738 176.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.35 -27.1 35.06 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.264 1.025 . . . . 0.0 111.686 176.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.1 pt -127.71 -11.55 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.026 0.93 . . . . 0.0 112.934 -178.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 66.06 39.09 94.59 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 126.02 1.771 . . . . 0.0 112.132 -174.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 61.9 mt -132.02 162.81 29.85 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 124.336 1.054 . . . . 0.0 109.311 170.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -74.26 140.12 44.77 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 126.013 1.725 . . . . 0.0 108.538 174.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -117.46 11.17 13.79 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.937 1.295 . . . . 0.0 109.839 178.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 27.2 mtm105 -140.14 161.57 37.32 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.716 1.206 . . . . 0.0 109.418 178.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.12 169.47 24.98 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 124.327 0.965 . . . . 0.0 110.874 -175.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.559 ' H ' ' HD3' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -68.42 -17.64 64.26 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 121.772 -0.84 . . . . 0.0 111.38 170.772 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -77.95 15.03 0.95 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.375 1.47 . . . . 0.0 110.792 173.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.3 tt -52.55 142.35 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 O-C-N 120.888 -1.132 . . . . 0.0 110.084 175.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.56 0.03 57.23 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-O 117.577 -1.68 . . . . 0.0 113.948 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 33.7 mmtt -77.33 154.53 81.99 Favored Pre-proline 0 N--CA 1.453 -0.321 0 CA-C-N 119.893 1.846 . . . . 0.0 107.46 157.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -70.32 163.68 37.83 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 123.266 2.644 . . . . 0.0 112.852 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.0 pt . . . . . 0 N--CA 1.464 0.258 0 C-N-CA 126.192 1.797 . . . . 0.0 108.507 172.59 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.55 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 t -61.17 138.8 58.21 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.181 0.992 . . . . 0.0 109.42 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.3 p -152.27 174.58 13.61 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 167.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 135.0 -149.32 19.87 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 108.511 -1.836 . . . . 0.0 108.511 -175.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.3 m 76.6 72.68 0.07 Allowed 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.636 1.974 . . . . 0.0 108.655 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.9 p -122.38 118.74 29.14 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 127.24 2.216 . . . . 0.0 108.188 176.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -164.71 79.6 0.13 Allowed Glycine 0 C--N 1.331 0.286 0 N-CA-C 108.008 -2.037 . . . . 0.0 108.008 -177.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 50.28 93.12 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 127.81 2.444 . . . . 0.0 113.422 175.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.62 176.65 8.87 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 125.647 1.579 . . . . 0.0 108.572 168.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.7 t -77.86 160.85 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 175.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 65.1 p -133.46 121.6 22.46 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 105.231 -2.137 . . . . 0.0 105.231 173.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.7 mp -59.25 162.46 4.56 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 118.473 0.578 . . . . 0.0 109.574 174.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -61.14 -33.18 72.98 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-O 119.149 -0.453 . . . . 0.0 111.322 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.8 t -57.51 -54.73 27.26 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.253 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 171.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.4 -44.18 93.65 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-N 118.388 0.54 . . . . 0.0 112.372 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -59.68 -56.93 15.76 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 117.631 -1.176 . . . . 0.0 109.636 175.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 69.3 t -58.84 -36.07 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 120.357 1.435 . . . . 0.0 110.375 -178.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.6 mt -57.3 -59.24 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 174.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -57.11 -48.31 78.94 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.753 1.221 . . . . 0.0 110.784 -178.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -62.87 -46.38 88.13 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 125.123 1.369 . . . . 0.0 111.636 -176.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.39 -35.73 63.28 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-O 118.816 -0.991 . . . . 0.0 111.493 178.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 13.1 mtm105 -54.82 -61.61 2.2 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 118.049 0.924 . . . . 0.0 109.211 170.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -62.39 -30.82 71.47 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.131 0.972 . . . . 0.0 111.663 -172.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.8 m -63.88 -16.87 62.43 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 118.92 -0.562 . . . . 0.0 112.422 175.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -124.22 11.42 8.78 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.891 2.076 . . . . 0.0 110.314 -176.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.33 13.97 31.66 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.514 1.054 . . . . 0.0 114.678 -176.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 44.4 mt -78.36 119.95 22.42 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 119.945 1.873 . . . . 0.0 108.845 -170.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 62.1 p -64.67 168.9 5.5 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.557 0.694 . . . . 0.0 110.362 172.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -62.91 -34.51 77.58 Favored 'General case' 0 N--CA 1.464 0.258 0 O-C-N 120.424 -1.422 . . . . 0.0 110.428 174.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.93 -33.02 63.79 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.186 0.594 . . . . 0.0 109.73 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -63.65 -39.44 94.35 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.641 1.11 . . . . 0.0 109.557 171.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.89 -52.81 54.51 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 123.917 0.887 . . . . 0.0 110.312 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.93 -43.24 63.35 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 124.679 1.192 . . . . 0.0 110.403 177.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 60.7 m -60.11 -52.39 65.57 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.998 0.919 . . . . 0.0 110.379 174.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.3 mttm -57.23 -25.28 58.84 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 119.24 0.927 . . . . 0.0 113.196 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.3 pt -113.81 5.16 7.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 118.972 0.806 . . . . 0.0 112.227 -176.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.9 m120 54.5 54.94 8.62 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.524 1.529 . . . . 0.0 109.537 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -128.59 -178.6 4.65 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 126.922 2.089 . . . . 0.0 109.168 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 51.7 mmtt -81.02 149.73 67.22 Favored Pre-proline 0 C--N 1.333 -0.148 0 C-N-CA 123.853 0.861 . . . . 0.0 109.546 167.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.48 -11.5 26.46 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.668 2.245 . . . . 0.0 112.115 167.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -59.49 -57.94 10.77 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.952 1.301 . . . . 0.0 109.448 169.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.9 m -63.92 -33.27 61.02 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.556 0 CA-C-O 118.128 -0.939 . . . . 0.0 110.689 -173.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 42.8 mm -60.5 -46.51 95.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 120.166 1.348 . . . . 0.0 110.044 176.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.08 -28.91 69.95 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.169 0.587 . . . . 0.0 112.356 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -85.23 -38.46 18.9 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.846 0.858 . . . . 0.0 110.61 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -54.98 -40.98 70.64 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 126.328 1.851 . . . . 0.0 110.537 173.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -58.68 -42.94 89.66 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.82 0.848 . . . . 0.0 112.084 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 9.0 m -75.41 -35.32 61.02 Favored 'General case' 0 C--N 1.331 -0.207 0 O-C-N 122.097 -0.377 . . . . 0.0 110.222 175.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.85 46.34 3.17 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 -168.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 21.2 mtm-85 -128.42 -0.35 5.63 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 125.272 1.429 . . . . 0.0 113.309 -177.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -89.48 175.76 7.17 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 161.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 48.8 mm -93.8 112.66 57.87 Favored Pre-proline 0 C--O 1.239 0.541 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 171.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -77.49 115.51 3.91 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 123.138 2.558 . . . . 0.0 108.064 -177.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -113.84 142.5 46.01 Favored 'General case' 0 CA--C 1.517 -0.317 0 O-C-N 121.695 -0.628 . . . . 0.0 109.674 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -58.24 -26.23 62.64 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.791 0.836 . . . . 0.0 113.146 -171.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -62.91 -57.61 10.21 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.98 0.912 . . . . 0.0 110.528 173.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.2 t -68.68 -43.75 82.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 118.409 -0.805 . . . . 0.0 109.573 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 54.5 mt -49.48 -46.84 48.65 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.08 0.855 . . . . 0.0 110.337 171.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.99 -43.2 95.12 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 123.998 0.809 . . . . 0.0 112.722 176.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -61.8 -45.65 92.92 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 118.373 1.087 . . . . 0.0 110.796 174.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.0 mt -61.47 -33.69 58.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 C-N-CA 123.939 0.896 . . . . 0.0 110.324 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -56.8 -51.3 69.49 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 119.538 1.063 . . . . 0.0 110.419 176.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 52.5 mtt180 -54.12 -42.03 69.02 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.27 0.628 . . . . 0.0 109.874 177.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.04 -42.22 68.94 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.72 1.608 . . . . 0.0 113.09 -173.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 45.7 pt -114.74 -16.94 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 123.593 0.757 . . . . 0.0 112.167 -174.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.57 25.18 54.61 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 125.09 1.328 . . . . 0.0 113.052 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 61.6 mt -130.59 162.95 28.18 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.081 1.352 . . . . 0.0 109.434 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 47.6 mttm -77.16 146.3 37.17 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 127.16 2.184 . . . . 0.0 110.312 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -121.32 5.03 10.24 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.512 1.525 . . . . 0.0 112.223 -175.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 66.3 mtm180 -139.59 163.5 32.39 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.681 1.592 . . . . 0.0 109.909 171.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.38 167.76 43.78 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 125.831 1.681 . . . . 0.0 109.538 -171.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -71.36 -9.76 58.67 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.455 -1.027 . . . . 0.0 110.137 163.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -75.09 8.17 2.78 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.547 1.939 . . . . 0.0 110.791 170.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.4 tt -52.54 141.46 6.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 O-C-N 120.275 -1.516 . . . . 0.0 110.279 175.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.3 -4.61 54.58 Favored Glycine 0 CA--C 1.537 1.428 0 CA-C-O 119.04 -0.867 . . . . 0.0 113.838 -177.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.5 mmtt -66.29 146.79 99.05 Favored Pre-proline 0 N--CA 1.454 -0.267 0 CA-C-N 119.877 1.839 . . . . 0.0 107.934 159.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -70.43 162.11 43.59 Favored 'Trans proline' 0 N--CA 1.447 -1.262 0 C-N-CA 123.441 2.76 . . . . 0.0 111.222 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.1 pt -101.19 109.82 26.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 172.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 70.48 -72.15 0.12 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.638 2.375 . . . . 0.0 111.994 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -129.07 142.79 50.78 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 126.378 1.871 . . . . 0.0 107.886 175.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 167.64 166.28 26.46 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 126.789 2.138 . . . . 0.0 108.486 174.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -71.5 166.13 30.34 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.886 2.39 . . . . 0.0 111.283 -178.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 19.8 ptt180 -65.73 163.19 17.07 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.093 0.473 . . . . 0.0 111.33 173.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -141.63 161.32 38.21 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 125.785 1.634 . . . . 0.0 108.993 163.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 16.7 tttt -78.33 176.49 9.27 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.218 1.407 . . . . 0.0 108.065 174.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 36.4 p -136.73 -172.28 3.13 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.656 1.182 . . . . 0.0 109.151 173.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 174.92 170.24 37.75 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.736 1.16 . . . . 0.0 110.477 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -77.04 -175.62 2.75 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.953 2.435 . . . . 0.0 110.467 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.4 p -123.91 -165.14 1.31 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 125.685 1.594 . . . . 0.0 106.995 168.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.9 t -152.09 -173.51 4.56 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 157.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.748 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 178.443 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.575 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.2 m -135.67 -52.34 0.75 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.37 1.068 . . . . 0.0 110.458 -176.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.3 m -152.29 129.34 11.09 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 123.943 0.897 . . . . 0.0 108.738 -175.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -65.68 84.38 0.09 OUTLIER Glycine 0 CA--C 1.526 0.76 0 C-N-CA 124.99 1.281 . . . . 0.0 111.582 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 76.87 -12.77 1.01 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 128.923 2.889 . . . . 0.0 113.992 171.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 78.1 p -90.78 166.25 13.21 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 120.495 1.498 . . . . 0.0 110.442 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 165.74 68.28 0.03 OUTLIER Glycine 0 C--N 1.333 0.414 0 O-C-N 121.569 -0.707 . . . . 0.0 112.17 173.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -152.67 108.37 3.32 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 117.909 0.855 . . . . 0.0 108.752 178.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.57 174.97 4.85 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.531 1.933 . . . . 0.0 109.346 169.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.7 p -73.56 171.28 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 CA-C-N 118.667 0.667 . . . . 0.0 109.505 170.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.4 p -102.7 162.89 12.56 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.015 1.326 . . . . 0.0 111.017 174.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.9 mp -69.38 155.64 40.11 Favored 'General case' 0 N--CA 1.456 -0.125 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 169.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -61.6 -40.2 93.95 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 123.61 0.764 . . . . 0.0 111.018 -172.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.5 t -55.68 -58.38 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 123.575 0.75 . . . . 0.0 109.389 173.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.31 -40.02 95.42 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 118.891 0.769 . . . . 0.0 112.666 -178.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.36 -54.44 45.66 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.563 1.145 . . . . 0.0 110.242 176.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.4 t -63.25 -38.24 81.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 C-N-CA 123.618 0.767 . . . . 0.0 110.268 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 52.0 mt -56.81 -56.71 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.065 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 175.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -52.61 -55.28 23.44 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.194 0.598 . . . . 0.0 110.115 -178.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.23 -41.94 98.87 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.138 0.575 . . . . 0.0 111.468 -174.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.34 -41.61 45.05 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-O 119.204 -0.775 . . . . 0.0 111.396 -176.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.1 mtm105 -52.5 -60.11 3.64 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 117.669 0.734 . . . . 0.0 109.514 171.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.72 -31.33 72.47 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 123.702 0.626 . . . . 0.0 110.953 -171.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.8 t -64.2 -25.03 67.89 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.029 0.532 . . . . 0.0 111.77 176.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -112.98 13.08 19.44 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.913 1.285 . . . . 0.0 111.226 178.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.31 13.4 43.16 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.221 0.915 . . . . 0.0 113.446 -178.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 54.4 mt -74.04 118.89 17.52 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -171.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 27.0 p -65.72 174.3 2.4 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.626 0.726 . . . . 0.0 109.564 171.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -68.6 -37.16 79.58 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 120.747 -1.22 . . . . 0.0 110.137 174.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -64.86 -35.3 80.67 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 119.246 0.93 . . . . 0.0 111.612 172.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.63 -51.54 69.35 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 118.973 0.806 . . . . 0.0 109.048 176.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.81 -50.76 72.15 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 124.332 1.053 . . . . 0.0 109.888 -177.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -49.64 -52.36 31.28 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.092 1.357 . . . . 0.0 110.2 175.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.0 m -58.25 -44.54 88.38 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.857 0.863 . . . . 0.0 112.439 175.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.3 mttp -59.71 -16.29 26.02 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.445 1.02 . . . . 0.0 112.764 176.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.9 pt -117.69 8.97 7.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 124.808 1.243 . . . . 0.0 111.886 173.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.6 t30 55.12 6.78 0.15 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 128.494 2.718 . . . . 0.0 115.609 -174.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -102.64 -171.0 1.88 Allowed 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 124.537 1.135 . . . . 0.0 109.216 -171.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -95.87 141.36 23.05 Favored Pre-proline 0 N--CA 1.464 0.263 0 O-C-N 120.743 -1.223 . . . . 0.0 113.359 -168.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.09 -20.82 43.59 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.175 2.583 . . . . 0.0 112.585 -177.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.4 tp60 -56.82 -44.0 81.59 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 117.74 -1.124 . . . . 0.0 110.696 167.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . 0.273 12.1 m -67.15 -36.1 75.99 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.345 0 CA-C-N 120.116 1.325 . . . . 0.0 109.917 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 42.1 mm -59.3 -49.01 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 119.827 1.194 . . . . 0.0 109.931 177.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.34 -36.59 71.36 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.24 -41.61 48.63 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.738 1.615 . . . . 0.0 111.827 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -57.94 -45.96 85.81 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.103 1.361 . . . . 0.0 108.81 175.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -55.17 -38.22 68.02 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.479 0.711 . . . . 0.0 111.392 175.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.52 2.24 56.49 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -179.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.15 13.21 77.65 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-N 120.27 1.396 . . . . 0.0 113.026 174.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -87.98 -57.52 2.9 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.671 1.588 . . . . 0.0 108.082 -169.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.52 142.62 48.42 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.76 0.824 . . . . 0.0 110.136 -177.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.8 mt -69.47 119.51 71.14 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 168.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.54 135.41 24.11 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.257 1.971 . . . . 0.0 109.149 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -133.8 132.78 40.88 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.008 0.923 . . . . 0.0 109.136 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -40.39 -46.18 2.33 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.647 1.979 . . . . 0.0 112.358 176.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -51.01 -48.88 61.32 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.377 0.671 . . . . 0.0 111.22 -178.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.455 ' HA ' ' HD3' ' A' ' 60' ' ' LYS . 58.2 t -79.73 -48.05 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 125.819 1.648 . . . . 0.0 108.636 -178.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 88.6 mt -50.46 -40.01 49.59 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.497 1.044 . . . . 0.0 111.742 177.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.17 -28.75 72.49 Favored Glycine 0 CA--C 1.526 0.768 0 O-C-N 121.036 -1.04 . . . . 0.0 112.47 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.455 ' HD3' ' HA ' ' A' ' 57' ' ' VAL . 18.9 mtpp -73.51 -47.51 40.53 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 124.619 1.168 . . . . 0.0 108.213 173.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.9 mt -58.1 -39.34 72.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 123.704 0.801 . . . . 0.0 110.32 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -60.32 -42.66 96.04 Favored 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 118.869 -1.132 . . . . 0.0 110.644 -178.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -66.78 -37.04 83.8 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 118.84 0.746 . . . . 0.0 111.447 174.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.66 -36.25 64.4 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.941 1.696 . . . . 0.0 111.946 -177.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 24.5 pt -113.25 -19.1 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 118.999 0.818 . . . . 0.0 112.029 176.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.74 30.08 60.29 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 125.506 1.526 . . . . 0.0 113.061 -176.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.9 mt -132.56 161.45 33.79 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 124.839 1.256 . . . . 0.0 108.3 173.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -71.32 141.12 50.47 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 125.499 1.52 . . . . 0.0 109.408 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -115.88 -1.34 12.6 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.721 1.608 . . . . 0.0 109.506 175.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.4 mtm105 -132.76 142.05 48.82 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.537 1.535 . . . . 0.0 108.491 -177.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.59 167.49 36.62 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 125.135 1.35 . . . . 0.0 111.104 -178.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -70.59 -12.14 61.38 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 121.687 -0.89 . . . . 0.0 111.396 172.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -82.04 16.91 1.73 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.106 2.162 . . . . 0.0 111.267 171.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.2 tt -52.06 141.88 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 O-C-N 120.613 -1.305 . . . . 0.0 110.161 176.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.97 -10.06 10.23 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-O 118.762 -1.021 . . . . 0.0 114.065 -177.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.3 mmtt -70.78 151.06 95.29 Favored Pre-proline 0 N--CA 1.453 -0.294 0 CA-C-N 120.843 2.321 . . . . 0.0 106.016 161.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -67.96 157.02 63.66 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.863 2.376 . . . . 0.0 111.246 -174.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 25.9 pt -101.02 160.1 3.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 161.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 44.36 80.17 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.616 1.566 . . . . 0.0 112.197 167.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -62.93 84.56 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.585 1.154 . . . . 0.0 112.132 -175.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.68 -151.35 16.22 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 125.292 1.425 . . . . 0.0 110.216 166.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.53 125.23 14.04 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.771 2.981 . . . . 0.0 111.745 -168.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 57.3 mtp180 37.59 53.37 1.41 Allowed 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.357 1.863 . . . . 0.0 111.692 -173.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.7 67.25 0.78 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.345 1.058 . . . . 0.0 109.655 172.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -68.95 166.34 18.11 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 127.567 2.347 . . . . 0.0 111.21 -176.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.5 t -146.9 -63.72 0.29 Allowed 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 121.303 -0.873 . . . . 0.0 109.105 167.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 129.76 94.7 0.73 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 106.647 -2.581 . . . . 0.0 106.647 -168.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -81.02 -7.68 13.16 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 122.526 2.15 . . . . 0.0 114.034 -165.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.6 t -86.31 -50.43 6.94 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 172.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.3 m 52.48 -179.08 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.02 1.328 . . . . 0.0 110.984 -157.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.629 0 N-CA-C 106.427 -2.669 . . . . 0.0 106.427 -159.572 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.802 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -105.6 82.46 1.81 Allowed 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 105.534 -2.025 . . . . 0.0 105.534 154.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.1 m -121.52 96.22 4.99 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -167.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 62.89 79.76 0.14 Allowed Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.788 1.185 . . . . 0.0 113.233 175.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.1 t -77.25 128.41 34.3 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.867 1.267 . . . . 0.0 108.997 173.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.7 m 47.55 48.15 17.06 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.118 1.367 . . . . 0.0 112.875 171.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.83 29.21 0.63 Allowed Glycine 0 CA--C 1.529 0.91 0 C-N-CA 126.397 1.951 . . . . 0.0 113.966 178.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -157.18 157.84 35.15 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 126.083 1.753 . . . . 0.0 108.113 -177.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -96.23 8.11 44.71 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.83 0.852 . . . . 0.0 113.062 -170.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 p -139.86 78.67 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 120.662 1.574 . . . . 0.0 108.595 -176.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -61.51 133.77 56.09 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.959 176.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -58.63 153.49 16.32 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 171.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -57.93 -42.13 84.21 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 119.091 -0.48 . . . . 0.0 110.737 -175.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 63.4 t -58.62 -66.38 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 125.028 1.331 . . . . 0.0 109.695 174.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.59 -29.41 40.07 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 119.182 0.901 . . . . 0.0 113.498 -177.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.7 tttt -72.58 -55.51 6.79 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 117.654 -1.165 . . . . 0.0 110.701 175.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.3 t -58.84 -39.26 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 120.101 1.319 . . . . 0.0 110.28 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 86.4 mt -54.96 -61.21 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 175.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -63.35 -39.9 95.81 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 -172.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -58.25 -46.82 85.26 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.688 1.595 . . . . 0.0 111.381 176.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.94 -43.74 81.46 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -178.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.9 mtm105 -54.89 -59.55 4.57 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 117.341 0.57 . . . . 0.0 110.54 173.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -58.89 -33.05 70.07 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.636 0.775 . . . . 0.0 110.885 -176.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.0 t -68.31 -8.45 39.82 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 118.23 -0.891 . . . . 0.0 113.395 177.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -132.37 7.88 4.25 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 120.363 1.438 . . . . 0.0 111.505 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 57.19 32.15 63.01 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-N 118.793 0.724 . . . . 0.0 112.174 -173.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 44.8 mt -85.38 119.78 26.13 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.7 t -73.88 171.71 12.9 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.143 0.883 . . . . 0.0 109.964 176.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -61.68 -37.64 84.87 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 120.364 -1.46 . . . . 0.0 110.841 176.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.4 mttp -59.28 -32.6 70.18 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.078 0.854 . . . . 0.0 112.684 170.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -70.32 -39.25 74.87 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 119.422 1.01 . . . . 0.0 108.604 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.68 -48.02 76.28 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -50.89 -51.2 54.15 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 126.221 1.808 . . . . 0.0 109.455 177.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 60.1 m -61.49 -47.29 86.3 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.985 1.314 . . . . 0.0 111.037 177.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.6 mttm -64.21 -20.49 66.06 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 26.6 pt -111.34 -2.33 10.25 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.356 0 CA-C-N 120.179 1.354 . . . . 0.0 111.214 174.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 53.5 t30 44.92 71.5 0.26 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.695 1.598 . . . . 0.0 112.466 -167.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -140.26 177.65 7.84 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 127.36 2.264 . . . . 0.0 109.179 166.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 28.2 mtmt -79.38 141.48 57.18 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 124.061 0.944 . . . . 0.0 111.916 177.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -66.51 -11.13 30.4 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.41 2.74 . . . . 0.0 115.227 -178.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 42.4 tp60 -75.89 -27.79 57.85 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 120.699 1.591 . . . . 0.0 111.379 169.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 m -68.1 -35.8 72.93 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.413 0 CA-C-N 120.832 1.651 . . . . 0.0 108.293 173.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 33.6 mm -59.67 -50.44 79.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 C-N-CA 124.207 1.003 . . . . 0.0 110.078 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.4 -32.11 73.45 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.928 -0.483 . . . . 0.0 112.089 176.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.82 -27.98 61.39 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 120.798 -1.189 . . . . 0.0 110.97 175.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -69.46 -37.7 77.43 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.653 1.581 . . . . 0.0 110.87 175.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -55.29 -56.8 15.93 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 167.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.5 m -66.58 -19.88 65.88 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.22 1.008 . . . . 0.0 113.46 -172.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.34 -10.31 73.37 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 123.773 0.702 . . . . 0.0 114.5 -175.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 28.9 mtt-85 -77.23 -21.21 54.13 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 118.199 1.0 . . . . 0.0 112.39 -174.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.14 115.22 19.58 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 105.264 -2.125 . . . . 0.0 105.264 168.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.2 mm -69.1 113.73 18.49 Favored Pre-proline 0 C--O 1.238 0.47 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 -171.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -77.33 114.57 3.77 Favored 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 121.783 1.655 . . . . 0.0 110.563 -163.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -110.5 144.23 39.65 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.945 0.898 . . . . 0.0 109.539 -174.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -53.41 -40.46 65.12 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -171.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -52.51 -60.63 3.0 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.052 0.941 . . . . 0.0 109.662 177.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.433 ' HA ' ' HD3' ' A' ' 60' ' ' LYS . 70.9 t -65.96 -44.8 92.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-O 118.328 -0.844 . . . . 0.0 109.49 -175.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.7 mt -51.3 -44.79 61.98 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.783 0.72 . . . . 0.0 110.2 176.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.82 -43.96 94.46 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.024 0.821 . . . . 0.0 113.068 175.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.433 ' HD3' ' HA ' ' A' ' 57' ' ' VAL . 15.8 mtpp -65.23 -42.88 92.94 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 121.304 -1.115 . . . . 0.0 109.651 178.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.2 mt -60.81 -32.99 53.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 123.563 0.745 . . . . 0.0 109.271 176.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -58.49 -49.03 78.84 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 120.078 1.308 . . . . 0.0 110.212 178.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 48.5 mtt85 -68.6 -20.91 64.52 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.606 -0.684 . . . . 0.0 112.496 175.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.27 -54.81 41.31 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 50.2 pt -100.22 -18.07 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -176.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.19 20.87 58.25 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 125.871 1.701 . . . . 0.0 113.533 -177.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 60.8 mt -125.47 161.73 26.46 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 125.14 1.376 . . . . 0.0 108.913 178.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -72.18 139.78 48.41 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 125.244 1.418 . . . . 0.0 109.226 177.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -119.72 -1.39 10.57 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.218 1.807 . . . . 0.0 110.961 177.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.3 mmm180 -125.46 155.14 40.95 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 119.496 1.044 . . . . 0.0 108.68 170.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.13 159.93 6.63 Favored Glycine 0 N--CA 1.447 -0.613 0 O-C-N 124.843 1.339 . . . . 0.0 110.573 -178.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -73.18 -4.24 31.66 Favored 'General case' 0 N--CA 1.464 0.273 0 O-C-N 121.001 -1.293 . . . . 0.0 112.131 -176.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -73.32 12.4 0.59 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.849 0.749 . . . . 0.0 110.572 162.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.7 tt -48.56 134.03 5.96 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 CA-C-N 120.269 1.395 . . . . 0.0 109.125 176.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.32 -4.76 66.15 Favored Glycine 0 CA--C 1.538 1.521 0 CA-C-O 119.155 -0.803 . . . . 0.0 114.15 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 40.9 mmtt -72.57 151.39 91.54 Favored Pre-proline 0 N--CA 1.455 -0.206 0 CA-C-N 119.989 1.895 . . . . 0.0 106.794 159.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -72.47 160.75 46.02 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 123.423 2.749 . . . . 0.0 111.489 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 36.8 pt -101.11 138.49 25.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 173.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 49.12 23.16 0.71 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.3 1.84 . . . . 0.0 114.187 170.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.1 pttp -22.82 85.46 0.0 OUTLIER 'General case' 0 C--O 1.236 0.358 0 C-N-CA 130.923 3.689 . . . . 0.0 115.257 -168.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.66 -164.49 39.15 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.898 1.713 . . . . 0.0 112.142 -174.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -62.02 95.06 0.14 Allowed 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 124.819 3.679 . . . . 0.0 111.148 176.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 65.0 ttt-85 -140.75 121.08 13.96 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 170.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 41.01 75.55 0.08 Allowed 'General case' 0 C--O 1.234 0.284 0 C-N-CA 126.886 2.074 . . . . 0.0 111.212 -175.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -152.21 -46.89 0.1 Allowed 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 118.545 -0.74 . . . . 0.0 111.055 -173.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.5 m 48.0 72.51 0.26 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.526 1.13 . . . . 0.0 111.544 -171.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -66.52 -163.37 1.5 Allowed Glycine 0 CA--C 1.538 1.523 0 C-N-CA 125.515 1.531 . . . . 0.0 112.572 173.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -61.3 -19.17 62.84 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 123.078 2.519 . . . . 0.0 114.341 -168.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.3 p -136.45 -69.75 0.47 Allowed 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 154.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.2 t -154.68 -67.61 0.13 Allowed 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 171.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.857 0 CA-C-O 117.857 -1.524 . . . . 0.0 109.317 -172.984 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.729 0 CA-C-O 118.648 -1.084 . . . . 0.0 110.716 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.2 m -166.33 167.6 15.77 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.496 1.519 . . . . 0.0 108.84 172.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.5 m -135.6 -53.1 0.76 Allowed 'General case' 0 C--N 1.334 -0.098 0 C-N-CA 124.293 1.037 . . . . 0.0 108.404 162.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 68.19 170.19 5.53 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -165.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.09 119.38 4.69 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 171.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.6 m 48.06 -160.53 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.962 1.705 . . . . 0.0 113.315 -176.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.17 129.98 2.91 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 126.376 1.941 . . . . 0.0 109.79 -177.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -61.29 119.6 8.78 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 125.019 1.328 . . . . 0.0 113.143 -166.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -98.49 175.19 6.11 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.522 1.129 . . . . 0.0 110.869 178.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.8 p -145.19 155.64 13.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 125.574 1.55 . . . . 0.0 108.36 -175.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 70.5 p -85.29 78.91 9.68 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 122.876 1.322 . . . . 0.0 108.563 166.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.0 tp -53.67 130.97 38.19 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 126.026 1.73 . . . . 0.0 107.928 178.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 69.5 mt-10 -55.76 -47.81 76.37 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 126.002 1.721 . . . . 0.0 112.856 -167.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.5 t -57.97 -51.22 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 176.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.45 -36.5 84.63 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 118.771 -1.016 . . . . 0.0 112.895 175.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -63.19 -55.92 21.04 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 119.024 1.412 . . . . 0.0 109.235 176.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.4 t -64.12 -34.55 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-N 119.311 0.96 . . . . 0.0 110.573 -178.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.4 mt -59.18 -59.49 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 171.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -56.69 -41.28 77.09 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 118.836 0.744 . . . . 0.0 110.75 -174.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -62.79 -57.13 11.98 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.405 1.882 . . . . 0.0 110.822 176.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.69 -32.66 83.76 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 118.205 0.457 . . . . 0.0 111.995 -175.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.418 HH21 ' CD ' ' A' ' 47' ' ' GLU . 25.3 mtm105 -53.51 -61.41 2.32 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 166.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -50.55 -46.56 57.6 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.713 1.205 . . . . 0.0 111.69 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.2 m -71.11 -6.79 41.97 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.42 1.088 . . . . 0.0 113.409 -176.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.423 ' HE3' HD12 ' A' ' 27' ' ' LEU . 26.5 mtpp -120.06 8.12 10.94 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.899 1.68 . . . . 0.0 111.535 167.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.09 19.58 51.71 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.777 1.179 . . . . 0.0 113.015 -176.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.423 HD12 ' HE3' ' A' ' 25' ' ' LYS . 79.6 mt -84.34 131.87 34.66 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 118.804 1.302 . . . . 0.0 108.552 -171.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.4 p -75.75 176.57 7.61 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 171.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -68.07 -37.58 81.41 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.179 -0.951 . . . . 0.0 110.73 172.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.6 tmtp? -63.26 -39.23 94.01 Favored 'General case' 0 N--CA 1.462 0.125 0 C-N-CA 123.107 0.563 . . . . 0.0 110.873 174.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.55 -42.22 83.01 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 177.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.04 -50.67 72.65 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 123.744 0.817 . . . . 0.0 110.089 176.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -48.54 -53.47 18.1 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 125.269 1.428 . . . . 0.0 109.978 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 35.1 m -63.09 -40.74 98.56 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.647 0.779 . . . . 0.0 111.933 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.7 mttp -61.81 -12.19 16.08 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 119.719 1.145 . . . . 0.0 113.81 174.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 24.8 pt -123.6 10.38 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 119.99 1.268 . . . . 0.0 111.583 175.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 37.09 68.85 0.25 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 128.453 2.701 . . . . 0.0 112.067 -168.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -131.35 -178.67 4.95 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 127.44 2.296 . . . . 0.0 107.437 173.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -93.67 151.57 40.11 Favored Pre-proline 0 CA--C 1.531 0.233 0 C-N-CA 124.362 1.065 . . . . 0.0 110.595 171.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -67.03 -17.27 51.03 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 123.676 2.917 . . . . 0.0 113.697 -178.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 -65.51 -52.24 54.08 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 118.502 0.592 . . . . 0.0 110.398 177.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.1 m -63.55 -27.61 43.33 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 C-N-CA 120.5 -0.48 . . . . 0.0 109.965 -175.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 38.0 mm -61.38 -53.32 50.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 123.084 0.554 . . . . 0.0 110.574 174.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.17 -39.9 73.07 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 118.957 0.798 . . . . 0.0 111.485 177.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.88 -31.15 67.72 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 118.678 -0.677 . . . . 0.0 111.086 -178.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -63.06 -45.63 91.28 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 125.288 1.435 . . . . 0.0 111.342 172.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.418 ' CD ' HH21 ' A' ' 22' ' ' ARG . 4.7 mt-10 -58.86 -32.96 69.92 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.292 0.637 . . . . 0.0 111.328 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 43.7 m -82.8 -23.15 33.96 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 174.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.2 0.15 80.72 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 119.624 1.102 . . . . 0.0 114.218 -169.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.8 mtt85 -69.49 -47.12 64.9 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 117.867 0.834 . . . . 0.0 109.561 -177.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.39 134.82 57.35 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 171.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 34.0 mm -68.95 120.39 76.02 Favored Pre-proline 0 C--O 1.237 0.416 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -71.44 115.54 4.33 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.503 2.135 . . . . 0.0 110.5 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -106.2 122.2 45.74 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 126.509 1.923 . . . . 0.0 107.697 -178.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -55.73 -24.8 37.08 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 119.813 1.188 . . . . 0.0 113.221 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -61.55 -55.93 25.53 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.491 0.716 . . . . 0.0 109.284 174.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.0 t -71.26 -38.76 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.4 -177.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.4 mt -50.44 -46.39 56.53 Favored 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 169.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.61 -46.89 91.6 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 124.138 0.875 . . . . 0.0 112.036 177.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -57.85 -43.7 86.05 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 117.935 0.867 . . . . 0.0 110.828 175.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.0 mt -65.24 -35.77 76.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 124.685 1.194 . . . . 0.0 110.325 178.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -59.93 -49.91 75.82 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 119.495 1.043 . . . . 0.0 108.616 176.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.8 mtm105 -57.59 -31.32 66.06 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 122.871 0.468 . . . . 0.0 111.288 175.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.47 -53.7 26.55 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.011 0.924 . . . . 0.0 112.227 -177.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 35.6 pt -90.05 -16.5 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 122.418 0.287 . . . . 0.0 111.269 -177.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.92 27.28 58.77 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 125.871 1.701 . . . . 0.0 113.186 -175.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.2 mt -143.37 161.38 38.51 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.727 1.764 . . . . 0.0 109.887 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -68.28 142.83 55.46 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 126.163 1.785 . . . . 0.0 110.746 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -118.17 10.33 12.89 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.467 1.107 . . . . 0.0 110.398 173.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 25.1 mtm105 -139.8 157.27 46.0 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 121.32 -0.863 . . . . 0.0 109.711 -178.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.96 167.91 21.04 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -170.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 43.2 tttp -68.94 -14.08 62.82 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.363 -1.08 . . . . 0.0 110.642 172.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -64.93 8.23 0.13 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.695 1.998 . . . . 0.0 112.426 168.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.7 tt -50.24 135.9 8.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-N 120.552 1.524 . . . . 0.0 110.283 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.28 -4.68 62.18 Favored Glycine 0 CA--C 1.533 1.204 0 CA-C-O 119.045 -0.864 . . . . 0.0 114.406 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 44.7 mmtt -70.07 153.14 95.57 Favored Pre-proline 0 N--CA 1.453 -0.314 0 CA-C-N 119.808 1.804 . . . . 0.0 107.101 161.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -67.18 168.78 16.67 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.062 2.508 . . . . 0.0 112.53 -176.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 34.4 pt -107.55 115.57 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 175.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 61.59 -171.15 0.15 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.667 1.187 . . . . 0.0 110.213 177.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? 46.96 53.53 10.38 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.368 1.067 . . . . 0.0 110.413 177.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 178.67 -167.35 37.7 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 108.453 -1.859 . . . . 0.0 108.453 -158.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -69.43 100.79 0.8 Allowed 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.245 2.63 . . . . 0.0 109.609 -171.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.51 141.62 23.08 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 -173.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -133.67 138.11 45.7 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.728 1.211 . . . . 0.0 108.167 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 40.2 mttm -145.08 113.57 6.67 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 160.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 59.1 m -138.88 29.52 2.3 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.634 1.173 . . . . 0.0 110.243 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -157.67 162.82 32.28 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 108.287 -1.925 . . . . 0.0 108.287 168.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.28 150.83 71.61 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.51 2.14 . . . . 0.0 109.845 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.8 t -72.0 132.21 43.97 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 157.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.2 m -60.23 148.63 35.79 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.55 0.74 . . . . 0.0 111.205 -172.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.412 -1.215 . . . . 0.0 110.85 176.976 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.282 0 CA-C-O 118.577 -1.124 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 83.4 p 49.47 30.51 3.44 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 162.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.7 t -75.44 117.46 17.25 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 121.029 -1.044 . . . . 0.0 109.085 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -100.48 -83.25 1.72 Allowed Glycine 0 CA--C 1.523 0.554 0 N-CA-C 108.299 -1.92 . . . . 0.0 108.299 167.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 62.9 m 60.25 -67.56 0.04 OUTLIER 'General case' 0 C--O 1.235 0.309 0 C-N-CA 129.018 2.927 . . . . 0.0 113.807 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 55.21 177.0 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.965 1.706 . . . . 0.0 111.911 -163.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 120.83 52.45 0.25 Allowed Glycine 0 C--N 1.333 0.415 0 C-N-CA 125.015 1.293 . . . . 0.0 110.42 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -158.67 175.71 13.29 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.149 1.38 . . . . 0.0 108.549 174.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -137.05 15.87 3.04 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.525 0.73 . . . . 0.0 112.225 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.8 m -70.77 154.61 7.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.9 p -148.94 93.54 2.12 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -171.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 18.1 tp -67.98 136.85 54.56 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 173.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -61.75 -58.12 9.25 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 119.238 -0.41 . . . . 0.0 111.235 -173.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.0 t -57.58 -57.37 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 125.742 1.617 . . . . 0.0 109.8 178.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -49.12 -46.7 33.79 Favored Glycine 0 C--O 1.223 -0.537 0 C-N-CA 124.849 1.214 . . . . 0.0 112.246 177.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -62.1 -49.08 77.36 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 119.008 1.404 . . . . 0.0 110.958 178.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 63.6 t -60.63 -41.99 90.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-N 119.482 1.037 . . . . 0.0 110.983 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 21.2 mt -54.15 -68.19 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 106.209 -1.775 . . . . 0.0 106.209 173.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -57.87 -30.37 65.77 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 125.079 1.352 . . . . 0.0 110.413 -167.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -64.55 -69.38 0.29 Allowed 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.715 1.606 . . . . 0.0 110.924 171.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.58 -29.34 74.62 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-N 119.413 1.006 . . . . 0.0 111.765 -171.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.4 ttp85 -53.74 -60.45 3.3 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 126.218 1.807 . . . . 0.0 108.76 168.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -67.42 -28.94 68.33 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 119.809 1.186 . . . . 0.0 113.334 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 59.0 m -61.03 -20.42 62.5 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.187 0.903 . . . . 0.0 111.99 172.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -109.67 5.9 23.29 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.915 1.686 . . . . 0.0 111.073 175.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.06 9.75 54.66 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 126.442 1.972 . . . . 0.0 113.68 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 34.7 mt -74.15 130.78 40.43 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 118.559 1.179 . . . . 0.0 109.231 -163.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 32.1 p -66.02 162.35 19.61 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 166.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -55.19 -37.24 66.8 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 121.469 -0.77 . . . . 0.0 109.863 169.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -63.85 -43.46 96.05 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.05 0.54 . . . . 0.0 111.298 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -70.02 -35.55 74.41 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 118.853 -0.594 . . . . 0.0 110.628 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.63 -46.05 90.15 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.747 0.703 . . . . 0.0 109.937 173.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.61 -54.44 45.98 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 124.722 1.209 . . . . 0.0 108.978 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 52.0 m -68.01 -31.4 71.06 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 117.962 -1.018 . . . . 0.0 111.608 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.1 mttp -52.75 -50.58 63.19 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 119.945 1.248 . . . . 0.0 110.47 173.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.9 pt -88.13 2.42 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 123.174 0.59 . . . . 0.0 112.383 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 62.3 t-20 45.02 74.21 0.14 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 128.973 2.909 . . . . 0.0 111.716 -170.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -139.35 173.6 11.37 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 128.612 2.765 . . . . 0.0 109.906 178.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.8 mmpt? -81.44 144.21 52.93 Favored Pre-proline 0 CA--C 1.534 0.341 0 O-C-N 121.505 -0.747 . . . . 0.0 109.882 173.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.32 -16.52 13.64 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.334 2.022 . . . . 0.0 114.452 -172.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 -68.04 -34.16 75.95 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 120.331 1.423 . . . . 0.0 110.782 173.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.6 m -72.22 -27.81 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 119.686 1.13 . . . . 0.0 110.155 177.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 36.3 mm -63.92 -50.51 77.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 C-N-CA 123.221 0.609 . . . . 0.0 109.414 172.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.17 -35.58 71.77 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.126 0.489 . . . . 0.0 110.462 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -72.94 -31.03 64.33 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 117.974 -1.012 . . . . 0.0 112.462 176.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -57.08 -50.84 71.54 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-N 120.019 1.281 . . . . 0.0 109.958 170.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -67.55 -29.68 69.12 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 119.188 -0.434 . . . . 0.0 110.965 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.6 m -71.11 -37.1 72.37 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.299 0.954 . . . . 0.0 111.716 176.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 113.85 9.37 16.45 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 124.943 1.259 . . . . 0.0 113.441 -176.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.5 mmt85 -101.29 -42.63 6.24 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 124.546 1.138 . . . . 0.0 110.955 -163.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.85 130.02 42.45 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 174.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 30.1 mm -68.3 124.9 90.89 Favored Pre-proline 0 C--O 1.238 0.456 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 -177.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -76.58 111.81 3.33 Favored 'Trans proline' 0 N--CA 1.442 -1.525 0 N-CA-C 106.836 -2.024 . . . . 0.0 106.836 -175.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -104.9 130.65 53.01 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 -174.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -50.54 -31.51 15.85 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 117.85 -1.071 . . . . 0.0 113.64 -178.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -65.24 -59.55 3.95 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 120.838 1.654 . . . . 0.0 110.673 172.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.1 t -59.7 -47.46 91.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 124.143 0.977 . . . . 0.0 110.034 -176.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 78.8 mt -47.68 -51.03 23.23 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 124.432 1.093 . . . . 0.0 109.538 169.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.72 -43.44 69.32 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 123.718 0.675 . . . . 0.0 112.576 177.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt -66.45 -44.04 83.88 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.14 0.97 . . . . 0.0 109.946 177.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.3 mt -60.01 -37.22 71.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 124.76 1.224 . . . . 0.0 109.903 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -58.35 -47.37 84.01 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 119.229 0.922 . . . . 0.0 109.564 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 26.1 mtt-85 -69.75 -27.22 64.76 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 118.296 -0.859 . . . . 0.0 112.326 176.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.75 -40.15 79.02 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.818 0.847 . . . . 0.0 112.056 176.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 22.1 pt -117.2 -16.07 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -174.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.1 30.88 62.4 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 125.225 1.393 . . . . 0.0 112.813 -176.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 69.7 mt -124.11 164.32 19.68 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 118.631 1.216 . . . . 0.0 109.489 169.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -78.76 140.85 38.2 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 126.033 1.733 . . . . 0.0 108.22 176.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -120.07 7.84 10.9 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.563 1.145 . . . . 0.0 108.985 -179.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 22.8 mtm105 -141.63 168.61 19.35 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 127.208 2.203 . . . . 0.0 108.461 177.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 68.91 158.26 1.45 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -162.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 24.3 mtmt -64.63 -15.6 61.46 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 120.876 -1.367 . . . . 0.0 111.387 164.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -66.62 11.69 0.09 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.323 2.249 . . . . 0.0 111.906 168.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.1 tt -51.84 144.52 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 O-C-N 120.485 -1.384 . . . . 0.0 110.532 177.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.79 -4.03 24.29 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-O 118.911 -0.938 . . . . 0.0 113.152 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 39.6 mmtt -69.51 150.79 96.87 Favored Pre-proline 0 N--CA 1.446 -0.667 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 157.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -69.33 158.5 57.28 Favored 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 122.448 2.099 . . . . 0.0 111.365 -177.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 27.8 pt -101.53 150.19 6.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 105.796 -1.928 . . . . 0.0 105.796 158.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 63.5 -77.27 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.487 1.915 . . . . 0.0 112.568 170.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.7 tttm -65.58 94.04 0.18 Allowed 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.786 1.234 . . . . 0.0 108.911 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -56.37 151.82 22.22 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.524 -0.631 . . . . 0.0 111.524 -170.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -62.04 125.39 16.35 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.739 2.293 . . . . 0.0 109.083 -167.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 35.7 mtt180 53.18 33.49 15.4 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.007 0.523 . . . . 0.0 111.705 175.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.76 113.9 1.12 Allowed 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.511 1.125 . . . . 0.0 108.118 167.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.0 tptm -74.21 -36.12 63.96 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -153.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 35.8 m -70.53 176.5 4.05 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.32 0.648 . . . . 0.0 112.037 -174.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 38.65 57.75 1.87 Allowed Glycine 0 CA--C 1.527 0.793 0 C-N-CA 127.111 2.291 . . . . 0.0 114.633 171.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -67.33 -18.19 49.95 Favored 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 122.336 2.024 . . . . 0.0 113.114 -177.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 70.5 m 36.67 79.96 0.03 OUTLIER 'General case' 0 C--O 1.236 0.347 0 C-N-CA 126.881 2.072 . . . . 0.0 112.339 178.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 70.0 m -58.94 154.24 15.73 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 154.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.924 0 CA-C-O 116.905 -2.053 . . . . 0.0 109.093 -165.817 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.66 0 N-CA-C 111.658 -0.577 . . . . 0.0 111.658 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.4 m 57.13 -172.07 0.09 Allowed 'General case' 0 C--O 1.241 0.649 0 C-N-CA 125.828 1.651 . . . . 0.0 112.391 -173.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.9 p -148.4 -169.62 3.4 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.284 1.834 . . . . 0.0 108.703 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 98.35 79.85 1.49 Allowed Glycine 0 C--N 1.335 0.524 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 171.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.1 m -161.81 84.24 0.6 Allowed 'General case' 0 C--O 1.24 0.602 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 165.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.1 m -58.48 -41.34 85.07 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.373 1.069 . . . . 0.0 110.716 -174.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.29 171.35 43.12 Favored Glycine 0 C--N 1.337 0.585 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -176.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -166.71 111.74 0.78 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 124.748 1.219 . . . . 0.0 108.252 172.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 62.5 mtt85 -152.05 159.0 43.81 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 124.786 1.234 . . . . 0.0 111.62 177.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.7 m -79.02 150.44 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 123.384 0.674 . . . . 0.0 110.078 155.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.1 t -172.36 172.06 4.55 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 127.92 2.488 . . . . 0.0 107.438 167.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.1 mp -58.09 152.61 16.38 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.223 1.409 . . . . 0.0 109.768 173.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -58.62 -43.96 89.84 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.467 0.307 . . . . 0.0 111.132 -178.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.5 t -57.9 -56.94 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 124.07 0.948 . . . . 0.0 109.094 177.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -55.21 -39.82 72.68 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-O 118.947 -0.918 . . . . 0.0 112.745 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 48.8 tptt -60.2 -57.7 11.69 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.633 1.216 . . . . 0.0 109.733 176.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.4 t -61.81 -31.9 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 118.662 0.665 . . . . 0.0 110.029 -177.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.1 mt -65.76 -56.41 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 CA-C-N 119.809 1.186 . . . . 0.0 109.061 176.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -51.88 -49.38 63.09 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.599 1.16 . . . . 0.0 110.404 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -66.39 -53.06 40.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.104 1.762 . . . . 0.0 111.958 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.23 -34.24 89.39 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 124.413 1.006 . . . . 0.0 111.519 -174.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.9 mtm105 -64.69 -51.31 63.13 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 118.531 -0.747 . . . . 0.0 111.28 168.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -51.8 -37.76 52.92 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.751 0.82 . . . . 0.0 111.399 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.2 m -73.92 -2.39 23.72 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.621 1.968 . . . . 0.0 112.493 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 21.0 mtpp -136.54 6.72 3.0 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.448 2.299 . . . . 0.0 111.314 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.26 21.04 69.9 Favored Glycine 0 CA--C 1.536 1.399 0 CA-C-O 118.681 -1.066 . . . . 0.0 114.742 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 20.8 mt -93.44 135.4 34.72 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.271 1.536 . . . . 0.0 110.964 -169.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 61.7 p -74.98 170.52 15.82 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.262 -0.899 . . . . 0.0 109.515 163.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -63.44 -29.01 70.37 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.237 -0.914 . . . . 0.0 111.568 166.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.53 -36.81 73.92 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.836 0.855 . . . . 0.0 110.8 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -66.13 -37.39 85.59 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 171.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.9 -48.42 66.08 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 118.207 0.458 . . . . 0.0 111.267 -175.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -48.24 -48.85 34.97 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 125.43 1.492 . . . . 0.0 109.209 172.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 63.0 m -60.91 -48.74 80.44 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.796 0.838 . . . . 0.0 111.528 175.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.3 mttm -58.4 -11.68 3.08 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 127.175 2.19 . . . . 0.0 114.233 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.9 pt -128.64 0.07 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 119.26 0.937 . . . . 0.0 112.273 177.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 53.2 t30 42.27 76.31 0.08 Allowed 'General case' 0 C--O 1.235 0.301 0 C-N-CA 126.768 2.027 . . . . 0.0 112.103 -163.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -137.6 -179.51 5.79 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 128.03 2.532 . . . . 0.0 107.567 168.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -88.01 141.71 31.54 Favored Pre-proline 0 C--N 1.335 -0.05 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 175.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -64.36 -18.82 64.47 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.587 2.192 . . . . 0.0 112.029 170.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.5 tp60 -62.23 -52.19 64.76 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 123.93 0.892 . . . . 0.0 110.429 171.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.1 m -69.88 -34.68 61.36 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.431 0 CA-C-N 119.36 0.982 . . . . 0.0 110.094 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 42.1 mm -56.57 -48.96 79.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 O-C-N 121.227 -0.921 . . . . 0.0 110.244 174.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.81 -20.91 66.65 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 178.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.16 -54.05 12.38 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 118.822 -0.608 . . . . 0.0 110.45 167.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -42.81 -50.65 5.62 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 124.535 1.134 . . . . 0.0 112.35 176.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.79 -29.35 68.51 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 120.897 1.68 . . . . 0.0 113.223 -171.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 12.8 m -69.85 -37.16 76.06 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.874 166.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.63 28.58 18.69 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -177.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -79.16 -50.8 10.42 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 117.494 0.647 . . . . 0.0 109.373 -174.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.35 167.32 18.38 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 127.366 2.266 . . . . 0.0 110.433 171.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 23.9 mm -89.73 127.34 54.61 Favored Pre-proline 0 C--O 1.235 0.333 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 174.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -72.75 115.07 4.2 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 N-CA-C 108.645 -1.329 . . . . 0.0 108.645 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -99.14 135.99 39.75 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.664 0.786 . . . . 0.0 110.795 -169.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -52.4 -36.95 55.4 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.365 1.066 . . . . 0.0 113.275 -170.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -57.59 -64.91 0.74 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.072 0.949 . . . . 0.0 109.226 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 92.4 t -63.3 -40.44 89.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 125.574 1.549 . . . . 0.0 109.844 -178.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.6 mt -49.61 -52.82 27.75 Favored 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 124.354 1.062 . . . . 0.0 110.223 175.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.76 -31.5 78.34 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-N 118.679 0.672 . . . . 0.0 112.523 -178.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -67.59 -43.55 80.27 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 121.401 -1.058 . . . . 0.0 110.371 173.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.0 mt -63.51 -37.12 78.74 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.091 0 C-N-CA 124.337 1.055 . . . . 0.0 109.843 176.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -56.39 -50.86 70.37 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.386 0.994 . . . . 0.0 109.227 176.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 23.2 mtm180 -64.95 -19.04 65.75 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 175.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.59 -44.76 73.67 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 118.426 -0.797 . . . . 0.0 111.264 177.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 21.5 pt -114.45 -10.13 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -173.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.51 23.36 78.13 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 127.561 2.505 . . . . 0.0 114.031 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.0 mt -121.94 161.59 22.59 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 118.453 1.126 . . . . 0.0 108.793 172.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -74.36 140.26 44.68 Favored 'General case' 0 CA--C 1.512 -0.51 0 C-N-CA 124.984 1.314 . . . . 0.0 108.753 176.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -119.56 9.92 11.64 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 125.087 1.355 . . . . 0.0 111.201 176.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.5 mtm180 -130.85 166.79 20.12 Favored 'General case' 0 C--O 1.233 0.209 0 O-C-N 121.023 -1.048 . . . . 0.0 109.04 174.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.63 176.91 43.56 Favored Glycine 0 N--CA 1.449 -0.495 0 O-C-N 124.233 0.958 . . . . 0.0 110.89 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -83.2 11.74 6.13 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.643 0.777 . . . . 0.0 111.114 171.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -102.91 16.25 27.14 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.381 1.472 . . . . 0.0 110.359 177.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.5 tt -54.68 142.98 7.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 O-C-N 121.219 -0.925 . . . . 0.0 110.545 -168.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.55 -4.48 59.9 Favored Glycine 0 CA--C 1.536 1.4 0 CA-C-O 119.307 -0.718 . . . . 0.0 114.257 -178.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -71.74 149.15 92.9 Favored Pre-proline 0 C--N 1.341 0.212 0 CA-C-N 119.938 1.869 . . . . 0.0 107.974 163.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.34 151.22 29.43 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 123.896 3.064 . . . . 0.0 112.85 -171.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.0 pt -101.36 127.87 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 175.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 41.22 55.72 3.22 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.561 1.544 . . . . 0.0 114.088 176.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 48.2 mttp 59.51 41.53 19.01 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.789 1.636 . . . . 0.0 112.891 -175.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -57.29 176.08 1.46 Allowed Glycine 0 CA--C 1.536 1.383 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.832 153.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.91 153.85 58.31 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.611 2.207 . . . . 0.0 113.468 -169.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 30.0 mtp180 -69.82 175.97 3.96 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.779 167.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.57 163.68 33.18 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 126.138 1.775 . . . . 0.0 108.569 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 52.9 mttp 71.03 -35.86 0.34 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 128.226 2.61 . . . . 0.0 112.522 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.7 p -66.12 -177.66 0.54 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.315 1.446 . . . . 0.0 110.662 162.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 102.76 100.33 2.55 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 176.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -66.06 168.19 16.23 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.533 2.155 . . . . 0.0 110.543 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.2 t -133.53 112.87 11.86 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.18 0.992 . . . . 0.0 108.528 -161.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.9 t -70.8 142.42 51.33 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.735 0.814 . . . . 0.0 108.933 176.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.929 0 N-CA-C 108.085 -2.006 . . . . 0.0 108.085 176.675 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.751 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.0 t 53.32 75.6 0.25 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.9 1.28 . . . . 0.0 110.466 -177.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.9 t -66.74 146.02 54.9 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 169.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -93.63 76.49 1.09 Allowed Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 108.051 -2.019 . . . . 0.0 108.051 172.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -172.39 158.15 4.25 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.217 1.407 . . . . 0.0 109.414 169.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.7 p -148.67 -4.78 0.43 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.798 1.239 . . . . 0.0 112.771 174.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 95.32 -106.51 3.41 Favored Glycine 0 C--N 1.337 0.602 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -153.22 -177.12 6.11 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.503 1.121 . . . . 0.0 108.357 -173.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.2 163.77 1.51 Allowed 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.142 -0.974 . . . . 0.0 109.749 160.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.8 m -133.36 178.59 5.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.605 0 C-N-CA 124.812 1.245 . . . . 0.0 109.466 -176.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.6 p -71.81 160.47 32.53 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.646 1.178 . . . . 0.0 111.953 174.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.4 mp 62.06 155.12 0.04 OUTLIER 'General case' 0 C--N 1.341 0.202 0 C-N-CA 128.658 2.783 . . . . 0.0 112.983 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -70.36 -48.83 54.56 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 120.574 -1.329 . . . . 0.0 107.501 171.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 53.5 t -57.31 -64.53 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.098 0 C-N-CA 125.41 1.484 . . . . 0.0 109.287 -178.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -49.16 -42.99 32.58 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-N 119.425 1.011 . . . . 0.0 112.998 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -67.44 -52.6 37.6 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 117.843 -1.075 . . . . 0.0 112.564 177.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 66.7 t -59.27 -31.34 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 119.805 1.184 . . . . 0.0 110.242 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 52.9 mt -61.32 -58.38 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 175.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -60.03 -47.0 87.65 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 123.608 0.568 . . . . 0.0 110.47 -177.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -60.3 -49.75 76.36 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.841 1.256 . . . . 0.0 110.734 178.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.17 -32.14 75.9 Favored Glycine 0 CA--C 1.52 0.377 0 O-C-N 120.535 -1.353 . . . . 0.0 112.663 -177.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 15.1 mtm105 -59.6 -61.42 2.63 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 118.145 0.973 . . . . 0.0 110.777 167.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.27 -22.95 67.2 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.169 0.988 . . . . 0.0 112.692 -174.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.4 t -61.4 -16.59 48.05 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.662 1.585 . . . . 0.0 111.303 171.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -126.98 2.12 6.57 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.413 1.885 . . . . 0.0 110.986 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 71.67 0.24 39.29 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 126.022 1.772 . . . . 0.0 113.024 -175.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.6 mt -78.63 145.32 34.74 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 119.034 1.417 . . . . 0.0 110.619 -162.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.1 p -83.86 174.61 10.25 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.656 0.782 . . . . 0.0 110.013 -173.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -69.09 -38.49 78.99 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 121.432 -0.793 . . . . 0.0 109.743 171.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.3 mtpm? -58.91 -41.99 88.57 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.82 0.848 . . . . 0.0 110.911 171.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -63.43 -43.46 97.4 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 118.832 0.742 . . . . 0.0 109.388 177.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.32 -49.3 77.56 Favored 'General case' 0 C--O 1.228 -0.069 0 C-N-CA 124.205 1.002 . . . . 0.0 110.091 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.15 -45.24 71.98 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.856 0.862 . . . . 0.0 109.919 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.7 m -61.82 -48.45 80.53 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.287 1.035 . . . . 0.0 110.576 177.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.2 mttm -54.48 -27.66 39.21 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.764 1.226 . . . . 0.0 113.274 176.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.6 pt -111.93 10.05 8.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 123.928 0.891 . . . . 0.0 112.13 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.5 m120 45.25 48.68 10.2 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.594 2.358 . . . . 0.0 111.421 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -132.27 -171.49 2.65 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.241 1.416 . . . . 0.0 109.224 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.6 mmmm -91.61 142.0 26.36 Favored Pre-proline 0 N--CA 1.466 0.355 0 O-C-N 121.015 -1.053 . . . . 0.0 109.713 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.52 -10.18 28.24 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.715 2.277 . . . . 0.0 112.123 169.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 30.0 tp60 -50.92 -61.68 2.07 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.901 1.28 . . . . 0.0 109.361 163.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.4 m -66.42 -29.5 46.77 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.677 0 C-N-CA 119.741 -0.783 . . . . 0.0 110.419 -175.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 51.4 mm -62.77 -45.08 99.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 119.686 1.13 . . . . 0.0 109.952 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.82 -39.64 92.48 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 121.496 -0.082 . . . . 0.0 111.09 172.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -63.62 -40.28 96.51 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.512 0.725 . . . . 0.0 110.68 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -63.25 -44.73 94.34 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 126.183 1.793 . . . . 0.0 108.867 176.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -60.73 -30.41 69.97 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.277 1.031 . . . . 0.0 113.164 176.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.7 m -90.49 -19.64 23.61 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 177.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.97 42.45 7.62 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 119.56 1.073 . . . . 0.0 111.188 -173.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -114.36 -47.83 2.91 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 124.941 1.297 . . . . 0.0 108.856 -176.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.21 150.11 11.5 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.31 0.644 . . . . 0.0 109.874 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 36.3 mm -68.98 117.32 50.51 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 167.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -69.76 115.6 4.17 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 N-CA-C 106.892 -2.003 . . . . 0.0 106.892 171.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -127.67 123.91 36.64 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 -172.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.2 p-10 -51.74 -29.59 19.25 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.909 1.684 . . . . 0.0 112.998 -174.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -58.54 -47.6 83.67 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.741 1.616 . . . . 0.0 111.205 173.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.2 t -91.66 -36.5 7.99 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-O 117.778 -1.106 . . . . 0.0 109.971 -175.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 14.1 mt -47.8 -45.63 29.83 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.56 1.073 . . . . 0.0 109.518 170.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.65 -40.31 94.57 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-O 119.492 -0.616 . . . . 0.0 112.813 176.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -64.99 -47.63 76.86 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 118.836 1.318 . . . . 0.0 109.683 177.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.3 mt -61.41 -36.1 70.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 123.226 0.611 . . . . 0.0 110.117 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -58.3 -50.19 74.49 Favored 'General case' 0 C--N 1.33 -0.255 0 O-C-N 121.583 -0.698 . . . . 0.0 109.862 176.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 36.5 mtt180 -65.91 -24.77 66.9 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.301 -0.874 . . . . 0.0 112.807 174.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.85 -55.88 28.73 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 118.771 0.714 . . . . 0.0 109.525 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 45.9 pt -93.34 -15.92 7.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 123.548 0.739 . . . . 0.0 112.002 -177.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.18 39.67 92.48 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 125.337 1.446 . . . . 0.0 111.682 -173.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 47.5 mt -135.45 166.14 23.88 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.4 1.08 . . . . 0.0 109.057 169.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -73.54 141.52 46.7 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 126.336 1.854 . . . . 0.0 109.52 176.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -119.36 5.25 11.18 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.425 1.89 . . . . 0.0 110.302 176.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 56.1 mtm180 -142.1 147.08 36.16 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.924 0.783 . . . . 0.0 110.009 -172.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.25 167.58 21.4 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 125.193 1.378 . . . . 0.0 109.931 -170.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.2 mttp -68.84 -11.57 60.62 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.119 -1.224 . . . . 0.0 111.667 176.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.98 13.74 0.49 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.924 1.69 . . . . 0.0 110.704 172.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.8 tt -52.65 150.45 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 O-C-N 120.843 -1.161 . . . . 0.0 110.761 176.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.53 -12.49 7.78 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-O 118.871 -0.96 . . . . 0.0 113.749 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 33.9 mmtt -70.77 150.57 95.27 Favored Pre-proline 0 N--CA 1.449 -0.515 0 CA-C-N 119.671 1.736 . . . . 0.0 107.784 166.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -73.16 162.44 40.67 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 123.575 2.85 . . . . 0.0 110.856 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 42.3 pt -110.69 141.24 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 124.364 1.065 . . . . 0.0 108.535 -178.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 53.19 23.64 3.23 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.783 2.033 . . . . 0.0 114.324 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -83.23 59.1 4.81 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 120.04 -1.662 . . . . 0.0 110.691 -171.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 145.24 -170.6 26.58 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 123.623 0.63 . . . . 0.0 112.706 172.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -75.55 -175.58 2.52 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 124.26 3.307 . . . . 0.0 111.409 169.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? 55.05 47.88 21.01 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.396 1.478 . . . . 0.0 109.141 -178.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.57 172.73 3.15 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.227 168.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt 53.12 -160.07 0.13 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.63 1.572 . . . . 0.0 111.709 170.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 11.8 t -153.77 -66.08 0.14 Allowed 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -81.29 -175.56 50.19 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 172.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -71.72 167.61 26.05 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.829 3.019 . . . . 0.0 111.164 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.3 m 176.53 164.04 0.43 Allowed 'General case' 0 C--O 1.237 0.408 0 C-N-CA 127.596 2.358 . . . . 0.0 109.293 168.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 13.4 m -72.78 -60.72 2.09 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 164.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.92 0 CA-C-O 117.762 -1.577 . . . . 0.0 110.993 173.18 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.81 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.2 m -76.63 -58.67 3.15 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 118.563 1.181 . . . . 0.0 111.722 -170.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.4 m 52.55 166.84 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 127.455 2.302 . . . . 0.0 113.539 -166.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 159.17 -165.99 34.48 Favored Glycine 0 CA--C 1.521 0.413 0 O-C-N 120.139 -1.6 . . . . 0.0 112.951 -172.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.0 t -146.69 167.74 23.06 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.561 1.544 . . . . 0.0 108.397 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.5 p -153.74 48.82 0.66 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.591 0.71 . . . . 0.0 109.538 -173.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.43 131.8 5.68 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 107.796 -2.122 . . . . 0.0 107.796 -167.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -46.51 -45.39 18.44 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 127.551 2.34 . . . . 0.0 112.398 -174.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 91.2 mtm-85 59.2 162.6 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 127.843 2.457 . . . . 0.0 113.333 -176.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.1 m -76.07 160.43 5.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 170.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.2 p -139.26 165.48 27.07 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.969 1.308 . . . . 0.0 108.467 -174.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.8 mp -78.72 154.58 29.95 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 163.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -56.07 -38.24 70.39 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 122.37 0.268 . . . . 0.0 111.066 -177.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.1 t -56.13 -61.7 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 123.506 0.722 . . . . 0.0 109.464 176.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -56.67 -38.08 80.15 Favored Glycine 0 C--N 1.335 0.527 0 CA-C-N 119.523 1.056 . . . . 0.0 112.523 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.4 -56.35 21.24 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.276 1.038 . . . . 0.0 109.86 177.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.3 t -60.13 -37.88 74.87 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.128 0 C-N-CA 123.808 0.843 . . . . 0.0 110.298 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 64.4 mt -59.98 -57.74 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 176.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -55.68 -49.0 74.11 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.142 0.577 . . . . 0.0 110.125 -176.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -56.67 -60.61 3.3 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 123.362 0.665 . . . . 0.0 110.801 176.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.38 -30.84 78.96 Favored Glycine 0 CA--C 1.521 0.442 0 CA-C-N 119.914 1.234 . . . . 0.0 112.719 -171.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 16.7 mtm105 -57.12 -65.72 0.57 Allowed 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 118.272 1.036 . . . . 0.0 109.782 166.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -61.52 -29.88 70.28 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.806 1.242 . . . . 0.0 112.161 -173.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.7 m -72.6 -4.73 32.58 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.984 1.314 . . . . 0.0 112.295 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp -127.72 12.35 6.82 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.465 1.906 . . . . 0.0 110.16 176.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.21 17.56 66.11 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.297 0.951 . . . . 0.0 113.725 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 59.4 mt -88.62 144.77 26.08 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 118.652 1.226 . . . . 0.0 111.505 -168.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 81.9 p -84.18 168.75 15.48 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.305 173.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -58.91 -43.38 91.04 Favored 'General case' 0 N--CA 1.464 0.267 0 O-C-N 121.321 -0.862 . . . . 0.0 110.216 166.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.5 mttt -57.1 -36.27 70.43 Favored 'General case' 0 CA--C 1.521 -0.136 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 176.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -64.13 -38.37 90.83 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 118.244 0.474 . . . . 0.0 110.232 176.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.59 -48.68 71.5 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 123.34 0.656 . . . . 0.0 109.256 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -50.16 -56.42 11.05 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.48 1.512 . . . . 0.0 108.643 178.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 95.9 m -59.59 -44.14 93.47 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.491 0.717 . . . . 0.0 112.299 177.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -58.86 -32.83 69.81 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 119.595 1.089 . . . . 0.0 112.137 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.2 pt -103.39 1.44 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 119.12 0.873 . . . . 0.0 112.073 176.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 63.3 t30 54.11 44.38 29.3 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 128.236 2.614 . . . . 0.0 113.709 -175.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -113.76 177.85 4.49 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.788 2.035 . . . . 0.0 110.907 176.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -75.93 147.99 81.26 Favored Pre-proline 0 C--N 1.342 0.26 0 CA-C-N 118.991 0.814 . . . . 0.0 109.542 168.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.0 -7.48 20.94 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 123.023 2.482 . . . . 0.0 112.616 170.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.4 tp60 -55.63 -63.44 1.17 Allowed 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 123.278 0.631 . . . . 0.0 109.551 166.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.8 m -67.98 -22.92 28.39 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.339 0 C-N-CA 119.954 -0.698 . . . . 0.0 111.014 -169.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 44.1 mm -61.63 -46.93 95.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 123.98 0.912 . . . . 0.0 110.298 171.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.31 -27.13 68.39 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 123.259 0.623 . . . . 0.0 112.287 177.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -79.75 -39.11 31.79 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.214 1.006 . . . . 0.0 110.789 176.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -55.0 -40.15 69.82 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 125.92 1.688 . . . . 0.0 111.054 175.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -61.14 -39.9 91.81 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 119.177 -0.44 . . . . 0.0 111.895 -177.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.5 m -80.87 -23.89 38.73 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 118.478 -0.772 . . . . 0.0 112.954 172.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.05 7.2 62.65 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-O 119.286 -0.73 . . . . 0.0 112.8 -171.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 45.8 mtt180 -67.44 -37.55 83.17 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.062 1.431 . . . . 0.0 110.195 177.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.63 115.1 7.62 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 167.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.6 mm -70.04 117.42 53.91 Favored Pre-proline 0 C--O 1.236 0.364 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 170.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -80.75 154.48 20.31 Favored 'Trans proline' 0 N--CA 1.446 -1.28 0 C-N-CA 122.188 1.925 . . . . 0.0 110.238 -173.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -127.47 153.92 45.72 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.526 1.13 . . . . 0.0 108.506 174.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 72.9 m-80 -62.12 -31.84 72.35 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.883 0.765 . . . . 0.0 112.309 -172.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -56.61 -61.37 2.47 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.004 0.922 . . . . 0.0 109.381 174.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.0 t -66.15 -48.94 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-O 118.087 -0.959 . . . . 0.0 109.69 -176.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 51.9 mt -44.91 -48.4 11.27 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 119.366 0.985 . . . . 0.0 110.164 170.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.14 -47.45 73.83 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 125.236 1.398 . . . . 0.0 112.562 176.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -61.73 -41.95 98.32 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 121.732 -0.863 . . . . 0.0 110.425 175.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 77.5 mt -63.68 -34.63 69.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 118.755 0.707 . . . . 0.0 109.651 176.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -62.11 -43.5 98.69 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 120.957 -1.089 . . . . 0.0 109.873 174.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 84.8 mtt-85 -59.22 -39.01 81.36 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.453 -0.78 . . . . 0.0 111.004 173.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.74 -55.36 31.1 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.619 1.568 . . . . 0.0 111.453 -175.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.0 pt -91.02 -26.51 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 118.673 0.669 . . . . 0.0 110.942 -178.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.59 28.08 36.82 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 125.614 1.578 . . . . 0.0 112.215 -178.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.6 mt -133.65 165.09 25.74 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.542 1.537 . . . . 0.0 108.572 173.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.2 mttm -69.41 140.96 54.19 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 126.236 1.814 . . . . 0.0 109.947 176.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -119.75 8.02 11.11 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.429 1.892 . . . . 0.0 109.791 174.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -133.42 154.93 50.36 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.578 1.551 . . . . 0.0 108.082 -175.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 65.51 174.18 4.7 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.627 1.584 . . . . 0.0 112.624 -178.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 72.1 mttt -69.15 -16.83 63.73 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 121.883 -0.775 . . . . 0.0 111.867 178.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -76.82 16.04 0.58 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.391 0.996 . . . . 0.0 111.362 176.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.6 tt -52.15 139.51 8.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 O-C-N 120.718 -1.239 . . . . 0.0 110.78 -176.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.27 -8.05 41.96 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 118.79 -1.006 . . . . 0.0 113.386 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 16.5 mmtt -72.55 154.38 91.57 Favored Pre-proline 0 N--CA 1.451 -0.411 0 CA-C-N 120.546 2.173 . . . . 0.0 106.672 161.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -67.8 170.67 13.57 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 123.388 2.725 . . . . 0.0 112.204 -175.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 25.2 pt -109.04 164.45 5.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 124.637 1.175 . . . . 0.0 108.679 171.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -72.81 135.05 45.16 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 174.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 35.5 mttt -152.37 158.83 43.26 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.733 1.613 . . . . 0.0 108.095 161.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 43.22 -114.42 0.85 Allowed Glycine 0 CA--C 1.534 1.275 0 C-N-CA 125.126 1.346 . . . . 0.0 112.486 174.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.95 104.17 1.31 Allowed 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 123.901 3.067 . . . . 0.0 111.304 -176.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 42.1 ttt180 95.08 121.63 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 130.46 3.504 . . . . 0.0 110.22 168.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.6 -61.49 0.37 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.027 1.731 . . . . 0.0 109.108 177.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.5 mtmt 61.26 163.21 0.07 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 127.675 2.39 . . . . 0.0 112.186 -173.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 43.9 m 30.8 77.29 0.03 OUTLIER 'General case' 0 C--O 1.234 0.25 0 C-N-CA 126.901 2.08 . . . . 0.0 113.205 -170.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 165.98 66.29 0.03 OUTLIER Glycine 0 CA--C 1.523 0.576 0 N-CA-C 106.318 -2.713 . . . . 0.0 106.318 174.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -64.73 149.42 89.74 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 121.757 1.638 . . . . 0.0 110.023 -174.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.8 m -157.3 165.57 35.47 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.729 1.211 . . . . 0.0 109.155 176.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.6 p -128.01 171.41 11.87 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.0 1.32 . . . . 0.0 108.47 171.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.852 0 N-CA-C 104.735 -3.346 . . . . 0.0 104.735 167.981 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.853 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.3 t -145.95 -37.85 0.25 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.454 0.702 . . . . 0.0 111.148 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.1 m 33.96 49.38 0.28 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.419 2.287 . . . . 0.0 115.591 172.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -61.1 152.79 39.79 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.825 -0.51 . . . . 0.0 111.825 -176.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.0 p -162.87 74.88 0.4 Allowed 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.6 0.76 . . . . 0.0 109.13 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.9 m -143.81 154.17 43.13 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 122.655 0.382 . . . . 0.0 110.804 176.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -81.04 -105.08 0.32 Allowed Glycine 0 CA--C 1.522 0.48 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 173.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -137.3 97.48 3.49 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.026 1.33 . . . . 0.0 109.218 -168.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 24.7 mmt85 -134.55 6.02 3.48 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.748 0.819 . . . . 0.0 113.104 -173.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.1 p -62.72 149.92 9.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-N 118.726 0.694 . . . . 0.0 110.859 177.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.2 p -127.5 180.0 5.2 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 127.038 2.135 . . . . 0.0 108.907 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.4 mp 66.3 -177.12 0.19 Allowed 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.044 1.338 . . . . 0.0 113.158 165.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -97.85 -44.85 6.54 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.808 0.843 . . . . 0.0 110.034 158.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 37.1 t -60.95 -57.44 12.12 Favored 'Isoleucine or valine' 0 C--N 1.344 0.329 0 CA-C-N 119.372 0.987 . . . . 0.0 109.14 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.91 -40.9 66.38 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 119.677 -0.513 . . . . 0.0 112.1 177.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.8 tptt -57.85 -61.22 2.68 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 117.827 0.814 . . . . 0.0 110.826 173.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 78.6 t -58.49 -31.85 44.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 118.994 0.816 . . . . 0.0 110.068 -176.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 52.3 mt -64.74 -59.19 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-O 117.799 -1.096 . . . . 0.0 108.753 175.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -54.23 -50.03 68.1 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.706 0.803 . . . . 0.0 109.839 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.85 -52.22 63.96 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 123.786 0.835 . . . . 0.0 110.394 -177.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.99 -33.87 88.4 Favored Glycine 0 CA--C 1.524 0.618 0 CA-C-O 118.862 -0.966 . . . . 0.0 112.098 -177.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.438 HH21 ' CD ' ' A' ' 47' ' ' GLU . 17.3 mtm105 -59.68 -58.14 9.89 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 118.321 1.061 . . . . 0.0 109.7 170.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.9 mm100 -64.36 -17.68 63.95 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.753 1.621 . . . . 0.0 113.216 -176.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 65.3 m -72.15 -11.33 60.69 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.144 0.978 . . . . 0.0 112.941 168.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -135.66 23.06 3.38 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 120.399 1.454 . . . . 0.0 111.993 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 61.2 14.19 38.92 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.477 1.037 . . . . 0.0 113.924 -178.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 44.5 mt -73.09 125.27 27.28 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 118.67 1.235 . . . . 0.0 108.898 -167.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 67.2 p -66.7 170.42 6.44 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 165.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -63.04 -32.39 73.75 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.098 -1.001 . . . . 0.0 110.399 169.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -72.15 -36.32 69.3 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.481 0.712 . . . . 0.0 111.058 178.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -59.91 -40.54 89.19 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.96 0.8 . . . . 0.0 109.129 174.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.82 -47.5 74.81 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.406 0.682 . . . . 0.0 110.803 177.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.64 -47.4 67.1 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.485 1.114 . . . . 0.0 110.487 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 95.3 m -58.89 -49.12 78.98 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 125.03 1.332 . . . . 0.0 111.081 172.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.6 mttp -57.88 -22.55 48.86 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 117.837 -1.078 . . . . 0.0 113.563 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.6 pt -115.3 8.15 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 120.021 1.282 . . . . 0.0 112.096 173.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 42.1 t30 36.74 72.15 0.12 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.424 1.889 . . . . 0.0 112.015 -170.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.77 -179.69 6.48 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.691 1.596 . . . . 0.0 109.706 171.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -68.54 143.51 95.33 Favored Pre-proline 0 N--CA 1.455 -0.203 0 O-C-N 121.347 -0.846 . . . . 0.0 109.797 172.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -69.72 -10.33 28.34 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 122.599 2.199 . . . . 0.0 112.123 170.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -61.29 -42.22 98.28 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.897 1.279 . . . . 0.0 110.73 170.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.3 m -76.39 -27.27 17.35 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.382 0 C-N-CA 119.687 -0.805 . . . . 0.0 110.294 -176.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.3 mm -62.99 -47.47 92.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 119.44 1.018 . . . . 0.0 109.226 176.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.68 -42.38 71.32 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 122.885 0.474 . . . . 0.0 110.834 175.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -78.58 -32.9 47.87 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 118.608 -0.71 . . . . 0.0 111.263 -173.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -58.8 -43.72 90.59 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.33 1.052 . . . . 0.0 109.533 168.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.438 ' CD ' HH21 ' A' ' 22' ' ' ARG . 7.0 mt-10 -62.43 -40.55 96.93 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 118.44 -0.79 . . . . 0.0 112.501 -178.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.3 m -82.11 -25.62 34.29 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 119.145 0.884 . . . . 0.0 112.657 175.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 108.84 3.33 32.07 Favored Glycine 0 CA--C 1.523 0.538 0 C-N-CA 123.464 0.554 . . . . 0.0 113.052 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 55.0 mmt-85 -67.3 -58.34 4.98 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.32 1.448 . . . . 0.0 109.416 -175.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.11 142.71 53.75 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.438 0.563 . . . . 0.0 109.894 -175.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 mt -68.43 126.86 93.15 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 174.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.15 116.86 4.79 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 122.72 2.28 . . . . 0.0 108.192 175.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -114.67 126.72 55.2 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 178.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -44.69 -38.19 4.2 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.767 1.627 . . . . 0.0 114.103 175.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -58.18 -33.15 68.94 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 123.245 0.618 . . . . 0.0 111.979 177.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 75.3 t -94.19 -46.8 13.58 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 C-N-CA 124.898 1.279 . . . . 0.0 109.425 176.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 78.0 mt -47.97 -49.35 30.91 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 120.463 1.483 . . . . 0.0 111.115 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.78 -31.47 71.75 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 118.459 0.572 . . . . 0.0 113.131 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.9 mtpp -74.31 -43.39 56.95 Favored 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 125.071 1.348 . . . . 0.0 109.419 175.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.0 mt -59.17 -36.79 64.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 175.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -59.12 -46.16 89.05 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.426 1.012 . . . . 0.0 109.995 176.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 48.0 mtt180 -67.57 -23.31 65.39 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.329 -0.857 . . . . 0.0 112.713 174.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.95 -37.09 81.16 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.614 1.166 . . . . 0.0 111.893 -178.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 29.7 pt -119.25 -20.38 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.021 0.929 . . . . 0.0 112.544 -177.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.61 29.43 52.43 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 125.476 1.512 . . . . 0.0 113.345 -177.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 81.1 mt -124.92 166.09 16.92 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 118.267 1.033 . . . . 0.0 108.569 170.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.7 mttm -74.59 143.27 44.48 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 125.357 1.463 . . . . 0.0 109.738 175.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -121.26 9.71 10.47 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.56 1.544 . . . . 0.0 110.387 176.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 33.9 mtt-85 -137.64 163.06 32.16 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 119.371 0.987 . . . . 0.0 110.951 175.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.82 177.95 49.94 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 125.413 1.483 . . . . 0.0 110.811 -174.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -69.75 -20.91 63.49 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 121.694 -0.886 . . . . 0.0 110.741 163.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.34 15.71 0.09 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 128.755 2.822 . . . . 0.0 111.382 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.3 tt -56.86 150.89 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 O-C-N 121.106 -0.997 . . . . 0.0 109.334 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.73 -7.15 7.42 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-O 118.533 -1.148 . . . . 0.0 114.13 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.9 mmmt -61.47 149.79 82.65 Favored Pre-proline 0 C--N 1.342 0.242 0 CA-C-N 120.04 1.92 . . . . 0.0 107.137 158.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -67.73 154.79 72.28 Favored 'Trans proline' 0 N--CA 1.445 -1.337 0 C-N-CA 123.139 2.56 . . . . 0.0 110.462 170.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.7 pt -101.94 144.56 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 164.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 51.39 34.83 12.65 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.077 1.351 . . . . 0.0 113.603 164.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -116.65 66.95 0.72 Allowed 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 176.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 154.87 171.62 21.79 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 125.259 1.409 . . . . 0.0 110.112 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.44 94.72 0.98 Allowed 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.824 3.016 . . . . 0.0 110.908 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.5 ttm180 -159.92 141.78 12.99 Favored 'General case' 0 C--O 1.234 0.243 0 O-C-N 121.104 -0.998 . . . . 0.0 109.881 170.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -140.09 135.23 32.36 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 149.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 11.6 ptpt -73.98 173.09 10.49 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 118.282 0.492 . . . . 0.0 110.651 172.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.0 m -121.63 176.62 5.62 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 124.359 1.064 . . . . 0.0 108.469 159.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 163.45 -81.92 0.12 Allowed Glycine 0 CA--C 1.518 0.257 0 N-CA-C 107.853 -2.099 . . . . 0.0 107.853 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -70.05 97.78 0.68 Allowed 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.462 2.108 . . . . 0.0 108.241 173.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.3 m -61.48 108.53 0.97 Allowed 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 173.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 63.44 170.2 0.16 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.373 1.469 . . . . 0.0 112.425 -168.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.426 0 N-CA-C 106.606 -2.597 . . . . 0.0 106.606 167.675 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.313 0 CA-C-O 118.846 -0.974 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.5 m -151.89 159.96 43.67 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.592 1.557 . . . . 0.0 107.54 166.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.8 t -140.47 1.89 1.79 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.969 1.308 . . . . 0.0 111.335 172.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 75.38 -174.36 52.25 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 -164.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.9 p -156.2 26.56 0.36 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.332 1.053 . . . . 0.0 111.223 176.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.4 m -132.32 128.27 37.36 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.291 1.436 . . . . 0.0 109.827 -168.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -97.38 -123.61 4.65 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 107.781 -2.128 . . . . 0.0 107.781 165.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 45.84 68.92 0.52 Allowed 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.512 1.925 . . . . 0.0 111.595 175.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.24 163.75 35.37 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 123.843 0.857 . . . . 0.0 110.337 -173.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.2 m -65.77 163.42 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 123.764 0.826 . . . . 0.0 109.22 165.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 40.2 p -131.81 91.14 2.93 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 175.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.4 mp -61.83 150.43 37.23 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 172.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -57.89 -43.7 86.25 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 117.99 0.359 . . . . 0.0 111.207 -175.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.1 t -56.3 -53.88 34.59 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.15 0 C-N-CA 124.044 0.938 . . . . 0.0 109.498 173.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -56.63 -39.7 86.32 Favored Glycine 0 CA--C 1.529 0.924 0 CA-C-N 119.363 0.983 . . . . 0.0 112.719 178.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -63.63 -55.44 23.58 Favored 'General case' 0 N--CA 1.46 0.048 0 CA-C-N 118.51 1.155 . . . . 0.0 109.943 176.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.3 t -58.71 -38.47 72.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 123.465 0.706 . . . . 0.0 110.443 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 57.0 mt -58.64 -59.48 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 176.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -61.93 -37.15 83.6 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 118.073 0.397 . . . . 0.0 111.229 -173.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.88 -53.98 50.66 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 121.418 -0.801 . . . . 0.0 111.914 171.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.64 -37.12 93.24 Favored Glycine 0 CA--C 1.521 0.457 0 CA-C-O 119.177 -0.79 . . . . 0.0 111.899 -173.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 17.6 mtm105 -57.3 -61.33 2.55 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 117.69 0.745 . . . . 0.0 109.407 173.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -60.74 -29.91 69.68 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.132 0.973 . . . . 0.0 112.347 -177.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.4 m -65.05 -12.95 56.27 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.285 0.948 . . . . 0.0 112.959 177.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 41.6 mttm -121.69 8.83 10.07 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.484 1.513 . . . . 0.0 110.295 171.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.12 24.86 61.42 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 126.014 1.769 . . . . 0.0 113.249 -177.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 57.6 mt -87.55 139.89 30.08 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.264 1.532 . . . . 0.0 111.536 -171.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.1 t -78.88 163.68 25.09 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.613 1.165 . . . . 0.0 110.156 177.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -59.21 -40.84 87.08 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 121.015 -1.053 . . . . 0.0 110.086 175.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.47 -34.85 76.15 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 118.512 -0.756 . . . . 0.0 111.972 178.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.39 -36.53 81.51 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.354 0.979 . . . . 0.0 110.787 175.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.78 -47.21 84.49 Favored 'General case' 0 C--N 1.338 0.108 0 O-C-N 121.896 -0.503 . . . . 0.0 109.875 178.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.23 -53.31 36.38 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 125.859 1.664 . . . . 0.0 108.738 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 29.3 m -58.09 -49.58 76.44 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.851 0.861 . . . . 0.0 111.55 174.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 49.1 mttm -57.53 -20.52 32.29 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.6 pt -116.6 5.2 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 119.399 1.0 . . . . 0.0 112.009 176.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 46.6 t30 48.01 64.42 1.65 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 127.04 2.136 . . . . 0.0 110.821 -175.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -137.9 174.88 10.11 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 127.38 2.272 . . . . 0.0 109.862 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.1 mmmm -73.72 143.07 81.22 Favored Pre-proline 0 CA--C 1.53 0.175 0 C-N-CA 124.448 1.099 . . . . 0.0 109.647 172.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -71.99 -12.22 28.07 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.678 2.252 . . . . 0.0 112.829 175.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 44.4 tp60 -73.83 -28.24 61.51 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 117.626 -1.178 . . . . 0.0 111.752 173.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.0 m -75.71 -34.29 28.24 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 CA-C-N 120.544 1.52 . . . . 0.0 109.984 174.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 35.9 mm -59.96 -52.72 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 119.579 1.081 . . . . 0.0 109.893 178.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.67 -31.78 71.92 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.252 -177.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -78.32 -36.26 46.65 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.769 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -54.73 -46.79 74.31 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 126.087 1.755 . . . . 0.0 110.147 173.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -59.65 -48.61 80.97 Favored 'General case' 0 C--N 1.34 0.152 0 C-N-CA 124.011 0.924 . . . . 0.0 110.854 177.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.9 -19.88 61.19 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 107.75 -3.21 34.07 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 125.1 1.333 . . . . 0.0 113.723 176.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 13.0 mmt180 -71.77 -52.87 15.41 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.895 1.347 . . . . 0.0 111.896 -170.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.56 129.23 40.92 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -175.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 35.4 mm -70.11 120.1 75.97 Favored Pre-proline 0 C--O 1.236 0.375 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 174.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -84.39 113.6 1.74 Allowed 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 121.093 1.195 . . . . 0.0 110.216 -171.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -81.24 142.12 33.47 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 177.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -55.54 -38.59 69.46 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.899 0.88 . . . . 0.0 111.849 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -67.19 -50.76 59.82 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.288 0.635 . . . . 0.0 111.351 174.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.6 t -64.42 -43.62 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 119.543 1.065 . . . . 0.0 109.962 -176.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 22.4 mt -45.36 -51.95 10.52 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 125.172 1.389 . . . . 0.0 109.447 165.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.98 -32.66 76.07 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 123.683 0.659 . . . . 0.0 114.105 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -71.71 -48.07 49.74 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 118.984 1.392 . . . . 0.0 109.522 174.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.1 mt -54.8 -36.12 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.104 0 C-N-CA 124.128 0.971 . . . . 0.0 109.923 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -56.27 -50.82 70.28 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 121.884 -0.51 . . . . 0.0 111.081 176.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 65.9 mtt85 -65.58 -24.9 67.19 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.678 0.672 . . . . 0.0 111.954 177.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.36 -33.96 77.2 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.97 0.908 . . . . 0.0 112.95 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 44.6 pt -117.41 -11.78 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.815 0.846 . . . . 0.0 112.174 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.0 36.18 72.64 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 126.078 1.799 . . . . 0.0 113.294 -175.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 48.7 mt -134.88 164.58 27.27 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 118.589 1.195 . . . . 0.0 109.894 171.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -69.99 141.29 52.98 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 127.404 2.281 . . . . 0.0 109.086 172.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -118.64 6.12 11.62 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.874 1.67 . . . . 0.0 110.005 176.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -138.88 162.23 35.32 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 125.01 1.324 . . . . 0.0 108.647 -175.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 67.27 170.65 4.7 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 -165.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -69.38 -15.72 63.37 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 123.472 0.709 . . . . 0.0 110.774 168.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -69.91 16.73 0.06 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.635 1.574 . . . . 0.0 111.71 172.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.0 tt -55.66 146.76 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 O-C-N 120.699 -1.251 . . . . 0.0 110.108 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.69 -1.4 53.11 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-O 119.664 -0.52 . . . . 0.0 113.63 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 20.1 mmtm -85.6 151.03 55.08 Favored Pre-proline 0 N--CA 1.45 -0.455 0 CA-C-N 119.447 1.624 . . . . 0.0 108.469 171.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -70.31 161.65 45.22 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 124.271 3.314 . . . . 0.0 113.191 -173.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 32.7 pt -113.16 158.9 13.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 125.56 1.544 . . . . 0.0 110.961 -175.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 59.43 -178.33 0.09 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.829 2.452 . . . . 0.0 111.17 -171.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -67.57 128.29 35.89 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 120.654 -1.278 . . . . 0.0 109.758 176.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -160.8 166.1 35.4 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 108.148 -1.981 . . . . 0.0 108.148 169.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.12 123.39 9.94 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.979 2.452 . . . . 0.0 110.445 -177.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 17.7 ptt-85 -152.45 -48.91 0.1 Allowed 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 177.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 53.39 -176.46 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.848 1.259 . . . . 0.0 111.889 -164.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 38.0 mmtt 29.1 83.55 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 128.092 2.557 . . . . 0.0 114.136 -178.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.4 m -146.05 -175.09 4.61 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.882 1.273 . . . . 0.0 109.653 170.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -65.11 154.83 49.61 Favored Glycine 0 CA--C 1.533 1.172 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 173.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.408 ' C ' ' HG ' ' A' ' 89' ' ' SER . 48.3 Cg_endo -65.06 154.71 72.08 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.151 1.9 . . . . 0.0 110.064 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.408 ' HG ' ' C ' ' A' ' 88' ' ' PRO . 58.0 m -159.48 138.85 11.3 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.036 0.934 . . . . 0.0 109.327 175.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.0 m -61.4 171.77 1.34 Allowed 'General case' 0 C--O 1.241 0.627 0 C-N-CA 125.52 1.528 . . . . 0.0 109.01 164.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.832 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 178.065 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.541 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.48 -64.09 0.36 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 167.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.1 m 51.99 -165.48 0.06 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.891 1.276 . . . . 0.0 111.953 -177.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 179.47 -148.16 7.98 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 106.332 -2.707 . . . . 0.0 106.332 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.4 p -63.59 152.81 37.73 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.414 0.686 . . . . 0.0 110.81 168.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.7 m -140.88 -179.18 5.92 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.645 1.578 . . . . 0.0 107.825 169.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -146.9 37.35 1.18 Allowed Glycine 0 CA--C 1.519 0.326 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.18 166.39 14.16 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 122.37 -0.488 . . . . 0.0 111.002 -174.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -136.99 123.29 20.61 Favored 'General case' 0 CA--C 1.512 -0.512 0 O-C-N 121.597 -0.689 . . . . 0.0 109.36 -170.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.0 t -69.87 115.68 9.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 177.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.0 m -136.28 157.96 45.55 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.484 0.714 . . . . 0.0 109.199 -168.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 64.94 172.18 0.2 Allowed 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 127.117 2.167 . . . . 0.0 113.222 168.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.0 mp0 -66.52 -55.14 16.93 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 168.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.6 t -53.8 -62.32 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 C-N-CA 125.299 1.44 . . . . 0.0 109.949 -178.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -52.36 -51.47 42.25 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-N 119.759 1.163 . . . . 0.0 112.678 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.03 -41.01 86.78 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 118.352 1.076 . . . . 0.0 111.923 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 68.1 t -70.99 -37.72 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 119.358 0.981 . . . . 0.0 110.913 176.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 40.5 mt -57.34 -56.98 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 176.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -54.17 -54.63 37.14 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 125.191 1.396 . . . . 0.0 109.512 -176.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -51.61 -60.72 2.83 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.788 1.235 . . . . 0.0 111.137 177.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.84 -27.35 72.44 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-O 118.692 -1.06 . . . . 0.0 113.042 -170.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.433 HH21 ' CD ' ' A' ' 47' ' ' GLU . 18.9 mtm105 -59.39 -59.42 5.48 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 118.314 1.057 . . . . 0.0 108.324 167.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -57.19 -39.55 75.61 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 125.547 1.539 . . . . 0.0 112.5 -175.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 56.7 m -58.91 -40.41 84.42 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 120.004 1.274 . . . . 0.0 110.529 177.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -81.27 -2.89 50.7 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.042 0.937 . . . . 0.0 111.568 176.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.31 7.9 69.11 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 126.393 1.949 . . . . 0.0 113.207 -176.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.2 mt -83.99 147.13 27.61 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 118.033 0.917 . . . . 0.0 110.408 -165.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 62.7 p -80.43 176.16 10.02 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.265 0.626 . . . . 0.0 110.344 177.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -63.6 -42.19 98.28 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 118.799 -0.62 . . . . 0.0 110.081 168.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -55.63 -42.35 74.84 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.245 1.018 . . . . 0.0 111.661 174.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -65.34 -40.08 93.21 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.52 -49.5 75.08 Favored 'General case' 0 C--N 1.344 0.336 0 C-N-CA 123.578 0.751 . . . . 0.0 109.105 176.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.83 -57.25 10.84 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 124.947 1.299 . . . . 0.0 108.363 -177.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 85.7 m -61.71 -34.16 75.3 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.466 0.707 . . . . 0.0 112.229 176.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.5 mttm -63.35 -15.31 57.02 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 120.832 1.651 . . . . 0.0 112.817 173.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.0 pt -120.41 6.4 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 124.731 1.212 . . . . 0.0 111.072 175.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 40.8 t30 55.65 31.09 16.64 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 128.131 2.573 . . . . 0.0 114.53 -173.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -105.68 -177.01 3.24 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 125.424 1.49 . . . . 0.0 110.918 177.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -84.81 145.66 44.49 Favored Pre-proline 0 C--O 1.228 -0.059 0 C-N-CA 126.458 1.903 . . . . 0.0 111.359 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.03 -19.76 63.69 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.798 2.332 . . . . 0.0 111.961 171.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 28.5 tp60 -64.45 -46.93 81.0 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.87 175.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.6 m -69.6 -31.56 49.3 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.731 0 O-C-N 123.766 0.666 . . . . 0.0 110.244 -173.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 23.7 mm -64.8 -44.44 96.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 O-C-N 119.953 -1.717 . . . . 0.0 110.241 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.59 -32.52 72.62 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 174.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.43 -57.32 10.64 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.765 170.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -52.02 -35.61 47.5 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 126.236 1.815 . . . . 0.0 112.48 -178.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.433 ' CD ' HH21 ' A' ' 22' ' ' ARG . 22.6 mt-10 -67.89 -24.47 65.23 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.076 0.853 . . . . 0.0 112.036 176.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.42 -32.84 28.87 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.874 1.27 . . . . 0.0 110.419 164.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.95 33.74 32.43 Favored Glycine 0 CA--C 1.525 0.694 0 O-C-N 121.185 -0.947 . . . . 0.0 112.573 -173.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.5 mtt85 -71.69 -60.02 2.45 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 118.29 1.045 . . . . 0.0 109.56 177.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.71 137.87 43.19 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 128.081 2.553 . . . . 0.0 108.918 173.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.9 mt -73.53 116.77 54.69 Favored Pre-proline 0 C--O 1.236 0.386 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 175.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -67.35 115.64 3.79 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 122.489 2.126 . . . . 0.0 107.29 -172.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -97.13 142.6 28.86 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -173.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -60.72 -39.26 87.94 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 119.039 -0.505 . . . . 0.0 110.357 -171.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -59.91 -26.55 66.02 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 175.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 73.2 t -93.44 -43.92 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 119.997 1.271 . . . . 0.0 109.085 177.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 26.9 mt -50.0 -46.73 53.0 Favored 'General case' 0 C--O 1.227 -0.086 0 C-N-CA 124.244 1.018 . . . . 0.0 110.105 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.98 -40.1 95.03 Favored Glycine 0 CA--C 1.535 1.336 0 CA-C-N 118.207 0.458 . . . . 0.0 113.009 176.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.6 mtmm -60.67 -42.78 97.76 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 118.794 1.297 . . . . 0.0 110.803 175.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.8 mt -67.31 -35.79 74.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 123.759 0.824 . . . . 0.0 109.515 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -58.77 -47.66 83.94 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 119.43 1.014 . . . . 0.0 109.519 175.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 16.5 mtm-85 -64.4 -20.69 66.3 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 175.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.92 -52.41 24.78 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.872 0.869 . . . . 0.0 111.478 -179.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 47.8 pt -99.96 -15.7 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.762 0.825 . . . . 0.0 111.828 -177.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.38 27.77 61.02 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 126.011 1.767 . . . . 0.0 113.563 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 58.9 mt -129.38 165.42 21.55 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.883 0.873 . . . . 0.0 108.973 173.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -70.32 145.05 51.48 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 125.326 1.451 . . . . 0.0 109.382 175.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -118.83 16.39 13.49 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.255 1.822 . . . . 0.0 109.462 175.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -144.92 162.18 37.5 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 125.364 1.466 . . . . 0.0 108.826 -171.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 70.44 171.63 10.27 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 124.633 1.111 . . . . 0.0 110.855 -174.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -67.54 -24.7 65.57 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.351 -1.088 . . . . 0.0 109.447 165.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -73.52 21.33 0.08 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.729 2.012 . . . . 0.0 112.126 175.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.7 tt -53.54 151.68 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 O-C-N 120.734 -1.229 . . . . 0.0 110.233 172.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.61 -6.83 10.31 Favored Glycine 0 CA--C 1.536 1.397 0 O-C-N 121.118 -0.989 . . . . 0.0 114.108 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 52.9 mmtt -71.01 148.5 94.47 Favored Pre-proline 0 N--CA 1.453 -0.313 0 CA-C-N 120.022 1.911 . . . . 0.0 107.529 163.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -71.05 158.78 54.3 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.419 2.746 . . . . 0.0 111.609 -175.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 17.8 pt -105.66 139.67 26.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 C-N-CA 123.589 0.756 . . . . 0.0 109.187 177.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 49.32 54.16 11.43 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.211 1.804 . . . . 0.0 110.769 176.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.3 tmtm? -127.84 107.23 9.69 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -171.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 119.53 -173.61 15.15 Favored Glycine 0 CA--C 1.533 1.156 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -177.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.19 79.87 2.83 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 125.266 3.977 . . . . 0.0 110.167 -169.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -163.3 88.51 0.58 Allowed 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 178.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -153.94 168.12 27.44 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 125.212 1.405 . . . . 0.0 107.973 173.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.49 10.1 9.11 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.837 0.855 . . . . 0.0 113.283 -175.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.8 t -130.89 170.0 15.01 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 -178.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 114.85 82.81 1.08 Allowed Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.813 1.673 . . . . 0.0 109.815 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -72.59 177.49 7.42 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.5 2.133 . . . . 0.0 112.35 -177.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.8 167.71 21.44 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.951 2.101 . . . . 0.0 106.517 161.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 25.0 t -148.15 20.7 1.1 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.458 1.903 . . . . 0.0 108.694 174.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.519 0 N-CA-C 106.405 -2.678 . . . . 0.0 106.405 -129.522 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.685 0 N-CA-C 108.842 -1.703 . . . . 0.0 108.842 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.7 m 64.06 -66.79 0.11 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.997 1.319 . . . . 0.0 109.777 -162.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.6 p -60.46 166.68 2.96 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.81 1.244 . . . . 0.0 111.016 158.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.97 -80.08 1.5 Allowed Glycine 0 C--N 1.333 0.386 0 N-CA-C 108.919 -1.673 . . . . 0.0 108.919 171.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.9 m 52.8 94.01 0.02 OUTLIER 'General case' 0 C--O 1.232 0.179 0 C-N-CA 127.262 2.225 . . . . 0.0 112.465 -176.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 88.0 p -142.97 140.69 31.17 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.286 1.034 . . . . 0.0 109.683 168.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 72.59 168.74 12.26 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.315 1.436 . . . . 0.0 113.069 -177.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -81.66 48.44 1.19 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.685 1.594 . . . . 0.0 110.938 -173.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -64.31 132.76 51.13 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 120.899 -1.126 . . . . 0.0 110.306 -176.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.0 m -61.94 163.89 1.24 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 123.923 0.889 . . . . 0.0 109.809 162.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.9 t -116.76 174.9 5.83 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 158.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.9 mp -65.09 160.94 19.96 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.314 1.046 . . . . 0.0 109.898 177.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -52.44 -50.74 62.0 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.289 0.636 . . . . 0.0 111.385 -173.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.7 t -52.23 -63.84 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 C-N-CA 126.433 1.893 . . . . 0.0 109.141 176.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -51.56 -41.26 49.07 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-N 118.493 0.588 . . . . 0.0 112.998 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -64.94 -51.02 64.1 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 117.287 0.544 . . . . 0.0 110.299 -178.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.7 t -66.83 -33.77 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.104 0 C-N-CA 123.299 0.639 . . . . 0.0 110.149 -178.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 59.0 mt -56.03 -58.0 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 173.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -58.61 -47.61 83.76 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 123.898 0.879 . . . . 0.0 110.806 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -60.17 -53.29 59.5 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 118.899 0.772 . . . . 0.0 111.827 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.1 -25.45 74.62 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-O 118.48 -1.178 . . . . 0.0 112.966 -174.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.8 mtm105 -54.54 -67.71 0.24 Allowed 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 119.214 1.507 . . . . 0.0 110.482 160.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -61.46 -34.2 75.04 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 123.933 0.77 . . . . 0.0 110.527 -167.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.2 t -69.7 -10.39 58.1 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.031 0.932 . . . . 0.0 111.546 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -118.46 7.41 11.88 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.933 1.693 . . . . 0.0 110.308 173.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.15 2.44 40.05 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 126.308 1.908 . . . . 0.0 114.148 -177.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 21.4 mt -67.09 119.69 12.45 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 124.779 1.231 . . . . 0.0 107.71 -176.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.2 t -71.53 173.5 7.91 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.911 168.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -53.07 -55.33 24.69 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.51 -0.744 . . . . 0.0 109.754 174.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -58.58 -27.28 64.48 Favored 'General case' 0 C--O 1.227 -0.103 0 CA-C-N 118.515 0.598 . . . . 0.0 112.239 178.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -69.13 -36.07 77.07 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.125 -0.984 . . . . 0.0 111.109 173.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.77 -48.72 62.96 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.526 0.731 . . . . 0.0 110.943 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.56 -51.95 57.28 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.854 0.862 . . . . 0.0 109.664 174.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 83.5 m -67.6 -30.07 69.57 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 118.734 -0.65 . . . . 0.0 111.592 -179.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.8 mttm -59.98 -49.55 77.24 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 120.279 1.399 . . . . 0.0 111.138 170.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.7 pt -86.53 -6.03 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 119.302 0.955 . . . . 0.0 112.731 -176.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.7 t30 59.15 65.16 1.24 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 128.851 2.861 . . . . 0.0 112.561 -171.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -133.86 178.78 6.68 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 126.913 2.085 . . . . 0.0 110.089 176.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -79.29 151.93 75.69 Favored Pre-proline 0 N--CA 1.463 0.18 0 C-N-CA 124.73 1.212 . . . . 0.0 109.116 169.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -79.78 -11.96 13.74 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.192 1.928 . . . . 0.0 115.306 -179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -71.82 -43.85 64.89 Favored 'General case' 0 CA--C 1.515 -0.368 0 O-C-N 120.981 -1.075 . . . . 0.0 110.075 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.6 m -67.32 -38.22 80.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 -172.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 27.6 mm -55.82 -50.66 66.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 125.796 1.639 . . . . 0.0 110.821 170.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.11 -30.73 68.33 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 122.244 -0.285 . . . . 0.0 111.36 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.2 -30.93 49.19 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 118.418 -0.801 . . . . 0.0 111.382 177.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -59.11 -43.97 91.96 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 120.026 1.285 . . . . 0.0 110.231 169.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -56.23 -40.84 74.73 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -171.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.2 m -105.2 9.27 34.14 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.66 -0.92 58.14 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.144 -1.027 . . . . 0.0 114.258 163.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 19.5 mtm180 -91.91 -21.52 20.54 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 118.941 1.371 . . . . 0.0 114.367 -174.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.72 145.81 55.56 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 166.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 26.9 mm -72.79 116.77 53.47 Favored Pre-proline 0 C--O 1.238 0.49 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 171.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.42 123.26 9.37 Favored 'Trans proline' 0 N--CA 1.445 -1.324 0 N-CA-C 108.21 -1.496 . . . . 0.0 108.21 -178.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 63.3 t-20 -131.8 122.46 25.82 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 -171.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -48.99 -34.09 12.35 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.842 1.257 . . . . 0.0 113.522 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -57.27 -35.19 69.45 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 65.6 t -93.98 -41.97 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 126.968 2.107 . . . . 0.0 109.937 176.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 76.9 mt -56.81 -39.73 74.7 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 120.457 1.48 . . . . 0.0 110.753 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.02 -38.66 93.26 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-N 118.922 0.783 . . . . 0.0 112.573 175.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 24.0 mtmm -65.39 -47.54 75.97 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 117.627 0.714 . . . . 0.0 110.574 173.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 78.1 mt -60.64 -34.6 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 123.86 0.864 . . . . 0.0 110.331 -178.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -56.57 -50.31 72.31 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.654 -0.654 . . . . 0.0 110.396 175.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.4 mtt85 -59.42 -35.37 73.87 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 118.763 0.71 . . . . 0.0 110.72 176.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.72 -32.86 70.94 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.006 1.323 . . . . 0.0 112.929 -174.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 44.4 pt -115.57 -12.15 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 123.755 0.822 . . . . 0.0 112.172 177.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.79 40.0 98.0 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 126.516 2.008 . . . . 0.0 112.648 -174.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 41.0 mt -142.78 164.31 30.44 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.711 1.256 . . . . 0.0 109.33 173.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -68.72 142.99 54.85 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 126.442 1.897 . . . . 0.0 110.902 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -117.54 4.28 12.41 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.865 2.066 . . . . 0.0 111.226 177.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 37.1 mtt-85 -138.44 163.29 32.31 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.258 1.023 . . . . 0.0 110.804 176.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.76 166.56 16.94 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 125.581 1.562 . . . . 0.0 110.09 -170.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -73.63 -7.41 51.84 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.036 -1.273 . . . . 0.0 110.296 168.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -67.53 6.94 0.54 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.729 1.612 . . . . 0.0 112.286 164.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.7 tt -51.36 142.4 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 120.151 1.342 . . . . 0.0 110.983 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.14 3.6 53.02 Favored Glycine 0 CA--C 1.537 1.452 0 O-C-N 121.637 -0.664 . . . . 0.0 114.002 -178.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 20.3 mmtt -81.46 155.09 71.67 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 120.709 2.255 . . . . 0.0 105.959 159.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -70.92 158.25 55.93 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.803 2.335 . . . . 0.0 113.072 -171.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 28.5 pt -100.96 145.98 10.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 171.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 23.83 58.97 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 127.506 2.322 . . . . 0.0 114.305 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 24.0 ttpt -61.7 -40.21 94.21 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-O 119.024 -0.512 . . . . 0.0 110.421 -164.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -142.13 171.38 24.6 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 123.802 0.715 . . . . 0.0 111.498 172.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -63.63 101.3 0.31 Allowed 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 124.746 3.631 . . . . 0.0 111.086 178.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 80.8 mtt85 47.43 -119.03 0.98 Allowed 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 125.974 1.71 . . . . 0.0 109.486 -171.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 21.3 76.76 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 128.746 2.818 . . . . 0.0 113.544 173.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -56.78 -33.33 66.53 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.279 0.631 . . . . 0.0 112.557 -172.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.8 p -148.24 174.03 12.41 Favored 'General case' 0 C--O 1.237 0.436 0 O-C-N 121.424 -0.797 . . . . 0.0 109.263 173.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 93.66 130.85 5.79 Favored Glycine 0 CA--C 1.532 1.098 0 N-CA-C 108.11 -1.996 . . . . 0.0 108.11 -169.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -68.66 163.33 37.43 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 122.242 1.961 . . . . 0.0 109.282 170.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.9 p -156.39 -66.68 0.11 Allowed 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -178.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 33.1 t -80.59 134.77 35.96 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 161.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.955 0 CA-C-O 117.276 -1.847 . . . . 0.0 108.606 164.709 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.923 0 CA-C-O 118.534 -1.148 . . . . 0.0 111.555 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.4 m 93.78 53.72 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 129.171 2.988 . . . . 0.0 111.406 174.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.7 m -141.35 166.36 24.99 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 126.072 1.749 . . . . 0.0 106.708 161.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 143.99 12.39 0.31 Allowed Glycine 0 CA--C 1.529 0.942 0 CA-C-O 118.533 -1.148 . . . . 0.0 113.88 -177.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.0 m -74.47 171.88 12.97 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 119.377 1.589 . . . . 0.0 109.655 170.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.7 t -72.92 -55.71 6.21 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 166.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 153.06 -176.92 30.98 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 -178.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -162.11 142.31 10.11 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.612 1.165 . . . . 0.0 108.438 172.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? 56.76 -172.29 0.08 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.702 1.601 . . . . 0.0 110.438 -161.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.2 m -84.22 167.1 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.558 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 156.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.1 t -81.57 158.3 24.46 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 122.548 1.166 . . . . 0.0 110.26 169.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -69.39 167.59 16.22 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.42 1.888 . . . . 0.0 109.019 164.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.09 -56.85 16.44 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.914 1.285 . . . . 0.0 111.934 173.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.0 t -53.89 -58.52 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 123.844 0.858 . . . . 0.0 108.728 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -51.47 -46.12 53.05 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-O 118.571 -1.127 . . . . 0.0 112.929 176.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 36.1 tttm -59.06 -53.04 62.83 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 118.874 1.337 . . . . 0.0 109.244 -178.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 92.6 t -62.67 -33.59 60.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 118.707 -0.663 . . . . 0.0 110.548 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 70.1 mt -66.16 -59.19 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 119.913 1.233 . . . . 0.0 108.634 176.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -51.59 -47.33 63.59 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 126.545 1.938 . . . . 0.0 110.209 -178.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -60.4 -66.34 0.54 Allowed 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.726 1.61 . . . . 0.0 109.994 174.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.16 -26.19 69.0 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-O 118.736 -1.036 . . . . 0.0 113.303 -169.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 19.2 mtm105 -58.13 -64.28 0.97 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.546 1.173 . . . . 0.0 109.045 165.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -69.41 -8.43 46.53 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.562 1.545 . . . . 0.0 113.571 -175.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.8 m -69.24 -13.77 62.59 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.877 1.271 . . . . 0.0 112.201 162.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -133.86 12.71 4.01 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.484 1.914 . . . . 0.0 111.475 172.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.41 4.43 17.58 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 125.292 1.425 . . . . 0.0 114.758 -175.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 25.3 mt -66.69 125.85 27.13 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 119.635 1.717 . . . . 0.0 109.431 -165.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 52.1 p -65.88 168.98 7.2 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.754 0.788 . . . . 0.0 110.248 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -64.42 -34.6 78.55 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.459 -0.776 . . . . 0.0 110.733 172.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.2 mtpt -61.33 -44.44 97.19 Favored 'General case' 0 CA--C 1.518 -0.271 0 O-C-N 121.737 -0.602 . . . . 0.0 110.976 171.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -66.23 -37.85 86.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 118.312 0.506 . . . . 0.0 110.419 -177.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.11 -51.95 67.81 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 171.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.76 -48.55 69.6 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.283 1.033 . . . . 0.0 110.151 -177.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.7 m -57.76 -46.1 84.99 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.282 1.033 . . . . 0.0 111.369 175.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.2 mttm -59.03 -22.28 60.43 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.41 1.004 . . . . 0.0 113.681 178.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 26.9 pt -113.41 6.05 7.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 119.534 1.061 . . . . 0.0 111.992 178.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 49.88 48.33 21.92 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.234 1.814 . . . . 0.0 111.156 -174.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.468 ' HG3' ' H ' ' A' ' 39' ' ' LYS . 3.1 tp10 -127.68 -171.06 2.35 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.618 1.967 . . . . 0.0 109.007 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.468 ' H ' ' HG3' ' A' ' 38' ' ' GLU . 11.0 mmpt? -103.87 146.18 32.04 Favored Pre-proline 0 CA--C 1.531 0.242 0 O-C-N 120.655 -1.278 . . . . 0.0 111.169 -174.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -73.19 -19.2 22.88 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.46 2.106 . . . . 0.0 114.161 -178.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -58.47 -52.31 66.18 Favored 'General case' 0 C--N 1.339 0.127 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 167.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.4 m -66.1 -29.04 45.49 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.532 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.808 -175.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 49.1 mm -61.62 -50.16 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 120.421 1.464 . . . . 0.0 110.251 174.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.24 -31.85 73.11 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 122.396 0.279 . . . . 0.0 111.589 178.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -77.08 -33.45 57.08 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 122.943 0.497 . . . . 0.0 110.405 177.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -57.69 -43.63 85.27 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 125.657 1.583 . . . . 0.0 110.016 170.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -60.06 -58.31 9.08 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.014 0.926 . . . . 0.0 109.451 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.46 -9.42 34.13 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 178.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.1 0.15 77.86 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-N 120.061 1.301 . . . . 0.0 113.457 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 72.4 mtt-85 -70.82 -43.9 67.63 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.896 1.279 . . . . 0.0 111.125 -176.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.19 139.25 58.75 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 173.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 50.3 mm -74.45 117.13 59.57 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 105.669 -1.975 . . . . 0.0 105.669 168.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -77.04 115.01 3.92 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 C-N-CA 121.223 1.282 . . . . 0.0 109.072 -171.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -81.38 131.18 35.27 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.892 1.677 . . . . 0.0 107.77 -174.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -54.8 -33.5 61.6 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.33 1.052 . . . . 0.0 113.137 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -60.97 -64.02 1.1 Allowed 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 122.1 0.952 . . . . 0.0 108.577 174.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.414 ' HA ' ' HD3' ' A' ' 60' ' ' LYS . 77.5 t -60.6 -41.11 86.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.816 1.247 . . . . 0.0 110.272 -174.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.2 mt -48.23 -46.22 35.11 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.047 0.939 . . . . 0.0 110.551 177.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.02 -33.56 62.41 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 118.6 0.637 . . . . 0.0 113.561 178.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.414 ' HD3' ' HA ' ' A' ' 57' ' ' VAL . 37.3 mtpt -64.46 -40.19 95.25 Favored 'General case' 0 N--CA 1.463 0.205 0 O-C-N 121.305 -1.115 . . . . 0.0 109.541 174.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.9 mt -63.64 -36.77 77.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 124.681 1.192 . . . . 0.0 108.746 174.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -57.19 -51.23 70.16 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 119.739 1.154 . . . . 0.0 110.241 174.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 60.6 mtt85 -63.18 -27.48 69.39 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.188 0.449 . . . . 0.0 111.545 175.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.1 -38.11 87.61 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.948 0.899 . . . . 0.0 112.187 179.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 22.9 pt -118.6 -9.04 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 119.134 0.879 . . . . 0.0 113.256 -176.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.44 36.36 93.28 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 126.555 2.026 . . . . 0.0 113.343 -176.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 84.7 mt -133.37 165.51 24.67 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.345 1.458 . . . . 0.0 108.156 169.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 53.3 mttm -76.25 141.88 41.57 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.615 1.566 . . . . 0.0 109.565 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -118.6 11.07 12.73 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 126.267 1.827 . . . . 0.0 110.968 178.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 5.8 mtt85 -140.22 167.9 21.06 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.254 1.422 . . . . 0.0 108.255 176.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 73.4 171.04 21.25 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.543 1.544 . . . . 0.0 111.158 -173.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.75 -13.08 60.06 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.359 -1.083 . . . . 0.0 110.163 165.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -75.01 18.5 0.18 Allowed 'General case' 0 CA--C 1.549 0.921 0 O-C-N 120.577 -1.327 . . . . 0.0 110.146 168.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.9 tt -53.85 148.04 2.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 O-C-N 120.301 -1.499 . . . . 0.0 110.62 173.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 67.62 -1.43 7.45 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 123.781 0.705 . . . . 0.0 113.504 -178.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 12.3 mmtp -73.69 155.12 89.28 Favored Pre-proline 0 N--CA 1.452 -0.367 0 CA-C-N 119.634 1.717 . . . . 0.0 106.968 160.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -57.22 156.64 24.32 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 122.792 2.328 . . . . 0.0 112.559 177.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 30.7 pt -100.86 153.94 4.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 154.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 25.02 61.25 0.06 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 128.214 2.605 . . . . 0.0 113.612 166.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -171.0 -30.48 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.539 1.936 . . . . 0.0 111.813 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -109.77 107.9 2.42 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-O 118.2 -1.333 . . . . 0.0 111.49 -169.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -73.77 68.32 4.67 Favored 'Trans proline' 0 CA--C 1.537 0.667 1 C-N-CA 125.42 4.08 . . . . 0.0 111.126 -177.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.11 116.03 9.78 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.404 1.482 . . . . 0.0 108.546 -173.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.3 140.99 43.22 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 123.914 0.886 . . . . 0.0 109.973 174.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 31.7 mttp -64.38 147.41 52.67 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.223 1.009 . . . . 0.0 109.16 178.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.5 t -71.07 -47.27 59.29 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 168.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -78.68 117.38 4.59 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-O 117.519 -1.711 . . . . 0.0 110.91 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -76.1 -175.2 2.4 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.971 2.447 . . . . 0.0 109.698 167.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 10.0 p -137.75 163.01 32.41 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 161.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 30.1 t -79.5 124.83 28.85 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 104.306 -2.479 . . . . 0.0 104.306 149.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.911 0 N-CA-C 104.308 -3.517 . . . . 0.0 104.308 -171.212 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.906 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.9 t -72.04 159.53 34.03 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.288 0.635 . . . . 0.0 111.157 -175.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 64.3 m -136.14 100.48 4.42 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.261 1.424 . . . . 0.0 109.276 169.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -131.28 168.18 22.21 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 164.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.7 t -159.26 -40.42 0.06 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 118.149 -0.929 . . . . 0.0 112.365 175.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.8 m 38.05 75.26 0.07 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.816 2.046 . . . . 0.0 112.726 178.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -138.09 179.83 17.88 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 124.82 1.2 . . . . 0.0 110.283 178.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -147.39 145.63 29.33 Favored 'General case' 0 C--O 1.238 0.459 0 O-C-N 121.681 -0.894 . . . . 0.0 109.01 -174.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -173.93 156.54 2.79 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.558 1.143 . . . . 0.0 111.568 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.7 p -66.0 162.38 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 123.521 0.728 . . . . 0.0 109.285 159.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.2 t -135.18 169.72 17.02 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.787 1.235 . . . . 0.0 108.851 165.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.1 mp -67.96 163.16 22.78 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 125.281 1.432 . . . . 0.0 109.367 174.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -58.18 -40.14 80.74 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-O 119.422 -0.323 . . . . 0.0 110.473 176.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.2 t -56.71 -58.26 6.27 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.316 0 C-N-CA 123.668 0.787 . . . . 0.0 109.67 177.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -56.57 -38.59 81.95 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 119.571 1.078 . . . . 0.0 112.363 178.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -62.05 -59.3 5.29 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.257 1.028 . . . . 0.0 110.096 175.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.4 t -61.35 -37.57 77.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 125.308 1.443 . . . . 0.0 110.347 -175.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 51.4 mt -53.47 -68.67 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 170.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -58.4 -34.05 70.32 Favored 'General case' 0 N--CA 1.445 -0.697 0 O-C-N 123.882 0.739 . . . . 0.0 110.8 -168.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -57.22 -69.69 0.15 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.093 1.757 . . . . 0.0 109.906 174.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.95 -32.1 73.14 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.776 -0.529 . . . . 0.0 111.776 -172.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -54.58 -62.01 1.93 Allowed 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 125.392 1.477 . . . . 0.0 108.798 172.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -63.19 -38.21 90.27 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 119.14 0.882 . . . . 0.0 111.449 -177.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 43.5 m -76.26 -2.31 30.79 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.377 0.99 . . . . 0.0 112.561 -177.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -115.55 12.86 16.25 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.256 1.022 . . . . 0.0 111.229 165.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.79 3.15 66.76 Favored Glycine 0 C--N 1.34 0.769 0 C-N-CA 128.03 2.729 . . . . 0.0 114.676 175.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 33.6 mt -72.95 130.16 39.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 118.781 1.29 . . . . 0.0 109.087 -159.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.0 p -68.51 170.75 8.52 Favored 'General case' 0 C--O 1.239 0.507 0 O-C-N 121.328 -0.858 . . . . 0.0 109.143 169.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -61.73 -30.1 70.55 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.64 -0.663 . . . . 0.0 110.408 168.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.4 mttt -71.24 -39.09 71.88 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.645 1.111 . . . . 0.0 112.3 175.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -64.65 -48.76 73.62 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.23 -47.63 78.08 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.789 0.836 . . . . 0.0 110.772 176.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.41 -50.39 73.86 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.536 0.734 . . . . 0.0 111.269 178.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.7 m -55.13 -47.72 74.67 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.068 1.347 . . . . 0.0 109.712 177.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 51.0 mttm -59.88 -15.45 21.47 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 125.453 1.501 . . . . 0.0 113.981 178.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.4 pt -122.35 15.43 5.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 118.998 0.817 . . . . 0.0 111.348 175.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.8 t30 57.53 13.14 1.75 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.166 1.386 . . . . 0.0 113.686 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -107.29 -170.87 1.77 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.762 2.025 . . . . 0.0 108.89 -173.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -102.51 149.65 36.9 Favored Pre-proline 0 N--CA 1.466 0.327 0 CA-C-N 120.024 1.284 . . . . 0.0 112.783 -175.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.71 -13.98 35.6 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 123.39 2.727 . . . . 0.0 112.919 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.9 tp60 -54.81 -60.15 3.76 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 123.588 0.755 . . . . 0.0 109.343 165.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.0 m -60.68 -41.09 86.93 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.52 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -172.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 44.0 mm -54.23 -47.28 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 119.252 0.933 . . . . 0.0 110.726 -178.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.8 -35.72 73.28 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.121 0.486 . . . . 0.0 112.134 176.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -79.18 -38.31 36.17 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.369 1.068 . . . . 0.0 110.992 -177.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -58.37 -39.7 80.28 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.216 1.407 . . . . 0.0 109.026 170.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -70.12 -33.09 71.41 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -178.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.2 t -73.85 -29.48 62.14 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.958 1.253 . . . . 0.0 109.41 167.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.55 10.84 49.48 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 124.002 0.81 . . . . 0.0 111.364 -174.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.7 mmt-85 -64.62 -60.93 2.55 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.258 1.023 . . . . 0.0 109.666 176.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.89 141.28 49.8 Favored 'General case' 0 C--O 1.239 0.543 0 O-C-N 124.787 1.304 . . . . 0.0 110.073 -172.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 mp -74.14 123.99 89.66 Favored Pre-proline 0 CA--C 1.533 0.31 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 -177.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -67.18 114.86 3.37 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 121.561 1.508 . . . . 0.0 110.215 -178.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 -103.94 116.86 33.02 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 125.039 1.336 . . . . 0.0 108.418 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -47.27 -39.24 14.05 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.23 1.412 . . . . 0.0 113.472 -175.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -63.08 -52.97 60.59 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 118.416 0.553 . . . . 0.0 110.356 -178.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.457 ' HA ' ' HD3' ' A' ' 60' ' ' LYS . 23.9 t -63.66 -43.24 98.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 124.391 1.076 . . . . 0.0 108.36 -178.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 81.6 mt -53.7 -48.88 69.13 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-O 118.528 -0.748 . . . . 0.0 110.257 176.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.5 -34.4 69.0 Favored Glycine 0 CA--C 1.534 1.266 0 CA-C-N 119.24 0.927 . . . . 0.0 113.309 177.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.457 ' HD3' ' HA ' ' A' ' 57' ' ' VAL . 17.9 mtpp -70.57 -44.86 66.5 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.493 -1.004 . . . . 0.0 109.5 175.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.8 mt -59.62 -35.4 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.114 0 C-N-CA 124.862 1.265 . . . . 0.0 109.792 178.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -54.28 -51.76 63.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 119.039 0.836 . . . . 0.0 110.245 177.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 58.1 mtt180 -71.81 -8.4 54.05 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.493 -0.755 . . . . 0.0 112.804 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.37 -38.46 63.18 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.436 0.694 . . . . 0.0 110.719 173.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 25.7 pt -120.25 -10.51 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -172.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.26 33.69 83.38 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 126.628 2.061 . . . . 0.0 113.027 -178.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 67.8 mt -128.8 164.82 22.2 Favored 'General case' 0 CA--C 1.527 0.076 0 CA-C-N 118.126 0.963 . . . . 0.0 109.635 170.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -78.84 140.68 38.13 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 126.055 1.742 . . . . 0.0 108.738 174.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -120.01 -2.18 10.29 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 127.897 2.479 . . . . 0.0 110.462 -177.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.435 HH11 ' HG2' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -141.02 169.67 17.17 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.673 1.189 . . . . 0.0 109.136 176.935 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.53 164.51 18.96 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -169.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.9 ttmt -78.06 3.21 15.49 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.884 -0.774 . . . . 0.0 111.061 175.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -96.69 23.11 7.3 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.827 2.051 . . . . 0.0 110.499 171.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.3 tt -52.96 151.94 1.04 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-N 120.238 1.381 . . . . 0.0 110.763 177.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.83 -6.03 14.71 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 119.058 -0.857 . . . . 0.0 113.36 178.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 40.1 mmtt -76.02 150.97 83.85 Favored Pre-proline 0 N--CA 1.45 -0.441 0 CA-C-N 119.83 1.815 . . . . 0.0 107.744 166.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -69.99 157.15 60.87 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 123.253 2.636 . . . . 0.0 111.64 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.0 pt -101.45 148.43 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.093 0 C-N-CA 123.959 0.904 . . . . 0.0 108.775 177.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 35.42 68.86 0.19 Allowed 'General case' 0 C--O 1.237 0.445 0 C-N-CA 127.466 2.306 . . . . 0.0 111.707 175.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.0 ptpt -120.71 174.31 6.66 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 125.075 1.35 . . . . 0.0 109.169 170.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -57.55 168.62 4.52 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 123.467 0.556 . . . . 0.0 112.072 177.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.11 157.02 55.0 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.57 2.18 . . . . 0.0 110.884 -177.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -153.11 6.03 0.36 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.537 0.735 . . . . 0.0 112.022 165.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -171.66 -177.76 2.09 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 128.05 2.54 . . . . 0.0 106.359 177.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -143.49 -162.27 1.42 Allowed 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.49 1.116 . . . . 0.0 109.037 159.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 44.9 m 61.37 178.69 0.11 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.554 1.941 . . . . 0.0 113.945 174.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -129.86 178.49 17.44 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 160.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -75.16 -35.34 3.09 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.375 2.05 . . . . 0.0 111.429 172.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.6 m 57.74 166.89 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 128.26 2.624 . . . . 0.0 114.405 172.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 61.7 m -162.24 -25.72 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.457 1.903 . . . . 0.0 112.182 171.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.447 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 -176.793 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.698 0 CA-C-O 119.269 -0.74 . . . . 0.0 112.164 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.3 t 49.31 46.14 23.21 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.032 1.416 . . . . 0.0 109.26 -157.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.6 m -65.48 135.02 54.65 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.805 0.842 . . . . 0.0 109.607 -172.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.88 -95.96 0.95 Allowed Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 107.114 -2.394 . . . . 0.0 107.114 168.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.5 t -153.96 117.03 4.51 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.998 1.719 . . . . 0.0 107.573 177.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.0 p -141.15 135.86 31.28 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 164.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 158.03 -156.59 27.49 Favored Glycine 0 CA--C 1.521 0.447 0 CA-C-N 119.739 1.154 . . . . 0.0 112.505 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -145.83 108.58 4.51 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 126.116 1.766 . . . . 0.0 108.777 169.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.7 tpm_? -159.1 162.41 36.52 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 177.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.2 p -60.29 156.88 2.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 C-N-CA 123.749 0.82 . . . . 0.0 109.559 165.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.7 p -106.47 107.24 18.16 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 172.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.1 mp -65.16 154.07 39.06 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 118.602 -0.713 . . . . 0.0 109.215 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -41.07 -55.41 2.58 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.739 1.616 . . . . 0.0 112.201 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.2 t -56.91 -61.33 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 C-N-CA 123.473 0.709 . . . . 0.0 109.227 -178.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.37 -33.1 65.06 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-N 119.325 0.966 . . . . 0.0 113.562 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 59.2 tptt -65.31 -55.09 20.22 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 125.421 1.488 . . . . 0.0 109.768 176.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 76.8 t -63.3 -39.16 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 CA-C-N 118.586 0.63 . . . . 0.0 110.573 178.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 83.3 mt -58.6 -56.31 17.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -51.47 -53.48 36.78 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.15 0.98 . . . . 0.0 109.662 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -58.98 -54.92 41.75 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 123.21 0.319 . . . . 0.0 110.977 -178.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.28 -25.01 76.32 Favored Glycine 0 CA--C 1.523 0.556 0 O-C-N 120.701 -1.249 . . . . 0.0 113.033 -172.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 20.0 mtm105 -60.07 -60.6 3.57 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 119.2 1.5 . . . . 0.0 109.511 162.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -64.6 -29.67 70.68 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.96 0.904 . . . . 0.0 111.916 -169.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.2 m -57.3 -20.97 31.73 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.485 1.114 . . . . 0.0 111.831 171.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -120.12 9.89 11.26 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.446 1.899 . . . . 0.0 109.462 -176.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 73.34 -4.75 24.47 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 126.565 2.031 . . . . 0.0 114.739 -177.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 52.1 mt -70.61 152.95 43.36 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 118.815 1.307 . . . . 0.0 111.539 -159.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.43 HG22 ' H ' ' A' ' 31' ' ' ASP . 0.5 OUTLIER -93.53 167.75 11.49 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.72 1.208 . . . . 0.0 110.393 172.056 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 9.3 mp0 -50.48 -39.72 48.98 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.64 0.776 . . . . 0.0 111.852 163.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 43.4 mttt -62.25 -38.61 89.89 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 118.502 0.592 . . . . 0.0 110.884 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.43 ' H ' HG22 ' A' ' 28' ' ' THR . 81.4 m-20 -66.65 -40.8 88.84 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 122.753 0.421 . . . . 0.0 110.089 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.84 -53.9 49.48 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 125.258 1.423 . . . . 0.0 109.161 177.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -48.83 -57.22 6.74 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.652 1.581 . . . . 0.0 109.739 178.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 18.5 m -57.93 -39.12 77.24 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.237 1.015 . . . . 0.0 112.803 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.9 mttm -58.68 -39.67 81.38 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 119.457 1.026 . . . . 0.0 112.36 176.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.7 pt -103.3 10.61 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 123.624 0.77 . . . . 0.0 111.376 -173.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.8 t30 65.32 42.68 3.81 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.925 2.09 . . . . 0.0 113.674 176.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -135.64 -177.44 4.68 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.032 0.933 . . . . 0.0 113.149 -174.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -92.43 145.23 30.17 Favored Pre-proline 0 C--N 1.339 0.135 0 C-N-CA 125.314 1.445 . . . . 0.0 110.345 178.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.1 -6.07 18.39 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.73 2.287 . . . . 0.0 112.951 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.3 tp60 -61.35 -51.39 69.04 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 118.501 -0.761 . . . . 0.0 110.684 169.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.7 m -68.79 -29.97 45.41 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.305 0 CA-C-N 118.906 0.775 . . . . 0.0 109.468 -176.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.7 mm -64.84 -46.64 91.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 124.048 0.939 . . . . 0.0 109.942 177.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.33 -35.91 74.7 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.061 0.544 . . . . 0.0 111.112 175.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.94 -40.94 62.72 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 121.731 -0.606 . . . . 0.0 110.978 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.42 ' HH ' ' HG ' ' A' ' 58' ' ' LEU . 0.9 OUTLIER -53.91 -47.43 71.17 Favored 'General case' 0 C--N 1.334 -0.081 0 C-N-CA 125.066 1.346 . . . . 0.0 110.331 172.129 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -57.41 -42.69 82.81 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.572 0.749 . . . . 0.0 112.03 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.1 t -78.45 -25.41 45.91 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.825 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.72 44.89 2.58 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 -174.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 15.9 mmt85 -129.76 -21.65 3.05 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 125.171 1.388 . . . . 0.0 112.793 -171.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.28 133.48 49.78 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 169.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 41.0 mm -68.91 109.18 3.83 Favored Pre-proline 0 C--O 1.237 0.432 0 N-CA-C 104.779 -2.304 . . . . 0.0 104.779 169.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -84.19 114.2 1.85 Allowed 'Trans proline' 0 N--CA 1.445 -1.359 0 N-CA-C 108.568 -1.358 . . . . 0.0 108.568 -159.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -80.84 140.31 35.48 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -63.02 -29.26 70.68 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.077 0.853 . . . . 0.0 110.798 173.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -57.88 -60.85 3.07 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.522 1.129 . . . . 0.0 109.593 173.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.438 ' HA ' ' HE3' ' A' ' 60' ' ' LYS . 59.8 t -64.68 -46.19 93.04 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.259 0 CA-C-O 118.38 -0.819 . . . . 0.0 110.098 -177.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.42 ' HG ' ' HH ' ' A' ' 46' ' ' TYR . 25.1 mt -48.88 -48.43 42.17 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 123.894 0.878 . . . . 0.0 109.501 172.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.56 -44.15 85.82 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 125.721 1.629 . . . . 0.0 113.687 176.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.438 ' HE3' ' HA ' ' A' ' 57' ' ' VAL . 44.6 mtmt -65.66 -42.47 91.33 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 117.762 0.781 . . . . 0.0 110.753 175.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.1 mt -60.75 -33.32 54.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.743 0.817 . . . . 0.0 109.307 175.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -59.36 -46.38 88.81 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.775 1.17 . . . . 0.0 110.656 174.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 40.4 mtt-85 -58.13 -40.24 80.76 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 118.698 0.681 . . . . 0.0 110.367 173.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.0 -25.18 67.49 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.523 1.529 . . . . 0.0 114.627 -171.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 26.3 pt -125.41 -12.98 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-N 119.264 0.938 . . . . 0.0 112.086 176.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.9 29.89 64.34 Favored Glycine 0 C--N 1.336 0.577 0 C-N-CA 126.369 1.938 . . . . 0.0 113.165 -178.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.2 mt -130.05 163.32 26.78 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.397 1.479 . . . . 0.0 109.35 174.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -73.45 143.55 46.63 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 125.198 1.399 . . . . 0.0 108.946 175.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -119.03 8.81 11.67 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.105 1.362 . . . . 0.0 110.472 178.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 34.6 mtm105 -141.03 127.61 20.11 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 121.549 -0.72 . . . . 0.0 109.272 -166.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.01 179.22 48.83 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 125.168 1.366 . . . . 0.0 112.038 176.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -64.41 -13.17 49.67 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -93.51 22.81 5.03 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.094 0.861 . . . . 0.0 109.745 177.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.1 tt -55.2 149.24 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 O-C-N 120.95 -1.093 . . . . 0.0 110.368 178.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.57 -14.22 7.26 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-O 117.681 -1.622 . . . . 0.0 113.148 178.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 32.4 mmtt -68.19 144.36 96.74 Favored Pre-proline 0 N--CA 1.452 -0.373 0 CA-C-N 120.459 2.13 . . . . 0.0 107.882 173.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -69.27 150.75 71.57 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.613 2.875 . . . . 0.0 111.648 -177.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.4 pt -101.59 147.03 8.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 C-N-CA 124.146 0.978 . . . . 0.0 109.663 -178.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 46.6 59.49 3.87 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.878 2.071 . . . . 0.0 112.225 177.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -125.14 108.28 11.62 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 172.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 151.58 -167.37 30.91 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 -177.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -60.54 171.71 3.23 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.153 1.902 . . . . 0.0 109.763 160.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.4 ttm180 -149.72 145.72 26.83 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 170.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.45 -45.09 69.91 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 170.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.9 tttm -162.24 -179.15 6.82 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.591 1.556 . . . . 0.0 107.579 178.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.5 m -132.36 -1.28 3.57 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.713 1.205 . . . . 0.0 112.74 172.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 150.95 -178.95 28.06 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 -172.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -62.1 145.88 96.31 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 121.748 1.632 . . . . 0.0 109.787 166.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 71.8 m -142.78 119.18 10.91 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 170.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.9 t -131.18 2.15 4.25 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.478 1.511 . . . . 0.0 111.921 -176.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.124 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 178.702 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.697 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.5 p -164.97 -37.75 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.769 1.228 . . . . 0.0 110.795 162.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.4 t -152.78 -26.17 0.16 Allowed 'General case' 0 C--O 1.236 0.342 0 C-N-CA 123.864 0.866 . . . . 0.0 111.795 -172.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.53 -142.95 20.58 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 108.256 -1.938 . . . . 0.0 108.256 -160.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 25.8 t -136.07 157.55 46.57 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.11 1.364 . . . . 0.0 108.211 -178.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.3 t -136.37 -167.91 2.14 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 122.489 1.138 . . . . 0.0 112.039 -171.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -149.55 170.86 29.73 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 126.653 2.073 . . . . 0.0 109.38 175.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -154.69 150.97 28.2 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 126.057 1.743 . . . . 0.0 107.414 179.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.5 mmt180 -139.5 156.81 46.69 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 123.972 0.909 . . . . 0.0 110.065 -169.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 t 48.2 42.05 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 124.748 1.219 . . . . 0.0 109.878 -177.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.8 m -64.96 147.52 53.28 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 123.308 0.643 . . . . 0.0 109.937 -174.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -54.95 148.85 12.63 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.821 1.248 . . . . 0.0 108.48 171.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -59.31 -30.37 68.29 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.671 0.669 . . . . 0.0 111.404 174.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.7 t -58.18 -62.06 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 124.24 1.016 . . . . 0.0 108.479 172.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.37 -40.13 60.52 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-N 119.394 0.997 . . . . 0.0 111.968 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -61.52 -58.14 9.33 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.098 0.949 . . . . 0.0 111.27 177.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.2 t -60.04 -36.98 70.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 123.955 0.902 . . . . 0.0 109.774 -178.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 75.4 mt -57.94 -62.27 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 174.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -56.14 -40.68 74.19 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 118.654 0.661 . . . . 0.0 111.411 -175.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -62.03 -43.93 97.79 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.511 1.524 . . . . 0.0 112.117 175.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -75.02 -33.29 55.21 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 124.742 1.163 . . . . 0.0 112.226 -176.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 15.4 mtm105 -65.71 -48.65 71.28 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 117.687 0.744 . . . . 0.0 110.216 169.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -55.5 -33.82 64.06 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.914 0.886 . . . . 0.0 112.485 175.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.1 t -64.08 -19.06 64.97 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.143 0.977 . . . . 0.0 111.701 -178.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.401 ' HE3' ' HA ' ' A' ' 65' ' ' ILE . 5.7 mtmm -130.57 7.22 4.85 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.785 1.234 . . . . 0.0 110.811 -175.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 48.58 47.31 29.79 Favored Glycine 0 C--N 1.337 0.614 0 C-N-CA 126.068 1.794 . . . . 0.0 113.127 -173.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.506 ' CD1' ' HE3' ' A' ' 35' ' ' LYS . 61.1 mt -101.81 119.52 38.91 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -177.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.479 HG22 ' H ' ' A' ' 31' ' ' ASP . 13.3 t -68.01 169.26 10.35 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.627 0.727 . . . . 0.0 109.462 176.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -64.38 -36.72 85.06 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.389 0.676 . . . . 0.0 109.842 178.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.4 mttt -57.4 -44.65 84.7 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.191 0.997 . . . . 0.0 113.434 167.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.479 ' H ' HG22 ' A' ' 28' ' ' THR . 2.3 m-20 -65.9 -43.53 87.93 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -176.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.87 -50.48 73.6 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.082 1.353 . . . . 0.0 111.387 176.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.23 -48.5 65.13 Favored 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 125.485 1.514 . . . . 0.0 109.981 177.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 20.5 m -61.42 -47.87 83.78 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.932 0.787 . . . . 0.0 111.508 175.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.506 ' HE3' ' CD1' ' A' ' 27' ' ' LEU . 50.5 mttm -55.56 -40.33 71.79 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 119.282 0.946 . . . . 0.0 111.98 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.3 pt -98.28 6.16 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 123.438 0.695 . . . . 0.0 112.256 -178.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 52.4 t30 44.46 63.94 1.5 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.488 2.315 . . . . 0.0 113.383 -173.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -138.93 -173.32 3.54 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.835 2.054 . . . . 0.0 110.114 174.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -82.55 148.16 57.78 Favored Pre-proline 0 N--CA 1.467 0.412 0 O-C-N 120.791 -1.193 . . . . 0.0 110.594 177.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -66.39 -28.02 46.9 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.608 2.205 . . . . 0.0 111.872 169.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -67.67 -43.54 79.98 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 118.56 -0.733 . . . . 0.0 109.97 -178.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.9 m -68.37 -31.64 52.23 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.373 0 CA-C-O 117.827 -1.082 . . . . 0.0 110.69 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 41.5 mm -57.92 -49.82 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 120.093 1.315 . . . . 0.0 109.367 170.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.09 -22.92 65.08 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 121.541 -0.724 . . . . 0.0 112.622 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.67 -26.53 27.71 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 118.177 -0.916 . . . . 0.0 112.015 172.072 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -62.22 -59.09 5.54 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.395 1.452 . . . . 0.0 108.585 173.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -52.66 -42.82 65.06 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 123.69 0.796 . . . . 0.0 112.859 176.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 27.3 m -66.68 -24.04 66.22 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 117.841 -1.076 . . . . 0.0 113.634 177.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.42 24.84 11.67 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 119.97 1.259 . . . . 0.0 113.732 -177.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -122.98 -30.85 3.72 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.015 1.407 . . . . 0.0 113.457 -170.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.7 132.94 49.19 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 170.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 39.4 mm -69.25 113.56 17.57 Favored Pre-proline 0 C--O 1.24 0.582 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 179.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.57 115.36 3.38 Favored 'Trans proline' 0 N--CA 1.445 -1.36 0 C-N-CA 122.648 2.232 . . . . 0.0 108.426 -175.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -95.77 147.8 23.25 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 174.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 59.6 t-20 -54.07 -45.02 71.62 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.913 1.285 . . . . 0.0 110.782 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -57.6 -52.01 67.17 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.513 0.725 . . . . 0.0 111.106 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.1 t -68.66 -40.48 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 O-C-N 121.748 -0.595 . . . . 0.0 110.635 -178.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 31.5 mt -51.49 -43.37 62.18 Favored 'General case' 0 C--O 1.22 -0.469 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 171.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.13 -39.59 97.35 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-N 119.169 0.895 . . . . 0.0 112.841 175.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -63.85 -44.48 93.03 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 119.185 1.492 . . . . 0.0 110.046 175.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.3 mt -64.34 -35.46 74.24 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.095 0 C-N-CA 124.984 1.314 . . . . 0.0 110.162 178.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -58.63 -51.0 71.76 Favored 'General case' 0 CA--C 1.512 -0.497 0 O-C-N 121.509 -0.744 . . . . 0.0 109.524 177.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -58.64 -40.1 82.44 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-O 118.789 -0.624 . . . . 0.0 110.804 176.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.18 -26.43 60.61 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.507 1.523 . . . . 0.0 113.895 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.401 ' HA ' ' HE3' ' A' ' 25' ' ' LYS . 16.9 pt -114.55 -15.02 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 119.74 1.155 . . . . 0.0 112.353 173.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.74 27.83 70.15 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 127.847 2.642 . . . . 0.0 113.597 -174.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.9 mt -136.56 158.58 44.11 Favored 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 124.842 1.257 . . . . 0.0 109.36 -179.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -66.65 139.99 57.89 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 125.598 1.559 . . . . 0.0 109.572 176.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -114.54 0.87 14.13 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.472 1.509 . . . . 0.0 109.972 171.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 53.2 mtm180 -135.42 142.39 45.61 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.863 1.265 . . . . 0.0 108.161 -169.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.62 163.03 12.34 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -173.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -73.41 -1.77 19.63 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.564 -0.962 . . . . 0.0 113.379 -175.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -77.44 16.07 0.68 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.883 0.765 . . . . 0.0 111.174 165.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.1 tt -50.3 135.54 9.3 Favored 'Isoleucine or valine' 0 C--O 1.242 0.706 0 CA-C-N 120.091 1.314 . . . . 0.0 110.699 -175.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.46 -3.85 71.29 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-O 119.541 -0.588 . . . . 0.0 113.537 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 20.0 mmtm -74.86 150.13 85.95 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 120.655 2.227 . . . . 0.0 107.202 163.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -66.14 157.96 57.04 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.951 2.434 . . . . 0.0 111.992 -174.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 17.8 pt -101.34 138.41 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 168.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 38.32 -23.78 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.736 1 C-N-CA 134.266 5.027 . . . . 0.0 120.789 178.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.7 mmtp -67.58 170.34 7.83 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 121.607 2.003 . . . . 0.0 109.058 176.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -55.78 142.33 37.98 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-O 119.233 -0.759 . . . . 0.0 112.282 -166.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.44 155.95 67.32 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.009 2.473 . . . . 0.0 110.437 -178.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 22.6 ttt-85 -162.82 29.75 0.1 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.532 0.733 . . . . 0.0 110.671 174.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -132.61 174.76 9.95 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.028 0.931 . . . . 0.0 109.607 176.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.49 138.52 43.54 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.541 1.136 . . . . 0.0 108.645 174.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 43.6 t 176.2 155.76 0.22 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.969 2.508 . . . . 0.0 105.957 -177.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -103.46 101.71 2.09 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 117.988 -1.451 . . . . 0.0 109.505 176.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.48 167.49 20.58 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 CA-C-N 120.736 2.268 . . . . 0.0 111.966 177.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.7 p -146.26 -178.6 6.23 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 125.493 1.517 . . . . 0.0 109.287 174.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 13.7 t -153.37 162.41 41.31 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.54 1.536 . . . . 0.0 107.793 175.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.118 0 N-CA-C 107.886 -2.085 . . . . 0.0 107.886 149.881 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.64 0 N-CA-C 107.352 -2.299 . . . . 0.0 107.352 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.9 m 52.21 169.58 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 122.052 0.93 . . . . 0.0 111.644 -133.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.8 t -150.82 -177.55 6.06 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 150.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -127.34 178.17 17.07 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 124.164 0.888 . . . . 0.0 113.072 -170.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.9 m -135.86 -51.25 0.72 Allowed 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.667 1.187 . . . . 0.0 110.019 172.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 46.3 p -148.44 159.99 43.49 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.528 0.603 . . . . 0.0 110.784 -178.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 152.15 15.6 0.07 OUTLIER Glycine 0 CA--C 1.53 0.998 0 CA-C-O 118.324 -1.264 . . . . 0.0 113.429 -166.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 81.38 136.8 0.06 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 129.66 3.184 . . . . 0.0 110.697 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 26.9 mtt-85 -160.4 171.61 18.77 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 127.377 2.271 . . . . 0.0 109.178 178.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . 0.327 0.8 OUTLIER 55.4 -153.68 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 130.796 3.638 . . . . 0.0 110.478 -175.211 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.29 1.6 p 52.57 -157.02 0.15 Allowed 'General case' 0 C--O 1.239 0.526 0 C-N-CA 126.192 1.797 . . . . 0.0 111.824 174.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 74.52 157.98 0.2 Allowed 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 126.845 2.058 . . . . 0.0 114.102 164.29 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -98.21 -61.99 1.3 Allowed 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.416 165.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 49.7 t -54.26 -56.73 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 120.054 1.297 . . . . 0.0 110.669 -173.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -54.71 -42.37 77.75 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-O 119.129 -0.817 . . . . 0.0 113.041 176.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.406 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 1.8 tpmt? -62.5 -48.5 79.3 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 118.599 1.199 . . . . 0.0 110.177 177.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 74.9 t -61.43 -43.09 96.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 124.536 1.134 . . . . 0.0 109.589 -179.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.5 mt -59.51 -52.98 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 C-N-CA 124.324 1.05 . . . . 0.0 108.624 177.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -54.79 -50.18 69.13 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.267 1.427 . . . . 0.0 110.262 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -58.74 -56.2 25.32 Favored 'General case' 0 C--O 1.227 -0.109 0 C-N-CA 124.915 1.286 . . . . 0.0 111.31 178.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.5 -23.18 76.07 Favored Glycine 0 CA--C 1.52 0.403 0 CA-C-O 118.678 -1.068 . . . . 0.0 112.395 -171.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.4 mtm105 -60.6 -64.36 0.98 Allowed 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 119.178 1.489 . . . . 0.0 108.805 164.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -56.71 -37.74 71.34 Favored 'General case' 0 CA--C 1.52 -0.196 0 O-C-N 124.199 0.937 . . . . 0.0 111.098 -171.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.3 t -65.96 -13.84 60.5 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.812 -0.555 . . . . 0.0 111.52 -175.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -126.91 8.37 6.78 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.143 2.177 . . . . 0.0 110.212 -173.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.83 5.13 50.69 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 125.506 1.527 . . . . 0.0 114.221 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 19.7 mt -71.36 120.39 16.87 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 119.258 1.529 . . . . 0.0 108.882 -168.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.404 ' HG1' ' CG ' ' A' ' 31' ' ' ASP . 69.4 p -66.01 174.35 2.54 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.661 -0.65 . . . . 0.0 109.778 170.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -66.81 -41.35 87.67 Favored 'General case' 0 C--O 1.231 0.127 0 O-C-N 120.217 -1.552 . . . . 0.0 109.849 174.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.1 tttp -64.67 -25.33 67.9 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.11 0.564 . . . . 0.0 111.589 177.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.404 ' CG ' ' HG1' ' A' ' 28' ' ' THR . 83.0 m-20 -72.07 -45.37 60.98 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.437 0.695 . . . . 0.0 109.97 172.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.16 -46.85 88.27 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.374 0.534 . . . . 0.0 109.807 176.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.34 -50.37 65.15 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 125.232 1.413 . . . . 0.0 109.788 175.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.2 m -56.21 -49.63 73.56 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.367 1.067 . . . . 0.0 110.55 175.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -59.94 -16.12 27.38 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 124.935 1.294 . . . . 0.0 114.432 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.8 pt -126.82 9.39 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 119.807 1.185 . . . . 0.0 110.997 177.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.1 m120 54.88 30.7 14.34 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.042 1.737 . . . . 0.0 112.282 179.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -102.45 178.89 4.46 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.487 1.515 . . . . 0.0 110.318 -176.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -77.35 137.3 64.21 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 173.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -67.93 -22.47 42.21 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.488 2.125 . . . . 0.0 111.971 176.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 48.5 tp60 -61.65 -43.18 99.35 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.547 -0.721 . . . . 0.0 110.923 173.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.0 m -73.87 -28.16 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 119.013 0.824 . . . . 0.0 110.737 -176.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.4 mm -56.67 -48.21 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 119.298 0.954 . . . . 0.0 109.691 169.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.5 -35.53 70.34 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 123.43 0.457 . . . . 0.0 111.179 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -83.21 -23.18 32.91 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.551 0.741 . . . . 0.0 112.605 -177.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -62.23 -35.89 80.29 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.901 0.773 . . . . 0.0 109.801 166.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -70.48 -36.67 73.98 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.302 0.956 . . . . 0.0 111.627 175.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.4 m -66.73 -32.29 73.49 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.36 0.527 . . . . 0.0 111.876 173.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.46 7.28 57.05 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 124.82 1.2 . . . . 0.0 112.518 -172.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -78.52 -57.09 3.95 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.76 1.624 . . . . 0.0 110.822 -173.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.29 146.86 42.41 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 124.012 0.82 . . . . 0.0 109.078 -175.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 25.6 mm -68.84 122.06 83.62 Favored Pre-proline 0 C--O 1.237 0.406 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 -178.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.91 113.3 3.73 Favored 'Trans proline' 0 N--CA 1.444 -1.409 0 N-CA-C 106.148 -2.289 . . . . 0.0 106.148 171.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -125.56 138.78 53.96 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 118.878 -0.582 . . . . 0.0 109.721 -171.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -52.25 -46.28 65.7 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.999 1.32 . . . . 0.0 112.99 -165.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -55.39 -50.89 68.55 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -178.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.467 ' HA ' ' HD3' ' A' ' 60' ' ' LYS . 94.3 t -74.38 -47.87 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 124.785 1.234 . . . . 0.0 109.891 -174.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 42.5 mt -45.33 -49.65 12.69 Favored 'General case' 0 C--O 1.225 -0.218 0 C-N-CA 125.126 1.37 . . . . 0.0 110.378 175.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.76 -44.49 80.52 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 123.646 0.641 . . . . 0.0 113.184 176.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.467 ' HD3' ' HA ' ' A' ' 57' ' ' VAL . 17.6 mtpp -68.69 -38.24 80.16 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 121.771 -0.841 . . . . 0.0 109.125 -178.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.5 mt -62.4 -39.72 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 C-N-CA 123.777 0.831 . . . . 0.0 109.471 174.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -59.36 -48.99 79.55 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 119.649 1.113 . . . . 0.0 109.299 176.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 26.4 mtm105 -64.15 -18.58 64.58 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.371 0.668 . . . . 0.0 112.408 176.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.25 -55.74 5.7 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.727 1.211 . . . . 0.0 109.941 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.1 pt -91.76 -24.18 5.56 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 123.111 0.565 . . . . 0.0 110.746 -176.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.38 32.6 34.13 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 125.284 1.421 . . . . 0.0 112.593 -174.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.0 mt -135.72 163.41 30.25 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.057 1.743 . . . . 0.0 109.161 175.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 71.8 mttt -74.93 144.47 43.24 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 125.314 1.445 . . . . 0.0 110.776 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -118.69 16.95 13.63 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 127.323 2.249 . . . . 0.0 109.494 174.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -135.95 163.91 29.19 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 126.678 1.991 . . . . 0.0 109.449 -178.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 66.62 177.11 8.03 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 124.971 1.272 . . . . 0.0 112.11 176.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.8 tptt -72.89 -10.17 59.51 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.447 -1.031 . . . . 0.0 111.149 168.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -78.92 11.96 2.41 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.767 1.627 . . . . 0.0 111.616 172.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.3 tt -53.66 140.02 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 119.736 1.153 . . . . 0.0 110.704 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.24 -10.79 40.46 Favored Glycine 0 CA--C 1.533 1.178 0 CA-C-O 117.743 -1.587 . . . . 0.0 114.078 -176.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 33.2 mmtt -66.53 151.76 95.82 Favored Pre-proline 0 C--N 1.345 0.373 0 CA-C-N 120.608 2.204 . . . . 0.0 107.768 166.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -58.04 158.93 19.76 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 123.76 2.973 . . . . 0.0 112.549 175.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 24.7 pt -101.87 141.96 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 165.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 37.26 72.38 0.12 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.743 2.417 . . . . 0.0 112.702 177.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 24.3 mtmm -56.04 -43.21 77.63 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 117.878 -1.058 . . . . 0.0 112.573 -176.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -131.97 -177.26 14.8 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 177.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -73.47 99.39 1.13 Allowed 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.958 2.439 . . . . 0.0 109.719 176.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.2 mmt85 -140.39 75.49 1.51 Allowed 'General case' 0 C--O 1.237 0.429 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -106.33 -179.74 4.03 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.04 1.336 . . . . 0.0 110.558 177.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 49.2 pttt -117.26 -43.17 2.85 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.798 1.239 . . . . 0.0 109.603 172.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.7 m 55.23 59.34 4.03 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.565 1.146 . . . . 0.0 111.963 166.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -123.71 69.33 0.46 Allowed Glycine 0 CA--C 1.527 0.837 0 CA-C-O 118.391 -1.227 . . . . 0.0 110.414 177.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -61.11 153.36 65.09 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 123.253 2.635 . . . . 0.0 110.988 -178.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.3 p -123.13 51.58 1.44 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.72 1.208 . . . . 0.0 109.403 -171.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.7 p -71.02 109.88 5.38 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.918 1.287 . . . . 0.0 110.49 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.847 0 N-CA-C 106.827 -2.509 . . . . 0.0 106.827 162.621 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.691 0 CA-C-O 121.661 0.59 . . . . 0.0 111.89 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.5 m -104.95 161.82 13.87 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 165.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.29 -26.27 66.45 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.465 -0.772 . . . . 0.0 112.474 -178.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.8 171.38 47.05 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 124.525 1.059 . . . . 0.0 110.647 -175.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 t -78.42 96.33 5.33 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.065 0.946 . . . . 0.0 108.905 -176.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.0 m -125.02 72.9 1.25 Allowed 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.252 1.421 . . . . 0.0 109.156 176.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.41 -176.55 44.71 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 -170.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -147.17 -53.3 0.22 Allowed 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.739 0.816 . . . . 0.0 108.832 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 58.04 154.5 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 130.263 3.425 . . . . 0.0 115.472 177.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.7 t 41.0 65.94 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 125.779 1.632 . . . . 0.0 107.716 -168.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.6 p -57.67 103.07 0.11 Allowed 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 174.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.3 mp -58.96 162.48 4.17 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 176.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 56.1 mp0 -51.46 -48.45 62.79 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 118.288 -0.863 . . . . 0.0 112.192 -174.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 55.8 t -59.12 -59.59 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 119.384 0.993 . . . . 0.0 110.138 179.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -55.52 -45.65 83.6 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-N 119.994 1.27 . . . . 0.0 113.267 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 49.7 tttp -56.75 -54.65 43.78 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 118.846 1.323 . . . . 0.0 109.462 175.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.2 t -61.94 -37.53 78.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 123.207 0.603 . . . . 0.0 110.586 -177.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 69.5 mt -61.16 -61.67 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 175.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -53.01 -45.56 67.99 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.209 1.404 . . . . 0.0 110.076 -175.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -59.9 -58.78 7.09 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.884 1.674 . . . . 0.0 111.749 175.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -52.48 -51.38 43.46 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.9 mtm105 -48.38 -61.86 1.79 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.179 0.992 . . . . 0.0 109.742 175.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -57.56 -33.39 68.09 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 124.344 1.057 . . . . 0.0 112.22 -177.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.89 -28.93 64.91 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.851 1.205 . . . . 0.0 111.703 -172.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -94.73 2.69 55.55 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.177 0.898 . . . . 0.0 111.832 167.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 61.51 43.7 98.96 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 110.816 -0.913 . . . . 0.0 110.816 -176.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 68.3 mt -109.97 159.58 17.15 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.163 1.385 . . . . 0.0 108.324 178.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.9 t -116.38 169.32 9.4 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.787 1.235 . . . . 0.0 110.046 -170.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -55.24 -44.25 75.34 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.527 1.131 . . . . 0.0 110.739 174.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.25 -39.67 72.95 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 118.347 -0.835 . . . . 0.0 111.769 173.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -75.76 -37.28 59.42 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 119.558 1.072 . . . . 0.0 111.158 -176.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.67 -49.05 79.23 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.78 1.232 . . . . 0.0 108.744 173.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.7 -49.33 73.29 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.15 1.38 . . . . 0.0 109.656 178.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.8 m -58.66 -44.87 90.27 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.812 0.733 . . . . 0.0 110.928 174.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.8 mttm -62.2 -27.29 68.87 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 117.295 -1.336 . . . . 0.0 113.263 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.0 pt -107.95 6.19 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 120.461 1.482 . . . . 0.0 112.578 176.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 56.5 t30 48.63 62.21 2.68 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.101 1.76 . . . . 0.0 112.738 -172.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -133.42 179.88 5.93 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 126.982 2.113 . . . . 0.0 109.242 176.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 25.0 mmtp -87.01 153.24 54.35 Favored Pre-proline 0 N--CA 1.47 0.551 0 C-N-CA 124.692 1.197 . . . . 0.0 109.796 169.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.68 -26.64 39.1 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.26 1.974 . . . . 0.0 111.391 176.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.0 tp60 -60.5 -29.81 69.31 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.01 0.924 . . . . 0.0 112.514 178.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.6 m -79.72 -35.35 16.38 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.37 0 CA-C-N 119.439 1.018 . . . . 0.0 109.81 174.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 29.8 mm -60.72 -44.74 97.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 120.273 1.397 . . . . 0.0 110.056 179.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.58 -30.36 65.2 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 176.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -89.09 -24.93 22.16 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.98 0.912 . . . . 0.0 111.854 178.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -62.9 -44.39 96.23 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 120.029 1.286 . . . . 0.0 108.917 166.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -59.92 -43.57 94.84 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.22 0.608 . . . . 0.0 110.582 172.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.2 m -66.3 -37.45 85.44 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.636 0.653 . . . . 0.0 111.815 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.74 29.37 8.21 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -169.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -111.11 -29.21 7.97 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.409 1.483 . . . . 0.0 111.477 -171.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.42 178.36 2.95 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.655 0.782 . . . . 0.0 110.082 170.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.4 mm -109.75 113.69 57.38 Favored Pre-proline 0 C--O 1.237 0.423 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -78.31 115.61 3.74 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 123.375 2.716 . . . . 0.0 109.298 -175.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -118.92 144.61 46.34 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.296 1.439 . . . . 0.0 108.958 -175.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.4 m-20 -48.33 -45.42 35.27 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.6 1.56 . . . . 0.0 111.942 -171.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -63.87 -52.15 61.32 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -173.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.414 ' HA ' ' HD3' ' A' ' 60' ' ' LYS . 8.9 t -64.1 -47.74 88.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-O 117.834 -1.079 . . . . 0.0 108.931 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 25.7 mt -46.6 -56.46 6.03 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 125.405 1.482 . . . . 0.0 109.625 174.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.13 -33.68 70.61 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 123.627 0.632 . . . . 0.0 113.559 178.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.414 ' HD3' ' HA ' ' A' ' 57' ' ' VAL . 23.8 mtpp -71.11 -46.67 61.23 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 118.746 1.273 . . . . 0.0 109.228 177.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.7 mt -61.82 -35.9 70.55 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.08 0 C-N-CA 124.542 1.137 . . . . 0.0 109.414 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -57.13 -50.52 72.55 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 176.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 61.0 mtt180 -58.48 -38.31 77.33 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 120.832 -1.168 . . . . 0.0 111.449 173.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.46 -25.91 60.42 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.229 1.012 . . . . 0.0 113.713 -176.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 45.5 pt -120.87 -10.73 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 124.323 1.049 . . . . 0.0 111.984 175.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.39 28.56 72.4 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 126.891 2.186 . . . . 0.0 113.337 -176.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 69.3 mt -138.27 163.18 32.42 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.419 1.488 . . . . 0.0 107.752 -178.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -86.41 143.13 27.96 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 126.778 2.031 . . . . 0.0 112.335 -170.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -118.98 6.53 11.35 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.756 1.622 . . . . 0.0 111.004 -176.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -141.8 156.92 45.55 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.789 1.236 . . . . 0.0 109.454 -177.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 73.98 172.39 26.3 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.505 1.05 . . . . 0.0 111.823 -174.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -65.4 -16.11 63.28 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.9 -0.765 . . . . 0.0 110.896 171.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.44 9.31 0.48 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.313 1.445 . . . . 0.0 111.913 173.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.5 tt -54.11 129.87 15.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 121.42 1.918 . . . . 0.0 110.009 -177.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.97 -15.44 59.39 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-O 118.743 -1.032 . . . . 0.0 114.404 -177.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.3 mtmt -68.24 152.4 96.55 Favored Pre-proline 0 N--CA 1.444 -0.748 0 CA-C-N 119.235 1.518 . . . . 0.0 107.765 170.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -71.91 157.96 53.78 Favored 'Trans proline' 0 N--CA 1.447 -1.228 0 C-N-CA 122.724 2.283 . . . . 0.0 111.082 -174.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.5 pt -101.53 129.1 53.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 105.512 -2.032 . . . . 0.0 105.512 165.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 31.19 59.32 0.26 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.821 2.048 . . . . 0.0 113.114 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -60.07 140.81 56.61 Favored 'General case' 0 C--N 1.344 0.356 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -174.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -120.64 -116.98 2.53 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 107.901 -2.079 . . . . 0.0 107.901 -178.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -65.48 160.8 41.11 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 122.475 2.117 . . . . 0.0 111.262 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 61.15 83.22 0.15 Allowed 'General case' 0 C--O 1.234 0.251 0 C-N-CA 126.07 1.748 . . . . 0.0 110.813 175.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.36 144.42 16.56 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 114.816 -1.083 . . . . 0.0 109.025 164.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.5 tmtt? -157.0 93.49 1.35 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 178.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 26.2 p -72.66 115.02 11.43 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -175.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -156.09 73.53 0.24 Allowed Glycine 0 N--CA 1.447 -0.579 0 CA-C-O 117.682 -1.621 . . . . 0.0 111.444 -173.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -71.1 179.93 4.02 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.894 2.396 . . . . 0.0 110.709 170.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 26.1 p -114.01 -71.72 0.74 Allowed 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.47 1.108 . . . . 0.0 109.944 -177.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 49.2 m -62.0 -40.59 96.19 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 119.038 -0.506 . . . . 0.0 111.058 177.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.779 0 C-N-CA 126.326 1.917 . . . . 0.0 109.129 179.091 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.665 0 N-CA-C 112.41 -0.276 . . . . 0.0 112.41 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.9 p -55.36 136.97 48.86 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 122.159 0.981 . . . . 0.0 110.832 -176.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 56.1 m -79.01 97.54 6.12 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 176.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -64.44 91.07 0.1 OUTLIER Glycine 0 CA--C 1.523 0.545 0 N-CA-C 108.127 -1.989 . . . . 0.0 108.127 167.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.2 m 67.17 -52.81 0.48 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 129.184 2.994 . . . . 0.0 113.693 -172.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . 0.277 66.1 p 50.41 15.84 0.24 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.739 2.016 . . . . 0.0 113.62 -164.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -93.49 -161.96 35.98 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 126.607 2.051 . . . . 0.0 111.678 -171.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 61.61 159.38 0.06 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 128.378 2.671 . . . . 0.0 113.758 -178.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -130.5 -11.15 4.02 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 120.985 -1.072 . . . . 0.0 113.846 172.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.7 t -92.29 77.13 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 124.006 0.922 . . . . 0.0 109.097 -164.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.5 p -137.28 149.59 47.2 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 123.572 0.749 . . . . 0.0 110.074 177.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.9 mp -63.06 146.72 52.64 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 172.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -62.02 -36.88 82.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 118.371 -0.823 . . . . 0.0 112.797 -167.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.9 t -55.8 -61.12 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 171.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.56 -34.23 49.25 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-O 118.379 -1.234 . . . . 0.0 113.369 177.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -73.07 -48.38 36.45 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 119.405 1.603 . . . . 0.0 110.89 178.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 79.1 t -59.77 -40.01 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 118.945 0.793 . . . . 0.0 109.006 176.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 53.1 mt -58.17 -59.17 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 174.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -54.15 -45.9 72.14 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.151 0.58 . . . . 0.0 110.467 -177.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -54.94 -63.74 1.06 Allowed 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.071 1.349 . . . . 0.0 110.55 174.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.48 -34.95 87.67 Favored Glycine 0 CA--C 1.519 0.308 0 CA-C-N 119.002 0.819 . . . . 0.0 112.714 -172.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.462 HH21 ' HG2' ' A' ' 47' ' ' GLU . 27.1 mtm105 -62.74 -56.25 19.31 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 117.881 0.841 . . . . 0.0 109.125 173.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -54.97 -40.9 70.53 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.094 1.358 . . . . 0.0 111.467 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.7 m -66.63 -41.2 88.71 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.985 0.811 . . . . 0.0 109.484 -176.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 37.8 mtpt -84.21 -1.12 54.58 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.027 0.931 . . . . 0.0 112.682 177.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.39 16.38 64.95 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.503 1.049 . . . . 0.0 113.216 -175.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 43.1 mt -79.25 154.89 28.84 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 119.105 1.452 . . . . 0.0 109.694 -176.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 82.8 p -92.99 170.21 9.83 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.847 0.859 . . . . 0.0 110.718 175.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -60.45 -38.57 84.58 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.326 -0.859 . . . . 0.0 110.407 165.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.06 -38.59 83.27 Favored 'General case' 0 C--O 1.231 0.129 0 O-C-N 121.67 -0.644 . . . . 0.0 111.252 175.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -67.09 -35.1 79.07 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 117.968 0.349 . . . . 0.0 110.469 176.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.24 -49.78 68.33 Favored 'General case' 0 CA--C 1.529 0.14 0 O-C-N 121.545 -0.722 . . . . 0.0 109.172 178.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.93 -44.9 64.09 Favored 'General case' 0 CA--C 1.522 -0.117 0 C-N-CA 124.701 1.2 . . . . 0.0 109.9 176.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 43.9 m -62.85 -52.22 63.96 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.619 1.167 . . . . 0.0 109.927 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -58.68 -20.78 51.44 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.203 1.401 . . . . 0.0 114.297 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.4 pt -115.15 2.66 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 123.809 0.844 . . . . 0.0 111.937 177.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.8 t30 50.97 55.6 9.3 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.275 1.83 . . . . 0.0 112.878 -175.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -128.11 -175.69 3.57 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 127.344 2.258 . . . . 0.0 109.725 175.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.75 146.55 37.25 Favored Pre-proline 0 N--CA 1.464 0.226 0 O-C-N 120.81 -1.181 . . . . 0.0 110.223 174.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -66.34 -16.86 52.93 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.57 2.18 . . . . 0.0 114.242 178.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -61.55 -43.21 99.27 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 119.413 1.006 . . . . 0.0 110.829 172.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.4 m -63.71 -32.6 57.53 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.412 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.132 -176.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 25.2 mm -63.28 -46.51 95.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 124.754 1.221 . . . . 0.0 109.648 177.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.21 -40.1 67.32 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.928 -0.483 . . . . 0.0 111.146 174.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -79.7 -28.45 40.65 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.392 0.677 . . . . 0.0 112.566 -178.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -62.91 -52.28 63.66 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.405 1.082 . . . . 0.0 108.918 171.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.462 ' HG2' HH21 ' A' ' 22' ' ' ARG . 0.7 OUTLIER -60.07 -42.71 95.15 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 175.563 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.6 t -66.97 -37.82 84.94 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 124.043 0.839 . . . . 0.0 110.713 -177.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.94 3.12 20.11 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 118.596 -1.113 . . . . 0.0 114.269 -175.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 49.4 mtm180 -102.86 -14.28 16.63 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.453 1.626 . . . . 0.0 113.764 -170.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.72 151.66 41.39 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 119.665 1.12 . . . . 0.0 108.458 174.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.2 mm -79.6 116.17 58.84 Favored Pre-proline 0 C--O 1.236 0.354 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 165.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -70.78 141.92 42.22 Favored 'Trans proline' 0 N--CA 1.448 -1.175 0 N-CA-C 108.897 -1.232 . . . . 0.0 108.897 175.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -136.34 150.33 48.8 Favored 'General case' 0 CA--C 1.513 -0.445 0 O-C-N 121.472 -0.767 . . . . 0.0 110.064 169.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -55.29 -41.65 72.59 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 125.106 1.362 . . . . 0.0 111.149 -175.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -52.98 -60.06 3.75 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.412 1.085 . . . . 0.0 110.051 175.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.475 ' HA ' ' HD3' ' A' ' 60' ' ' LYS . 41.1 t -64.87 -51.08 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-O 118.285 -0.864 . . . . 0.0 109.713 -176.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 71.9 mt -44.38 -50.69 9.07 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 124.922 1.289 . . . . 0.0 110.804 175.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.77 -36.07 92.19 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 118.691 0.678 . . . . 0.0 113.126 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.475 ' HD3' ' HA ' ' A' ' 57' ' ' VAL . 16.2 mtpp -68.67 -44.25 74.48 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 118.7 1.25 . . . . 0.0 108.96 175.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.5 mt -59.1 -35.73 58.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 123.493 0.717 . . . . 0.0 109.362 177.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -57.45 -44.45 84.76 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 119.642 1.11 . . . . 0.0 109.859 176.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -73.01 -13.89 61.31 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.541 1.136 . . . . 0.0 113.199 178.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.33 -41.61 63.29 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.294 1.038 . . . . 0.0 111.455 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 36.0 pt -116.56 -16.69 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.293 1.037 . . . . 0.0 111.552 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.44 30.22 46.08 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 125.793 1.663 . . . . 0.0 113.091 -178.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 74.5 mt -123.72 163.12 21.75 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 118.486 1.143 . . . . 0.0 109.427 173.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.0 mttm -72.09 131.91 43.48 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 127.411 2.284 . . . . 0.0 108.252 172.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -112.67 7.98 18.87 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 126.666 1.986 . . . . 0.0 110.206 176.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.47 161.69 39.89 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 126.832 2.053 . . . . 0.0 107.634 -175.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 70.17 160.49 3.03 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.165 0.888 . . . . 0.0 111.166 -168.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -63.73 -11.99 30.94 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 120.929 -1.336 . . . . 0.0 111.203 173.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.22 6.46 1.68 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.04 1.736 . . . . 0.0 111.35 173.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.9 tt -48.98 136.27 5.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-N 121.241 1.837 . . . . 0.0 110.909 -173.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.06 -11.62 66.67 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 124.001 0.81 . . . . 0.0 113.992 -177.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 49.7 mmtt -74.4 150.32 87.09 Favored Pre-proline 0 N--CA 1.452 -0.35 0 CA-C-N 119.271 1.536 . . . . 0.0 108.477 169.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -70.8 161.99 44.15 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.309 2.672 . . . . 0.0 111.733 -177.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.7 pt -101.27 108.63 23.82 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 178.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 58.62 104.81 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 127.784 2.434 . . . . 0.0 113.883 177.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.5 mptt 70.53 -167.85 0.16 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.028 2.131 . . . . 0.0 109.425 -167.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.93 175.58 36.52 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 123.95 0.786 . . . . 0.0 114.629 169.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -66.18 105.92 0.92 Allowed 'Trans proline' 0 C--N 1.349 0.576 1 C-N-CA 126.095 4.53 . . . . 0.0 112.365 -171.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 46.1 ttt180 -81.36 -24.83 36.79 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.706 0.802 . . . . 0.0 112.388 -170.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -82.14 163.86 21.69 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.792 0.724 . . . . 0.0 110.074 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.8 pttp -155.1 172.42 18.17 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.752 1.221 . . . . 0.0 111.808 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 39.9 t -139.01 169.84 17.07 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 127.305 2.242 . . . . 0.0 105.786 162.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 137.38 156.47 7.27 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 170.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -82.26 48.99 2.98 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 124.489 3.46 . . . . 0.0 111.942 -173.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.6 m -119.6 104.42 10.27 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 105.747 -1.945 . . . . 0.0 105.747 177.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.6 p -81.24 92.4 6.33 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.565 0 CA-C-O 117.351 -1.805 . . . . 0.0 109.34 -175.884 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.573 0 CA-C-O 120.172 -0.238 . . . . 0.0 112.563 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.0 m -141.67 170.52 15.56 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 125.211 1.404 . . . . 0.0 109.894 175.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 71.3 m 45.71 69.71 0.43 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.773 2.029 . . . . 0.0 112.883 -177.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.25 171.01 38.04 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 110.969 -0.853 . . . . 0.0 110.969 172.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -165.43 159.73 17.26 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 125.667 1.587 . . . . 0.0 108.829 178.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.7 p -73.68 161.42 30.28 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.219 0.608 . . . . 0.0 109.552 163.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.26 153.4 49.46 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 170.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -137.38 141.78 41.74 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.109 0.964 . . . . 0.0 109.149 173.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.43 ' HG2' ' H ' ' A' ' 10' ' ' VAL . 16.2 ttp85 56.74 -165.45 0.14 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.836 1.254 . . . . 0.0 110.737 -174.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.43 ' H ' ' HG2' ' A' ' 9' ' ' ARG . 27.0 m -78.51 116.57 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -174.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.2 p -71.66 107.79 4.68 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.162 0.585 . . . . 0.0 109.522 -178.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -56.19 155.1 7.03 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.442 1.097 . . . . 0.0 109.916 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -44.45 -57.93 3.27 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.647 1.579 . . . . 0.0 111.925 177.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 52.5 t -58.37 -57.06 12.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -178.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.14 -35.39 77.1 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 118.885 0.766 . . . . 0.0 113.191 -178.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.2 tptt -68.59 -52.75 28.24 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 124.001 0.92 . . . . 0.0 110.011 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 67.0 t -61.61 -36.52 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 49.1 mt -57.98 -60.12 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-O 118.161 -0.923 . . . . 0.0 108.924 173.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -53.8 -50.99 64.89 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.976 0.807 . . . . 0.0 109.905 -177.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -56.45 -48.47 76.98 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 126.345 1.858 . . . . 0.0 112.283 -178.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.99 -36.73 45.79 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-O 118.668 -1.073 . . . . 0.0 111.175 -175.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 15.4 mtm105 -56.77 -55.85 29.07 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 118.571 1.185 . . . . 0.0 109.763 170.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -50.78 -49.45 58.27 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 126.284 1.833 . . . . 0.0 110.883 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.6 m -63.63 -5.75 4.43 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.562 0.745 . . . . 0.0 112.412 -174.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -130.93 4.53 4.49 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.698 1.999 . . . . 0.0 110.638 -175.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.81 15.67 60.37 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.134 1.349 . . . . 0.0 113.546 -175.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 42.1 mt -73.73 127.08 31.84 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 119.086 1.443 . . . . 0.0 109.042 -170.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.4 p -67.57 169.54 9.12 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.697 0.761 . . . . 0.0 109.79 168.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -61.68 -34.55 75.93 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 120.999 -1.063 . . . . 0.0 110.086 166.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.89 -34.53 71.67 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-O 117.485 -1.245 . . . . 0.0 111.696 176.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -57.66 -51.76 68.19 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 119.787 1.176 . . . . 0.0 108.013 176.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.88 -48.23 80.44 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.882 0.873 . . . . 0.0 110.019 -176.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.07 -49.71 65.83 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.157 1.383 . . . . 0.0 110.202 177.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.1 m -60.66 -44.78 96.04 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.156 0.982 . . . . 0.0 111.174 175.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.8 mttm -53.19 -28.68 27.78 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.453 1.101 . . . . 0.0 112.208 175.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.3 pt -112.66 7.71 8.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 124.202 1.001 . . . . 0.0 113.079 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.16 21.77 5.49 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 127.027 2.131 . . . . 0.0 113.311 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.78 173.23 6.66 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.547 1.139 . . . . 0.0 109.853 -173.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -71.43 139.56 84.22 Favored Pre-proline 0 CA--C 1.53 0.204 0 C-N-CA 124.182 0.993 . . . . 0.0 110.93 -173.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -74.78 -10.73 21.73 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.451 2.767 . . . . 0.0 112.373 177.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.2 tp60 -58.84 -57.64 12.16 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 163.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.0 m -67.14 -24.32 31.9 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 CA-C-O 119.077 -0.487 . . . . 0.0 111.102 -169.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 43.6 mm -63.22 -47.68 91.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 124.489 1.116 . . . . 0.0 111.475 171.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.06 -36.62 84.92 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 122.562 0.345 . . . . 0.0 110.574 176.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.45 -31.69 65.66 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.201 0.6 . . . . 0.0 111.363 177.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -58.82 -38.32 78.38 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 125.341 1.456 . . . . 0.0 111.82 170.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -60.81 -58.83 6.8 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.019 0.528 . . . . 0.0 110.361 178.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.3 p -66.63 -27.11 67.43 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -176.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.21 8.11 56.75 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-O 119.856 -0.414 . . . . 0.0 112.281 -170.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 21.0 mtm180 -69.17 -38.12 78.54 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 118.288 1.044 . . . . 0.0 110.369 172.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.67 138.29 48.5 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.8 mm -76.62 126.25 86.28 Favored Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 168.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -68.76 158.83 56.23 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 121.645 1.563 . . . . 0.0 109.851 177.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 -136.51 137.26 40.12 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 171.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -54.51 -34.42 61.66 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.446 1.099 . . . . 0.0 110.925 -179.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -61.95 -58.26 8.58 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.566 0.746 . . . . 0.0 109.773 178.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 83.9 t -66.97 -46.15 85.51 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.453 0 CA-C-O 117.402 -1.285 . . . . 0.0 109.151 -176.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 62.3 mt -44.72 -56.17 4.67 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 120.794 1.634 . . . . 0.0 110.895 169.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.18 -14.19 52.36 Favored Glycine 0 CA--C 1.536 1.39 0 CA-C-N 118.566 0.621 . . . . 0.0 114.007 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 22.7 mtpp -89.39 -46.74 8.5 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 125.557 1.543 . . . . 0.0 110.444 171.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.0 mt -53.47 -37.5 30.26 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.191 0 C-N-CA 124.532 1.133 . . . . 0.0 108.698 175.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -55.95 -54.47 44.38 Favored 'General case' 0 C--O 1.223 -0.327 0 C-N-CA 119.65 -0.82 . . . . 0.0 111.343 175.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 23.6 mtm180 -69.35 -7.58 38.63 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.977 0.808 . . . . 0.0 112.738 176.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.35 -27.1 35.06 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.264 1.025 . . . . 0.0 111.686 176.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.1 pt -127.71 -11.55 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.026 0.93 . . . . 0.0 112.934 -178.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 66.06 39.09 94.59 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 126.02 1.771 . . . . 0.0 112.132 -174.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 61.9 mt -132.02 162.81 29.85 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 124.336 1.054 . . . . 0.0 109.311 170.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -74.26 140.12 44.77 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 126.013 1.725 . . . . 0.0 108.538 174.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -117.46 11.17 13.79 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.937 1.295 . . . . 0.0 109.839 178.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 27.2 mtm105 -140.14 161.57 37.32 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.716 1.206 . . . . 0.0 109.418 178.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.12 169.47 24.98 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 124.327 0.965 . . . . 0.0 110.874 -175.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.559 ' H ' ' HD3' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -68.42 -17.64 64.26 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 121.772 -0.84 . . . . 0.0 111.38 170.772 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -77.95 15.03 0.95 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.375 1.47 . . . . 0.0 110.792 173.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.3 tt -52.55 142.35 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 O-C-N 120.888 -1.132 . . . . 0.0 110.084 175.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.56 0.03 57.23 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-O 117.577 -1.68 . . . . 0.0 113.948 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 33.7 mmtt -77.33 154.53 81.99 Favored Pre-proline 0 N--CA 1.453 -0.321 0 CA-C-N 119.893 1.846 . . . . 0.0 107.46 157.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -70.32 163.68 37.83 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 123.266 2.644 . . . . 0.0 112.852 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.0 pt -112.15 170.34 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 C-N-CA 126.192 1.797 . . . . 0.0 108.507 172.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 67.04 161.29 0.16 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.3 1.84 . . . . 0.0 110.227 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -82.3 80.04 8.6 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 120.018 -1.676 . . . . 0.0 109.535 179.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -148.17 120.87 1.26 Allowed Glycine 0 CA--C 1.525 0.68 0 N-CA-C 107.357 -2.297 . . . . 0.0 107.357 161.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -76.01 66.88 6.84 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.647 2.898 . . . . 0.0 110.077 174.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.2 mmp_? -72.13 177.9 4.14 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.657 1.183 . . . . 0.0 108.269 165.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 8.39 92.47 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 128.658 2.783 . . . . 0.0 113.942 162.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -75.56 67.84 2.12 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 166.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.2 m -76.93 149.57 36.01 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 156.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -171.51 78.63 0.09 OUTLIER Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 107.268 -2.333 . . . . 0.0 107.268 -175.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -62.16 170.03 6.94 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.085 1.857 . . . . 0.0 111.175 178.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.3 t -145.96 148.84 33.19 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.45 1.1 . . . . 0.0 108.311 175.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.9 m -144.87 159.7 42.47 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.233 1.013 . . . . 0.0 110.294 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.168 0 N-CA-C 105.729 -2.948 . . . . 0.0 105.729 163.32 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 . . . . . 0 C--O 1.225 -0.199 0 CA-C-O 119.149 -0.453 . . . . 0.0 111.322 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.8 t -57.51 -54.73 27.26 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.253 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 171.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.4 -44.18 93.65 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-N 118.388 0.54 . . . . 0.0 112.372 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -59.68 -56.93 15.76 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 117.631 -1.176 . . . . 0.0 109.636 175.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 69.3 t -58.84 -36.07 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 120.357 1.435 . . . . 0.0 110.375 -178.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.6 mt -57.3 -59.24 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 174.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -57.11 -48.31 78.94 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.753 1.221 . . . . 0.0 110.784 -178.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -62.87 -46.38 88.13 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 125.123 1.369 . . . . 0.0 111.636 -176.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.39 -35.73 63.28 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-O 118.816 -0.991 . . . . 0.0 111.493 178.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.621 ' HG2' HD23 ' A' ' 32' ' ' LEU . 13.1 mtm105 -54.82 -61.61 2.2 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 118.049 0.924 . . . . 0.0 109.211 170.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.39 -30.82 71.47 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.131 0.972 . . . . 0.0 111.663 -172.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.8 m -63.88 -16.87 62.43 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 118.92 -0.562 . . . . 0.0 112.422 175.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -124.22 11.42 8.78 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.891 2.076 . . . . 0.0 110.314 -176.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.33 13.97 31.66 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.514 1.054 . . . . 0.0 114.678 -176.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 44.4 mt -78.36 119.95 22.42 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 119.945 1.873 . . . . 0.0 108.845 -170.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 62.1 p -64.67 168.9 5.5 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.557 0.694 . . . . 0.0 110.362 172.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -62.91 -34.51 77.58 Favored 'General case' 0 N--CA 1.464 0.258 0 O-C-N 120.424 -1.422 . . . . 0.0 110.428 174.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.93 -33.02 63.79 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.186 0.594 . . . . 0.0 109.73 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -63.65 -39.44 94.35 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.641 1.11 . . . . 0.0 109.557 171.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.621 HD23 ' HG2' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -64.89 -52.81 54.51 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 123.917 0.887 . . . . 0.0 110.312 179.848 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.93 -43.24 63.35 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 124.679 1.192 . . . . 0.0 110.403 177.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 60.7 m -60.11 -52.39 65.57 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.998 0.919 . . . . 0.0 110.379 174.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.3 mttm -57.23 -25.28 58.84 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 119.24 0.927 . . . . 0.0 113.196 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.3 pt -113.81 5.16 7.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 118.972 0.806 . . . . 0.0 112.227 -176.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.9 m120 54.5 54.94 8.62 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.524 1.529 . . . . 0.0 109.537 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -128.59 -178.6 4.65 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 126.922 2.089 . . . . 0.0 109.168 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 51.7 mmtt -81.02 149.73 67.22 Favored Pre-proline 0 C--N 1.333 -0.148 0 C-N-CA 123.853 0.861 . . . . 0.0 109.546 167.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.48 -11.5 26.46 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.668 2.245 . . . . 0.0 112.115 167.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -59.49 -57.94 10.77 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.952 1.301 . . . . 0.0 109.448 169.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.9 m -63.92 -33.27 61.02 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.556 0 CA-C-O 118.128 -0.939 . . . . 0.0 110.689 -173.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 42.8 mm -60.5 -46.51 95.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 120.166 1.348 . . . . 0.0 110.044 176.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.08 -28.91 69.95 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.169 0.587 . . . . 0.0 112.356 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -85.23 -38.46 18.9 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.846 0.858 . . . . 0.0 110.61 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -54.98 -40.98 70.64 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 126.328 1.851 . . . . 0.0 110.537 173.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -58.68 -42.94 89.66 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.82 0.848 . . . . 0.0 112.084 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 9.0 m -75.41 -35.32 61.02 Favored 'General case' 0 C--N 1.331 -0.207 0 O-C-N 122.097 -0.377 . . . . 0.0 110.222 175.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.85 46.34 3.17 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 -168.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 21.2 mtm-85 -128.42 -0.35 5.63 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 125.272 1.429 . . . . 0.0 113.309 -177.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -89.48 175.76 7.17 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 161.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 48.8 mm -93.8 112.66 57.87 Favored Pre-proline 0 C--O 1.239 0.541 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 171.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -77.49 115.51 3.91 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 123.138 2.558 . . . . 0.0 108.064 -177.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -113.84 142.5 46.01 Favored 'General case' 0 CA--C 1.517 -0.317 0 O-C-N 121.695 -0.628 . . . . 0.0 109.674 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -58.24 -26.23 62.64 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.791 0.836 . . . . 0.0 113.146 -171.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -62.91 -57.61 10.21 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.98 0.912 . . . . 0.0 110.528 173.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.2 t -68.68 -43.75 82.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 118.409 -0.805 . . . . 0.0 109.573 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 54.5 mt -49.48 -46.84 48.65 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.08 0.855 . . . . 0.0 110.337 171.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.99 -43.2 95.12 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 123.998 0.809 . . . . 0.0 112.722 176.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -61.8 -45.65 92.92 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 118.373 1.087 . . . . 0.0 110.796 174.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.0 mt -61.47 -33.69 58.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 C-N-CA 123.939 0.896 . . . . 0.0 110.324 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -56.8 -51.3 69.49 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 119.538 1.063 . . . . 0.0 110.419 176.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 52.5 mtt180 -54.12 -42.03 69.02 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.27 0.628 . . . . 0.0 109.874 177.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.04 -42.22 68.94 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.72 1.608 . . . . 0.0 113.09 -173.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 45.7 pt -114.74 -16.94 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 123.593 0.757 . . . . 0.0 112.167 -174.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.57 25.18 54.61 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 125.09 1.328 . . . . 0.0 113.052 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 77' ' ' PRO . 61.6 mt -130.59 162.95 28.18 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.081 1.352 . . . . 0.0 109.434 179.317 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 47.6 mttm -77.16 146.3 37.17 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 127.16 2.184 . . . . 0.0 110.312 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -121.32 5.03 10.24 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.512 1.525 . . . . 0.0 112.223 -175.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 66.3 mtm180 -139.59 163.5 32.39 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.681 1.592 . . . . 0.0 109.909 171.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.38 167.76 43.78 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 125.831 1.681 . . . . 0.0 109.538 -171.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -71.36 -9.76 58.67 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.455 -1.027 . . . . 0.0 110.137 163.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -75.09 8.17 2.78 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.547 1.939 . . . . 0.0 110.791 170.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.4 tt -52.54 141.46 6.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 O-C-N 120.275 -1.516 . . . . 0.0 110.279 175.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.3 -4.61 54.58 Favored Glycine 0 CA--C 1.537 1.428 0 CA-C-O 119.04 -0.867 . . . . 0.0 113.838 -177.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.5 mmtt -66.29 146.79 99.05 Favored Pre-proline 0 N--CA 1.454 -0.267 0 CA-C-N 119.877 1.839 . . . . 0.0 107.934 159.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.432 ' HA ' HD23 ' A' ' 67' ' ' LEU . 33.5 Cg_endo -70.43 162.11 43.59 Favored 'Trans proline' 0 N--CA 1.447 -1.262 0 C-N-CA 123.441 2.76 . . . . 0.0 111.222 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.1 pt . . . . . 0 C--N 1.332 -0.155 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 172.459 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 . . . . . 0 C--O 1.226 -0.144 0 CA-C-O 119.875 -0.107 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.5 t -55.68 -58.38 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 123.575 0.75 . . . . 0.0 109.389 173.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.31 -40.02 95.42 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 118.891 0.769 . . . . 0.0 112.666 -178.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.36 -54.44 45.66 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.563 1.145 . . . . 0.0 110.242 176.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.4 t -63.25 -38.24 81.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 C-N-CA 123.618 0.767 . . . . 0.0 110.268 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 52.0 mt -56.81 -56.71 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.065 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 175.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -52.61 -55.28 23.44 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.194 0.598 . . . . 0.0 110.115 -178.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.23 -41.94 98.87 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.138 0.575 . . . . 0.0 111.468 -174.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.34 -41.61 45.05 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-O 119.204 -0.775 . . . . 0.0 111.396 -176.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.545 ' HG2' HD23 ' A' ' 32' ' ' LEU . 14.1 mtm105 -52.5 -60.11 3.64 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 117.669 0.734 . . . . 0.0 109.514 171.033 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.72 -31.33 72.47 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 123.702 0.626 . . . . 0.0 110.953 -171.287 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.8 t -64.2 -25.03 67.89 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.029 0.532 . . . . 0.0 111.77 176.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -112.98 13.08 19.44 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.913 1.285 . . . . 0.0 111.226 178.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.31 13.4 43.16 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.221 0.915 . . . . 0.0 113.446 -178.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 54.4 mt -74.04 118.89 17.52 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -171.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 27.0 p -65.72 174.3 2.4 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.626 0.726 . . . . 0.0 109.564 171.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -68.6 -37.16 79.58 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 120.747 -1.22 . . . . 0.0 110.137 174.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -64.86 -35.3 80.67 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 119.246 0.93 . . . . 0.0 111.612 172.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.63 -51.54 69.35 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 118.973 0.806 . . . . 0.0 109.048 176.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.545 HD23 ' HG2' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -60.81 -50.76 72.15 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 124.332 1.053 . . . . 0.0 109.888 -177.024 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -49.64 -52.36 31.28 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.092 1.357 . . . . 0.0 110.2 175.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.0 m -58.25 -44.54 88.38 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.857 0.863 . . . . 0.0 112.439 175.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.3 mttp -59.71 -16.29 26.02 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.445 1.02 . . . . 0.0 112.764 176.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.485 HG22 ' HB3' ' A' ' 60' ' ' LYS . 18.9 pt -117.69 8.97 7.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 124.808 1.243 . . . . 0.0 111.886 173.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.6 t30 55.12 6.78 0.15 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 128.494 2.718 . . . . 0.0 115.609 -174.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -102.64 -171.0 1.88 Allowed 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 124.537 1.135 . . . . 0.0 109.216 -171.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.413 ' O ' HG22 ' A' ' 42' ' ' VAL . 69.6 mmtt -95.87 141.36 23.05 Favored Pre-proline 0 N--CA 1.464 0.263 0 O-C-N 120.743 -1.223 . . . . 0.0 113.359 -168.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.09 -20.82 43.59 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.175 2.583 . . . . 0.0 112.585 -177.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.4 tp60 -56.82 -44.0 81.59 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 117.74 -1.124 . . . . 0.0 110.696 167.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.413 HG22 ' O ' ' A' ' 39' ' ' LYS 0.273 12.1 m -67.15 -36.1 75.99 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.345 0 CA-C-N 120.116 1.325 . . . . 0.0 109.917 179.812 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 42.1 mm -59.3 -49.01 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 119.827 1.194 . . . . 0.0 109.931 177.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.34 -36.59 71.36 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.24 -41.61 48.63 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.738 1.615 . . . . 0.0 111.827 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -57.94 -45.96 85.81 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.103 1.361 . . . . 0.0 108.81 175.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -55.17 -38.22 68.02 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.479 0.711 . . . . 0.0 111.392 175.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.52 2.24 56.49 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -179.243 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.15 13.21 77.65 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-N 120.27 1.396 . . . . 0.0 113.026 174.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -87.98 -57.52 2.9 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.671 1.588 . . . . 0.0 108.082 -169.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.52 142.62 48.42 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.76 0.824 . . . . 0.0 110.136 -177.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.8 mt -69.47 119.51 71.14 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 168.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.54 135.41 24.11 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.257 1.971 . . . . 0.0 109.149 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -133.8 132.78 40.88 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.008 0.923 . . . . 0.0 109.136 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -40.39 -46.18 2.33 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.647 1.979 . . . . 0.0 112.358 176.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -51.01 -48.88 61.32 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.377 0.671 . . . . 0.0 111.22 -178.135 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.501 ' HA ' ' HD3' ' A' ' 60' ' ' LYS . 58.2 t -79.73 -48.05 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 125.819 1.648 . . . . 0.0 108.636 -178.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 88.6 mt -50.46 -40.01 49.59 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.497 1.044 . . . . 0.0 111.742 177.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.17 -28.75 72.49 Favored Glycine 0 CA--C 1.526 0.768 0 O-C-N 121.036 -1.04 . . . . 0.0 112.47 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.501 ' HD3' ' HA ' ' A' ' 57' ' ' VAL . 18.9 mtpp -73.51 -47.51 40.53 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 124.619 1.168 . . . . 0.0 108.213 173.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.9 mt -58.1 -39.34 72.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 123.704 0.801 . . . . 0.0 110.32 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -60.32 -42.66 96.04 Favored 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 118.869 -1.132 . . . . 0.0 110.644 -178.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -66.78 -37.04 83.8 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 118.84 0.746 . . . . 0.0 111.447 174.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.66 -36.25 64.4 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.941 1.696 . . . . 0.0 111.946 -177.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 24.5 pt -113.25 -19.1 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 118.999 0.818 . . . . 0.0 112.029 176.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.74 30.08 60.29 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 125.506 1.526 . . . . 0.0 113.061 -176.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' A' ' 77' ' ' PRO . 29.9 mt -132.56 161.45 33.79 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 124.839 1.256 . . . . 0.0 108.3 173.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -71.32 141.12 50.47 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 125.499 1.52 . . . . 0.0 109.408 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -115.88 -1.34 12.6 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.721 1.608 . . . . 0.0 109.506 175.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.4 mtm105 -132.76 142.05 48.82 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.537 1.535 . . . . 0.0 108.491 -177.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.59 167.49 36.62 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 125.135 1.35 . . . . 0.0 111.104 -178.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -70.59 -12.14 61.38 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 121.687 -0.89 . . . . 0.0 111.396 172.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -82.04 16.91 1.73 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.106 2.162 . . . . 0.0 111.267 171.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.2 tt -52.06 141.88 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 O-C-N 120.613 -1.305 . . . . 0.0 110.161 176.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.97 -10.06 10.23 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-O 118.762 -1.021 . . . . 0.0 114.065 -177.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.3 mmtt -70.78 151.06 95.29 Favored Pre-proline 0 N--CA 1.453 -0.294 0 CA-C-N 120.843 2.321 . . . . 0.0 106.016 161.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.455 ' HA ' HD23 ' A' ' 67' ' ' LEU . 14.1 Cg_endo -67.96 157.02 63.66 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.863 2.376 . . . . 0.0 111.246 -174.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 25.9 pt . . . . . 0 C--O 1.234 0.242 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 161.198 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 . . . . . 0 CA--C 1.533 0.32 0 CA-C-O 119.091 -0.48 . . . . 0.0 110.737 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 63.4 t -58.62 -66.38 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 125.028 1.331 . . . . 0.0 109.695 174.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.59 -29.41 40.07 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 119.182 0.901 . . . . 0.0 113.498 -177.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.7 tttt -72.58 -55.51 6.79 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 117.654 -1.165 . . . . 0.0 110.701 175.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.3 t -58.84 -39.26 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 120.101 1.319 . . . . 0.0 110.28 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 86.4 mt -54.96 -61.21 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 175.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -63.35 -39.9 95.81 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 -172.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -58.25 -46.82 85.26 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.688 1.595 . . . . 0.0 111.381 176.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.94 -43.74 81.46 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -178.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.9 mtm105 -54.89 -59.55 4.57 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 117.341 0.57 . . . . 0.0 110.54 173.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -58.89 -33.05 70.07 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.636 0.775 . . . . 0.0 110.885 -176.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.0 t -68.31 -8.45 39.82 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 118.23 -0.891 . . . . 0.0 113.395 177.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -132.37 7.88 4.25 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 120.363 1.438 . . . . 0.0 111.505 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 57.19 32.15 63.01 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-N 118.793 0.724 . . . . 0.0 112.174 -173.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 44.8 mt -85.38 119.78 26.13 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.7 t -73.88 171.71 12.9 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.143 0.883 . . . . 0.0 109.964 176.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -61.68 -37.64 84.87 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 120.364 -1.46 . . . . 0.0 110.841 176.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.4 mttp -59.28 -32.6 70.18 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.078 0.854 . . . . 0.0 112.684 170.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -70.32 -39.25 74.87 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 119.422 1.01 . . . . 0.0 108.604 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.68 -48.02 76.28 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -50.89 -51.2 54.15 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 126.221 1.808 . . . . 0.0 109.455 177.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 60.1 m -61.49 -47.29 86.3 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.985 1.314 . . . . 0.0 111.037 177.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.6 mttm -64.21 -20.49 66.06 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 26.6 pt -111.34 -2.33 10.25 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.356 0 CA-C-N 120.179 1.354 . . . . 0.0 111.214 174.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 53.5 t30 44.92 71.5 0.26 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.695 1.598 . . . . 0.0 112.466 -167.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -140.26 177.65 7.84 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 127.36 2.264 . . . . 0.0 109.179 166.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 28.2 mtmt -79.38 141.48 57.18 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 124.061 0.944 . . . . 0.0 111.916 177.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -66.51 -11.13 30.4 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.41 2.74 . . . . 0.0 115.227 -178.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 42.4 tp60 -75.89 -27.79 57.85 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 120.699 1.591 . . . . 0.0 111.379 169.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 m -68.1 -35.8 72.93 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.413 0 CA-C-N 120.832 1.651 . . . . 0.0 108.293 173.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 33.6 mm -59.67 -50.44 79.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 C-N-CA 124.207 1.003 . . . . 0.0 110.078 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.4 -32.11 73.45 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.928 -0.483 . . . . 0.0 112.089 176.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.82 -27.98 61.39 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 120.798 -1.189 . . . . 0.0 110.97 175.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -69.46 -37.7 77.43 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.653 1.581 . . . . 0.0 110.87 175.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -55.29 -56.8 15.93 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 167.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.5 m -66.58 -19.88 65.88 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.22 1.008 . . . . 0.0 113.46 -172.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.34 -10.31 73.37 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 123.773 0.702 . . . . 0.0 114.5 -175.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 28.9 mtt-85 -77.23 -21.21 54.13 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 118.199 1.0 . . . . 0.0 112.39 -174.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.14 115.22 19.58 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 105.264 -2.125 . . . . 0.0 105.264 168.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.2 mm -69.1 113.73 18.49 Favored Pre-proline 0 C--O 1.238 0.47 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 -171.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -77.33 114.57 3.77 Favored 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 121.783 1.655 . . . . 0.0 110.563 -163.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -110.5 144.23 39.65 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.945 0.898 . . . . 0.0 109.539 -174.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -53.41 -40.46 65.12 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -171.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -52.51 -60.63 3.0 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.052 0.941 . . . . 0.0 109.662 177.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.579 ' HA ' ' HD3' ' A' ' 60' ' ' LYS . 70.9 t -65.96 -44.8 92.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-O 118.328 -0.844 . . . . 0.0 109.49 -175.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.7 mt -51.3 -44.79 61.98 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.783 0.72 . . . . 0.0 110.2 176.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.82 -43.96 94.46 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.024 0.821 . . . . 0.0 113.068 175.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.579 ' HD3' ' HA ' ' A' ' 57' ' ' VAL . 15.8 mtpp -65.23 -42.88 92.94 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 121.304 -1.115 . . . . 0.0 109.651 178.277 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.2 mt -60.81 -32.99 53.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 123.563 0.745 . . . . 0.0 109.271 176.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.465 ' HA ' HD23 ' A' ' 69' ' ' LEU . 38.3 mt-10 -58.49 -49.03 78.84 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 120.078 1.308 . . . . 0.0 110.212 178.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 48.5 mtt85 -68.6 -20.91 64.52 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.606 -0.684 . . . . 0.0 112.496 175.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.27 -54.81 41.31 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.405 HD11 HD21 ' A' ' 69' ' ' LEU . 50.2 pt -100.22 -18.07 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -176.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.19 20.87 58.25 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 125.871 1.701 . . . . 0.0 113.533 -177.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 77' ' ' PRO . 60.8 mt -125.47 161.73 26.46 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 125.14 1.376 . . . . 0.0 108.913 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -72.18 139.78 48.41 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 125.244 1.418 . . . . 0.0 109.226 177.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 62' ' ' GLU . 3.2 mm? -119.72 -1.39 10.57 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.218 1.807 . . . . 0.0 110.961 177.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.3 mmm180 -125.46 155.14 40.95 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 119.496 1.044 . . . . 0.0 108.68 170.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.13 159.93 6.63 Favored Glycine 0 N--CA 1.447 -0.613 0 O-C-N 124.843 1.339 . . . . 0.0 110.573 -178.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -73.18 -4.24 31.66 Favored 'General case' 0 N--CA 1.464 0.273 0 O-C-N 121.001 -1.293 . . . . 0.0 112.131 -176.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -73.32 12.4 0.59 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.849 0.749 . . . . 0.0 110.572 162.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.7 tt -48.56 134.03 5.96 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 CA-C-N 120.269 1.395 . . . . 0.0 109.125 176.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.32 -4.76 66.15 Favored Glycine 0 CA--C 1.538 1.521 0 CA-C-O 119.155 -0.803 . . . . 0.0 114.15 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 40.9 mmtt -72.57 151.39 91.54 Favored Pre-proline 0 N--CA 1.455 -0.206 0 CA-C-N 119.989 1.895 . . . . 0.0 106.794 159.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 30.8 Cg_endo -72.47 160.75 46.02 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 123.423 2.749 . . . . 0.0 111.489 -178.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 36.8 pt . . . . . 0 C--O 1.235 0.294 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 173.518 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 69.5 mt-10 . . . . . 0 N--CA 1.462 0.155 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.5 t -57.97 -51.22 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 176.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.45 -36.5 84.63 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 118.771 -1.016 . . . . 0.0 112.895 175.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -63.19 -55.92 21.04 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 119.024 1.412 . . . . 0.0 109.235 176.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.4 t -64.12 -34.55 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-N 119.311 0.96 . . . . 0.0 110.573 -178.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.4 mt -59.18 -59.49 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 171.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -56.69 -41.28 77.09 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 118.836 0.744 . . . . 0.0 110.75 -174.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -62.79 -57.13 11.98 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.405 1.882 . . . . 0.0 110.822 176.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.69 -32.66 83.76 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 118.205 0.457 . . . . 0.0 111.995 -175.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.566 ' HG2' HD23 ' A' ' 32' ' ' LEU . 25.3 mtm105 -53.51 -61.41 2.32 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 166.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -50.55 -46.56 57.6 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.713 1.205 . . . . 0.0 111.69 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.2 m -71.11 -6.79 41.97 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.42 1.088 . . . . 0.0 113.409 -176.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.546 ' HE3' HD11 ' A' ' 27' ' ' LEU . 26.5 mtpp -120.06 8.12 10.94 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.899 1.68 . . . . 0.0 111.535 167.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.09 19.58 51.71 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.777 1.179 . . . . 0.0 113.015 -176.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.546 HD11 ' HE3' ' A' ' 25' ' ' LYS . 79.6 mt -84.34 131.87 34.66 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 118.804 1.302 . . . . 0.0 108.552 -171.292 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.4 p -75.75 176.57 7.61 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 171.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -68.07 -37.58 81.41 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.179 -0.951 . . . . 0.0 110.73 172.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.6 tmtp? -63.26 -39.23 94.01 Favored 'General case' 0 N--CA 1.462 0.125 0 C-N-CA 123.107 0.563 . . . . 0.0 110.873 174.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.55 -42.22 83.01 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 177.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.566 HD23 ' HG2' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -58.04 -50.67 72.65 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 123.744 0.817 . . . . 0.0 110.089 176.35 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -48.54 -53.47 18.1 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 125.269 1.428 . . . . 0.0 109.978 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 35.1 m -63.09 -40.74 98.56 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.647 0.779 . . . . 0.0 111.933 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.7 mttp -61.81 -12.19 16.08 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 119.719 1.145 . . . . 0.0 113.81 174.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 24.8 pt -123.6 10.38 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 119.99 1.268 . . . . 0.0 111.583 175.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 37.09 68.85 0.25 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 128.453 2.701 . . . . 0.0 112.067 -168.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -131.35 -178.67 4.95 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 127.44 2.296 . . . . 0.0 107.437 173.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -93.67 151.57 40.11 Favored Pre-proline 0 CA--C 1.531 0.233 0 C-N-CA 124.362 1.065 . . . . 0.0 110.595 171.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -67.03 -17.27 51.03 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 123.676 2.917 . . . . 0.0 113.697 -178.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 -65.51 -52.24 54.08 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 118.502 0.592 . . . . 0.0 110.398 177.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.1 m -63.55 -27.61 43.33 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 C-N-CA 120.5 -0.48 . . . . 0.0 109.965 -175.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 38.0 mm -61.38 -53.32 50.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 123.084 0.554 . . . . 0.0 110.574 174.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.17 -39.9 73.07 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 118.957 0.798 . . . . 0.0 111.485 177.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.88 -31.15 67.72 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 118.678 -0.677 . . . . 0.0 111.086 -178.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -63.06 -45.63 91.28 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 125.288 1.435 . . . . 0.0 111.342 172.121 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.415 ' CD ' HH21 ' A' ' 22' ' ' ARG . 4.7 mt-10 -58.86 -32.96 69.92 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.292 0.637 . . . . 0.0 111.328 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 43.7 m -82.8 -23.15 33.96 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 174.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.2 0.15 80.72 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 119.624 1.102 . . . . 0.0 114.218 -169.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.8 mtt85 -69.49 -47.12 64.9 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 117.867 0.834 . . . . 0.0 109.561 -177.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.39 134.82 57.35 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 171.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 34.0 mm -68.95 120.39 76.02 Favored Pre-proline 0 C--O 1.237 0.416 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -71.44 115.54 4.33 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.503 2.135 . . . . 0.0 110.5 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -106.2 122.2 45.74 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 126.509 1.923 . . . . 0.0 107.697 -178.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -55.73 -24.8 37.08 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 119.813 1.188 . . . . 0.0 113.221 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -61.55 -55.93 25.53 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.491 0.716 . . . . 0.0 109.284 174.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.0 t -71.26 -38.76 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.4 -177.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.4 mt -50.44 -46.39 56.53 Favored 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 169.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.61 -46.89 91.6 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 124.138 0.875 . . . . 0.0 112.036 177.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -57.85 -43.7 86.05 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 117.935 0.867 . . . . 0.0 110.828 175.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.0 mt -65.24 -35.77 76.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 124.685 1.194 . . . . 0.0 110.325 178.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.488 ' HB3' HG21 ' A' ' 78' ' ' ILE . 69.9 mt-10 -59.93 -49.91 75.82 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 119.495 1.043 . . . . 0.0 108.616 176.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.8 mtm105 -57.59 -31.32 66.06 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 122.871 0.468 . . . . 0.0 111.288 175.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.47 -53.7 26.55 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.011 0.924 . . . . 0.0 112.227 -177.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 35.6 pt -90.05 -16.5 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 122.418 0.287 . . . . 0.0 111.269 -177.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.92 27.28 58.77 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 125.871 1.701 . . . . 0.0 113.186 -175.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 77' ' ' PRO . 24.2 mt -143.37 161.38 38.51 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.727 1.764 . . . . 0.0 109.887 179.012 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -68.28 142.83 55.46 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 126.163 1.785 . . . . 0.0 110.746 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 62' ' ' GLU . 4.2 mm? -118.17 10.33 12.89 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.467 1.107 . . . . 0.0 110.398 173.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 25.1 mtm105 -139.8 157.27 46.0 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 121.32 -0.863 . . . . 0.0 109.711 -178.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.96 167.91 21.04 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -170.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 43.2 tttp -68.94 -14.08 62.82 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.363 -1.08 . . . . 0.0 110.642 172.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -64.93 8.23 0.13 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.695 1.998 . . . . 0.0 112.426 168.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.7 tt -50.24 135.9 8.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-N 120.552 1.524 . . . . 0.0 110.283 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.28 -4.68 62.18 Favored Glycine 0 CA--C 1.533 1.204 0 CA-C-O 119.045 -0.864 . . . . 0.0 114.406 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 44.7 mmtt -70.07 153.14 95.57 Favored Pre-proline 0 N--CA 1.453 -0.314 0 CA-C-N 119.808 1.804 . . . . 0.0 107.101 161.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.42 ' HA ' HD23 ' A' ' 67' ' ' LEU . 11.5 Cg_endo -67.18 168.78 16.67 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.062 2.508 . . . . 0.0 112.53 -176.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.488 HG21 ' HB3' ' A' ' 62' ' ' GLU . 34.4 pt . . . . . 0 N--CA 1.453 -0.302 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 175.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 . . . . . 0 CA--C 1.54 0.596 0 CA-C-O 119.238 -0.41 . . . . 0.0 111.235 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.0 t -57.58 -57.37 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 125.742 1.617 . . . . 0.0 109.8 178.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -49.12 -46.7 33.79 Favored Glycine 0 C--O 1.223 -0.537 0 C-N-CA 124.849 1.214 . . . . 0.0 112.246 177.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -62.1 -49.08 77.36 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 119.008 1.404 . . . . 0.0 110.958 178.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 63.6 t -60.63 -41.99 90.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-N 119.482 1.037 . . . . 0.0 110.983 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.402 HG13 HD11 ' A' ' 69' ' ' LEU . 21.2 mt -54.15 -68.19 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 106.209 -1.775 . . . . 0.0 106.209 173.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -57.87 -30.37 65.77 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 125.079 1.352 . . . . 0.0 110.413 -167.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -64.55 -69.38 0.29 Allowed 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.715 1.606 . . . . 0.0 110.924 171.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.58 -29.34 74.62 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-N 119.413 1.006 . . . . 0.0 111.765 -171.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.4 ttp85 -53.74 -60.45 3.3 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 126.218 1.807 . . . . 0.0 108.76 168.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -67.42 -28.94 68.33 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 119.809 1.186 . . . . 0.0 113.334 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 59.0 m -61.03 -20.42 62.5 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.187 0.903 . . . . 0.0 111.99 172.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.456 ' HE3' HD11 ' A' ' 27' ' ' LEU . 25.7 mtpp -109.67 5.9 23.29 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.915 1.686 . . . . 0.0 111.073 175.099 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.06 9.75 54.66 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 126.442 1.972 . . . . 0.0 113.68 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.456 HD11 ' HE3' ' A' ' 25' ' ' LYS . 34.7 mt -74.15 130.78 40.43 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 118.559 1.179 . . . . 0.0 109.231 -163.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 32.1 p -66.02 162.35 19.61 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 166.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -55.19 -37.24 66.8 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 121.469 -0.77 . . . . 0.0 109.863 169.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -63.85 -43.46 96.05 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.05 0.54 . . . . 0.0 111.298 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -70.02 -35.55 74.41 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 118.853 -0.594 . . . . 0.0 110.628 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.63 -46.05 90.15 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.747 0.703 . . . . 0.0 109.937 173.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.61 -54.44 45.98 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 124.722 1.209 . . . . 0.0 108.978 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 52.0 m -68.01 -31.4 71.06 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 117.962 -1.018 . . . . 0.0 111.608 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.1 mttp -52.75 -50.58 63.19 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 119.945 1.248 . . . . 0.0 110.47 173.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.9 pt -88.13 2.42 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 123.174 0.59 . . . . 0.0 112.383 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 62.3 t-20 45.02 74.21 0.14 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 128.973 2.909 . . . . 0.0 111.716 -170.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -139.35 173.6 11.37 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 128.612 2.765 . . . . 0.0 109.906 178.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.8 mmpt? -81.44 144.21 52.93 Favored Pre-proline 0 CA--C 1.534 0.341 0 O-C-N 121.505 -0.747 . . . . 0.0 109.882 173.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.32 -16.52 13.64 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.334 2.022 . . . . 0.0 114.452 -172.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 -68.04 -34.16 75.95 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 120.331 1.423 . . . . 0.0 110.782 173.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.6 m -72.22 -27.81 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 119.686 1.13 . . . . 0.0 110.155 177.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 36.3 mm -63.92 -50.51 77.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 C-N-CA 123.221 0.609 . . . . 0.0 109.414 172.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.17 -35.58 71.77 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.126 0.489 . . . . 0.0 110.462 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -72.94 -31.03 64.33 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 117.974 -1.012 . . . . 0.0 112.462 176.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -57.08 -50.84 71.54 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-N 120.019 1.281 . . . . 0.0 109.958 170.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -67.55 -29.68 69.12 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 119.188 -0.434 . . . . 0.0 110.965 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.6 m -71.11 -37.1 72.37 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.299 0.954 . . . . 0.0 111.716 176.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 113.85 9.37 16.45 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 124.943 1.259 . . . . 0.0 113.441 -176.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.5 mmt85 -101.29 -42.63 6.24 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 124.546 1.138 . . . . 0.0 110.955 -163.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.85 130.02 42.45 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 174.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 30.1 mm -68.3 124.9 90.89 Favored Pre-proline 0 C--O 1.238 0.456 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 -177.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -76.58 111.81 3.33 Favored 'Trans proline' 0 N--CA 1.442 -1.525 0 N-CA-C 106.836 -2.024 . . . . 0.0 106.836 -175.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -104.9 130.65 53.01 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 -174.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -50.54 -31.51 15.85 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 117.85 -1.071 . . . . 0.0 113.64 -178.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -65.24 -59.55 3.95 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 120.838 1.654 . . . . 0.0 110.673 172.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.1 t -59.7 -47.46 91.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 124.143 0.977 . . . . 0.0 110.034 -176.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 78.8 mt -47.68 -51.03 23.23 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 124.432 1.093 . . . . 0.0 109.538 169.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.72 -43.44 69.32 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 123.718 0.675 . . . . 0.0 112.576 177.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt -66.45 -44.04 83.88 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.14 0.97 . . . . 0.0 109.946 177.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.3 mt -60.01 -37.22 71.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 124.76 1.224 . . . . 0.0 109.903 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -58.35 -47.37 84.01 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 119.229 0.922 . . . . 0.0 109.564 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 26.1 mtt-85 -69.75 -27.22 64.76 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 118.296 -0.859 . . . . 0.0 112.326 176.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.75 -40.15 79.02 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.818 0.847 . . . . 0.0 112.056 176.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 22.1 pt -117.2 -16.07 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -174.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.1 30.88 62.4 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 125.225 1.393 . . . . 0.0 112.813 -176.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 77' ' ' PRO . 69.7 mt -124.11 164.32 19.68 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 118.631 1.216 . . . . 0.0 109.489 169.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -78.76 140.85 38.2 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 126.033 1.733 . . . . 0.0 108.22 176.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.402 HD11 HG13 ' A' ' 18' ' ' ILE . 3.0 mm? -120.07 7.84 10.9 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.563 1.145 . . . . 0.0 108.985 -179.244 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 22.8 mtm105 -141.63 168.61 19.35 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 127.208 2.203 . . . . 0.0 108.461 177.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 68.91 158.26 1.45 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -162.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 24.3 mtmt -64.63 -15.6 61.46 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 120.876 -1.367 . . . . 0.0 111.387 164.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -66.62 11.69 0.09 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.323 2.249 . . . . 0.0 111.906 168.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.1 tt -51.84 144.52 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 O-C-N 120.485 -1.384 . . . . 0.0 110.532 177.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.79 -4.03 24.29 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-O 118.911 -0.938 . . . . 0.0 113.152 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 39.6 mmtt -69.51 150.79 96.87 Favored Pre-proline 0 N--CA 1.446 -0.667 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 157.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.459 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 14.8 Cg_endo -69.33 158.5 57.28 Favored 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 122.448 2.099 . . . . 0.0 111.365 -177.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 27.8 pt . . . . . 0 C--O 1.238 0.474 0 N-CA-C 105.796 -1.928 . . . . 0.0 105.796 158.876 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 . . . . . 0 CA--C 1.532 0.254 0 N-CA-C 111.132 0.049 . . . . 0.0 111.132 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.5 t -57.9 -56.94 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 124.07 0.948 . . . . 0.0 109.094 177.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -55.21 -39.82 72.68 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-O 118.947 -0.918 . . . . 0.0 112.745 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 48.8 tptt -60.2 -57.7 11.69 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.633 1.216 . . . . 0.0 109.733 176.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.4 t -61.81 -31.9 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 118.662 0.665 . . . . 0.0 110.029 -177.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.1 mt -65.76 -56.41 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 CA-C-N 119.809 1.186 . . . . 0.0 109.061 176.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -51.88 -49.38 63.09 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.599 1.16 . . . . 0.0 110.404 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -66.39 -53.06 40.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.104 1.762 . . . . 0.0 111.958 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.23 -34.24 89.39 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 124.413 1.006 . . . . 0.0 111.519 -174.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.9 mtm105 -64.69 -51.31 63.13 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 118.531 -0.747 . . . . 0.0 111.28 168.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -51.8 -37.76 52.92 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.751 0.82 . . . . 0.0 111.399 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.2 m -73.92 -2.39 23.72 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.621 1.968 . . . . 0.0 112.493 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 21.0 mtpp -136.54 6.72 3.0 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.448 2.299 . . . . 0.0 111.314 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.26 21.04 69.9 Favored Glycine 0 CA--C 1.536 1.399 0 CA-C-O 118.681 -1.066 . . . . 0.0 114.742 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 20.8 mt -93.44 135.4 34.72 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.271 1.536 . . . . 0.0 110.964 -169.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 61.7 p -74.98 170.52 15.82 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.262 -0.899 . . . . 0.0 109.515 163.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -63.44 -29.01 70.37 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.237 -0.914 . . . . 0.0 111.568 166.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.53 -36.81 73.92 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.836 0.855 . . . . 0.0 110.8 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -66.13 -37.39 85.59 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 171.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.408 HD22 ' HA ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -67.9 -48.42 66.08 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 118.207 0.458 . . . . 0.0 111.267 -175.236 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -48.24 -48.85 34.97 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 125.43 1.492 . . . . 0.0 109.209 172.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 63.0 m -60.91 -48.74 80.44 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.796 0.838 . . . . 0.0 111.528 175.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.3 mttm -58.4 -11.68 3.08 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 127.175 2.19 . . . . 0.0 114.233 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.9 pt -128.64 0.07 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 119.26 0.937 . . . . 0.0 112.273 177.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 53.2 t30 42.27 76.31 0.08 Allowed 'General case' 0 C--O 1.235 0.301 0 C-N-CA 126.768 2.027 . . . . 0.0 112.103 -163.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -137.6 -179.51 5.79 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 128.03 2.532 . . . . 0.0 107.567 168.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -88.01 141.71 31.54 Favored Pre-proline 0 C--N 1.335 -0.05 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 175.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -64.36 -18.82 64.47 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.587 2.192 . . . . 0.0 112.029 170.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.5 tp60 -62.23 -52.19 64.76 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 123.93 0.892 . . . . 0.0 110.429 171.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.1 m -69.88 -34.68 61.36 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.431 0 CA-C-N 119.36 0.982 . . . . 0.0 110.094 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 42.1 mm -56.57 -48.96 79.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 O-C-N 121.227 -0.921 . . . . 0.0 110.244 174.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.81 -20.91 66.65 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 178.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.16 -54.05 12.38 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 118.822 -0.608 . . . . 0.0 110.45 167.403 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -42.81 -50.65 5.62 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 124.535 1.134 . . . . 0.0 112.35 176.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.79 -29.35 68.51 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 120.897 1.68 . . . . 0.0 113.223 -171.023 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 12.8 m -69.85 -37.16 76.06 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.874 166.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.63 28.58 18.69 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -177.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -79.16 -50.8 10.42 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 117.494 0.647 . . . . 0.0 109.373 -174.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.35 167.32 18.38 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 127.366 2.266 . . . . 0.0 110.433 171.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 23.9 mm -89.73 127.34 54.61 Favored Pre-proline 0 C--O 1.235 0.333 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 174.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -72.75 115.07 4.2 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 N-CA-C 108.645 -1.329 . . . . 0.0 108.645 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -99.14 135.99 39.75 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.664 0.786 . . . . 0.0 110.795 -169.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -52.4 -36.95 55.4 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.365 1.066 . . . . 0.0 113.275 -170.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -57.59 -64.91 0.74 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.072 0.949 . . . . 0.0 109.226 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 92.4 t -63.3 -40.44 89.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 125.574 1.549 . . . . 0.0 109.844 -178.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.6 mt -49.61 -52.82 27.75 Favored 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 124.354 1.062 . . . . 0.0 110.223 175.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.76 -31.5 78.34 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-N 118.679 0.672 . . . . 0.0 112.523 -178.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -67.59 -43.55 80.27 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 121.401 -1.058 . . . . 0.0 110.371 173.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.0 mt -63.51 -37.12 78.74 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.091 0 C-N-CA 124.337 1.055 . . . . 0.0 109.843 176.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.475 ' HA ' HD23 ' A' ' 69' ' ' LEU . 42.6 mt-10 -56.39 -50.86 70.37 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.386 0.994 . . . . 0.0 109.227 176.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 23.2 mtm180 -64.95 -19.04 65.75 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 175.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.59 -44.76 73.67 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 118.426 -0.797 . . . . 0.0 111.264 177.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.482 HD11 HD21 ' A' ' 69' ' ' LEU . 21.5 pt -114.45 -10.13 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -173.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.51 23.36 78.13 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 127.561 2.505 . . . . 0.0 114.031 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.0 mt -121.94 161.59 22.59 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 118.453 1.126 . . . . 0.0 108.793 172.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -74.36 140.26 44.68 Favored 'General case' 0 CA--C 1.512 -0.51 0 C-N-CA 124.984 1.314 . . . . 0.0 108.753 176.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.482 HD21 HD11 ' A' ' 65' ' ' ILE . 4.0 mm? -119.56 9.92 11.64 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 125.087 1.355 . . . . 0.0 111.201 176.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.5 mtm180 -130.85 166.79 20.12 Favored 'General case' 0 C--O 1.233 0.209 0 O-C-N 121.023 -1.048 . . . . 0.0 109.04 174.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.63 176.91 43.56 Favored Glycine 0 N--CA 1.449 -0.495 0 O-C-N 124.233 0.958 . . . . 0.0 110.89 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -83.2 11.74 6.13 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.643 0.777 . . . . 0.0 111.114 171.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -102.91 16.25 27.14 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.381 1.472 . . . . 0.0 110.359 177.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.5 tt -54.68 142.98 7.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 O-C-N 121.219 -0.925 . . . . 0.0 110.545 -168.139 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.55 -4.48 59.9 Favored Glycine 0 CA--C 1.536 1.4 0 CA-C-O 119.307 -0.718 . . . . 0.0 114.257 -178.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -71.74 149.15 92.9 Favored Pre-proline 0 C--N 1.341 0.212 0 CA-C-N 119.938 1.869 . . . . 0.0 107.974 163.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.34 151.22 29.43 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 123.896 3.064 . . . . 0.0 112.85 -171.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.0 pt . . . . . 0 N--CA 1.454 -0.232 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 175.541 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 . . . . . 0 N--CA 1.456 -0.154 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 53.5 t -57.31 -64.53 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.098 0 C-N-CA 125.41 1.484 . . . . 0.0 109.287 -178.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -49.16 -42.99 32.58 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-N 119.425 1.011 . . . . 0.0 112.998 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -67.44 -52.6 37.6 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 117.843 -1.075 . . . . 0.0 112.564 177.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 66.7 t -59.27 -31.34 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 119.805 1.184 . . . . 0.0 110.242 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 52.9 mt -61.32 -58.38 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 175.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -60.03 -47.0 87.65 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 123.608 0.568 . . . . 0.0 110.47 -177.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -60.3 -49.75 76.36 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.841 1.256 . . . . 0.0 110.734 178.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.17 -32.14 75.9 Favored Glycine 0 CA--C 1.52 0.377 0 O-C-N 120.535 -1.353 . . . . 0.0 112.663 -177.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 15.1 mtm105 -59.6 -61.42 2.63 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 118.145 0.973 . . . . 0.0 110.777 167.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.27 -22.95 67.2 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.169 0.988 . . . . 0.0 112.692 -174.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.4 t -61.4 -16.59 48.05 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.662 1.585 . . . . 0.0 111.303 171.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -126.98 2.12 6.57 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.413 1.885 . . . . 0.0 110.986 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 71.67 0.24 39.29 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 126.022 1.772 . . . . 0.0 113.024 -175.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.6 mt -78.63 145.32 34.74 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 119.034 1.417 . . . . 0.0 110.619 -162.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.1 p -83.86 174.61 10.25 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.656 0.782 . . . . 0.0 110.013 -173.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -69.09 -38.49 78.99 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 121.432 -0.793 . . . . 0.0 109.743 171.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.3 mtpm? -58.91 -41.99 88.57 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.82 0.848 . . . . 0.0 110.911 171.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -63.43 -43.46 97.4 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 118.832 0.742 . . . . 0.0 109.388 177.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.32 -49.3 77.56 Favored 'General case' 0 C--O 1.228 -0.069 0 C-N-CA 124.205 1.002 . . . . 0.0 110.091 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.15 -45.24 71.98 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.856 0.862 . . . . 0.0 109.919 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.7 m -61.82 -48.45 80.53 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.287 1.035 . . . . 0.0 110.576 177.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.2 mttm -54.48 -27.66 39.21 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.764 1.226 . . . . 0.0 113.274 176.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.6 pt -111.93 10.05 8.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 123.928 0.891 . . . . 0.0 112.13 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.5 m120 45.25 48.68 10.2 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.594 2.358 . . . . 0.0 111.421 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -132.27 -171.49 2.65 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.241 1.416 . . . . 0.0 109.224 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.6 mmmm -91.61 142.0 26.36 Favored Pre-proline 0 N--CA 1.466 0.355 0 O-C-N 121.015 -1.053 . . . . 0.0 109.713 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.52 -10.18 28.24 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.715 2.277 . . . . 0.0 112.123 169.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 30.0 tp60 -50.92 -61.68 2.07 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.901 1.28 . . . . 0.0 109.361 163.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.4 m -66.42 -29.5 46.77 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.677 0 C-N-CA 119.741 -0.783 . . . . 0.0 110.419 -175.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 51.4 mm -62.77 -45.08 99.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 119.686 1.13 . . . . 0.0 109.952 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.82 -39.64 92.48 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 121.496 -0.082 . . . . 0.0 111.09 172.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -63.62 -40.28 96.51 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.512 0.725 . . . . 0.0 110.68 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -63.25 -44.73 94.34 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 126.183 1.793 . . . . 0.0 108.867 176.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -60.73 -30.41 69.97 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.277 1.031 . . . . 0.0 113.164 176.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.7 m -90.49 -19.64 23.61 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 177.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.97 42.45 7.62 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 119.56 1.073 . . . . 0.0 111.188 -173.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -114.36 -47.83 2.91 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 124.941 1.297 . . . . 0.0 108.856 -176.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.21 150.11 11.5 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.31 0.644 . . . . 0.0 109.874 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 36.3 mm -68.98 117.32 50.51 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 167.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -69.76 115.6 4.17 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 N-CA-C 106.892 -2.003 . . . . 0.0 106.892 171.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -127.67 123.91 36.64 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 -172.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.2 p-10 -51.74 -29.59 19.25 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.909 1.684 . . . . 0.0 112.998 -174.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -58.54 -47.6 83.67 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.741 1.616 . . . . 0.0 111.205 173.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.2 t -91.66 -36.5 7.99 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-O 117.778 -1.106 . . . . 0.0 109.971 -175.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 14.1 mt -47.8 -45.63 29.83 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.56 1.073 . . . . 0.0 109.518 170.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.65 -40.31 94.57 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-O 119.492 -0.616 . . . . 0.0 112.813 176.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -64.99 -47.63 76.86 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 118.836 1.318 . . . . 0.0 109.683 177.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.3 mt -61.41 -36.1 70.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 123.226 0.611 . . . . 0.0 110.117 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -58.3 -50.19 74.49 Favored 'General case' 0 C--N 1.33 -0.255 0 O-C-N 121.583 -0.698 . . . . 0.0 109.862 176.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 36.5 mtt180 -65.91 -24.77 66.9 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.301 -0.874 . . . . 0.0 112.807 174.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.85 -55.88 28.73 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 118.771 0.714 . . . . 0.0 109.525 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.427 HD11 HD21 ' A' ' 69' ' ' LEU . 45.9 pt -93.34 -15.92 7.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 123.548 0.739 . . . . 0.0 112.002 -177.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.18 39.67 92.48 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 125.337 1.446 . . . . 0.0 111.682 -173.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 47.5 mt -135.45 166.14 23.88 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.4 1.08 . . . . 0.0 109.057 169.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -73.54 141.52 46.7 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 126.336 1.854 . . . . 0.0 109.52 176.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.427 HD21 HD11 ' A' ' 65' ' ' ILE . 3.4 mm? -119.36 5.25 11.18 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.425 1.89 . . . . 0.0 110.302 176.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 56.1 mtm180 -142.1 147.08 36.16 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.924 0.783 . . . . 0.0 110.009 -172.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.25 167.58 21.4 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 125.193 1.378 . . . . 0.0 109.931 -170.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.2 mttp -68.84 -11.57 60.62 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.119 -1.224 . . . . 0.0 111.667 176.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.98 13.74 0.49 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.924 1.69 . . . . 0.0 110.704 172.184 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.8 tt -52.65 150.45 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 O-C-N 120.843 -1.161 . . . . 0.0 110.761 176.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.53 -12.49 7.78 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-O 118.871 -0.96 . . . . 0.0 113.749 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 33.9 mmtt -70.77 150.57 95.27 Favored Pre-proline 0 N--CA 1.449 -0.515 0 CA-C-N 119.671 1.736 . . . . 0.0 107.784 166.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -73.16 162.44 40.67 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 123.575 2.85 . . . . 0.0 110.856 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 42.3 pt . . . . . 0 N--CA 1.465 0.296 0 C-N-CA 124.364 1.065 . . . . 0.0 108.535 -178.858 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 . . . . . 0 N--CA 1.465 0.31 0 CA-C-O 119.616 -0.23 . . . . 0.0 111.066 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.1 t -56.13 -61.7 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 123.506 0.722 . . . . 0.0 109.464 176.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -56.67 -38.08 80.15 Favored Glycine 0 C--N 1.335 0.527 0 CA-C-N 119.523 1.056 . . . . 0.0 112.523 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.4 -56.35 21.24 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.276 1.038 . . . . 0.0 109.86 177.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.3 t -60.13 -37.88 74.87 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.128 0 C-N-CA 123.808 0.843 . . . . 0.0 110.298 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 64.4 mt -59.98 -57.74 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 176.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -55.68 -49.0 74.11 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.142 0.577 . . . . 0.0 110.125 -176.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -56.67 -60.61 3.3 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 123.362 0.665 . . . . 0.0 110.801 176.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.38 -30.84 78.96 Favored Glycine 0 CA--C 1.521 0.442 0 CA-C-N 119.914 1.234 . . . . 0.0 112.719 -171.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.487 ' HB3' HH11 ' A' ' 22' ' ' ARG . 16.7 mtm105 -57.12 -65.72 0.57 Allowed 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 118.272 1.036 . . . . 0.0 109.782 166.001 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -61.52 -29.88 70.28 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.806 1.242 . . . . 0.0 112.161 -173.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.7 m -72.6 -4.73 32.58 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.984 1.314 . . . . 0.0 112.295 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp -127.72 12.35 6.82 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.465 1.906 . . . . 0.0 110.16 176.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.21 17.56 66.11 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.297 0.951 . . . . 0.0 113.725 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 59.4 mt -88.62 144.77 26.08 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 118.652 1.226 . . . . 0.0 111.505 -168.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 81.9 p -84.18 168.75 15.48 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.305 173.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -58.91 -43.38 91.04 Favored 'General case' 0 N--CA 1.464 0.267 0 O-C-N 121.321 -0.862 . . . . 0.0 110.216 166.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.5 mttt -57.1 -36.27 70.43 Favored 'General case' 0 CA--C 1.521 -0.136 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 176.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -64.13 -38.37 90.83 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 118.244 0.474 . . . . 0.0 110.232 176.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.59 -48.68 71.5 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 123.34 0.656 . . . . 0.0 109.256 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -50.16 -56.42 11.05 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.48 1.512 . . . . 0.0 108.643 178.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 95.9 m -59.59 -44.14 93.47 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.491 0.717 . . . . 0.0 112.299 177.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -58.86 -32.83 69.81 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 119.595 1.089 . . . . 0.0 112.137 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.2 pt -103.39 1.44 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 119.12 0.873 . . . . 0.0 112.073 176.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 63.3 t30 54.11 44.38 29.3 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 128.236 2.614 . . . . 0.0 113.709 -175.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -113.76 177.85 4.49 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.788 2.035 . . . . 0.0 110.907 176.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -75.93 147.99 81.26 Favored Pre-proline 0 C--N 1.342 0.26 0 CA-C-N 118.991 0.814 . . . . 0.0 109.542 168.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.0 -7.48 20.94 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 123.023 2.482 . . . . 0.0 112.616 170.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.4 tp60 -55.63 -63.44 1.17 Allowed 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 123.278 0.631 . . . . 0.0 109.551 166.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.8 m -67.98 -22.92 28.39 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.339 0 C-N-CA 119.954 -0.698 . . . . 0.0 111.014 -169.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 44.1 mm -61.63 -46.93 95.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 123.98 0.912 . . . . 0.0 110.298 171.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.31 -27.13 68.39 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 123.259 0.623 . . . . 0.0 112.287 177.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -79.75 -39.11 31.79 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.214 1.006 . . . . 0.0 110.789 176.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -55.0 -40.15 69.82 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 125.92 1.688 . . . . 0.0 111.054 175.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -61.14 -39.9 91.81 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 119.177 -0.44 . . . . 0.0 111.895 -177.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.5 m -80.87 -23.89 38.73 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 118.478 -0.772 . . . . 0.0 112.954 172.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.05 7.2 62.65 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-O 119.286 -0.73 . . . . 0.0 112.8 -171.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 45.8 mtt180 -67.44 -37.55 83.17 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.062 1.431 . . . . 0.0 110.195 177.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.63 115.1 7.62 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 167.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.6 mm -70.04 117.42 53.91 Favored Pre-proline 0 C--O 1.236 0.364 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 170.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -80.75 154.48 20.31 Favored 'Trans proline' 0 N--CA 1.446 -1.28 0 C-N-CA 122.188 1.925 . . . . 0.0 110.238 -173.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -127.47 153.92 45.72 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.526 1.13 . . . . 0.0 108.506 174.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 72.9 m-80 -62.12 -31.84 72.35 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.883 0.765 . . . . 0.0 112.309 -172.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -56.61 -61.37 2.47 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.004 0.922 . . . . 0.0 109.381 174.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.0 t -66.15 -48.94 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-O 118.087 -0.959 . . . . 0.0 109.69 -176.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 51.9 mt -44.91 -48.4 11.27 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 119.366 0.985 . . . . 0.0 110.164 170.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.14 -47.45 73.83 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 125.236 1.398 . . . . 0.0 112.562 176.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -61.73 -41.95 98.32 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 121.732 -0.863 . . . . 0.0 110.425 175.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 77.5 mt -63.68 -34.63 69.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 118.755 0.707 . . . . 0.0 109.651 176.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -62.11 -43.5 98.69 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 120.957 -1.089 . . . . 0.0 109.873 174.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 84.8 mtt-85 -59.22 -39.01 81.36 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.453 -0.78 . . . . 0.0 111.004 173.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.74 -55.36 31.1 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.619 1.568 . . . . 0.0 111.453 -175.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.0 pt -91.02 -26.51 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 118.673 0.669 . . . . 0.0 110.942 -178.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.59 28.08 36.82 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 125.614 1.578 . . . . 0.0 112.215 -178.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 77' ' ' PRO . 19.6 mt -133.65 165.09 25.74 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.542 1.537 . . . . 0.0 108.572 173.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.2 mttm -69.41 140.96 54.19 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 126.236 1.814 . . . . 0.0 109.947 176.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -119.75 8.02 11.11 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.429 1.892 . . . . 0.0 109.791 174.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -133.42 154.93 50.36 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.578 1.551 . . . . 0.0 108.082 -175.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 65.51 174.18 4.7 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.627 1.584 . . . . 0.0 112.624 -178.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 72.1 mttt -69.15 -16.83 63.73 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 121.883 -0.775 . . . . 0.0 111.867 178.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -76.82 16.04 0.58 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.391 0.996 . . . . 0.0 111.362 176.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.6 tt -52.15 139.51 8.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 O-C-N 120.718 -1.239 . . . . 0.0 110.78 -176.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.27 -8.05 41.96 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 118.79 -1.006 . . . . 0.0 113.386 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 16.5 mmtt -72.55 154.38 91.57 Favored Pre-proline 0 N--CA 1.451 -0.411 0 CA-C-N 120.546 2.173 . . . . 0.0 106.672 161.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.47 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 14.7 Cg_endo -67.8 170.67 13.57 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 123.388 2.725 . . . . 0.0 112.204 -175.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 25.2 pt . . . . . 0 C--O 1.236 0.353 0 C-N-CA 124.637 1.175 . . . . 0.0 108.679 171.822 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 . . . . . 0 CA--C 1.536 0.411 0 CA-C-O 118.906 -0.568 . . . . 0.0 110.034 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 37.1 t -60.95 -57.44 12.12 Favored 'Isoleucine or valine' 0 C--N 1.344 0.329 0 CA-C-N 119.372 0.987 . . . . 0.0 109.14 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.91 -40.9 66.38 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 119.677 -0.513 . . . . 0.0 112.1 177.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.8 tptt -57.85 -61.22 2.68 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 117.827 0.814 . . . . 0.0 110.826 173.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 78.6 t -58.49 -31.85 44.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 118.994 0.816 . . . . 0.0 110.068 -176.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 52.3 mt -64.74 -59.19 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-O 117.799 -1.096 . . . . 0.0 108.753 175.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -54.23 -50.03 68.1 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.706 0.803 . . . . 0.0 109.839 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.85 -52.22 63.96 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 123.786 0.835 . . . . 0.0 110.394 -177.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.99 -33.87 88.4 Favored Glycine 0 CA--C 1.524 0.618 0 CA-C-O 118.862 -0.966 . . . . 0.0 112.098 -177.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.679 ' HG2' HD23 ' A' ' 32' ' ' LEU . 17.3 mtm105 -59.68 -58.14 9.89 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 118.321 1.061 . . . . 0.0 109.7 170.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.9 mm100 -64.36 -17.68 63.95 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.753 1.621 . . . . 0.0 113.216 -176.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 65.3 m -72.15 -11.33 60.69 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.144 0.978 . . . . 0.0 112.941 168.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -135.66 23.06 3.38 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 120.399 1.454 . . . . 0.0 111.993 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 61.2 14.19 38.92 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.477 1.037 . . . . 0.0 113.924 -178.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 44.5 mt -73.09 125.27 27.28 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 118.67 1.235 . . . . 0.0 108.898 -167.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 67.2 p -66.7 170.42 6.44 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 165.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -63.04 -32.39 73.75 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.098 -1.001 . . . . 0.0 110.399 169.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -72.15 -36.32 69.3 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.481 0.712 . . . . 0.0 111.058 178.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -59.91 -40.54 89.19 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.96 0.8 . . . . 0.0 109.129 174.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.679 HD23 ' HG2' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -65.82 -47.5 74.81 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.406 0.682 . . . . 0.0 110.803 177.003 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.64 -47.4 67.1 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.485 1.114 . . . . 0.0 110.487 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 95.3 m -58.89 -49.12 78.98 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 125.03 1.332 . . . . 0.0 111.081 172.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.6 mttp -57.88 -22.55 48.86 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 117.837 -1.078 . . . . 0.0 113.563 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.487 HG22 ' HB3' ' A' ' 60' ' ' LYS . 25.6 pt -115.3 8.15 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 120.021 1.282 . . . . 0.0 112.096 173.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 42.1 t30 36.74 72.15 0.12 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.424 1.889 . . . . 0.0 112.015 -170.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.77 -179.69 6.48 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.691 1.596 . . . . 0.0 109.706 171.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -68.54 143.51 95.33 Favored Pre-proline 0 N--CA 1.455 -0.203 0 O-C-N 121.347 -0.846 . . . . 0.0 109.797 172.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -69.72 -10.33 28.34 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 122.599 2.199 . . . . 0.0 112.123 170.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -61.29 -42.22 98.28 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.897 1.279 . . . . 0.0 110.73 170.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.3 m -76.39 -27.27 17.35 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.382 0 C-N-CA 119.687 -0.805 . . . . 0.0 110.294 -176.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.3 mm -62.99 -47.47 92.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 119.44 1.018 . . . . 0.0 109.226 176.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.68 -42.38 71.32 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 122.885 0.474 . . . . 0.0 110.834 175.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -78.58 -32.9 47.87 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 118.608 -0.71 . . . . 0.0 111.263 -173.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -58.8 -43.72 90.59 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.33 1.052 . . . . 0.0 109.533 168.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.418 ' CD ' HH21 ' A' ' 22' ' ' ARG . 7.0 mt-10 -62.43 -40.55 96.93 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 118.44 -0.79 . . . . 0.0 112.501 -178.412 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.3 m -82.11 -25.62 34.29 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 119.145 0.884 . . . . 0.0 112.657 175.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 108.84 3.33 32.07 Favored Glycine 0 CA--C 1.523 0.538 0 C-N-CA 123.464 0.554 . . . . 0.0 113.052 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 55.0 mmt-85 -67.3 -58.34 4.98 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.32 1.448 . . . . 0.0 109.416 -175.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.11 142.71 53.75 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.438 0.563 . . . . 0.0 109.894 -175.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 mt -68.43 126.86 93.15 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 174.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.15 116.86 4.79 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 122.72 2.28 . . . . 0.0 108.192 175.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -114.67 126.72 55.2 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 178.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -44.69 -38.19 4.2 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.767 1.627 . . . . 0.0 114.103 175.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -58.18 -33.15 68.94 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 123.245 0.618 . . . . 0.0 111.979 177.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 75.3 t -94.19 -46.8 13.58 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 C-N-CA 124.898 1.279 . . . . 0.0 109.425 176.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 78.0 mt -47.97 -49.35 30.91 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 120.463 1.483 . . . . 0.0 111.115 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.78 -31.47 71.75 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 118.459 0.572 . . . . 0.0 113.131 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.487 ' HB3' HG22 ' A' ' 36' ' ' ILE . 9.9 mtpp -74.31 -43.39 56.95 Favored 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 125.071 1.348 . . . . 0.0 109.419 175.273 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.0 mt -59.17 -36.79 64.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 175.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -59.12 -46.16 89.05 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.426 1.012 . . . . 0.0 109.995 176.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 48.0 mtt180 -67.57 -23.31 65.39 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.329 -0.857 . . . . 0.0 112.713 174.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.95 -37.09 81.16 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.614 1.166 . . . . 0.0 111.893 -178.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 29.7 pt -119.25 -20.38 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.021 0.929 . . . . 0.0 112.544 -177.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.61 29.43 52.43 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 125.476 1.512 . . . . 0.0 113.345 -177.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.473 HD23 ' HA ' ' A' ' 77' ' ' PRO . 81.1 mt -124.92 166.09 16.92 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 118.267 1.033 . . . . 0.0 108.569 170.259 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.7 mttm -74.59 143.27 44.48 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 125.357 1.463 . . . . 0.0 109.738 175.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -121.26 9.71 10.47 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.56 1.544 . . . . 0.0 110.387 176.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 33.9 mtt-85 -137.64 163.06 32.16 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 119.371 0.987 . . . . 0.0 110.951 175.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.82 177.95 49.94 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 125.413 1.483 . . . . 0.0 110.811 -174.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -69.75 -20.91 63.49 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 121.694 -0.886 . . . . 0.0 110.741 163.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.34 15.71 0.09 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 128.755 2.822 . . . . 0.0 111.382 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.3 tt -56.86 150.89 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 O-C-N 121.106 -0.997 . . . . 0.0 109.334 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.73 -7.15 7.42 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-O 118.533 -1.148 . . . . 0.0 114.13 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.401 ' HE3' ' HB3' ' A' ' 76' ' ' LYS . 24.9 mmmt -61.47 149.79 82.65 Favored Pre-proline 0 C--N 1.342 0.242 0 CA-C-N 120.04 1.92 . . . . 0.0 107.137 158.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.473 ' HA ' HD23 ' A' ' 67' ' ' LEU . 19.6 Cg_endo -67.73 154.79 72.28 Favored 'Trans proline' 0 N--CA 1.445 -1.337 0 C-N-CA 123.139 2.56 . . . . 0.0 110.462 170.118 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.7 pt . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 164.489 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 . . . . . 0 N--CA 1.466 0.334 0 N-CA-C 111.207 0.077 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.1 t -56.3 -53.88 34.59 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.15 0 C-N-CA 124.044 0.938 . . . . 0.0 109.498 173.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -56.63 -39.7 86.32 Favored Glycine 0 CA--C 1.529 0.924 0 CA-C-N 119.363 0.983 . . . . 0.0 112.719 178.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -63.63 -55.44 23.58 Favored 'General case' 0 N--CA 1.46 0.048 0 CA-C-N 118.51 1.155 . . . . 0.0 109.943 176.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.3 t -58.71 -38.47 72.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 123.465 0.706 . . . . 0.0 110.443 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 57.0 mt -58.64 -59.48 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 176.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -61.93 -37.15 83.6 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 118.073 0.397 . . . . 0.0 111.229 -173.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.88 -53.98 50.66 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 121.418 -0.801 . . . . 0.0 111.914 171.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.64 -37.12 93.24 Favored Glycine 0 CA--C 1.521 0.457 0 CA-C-O 119.177 -0.79 . . . . 0.0 111.899 -173.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 17.6 mtm105 -57.3 -61.33 2.55 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 117.69 0.745 . . . . 0.0 109.407 173.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -60.74 -29.91 69.68 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.132 0.973 . . . . 0.0 112.347 -177.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.4 m -65.05 -12.95 56.27 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.285 0.948 . . . . 0.0 112.959 177.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 41.6 mttm -121.69 8.83 10.07 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.484 1.513 . . . . 0.0 110.295 171.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.12 24.86 61.42 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 126.014 1.769 . . . . 0.0 113.249 -177.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 57.6 mt -87.55 139.89 30.08 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.264 1.532 . . . . 0.0 111.536 -171.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.55 HG23 ' H ' ' A' ' 31' ' ' ASP . 14.1 t -78.88 163.68 25.09 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.613 1.165 . . . . 0.0 110.156 177.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -59.21 -40.84 87.08 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 121.015 -1.053 . . . . 0.0 110.086 175.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.47 -34.85 76.15 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 118.512 -0.756 . . . . 0.0 111.972 178.133 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.55 ' H ' HG23 ' A' ' 28' ' ' THR . 0.5 OUTLIER -67.39 -36.53 81.51 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.354 0.979 . . . . 0.0 110.787 175.928 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.78 -47.21 84.49 Favored 'General case' 0 C--N 1.338 0.108 0 O-C-N 121.896 -0.503 . . . . 0.0 109.875 178.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.23 -53.31 36.38 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 125.859 1.664 . . . . 0.0 108.738 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 29.3 m -58.09 -49.58 76.44 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.851 0.861 . . . . 0.0 111.55 174.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 49.1 mttm -57.53 -20.52 32.29 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.6 pt -116.6 5.2 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 119.399 1.0 . . . . 0.0 112.009 176.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 46.6 t30 48.01 64.42 1.65 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 127.04 2.136 . . . . 0.0 110.821 -175.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -137.9 174.88 10.11 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 127.38 2.272 . . . . 0.0 109.862 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.1 mmmm -73.72 143.07 81.22 Favored Pre-proline 0 CA--C 1.53 0.175 0 C-N-CA 124.448 1.099 . . . . 0.0 109.647 172.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -71.99 -12.22 28.07 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.678 2.252 . . . . 0.0 112.829 175.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 44.4 tp60 -73.83 -28.24 61.51 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 117.626 -1.178 . . . . 0.0 111.752 173.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.0 m -75.71 -34.29 28.24 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 CA-C-N 120.544 1.52 . . . . 0.0 109.984 174.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 35.9 mm -59.96 -52.72 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 119.579 1.081 . . . . 0.0 109.893 178.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.67 -31.78 71.92 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.252 -177.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -78.32 -36.26 46.65 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.769 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -54.73 -46.79 74.31 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 126.087 1.755 . . . . 0.0 110.147 173.258 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -59.65 -48.61 80.97 Favored 'General case' 0 C--N 1.34 0.152 0 C-N-CA 124.011 0.924 . . . . 0.0 110.854 177.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.9 -19.88 61.19 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 107.75 -3.21 34.07 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 125.1 1.333 . . . . 0.0 113.723 176.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 13.0 mmt180 -71.77 -52.87 15.41 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.895 1.347 . . . . 0.0 111.896 -170.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.56 129.23 40.92 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -175.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 35.4 mm -70.11 120.1 75.97 Favored Pre-proline 0 C--O 1.236 0.375 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 174.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -84.39 113.6 1.74 Allowed 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 121.093 1.195 . . . . 0.0 110.216 -171.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -81.24 142.12 33.47 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 177.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -55.54 -38.59 69.46 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.899 0.88 . . . . 0.0 111.849 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -67.19 -50.76 59.82 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.288 0.635 . . . . 0.0 111.351 174.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.6 t -64.42 -43.62 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 119.543 1.065 . . . . 0.0 109.962 -176.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 22.4 mt -45.36 -51.95 10.52 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 125.172 1.389 . . . . 0.0 109.447 165.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.98 -32.66 76.07 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 123.683 0.659 . . . . 0.0 114.105 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -71.71 -48.07 49.74 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 118.984 1.392 . . . . 0.0 109.522 174.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.1 mt -54.8 -36.12 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.104 0 C-N-CA 124.128 0.971 . . . . 0.0 109.923 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -56.27 -50.82 70.28 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 121.884 -0.51 . . . . 0.0 111.081 176.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 65.9 mtt85 -65.58 -24.9 67.19 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.678 0.672 . . . . 0.0 111.954 177.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.36 -33.96 77.2 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.97 0.908 . . . . 0.0 112.95 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.4 HD11 HD21 ' A' ' 69' ' ' LEU . 44.6 pt -117.41 -11.78 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.815 0.846 . . . . 0.0 112.174 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.0 36.18 72.64 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 126.078 1.799 . . . . 0.0 113.294 -175.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 48.7 mt -134.88 164.58 27.27 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 118.589 1.195 . . . . 0.0 109.894 171.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -69.99 141.29 52.98 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 127.404 2.281 . . . . 0.0 109.086 172.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.4 HD21 HD11 ' A' ' 65' ' ' ILE . 3.1 mm? -118.64 6.12 11.62 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.874 1.67 . . . . 0.0 110.005 176.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -138.88 162.23 35.32 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 125.01 1.324 . . . . 0.0 108.647 -175.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 67.27 170.65 4.7 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 -165.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -69.38 -15.72 63.37 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 123.472 0.709 . . . . 0.0 110.774 168.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -69.91 16.73 0.06 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.635 1.574 . . . . 0.0 111.71 172.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.0 tt -55.66 146.76 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 O-C-N 120.699 -1.251 . . . . 0.0 110.108 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.69 -1.4 53.11 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-O 119.664 -0.52 . . . . 0.0 113.63 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 20.1 mmtm -85.6 151.03 55.08 Favored Pre-proline 0 N--CA 1.45 -0.455 0 CA-C-N 119.447 1.624 . . . . 0.0 108.469 171.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -70.31 161.65 45.22 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 124.271 3.314 . . . . 0.0 113.191 -173.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 32.7 pt . . . . . 0 C--O 1.234 0.247 0 C-N-CA 125.56 1.544 . . . . 0.0 110.961 -175.55 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.0 mp0 . . . . . 0 N--CA 1.451 -0.424 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.6 t -53.8 -62.32 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 C-N-CA 125.299 1.44 . . . . 0.0 109.949 -178.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -52.36 -51.47 42.25 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-N 119.759 1.163 . . . . 0.0 112.678 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.03 -41.01 86.78 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 118.352 1.076 . . . . 0.0 111.923 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 68.1 t -70.99 -37.72 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 119.358 0.981 . . . . 0.0 110.913 176.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 40.5 mt -57.34 -56.98 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 176.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -54.17 -54.63 37.14 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 125.191 1.396 . . . . 0.0 109.512 -176.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -51.61 -60.72 2.83 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.788 1.235 . . . . 0.0 111.137 177.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.84 -27.35 72.44 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-O 118.692 -1.06 . . . . 0.0 113.042 -170.178 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.421 ' HG2' HD23 ' A' ' 32' ' ' LEU . 18.9 mtm105 -59.39 -59.42 5.48 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 118.314 1.057 . . . . 0.0 108.324 167.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -57.19 -39.55 75.61 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 125.547 1.539 . . . . 0.0 112.5 -175.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 56.7 m -58.91 -40.41 84.42 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 120.004 1.274 . . . . 0.0 110.529 177.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -81.27 -2.89 50.7 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.042 0.937 . . . . 0.0 111.568 176.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.31 7.9 69.11 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 126.393 1.949 . . . . 0.0 113.207 -176.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.2 mt -83.99 147.13 27.61 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 118.033 0.917 . . . . 0.0 110.408 -165.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 62.7 p -80.43 176.16 10.02 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.265 0.626 . . . . 0.0 110.344 177.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -63.6 -42.19 98.28 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 118.799 -0.62 . . . . 0.0 110.081 168.099 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -55.63 -42.35 74.84 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.245 1.018 . . . . 0.0 111.661 174.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -65.34 -40.08 93.21 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.421 HD23 ' HG2' ' A' ' 22' ' ' ARG . 0.3 OUTLIER -62.52 -49.5 75.08 Favored 'General case' 0 C--N 1.344 0.336 0 C-N-CA 123.578 0.751 . . . . 0.0 109.105 176.723 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.83 -57.25 10.84 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 124.947 1.299 . . . . 0.0 108.363 -177.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 85.7 m -61.71 -34.16 75.3 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.466 0.707 . . . . 0.0 112.229 176.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.5 mttm -63.35 -15.31 57.02 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 120.832 1.651 . . . . 0.0 112.817 173.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.0 pt -120.41 6.4 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 124.731 1.212 . . . . 0.0 111.072 175.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 40.8 t30 55.65 31.09 16.64 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 128.131 2.573 . . . . 0.0 114.53 -173.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -105.68 -177.01 3.24 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 125.424 1.49 . . . . 0.0 110.918 177.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -84.81 145.66 44.49 Favored Pre-proline 0 C--O 1.228 -0.059 0 C-N-CA 126.458 1.903 . . . . 0.0 111.359 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.03 -19.76 63.69 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.798 2.332 . . . . 0.0 111.961 171.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 28.5 tp60 -64.45 -46.93 81.0 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.87 175.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.6 m -69.6 -31.56 49.3 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.731 0 O-C-N 123.766 0.666 . . . . 0.0 110.244 -173.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 23.7 mm -64.8 -44.44 96.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 O-C-N 119.953 -1.717 . . . . 0.0 110.241 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.59 -32.52 72.62 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 174.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.43 -57.32 10.64 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.765 170.201 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -52.02 -35.61 47.5 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 126.236 1.815 . . . . 0.0 112.48 -178.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.42 ' CD ' HH21 ' A' ' 22' ' ' ARG . 22.6 mt-10 -67.89 -24.47 65.23 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.076 0.853 . . . . 0.0 112.036 176.316 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.42 -32.84 28.87 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.874 1.27 . . . . 0.0 110.419 164.264 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.95 33.74 32.43 Favored Glycine 0 CA--C 1.525 0.694 0 O-C-N 121.185 -0.947 . . . . 0.0 112.573 -173.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.5 mtt85 -71.69 -60.02 2.45 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 118.29 1.045 . . . . 0.0 109.56 177.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.71 137.87 43.19 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 128.081 2.553 . . . . 0.0 108.918 173.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.9 mt -73.53 116.77 54.69 Favored Pre-proline 0 C--O 1.236 0.386 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 175.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -67.35 115.64 3.79 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 122.489 2.126 . . . . 0.0 107.29 -172.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -97.13 142.6 28.86 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -173.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -60.72 -39.26 87.94 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 119.039 -0.505 . . . . 0.0 110.357 -171.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -59.91 -26.55 66.02 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 175.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 73.2 t -93.44 -43.92 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 119.997 1.271 . . . . 0.0 109.085 177.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 26.9 mt -50.0 -46.73 53.0 Favored 'General case' 0 C--O 1.227 -0.086 0 C-N-CA 124.244 1.018 . . . . 0.0 110.105 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.98 -40.1 95.03 Favored Glycine 0 CA--C 1.535 1.336 0 CA-C-N 118.207 0.458 . . . . 0.0 113.009 176.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.6 mtmm -60.67 -42.78 97.76 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 118.794 1.297 . . . . 0.0 110.803 175.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.8 mt -67.31 -35.79 74.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 123.759 0.824 . . . . 0.0 109.515 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -58.77 -47.66 83.94 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 119.43 1.014 . . . . 0.0 109.519 175.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 16.5 mtm-85 -64.4 -20.69 66.3 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 175.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.92 -52.41 24.78 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.872 0.869 . . . . 0.0 111.478 -179.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.426 HD11 HD21 ' A' ' 69' ' ' LEU . 47.8 pt -99.96 -15.7 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.762 0.825 . . . . 0.0 111.828 -177.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.38 27.77 61.02 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 126.011 1.767 . . . . 0.0 113.563 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 77' ' ' PRO . 58.9 mt -129.38 165.42 21.55 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.883 0.873 . . . . 0.0 108.973 173.081 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -70.32 145.05 51.48 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 125.326 1.451 . . . . 0.0 109.382 175.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.426 HD21 HD11 ' A' ' 65' ' ' ILE . 3.8 mm? -118.83 16.39 13.49 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.255 1.822 . . . . 0.0 109.462 175.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -144.92 162.18 37.5 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 125.364 1.466 . . . . 0.0 108.826 -171.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 70.44 171.63 10.27 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 124.633 1.111 . . . . 0.0 110.855 -174.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -67.54 -24.7 65.57 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.351 -1.088 . . . . 0.0 109.447 165.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -73.52 21.33 0.08 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.729 2.012 . . . . 0.0 112.126 175.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.7 tt -53.54 151.68 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 O-C-N 120.734 -1.229 . . . . 0.0 110.233 172.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.61 -6.83 10.31 Favored Glycine 0 CA--C 1.536 1.397 0 O-C-N 121.118 -0.989 . . . . 0.0 114.108 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 52.9 mmtt -71.01 148.5 94.47 Favored Pre-proline 0 N--CA 1.453 -0.313 0 CA-C-N 120.022 1.911 . . . . 0.0 107.529 163.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.412 ' HA ' HD23 ' A' ' 67' ' ' LEU . 27.9 Cg_endo -71.05 158.78 54.3 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.419 2.746 . . . . 0.0 111.609 -175.345 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 17.8 pt . . . . . 0 C--O 1.234 0.25 0 C-N-CA 123.589 0.756 . . . . 0.0 109.187 177.069 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 . . . . . 0 C--O 1.235 0.318 0 N-CA-C 111.385 0.143 . . . . 0.0 111.385 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.7 t -52.23 -63.84 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 C-N-CA 126.433 1.893 . . . . 0.0 109.141 176.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -51.56 -41.26 49.07 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-N 118.493 0.588 . . . . 0.0 112.998 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -64.94 -51.02 64.1 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 117.287 0.544 . . . . 0.0 110.299 -178.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.7 t -66.83 -33.77 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.104 0 C-N-CA 123.299 0.639 . . . . 0.0 110.149 -178.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 59.0 mt -56.03 -58.0 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 173.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -58.61 -47.61 83.76 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 123.898 0.879 . . . . 0.0 110.806 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -60.17 -53.29 59.5 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 118.899 0.772 . . . . 0.0 111.827 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.1 -25.45 74.62 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-O 118.48 -1.178 . . . . 0.0 112.966 -174.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.617 ' HG2' HD23 ' A' ' 32' ' ' LEU . 7.8 mtm105 -54.54 -67.71 0.24 Allowed 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 119.214 1.507 . . . . 0.0 110.482 160.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -61.46 -34.2 75.04 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 123.933 0.77 . . . . 0.0 110.527 -167.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.2 t -69.7 -10.39 58.1 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.031 0.932 . . . . 0.0 111.546 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -118.46 7.41 11.88 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.933 1.693 . . . . 0.0 110.308 173.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.15 2.44 40.05 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 126.308 1.908 . . . . 0.0 114.148 -177.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 21.4 mt -67.09 119.69 12.45 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 124.779 1.231 . . . . 0.0 107.71 -176.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.2 t -71.53 173.5 7.91 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.911 168.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -53.07 -55.33 24.69 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.51 -0.744 . . . . 0.0 109.754 174.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -58.58 -27.28 64.48 Favored 'General case' 0 C--O 1.227 -0.103 0 CA-C-N 118.515 0.598 . . . . 0.0 112.239 178.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -69.13 -36.07 77.07 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.125 -0.984 . . . . 0.0 111.109 173.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.617 HD23 ' HG2' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -68.77 -48.72 62.96 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.526 0.731 . . . . 0.0 110.943 -179.634 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.56 -51.95 57.28 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.854 0.862 . . . . 0.0 109.664 174.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 83.5 m -67.6 -30.07 69.57 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 118.734 -0.65 . . . . 0.0 111.592 -179.162 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.8 mttm -59.98 -49.55 77.24 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 120.279 1.399 . . . . 0.0 111.138 170.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.7 pt -86.53 -6.03 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 119.302 0.955 . . . . 0.0 112.731 -176.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.7 t30 59.15 65.16 1.24 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 128.851 2.861 . . . . 0.0 112.561 -171.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -133.86 178.78 6.68 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 126.913 2.085 . . . . 0.0 110.089 176.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -79.29 151.93 75.69 Favored Pre-proline 0 N--CA 1.463 0.18 0 C-N-CA 124.73 1.212 . . . . 0.0 109.116 169.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -79.78 -11.96 13.74 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.192 1.928 . . . . 0.0 115.306 -179.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -71.82 -43.85 64.89 Favored 'General case' 0 CA--C 1.515 -0.368 0 O-C-N 120.981 -1.075 . . . . 0.0 110.075 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.6 m -67.32 -38.22 80.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 -172.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 27.6 mm -55.82 -50.66 66.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 125.796 1.639 . . . . 0.0 110.821 170.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.11 -30.73 68.33 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 122.244 -0.285 . . . . 0.0 111.36 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.2 -30.93 49.19 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 118.418 -0.801 . . . . 0.0 111.382 177.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -59.11 -43.97 91.96 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 120.026 1.285 . . . . 0.0 110.231 169.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -56.23 -40.84 74.73 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -171.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.2 m -105.2 9.27 34.14 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.66 -0.92 58.14 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.144 -1.027 . . . . 0.0 114.258 163.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 19.5 mtm180 -91.91 -21.52 20.54 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 118.941 1.371 . . . . 0.0 114.367 -174.049 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.72 145.81 55.56 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 166.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 26.9 mm -72.79 116.77 53.47 Favored Pre-proline 0 C--O 1.238 0.49 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 171.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.42 123.26 9.37 Favored 'Trans proline' 0 N--CA 1.445 -1.324 0 N-CA-C 108.21 -1.496 . . . . 0.0 108.21 -178.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 63.3 t-20 -131.8 122.46 25.82 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 -171.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -48.99 -34.09 12.35 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.842 1.257 . . . . 0.0 113.522 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -57.27 -35.19 69.45 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 65.6 t -93.98 -41.97 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 126.968 2.107 . . . . 0.0 109.937 176.035 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 76.9 mt -56.81 -39.73 74.7 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 120.457 1.48 . . . . 0.0 110.753 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.02 -38.66 93.26 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-N 118.922 0.783 . . . . 0.0 112.573 175.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 24.0 mtmm -65.39 -47.54 75.97 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 117.627 0.714 . . . . 0.0 110.574 173.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 78.1 mt -60.64 -34.6 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 123.86 0.864 . . . . 0.0 110.331 -178.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -56.57 -50.31 72.31 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.654 -0.654 . . . . 0.0 110.396 175.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.4 mtt85 -59.42 -35.37 73.87 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 118.763 0.71 . . . . 0.0 110.72 176.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.72 -32.86 70.94 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.006 1.323 . . . . 0.0 112.929 -174.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 44.4 pt -115.57 -12.15 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 123.755 0.822 . . . . 0.0 112.172 177.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.79 40.0 98.0 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 126.516 2.008 . . . . 0.0 112.648 -174.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 41.0 mt -142.78 164.31 30.44 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.711 1.256 . . . . 0.0 109.33 173.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -68.72 142.99 54.85 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 126.442 1.897 . . . . 0.0 110.902 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -117.54 4.28 12.41 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.865 2.066 . . . . 0.0 111.226 177.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 37.1 mtt-85 -138.44 163.29 32.31 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.258 1.023 . . . . 0.0 110.804 176.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.76 166.56 16.94 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 125.581 1.562 . . . . 0.0 110.09 -170.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -73.63 -7.41 51.84 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.036 -1.273 . . . . 0.0 110.296 168.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -67.53 6.94 0.54 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.729 1.612 . . . . 0.0 112.286 164.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.7 tt -51.36 142.4 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 120.151 1.342 . . . . 0.0 110.983 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.14 3.6 53.02 Favored Glycine 0 CA--C 1.537 1.452 0 O-C-N 121.637 -0.664 . . . . 0.0 114.002 -178.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 20.3 mmtt -81.46 155.09 71.67 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 120.709 2.255 . . . . 0.0 105.959 159.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -70.92 158.25 55.93 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.803 2.335 . . . . 0.0 113.072 -171.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 28.5 pt . . . . . 0 C--N 1.332 -0.184 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 171.273 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.465 0.276 0 CA-C-O 118.979 -0.534 . . . . 0.0 111.934 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.0 t -53.89 -58.52 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 123.844 0.858 . . . . 0.0 108.728 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -51.47 -46.12 53.05 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-O 118.571 -1.127 . . . . 0.0 112.929 176.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 36.1 tttm -59.06 -53.04 62.83 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 118.874 1.337 . . . . 0.0 109.244 -178.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 92.6 t -62.67 -33.59 60.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 118.707 -0.663 . . . . 0.0 110.548 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 70.1 mt -66.16 -59.19 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 119.913 1.233 . . . . 0.0 108.634 176.277 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -51.59 -47.33 63.59 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 126.545 1.938 . . . . 0.0 110.209 -178.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -60.4 -66.34 0.54 Allowed 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.726 1.61 . . . . 0.0 109.994 174.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.16 -26.19 69.0 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-O 118.736 -1.036 . . . . 0.0 113.303 -169.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 19.2 mtm105 -58.13 -64.28 0.97 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.546 1.173 . . . . 0.0 109.045 165.01 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -69.41 -8.43 46.53 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.562 1.545 . . . . 0.0 113.571 -175.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.8 m -69.24 -13.77 62.59 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.877 1.271 . . . . 0.0 112.201 162.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -133.86 12.71 4.01 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.484 1.914 . . . . 0.0 111.475 172.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.41 4.43 17.58 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 125.292 1.425 . . . . 0.0 114.758 -175.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 25.3 mt -66.69 125.85 27.13 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 119.635 1.717 . . . . 0.0 109.431 -165.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 52.1 p -65.88 168.98 7.2 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.754 0.788 . . . . 0.0 110.248 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -64.42 -34.6 78.55 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.459 -0.776 . . . . 0.0 110.733 172.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.2 mtpt -61.33 -44.44 97.19 Favored 'General case' 0 CA--C 1.518 -0.271 0 O-C-N 121.737 -0.602 . . . . 0.0 110.976 171.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -66.23 -37.85 86.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 118.312 0.506 . . . . 0.0 110.419 -177.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.11 -51.95 67.81 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 171.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.76 -48.55 69.6 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.283 1.033 . . . . 0.0 110.151 -177.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.7 m -57.76 -46.1 84.99 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.282 1.033 . . . . 0.0 111.369 175.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.2 mttm -59.03 -22.28 60.43 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.41 1.004 . . . . 0.0 113.681 178.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.582 HG22 ' HB3' ' A' ' 60' ' ' LYS . 26.9 pt -113.41 6.05 7.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 119.534 1.061 . . . . 0.0 111.992 178.354 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 49.88 48.33 21.92 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.234 1.814 . . . . 0.0 111.156 -174.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.471 ' HG3' ' H ' ' A' ' 39' ' ' LYS . 3.1 tp10 -127.68 -171.06 2.35 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.618 1.967 . . . . 0.0 109.007 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.471 ' H ' ' HG3' ' A' ' 38' ' ' GLU . 11.0 mmpt? -103.87 146.18 32.04 Favored Pre-proline 0 CA--C 1.531 0.242 0 O-C-N 120.655 -1.278 . . . . 0.0 111.169 -174.426 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -73.19 -19.2 22.88 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.46 2.106 . . . . 0.0 114.161 -178.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -58.47 -52.31 66.18 Favored 'General case' 0 C--N 1.339 0.127 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 167.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.4 m -66.1 -29.04 45.49 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.532 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.808 -175.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 49.1 mm -61.62 -50.16 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 120.421 1.464 . . . . 0.0 110.251 174.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.24 -31.85 73.11 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 122.396 0.279 . . . . 0.0 111.589 178.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -77.08 -33.45 57.08 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 122.943 0.497 . . . . 0.0 110.405 177.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -57.69 -43.63 85.27 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 125.657 1.583 . . . . 0.0 110.016 170.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -60.06 -58.31 9.08 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.014 0.926 . . . . 0.0 109.451 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.46 -9.42 34.13 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 178.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.1 0.15 77.86 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-N 120.061 1.301 . . . . 0.0 113.457 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 72.4 mtt-85 -70.82 -43.9 67.63 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.896 1.279 . . . . 0.0 111.125 -176.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.19 139.25 58.75 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 173.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 50.3 mm -74.45 117.13 59.57 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 105.669 -1.975 . . . . 0.0 105.669 168.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -77.04 115.01 3.92 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 C-N-CA 121.223 1.282 . . . . 0.0 109.072 -171.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -81.38 131.18 35.27 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.892 1.677 . . . . 0.0 107.77 -174.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -54.8 -33.5 61.6 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.33 1.052 . . . . 0.0 113.137 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -60.97 -64.02 1.1 Allowed 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 122.1 0.952 . . . . 0.0 108.577 174.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.439 ' HA ' ' HD3' ' A' ' 60' ' ' LYS . 77.5 t -60.6 -41.11 86.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.816 1.247 . . . . 0.0 110.272 -174.008 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.2 mt -48.23 -46.22 35.11 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.047 0.939 . . . . 0.0 110.551 177.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.02 -33.56 62.41 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 118.6 0.637 . . . . 0.0 113.561 178.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.582 ' HB3' HG22 ' A' ' 36' ' ' ILE . 37.3 mtpt -64.46 -40.19 95.25 Favored 'General case' 0 N--CA 1.463 0.205 0 O-C-N 121.305 -1.115 . . . . 0.0 109.541 174.23 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.9 mt -63.64 -36.77 77.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 124.681 1.192 . . . . 0.0 108.746 174.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.458 ' HA ' HD23 ' A' ' 69' ' ' LEU . 54.6 mt-10 -57.19 -51.23 70.16 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 119.739 1.154 . . . . 0.0 110.241 174.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 60.6 mtt85 -63.18 -27.48 69.39 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.188 0.449 . . . . 0.0 111.545 175.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.1 -38.11 87.61 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.948 0.899 . . . . 0.0 112.187 179.169 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 22.9 pt -118.6 -9.04 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 119.134 0.879 . . . . 0.0 113.256 -176.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.44 36.36 93.28 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 126.555 2.026 . . . . 0.0 113.343 -176.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 84.7 mt -133.37 165.51 24.67 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.345 1.458 . . . . 0.0 108.156 169.011 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 53.3 mttm -76.25 141.88 41.57 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.615 1.566 . . . . 0.0 109.565 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.458 HD23 ' HA ' ' A' ' 62' ' ' GLU . 3.8 mm? -118.6 11.07 12.73 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 126.267 1.827 . . . . 0.0 110.968 178.46 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 5.8 mtt85 -140.22 167.9 21.06 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.254 1.422 . . . . 0.0 108.255 176.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 73.4 171.04 21.25 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.543 1.544 . . . . 0.0 111.158 -173.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.75 -13.08 60.06 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.359 -1.083 . . . . 0.0 110.163 165.259 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -75.01 18.5 0.18 Allowed 'General case' 0 CA--C 1.549 0.921 0 O-C-N 120.577 -1.327 . . . . 0.0 110.146 168.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.9 tt -53.85 148.04 2.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 O-C-N 120.301 -1.499 . . . . 0.0 110.62 173.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 67.62 -1.43 7.45 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 123.781 0.705 . . . . 0.0 113.504 -178.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 12.3 mmtp -73.69 155.12 89.28 Favored Pre-proline 0 N--CA 1.452 -0.367 0 CA-C-N 119.634 1.717 . . . . 0.0 106.968 160.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -57.22 156.64 24.32 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 122.792 2.328 . . . . 0.0 112.559 177.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 30.7 pt . . . . . 0 C--O 1.236 0.369 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 154.134 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 . . . . . 0 C--O 1.221 -0.4 0 CA-C-O 119.422 -0.323 . . . . 0.0 110.473 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.2 t -56.71 -58.26 6.27 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.316 0 C-N-CA 123.668 0.787 . . . . 0.0 109.67 177.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -56.57 -38.59 81.95 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 119.571 1.078 . . . . 0.0 112.363 178.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -62.05 -59.3 5.29 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.257 1.028 . . . . 0.0 110.096 175.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.4 t -61.35 -37.57 77.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 125.308 1.443 . . . . 0.0 110.347 -175.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 51.4 mt -53.47 -68.67 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 170.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -58.4 -34.05 70.32 Favored 'General case' 0 N--CA 1.445 -0.697 0 O-C-N 123.882 0.739 . . . . 0.0 110.8 -168.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -57.22 -69.69 0.15 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.093 1.757 . . . . 0.0 109.906 174.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.95 -32.1 73.14 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.776 -0.529 . . . . 0.0 111.776 -172.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -54.58 -62.01 1.93 Allowed 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 125.392 1.477 . . . . 0.0 108.798 172.294 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -63.19 -38.21 90.27 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 119.14 0.882 . . . . 0.0 111.449 -177.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 43.5 m -76.26 -2.31 30.79 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.377 0.99 . . . . 0.0 112.561 -177.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -115.55 12.86 16.25 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.256 1.022 . . . . 0.0 111.229 165.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.79 3.15 66.76 Favored Glycine 0 C--N 1.34 0.769 0 C-N-CA 128.03 2.729 . . . . 0.0 114.676 175.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.446 HD22 ' HE3' ' A' ' 35' ' ' LYS . 33.6 mt -72.95 130.16 39.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 118.781 1.29 . . . . 0.0 109.087 -159.167 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.0 p -68.51 170.75 8.52 Favored 'General case' 0 C--O 1.239 0.507 0 O-C-N 121.328 -0.858 . . . . 0.0 109.143 169.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -61.73 -30.1 70.55 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.64 -0.663 . . . . 0.0 110.408 168.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.4 mttt -71.24 -39.09 71.88 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.645 1.111 . . . . 0.0 112.3 175.035 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -64.65 -48.76 73.62 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.23 -47.63 78.08 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.789 0.836 . . . . 0.0 110.772 176.149 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.41 -50.39 73.86 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.536 0.734 . . . . 0.0 111.269 178.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.7 m -55.13 -47.72 74.67 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.068 1.347 . . . . 0.0 109.712 177.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.446 ' HE3' HD22 ' A' ' 27' ' ' LEU . 51.0 mttm -59.88 -15.45 21.47 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 125.453 1.501 . . . . 0.0 113.981 178.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.43 HD11 HD11 ' A' ' 43' ' ' ILE . 25.4 pt -122.35 15.43 5.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 118.998 0.817 . . . . 0.0 111.348 175.162 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.8 t30 57.53 13.14 1.75 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.166 1.386 . . . . 0.0 113.686 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -107.29 -170.87 1.77 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.762 2.025 . . . . 0.0 108.89 -173.206 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -102.51 149.65 36.9 Favored Pre-proline 0 N--CA 1.466 0.327 0 CA-C-N 120.024 1.284 . . . . 0.0 112.783 -175.129 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.71 -13.98 35.6 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 123.39 2.727 . . . . 0.0 112.919 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.9 tp60 -54.81 -60.15 3.76 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 123.588 0.755 . . . . 0.0 109.343 165.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.0 m -60.68 -41.09 86.93 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.52 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -172.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.43 HD11 HD11 ' A' ' 36' ' ' ILE . 44.0 mm -54.23 -47.28 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 119.252 0.933 . . . . 0.0 110.726 -178.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.8 -35.72 73.28 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.121 0.486 . . . . 0.0 112.134 176.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -79.18 -38.31 36.17 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.369 1.068 . . . . 0.0 110.992 -177.312 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -58.37 -39.7 80.28 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.216 1.407 . . . . 0.0 109.026 170.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -70.12 -33.09 71.41 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -178.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.2 t -73.85 -29.48 62.14 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.958 1.253 . . . . 0.0 109.41 167.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.55 10.84 49.48 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 124.002 0.81 . . . . 0.0 111.364 -174.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.7 mmt-85 -64.62 -60.93 2.55 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.258 1.023 . . . . 0.0 109.666 176.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.89 141.28 49.8 Favored 'General case' 0 C--O 1.239 0.543 0 O-C-N 124.787 1.304 . . . . 0.0 110.073 -172.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.402 HD12 ' N ' ' A' ' 52' ' ' ILE . 1.8 mp -74.14 123.99 89.66 Favored Pre-proline 0 CA--C 1.533 0.31 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 -177.241 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -67.18 114.86 3.37 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 121.561 1.508 . . . . 0.0 110.215 -178.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 -103.94 116.86 33.02 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 125.039 1.336 . . . . 0.0 108.418 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -47.27 -39.24 14.05 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.23 1.412 . . . . 0.0 113.472 -175.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -63.08 -52.97 60.59 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 118.416 0.553 . . . . 0.0 110.356 -178.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.525 ' HA ' ' HD3' ' A' ' 60' ' ' LYS . 23.9 t -63.66 -43.24 98.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 124.391 1.076 . . . . 0.0 108.36 -178.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 81.6 mt -53.7 -48.88 69.13 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-O 118.528 -0.748 . . . . 0.0 110.257 176.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.5 -34.4 69.0 Favored Glycine 0 CA--C 1.534 1.266 0 CA-C-N 119.24 0.927 . . . . 0.0 113.309 177.186 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.525 ' HD3' ' HA ' ' A' ' 57' ' ' VAL . 17.9 mtpp -70.57 -44.86 66.5 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.493 -1.004 . . . . 0.0 109.5 175.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.8 mt -59.62 -35.4 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.114 0 C-N-CA 124.862 1.265 . . . . 0.0 109.792 178.069 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -54.28 -51.76 63.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 119.039 0.836 . . . . 0.0 110.245 177.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 58.1 mtt180 -71.81 -8.4 54.05 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.493 -0.755 . . . . 0.0 112.804 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.37 -38.46 63.18 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.436 0.694 . . . . 0.0 110.719 173.312 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.429 HD11 HD21 ' A' ' 69' ' ' LEU . 25.7 pt -120.25 -10.51 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -172.363 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.26 33.69 83.38 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 126.628 2.061 . . . . 0.0 113.027 -178.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 67.8 mt -128.8 164.82 22.2 Favored 'General case' 0 CA--C 1.527 0.076 0 CA-C-N 118.126 0.963 . . . . 0.0 109.635 170.039 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -78.84 140.68 38.13 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 126.055 1.742 . . . . 0.0 108.738 174.037 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.429 HD21 HD11 ' A' ' 65' ' ' ILE . 4.3 mm? -120.01 -2.18 10.29 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 127.897 2.479 . . . . 0.0 110.462 -177.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.512 HH11 ' HG2' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -141.02 169.67 17.17 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.673 1.189 . . . . 0.0 109.136 176.935 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.53 164.51 18.96 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -169.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.9 ttmt -78.06 3.21 15.49 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.884 -0.774 . . . . 0.0 111.061 175.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -96.69 23.11 7.3 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.827 2.051 . . . . 0.0 110.499 171.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.3 tt -52.96 151.94 1.04 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-N 120.238 1.381 . . . . 0.0 110.763 177.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.83 -6.03 14.71 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 119.058 -0.857 . . . . 0.0 113.36 178.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 40.1 mmtt -76.02 150.97 83.85 Favored Pre-proline 0 N--CA 1.45 -0.441 0 CA-C-N 119.83 1.815 . . . . 0.0 107.744 166.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -69.99 157.15 60.87 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 123.253 2.636 . . . . 0.0 111.64 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.0 pt . . . . . 0 N--CA 1.461 0.093 0 C-N-CA 123.959 0.904 . . . . 0.0 108.775 177.069 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 . . . . . 0 N--CA 1.471 0.616 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.2 t -56.91 -61.33 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 C-N-CA 123.473 0.709 . . . . 0.0 109.227 -178.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.37 -33.1 65.06 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-N 119.325 0.966 . . . . 0.0 113.562 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 59.2 tptt -65.31 -55.09 20.22 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 125.421 1.488 . . . . 0.0 109.768 176.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 76.8 t -63.3 -39.16 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 CA-C-N 118.586 0.63 . . . . 0.0 110.573 178.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 83.3 mt -58.6 -56.31 17.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -51.47 -53.48 36.78 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.15 0.98 . . . . 0.0 109.662 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -58.98 -54.92 41.75 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 123.21 0.319 . . . . 0.0 110.977 -178.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.28 -25.01 76.32 Favored Glycine 0 CA--C 1.523 0.556 0 O-C-N 120.701 -1.249 . . . . 0.0 113.033 -172.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.427 ' HB3' HH11 ' A' ' 22' ' ' ARG . 20.0 mtm105 -60.07 -60.6 3.57 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 119.2 1.5 . . . . 0.0 109.511 162.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -64.6 -29.67 70.68 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.96 0.904 . . . . 0.0 111.916 -169.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.2 m -57.3 -20.97 31.73 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.485 1.114 . . . . 0.0 111.831 171.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -120.12 9.89 11.26 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.446 1.899 . . . . 0.0 109.462 -176.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 73.34 -4.75 24.47 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 126.565 2.031 . . . . 0.0 114.739 -177.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 52.1 mt -70.61 152.95 43.36 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 118.815 1.307 . . . . 0.0 111.539 -159.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.403 HG23 ' H ' ' A' ' 31' ' ' ASP . 0.5 OUTLIER -93.53 167.75 11.49 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.72 1.208 . . . . 0.0 110.393 172.056 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 9.3 mp0 -50.48 -39.72 48.98 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.64 0.776 . . . . 0.0 111.852 163.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 43.4 mttt -62.25 -38.61 89.89 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 118.502 0.592 . . . . 0.0 110.884 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.403 ' H ' HG23 ' A' ' 28' ' ' THR . 81.4 m-20 -66.65 -40.8 88.84 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 122.753 0.421 . . . . 0.0 110.089 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.84 -53.9 49.48 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 125.258 1.423 . . . . 0.0 109.161 177.143 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -48.83 -57.22 6.74 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.652 1.581 . . . . 0.0 109.739 178.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 18.5 m -57.93 -39.12 77.24 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.237 1.015 . . . . 0.0 112.803 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.9 mttm -58.68 -39.67 81.38 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 119.457 1.026 . . . . 0.0 112.36 176.003 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.7 pt -103.3 10.61 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 123.624 0.77 . . . . 0.0 111.376 -173.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.8 t30 65.32 42.68 3.81 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.925 2.09 . . . . 0.0 113.674 176.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -135.64 -177.44 4.68 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.032 0.933 . . . . 0.0 113.149 -174.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -92.43 145.23 30.17 Favored Pre-proline 0 C--N 1.339 0.135 0 C-N-CA 125.314 1.445 . . . . 0.0 110.345 178.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.1 -6.07 18.39 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.73 2.287 . . . . 0.0 112.951 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.3 tp60 -61.35 -51.39 69.04 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 118.501 -0.761 . . . . 0.0 110.684 169.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.7 m -68.79 -29.97 45.41 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.305 0 CA-C-N 118.906 0.775 . . . . 0.0 109.468 -176.133 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.7 mm -64.84 -46.64 91.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 124.048 0.939 . . . . 0.0 109.942 177.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.33 -35.91 74.7 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.061 0.544 . . . . 0.0 111.112 175.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.94 -40.94 62.72 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 121.731 -0.606 . . . . 0.0 110.978 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -53.91 -47.43 71.17 Favored 'General case' 0 C--N 1.334 -0.081 0 C-N-CA 125.066 1.346 . . . . 0.0 110.331 172.129 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -57.41 -42.69 82.81 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.572 0.749 . . . . 0.0 112.03 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.1 t -78.45 -25.41 45.91 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.825 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.72 44.89 2.58 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 -174.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 15.9 mmt85 -129.76 -21.65 3.05 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 125.171 1.388 . . . . 0.0 112.793 -171.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.28 133.48 49.78 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 169.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 41.0 mm -68.91 109.18 3.83 Favored Pre-proline 0 C--O 1.237 0.432 0 N-CA-C 104.779 -2.304 . . . . 0.0 104.779 169.07 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -84.19 114.2 1.85 Allowed 'Trans proline' 0 N--CA 1.445 -1.359 0 N-CA-C 108.568 -1.358 . . . . 0.0 108.568 -159.358 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -80.84 140.31 35.48 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -63.02 -29.26 70.68 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.077 0.853 . . . . 0.0 110.798 173.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -57.88 -60.85 3.07 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.522 1.129 . . . . 0.0 109.593 173.459 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.479 ' HA ' ' HE3' ' A' ' 60' ' ' LYS . 59.8 t -64.68 -46.19 93.04 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.259 0 CA-C-O 118.38 -0.819 . . . . 0.0 110.098 -177.014 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 25.1 mt -48.88 -48.43 42.17 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 123.894 0.878 . . . . 0.0 109.501 172.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.56 -44.15 85.82 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 125.721 1.629 . . . . 0.0 113.687 176.108 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.479 ' HE3' ' HA ' ' A' ' 57' ' ' VAL . 44.6 mtmt -65.66 -42.47 91.33 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 117.762 0.781 . . . . 0.0 110.753 175.223 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.1 mt -60.75 -33.32 54.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.743 0.817 . . . . 0.0 109.307 175.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.413 ' HA ' HD23 ' A' ' 69' ' ' LEU . 30.2 mt-10 -59.36 -46.38 88.81 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.775 1.17 . . . . 0.0 110.656 174.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 40.4 mtt-85 -58.13 -40.24 80.76 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 118.698 0.681 . . . . 0.0 110.367 173.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.0 -25.18 67.49 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.523 1.529 . . . . 0.0 114.627 -171.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.54 HD11 HD21 ' A' ' 69' ' ' LEU . 26.3 pt -125.41 -12.98 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-N 119.264 0.938 . . . . 0.0 112.086 176.233 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.9 29.89 64.34 Favored Glycine 0 C--N 1.336 0.577 0 C-N-CA 126.369 1.938 . . . . 0.0 113.165 -178.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.2 mt -130.05 163.32 26.78 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.397 1.479 . . . . 0.0 109.35 174.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -73.45 143.55 46.63 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 125.198 1.399 . . . . 0.0 108.946 175.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.54 HD21 HD11 ' A' ' 65' ' ' ILE . 3.9 mm? -119.03 8.81 11.67 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.105 1.362 . . . . 0.0 110.472 178.57 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 34.6 mtm105 -141.03 127.61 20.11 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 121.549 -0.72 . . . . 0.0 109.272 -166.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.01 179.22 48.83 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 125.168 1.366 . . . . 0.0 112.038 176.118 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -64.41 -13.17 49.67 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -93.51 22.81 5.03 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.094 0.861 . . . . 0.0 109.745 177.066 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.1 tt -55.2 149.24 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 O-C-N 120.95 -1.093 . . . . 0.0 110.368 178.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.57 -14.22 7.26 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-O 117.681 -1.622 . . . . 0.0 113.148 178.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 32.4 mmtt -68.19 144.36 96.74 Favored Pre-proline 0 N--CA 1.452 -0.373 0 CA-C-N 120.459 2.13 . . . . 0.0 107.882 173.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -69.27 150.75 71.57 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.613 2.875 . . . . 0.0 111.648 -177.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.4 pt . . . . . 0 C--O 1.235 0.298 0 C-N-CA 124.146 0.978 . . . . 0.0 109.663 -178.153 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 . . . . . 0 N--CA 1.465 0.283 0 CA-C-O 119.357 -0.354 . . . . 0.0 111.404 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.7 t -58.18 -62.06 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 124.24 1.016 . . . . 0.0 108.479 172.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.37 -40.13 60.52 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-N 119.394 0.997 . . . . 0.0 111.968 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -61.52 -58.14 9.33 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.098 0.949 . . . . 0.0 111.27 177.158 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.2 t -60.04 -36.98 70.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 123.955 0.902 . . . . 0.0 109.774 -178.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.444 HG13 HD11 ' A' ' 69' ' ' LEU . 75.4 mt -57.94 -62.27 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 174.435 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -56.14 -40.68 74.19 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 118.654 0.661 . . . . 0.0 111.411 -175.095 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -62.03 -43.93 97.79 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.511 1.524 . . . . 0.0 112.117 175.218 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -75.02 -33.29 55.21 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 124.742 1.163 . . . . 0.0 112.226 -176.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 15.4 mtm105 -65.71 -48.65 71.28 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 117.687 0.744 . . . . 0.0 110.216 169.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -55.5 -33.82 64.06 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.914 0.886 . . . . 0.0 112.485 175.071 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.1 t -64.08 -19.06 64.97 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.143 0.977 . . . . 0.0 111.701 -178.121 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.417 ' HE3' ' HA ' ' A' ' 65' ' ' ILE . 5.7 mtmm -130.57 7.22 4.85 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.785 1.234 . . . . 0.0 110.811 -175.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 48.58 47.31 29.79 Favored Glycine 0 C--N 1.337 0.614 0 C-N-CA 126.068 1.794 . . . . 0.0 113.127 -173.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.656 HD13 ' HE3' ' A' ' 35' ' ' LYS . 61.1 mt -101.81 119.52 38.91 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -177.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.464 HG23 ' H ' ' A' ' 31' ' ' ASP . 13.3 t -68.01 169.26 10.35 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.627 0.727 . . . . 0.0 109.462 176.305 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -64.38 -36.72 85.06 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.389 0.676 . . . . 0.0 109.842 178.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.423 ' HA ' ' HB3' ' A' ' 40' ' ' PRO . 7.4 mttt -57.4 -44.65 84.7 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.191 0.997 . . . . 0.0 113.434 167.544 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.464 ' H ' HG23 ' A' ' 28' ' ' THR . 2.3 m-20 -65.9 -43.53 87.93 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -176.316 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.87 -50.48 73.6 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.082 1.353 . . . . 0.0 111.387 176.118 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.23 -48.5 65.13 Favored 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 125.485 1.514 . . . . 0.0 109.981 177.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 20.5 m -61.42 -47.87 83.78 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.932 0.787 . . . . 0.0 111.508 175.272 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.656 ' HE3' HD13 ' A' ' 27' ' ' LEU . 50.5 mttm -55.56 -40.33 71.79 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 119.282 0.946 . . . . 0.0 111.98 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.3 pt -98.28 6.16 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 123.438 0.695 . . . . 0.0 112.256 -178.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 52.4 t30 44.46 63.94 1.5 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.488 2.315 . . . . 0.0 113.383 -173.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -138.93 -173.32 3.54 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.835 2.054 . . . . 0.0 110.114 174.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -82.55 148.16 57.78 Favored Pre-proline 0 N--CA 1.467 0.412 0 O-C-N 120.791 -1.193 . . . . 0.0 110.594 177.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.423 ' HB3' ' HA ' ' A' ' 30' ' ' LYS . 26.5 Cg_endo -66.39 -28.02 46.9 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.608 2.205 . . . . 0.0 111.872 169.378 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -67.67 -43.54 79.98 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 118.56 -0.733 . . . . 0.0 109.97 -178.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.9 m -68.37 -31.64 52.23 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.373 0 CA-C-O 117.827 -1.082 . . . . 0.0 110.69 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 41.5 mm -57.92 -49.82 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 120.093 1.315 . . . . 0.0 109.367 170.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.09 -22.92 65.08 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 121.541 -0.724 . . . . 0.0 112.622 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.67 -26.53 27.71 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 118.177 -0.916 . . . . 0.0 112.015 172.072 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -62.22 -59.09 5.54 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.395 1.452 . . . . 0.0 108.585 173.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.411 ' OE1' HG21 ' A' ' 18' ' ' ILE . 1.0 OUTLIER -52.66 -42.82 65.06 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 123.69 0.796 . . . . 0.0 112.859 176.521 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 27.3 m -66.68 -24.04 66.22 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 117.841 -1.076 . . . . 0.0 113.634 177.223 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.42 24.84 11.67 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 119.97 1.259 . . . . 0.0 113.732 -177.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -122.98 -30.85 3.72 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.015 1.407 . . . . 0.0 113.457 -170.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.7 132.94 49.19 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 170.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 39.4 mm -69.25 113.56 17.57 Favored Pre-proline 0 C--O 1.24 0.582 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 179.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.57 115.36 3.38 Favored 'Trans proline' 0 N--CA 1.445 -1.36 0 C-N-CA 122.648 2.232 . . . . 0.0 108.426 -175.328 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -95.77 147.8 23.25 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 174.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 59.6 t-20 -54.07 -45.02 71.62 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.913 1.285 . . . . 0.0 110.782 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -57.6 -52.01 67.17 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.513 0.725 . . . . 0.0 111.106 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.1 t -68.66 -40.48 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 O-C-N 121.748 -0.595 . . . . 0.0 110.635 -178.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 31.5 mt -51.49 -43.37 62.18 Favored 'General case' 0 C--O 1.22 -0.469 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 171.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.13 -39.59 97.35 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-N 119.169 0.895 . . . . 0.0 112.841 175.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -63.85 -44.48 93.03 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 119.185 1.492 . . . . 0.0 110.046 175.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.3 mt -64.34 -35.46 74.24 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.095 0 C-N-CA 124.984 1.314 . . . . 0.0 110.162 178.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.406 ' HA ' HD23 ' A' ' 69' ' ' LEU . 94.4 mt-10 -58.63 -51.0 71.76 Favored 'General case' 0 CA--C 1.512 -0.497 0 O-C-N 121.509 -0.744 . . . . 0.0 109.524 177.744 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -58.64 -40.1 82.44 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-O 118.789 -0.624 . . . . 0.0 110.804 176.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.18 -26.43 60.61 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.507 1.523 . . . . 0.0 113.895 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.424 HD11 HD21 ' A' ' 69' ' ' LEU . 16.9 pt -114.55 -15.02 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 119.74 1.155 . . . . 0.0 112.353 173.192 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.74 27.83 70.15 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 127.847 2.642 . . . . 0.0 113.597 -174.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.9 mt -136.56 158.58 44.11 Favored 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 124.842 1.257 . . . . 0.0 109.36 -179.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -66.65 139.99 57.89 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 125.598 1.559 . . . . 0.0 109.572 176.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.444 HD11 HG13 ' A' ' 18' ' ' ILE . 4.3 mm? -114.54 0.87 14.13 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.472 1.509 . . . . 0.0 109.972 171.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 53.2 mtm180 -135.42 142.39 45.61 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.863 1.265 . . . . 0.0 108.161 -169.202 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.62 163.03 12.34 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -173.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -73.41 -1.77 19.63 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.564 -0.962 . . . . 0.0 113.379 -175.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -77.44 16.07 0.68 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.883 0.765 . . . . 0.0 111.174 165.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.1 tt -50.3 135.54 9.3 Favored 'Isoleucine or valine' 0 C--O 1.242 0.706 0 CA-C-N 120.091 1.314 . . . . 0.0 110.699 -175.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.46 -3.85 71.29 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-O 119.541 -0.588 . . . . 0.0 113.537 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 20.0 mmtm -74.86 150.13 85.95 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 120.655 2.227 . . . . 0.0 107.202 163.297 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -66.14 157.96 57.04 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.951 2.434 . . . . 0.0 111.992 -174.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 17.8 pt . . . . . 0 N--CA 1.466 0.325 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 168.165 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 118.369 -0.824 . . . . 0.0 110.416 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 49.7 t -54.26 -56.73 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 120.054 1.297 . . . . 0.0 110.669 -173.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -54.71 -42.37 77.75 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-O 119.129 -0.817 . . . . 0.0 113.041 176.093 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.478 ' HE3' ' HA ' ' A' ' 16' ' ' LYS . 1.8 tpmt? -62.5 -48.5 79.3 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 118.599 1.199 . . . . 0.0 110.177 177.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.518 HG21 HG12 ' A' ' 74' ' ' ILE . 74.9 t -61.43 -43.09 96.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 124.536 1.134 . . . . 0.0 109.589 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.5 mt -59.51 -52.98 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 C-N-CA 124.324 1.05 . . . . 0.0 108.624 177.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -54.79 -50.18 69.13 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.267 1.427 . . . . 0.0 110.262 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -58.74 -56.2 25.32 Favored 'General case' 0 C--O 1.227 -0.109 0 C-N-CA 124.915 1.286 . . . . 0.0 111.31 178.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.5 -23.18 76.07 Favored Glycine 0 CA--C 1.52 0.403 0 CA-C-O 118.678 -1.068 . . . . 0.0 112.395 -171.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.4 mtm105 -60.6 -64.36 0.98 Allowed 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 119.178 1.489 . . . . 0.0 108.805 164.221 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -56.71 -37.74 71.34 Favored 'General case' 0 CA--C 1.52 -0.196 0 O-C-N 124.199 0.937 . . . . 0.0 111.098 -171.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.3 t -65.96 -13.84 60.5 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.812 -0.555 . . . . 0.0 111.52 -175.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -126.91 8.37 6.78 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.143 2.177 . . . . 0.0 110.212 -173.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.83 5.13 50.69 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 125.506 1.527 . . . . 0.0 114.221 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 19.7 mt -71.36 120.39 16.87 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 119.258 1.529 . . . . 0.0 108.882 -168.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 69.4 p -66.01 174.35 2.54 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.661 -0.65 . . . . 0.0 109.778 170.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -66.81 -41.35 87.67 Favored 'General case' 0 C--O 1.231 0.127 0 O-C-N 120.217 -1.552 . . . . 0.0 109.849 174.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.1 tttp -64.67 -25.33 67.9 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.11 0.564 . . . . 0.0 111.589 177.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -72.07 -45.37 60.98 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.437 0.695 . . . . 0.0 109.97 172.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.16 -46.85 88.27 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.374 0.534 . . . . 0.0 109.807 176.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.34 -50.37 65.15 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 125.232 1.413 . . . . 0.0 109.788 175.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.2 m -56.21 -49.63 73.56 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.367 1.067 . . . . 0.0 110.55 175.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -59.94 -16.12 27.38 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 124.935 1.294 . . . . 0.0 114.432 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.508 HD11 HD11 ' A' ' 43' ' ' ILE . 15.8 pt -126.82 9.39 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 119.807 1.185 . . . . 0.0 110.997 177.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.1 m120 54.88 30.7 14.34 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.042 1.737 . . . . 0.0 112.282 179.018 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -102.45 178.89 4.46 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.487 1.515 . . . . 0.0 110.318 -176.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -77.35 137.3 64.21 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 173.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -67.93 -22.47 42.21 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.488 2.125 . . . . 0.0 111.971 176.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 48.5 tp60 -61.65 -43.18 99.35 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.547 -0.721 . . . . 0.0 110.923 173.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.0 m -73.87 -28.16 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 119.013 0.824 . . . . 0.0 110.737 -176.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.508 HD11 HD11 ' A' ' 36' ' ' ILE . 37.4 mm -56.67 -48.21 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 119.298 0.954 . . . . 0.0 109.691 169.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.5 -35.53 70.34 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 123.43 0.457 . . . . 0.0 111.179 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -83.21 -23.18 32.91 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.551 0.741 . . . . 0.0 112.605 -177.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -62.23 -35.89 80.29 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.901 0.773 . . . . 0.0 109.801 166.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -70.48 -36.67 73.98 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.302 0.956 . . . . 0.0 111.627 175.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.4 m -66.73 -32.29 73.49 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.36 0.527 . . . . 0.0 111.876 173.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.46 7.28 57.05 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 124.82 1.2 . . . . 0.0 112.518 -172.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -78.52 -57.09 3.95 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.76 1.624 . . . . 0.0 110.822 -173.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.29 146.86 42.41 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 124.012 0.82 . . . . 0.0 109.078 -175.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 25.6 mm -68.84 122.06 83.62 Favored Pre-proline 0 C--O 1.237 0.406 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 -178.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.91 113.3 3.73 Favored 'Trans proline' 0 N--CA 1.444 -1.409 0 N-CA-C 106.148 -2.289 . . . . 0.0 106.148 171.093 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -125.56 138.78 53.96 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 118.878 -0.582 . . . . 0.0 109.721 -171.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -52.25 -46.28 65.7 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.999 1.32 . . . . 0.0 112.99 -165.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -55.39 -50.89 68.55 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -178.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.531 ' HA ' ' HD3' ' A' ' 60' ' ' LYS . 94.3 t -74.38 -47.87 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 124.785 1.234 . . . . 0.0 109.891 -174.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 42.5 mt -45.33 -49.65 12.69 Favored 'General case' 0 C--O 1.225 -0.218 0 C-N-CA 125.126 1.37 . . . . 0.0 110.378 175.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.76 -44.49 80.52 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 123.646 0.641 . . . . 0.0 113.184 176.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.531 ' HD3' ' HA ' ' A' ' 57' ' ' VAL . 17.6 mtpp -68.69 -38.24 80.16 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 121.771 -0.841 . . . . 0.0 109.125 -178.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.5 mt -62.4 -39.72 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 C-N-CA 123.777 0.831 . . . . 0.0 109.471 174.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -59.36 -48.99 79.55 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 119.649 1.113 . . . . 0.0 109.299 176.263 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 26.4 mtm105 -64.15 -18.58 64.58 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.371 0.668 . . . . 0.0 112.408 176.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.25 -55.74 5.7 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.727 1.211 . . . . 0.0 109.941 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.1 pt -91.76 -24.18 5.56 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 123.111 0.565 . . . . 0.0 110.746 -176.262 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.38 32.6 34.13 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 125.284 1.421 . . . . 0.0 112.593 -174.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.0 mt -135.72 163.41 30.25 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.057 1.743 . . . . 0.0 109.161 175.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 71.8 mttt -74.93 144.47 43.24 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 125.314 1.445 . . . . 0.0 110.776 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -118.69 16.95 13.63 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 127.323 2.249 . . . . 0.0 109.494 174.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -135.95 163.91 29.19 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 126.678 1.991 . . . . 0.0 109.449 -178.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 66.62 177.11 8.03 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 124.971 1.272 . . . . 0.0 112.11 176.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.8 tptt -72.89 -10.17 59.51 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.447 -1.031 . . . . 0.0 111.149 168.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -78.92 11.96 2.41 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.767 1.627 . . . . 0.0 111.616 172.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.518 HG12 HG21 ' A' ' 17' ' ' VAL . 5.3 tt -53.66 140.02 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 119.736 1.153 . . . . 0.0 110.704 -179.521 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.24 -10.79 40.46 Favored Glycine 0 CA--C 1.533 1.178 0 CA-C-O 117.743 -1.587 . . . . 0.0 114.078 -176.601 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 33.2 mmtt -66.53 151.76 95.82 Favored Pre-proline 0 C--N 1.345 0.373 0 CA-C-N 120.608 2.204 . . . . 0.0 107.768 166.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -58.04 158.93 19.76 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 123.76 2.973 . . . . 0.0 112.549 175.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 24.7 pt . . . . . 0 N--CA 1.466 0.332 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 165.841 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 56.1 mp0 . . . . . 0 CA--C 1.53 0.193 0 CA-C-O 118.288 -0.863 . . . . 0.0 112.192 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 55.8 t -59.12 -59.59 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 119.384 0.993 . . . . 0.0 110.138 179.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -55.52 -45.65 83.6 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-N 119.994 1.27 . . . . 0.0 113.267 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 49.7 tttp -56.75 -54.65 43.78 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 118.846 1.323 . . . . 0.0 109.462 175.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.2 t -61.94 -37.53 78.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 123.207 0.603 . . . . 0.0 110.586 -177.008 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 69.5 mt -61.16 -61.67 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 175.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -53.01 -45.56 67.99 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.209 1.404 . . . . 0.0 110.076 -175.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -59.9 -58.78 7.09 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.884 1.674 . . . . 0.0 111.749 175.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -52.48 -51.38 43.46 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.441 ' HB3' HH11 ' A' ' 22' ' ' ARG . 11.9 mtm105 -48.38 -61.86 1.79 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.179 0.992 . . . . 0.0 109.742 175.611 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -57.56 -33.39 68.09 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 124.344 1.057 . . . . 0.0 112.22 -177.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.89 -28.93 64.91 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.851 1.205 . . . . 0.0 111.703 -172.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -94.73 2.69 55.55 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.177 0.898 . . . . 0.0 111.832 167.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 61.51 43.7 98.96 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 110.816 -0.913 . . . . 0.0 110.816 -176.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 68.3 mt -109.97 159.58 17.15 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.163 1.385 . . . . 0.0 108.324 178.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.9 t -116.38 169.32 9.4 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.787 1.235 . . . . 0.0 110.046 -170.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -55.24 -44.25 75.34 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.527 1.131 . . . . 0.0 110.739 174.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.25 -39.67 72.95 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 118.347 -0.835 . . . . 0.0 111.769 173.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -75.76 -37.28 59.42 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 119.558 1.072 . . . . 0.0 111.158 -176.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.408 HD23 ' HG2' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -59.67 -49.05 79.23 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.78 1.232 . . . . 0.0 108.744 173.123 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.7 -49.33 73.29 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.15 1.38 . . . . 0.0 109.656 178.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.8 m -58.66 -44.87 90.27 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.812 0.733 . . . . 0.0 110.928 174.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.8 mttm -62.2 -27.29 68.87 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 117.295 -1.336 . . . . 0.0 113.263 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.53 HG22 ' HB3' ' A' ' 60' ' ' LYS . 28.0 pt -107.95 6.19 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 120.461 1.482 . . . . 0.0 112.578 176.353 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 56.5 t30 48.63 62.21 2.68 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.101 1.76 . . . . 0.0 112.738 -172.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -133.42 179.88 5.93 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 126.982 2.113 . . . . 0.0 109.242 176.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 25.0 mmtp -87.01 153.24 54.35 Favored Pre-proline 0 N--CA 1.47 0.551 0 C-N-CA 124.692 1.197 . . . . 0.0 109.796 169.499 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.68 -26.64 39.1 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.26 1.974 . . . . 0.0 111.391 176.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.0 tp60 -60.5 -29.81 69.31 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.01 0.924 . . . . 0.0 112.514 178.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.6 m -79.72 -35.35 16.38 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.37 0 CA-C-N 119.439 1.018 . . . . 0.0 109.81 174.086 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.403 HD11 HD11 ' A' ' 36' ' ' ILE . 29.8 mm -60.72 -44.74 97.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 120.273 1.397 . . . . 0.0 110.056 179.283 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.58 -30.36 65.2 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 176.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -89.09 -24.93 22.16 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.98 0.912 . . . . 0.0 111.854 178.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -62.9 -44.39 96.23 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 120.029 1.286 . . . . 0.0 108.917 166.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -59.92 -43.57 94.84 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.22 0.608 . . . . 0.0 110.582 172.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.2 m -66.3 -37.45 85.44 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.636 0.653 . . . . 0.0 111.815 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.74 29.37 8.21 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -169.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -111.11 -29.21 7.97 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.409 1.483 . . . . 0.0 111.477 -171.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.42 178.36 2.95 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.655 0.782 . . . . 0.0 110.082 170.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.4 mm -109.75 113.69 57.38 Favored Pre-proline 0 C--O 1.237 0.423 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -78.31 115.61 3.74 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 123.375 2.716 . . . . 0.0 109.298 -175.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -118.92 144.61 46.34 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.296 1.439 . . . . 0.0 108.958 -175.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.4 m-20 -48.33 -45.42 35.27 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.6 1.56 . . . . 0.0 111.942 -171.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -63.87 -52.15 61.32 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -173.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.433 ' HA ' ' HD3' ' A' ' 60' ' ' LYS . 8.9 t -64.1 -47.74 88.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-O 117.834 -1.079 . . . . 0.0 108.931 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.412 HD13 ' HD3' ' A' ' 70' ' ' ARG . 25.7 mt -46.6 -56.46 6.03 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 125.405 1.482 . . . . 0.0 109.625 174.11 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.13 -33.68 70.61 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 123.627 0.632 . . . . 0.0 113.559 178.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.53 ' HB3' HG22 ' A' ' 36' ' ' ILE . 23.8 mtpp -71.11 -46.67 61.23 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 118.746 1.273 . . . . 0.0 109.228 177.64 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.7 mt -61.82 -35.9 70.55 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.08 0 C-N-CA 124.542 1.137 . . . . 0.0 109.414 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -57.13 -50.52 72.55 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 176.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.457 ' HA ' HD11 ' A' ' 78' ' ' ILE . 61.0 mtt180 -58.48 -38.31 77.33 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 120.832 -1.168 . . . . 0.0 111.449 173.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.46 -25.91 60.42 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.229 1.012 . . . . 0.0 113.713 -176.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.415 HD11 HD21 ' A' ' 69' ' ' LEU . 45.5 pt -120.87 -10.73 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 124.323 1.049 . . . . 0.0 111.984 175.224 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.39 28.56 72.4 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 126.891 2.186 . . . . 0.0 113.337 -176.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.451 HD23 ' HA ' ' A' ' 77' ' ' PRO . 69.3 mt -138.27 163.18 32.42 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.419 1.488 . . . . 0.0 107.752 -178.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -86.41 143.13 27.96 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 126.778 2.031 . . . . 0.0 112.335 -170.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.415 HD21 HD11 ' A' ' 65' ' ' ILE . 4.1 mm? -118.98 6.53 11.35 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.756 1.622 . . . . 0.0 111.004 -176.167 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.412 ' HD3' HD13 ' A' ' 58' ' ' LEU . 81.5 mtm180 -141.8 156.92 45.55 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.789 1.236 . . . . 0.0 109.454 -177.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 73.98 172.39 26.3 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.505 1.05 . . . . 0.0 111.823 -174.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -65.4 -16.11 63.28 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.9 -0.765 . . . . 0.0 110.896 171.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.44 9.31 0.48 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.313 1.445 . . . . 0.0 111.913 173.335 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.5 tt -54.11 129.87 15.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 121.42 1.918 . . . . 0.0 110.009 -177.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.97 -15.44 59.39 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-O 118.743 -1.032 . . . . 0.0 114.404 -177.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.3 mtmt -68.24 152.4 96.55 Favored Pre-proline 0 N--CA 1.444 -0.748 0 CA-C-N 119.235 1.518 . . . . 0.0 107.765 170.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.451 ' HA ' HD23 ' A' ' 67' ' ' LEU . 28.2 Cg_endo -71.91 157.96 53.78 Favored 'Trans proline' 0 N--CA 1.447 -1.228 0 C-N-CA 122.724 2.283 . . . . 0.0 111.082 -174.401 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.457 HD11 ' HA ' ' A' ' 63' ' ' ARG . 10.5 pt . . . . . 0 C--O 1.235 0.322 0 N-CA-C 105.512 -2.032 . . . . 0.0 105.512 165.012 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 . . . . . 0 C--O 1.227 -0.122 0 CA-C-O 118.371 -0.823 . . . . 0.0 112.797 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.9 t -55.8 -61.12 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 171.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.56 -34.23 49.25 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-O 118.379 -1.234 . . . . 0.0 113.369 177.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -73.07 -48.38 36.45 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 119.405 1.603 . . . . 0.0 110.89 178.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 79.1 t -59.77 -40.01 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 118.945 0.793 . . . . 0.0 109.006 176.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.408 HG21 ' OE1' ' A' ' 47' ' ' GLU . 53.1 mt -58.17 -59.17 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 174.595 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -54.15 -45.9 72.14 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.151 0.58 . . . . 0.0 110.467 -177.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -54.94 -63.74 1.06 Allowed 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.071 1.349 . . . . 0.0 110.55 174.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.48 -34.95 87.67 Favored Glycine 0 CA--C 1.519 0.308 0 CA-C-N 119.002 0.819 . . . . 0.0 112.714 -172.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.518 HH21 ' HG2' ' A' ' 47' ' ' GLU . 27.1 mtm105 -62.74 -56.25 19.31 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 117.881 0.841 . . . . 0.0 109.125 173.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -54.97 -40.9 70.53 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.094 1.358 . . . . 0.0 111.467 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.7 m -66.63 -41.2 88.71 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.985 0.811 . . . . 0.0 109.484 -176.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 37.8 mtpt -84.21 -1.12 54.58 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.027 0.931 . . . . 0.0 112.682 177.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.39 16.38 64.95 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.503 1.049 . . . . 0.0 113.216 -175.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 43.1 mt -79.25 154.89 28.84 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 119.105 1.452 . . . . 0.0 109.694 -176.572 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 82.8 p -92.99 170.21 9.83 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.847 0.859 . . . . 0.0 110.718 175.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -60.45 -38.57 84.58 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.326 -0.859 . . . . 0.0 110.407 165.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.06 -38.59 83.27 Favored 'General case' 0 C--O 1.231 0.129 0 O-C-N 121.67 -0.644 . . . . 0.0 111.252 175.201 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -67.09 -35.1 79.07 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 117.968 0.349 . . . . 0.0 110.469 176.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.401 HD22 ' HB1' ' A' ' 64' ' ' ALA . 0.1 OUTLIER -65.24 -49.78 68.33 Favored 'General case' 0 CA--C 1.529 0.14 0 O-C-N 121.545 -0.722 . . . . 0.0 109.172 178.131 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.93 -44.9 64.09 Favored 'General case' 0 CA--C 1.522 -0.117 0 C-N-CA 124.701 1.2 . . . . 0.0 109.9 176.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 43.9 m -62.85 -52.22 63.96 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.619 1.167 . . . . 0.0 109.927 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -58.68 -20.78 51.44 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.203 1.401 . . . . 0.0 114.297 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.4 pt -115.15 2.66 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 123.809 0.844 . . . . 0.0 111.937 177.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.8 t30 50.97 55.6 9.3 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.275 1.83 . . . . 0.0 112.878 -175.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -128.11 -175.69 3.57 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 127.344 2.258 . . . . 0.0 109.725 175.106 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.75 146.55 37.25 Favored Pre-proline 0 N--CA 1.464 0.226 0 O-C-N 120.81 -1.181 . . . . 0.0 110.223 174.516 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -66.34 -16.86 52.93 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.57 2.18 . . . . 0.0 114.242 178.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -61.55 -43.21 99.27 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 119.413 1.006 . . . . 0.0 110.829 172.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.4 m -63.71 -32.6 57.53 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.412 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.132 -176.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 25.2 mm -63.28 -46.51 95.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 124.754 1.221 . . . . 0.0 109.648 177.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.21 -40.1 67.32 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.928 -0.483 . . . . 0.0 111.146 174.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -79.7 -28.45 40.65 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.392 0.677 . . . . 0.0 112.566 -178.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -62.91 -52.28 63.66 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.405 1.082 . . . . 0.0 108.918 171.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.518 ' HG2' HH21 ' A' ' 22' ' ' ARG . 0.7 OUTLIER -60.07 -42.71 95.15 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 175.563 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.6 t -66.97 -37.82 84.94 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 124.043 0.839 . . . . 0.0 110.713 -177.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.94 3.12 20.11 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 118.596 -1.113 . . . . 0.0 114.269 -175.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 49.4 mtm180 -102.86 -14.28 16.63 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.453 1.626 . . . . 0.0 113.764 -170.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.72 151.66 41.39 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 119.665 1.12 . . . . 0.0 108.458 174.268 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.2 mm -79.6 116.17 58.84 Favored Pre-proline 0 C--O 1.236 0.354 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 165.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -70.78 141.92 42.22 Favored 'Trans proline' 0 N--CA 1.448 -1.175 0 N-CA-C 108.897 -1.232 . . . . 0.0 108.897 175.113 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -136.34 150.33 48.8 Favored 'General case' 0 CA--C 1.513 -0.445 0 O-C-N 121.472 -0.767 . . . . 0.0 110.064 169.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -55.29 -41.65 72.59 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 125.106 1.362 . . . . 0.0 111.149 -175.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -52.98 -60.06 3.75 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.412 1.085 . . . . 0.0 110.051 175.219 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.578 ' HA ' ' HD3' ' A' ' 60' ' ' LYS . 41.1 t -64.87 -51.08 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-O 118.285 -0.864 . . . . 0.0 109.713 -176.205 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 71.9 mt -44.38 -50.69 9.07 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 124.922 1.289 . . . . 0.0 110.804 175.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.77 -36.07 92.19 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 118.691 0.678 . . . . 0.0 113.126 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.578 ' HD3' ' HA ' ' A' ' 57' ' ' VAL . 16.2 mtpp -68.67 -44.25 74.48 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 118.7 1.25 . . . . 0.0 108.96 175.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.428 HG21 HD13 ' A' ' 61' ' ' ILE . 61.5 mt -59.1 -35.73 58.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 123.493 0.717 . . . . 0.0 109.362 177.109 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.426 ' HA ' HD23 ' A' ' 69' ' ' LEU . 48.6 mt-10 -57.45 -44.45 84.76 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 119.642 1.11 . . . . 0.0 109.859 176.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -73.01 -13.89 61.31 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.541 1.136 . . . . 0.0 113.199 178.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.401 ' HB1' HD22 ' A' ' 32' ' ' LEU . . . -73.33 -41.61 63.29 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.294 1.038 . . . . 0.0 111.455 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 36.0 pt -116.56 -16.69 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.293 1.037 . . . . 0.0 111.552 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.44 30.22 46.08 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 125.793 1.663 . . . . 0.0 113.091 -178.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 77' ' ' PRO . 74.5 mt -123.72 163.12 21.75 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 118.486 1.143 . . . . 0.0 109.427 173.604 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.0 mttm -72.09 131.91 43.48 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 127.411 2.284 . . . . 0.0 108.252 172.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 62' ' ' GLU . 4.1 mm? -112.67 7.98 18.87 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 126.666 1.986 . . . . 0.0 110.206 176.635 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.47 161.69 39.89 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 126.832 2.053 . . . . 0.0 107.634 -175.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 70.17 160.49 3.03 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.165 0.888 . . . . 0.0 111.166 -168.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -63.73 -11.99 30.94 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 120.929 -1.336 . . . . 0.0 111.203 173.406 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.22 6.46 1.68 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.04 1.736 . . . . 0.0 111.35 173.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.9 tt -48.98 136.27 5.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-N 121.241 1.837 . . . . 0.0 110.909 -173.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.06 -11.62 66.67 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 124.001 0.81 . . . . 0.0 113.992 -177.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 49.7 mmtt -74.4 150.32 87.09 Favored Pre-proline 0 N--CA 1.452 -0.35 0 CA-C-N 119.271 1.536 . . . . 0.0 108.477 169.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 22.5 Cg_endo -70.8 161.99 44.15 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.309 2.672 . . . . 0.0 111.733 -177.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.7 pt . . . . . 0 C--N 1.339 0.148 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 178.464 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 . . . . . 0 CA--C 1.531 0.221 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 52.5 t -58.37 -57.06 12.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -178.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.14 -35.39 77.1 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 118.885 0.766 . . . . 0.0 113.191 -178.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.2 tptt -68.59 -52.75 28.24 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 124.001 0.92 . . . . 0.0 110.011 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 67.0 t -61.61 -36.52 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 49.1 mt -57.98 -60.12 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-O 118.161 -0.923 . . . . 0.0 108.924 173.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -53.8 -50.99 64.89 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.976 0.807 . . . . 0.0 109.905 -177.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -56.45 -48.47 76.98 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 126.345 1.858 . . . . 0.0 112.283 -178.098 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.99 -36.73 45.79 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-O 118.668 -1.073 . . . . 0.0 111.175 -175.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.483 ' HG2' HD23 ' A' ' 32' ' ' LEU . 15.4 mtm105 -56.77 -55.85 29.07 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 118.571 1.185 . . . . 0.0 109.763 170.151 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -50.78 -49.45 58.27 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 126.284 1.833 . . . . 0.0 110.883 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.6 m -63.63 -5.75 4.43 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.562 0.745 . . . . 0.0 112.412 -174.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -130.93 4.53 4.49 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.698 1.999 . . . . 0.0 110.638 -175.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.81 15.67 60.37 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.134 1.349 . . . . 0.0 113.546 -175.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 42.1 mt -73.73 127.08 31.84 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 119.086 1.443 . . . . 0.0 109.042 -170.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.4 p -67.57 169.54 9.12 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.697 0.761 . . . . 0.0 109.79 168.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -61.68 -34.55 75.93 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 120.999 -1.063 . . . . 0.0 110.086 166.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.89 -34.53 71.67 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-O 117.485 -1.245 . . . . 0.0 111.696 176.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -57.66 -51.76 68.19 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 119.787 1.176 . . . . 0.0 108.013 176.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.483 HD23 ' HG2' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -57.88 -48.23 80.44 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.882 0.873 . . . . 0.0 110.019 -176.967 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.07 -49.71 65.83 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.157 1.383 . . . . 0.0 110.202 177.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.1 m -60.66 -44.78 96.04 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.156 0.982 . . . . 0.0 111.174 175.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.8 mttm -53.19 -28.68 27.78 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.453 1.101 . . . . 0.0 112.208 175.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.576 HG22 ' HB3' ' A' ' 60' ' ' LYS . 20.3 pt -112.66 7.71 8.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 124.202 1.001 . . . . 0.0 113.079 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.16 21.77 5.49 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 127.027 2.131 . . . . 0.0 113.311 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.78 173.23 6.66 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.547 1.139 . . . . 0.0 109.853 -173.733 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -71.43 139.56 84.22 Favored Pre-proline 0 CA--C 1.53 0.204 0 C-N-CA 124.182 0.993 . . . . 0.0 110.93 -173.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -74.78 -10.73 21.73 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.451 2.767 . . . . 0.0 112.373 177.098 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.2 tp60 -58.84 -57.64 12.16 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 163.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.0 m -67.14 -24.32 31.9 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 CA-C-O 119.077 -0.487 . . . . 0.0 111.102 -169.287 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 43.6 mm -63.22 -47.68 91.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 124.489 1.116 . . . . 0.0 111.475 171.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.06 -36.62 84.92 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 122.562 0.345 . . . . 0.0 110.574 176.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.45 -31.69 65.66 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.201 0.6 . . . . 0.0 111.363 177.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -58.82 -38.32 78.38 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 125.341 1.456 . . . . 0.0 111.82 170.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -60.81 -58.83 6.8 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.019 0.528 . . . . 0.0 110.361 178.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.3 p -66.63 -27.11 67.43 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -176.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.21 8.11 56.75 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-O 119.856 -0.414 . . . . 0.0 112.281 -170.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 21.0 mtm180 -69.17 -38.12 78.54 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 118.288 1.044 . . . . 0.0 110.369 172.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.67 138.29 48.5 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.8 mm -76.62 126.25 86.28 Favored Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 168.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -68.76 158.83 56.23 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 121.645 1.563 . . . . 0.0 109.851 177.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 -136.51 137.26 40.12 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 171.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -54.51 -34.42 61.66 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.446 1.099 . . . . 0.0 110.925 -179.373 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -61.95 -58.26 8.58 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.566 0.746 . . . . 0.0 109.773 178.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 83.9 t -66.97 -46.15 85.51 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.453 0 CA-C-O 117.402 -1.285 . . . . 0.0 109.151 -176.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 62.3 mt -44.72 -56.17 4.67 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 120.794 1.634 . . . . 0.0 110.895 169.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.18 -14.19 52.36 Favored Glycine 0 CA--C 1.536 1.39 0 CA-C-N 118.566 0.621 . . . . 0.0 114.007 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.576 ' HB3' HG22 ' A' ' 36' ' ' ILE . 22.7 mtpp -89.39 -46.74 8.5 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 125.557 1.543 . . . . 0.0 110.444 171.147 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.0 mt -53.47 -37.5 30.26 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.191 0 C-N-CA 124.532 1.133 . . . . 0.0 108.698 175.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -55.95 -54.47 44.38 Favored 'General case' 0 C--O 1.223 -0.327 0 C-N-CA 119.65 -0.82 . . . . 0.0 111.343 175.323 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 23.6 mtm180 -69.35 -7.58 38.63 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.977 0.808 . . . . 0.0 112.738 176.007 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.35 -27.1 35.06 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.264 1.025 . . . . 0.0 111.686 176.113 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.541 HD11 HD21 ' A' ' 69' ' ' LEU . 16.1 pt -127.71 -11.55 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.026 0.93 . . . . 0.0 112.934 -178.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 66.06 39.09 94.59 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 126.02 1.771 . . . . 0.0 112.132 -174.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 77' ' ' PRO . 61.9 mt -132.02 162.81 29.85 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 124.336 1.054 . . . . 0.0 109.311 170.085 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -74.26 140.12 44.77 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 126.013 1.725 . . . . 0.0 108.538 174.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.541 HD21 HD11 ' A' ' 65' ' ' ILE . 3.4 mm? -117.46 11.17 13.79 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.937 1.295 . . . . 0.0 109.839 178.118 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 27.2 mtm105 -140.14 161.57 37.32 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.716 1.206 . . . . 0.0 109.418 178.042 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.12 169.47 24.98 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 124.327 0.965 . . . . 0.0 110.874 -175.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.658 ' H ' ' HD3' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -68.42 -17.64 64.26 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 121.772 -0.84 . . . . 0.0 111.38 170.772 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -77.95 15.03 0.95 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.375 1.47 . . . . 0.0 110.792 173.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.3 tt -52.55 142.35 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 O-C-N 120.888 -1.132 . . . . 0.0 110.084 175.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.56 0.03 57.23 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-O 117.577 -1.68 . . . . 0.0 113.948 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 33.7 mmtt -77.33 154.53 81.99 Favored Pre-proline 0 N--CA 1.453 -0.321 0 CA-C-N 119.893 1.846 . . . . 0.0 107.46 157.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 18.6 Cg_endo -70.32 163.68 37.83 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 123.266 2.644 . . . . 0.0 112.852 -179.319 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.0 pt . . . . . 0 N--CA 1.464 0.258 0 C-N-CA 126.192 1.797 . . . . 0.0 108.507 172.59 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.55 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 t -61.17 138.8 58.21 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.181 0.992 . . . . 0.0 109.42 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.3 p -152.27 174.58 13.61 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 167.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 135.0 -149.32 19.87 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 108.511 -1.836 . . . . 0.0 108.511 -175.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.3 m 76.6 72.68 0.07 Allowed 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.636 1.974 . . . . 0.0 108.655 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.9 p -122.38 118.74 29.14 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 127.24 2.216 . . . . 0.0 108.188 176.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -164.71 79.6 0.13 Allowed Glycine 0 C--N 1.331 0.286 0 N-CA-C 108.008 -2.037 . . . . 0.0 108.008 -177.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 50.28 93.12 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 127.81 2.444 . . . . 0.0 113.422 175.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.62 176.65 8.87 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 125.647 1.579 . . . . 0.0 108.572 168.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.7 t -77.86 160.85 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 175.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 65.1 p -133.46 121.6 22.46 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 105.231 -2.137 . . . . 0.0 105.231 173.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.7 mp -59.25 162.46 4.56 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 118.473 0.578 . . . . 0.0 109.574 174.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -61.14 -33.18 72.98 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-O 119.149 -0.453 . . . . 0.0 111.322 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.8 t -57.51 -54.73 27.26 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.253 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 171.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.4 -44.18 93.65 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-N 118.388 0.54 . . . . 0.0 112.372 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -59.68 -56.93 15.76 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 117.631 -1.176 . . . . 0.0 109.636 175.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 69.3 t -58.84 -36.07 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 120.357 1.435 . . . . 0.0 110.375 -178.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.6 mt -57.3 -59.24 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 174.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -57.11 -48.31 78.94 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.753 1.221 . . . . 0.0 110.784 -178.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -62.87 -46.38 88.13 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 125.123 1.369 . . . . 0.0 111.636 -176.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.39 -35.73 63.28 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-O 118.816 -0.991 . . . . 0.0 111.493 178.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.621 ' HG2' HD23 ' A' ' 32' ' ' LEU . 13.1 mtm105 -54.82 -61.61 2.2 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 118.049 0.924 . . . . 0.0 109.211 170.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.39 -30.82 71.47 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.131 0.972 . . . . 0.0 111.663 -172.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.8 m -63.88 -16.87 62.43 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 118.92 -0.562 . . . . 0.0 112.422 175.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -124.22 11.42 8.78 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.891 2.076 . . . . 0.0 110.314 -176.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.33 13.97 31.66 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.514 1.054 . . . . 0.0 114.678 -176.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 44.4 mt -78.36 119.95 22.42 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 119.945 1.873 . . . . 0.0 108.845 -170.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 62.1 p -64.67 168.9 5.5 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.557 0.694 . . . . 0.0 110.362 172.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -62.91 -34.51 77.58 Favored 'General case' 0 N--CA 1.464 0.258 0 O-C-N 120.424 -1.422 . . . . 0.0 110.428 174.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.93 -33.02 63.79 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.186 0.594 . . . . 0.0 109.73 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -63.65 -39.44 94.35 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.641 1.11 . . . . 0.0 109.557 171.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.621 HD23 ' HG2' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -64.89 -52.81 54.51 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 123.917 0.887 . . . . 0.0 110.312 179.848 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.93 -43.24 63.35 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 124.679 1.192 . . . . 0.0 110.403 177.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 60.7 m -60.11 -52.39 65.57 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.998 0.919 . . . . 0.0 110.379 174.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.3 mttm -57.23 -25.28 58.84 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 119.24 0.927 . . . . 0.0 113.196 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.3 pt -113.81 5.16 7.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 118.972 0.806 . . . . 0.0 112.227 -176.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.9 m120 54.5 54.94 8.62 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.524 1.529 . . . . 0.0 109.537 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -128.59 -178.6 4.65 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 126.922 2.089 . . . . 0.0 109.168 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 51.7 mmtt -81.02 149.73 67.22 Favored Pre-proline 0 C--N 1.333 -0.148 0 C-N-CA 123.853 0.861 . . . . 0.0 109.546 167.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.48 -11.5 26.46 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.668 2.245 . . . . 0.0 112.115 167.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -59.49 -57.94 10.77 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.952 1.301 . . . . 0.0 109.448 169.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.9 m -63.92 -33.27 61.02 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.556 0 CA-C-O 118.128 -0.939 . . . . 0.0 110.689 -173.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 42.8 mm -60.5 -46.51 95.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 120.166 1.348 . . . . 0.0 110.044 176.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.08 -28.91 69.95 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.169 0.587 . . . . 0.0 112.356 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -85.23 -38.46 18.9 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.846 0.858 . . . . 0.0 110.61 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -54.98 -40.98 70.64 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 126.328 1.851 . . . . 0.0 110.537 173.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -58.68 -42.94 89.66 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.82 0.848 . . . . 0.0 112.084 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 9.0 m -75.41 -35.32 61.02 Favored 'General case' 0 C--N 1.331 -0.207 0 O-C-N 122.097 -0.377 . . . . 0.0 110.222 175.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.85 46.34 3.17 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 -168.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 21.2 mtm-85 -128.42 -0.35 5.63 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 125.272 1.429 . . . . 0.0 113.309 -177.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -89.48 175.76 7.17 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 161.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 48.8 mm -93.8 112.66 57.87 Favored Pre-proline 0 C--O 1.239 0.541 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 171.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -77.49 115.51 3.91 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 123.138 2.558 . . . . 0.0 108.064 -177.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -113.84 142.5 46.01 Favored 'General case' 0 CA--C 1.517 -0.317 0 O-C-N 121.695 -0.628 . . . . 0.0 109.674 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -58.24 -26.23 62.64 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.791 0.836 . . . . 0.0 113.146 -171.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -62.91 -57.61 10.21 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.98 0.912 . . . . 0.0 110.528 173.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.2 t -68.68 -43.75 82.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 118.409 -0.805 . . . . 0.0 109.573 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 54.5 mt -49.48 -46.84 48.65 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.08 0.855 . . . . 0.0 110.337 171.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.99 -43.2 95.12 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 123.998 0.809 . . . . 0.0 112.722 176.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -61.8 -45.65 92.92 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 118.373 1.087 . . . . 0.0 110.796 174.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.0 mt -61.47 -33.69 58.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 C-N-CA 123.939 0.896 . . . . 0.0 110.324 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -56.8 -51.3 69.49 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 119.538 1.063 . . . . 0.0 110.419 176.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 52.5 mtt180 -54.12 -42.03 69.02 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.27 0.628 . . . . 0.0 109.874 177.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.04 -42.22 68.94 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.72 1.608 . . . . 0.0 113.09 -173.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 45.7 pt -114.74 -16.94 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 123.593 0.757 . . . . 0.0 112.167 -174.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.57 25.18 54.61 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 125.09 1.328 . . . . 0.0 113.052 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 77' ' ' PRO . 61.6 mt -130.59 162.95 28.18 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.081 1.352 . . . . 0.0 109.434 179.317 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 47.6 mttm -77.16 146.3 37.17 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 127.16 2.184 . . . . 0.0 110.312 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -121.32 5.03 10.24 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.512 1.525 . . . . 0.0 112.223 -175.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 66.3 mtm180 -139.59 163.5 32.39 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.681 1.592 . . . . 0.0 109.909 171.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.38 167.76 43.78 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 125.831 1.681 . . . . 0.0 109.538 -171.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -71.36 -9.76 58.67 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.455 -1.027 . . . . 0.0 110.137 163.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -75.09 8.17 2.78 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.547 1.939 . . . . 0.0 110.791 170.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.4 tt -52.54 141.46 6.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 O-C-N 120.275 -1.516 . . . . 0.0 110.279 175.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.3 -4.61 54.58 Favored Glycine 0 CA--C 1.537 1.428 0 CA-C-O 119.04 -0.867 . . . . 0.0 113.838 -177.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.5 mmtt -66.29 146.79 99.05 Favored Pre-proline 0 N--CA 1.454 -0.267 0 CA-C-N 119.877 1.839 . . . . 0.0 107.934 159.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.432 ' HA ' HD23 ' A' ' 67' ' ' LEU . 33.5 Cg_endo -70.43 162.11 43.59 Favored 'Trans proline' 0 N--CA 1.447 -1.262 0 C-N-CA 123.441 2.76 . . . . 0.0 111.222 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.1 pt -101.19 109.82 26.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 172.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 70.48 -72.15 0.12 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.638 2.375 . . . . 0.0 111.994 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -129.07 142.79 50.78 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 126.378 1.871 . . . . 0.0 107.886 175.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 167.64 166.28 26.46 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 126.789 2.138 . . . . 0.0 108.486 174.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -71.5 166.13 30.34 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.886 2.39 . . . . 0.0 111.283 -178.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 19.8 ptt180 -65.73 163.19 17.07 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.093 0.473 . . . . 0.0 111.33 173.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -141.63 161.32 38.21 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 125.785 1.634 . . . . 0.0 108.993 163.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 16.7 tttt -78.33 176.49 9.27 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.218 1.407 . . . . 0.0 108.065 174.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 36.4 p -136.73 -172.28 3.13 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.656 1.182 . . . . 0.0 109.151 173.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 174.92 170.24 37.75 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.736 1.16 . . . . 0.0 110.477 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -77.04 -175.62 2.75 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.953 2.435 . . . . 0.0 110.467 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.4 p -123.91 -165.14 1.31 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 125.685 1.594 . . . . 0.0 106.995 168.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.9 t -152.09 -173.51 4.56 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 157.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.748 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 178.443 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.575 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.2 m -135.67 -52.34 0.75 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.37 1.068 . . . . 0.0 110.458 -176.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.3 m -152.29 129.34 11.09 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 123.943 0.897 . . . . 0.0 108.738 -175.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -65.68 84.38 0.09 OUTLIER Glycine 0 CA--C 1.526 0.76 0 C-N-CA 124.99 1.281 . . . . 0.0 111.582 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 76.87 -12.77 1.01 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 128.923 2.889 . . . . 0.0 113.992 171.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 78.1 p -90.78 166.25 13.21 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 120.495 1.498 . . . . 0.0 110.442 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 165.74 68.28 0.03 OUTLIER Glycine 0 C--N 1.333 0.414 0 O-C-N 121.569 -0.707 . . . . 0.0 112.17 173.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -152.67 108.37 3.32 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 117.909 0.855 . . . . 0.0 108.752 178.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.57 174.97 4.85 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.531 1.933 . . . . 0.0 109.346 169.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.7 p -73.56 171.28 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 CA-C-N 118.667 0.667 . . . . 0.0 109.505 170.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.4 p -102.7 162.89 12.56 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.015 1.326 . . . . 0.0 111.017 174.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.9 mp -69.38 155.64 40.11 Favored 'General case' 0 N--CA 1.456 -0.125 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 169.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -61.6 -40.2 93.95 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 123.61 0.764 . . . . 0.0 111.018 -172.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.5 t -55.68 -58.38 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 123.575 0.75 . . . . 0.0 109.389 173.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.31 -40.02 95.42 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 118.891 0.769 . . . . 0.0 112.666 -178.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.36 -54.44 45.66 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.563 1.145 . . . . 0.0 110.242 176.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.4 t -63.25 -38.24 81.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 C-N-CA 123.618 0.767 . . . . 0.0 110.268 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 52.0 mt -56.81 -56.71 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.065 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 175.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -52.61 -55.28 23.44 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.194 0.598 . . . . 0.0 110.115 -178.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.23 -41.94 98.87 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.138 0.575 . . . . 0.0 111.468 -174.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.34 -41.61 45.05 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-O 119.204 -0.775 . . . . 0.0 111.396 -176.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.545 ' HG2' HD23 ' A' ' 32' ' ' LEU . 14.1 mtm105 -52.5 -60.11 3.64 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 117.669 0.734 . . . . 0.0 109.514 171.033 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.72 -31.33 72.47 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 123.702 0.626 . . . . 0.0 110.953 -171.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.8 t -64.2 -25.03 67.89 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.029 0.532 . . . . 0.0 111.77 176.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -112.98 13.08 19.44 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.913 1.285 . . . . 0.0 111.226 178.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.31 13.4 43.16 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.221 0.915 . . . . 0.0 113.446 -178.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 54.4 mt -74.04 118.89 17.52 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -171.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 27.0 p -65.72 174.3 2.4 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.626 0.726 . . . . 0.0 109.564 171.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -68.6 -37.16 79.58 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 120.747 -1.22 . . . . 0.0 110.137 174.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -64.86 -35.3 80.67 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 119.246 0.93 . . . . 0.0 111.612 172.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.63 -51.54 69.35 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 118.973 0.806 . . . . 0.0 109.048 176.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.545 HD23 ' HG2' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -60.81 -50.76 72.15 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 124.332 1.053 . . . . 0.0 109.888 -177.024 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -49.64 -52.36 31.28 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.092 1.357 . . . . 0.0 110.2 175.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.0 m -58.25 -44.54 88.38 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.857 0.863 . . . . 0.0 112.439 175.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.3 mttp -59.71 -16.29 26.02 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.445 1.02 . . . . 0.0 112.764 176.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.485 HG22 ' HB3' ' A' ' 60' ' ' LYS . 18.9 pt -117.69 8.97 7.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 124.808 1.243 . . . . 0.0 111.886 173.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.6 t30 55.12 6.78 0.15 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 128.494 2.718 . . . . 0.0 115.609 -174.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -102.64 -171.0 1.88 Allowed 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 124.537 1.135 . . . . 0.0 109.216 -171.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.413 ' O ' HG22 ' A' ' 42' ' ' VAL . 69.6 mmtt -95.87 141.36 23.05 Favored Pre-proline 0 N--CA 1.464 0.263 0 O-C-N 120.743 -1.223 . . . . 0.0 113.359 -168.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.09 -20.82 43.59 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.175 2.583 . . . . 0.0 112.585 -177.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.4 tp60 -56.82 -44.0 81.59 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 117.74 -1.124 . . . . 0.0 110.696 167.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.413 HG22 ' O ' ' A' ' 39' ' ' LYS 0.273 12.1 m -67.15 -36.1 75.99 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.345 0 CA-C-N 120.116 1.325 . . . . 0.0 109.917 179.812 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 42.1 mm -59.3 -49.01 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 119.827 1.194 . . . . 0.0 109.931 177.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.34 -36.59 71.36 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.24 -41.61 48.63 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.738 1.615 . . . . 0.0 111.827 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -57.94 -45.96 85.81 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.103 1.361 . . . . 0.0 108.81 175.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -55.17 -38.22 68.02 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.479 0.711 . . . . 0.0 111.392 175.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.52 2.24 56.49 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -179.243 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.15 13.21 77.65 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-N 120.27 1.396 . . . . 0.0 113.026 174.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -87.98 -57.52 2.9 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.671 1.588 . . . . 0.0 108.082 -169.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.52 142.62 48.42 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.76 0.824 . . . . 0.0 110.136 -177.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.8 mt -69.47 119.51 71.14 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 168.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.54 135.41 24.11 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.257 1.971 . . . . 0.0 109.149 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -133.8 132.78 40.88 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.008 0.923 . . . . 0.0 109.136 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -40.39 -46.18 2.33 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.647 1.979 . . . . 0.0 112.358 176.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -51.01 -48.88 61.32 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.377 0.671 . . . . 0.0 111.22 -178.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.501 ' HA ' ' HD3' ' A' ' 60' ' ' LYS . 58.2 t -79.73 -48.05 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 125.819 1.648 . . . . 0.0 108.636 -178.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 88.6 mt -50.46 -40.01 49.59 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.497 1.044 . . . . 0.0 111.742 177.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.17 -28.75 72.49 Favored Glycine 0 CA--C 1.526 0.768 0 O-C-N 121.036 -1.04 . . . . 0.0 112.47 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.501 ' HD3' ' HA ' ' A' ' 57' ' ' VAL . 18.9 mtpp -73.51 -47.51 40.53 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 124.619 1.168 . . . . 0.0 108.213 173.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.9 mt -58.1 -39.34 72.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 123.704 0.801 . . . . 0.0 110.32 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -60.32 -42.66 96.04 Favored 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 118.869 -1.132 . . . . 0.0 110.644 -178.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -66.78 -37.04 83.8 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 118.84 0.746 . . . . 0.0 111.447 174.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.66 -36.25 64.4 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.941 1.696 . . . . 0.0 111.946 -177.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 24.5 pt -113.25 -19.1 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 118.999 0.818 . . . . 0.0 112.029 176.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.74 30.08 60.29 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 125.506 1.526 . . . . 0.0 113.061 -176.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' A' ' 77' ' ' PRO . 29.9 mt -132.56 161.45 33.79 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 124.839 1.256 . . . . 0.0 108.3 173.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -71.32 141.12 50.47 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 125.499 1.52 . . . . 0.0 109.408 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -115.88 -1.34 12.6 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.721 1.608 . . . . 0.0 109.506 175.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.4 mtm105 -132.76 142.05 48.82 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.537 1.535 . . . . 0.0 108.491 -177.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.59 167.49 36.62 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 125.135 1.35 . . . . 0.0 111.104 -178.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -70.59 -12.14 61.38 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 121.687 -0.89 . . . . 0.0 111.396 172.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -82.04 16.91 1.73 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.106 2.162 . . . . 0.0 111.267 171.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.2 tt -52.06 141.88 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 O-C-N 120.613 -1.305 . . . . 0.0 110.161 176.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.97 -10.06 10.23 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-O 118.762 -1.021 . . . . 0.0 114.065 -177.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.3 mmtt -70.78 151.06 95.29 Favored Pre-proline 0 N--CA 1.453 -0.294 0 CA-C-N 120.843 2.321 . . . . 0.0 106.016 161.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.455 ' HA ' HD23 ' A' ' 67' ' ' LEU . 14.1 Cg_endo -67.96 157.02 63.66 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.863 2.376 . . . . 0.0 111.246 -174.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 25.9 pt -101.02 160.1 3.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 161.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 44.36 80.17 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.616 1.566 . . . . 0.0 112.197 167.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -62.93 84.56 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.585 1.154 . . . . 0.0 112.132 -175.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.68 -151.35 16.22 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 125.292 1.425 . . . . 0.0 110.216 166.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.53 125.23 14.04 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.771 2.981 . . . . 0.0 111.745 -168.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 57.3 mtp180 37.59 53.37 1.41 Allowed 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.357 1.863 . . . . 0.0 111.692 -173.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.7 67.25 0.78 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.345 1.058 . . . . 0.0 109.655 172.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -68.95 166.34 18.11 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 127.567 2.347 . . . . 0.0 111.21 -176.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.5 t -146.9 -63.72 0.29 Allowed 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 121.303 -0.873 . . . . 0.0 109.105 167.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 129.76 94.7 0.73 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 106.647 -2.581 . . . . 0.0 106.647 -168.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -81.02 -7.68 13.16 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 122.526 2.15 . . . . 0.0 114.034 -165.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.6 t -86.31 -50.43 6.94 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 172.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.3 m 52.48 -179.08 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.02 1.328 . . . . 0.0 110.984 -157.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.629 0 N-CA-C 106.427 -2.669 . . . . 0.0 106.427 -159.572 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.802 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -105.6 82.46 1.81 Allowed 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 105.534 -2.025 . . . . 0.0 105.534 154.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.1 m -121.52 96.22 4.99 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -167.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 62.89 79.76 0.14 Allowed Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.788 1.185 . . . . 0.0 113.233 175.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.1 t -77.25 128.41 34.3 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.867 1.267 . . . . 0.0 108.997 173.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.7 m 47.55 48.15 17.06 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.118 1.367 . . . . 0.0 112.875 171.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.83 29.21 0.63 Allowed Glycine 0 CA--C 1.529 0.91 0 C-N-CA 126.397 1.951 . . . . 0.0 113.966 178.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -157.18 157.84 35.15 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 126.083 1.753 . . . . 0.0 108.113 -177.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -96.23 8.11 44.71 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.83 0.852 . . . . 0.0 113.062 -170.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 p -139.86 78.67 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 120.662 1.574 . . . . 0.0 108.595 -176.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -61.51 133.77 56.09 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.959 176.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -58.63 153.49 16.32 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 171.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -57.93 -42.13 84.21 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 119.091 -0.48 . . . . 0.0 110.737 -175.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 63.4 t -58.62 -66.38 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 125.028 1.331 . . . . 0.0 109.695 174.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.59 -29.41 40.07 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 119.182 0.901 . . . . 0.0 113.498 -177.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.7 tttt -72.58 -55.51 6.79 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 117.654 -1.165 . . . . 0.0 110.701 175.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.3 t -58.84 -39.26 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 120.101 1.319 . . . . 0.0 110.28 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 86.4 mt -54.96 -61.21 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 175.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -63.35 -39.9 95.81 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 -172.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -58.25 -46.82 85.26 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.688 1.595 . . . . 0.0 111.381 176.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.94 -43.74 81.46 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -178.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.9 mtm105 -54.89 -59.55 4.57 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 117.341 0.57 . . . . 0.0 110.54 173.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -58.89 -33.05 70.07 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.636 0.775 . . . . 0.0 110.885 -176.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.0 t -68.31 -8.45 39.82 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 118.23 -0.891 . . . . 0.0 113.395 177.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -132.37 7.88 4.25 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 120.363 1.438 . . . . 0.0 111.505 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 57.19 32.15 63.01 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-N 118.793 0.724 . . . . 0.0 112.174 -173.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 44.8 mt -85.38 119.78 26.13 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.7 t -73.88 171.71 12.9 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.143 0.883 . . . . 0.0 109.964 176.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -61.68 -37.64 84.87 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 120.364 -1.46 . . . . 0.0 110.841 176.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.4 mttp -59.28 -32.6 70.18 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.078 0.854 . . . . 0.0 112.684 170.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -70.32 -39.25 74.87 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 119.422 1.01 . . . . 0.0 108.604 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.68 -48.02 76.28 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -50.89 -51.2 54.15 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 126.221 1.808 . . . . 0.0 109.455 177.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 60.1 m -61.49 -47.29 86.3 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.985 1.314 . . . . 0.0 111.037 177.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.6 mttm -64.21 -20.49 66.06 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 26.6 pt -111.34 -2.33 10.25 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.356 0 CA-C-N 120.179 1.354 . . . . 0.0 111.214 174.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 53.5 t30 44.92 71.5 0.26 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.695 1.598 . . . . 0.0 112.466 -167.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -140.26 177.65 7.84 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 127.36 2.264 . . . . 0.0 109.179 166.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 28.2 mtmt -79.38 141.48 57.18 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 124.061 0.944 . . . . 0.0 111.916 177.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -66.51 -11.13 30.4 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.41 2.74 . . . . 0.0 115.227 -178.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 42.4 tp60 -75.89 -27.79 57.85 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 120.699 1.591 . . . . 0.0 111.379 169.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 m -68.1 -35.8 72.93 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.413 0 CA-C-N 120.832 1.651 . . . . 0.0 108.293 173.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 33.6 mm -59.67 -50.44 79.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 C-N-CA 124.207 1.003 . . . . 0.0 110.078 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.4 -32.11 73.45 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.928 -0.483 . . . . 0.0 112.089 176.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.82 -27.98 61.39 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 120.798 -1.189 . . . . 0.0 110.97 175.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -69.46 -37.7 77.43 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.653 1.581 . . . . 0.0 110.87 175.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -55.29 -56.8 15.93 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 167.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.5 m -66.58 -19.88 65.88 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.22 1.008 . . . . 0.0 113.46 -172.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.34 -10.31 73.37 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 123.773 0.702 . . . . 0.0 114.5 -175.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 28.9 mtt-85 -77.23 -21.21 54.13 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 118.199 1.0 . . . . 0.0 112.39 -174.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.14 115.22 19.58 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 105.264 -2.125 . . . . 0.0 105.264 168.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.2 mm -69.1 113.73 18.49 Favored Pre-proline 0 C--O 1.238 0.47 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 -171.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -77.33 114.57 3.77 Favored 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 121.783 1.655 . . . . 0.0 110.563 -163.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -110.5 144.23 39.65 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.945 0.898 . . . . 0.0 109.539 -174.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -53.41 -40.46 65.12 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -171.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -52.51 -60.63 3.0 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.052 0.941 . . . . 0.0 109.662 177.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.579 ' HA ' ' HD3' ' A' ' 60' ' ' LYS . 70.9 t -65.96 -44.8 92.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-O 118.328 -0.844 . . . . 0.0 109.49 -175.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.7 mt -51.3 -44.79 61.98 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.783 0.72 . . . . 0.0 110.2 176.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.82 -43.96 94.46 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.024 0.821 . . . . 0.0 113.068 175.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.579 ' HD3' ' HA ' ' A' ' 57' ' ' VAL . 15.8 mtpp -65.23 -42.88 92.94 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 121.304 -1.115 . . . . 0.0 109.651 178.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.2 mt -60.81 -32.99 53.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 123.563 0.745 . . . . 0.0 109.271 176.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.465 ' HA ' HD23 ' A' ' 69' ' ' LEU . 38.3 mt-10 -58.49 -49.03 78.84 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 120.078 1.308 . . . . 0.0 110.212 178.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 48.5 mtt85 -68.6 -20.91 64.52 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.606 -0.684 . . . . 0.0 112.496 175.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.27 -54.81 41.31 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.405 HD11 HD21 ' A' ' 69' ' ' LEU . 50.2 pt -100.22 -18.07 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -176.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.19 20.87 58.25 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 125.871 1.701 . . . . 0.0 113.533 -177.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 77' ' ' PRO . 60.8 mt -125.47 161.73 26.46 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 125.14 1.376 . . . . 0.0 108.913 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -72.18 139.78 48.41 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 125.244 1.418 . . . . 0.0 109.226 177.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 62' ' ' GLU . 3.2 mm? -119.72 -1.39 10.57 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.218 1.807 . . . . 0.0 110.961 177.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.3 mmm180 -125.46 155.14 40.95 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 119.496 1.044 . . . . 0.0 108.68 170.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.13 159.93 6.63 Favored Glycine 0 N--CA 1.447 -0.613 0 O-C-N 124.843 1.339 . . . . 0.0 110.573 -178.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -73.18 -4.24 31.66 Favored 'General case' 0 N--CA 1.464 0.273 0 O-C-N 121.001 -1.293 . . . . 0.0 112.131 -176.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -73.32 12.4 0.59 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.849 0.749 . . . . 0.0 110.572 162.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.7 tt -48.56 134.03 5.96 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 CA-C-N 120.269 1.395 . . . . 0.0 109.125 176.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.32 -4.76 66.15 Favored Glycine 0 CA--C 1.538 1.521 0 CA-C-O 119.155 -0.803 . . . . 0.0 114.15 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 40.9 mmtt -72.57 151.39 91.54 Favored Pre-proline 0 N--CA 1.455 -0.206 0 CA-C-N 119.989 1.895 . . . . 0.0 106.794 159.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 30.8 Cg_endo -72.47 160.75 46.02 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 123.423 2.749 . . . . 0.0 111.489 -178.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 36.8 pt -101.11 138.49 25.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 173.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 49.12 23.16 0.71 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.3 1.84 . . . . 0.0 114.187 170.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.1 pttp -22.82 85.46 0.0 OUTLIER 'General case' 0 C--O 1.236 0.358 0 C-N-CA 130.923 3.689 . . . . 0.0 115.257 -168.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.66 -164.49 39.15 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.898 1.713 . . . . 0.0 112.142 -174.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -62.02 95.06 0.14 Allowed 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 124.819 3.679 . . . . 0.0 111.148 176.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 65.0 ttt-85 -140.75 121.08 13.96 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 170.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 41.01 75.55 0.08 Allowed 'General case' 0 C--O 1.234 0.284 0 C-N-CA 126.886 2.074 . . . . 0.0 111.212 -175.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -152.21 -46.89 0.1 Allowed 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 118.545 -0.74 . . . . 0.0 111.055 -173.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.5 m 48.0 72.51 0.26 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.526 1.13 . . . . 0.0 111.544 -171.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -66.52 -163.37 1.5 Allowed Glycine 0 CA--C 1.538 1.523 0 C-N-CA 125.515 1.531 . . . . 0.0 112.572 173.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -61.3 -19.17 62.84 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 123.078 2.519 . . . . 0.0 114.341 -168.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.3 p -136.45 -69.75 0.47 Allowed 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 154.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.2 t -154.68 -67.61 0.13 Allowed 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 171.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.857 0 CA-C-O 117.857 -1.524 . . . . 0.0 109.317 -172.984 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.729 0 CA-C-O 118.648 -1.084 . . . . 0.0 110.716 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.2 m -166.33 167.6 15.77 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.496 1.519 . . . . 0.0 108.84 172.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.5 m -135.6 -53.1 0.76 Allowed 'General case' 0 C--N 1.334 -0.098 0 C-N-CA 124.293 1.037 . . . . 0.0 108.404 162.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 68.19 170.19 5.53 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -165.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.09 119.38 4.69 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 171.112 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.6 m 48.06 -160.53 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.962 1.705 . . . . 0.0 113.315 -176.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.17 129.98 2.91 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 126.376 1.941 . . . . 0.0 109.79 -177.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -61.29 119.6 8.78 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 125.019 1.328 . . . . 0.0 113.143 -166.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -98.49 175.19 6.11 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.522 1.129 . . . . 0.0 110.869 178.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.8 p -145.19 155.64 13.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 125.574 1.55 . . . . 0.0 108.36 -175.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 70.5 p -85.29 78.91 9.68 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 122.876 1.322 . . . . 0.0 108.563 166.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.0 tp -53.67 130.97 38.19 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 126.026 1.73 . . . . 0.0 107.928 178.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 69.5 mt-10 -55.76 -47.81 76.37 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 126.002 1.721 . . . . 0.0 112.856 -167.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.5 t -57.97 -51.22 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 176.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.45 -36.5 84.63 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 118.771 -1.016 . . . . 0.0 112.895 175.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -63.19 -55.92 21.04 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 119.024 1.412 . . . . 0.0 109.235 176.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.4 t -64.12 -34.55 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-N 119.311 0.96 . . . . 0.0 110.573 -178.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.4 mt -59.18 -59.49 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 171.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -56.69 -41.28 77.09 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 118.836 0.744 . . . . 0.0 110.75 -174.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -62.79 -57.13 11.98 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.405 1.882 . . . . 0.0 110.822 176.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.69 -32.66 83.76 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 118.205 0.457 . . . . 0.0 111.995 -175.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.566 ' HG2' HD23 ' A' ' 32' ' ' LEU . 25.3 mtm105 -53.51 -61.41 2.32 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 166.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -50.55 -46.56 57.6 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.713 1.205 . . . . 0.0 111.69 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.2 m -71.11 -6.79 41.97 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.42 1.088 . . . . 0.0 113.409 -176.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.546 ' HE3' HD11 ' A' ' 27' ' ' LEU . 26.5 mtpp -120.06 8.12 10.94 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.899 1.68 . . . . 0.0 111.535 167.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.09 19.58 51.71 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.777 1.179 . . . . 0.0 113.015 -176.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.546 HD11 ' HE3' ' A' ' 25' ' ' LYS . 79.6 mt -84.34 131.87 34.66 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 118.804 1.302 . . . . 0.0 108.552 -171.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.4 p -75.75 176.57 7.61 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 171.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -68.07 -37.58 81.41 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.179 -0.951 . . . . 0.0 110.73 172.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.6 tmtp? -63.26 -39.23 94.01 Favored 'General case' 0 N--CA 1.462 0.125 0 C-N-CA 123.107 0.563 . . . . 0.0 110.873 174.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.55 -42.22 83.01 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 177.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.566 HD23 ' HG2' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -58.04 -50.67 72.65 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 123.744 0.817 . . . . 0.0 110.089 176.35 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -48.54 -53.47 18.1 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 125.269 1.428 . . . . 0.0 109.978 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 35.1 m -63.09 -40.74 98.56 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.647 0.779 . . . . 0.0 111.933 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.7 mttp -61.81 -12.19 16.08 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 119.719 1.145 . . . . 0.0 113.81 174.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 24.8 pt -123.6 10.38 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 119.99 1.268 . . . . 0.0 111.583 175.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 37.09 68.85 0.25 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 128.453 2.701 . . . . 0.0 112.067 -168.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -131.35 -178.67 4.95 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 127.44 2.296 . . . . 0.0 107.437 173.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -93.67 151.57 40.11 Favored Pre-proline 0 CA--C 1.531 0.233 0 C-N-CA 124.362 1.065 . . . . 0.0 110.595 171.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -67.03 -17.27 51.03 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 123.676 2.917 . . . . 0.0 113.697 -178.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 -65.51 -52.24 54.08 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 118.502 0.592 . . . . 0.0 110.398 177.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.1 m -63.55 -27.61 43.33 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 C-N-CA 120.5 -0.48 . . . . 0.0 109.965 -175.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 38.0 mm -61.38 -53.32 50.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 123.084 0.554 . . . . 0.0 110.574 174.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.17 -39.9 73.07 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 118.957 0.798 . . . . 0.0 111.485 177.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.88 -31.15 67.72 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 118.678 -0.677 . . . . 0.0 111.086 -178.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -63.06 -45.63 91.28 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 125.288 1.435 . . . . 0.0 111.342 172.121 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.415 ' CD ' HH21 ' A' ' 22' ' ' ARG . 4.7 mt-10 -58.86 -32.96 69.92 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.292 0.637 . . . . 0.0 111.328 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 43.7 m -82.8 -23.15 33.96 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 174.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.2 0.15 80.72 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 119.624 1.102 . . . . 0.0 114.218 -169.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.8 mtt85 -69.49 -47.12 64.9 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 117.867 0.834 . . . . 0.0 109.561 -177.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.39 134.82 57.35 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 171.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 34.0 mm -68.95 120.39 76.02 Favored Pre-proline 0 C--O 1.237 0.416 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -71.44 115.54 4.33 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.503 2.135 . . . . 0.0 110.5 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -106.2 122.2 45.74 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 126.509 1.923 . . . . 0.0 107.697 -178.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -55.73 -24.8 37.08 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 119.813 1.188 . . . . 0.0 113.221 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -61.55 -55.93 25.53 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.491 0.716 . . . . 0.0 109.284 174.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.0 t -71.26 -38.76 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.4 -177.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.4 mt -50.44 -46.39 56.53 Favored 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 169.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.61 -46.89 91.6 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 124.138 0.875 . . . . 0.0 112.036 177.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -57.85 -43.7 86.05 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 117.935 0.867 . . . . 0.0 110.828 175.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.0 mt -65.24 -35.77 76.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 124.685 1.194 . . . . 0.0 110.325 178.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.488 ' HB3' HG21 ' A' ' 78' ' ' ILE . 69.9 mt-10 -59.93 -49.91 75.82 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 119.495 1.043 . . . . 0.0 108.616 176.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.8 mtm105 -57.59 -31.32 66.06 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 122.871 0.468 . . . . 0.0 111.288 175.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.47 -53.7 26.55 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.011 0.924 . . . . 0.0 112.227 -177.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 35.6 pt -90.05 -16.5 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 122.418 0.287 . . . . 0.0 111.269 -177.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.92 27.28 58.77 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 125.871 1.701 . . . . 0.0 113.186 -175.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 77' ' ' PRO . 24.2 mt -143.37 161.38 38.51 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.727 1.764 . . . . 0.0 109.887 179.012 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -68.28 142.83 55.46 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 126.163 1.785 . . . . 0.0 110.746 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 62' ' ' GLU . 4.2 mm? -118.17 10.33 12.89 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.467 1.107 . . . . 0.0 110.398 173.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 25.1 mtm105 -139.8 157.27 46.0 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 121.32 -0.863 . . . . 0.0 109.711 -178.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.96 167.91 21.04 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -170.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 43.2 tttp -68.94 -14.08 62.82 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.363 -1.08 . . . . 0.0 110.642 172.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -64.93 8.23 0.13 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.695 1.998 . . . . 0.0 112.426 168.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.7 tt -50.24 135.9 8.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-N 120.552 1.524 . . . . 0.0 110.283 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.28 -4.68 62.18 Favored Glycine 0 CA--C 1.533 1.204 0 CA-C-O 119.045 -0.864 . . . . 0.0 114.406 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 44.7 mmtt -70.07 153.14 95.57 Favored Pre-proline 0 N--CA 1.453 -0.314 0 CA-C-N 119.808 1.804 . . . . 0.0 107.101 161.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.42 ' HA ' HD23 ' A' ' 67' ' ' LEU . 11.5 Cg_endo -67.18 168.78 16.67 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.062 2.508 . . . . 0.0 112.53 -176.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.488 HG21 ' HB3' ' A' ' 62' ' ' GLU . 34.4 pt -107.55 115.57 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 175.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 61.59 -171.15 0.15 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.667 1.187 . . . . 0.0 110.213 177.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? 46.96 53.53 10.38 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.368 1.067 . . . . 0.0 110.413 177.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 178.67 -167.35 37.7 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 108.453 -1.859 . . . . 0.0 108.453 -158.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -69.43 100.79 0.8 Allowed 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.245 2.63 . . . . 0.0 109.609 -171.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.51 141.62 23.08 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 -173.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -133.67 138.11 45.7 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.728 1.211 . . . . 0.0 108.167 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 40.2 mttm -145.08 113.57 6.67 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 160.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 59.1 m -138.88 29.52 2.3 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.634 1.173 . . . . 0.0 110.243 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -157.67 162.82 32.28 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 108.287 -1.925 . . . . 0.0 108.287 168.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.28 150.83 71.61 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.51 2.14 . . . . 0.0 109.845 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.8 t -72.0 132.21 43.97 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 157.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.2 m -60.23 148.63 35.79 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.55 0.74 . . . . 0.0 111.205 -172.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.412 -1.215 . . . . 0.0 110.85 176.976 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.282 0 CA-C-O 118.577 -1.124 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 83.4 p 49.47 30.51 3.44 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 162.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.7 t -75.44 117.46 17.25 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 121.029 -1.044 . . . . 0.0 109.085 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -100.48 -83.25 1.72 Allowed Glycine 0 CA--C 1.523 0.554 0 N-CA-C 108.299 -1.92 . . . . 0.0 108.299 167.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 62.9 m 60.25 -67.56 0.04 OUTLIER 'General case' 0 C--O 1.235 0.309 0 C-N-CA 129.018 2.927 . . . . 0.0 113.807 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 55.21 177.0 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.965 1.706 . . . . 0.0 111.911 -163.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 120.83 52.45 0.25 Allowed Glycine 0 C--N 1.333 0.415 0 C-N-CA 125.015 1.293 . . . . 0.0 110.42 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -158.67 175.71 13.29 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.149 1.38 . . . . 0.0 108.549 174.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -137.05 15.87 3.04 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.525 0.73 . . . . 0.0 112.225 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.8 m -70.77 154.61 7.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.9 p -148.94 93.54 2.12 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -171.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 18.1 tp -67.98 136.85 54.56 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 173.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -61.75 -58.12 9.25 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 119.238 -0.41 . . . . 0.0 111.235 -173.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.0 t -57.58 -57.37 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 125.742 1.617 . . . . 0.0 109.8 178.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -49.12 -46.7 33.79 Favored Glycine 0 C--O 1.223 -0.537 0 C-N-CA 124.849 1.214 . . . . 0.0 112.246 177.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -62.1 -49.08 77.36 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 119.008 1.404 . . . . 0.0 110.958 178.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 63.6 t -60.63 -41.99 90.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-N 119.482 1.037 . . . . 0.0 110.983 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.402 HG13 HD11 ' A' ' 69' ' ' LEU . 21.2 mt -54.15 -68.19 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 106.209 -1.775 . . . . 0.0 106.209 173.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -57.87 -30.37 65.77 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 125.079 1.352 . . . . 0.0 110.413 -167.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -64.55 -69.38 0.29 Allowed 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.715 1.606 . . . . 0.0 110.924 171.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.58 -29.34 74.62 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-N 119.413 1.006 . . . . 0.0 111.765 -171.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.4 ttp85 -53.74 -60.45 3.3 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 126.218 1.807 . . . . 0.0 108.76 168.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -67.42 -28.94 68.33 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 119.809 1.186 . . . . 0.0 113.334 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 59.0 m -61.03 -20.42 62.5 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.187 0.903 . . . . 0.0 111.99 172.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.456 ' HE3' HD11 ' A' ' 27' ' ' LEU . 25.7 mtpp -109.67 5.9 23.29 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.915 1.686 . . . . 0.0 111.073 175.099 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.06 9.75 54.66 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 126.442 1.972 . . . . 0.0 113.68 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.456 HD11 ' HE3' ' A' ' 25' ' ' LYS . 34.7 mt -74.15 130.78 40.43 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 118.559 1.179 . . . . 0.0 109.231 -163.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 32.1 p -66.02 162.35 19.61 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 166.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -55.19 -37.24 66.8 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 121.469 -0.77 . . . . 0.0 109.863 169.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -63.85 -43.46 96.05 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.05 0.54 . . . . 0.0 111.298 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -70.02 -35.55 74.41 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 118.853 -0.594 . . . . 0.0 110.628 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.63 -46.05 90.15 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.747 0.703 . . . . 0.0 109.937 173.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.61 -54.44 45.98 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 124.722 1.209 . . . . 0.0 108.978 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 52.0 m -68.01 -31.4 71.06 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 117.962 -1.018 . . . . 0.0 111.608 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.1 mttp -52.75 -50.58 63.19 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 119.945 1.248 . . . . 0.0 110.47 173.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.9 pt -88.13 2.42 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 123.174 0.59 . . . . 0.0 112.383 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 62.3 t-20 45.02 74.21 0.14 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 128.973 2.909 . . . . 0.0 111.716 -170.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -139.35 173.6 11.37 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 128.612 2.765 . . . . 0.0 109.906 178.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.8 mmpt? -81.44 144.21 52.93 Favored Pre-proline 0 CA--C 1.534 0.341 0 O-C-N 121.505 -0.747 . . . . 0.0 109.882 173.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.32 -16.52 13.64 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.334 2.022 . . . . 0.0 114.452 -172.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 -68.04 -34.16 75.95 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 120.331 1.423 . . . . 0.0 110.782 173.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.6 m -72.22 -27.81 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 119.686 1.13 . . . . 0.0 110.155 177.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 36.3 mm -63.92 -50.51 77.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 C-N-CA 123.221 0.609 . . . . 0.0 109.414 172.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.17 -35.58 71.77 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.126 0.489 . . . . 0.0 110.462 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -72.94 -31.03 64.33 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 117.974 -1.012 . . . . 0.0 112.462 176.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -57.08 -50.84 71.54 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-N 120.019 1.281 . . . . 0.0 109.958 170.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -67.55 -29.68 69.12 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 119.188 -0.434 . . . . 0.0 110.965 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.6 m -71.11 -37.1 72.37 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.299 0.954 . . . . 0.0 111.716 176.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 113.85 9.37 16.45 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 124.943 1.259 . . . . 0.0 113.441 -176.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.5 mmt85 -101.29 -42.63 6.24 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 124.546 1.138 . . . . 0.0 110.955 -163.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.85 130.02 42.45 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 174.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 30.1 mm -68.3 124.9 90.89 Favored Pre-proline 0 C--O 1.238 0.456 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 -177.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -76.58 111.81 3.33 Favored 'Trans proline' 0 N--CA 1.442 -1.525 0 N-CA-C 106.836 -2.024 . . . . 0.0 106.836 -175.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -104.9 130.65 53.01 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 -174.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -50.54 -31.51 15.85 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 117.85 -1.071 . . . . 0.0 113.64 -178.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -65.24 -59.55 3.95 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 120.838 1.654 . . . . 0.0 110.673 172.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.1 t -59.7 -47.46 91.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 124.143 0.977 . . . . 0.0 110.034 -176.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 78.8 mt -47.68 -51.03 23.23 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 124.432 1.093 . . . . 0.0 109.538 169.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.72 -43.44 69.32 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 123.718 0.675 . . . . 0.0 112.576 177.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt -66.45 -44.04 83.88 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.14 0.97 . . . . 0.0 109.946 177.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.3 mt -60.01 -37.22 71.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 124.76 1.224 . . . . 0.0 109.903 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -58.35 -47.37 84.01 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 119.229 0.922 . . . . 0.0 109.564 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 26.1 mtt-85 -69.75 -27.22 64.76 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 118.296 -0.859 . . . . 0.0 112.326 176.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.75 -40.15 79.02 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.818 0.847 . . . . 0.0 112.056 176.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 22.1 pt -117.2 -16.07 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -174.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.1 30.88 62.4 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 125.225 1.393 . . . . 0.0 112.813 -176.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 77' ' ' PRO . 69.7 mt -124.11 164.32 19.68 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 118.631 1.216 . . . . 0.0 109.489 169.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -78.76 140.85 38.2 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 126.033 1.733 . . . . 0.0 108.22 176.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.402 HD11 HG13 ' A' ' 18' ' ' ILE . 3.0 mm? -120.07 7.84 10.9 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.563 1.145 . . . . 0.0 108.985 -179.244 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 22.8 mtm105 -141.63 168.61 19.35 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 127.208 2.203 . . . . 0.0 108.461 177.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 68.91 158.26 1.45 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -162.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 24.3 mtmt -64.63 -15.6 61.46 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 120.876 -1.367 . . . . 0.0 111.387 164.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -66.62 11.69 0.09 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.323 2.249 . . . . 0.0 111.906 168.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.1 tt -51.84 144.52 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 O-C-N 120.485 -1.384 . . . . 0.0 110.532 177.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.79 -4.03 24.29 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-O 118.911 -0.938 . . . . 0.0 113.152 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 39.6 mmtt -69.51 150.79 96.87 Favored Pre-proline 0 N--CA 1.446 -0.667 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 157.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.459 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 14.8 Cg_endo -69.33 158.5 57.28 Favored 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 122.448 2.099 . . . . 0.0 111.365 -177.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 27.8 pt -101.53 150.19 6.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 105.796 -1.928 . . . . 0.0 105.796 158.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 63.5 -77.27 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.487 1.915 . . . . 0.0 112.568 170.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.7 tttm -65.58 94.04 0.18 Allowed 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.786 1.234 . . . . 0.0 108.911 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -56.37 151.82 22.22 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.524 -0.631 . . . . 0.0 111.524 -170.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -62.04 125.39 16.35 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.739 2.293 . . . . 0.0 109.083 -167.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 35.7 mtt180 53.18 33.49 15.4 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.007 0.523 . . . . 0.0 111.705 175.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.76 113.9 1.12 Allowed 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.511 1.125 . . . . 0.0 108.118 167.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.0 tptm -74.21 -36.12 63.96 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -153.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 35.8 m -70.53 176.5 4.05 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.32 0.648 . . . . 0.0 112.037 -174.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 38.65 57.75 1.87 Allowed Glycine 0 CA--C 1.527 0.793 0 C-N-CA 127.111 2.291 . . . . 0.0 114.633 171.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -67.33 -18.19 49.95 Favored 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 122.336 2.024 . . . . 0.0 113.114 -177.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 70.5 m 36.67 79.96 0.03 OUTLIER 'General case' 0 C--O 1.236 0.347 0 C-N-CA 126.881 2.072 . . . . 0.0 112.339 178.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 70.0 m -58.94 154.24 15.73 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 154.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.924 0 CA-C-O 116.905 -2.053 . . . . 0.0 109.093 -165.817 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.66 0 N-CA-C 111.658 -0.577 . . . . 0.0 111.658 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.4 m 57.13 -172.07 0.09 Allowed 'General case' 0 C--O 1.241 0.649 0 C-N-CA 125.828 1.651 . . . . 0.0 112.391 -173.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.9 p -148.4 -169.62 3.4 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.284 1.834 . . . . 0.0 108.703 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 98.35 79.85 1.49 Allowed Glycine 0 C--N 1.335 0.524 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 171.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.1 m -161.81 84.24 0.6 Allowed 'General case' 0 C--O 1.24 0.602 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 165.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.1 m -58.48 -41.34 85.07 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.373 1.069 . . . . 0.0 110.716 -174.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.29 171.35 43.12 Favored Glycine 0 C--N 1.337 0.585 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -176.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -166.71 111.74 0.78 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 124.748 1.219 . . . . 0.0 108.252 172.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 62.5 mtt85 -152.05 159.0 43.81 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 124.786 1.234 . . . . 0.0 111.62 177.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.7 m -79.02 150.44 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 123.384 0.674 . . . . 0.0 110.078 155.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.1 t -172.36 172.06 4.55 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 127.92 2.488 . . . . 0.0 107.438 167.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.1 mp -58.09 152.61 16.38 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.223 1.409 . . . . 0.0 109.768 173.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -58.62 -43.96 89.84 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.467 0.307 . . . . 0.0 111.132 -178.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.5 t -57.9 -56.94 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 124.07 0.948 . . . . 0.0 109.094 177.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -55.21 -39.82 72.68 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-O 118.947 -0.918 . . . . 0.0 112.745 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 48.8 tptt -60.2 -57.7 11.69 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.633 1.216 . . . . 0.0 109.733 176.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.4 t -61.81 -31.9 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 118.662 0.665 . . . . 0.0 110.029 -177.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.1 mt -65.76 -56.41 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 CA-C-N 119.809 1.186 . . . . 0.0 109.061 176.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -51.88 -49.38 63.09 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.599 1.16 . . . . 0.0 110.404 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -66.39 -53.06 40.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.104 1.762 . . . . 0.0 111.958 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.23 -34.24 89.39 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 124.413 1.006 . . . . 0.0 111.519 -174.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.9 mtm105 -64.69 -51.31 63.13 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 118.531 -0.747 . . . . 0.0 111.28 168.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -51.8 -37.76 52.92 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.751 0.82 . . . . 0.0 111.399 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.2 m -73.92 -2.39 23.72 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.621 1.968 . . . . 0.0 112.493 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 21.0 mtpp -136.54 6.72 3.0 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.448 2.299 . . . . 0.0 111.314 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.26 21.04 69.9 Favored Glycine 0 CA--C 1.536 1.399 0 CA-C-O 118.681 -1.066 . . . . 0.0 114.742 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 20.8 mt -93.44 135.4 34.72 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.271 1.536 . . . . 0.0 110.964 -169.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 61.7 p -74.98 170.52 15.82 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.262 -0.899 . . . . 0.0 109.515 163.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -63.44 -29.01 70.37 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.237 -0.914 . . . . 0.0 111.568 166.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.53 -36.81 73.92 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.836 0.855 . . . . 0.0 110.8 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -66.13 -37.39 85.59 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 171.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.408 HD22 ' HA ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -67.9 -48.42 66.08 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 118.207 0.458 . . . . 0.0 111.267 -175.236 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -48.24 -48.85 34.97 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 125.43 1.492 . . . . 0.0 109.209 172.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 63.0 m -60.91 -48.74 80.44 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.796 0.838 . . . . 0.0 111.528 175.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.3 mttm -58.4 -11.68 3.08 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 127.175 2.19 . . . . 0.0 114.233 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.9 pt -128.64 0.07 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 119.26 0.937 . . . . 0.0 112.273 177.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 53.2 t30 42.27 76.31 0.08 Allowed 'General case' 0 C--O 1.235 0.301 0 C-N-CA 126.768 2.027 . . . . 0.0 112.103 -163.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -137.6 -179.51 5.79 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 128.03 2.532 . . . . 0.0 107.567 168.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -88.01 141.71 31.54 Favored Pre-proline 0 C--N 1.335 -0.05 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 175.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -64.36 -18.82 64.47 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.587 2.192 . . . . 0.0 112.029 170.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.5 tp60 -62.23 -52.19 64.76 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 123.93 0.892 . . . . 0.0 110.429 171.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.1 m -69.88 -34.68 61.36 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.431 0 CA-C-N 119.36 0.982 . . . . 0.0 110.094 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 42.1 mm -56.57 -48.96 79.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 O-C-N 121.227 -0.921 . . . . 0.0 110.244 174.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.81 -20.91 66.65 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 178.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.16 -54.05 12.38 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 118.822 -0.608 . . . . 0.0 110.45 167.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -42.81 -50.65 5.62 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 124.535 1.134 . . . . 0.0 112.35 176.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.79 -29.35 68.51 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 120.897 1.68 . . . . 0.0 113.223 -171.023 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 12.8 m -69.85 -37.16 76.06 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.874 166.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.63 28.58 18.69 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -177.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -79.16 -50.8 10.42 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 117.494 0.647 . . . . 0.0 109.373 -174.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.35 167.32 18.38 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 127.366 2.266 . . . . 0.0 110.433 171.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 23.9 mm -89.73 127.34 54.61 Favored Pre-proline 0 C--O 1.235 0.333 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 174.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -72.75 115.07 4.2 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 N-CA-C 108.645 -1.329 . . . . 0.0 108.645 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -99.14 135.99 39.75 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.664 0.786 . . . . 0.0 110.795 -169.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -52.4 -36.95 55.4 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.365 1.066 . . . . 0.0 113.275 -170.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -57.59 -64.91 0.74 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.072 0.949 . . . . 0.0 109.226 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 92.4 t -63.3 -40.44 89.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 125.574 1.549 . . . . 0.0 109.844 -178.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.6 mt -49.61 -52.82 27.75 Favored 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 124.354 1.062 . . . . 0.0 110.223 175.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.76 -31.5 78.34 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-N 118.679 0.672 . . . . 0.0 112.523 -178.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -67.59 -43.55 80.27 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 121.401 -1.058 . . . . 0.0 110.371 173.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.0 mt -63.51 -37.12 78.74 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.091 0 C-N-CA 124.337 1.055 . . . . 0.0 109.843 176.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.475 ' HA ' HD23 ' A' ' 69' ' ' LEU . 42.6 mt-10 -56.39 -50.86 70.37 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.386 0.994 . . . . 0.0 109.227 176.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 23.2 mtm180 -64.95 -19.04 65.75 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 175.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.59 -44.76 73.67 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 118.426 -0.797 . . . . 0.0 111.264 177.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.482 HD11 HD21 ' A' ' 69' ' ' LEU . 21.5 pt -114.45 -10.13 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -173.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.51 23.36 78.13 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 127.561 2.505 . . . . 0.0 114.031 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.0 mt -121.94 161.59 22.59 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 118.453 1.126 . . . . 0.0 108.793 172.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -74.36 140.26 44.68 Favored 'General case' 0 CA--C 1.512 -0.51 0 C-N-CA 124.984 1.314 . . . . 0.0 108.753 176.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.482 HD21 HD11 ' A' ' 65' ' ' ILE . 4.0 mm? -119.56 9.92 11.64 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 125.087 1.355 . . . . 0.0 111.201 176.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.5 mtm180 -130.85 166.79 20.12 Favored 'General case' 0 C--O 1.233 0.209 0 O-C-N 121.023 -1.048 . . . . 0.0 109.04 174.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.63 176.91 43.56 Favored Glycine 0 N--CA 1.449 -0.495 0 O-C-N 124.233 0.958 . . . . 0.0 110.89 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -83.2 11.74 6.13 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.643 0.777 . . . . 0.0 111.114 171.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -102.91 16.25 27.14 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.381 1.472 . . . . 0.0 110.359 177.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.5 tt -54.68 142.98 7.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 O-C-N 121.219 -0.925 . . . . 0.0 110.545 -168.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.55 -4.48 59.9 Favored Glycine 0 CA--C 1.536 1.4 0 CA-C-O 119.307 -0.718 . . . . 0.0 114.257 -178.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -71.74 149.15 92.9 Favored Pre-proline 0 C--N 1.341 0.212 0 CA-C-N 119.938 1.869 . . . . 0.0 107.974 163.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.34 151.22 29.43 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 123.896 3.064 . . . . 0.0 112.85 -171.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.0 pt -101.36 127.87 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 175.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 41.22 55.72 3.22 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.561 1.544 . . . . 0.0 114.088 176.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 48.2 mttp 59.51 41.53 19.01 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.789 1.636 . . . . 0.0 112.891 -175.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -57.29 176.08 1.46 Allowed Glycine 0 CA--C 1.536 1.383 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.832 153.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.91 153.85 58.31 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.611 2.207 . . . . 0.0 113.468 -169.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 30.0 mtp180 -69.82 175.97 3.96 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.779 167.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.57 163.68 33.18 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 126.138 1.775 . . . . 0.0 108.569 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 52.9 mttp 71.03 -35.86 0.34 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 128.226 2.61 . . . . 0.0 112.522 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.7 p -66.12 -177.66 0.54 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.315 1.446 . . . . 0.0 110.662 162.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 102.76 100.33 2.55 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 176.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -66.06 168.19 16.23 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.533 2.155 . . . . 0.0 110.543 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.2 t -133.53 112.87 11.86 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.18 0.992 . . . . 0.0 108.528 -161.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.9 t -70.8 142.42 51.33 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.735 0.814 . . . . 0.0 108.933 176.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.929 0 N-CA-C 108.085 -2.006 . . . . 0.0 108.085 176.675 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.751 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.0 t 53.32 75.6 0.25 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.9 1.28 . . . . 0.0 110.466 -177.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.9 t -66.74 146.02 54.9 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 169.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -93.63 76.49 1.09 Allowed Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 108.051 -2.019 . . . . 0.0 108.051 172.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -172.39 158.15 4.25 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.217 1.407 . . . . 0.0 109.414 169.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.7 p -148.67 -4.78 0.43 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.798 1.239 . . . . 0.0 112.771 174.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 95.32 -106.51 3.41 Favored Glycine 0 C--N 1.337 0.602 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -153.22 -177.12 6.11 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.503 1.121 . . . . 0.0 108.357 -173.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.2 163.77 1.51 Allowed 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.142 -0.974 . . . . 0.0 109.749 160.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.8 m -133.36 178.59 5.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.605 0 C-N-CA 124.812 1.245 . . . . 0.0 109.466 -176.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.6 p -71.81 160.47 32.53 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.646 1.178 . . . . 0.0 111.953 174.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.4 mp 62.06 155.12 0.04 OUTLIER 'General case' 0 C--N 1.341 0.202 0 C-N-CA 128.658 2.783 . . . . 0.0 112.983 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -70.36 -48.83 54.56 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 120.574 -1.329 . . . . 0.0 107.501 171.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 53.5 t -57.31 -64.53 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.098 0 C-N-CA 125.41 1.484 . . . . 0.0 109.287 -178.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -49.16 -42.99 32.58 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-N 119.425 1.011 . . . . 0.0 112.998 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -67.44 -52.6 37.6 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 117.843 -1.075 . . . . 0.0 112.564 177.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 66.7 t -59.27 -31.34 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 119.805 1.184 . . . . 0.0 110.242 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 52.9 mt -61.32 -58.38 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 175.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -60.03 -47.0 87.65 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 123.608 0.568 . . . . 0.0 110.47 -177.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -60.3 -49.75 76.36 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.841 1.256 . . . . 0.0 110.734 178.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.17 -32.14 75.9 Favored Glycine 0 CA--C 1.52 0.377 0 O-C-N 120.535 -1.353 . . . . 0.0 112.663 -177.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 15.1 mtm105 -59.6 -61.42 2.63 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 118.145 0.973 . . . . 0.0 110.777 167.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.27 -22.95 67.2 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.169 0.988 . . . . 0.0 112.692 -174.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.4 t -61.4 -16.59 48.05 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.662 1.585 . . . . 0.0 111.303 171.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -126.98 2.12 6.57 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.413 1.885 . . . . 0.0 110.986 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 71.67 0.24 39.29 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 126.022 1.772 . . . . 0.0 113.024 -175.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.6 mt -78.63 145.32 34.74 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 119.034 1.417 . . . . 0.0 110.619 -162.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.1 p -83.86 174.61 10.25 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.656 0.782 . . . . 0.0 110.013 -173.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -69.09 -38.49 78.99 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 121.432 -0.793 . . . . 0.0 109.743 171.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.3 mtpm? -58.91 -41.99 88.57 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.82 0.848 . . . . 0.0 110.911 171.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -63.43 -43.46 97.4 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 118.832 0.742 . . . . 0.0 109.388 177.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.32 -49.3 77.56 Favored 'General case' 0 C--O 1.228 -0.069 0 C-N-CA 124.205 1.002 . . . . 0.0 110.091 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.15 -45.24 71.98 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.856 0.862 . . . . 0.0 109.919 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.7 m -61.82 -48.45 80.53 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.287 1.035 . . . . 0.0 110.576 177.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.2 mttm -54.48 -27.66 39.21 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.764 1.226 . . . . 0.0 113.274 176.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.6 pt -111.93 10.05 8.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 123.928 0.891 . . . . 0.0 112.13 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.5 m120 45.25 48.68 10.2 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.594 2.358 . . . . 0.0 111.421 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -132.27 -171.49 2.65 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.241 1.416 . . . . 0.0 109.224 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.6 mmmm -91.61 142.0 26.36 Favored Pre-proline 0 N--CA 1.466 0.355 0 O-C-N 121.015 -1.053 . . . . 0.0 109.713 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.52 -10.18 28.24 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.715 2.277 . . . . 0.0 112.123 169.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 30.0 tp60 -50.92 -61.68 2.07 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.901 1.28 . . . . 0.0 109.361 163.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.4 m -66.42 -29.5 46.77 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.677 0 C-N-CA 119.741 -0.783 . . . . 0.0 110.419 -175.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 51.4 mm -62.77 -45.08 99.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 119.686 1.13 . . . . 0.0 109.952 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.82 -39.64 92.48 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 121.496 -0.082 . . . . 0.0 111.09 172.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -63.62 -40.28 96.51 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.512 0.725 . . . . 0.0 110.68 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -63.25 -44.73 94.34 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 126.183 1.793 . . . . 0.0 108.867 176.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -60.73 -30.41 69.97 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.277 1.031 . . . . 0.0 113.164 176.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.7 m -90.49 -19.64 23.61 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 177.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.97 42.45 7.62 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 119.56 1.073 . . . . 0.0 111.188 -173.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -114.36 -47.83 2.91 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 124.941 1.297 . . . . 0.0 108.856 -176.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.21 150.11 11.5 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.31 0.644 . . . . 0.0 109.874 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 36.3 mm -68.98 117.32 50.51 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 167.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -69.76 115.6 4.17 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 N-CA-C 106.892 -2.003 . . . . 0.0 106.892 171.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -127.67 123.91 36.64 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 -172.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.2 p-10 -51.74 -29.59 19.25 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.909 1.684 . . . . 0.0 112.998 -174.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -58.54 -47.6 83.67 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.741 1.616 . . . . 0.0 111.205 173.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.2 t -91.66 -36.5 7.99 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-O 117.778 -1.106 . . . . 0.0 109.971 -175.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 14.1 mt -47.8 -45.63 29.83 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.56 1.073 . . . . 0.0 109.518 170.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.65 -40.31 94.57 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-O 119.492 -0.616 . . . . 0.0 112.813 176.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -64.99 -47.63 76.86 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 118.836 1.318 . . . . 0.0 109.683 177.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.3 mt -61.41 -36.1 70.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 123.226 0.611 . . . . 0.0 110.117 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -58.3 -50.19 74.49 Favored 'General case' 0 C--N 1.33 -0.255 0 O-C-N 121.583 -0.698 . . . . 0.0 109.862 176.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 36.5 mtt180 -65.91 -24.77 66.9 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.301 -0.874 . . . . 0.0 112.807 174.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.85 -55.88 28.73 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 118.771 0.714 . . . . 0.0 109.525 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.427 HD11 HD21 ' A' ' 69' ' ' LEU . 45.9 pt -93.34 -15.92 7.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 123.548 0.739 . . . . 0.0 112.002 -177.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.18 39.67 92.48 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 125.337 1.446 . . . . 0.0 111.682 -173.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 47.5 mt -135.45 166.14 23.88 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.4 1.08 . . . . 0.0 109.057 169.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -73.54 141.52 46.7 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 126.336 1.854 . . . . 0.0 109.52 176.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.427 HD21 HD11 ' A' ' 65' ' ' ILE . 3.4 mm? -119.36 5.25 11.18 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.425 1.89 . . . . 0.0 110.302 176.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 56.1 mtm180 -142.1 147.08 36.16 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.924 0.783 . . . . 0.0 110.009 -172.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.25 167.58 21.4 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 125.193 1.378 . . . . 0.0 109.931 -170.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.2 mttp -68.84 -11.57 60.62 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.119 -1.224 . . . . 0.0 111.667 176.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.98 13.74 0.49 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.924 1.69 . . . . 0.0 110.704 172.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.8 tt -52.65 150.45 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 O-C-N 120.843 -1.161 . . . . 0.0 110.761 176.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.53 -12.49 7.78 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-O 118.871 -0.96 . . . . 0.0 113.749 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 33.9 mmtt -70.77 150.57 95.27 Favored Pre-proline 0 N--CA 1.449 -0.515 0 CA-C-N 119.671 1.736 . . . . 0.0 107.784 166.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -73.16 162.44 40.67 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 123.575 2.85 . . . . 0.0 110.856 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 42.3 pt -110.69 141.24 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 124.364 1.065 . . . . 0.0 108.535 -178.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 53.19 23.64 3.23 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.783 2.033 . . . . 0.0 114.324 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -83.23 59.1 4.81 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 120.04 -1.662 . . . . 0.0 110.691 -171.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 145.24 -170.6 26.58 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 123.623 0.63 . . . . 0.0 112.706 172.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -75.55 -175.58 2.52 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 124.26 3.307 . . . . 0.0 111.409 169.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? 55.05 47.88 21.01 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.396 1.478 . . . . 0.0 109.141 -178.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.57 172.73 3.15 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.227 168.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt 53.12 -160.07 0.13 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.63 1.572 . . . . 0.0 111.709 170.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 11.8 t -153.77 -66.08 0.14 Allowed 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -81.29 -175.56 50.19 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 172.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -71.72 167.61 26.05 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.829 3.019 . . . . 0.0 111.164 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.3 m 176.53 164.04 0.43 Allowed 'General case' 0 C--O 1.237 0.408 0 C-N-CA 127.596 2.358 . . . . 0.0 109.293 168.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 13.4 m -72.78 -60.72 2.09 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 164.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.92 0 CA-C-O 117.762 -1.577 . . . . 0.0 110.993 173.18 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.81 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.2 m -76.63 -58.67 3.15 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 118.563 1.181 . . . . 0.0 111.722 -170.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.4 m 52.55 166.84 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 127.455 2.302 . . . . 0.0 113.539 -166.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 159.17 -165.99 34.48 Favored Glycine 0 CA--C 1.521 0.413 0 O-C-N 120.139 -1.6 . . . . 0.0 112.951 -172.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.0 t -146.69 167.74 23.06 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.561 1.544 . . . . 0.0 108.397 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.5 p -153.74 48.82 0.66 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.591 0.71 . . . . 0.0 109.538 -173.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.43 131.8 5.68 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 107.796 -2.122 . . . . 0.0 107.796 -167.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -46.51 -45.39 18.44 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 127.551 2.34 . . . . 0.0 112.398 -174.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 91.2 mtm-85 59.2 162.6 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 127.843 2.457 . . . . 0.0 113.333 -176.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.1 m -76.07 160.43 5.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 170.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.2 p -139.26 165.48 27.07 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.969 1.308 . . . . 0.0 108.467 -174.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.8 mp -78.72 154.58 29.95 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 163.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -56.07 -38.24 70.39 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 122.37 0.268 . . . . 0.0 111.066 -177.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.1 t -56.13 -61.7 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 123.506 0.722 . . . . 0.0 109.464 176.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -56.67 -38.08 80.15 Favored Glycine 0 C--N 1.335 0.527 0 CA-C-N 119.523 1.056 . . . . 0.0 112.523 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.4 -56.35 21.24 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.276 1.038 . . . . 0.0 109.86 177.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.3 t -60.13 -37.88 74.87 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.128 0 C-N-CA 123.808 0.843 . . . . 0.0 110.298 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 64.4 mt -59.98 -57.74 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 176.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -55.68 -49.0 74.11 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.142 0.577 . . . . 0.0 110.125 -176.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -56.67 -60.61 3.3 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 123.362 0.665 . . . . 0.0 110.801 176.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.38 -30.84 78.96 Favored Glycine 0 CA--C 1.521 0.442 0 CA-C-N 119.914 1.234 . . . . 0.0 112.719 -171.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.487 ' HB3' HH11 ' A' ' 22' ' ' ARG . 16.7 mtm105 -57.12 -65.72 0.57 Allowed 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 118.272 1.036 . . . . 0.0 109.782 166.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -61.52 -29.88 70.28 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.806 1.242 . . . . 0.0 112.161 -173.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.7 m -72.6 -4.73 32.58 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.984 1.314 . . . . 0.0 112.295 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp -127.72 12.35 6.82 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.465 1.906 . . . . 0.0 110.16 176.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.21 17.56 66.11 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.297 0.951 . . . . 0.0 113.725 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 59.4 mt -88.62 144.77 26.08 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 118.652 1.226 . . . . 0.0 111.505 -168.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 81.9 p -84.18 168.75 15.48 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.305 173.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -58.91 -43.38 91.04 Favored 'General case' 0 N--CA 1.464 0.267 0 O-C-N 121.321 -0.862 . . . . 0.0 110.216 166.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.5 mttt -57.1 -36.27 70.43 Favored 'General case' 0 CA--C 1.521 -0.136 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 176.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -64.13 -38.37 90.83 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 118.244 0.474 . . . . 0.0 110.232 176.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.59 -48.68 71.5 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 123.34 0.656 . . . . 0.0 109.256 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -50.16 -56.42 11.05 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.48 1.512 . . . . 0.0 108.643 178.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 95.9 m -59.59 -44.14 93.47 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.491 0.717 . . . . 0.0 112.299 177.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -58.86 -32.83 69.81 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 119.595 1.089 . . . . 0.0 112.137 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.2 pt -103.39 1.44 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 119.12 0.873 . . . . 0.0 112.073 176.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 63.3 t30 54.11 44.38 29.3 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 128.236 2.614 . . . . 0.0 113.709 -175.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -113.76 177.85 4.49 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.788 2.035 . . . . 0.0 110.907 176.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -75.93 147.99 81.26 Favored Pre-proline 0 C--N 1.342 0.26 0 CA-C-N 118.991 0.814 . . . . 0.0 109.542 168.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.0 -7.48 20.94 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 123.023 2.482 . . . . 0.0 112.616 170.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.4 tp60 -55.63 -63.44 1.17 Allowed 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 123.278 0.631 . . . . 0.0 109.551 166.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.8 m -67.98 -22.92 28.39 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.339 0 C-N-CA 119.954 -0.698 . . . . 0.0 111.014 -169.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 44.1 mm -61.63 -46.93 95.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 123.98 0.912 . . . . 0.0 110.298 171.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.31 -27.13 68.39 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 123.259 0.623 . . . . 0.0 112.287 177.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -79.75 -39.11 31.79 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.214 1.006 . . . . 0.0 110.789 176.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -55.0 -40.15 69.82 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 125.92 1.688 . . . . 0.0 111.054 175.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -61.14 -39.9 91.81 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 119.177 -0.44 . . . . 0.0 111.895 -177.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.5 m -80.87 -23.89 38.73 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 118.478 -0.772 . . . . 0.0 112.954 172.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.05 7.2 62.65 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-O 119.286 -0.73 . . . . 0.0 112.8 -171.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 45.8 mtt180 -67.44 -37.55 83.17 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.062 1.431 . . . . 0.0 110.195 177.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.63 115.1 7.62 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 167.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.6 mm -70.04 117.42 53.91 Favored Pre-proline 0 C--O 1.236 0.364 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 170.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -80.75 154.48 20.31 Favored 'Trans proline' 0 N--CA 1.446 -1.28 0 C-N-CA 122.188 1.925 . . . . 0.0 110.238 -173.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -127.47 153.92 45.72 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.526 1.13 . . . . 0.0 108.506 174.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 72.9 m-80 -62.12 -31.84 72.35 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.883 0.765 . . . . 0.0 112.309 -172.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -56.61 -61.37 2.47 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.004 0.922 . . . . 0.0 109.381 174.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.0 t -66.15 -48.94 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-O 118.087 -0.959 . . . . 0.0 109.69 -176.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 51.9 mt -44.91 -48.4 11.27 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 119.366 0.985 . . . . 0.0 110.164 170.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.14 -47.45 73.83 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 125.236 1.398 . . . . 0.0 112.562 176.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -61.73 -41.95 98.32 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 121.732 -0.863 . . . . 0.0 110.425 175.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 77.5 mt -63.68 -34.63 69.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 118.755 0.707 . . . . 0.0 109.651 176.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -62.11 -43.5 98.69 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 120.957 -1.089 . . . . 0.0 109.873 174.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 84.8 mtt-85 -59.22 -39.01 81.36 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.453 -0.78 . . . . 0.0 111.004 173.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.74 -55.36 31.1 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.619 1.568 . . . . 0.0 111.453 -175.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.0 pt -91.02 -26.51 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 118.673 0.669 . . . . 0.0 110.942 -178.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.59 28.08 36.82 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 125.614 1.578 . . . . 0.0 112.215 -178.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 77' ' ' PRO . 19.6 mt -133.65 165.09 25.74 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.542 1.537 . . . . 0.0 108.572 173.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.2 mttm -69.41 140.96 54.19 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 126.236 1.814 . . . . 0.0 109.947 176.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -119.75 8.02 11.11 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.429 1.892 . . . . 0.0 109.791 174.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -133.42 154.93 50.36 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.578 1.551 . . . . 0.0 108.082 -175.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 65.51 174.18 4.7 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.627 1.584 . . . . 0.0 112.624 -178.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 72.1 mttt -69.15 -16.83 63.73 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 121.883 -0.775 . . . . 0.0 111.867 178.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -76.82 16.04 0.58 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.391 0.996 . . . . 0.0 111.362 176.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.6 tt -52.15 139.51 8.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 O-C-N 120.718 -1.239 . . . . 0.0 110.78 -176.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.27 -8.05 41.96 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 118.79 -1.006 . . . . 0.0 113.386 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 16.5 mmtt -72.55 154.38 91.57 Favored Pre-proline 0 N--CA 1.451 -0.411 0 CA-C-N 120.546 2.173 . . . . 0.0 106.672 161.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.47 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 14.7 Cg_endo -67.8 170.67 13.57 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 123.388 2.725 . . . . 0.0 112.204 -175.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 25.2 pt -109.04 164.45 5.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 124.637 1.175 . . . . 0.0 108.679 171.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -72.81 135.05 45.16 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 174.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 35.5 mttt -152.37 158.83 43.26 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.733 1.613 . . . . 0.0 108.095 161.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 43.22 -114.42 0.85 Allowed Glycine 0 CA--C 1.534 1.275 0 C-N-CA 125.126 1.346 . . . . 0.0 112.486 174.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.95 104.17 1.31 Allowed 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 123.901 3.067 . . . . 0.0 111.304 -176.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 42.1 ttt180 95.08 121.63 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 130.46 3.504 . . . . 0.0 110.22 168.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.6 -61.49 0.37 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.027 1.731 . . . . 0.0 109.108 177.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.5 mtmt 61.26 163.21 0.07 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 127.675 2.39 . . . . 0.0 112.186 -173.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 43.9 m 30.8 77.29 0.03 OUTLIER 'General case' 0 C--O 1.234 0.25 0 C-N-CA 126.901 2.08 . . . . 0.0 113.205 -170.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 165.98 66.29 0.03 OUTLIER Glycine 0 CA--C 1.523 0.576 0 N-CA-C 106.318 -2.713 . . . . 0.0 106.318 174.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -64.73 149.42 89.74 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 121.757 1.638 . . . . 0.0 110.023 -174.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.8 m -157.3 165.57 35.47 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.729 1.211 . . . . 0.0 109.155 176.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.6 p -128.01 171.41 11.87 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.0 1.32 . . . . 0.0 108.47 171.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.852 0 N-CA-C 104.735 -3.346 . . . . 0.0 104.735 167.981 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.853 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.3 t -145.95 -37.85 0.25 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.454 0.702 . . . . 0.0 111.148 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.1 m 33.96 49.38 0.28 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.419 2.287 . . . . 0.0 115.591 172.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -61.1 152.79 39.79 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.825 -0.51 . . . . 0.0 111.825 -176.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.0 p -162.87 74.88 0.4 Allowed 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.6 0.76 . . . . 0.0 109.13 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.9 m -143.81 154.17 43.13 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 122.655 0.382 . . . . 0.0 110.804 176.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -81.04 -105.08 0.32 Allowed Glycine 0 CA--C 1.522 0.48 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 173.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -137.3 97.48 3.49 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.026 1.33 . . . . 0.0 109.218 -168.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 24.7 mmt85 -134.55 6.02 3.48 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.748 0.819 . . . . 0.0 113.104 -173.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.1 p -62.72 149.92 9.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-N 118.726 0.694 . . . . 0.0 110.859 177.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.2 p -127.5 180.0 5.2 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 127.038 2.135 . . . . 0.0 108.907 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.4 mp 66.3 -177.12 0.19 Allowed 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.044 1.338 . . . . 0.0 113.158 165.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -97.85 -44.85 6.54 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.808 0.843 . . . . 0.0 110.034 158.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 37.1 t -60.95 -57.44 12.12 Favored 'Isoleucine or valine' 0 C--N 1.344 0.329 0 CA-C-N 119.372 0.987 . . . . 0.0 109.14 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.91 -40.9 66.38 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 119.677 -0.513 . . . . 0.0 112.1 177.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.8 tptt -57.85 -61.22 2.68 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 117.827 0.814 . . . . 0.0 110.826 173.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 78.6 t -58.49 -31.85 44.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 118.994 0.816 . . . . 0.0 110.068 -176.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 52.3 mt -64.74 -59.19 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-O 117.799 -1.096 . . . . 0.0 108.753 175.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -54.23 -50.03 68.1 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.706 0.803 . . . . 0.0 109.839 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.85 -52.22 63.96 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 123.786 0.835 . . . . 0.0 110.394 -177.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.99 -33.87 88.4 Favored Glycine 0 CA--C 1.524 0.618 0 CA-C-O 118.862 -0.966 . . . . 0.0 112.098 -177.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.679 ' HG2' HD23 ' A' ' 32' ' ' LEU . 17.3 mtm105 -59.68 -58.14 9.89 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 118.321 1.061 . . . . 0.0 109.7 170.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.9 mm100 -64.36 -17.68 63.95 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.753 1.621 . . . . 0.0 113.216 -176.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 65.3 m -72.15 -11.33 60.69 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.144 0.978 . . . . 0.0 112.941 168.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -135.66 23.06 3.38 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 120.399 1.454 . . . . 0.0 111.993 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 61.2 14.19 38.92 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.477 1.037 . . . . 0.0 113.924 -178.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 44.5 mt -73.09 125.27 27.28 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 118.67 1.235 . . . . 0.0 108.898 -167.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 67.2 p -66.7 170.42 6.44 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 165.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -63.04 -32.39 73.75 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.098 -1.001 . . . . 0.0 110.399 169.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -72.15 -36.32 69.3 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.481 0.712 . . . . 0.0 111.058 178.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -59.91 -40.54 89.19 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.96 0.8 . . . . 0.0 109.129 174.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.679 HD23 ' HG2' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -65.82 -47.5 74.81 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.406 0.682 . . . . 0.0 110.803 177.003 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.64 -47.4 67.1 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.485 1.114 . . . . 0.0 110.487 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 95.3 m -58.89 -49.12 78.98 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 125.03 1.332 . . . . 0.0 111.081 172.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.6 mttp -57.88 -22.55 48.86 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 117.837 -1.078 . . . . 0.0 113.563 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.487 HG22 ' HB3' ' A' ' 60' ' ' LYS . 25.6 pt -115.3 8.15 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 120.021 1.282 . . . . 0.0 112.096 173.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 42.1 t30 36.74 72.15 0.12 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.424 1.889 . . . . 0.0 112.015 -170.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.77 -179.69 6.48 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.691 1.596 . . . . 0.0 109.706 171.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -68.54 143.51 95.33 Favored Pre-proline 0 N--CA 1.455 -0.203 0 O-C-N 121.347 -0.846 . . . . 0.0 109.797 172.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -69.72 -10.33 28.34 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 122.599 2.199 . . . . 0.0 112.123 170.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -61.29 -42.22 98.28 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.897 1.279 . . . . 0.0 110.73 170.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.3 m -76.39 -27.27 17.35 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.382 0 C-N-CA 119.687 -0.805 . . . . 0.0 110.294 -176.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.3 mm -62.99 -47.47 92.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 119.44 1.018 . . . . 0.0 109.226 176.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.68 -42.38 71.32 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 122.885 0.474 . . . . 0.0 110.834 175.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -78.58 -32.9 47.87 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 118.608 -0.71 . . . . 0.0 111.263 -173.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -58.8 -43.72 90.59 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.33 1.052 . . . . 0.0 109.533 168.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.418 ' CD ' HH21 ' A' ' 22' ' ' ARG . 7.0 mt-10 -62.43 -40.55 96.93 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 118.44 -0.79 . . . . 0.0 112.501 -178.412 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.3 m -82.11 -25.62 34.29 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 119.145 0.884 . . . . 0.0 112.657 175.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 108.84 3.33 32.07 Favored Glycine 0 CA--C 1.523 0.538 0 C-N-CA 123.464 0.554 . . . . 0.0 113.052 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 55.0 mmt-85 -67.3 -58.34 4.98 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.32 1.448 . . . . 0.0 109.416 -175.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.11 142.71 53.75 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.438 0.563 . . . . 0.0 109.894 -175.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 mt -68.43 126.86 93.15 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 174.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.15 116.86 4.79 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 122.72 2.28 . . . . 0.0 108.192 175.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -114.67 126.72 55.2 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 178.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -44.69 -38.19 4.2 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.767 1.627 . . . . 0.0 114.103 175.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -58.18 -33.15 68.94 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 123.245 0.618 . . . . 0.0 111.979 177.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 75.3 t -94.19 -46.8 13.58 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 C-N-CA 124.898 1.279 . . . . 0.0 109.425 176.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 78.0 mt -47.97 -49.35 30.91 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 120.463 1.483 . . . . 0.0 111.115 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.78 -31.47 71.75 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 118.459 0.572 . . . . 0.0 113.131 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.487 ' HB3' HG22 ' A' ' 36' ' ' ILE . 9.9 mtpp -74.31 -43.39 56.95 Favored 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 125.071 1.348 . . . . 0.0 109.419 175.273 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.0 mt -59.17 -36.79 64.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 175.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -59.12 -46.16 89.05 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.426 1.012 . . . . 0.0 109.995 176.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 48.0 mtt180 -67.57 -23.31 65.39 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.329 -0.857 . . . . 0.0 112.713 174.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.95 -37.09 81.16 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.614 1.166 . . . . 0.0 111.893 -178.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 29.7 pt -119.25 -20.38 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.021 0.929 . . . . 0.0 112.544 -177.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.61 29.43 52.43 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 125.476 1.512 . . . . 0.0 113.345 -177.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.473 HD23 ' HA ' ' A' ' 77' ' ' PRO . 81.1 mt -124.92 166.09 16.92 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 118.267 1.033 . . . . 0.0 108.569 170.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.7 mttm -74.59 143.27 44.48 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 125.357 1.463 . . . . 0.0 109.738 175.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -121.26 9.71 10.47 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.56 1.544 . . . . 0.0 110.387 176.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 33.9 mtt-85 -137.64 163.06 32.16 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 119.371 0.987 . . . . 0.0 110.951 175.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.82 177.95 49.94 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 125.413 1.483 . . . . 0.0 110.811 -174.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -69.75 -20.91 63.49 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 121.694 -0.886 . . . . 0.0 110.741 163.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.34 15.71 0.09 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 128.755 2.822 . . . . 0.0 111.382 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.3 tt -56.86 150.89 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 O-C-N 121.106 -0.997 . . . . 0.0 109.334 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.73 -7.15 7.42 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-O 118.533 -1.148 . . . . 0.0 114.13 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.401 ' HE3' ' HB3' ' A' ' 76' ' ' LYS . 24.9 mmmt -61.47 149.79 82.65 Favored Pre-proline 0 C--N 1.342 0.242 0 CA-C-N 120.04 1.92 . . . . 0.0 107.137 158.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.473 ' HA ' HD23 ' A' ' 67' ' ' LEU . 19.6 Cg_endo -67.73 154.79 72.28 Favored 'Trans proline' 0 N--CA 1.445 -1.337 0 C-N-CA 123.139 2.56 . . . . 0.0 110.462 170.118 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.7 pt -101.94 144.56 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 164.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 51.39 34.83 12.65 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.077 1.351 . . . . 0.0 113.603 164.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -116.65 66.95 0.72 Allowed 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 176.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 154.87 171.62 21.79 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 125.259 1.409 . . . . 0.0 110.112 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.44 94.72 0.98 Allowed 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.824 3.016 . . . . 0.0 110.908 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.5 ttm180 -159.92 141.78 12.99 Favored 'General case' 0 C--O 1.234 0.243 0 O-C-N 121.104 -0.998 . . . . 0.0 109.881 170.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -140.09 135.23 32.36 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 149.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 11.6 ptpt -73.98 173.09 10.49 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 118.282 0.492 . . . . 0.0 110.651 172.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.0 m -121.63 176.62 5.62 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 124.359 1.064 . . . . 0.0 108.469 159.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 163.45 -81.92 0.12 Allowed Glycine 0 CA--C 1.518 0.257 0 N-CA-C 107.853 -2.099 . . . . 0.0 107.853 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -70.05 97.78 0.68 Allowed 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.462 2.108 . . . . 0.0 108.241 173.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.3 m -61.48 108.53 0.97 Allowed 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 173.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 63.44 170.2 0.16 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.373 1.469 . . . . 0.0 112.425 -168.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.426 0 N-CA-C 106.606 -2.597 . . . . 0.0 106.606 167.675 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.313 0 CA-C-O 118.846 -0.974 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.5 m -151.89 159.96 43.67 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.592 1.557 . . . . 0.0 107.54 166.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.8 t -140.47 1.89 1.79 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.969 1.308 . . . . 0.0 111.335 172.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 75.38 -174.36 52.25 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 -164.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.9 p -156.2 26.56 0.36 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.332 1.053 . . . . 0.0 111.223 176.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.4 m -132.32 128.27 37.36 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.291 1.436 . . . . 0.0 109.827 -168.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -97.38 -123.61 4.65 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 107.781 -2.128 . . . . 0.0 107.781 165.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 45.84 68.92 0.52 Allowed 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.512 1.925 . . . . 0.0 111.595 175.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.24 163.75 35.37 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 123.843 0.857 . . . . 0.0 110.337 -173.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.2 m -65.77 163.42 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 123.764 0.826 . . . . 0.0 109.22 165.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 40.2 p -131.81 91.14 2.93 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 175.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.4 mp -61.83 150.43 37.23 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 172.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -57.89 -43.7 86.25 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 117.99 0.359 . . . . 0.0 111.207 -175.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.1 t -56.3 -53.88 34.59 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.15 0 C-N-CA 124.044 0.938 . . . . 0.0 109.498 173.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -56.63 -39.7 86.32 Favored Glycine 0 CA--C 1.529 0.924 0 CA-C-N 119.363 0.983 . . . . 0.0 112.719 178.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -63.63 -55.44 23.58 Favored 'General case' 0 N--CA 1.46 0.048 0 CA-C-N 118.51 1.155 . . . . 0.0 109.943 176.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.3 t -58.71 -38.47 72.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 123.465 0.706 . . . . 0.0 110.443 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 57.0 mt -58.64 -59.48 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 176.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -61.93 -37.15 83.6 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 118.073 0.397 . . . . 0.0 111.229 -173.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.88 -53.98 50.66 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 121.418 -0.801 . . . . 0.0 111.914 171.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.64 -37.12 93.24 Favored Glycine 0 CA--C 1.521 0.457 0 CA-C-O 119.177 -0.79 . . . . 0.0 111.899 -173.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 17.6 mtm105 -57.3 -61.33 2.55 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 117.69 0.745 . . . . 0.0 109.407 173.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -60.74 -29.91 69.68 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.132 0.973 . . . . 0.0 112.347 -177.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.4 m -65.05 -12.95 56.27 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.285 0.948 . . . . 0.0 112.959 177.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 41.6 mttm -121.69 8.83 10.07 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.484 1.513 . . . . 0.0 110.295 171.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.12 24.86 61.42 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 126.014 1.769 . . . . 0.0 113.249 -177.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 57.6 mt -87.55 139.89 30.08 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.264 1.532 . . . . 0.0 111.536 -171.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.55 HG23 ' H ' ' A' ' 31' ' ' ASP . 14.1 t -78.88 163.68 25.09 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.613 1.165 . . . . 0.0 110.156 177.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -59.21 -40.84 87.08 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 121.015 -1.053 . . . . 0.0 110.086 175.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.47 -34.85 76.15 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 118.512 -0.756 . . . . 0.0 111.972 178.133 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.55 ' H ' HG23 ' A' ' 28' ' ' THR . 0.5 OUTLIER -67.39 -36.53 81.51 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.354 0.979 . . . . 0.0 110.787 175.928 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.78 -47.21 84.49 Favored 'General case' 0 C--N 1.338 0.108 0 O-C-N 121.896 -0.503 . . . . 0.0 109.875 178.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.23 -53.31 36.38 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 125.859 1.664 . . . . 0.0 108.738 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 29.3 m -58.09 -49.58 76.44 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.851 0.861 . . . . 0.0 111.55 174.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 49.1 mttm -57.53 -20.52 32.29 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.6 pt -116.6 5.2 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 119.399 1.0 . . . . 0.0 112.009 176.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 46.6 t30 48.01 64.42 1.65 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 127.04 2.136 . . . . 0.0 110.821 -175.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -137.9 174.88 10.11 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 127.38 2.272 . . . . 0.0 109.862 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.1 mmmm -73.72 143.07 81.22 Favored Pre-proline 0 CA--C 1.53 0.175 0 C-N-CA 124.448 1.099 . . . . 0.0 109.647 172.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -71.99 -12.22 28.07 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.678 2.252 . . . . 0.0 112.829 175.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 44.4 tp60 -73.83 -28.24 61.51 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 117.626 -1.178 . . . . 0.0 111.752 173.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.0 m -75.71 -34.29 28.24 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 CA-C-N 120.544 1.52 . . . . 0.0 109.984 174.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 35.9 mm -59.96 -52.72 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 119.579 1.081 . . . . 0.0 109.893 178.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.67 -31.78 71.92 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.252 -177.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -78.32 -36.26 46.65 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.769 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -54.73 -46.79 74.31 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 126.087 1.755 . . . . 0.0 110.147 173.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -59.65 -48.61 80.97 Favored 'General case' 0 C--N 1.34 0.152 0 C-N-CA 124.011 0.924 . . . . 0.0 110.854 177.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.9 -19.88 61.19 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 107.75 -3.21 34.07 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 125.1 1.333 . . . . 0.0 113.723 176.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 13.0 mmt180 -71.77 -52.87 15.41 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.895 1.347 . . . . 0.0 111.896 -170.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.56 129.23 40.92 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -175.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 35.4 mm -70.11 120.1 75.97 Favored Pre-proline 0 C--O 1.236 0.375 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 174.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -84.39 113.6 1.74 Allowed 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 121.093 1.195 . . . . 0.0 110.216 -171.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -81.24 142.12 33.47 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 177.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -55.54 -38.59 69.46 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.899 0.88 . . . . 0.0 111.849 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -67.19 -50.76 59.82 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.288 0.635 . . . . 0.0 111.351 174.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.6 t -64.42 -43.62 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 119.543 1.065 . . . . 0.0 109.962 -176.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 22.4 mt -45.36 -51.95 10.52 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 125.172 1.389 . . . . 0.0 109.447 165.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.98 -32.66 76.07 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 123.683 0.659 . . . . 0.0 114.105 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -71.71 -48.07 49.74 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 118.984 1.392 . . . . 0.0 109.522 174.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.1 mt -54.8 -36.12 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.104 0 C-N-CA 124.128 0.971 . . . . 0.0 109.923 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -56.27 -50.82 70.28 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 121.884 -0.51 . . . . 0.0 111.081 176.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 65.9 mtt85 -65.58 -24.9 67.19 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.678 0.672 . . . . 0.0 111.954 177.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.36 -33.96 77.2 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.97 0.908 . . . . 0.0 112.95 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.4 HD11 HD21 ' A' ' 69' ' ' LEU . 44.6 pt -117.41 -11.78 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.815 0.846 . . . . 0.0 112.174 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.0 36.18 72.64 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 126.078 1.799 . . . . 0.0 113.294 -175.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 48.7 mt -134.88 164.58 27.27 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 118.589 1.195 . . . . 0.0 109.894 171.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -69.99 141.29 52.98 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 127.404 2.281 . . . . 0.0 109.086 172.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.4 HD21 HD11 ' A' ' 65' ' ' ILE . 3.1 mm? -118.64 6.12 11.62 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.874 1.67 . . . . 0.0 110.005 176.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -138.88 162.23 35.32 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 125.01 1.324 . . . . 0.0 108.647 -175.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 67.27 170.65 4.7 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 -165.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -69.38 -15.72 63.37 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 123.472 0.709 . . . . 0.0 110.774 168.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -69.91 16.73 0.06 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.635 1.574 . . . . 0.0 111.71 172.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.0 tt -55.66 146.76 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 O-C-N 120.699 -1.251 . . . . 0.0 110.108 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.69 -1.4 53.11 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-O 119.664 -0.52 . . . . 0.0 113.63 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 20.1 mmtm -85.6 151.03 55.08 Favored Pre-proline 0 N--CA 1.45 -0.455 0 CA-C-N 119.447 1.624 . . . . 0.0 108.469 171.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -70.31 161.65 45.22 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 124.271 3.314 . . . . 0.0 113.191 -173.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 32.7 pt -113.16 158.9 13.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 125.56 1.544 . . . . 0.0 110.961 -175.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 59.43 -178.33 0.09 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.829 2.452 . . . . 0.0 111.17 -171.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -67.57 128.29 35.89 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 120.654 -1.278 . . . . 0.0 109.758 176.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -160.8 166.1 35.4 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 108.148 -1.981 . . . . 0.0 108.148 169.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.12 123.39 9.94 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.979 2.452 . . . . 0.0 110.445 -177.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 17.7 ptt-85 -152.45 -48.91 0.1 Allowed 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 177.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 53.39 -176.46 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.848 1.259 . . . . 0.0 111.889 -164.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 38.0 mmtt 29.1 83.55 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 128.092 2.557 . . . . 0.0 114.136 -178.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.4 m -146.05 -175.09 4.61 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.882 1.273 . . . . 0.0 109.653 170.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -65.11 154.83 49.61 Favored Glycine 0 CA--C 1.533 1.172 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 173.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -65.06 154.71 72.08 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.151 1.9 . . . . 0.0 110.064 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 58.0 m -159.48 138.85 11.3 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.036 0.934 . . . . 0.0 109.327 175.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.0 m -61.4 171.77 1.34 Allowed 'General case' 0 C--O 1.241 0.627 0 C-N-CA 125.52 1.528 . . . . 0.0 109.01 164.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.832 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 178.065 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.541 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.48 -64.09 0.36 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 167.305 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.1 m 51.99 -165.48 0.06 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.891 1.276 . . . . 0.0 111.953 -177.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 179.47 -148.16 7.98 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 106.332 -2.707 . . . . 0.0 106.332 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.4 p -63.59 152.81 37.73 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.414 0.686 . . . . 0.0 110.81 168.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.7 m -140.88 -179.18 5.92 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.645 1.578 . . . . 0.0 107.825 169.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -146.9 37.35 1.18 Allowed Glycine 0 CA--C 1.519 0.326 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.18 166.39 14.16 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 122.37 -0.488 . . . . 0.0 111.002 -174.283 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -136.99 123.29 20.61 Favored 'General case' 0 CA--C 1.512 -0.512 0 O-C-N 121.597 -0.689 . . . . 0.0 109.36 -170.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.543 HG22 HE22 ' A' ' 19' ' ' GLN . 22.0 t -69.87 115.68 9.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 177.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.0 m -136.28 157.96 45.55 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.484 0.714 . . . . 0.0 109.199 -168.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 64.94 172.18 0.2 Allowed 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 127.117 2.167 . . . . 0.0 113.222 168.016 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.0 mp0 -66.52 -55.14 16.93 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 168.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.6 t -53.8 -62.32 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 C-N-CA 125.299 1.44 . . . . 0.0 109.949 -178.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -52.36 -51.47 42.25 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-N 119.759 1.163 . . . . 0.0 112.678 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.03 -41.01 86.78 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 118.352 1.076 . . . . 0.0 111.923 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 68.1 t -70.99 -37.72 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 119.358 0.981 . . . . 0.0 110.913 176.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 40.5 mt -57.34 -56.98 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 176.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.543 HE22 HG22 ' A' ' 10' ' ' VAL . 18.0 tt0 -54.17 -54.63 37.14 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 125.191 1.396 . . . . 0.0 109.512 -176.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -51.61 -60.72 2.83 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.788 1.235 . . . . 0.0 111.137 177.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.84 -27.35 72.44 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-O 118.692 -1.06 . . . . 0.0 113.042 -170.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.421 ' HG2' HD23 ' A' ' 32' ' ' LEU . 18.9 mtm105 -59.39 -59.42 5.48 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 118.314 1.057 . . . . 0.0 108.324 167.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -57.19 -39.55 75.61 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 125.547 1.539 . . . . 0.0 112.5 -175.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 56.7 m -58.91 -40.41 84.42 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 120.004 1.274 . . . . 0.0 110.529 177.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -81.27 -2.89 50.7 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.042 0.937 . . . . 0.0 111.568 176.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.31 7.9 69.11 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 126.393 1.949 . . . . 0.0 113.207 -176.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.2 mt -83.99 147.13 27.61 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 118.033 0.917 . . . . 0.0 110.408 -165.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 62.7 p -80.43 176.16 10.02 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.265 0.626 . . . . 0.0 110.344 177.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -63.6 -42.19 98.28 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 118.799 -0.62 . . . . 0.0 110.081 168.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -55.63 -42.35 74.84 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.245 1.018 . . . . 0.0 111.661 174.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -65.34 -40.08 93.21 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.421 HD23 ' HG2' ' A' ' 22' ' ' ARG . 0.3 OUTLIER -62.52 -49.5 75.08 Favored 'General case' 0 C--N 1.344 0.336 0 C-N-CA 123.578 0.751 . . . . 0.0 109.105 176.723 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.83 -57.25 10.84 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 124.947 1.299 . . . . 0.0 108.363 -177.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 85.7 m -61.71 -34.16 75.3 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.466 0.707 . . . . 0.0 112.229 176.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.5 mttm -63.35 -15.31 57.02 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 120.832 1.651 . . . . 0.0 112.817 173.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.0 pt -120.41 6.4 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 124.731 1.212 . . . . 0.0 111.072 175.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 40.8 t30 55.65 31.09 16.64 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 128.131 2.573 . . . . 0.0 114.53 -173.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -105.68 -177.01 3.24 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 125.424 1.49 . . . . 0.0 110.918 177.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -84.81 145.66 44.49 Favored Pre-proline 0 C--O 1.228 -0.059 0 C-N-CA 126.458 1.903 . . . . 0.0 111.359 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.03 -19.76 63.69 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.798 2.332 . . . . 0.0 111.961 171.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 28.5 tp60 -64.45 -46.93 81.0 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.87 175.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.6 m -69.6 -31.56 49.3 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.731 0 O-C-N 123.766 0.666 . . . . 0.0 110.244 -173.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 23.7 mm -64.8 -44.44 96.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 O-C-N 119.953 -1.717 . . . . 0.0 110.241 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.59 -32.52 72.62 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 174.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.43 -57.32 10.64 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.765 170.201 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -52.02 -35.61 47.5 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 126.236 1.815 . . . . 0.0 112.48 -178.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.42 ' CD ' HH21 ' A' ' 22' ' ' ARG . 22.6 mt-10 -67.89 -24.47 65.23 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.076 0.853 . . . . 0.0 112.036 176.316 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.42 -32.84 28.87 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.874 1.27 . . . . 0.0 110.419 164.264 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.95 33.74 32.43 Favored Glycine 0 CA--C 1.525 0.694 0 O-C-N 121.185 -0.947 . . . . 0.0 112.573 -173.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.5 mtt85 -71.69 -60.02 2.45 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 118.29 1.045 . . . . 0.0 109.56 177.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.71 137.87 43.19 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 128.081 2.553 . . . . 0.0 108.918 173.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.9 mt -73.53 116.77 54.69 Favored Pre-proline 0 C--O 1.236 0.386 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 175.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -67.35 115.64 3.79 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 122.489 2.126 . . . . 0.0 107.29 -172.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -97.13 142.6 28.86 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -173.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -60.72 -39.26 87.94 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 119.039 -0.505 . . . . 0.0 110.357 -171.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -59.91 -26.55 66.02 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 175.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 73.2 t -93.44 -43.92 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 119.997 1.271 . . . . 0.0 109.085 177.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 26.9 mt -50.0 -46.73 53.0 Favored 'General case' 0 C--O 1.227 -0.086 0 C-N-CA 124.244 1.018 . . . . 0.0 110.105 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.98 -40.1 95.03 Favored Glycine 0 CA--C 1.535 1.336 0 CA-C-N 118.207 0.458 . . . . 0.0 113.009 176.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.6 mtmm -60.67 -42.78 97.76 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 118.794 1.297 . . . . 0.0 110.803 175.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.8 mt -67.31 -35.79 74.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 123.759 0.824 . . . . 0.0 109.515 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -58.77 -47.66 83.94 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 119.43 1.014 . . . . 0.0 109.519 175.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 16.5 mtm-85 -64.4 -20.69 66.3 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 175.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.92 -52.41 24.78 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.872 0.869 . . . . 0.0 111.478 -179.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.426 HD11 HD21 ' A' ' 69' ' ' LEU . 47.8 pt -99.96 -15.7 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.762 0.825 . . . . 0.0 111.828 -177.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.38 27.77 61.02 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 126.011 1.767 . . . . 0.0 113.563 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 77' ' ' PRO . 58.9 mt -129.38 165.42 21.55 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.883 0.873 . . . . 0.0 108.973 173.081 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -70.32 145.05 51.48 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 125.326 1.451 . . . . 0.0 109.382 175.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.426 HD21 HD11 ' A' ' 65' ' ' ILE . 3.8 mm? -118.83 16.39 13.49 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.255 1.822 . . . . 0.0 109.462 175.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -144.92 162.18 37.5 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 125.364 1.466 . . . . 0.0 108.826 -171.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 70.44 171.63 10.27 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 124.633 1.111 . . . . 0.0 110.855 -174.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -67.54 -24.7 65.57 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.351 -1.088 . . . . 0.0 109.447 165.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -73.52 21.33 0.08 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.729 2.012 . . . . 0.0 112.126 175.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.7 tt -53.54 151.68 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 O-C-N 120.734 -1.229 . . . . 0.0 110.233 172.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.61 -6.83 10.31 Favored Glycine 0 CA--C 1.536 1.397 0 O-C-N 121.118 -0.989 . . . . 0.0 114.108 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 52.9 mmtt -71.01 148.5 94.47 Favored Pre-proline 0 N--CA 1.453 -0.313 0 CA-C-N 120.022 1.911 . . . . 0.0 107.529 163.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.412 ' HA ' HD23 ' A' ' 67' ' ' LEU . 27.9 Cg_endo -71.05 158.78 54.3 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.419 2.746 . . . . 0.0 111.609 -175.345 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 17.8 pt -105.66 139.67 26.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 C-N-CA 123.589 0.756 . . . . 0.0 109.187 177.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 49.32 54.16 11.43 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.211 1.804 . . . . 0.0 110.769 176.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.3 tmtm? -127.84 107.23 9.69 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -171.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 119.53 -173.61 15.15 Favored Glycine 0 CA--C 1.533 1.156 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -177.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.19 79.87 2.83 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 125.266 3.977 . . . . 0.0 110.167 -169.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -163.3 88.51 0.58 Allowed 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 178.142 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -153.94 168.12 27.44 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 125.212 1.405 . . . . 0.0 107.973 173.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.49 10.1 9.11 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.837 0.855 . . . . 0.0 113.283 -175.454 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.8 t -130.89 170.0 15.01 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 -178.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 114.85 82.81 1.08 Allowed Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.813 1.673 . . . . 0.0 109.815 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -72.59 177.49 7.42 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.5 2.133 . . . . 0.0 112.35 -177.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.8 167.71 21.44 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.951 2.101 . . . . 0.0 106.517 161.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 25.0 t -148.15 20.7 1.1 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.458 1.903 . . . . 0.0 108.694 174.223 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.519 0 N-CA-C 106.405 -2.678 . . . . 0.0 106.405 -129.522 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.685 0 N-CA-C 108.842 -1.703 . . . . 0.0 108.842 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.7 m 64.06 -66.79 0.11 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.997 1.319 . . . . 0.0 109.777 -162.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.6 p -60.46 166.68 2.96 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.81 1.244 . . . . 0.0 111.016 158.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.97 -80.08 1.5 Allowed Glycine 0 C--N 1.333 0.386 0 N-CA-C 108.919 -1.673 . . . . 0.0 108.919 171.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.9 m 52.8 94.01 0.02 OUTLIER 'General case' 0 C--O 1.232 0.179 0 C-N-CA 127.262 2.225 . . . . 0.0 112.465 -176.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 88.0 p -142.97 140.69 31.17 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.286 1.034 . . . . 0.0 109.683 168.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 72.59 168.74 12.26 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.315 1.436 . . . . 0.0 113.069 -177.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -81.66 48.44 1.19 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.685 1.594 . . . . 0.0 110.938 -173.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -64.31 132.76 51.13 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 120.899 -1.126 . . . . 0.0 110.306 -176.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.0 m -61.94 163.89 1.24 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 123.923 0.889 . . . . 0.0 109.809 162.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.9 t -116.76 174.9 5.83 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 158.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.9 mp -65.09 160.94 19.96 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.314 1.046 . . . . 0.0 109.898 177.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -52.44 -50.74 62.0 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.289 0.636 . . . . 0.0 111.385 -173.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.7 t -52.23 -63.84 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 C-N-CA 126.433 1.893 . . . . 0.0 109.141 176.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -51.56 -41.26 49.07 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-N 118.493 0.588 . . . . 0.0 112.998 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -64.94 -51.02 64.1 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 117.287 0.544 . . . . 0.0 110.299 -178.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.7 t -66.83 -33.77 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.104 0 C-N-CA 123.299 0.639 . . . . 0.0 110.149 -178.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 59.0 mt -56.03 -58.0 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 173.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -58.61 -47.61 83.76 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 123.898 0.879 . . . . 0.0 110.806 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -60.17 -53.29 59.5 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 118.899 0.772 . . . . 0.0 111.827 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.1 -25.45 74.62 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-O 118.48 -1.178 . . . . 0.0 112.966 -174.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.617 ' HG2' HD23 ' A' ' 32' ' ' LEU . 7.8 mtm105 -54.54 -67.71 0.24 Allowed 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 119.214 1.507 . . . . 0.0 110.482 160.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -61.46 -34.2 75.04 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 123.933 0.77 . . . . 0.0 110.527 -167.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.2 t -69.7 -10.39 58.1 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.031 0.932 . . . . 0.0 111.546 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -118.46 7.41 11.88 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.933 1.693 . . . . 0.0 110.308 173.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.15 2.44 40.05 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 126.308 1.908 . . . . 0.0 114.148 -177.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 21.4 mt -67.09 119.69 12.45 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 124.779 1.231 . . . . 0.0 107.71 -176.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.2 t -71.53 173.5 7.91 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.911 168.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -53.07 -55.33 24.69 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.51 -0.744 . . . . 0.0 109.754 174.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -58.58 -27.28 64.48 Favored 'General case' 0 C--O 1.227 -0.103 0 CA-C-N 118.515 0.598 . . . . 0.0 112.239 178.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -69.13 -36.07 77.07 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.125 -0.984 . . . . 0.0 111.109 173.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.617 HD23 ' HG2' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -68.77 -48.72 62.96 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.526 0.731 . . . . 0.0 110.943 -179.634 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.56 -51.95 57.28 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.854 0.862 . . . . 0.0 109.664 174.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 83.5 m -67.6 -30.07 69.57 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 118.734 -0.65 . . . . 0.0 111.592 -179.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.8 mttm -59.98 -49.55 77.24 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 120.279 1.399 . . . . 0.0 111.138 170.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.7 pt -86.53 -6.03 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 119.302 0.955 . . . . 0.0 112.731 -176.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.7 t30 59.15 65.16 1.24 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 128.851 2.861 . . . . 0.0 112.561 -171.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -133.86 178.78 6.68 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 126.913 2.085 . . . . 0.0 110.089 176.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -79.29 151.93 75.69 Favored Pre-proline 0 N--CA 1.463 0.18 0 C-N-CA 124.73 1.212 . . . . 0.0 109.116 169.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -79.78 -11.96 13.74 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.192 1.928 . . . . 0.0 115.306 -179.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -71.82 -43.85 64.89 Favored 'General case' 0 CA--C 1.515 -0.368 0 O-C-N 120.981 -1.075 . . . . 0.0 110.075 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.6 m -67.32 -38.22 80.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 -172.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 27.6 mm -55.82 -50.66 66.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 125.796 1.639 . . . . 0.0 110.821 170.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.11 -30.73 68.33 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 122.244 -0.285 . . . . 0.0 111.36 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.2 -30.93 49.19 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 118.418 -0.801 . . . . 0.0 111.382 177.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -59.11 -43.97 91.96 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 120.026 1.285 . . . . 0.0 110.231 169.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -56.23 -40.84 74.73 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -171.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.2 m -105.2 9.27 34.14 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.66 -0.92 58.14 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.144 -1.027 . . . . 0.0 114.258 163.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 19.5 mtm180 -91.91 -21.52 20.54 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 118.941 1.371 . . . . 0.0 114.367 -174.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.72 145.81 55.56 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 166.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 26.9 mm -72.79 116.77 53.47 Favored Pre-proline 0 C--O 1.238 0.49 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 171.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.42 123.26 9.37 Favored 'Trans proline' 0 N--CA 1.445 -1.324 0 N-CA-C 108.21 -1.496 . . . . 0.0 108.21 -178.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 63.3 t-20 -131.8 122.46 25.82 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 -171.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -48.99 -34.09 12.35 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.842 1.257 . . . . 0.0 113.522 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -57.27 -35.19 69.45 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 65.6 t -93.98 -41.97 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 126.968 2.107 . . . . 0.0 109.937 176.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 76.9 mt -56.81 -39.73 74.7 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 120.457 1.48 . . . . 0.0 110.753 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.02 -38.66 93.26 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-N 118.922 0.783 . . . . 0.0 112.573 175.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 24.0 mtmm -65.39 -47.54 75.97 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 117.627 0.714 . . . . 0.0 110.574 173.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 78.1 mt -60.64 -34.6 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 123.86 0.864 . . . . 0.0 110.331 -178.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -56.57 -50.31 72.31 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.654 -0.654 . . . . 0.0 110.396 175.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.4 mtt85 -59.42 -35.37 73.87 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 118.763 0.71 . . . . 0.0 110.72 176.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.72 -32.86 70.94 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.006 1.323 . . . . 0.0 112.929 -174.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 44.4 pt -115.57 -12.15 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 123.755 0.822 . . . . 0.0 112.172 177.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.79 40.0 98.0 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 126.516 2.008 . . . . 0.0 112.648 -174.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 41.0 mt -142.78 164.31 30.44 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.711 1.256 . . . . 0.0 109.33 173.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -68.72 142.99 54.85 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 126.442 1.897 . . . . 0.0 110.902 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -117.54 4.28 12.41 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.865 2.066 . . . . 0.0 111.226 177.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 37.1 mtt-85 -138.44 163.29 32.31 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.258 1.023 . . . . 0.0 110.804 176.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.76 166.56 16.94 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 125.581 1.562 . . . . 0.0 110.09 -170.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -73.63 -7.41 51.84 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.036 -1.273 . . . . 0.0 110.296 168.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -67.53 6.94 0.54 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.729 1.612 . . . . 0.0 112.286 164.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.7 tt -51.36 142.4 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 120.151 1.342 . . . . 0.0 110.983 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.14 3.6 53.02 Favored Glycine 0 CA--C 1.537 1.452 0 O-C-N 121.637 -0.664 . . . . 0.0 114.002 -178.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 20.3 mmtt -81.46 155.09 71.67 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 120.709 2.255 . . . . 0.0 105.959 159.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -70.92 158.25 55.93 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.803 2.335 . . . . 0.0 113.072 -171.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 28.5 pt -100.96 145.98 10.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 171.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 23.83 58.97 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 127.506 2.322 . . . . 0.0 114.305 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 24.0 ttpt -61.7 -40.21 94.21 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-O 119.024 -0.512 . . . . 0.0 110.421 -164.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -142.13 171.38 24.6 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 123.802 0.715 . . . . 0.0 111.498 172.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -63.63 101.3 0.31 Allowed 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 124.746 3.631 . . . . 0.0 111.086 178.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 80.8 mtt85 47.43 -119.03 0.98 Allowed 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 125.974 1.71 . . . . 0.0 109.486 -171.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 21.3 76.76 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 128.746 2.818 . . . . 0.0 113.544 173.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -56.78 -33.33 66.53 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.279 0.631 . . . . 0.0 112.557 -172.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.8 p -148.24 174.03 12.41 Favored 'General case' 0 C--O 1.237 0.436 0 O-C-N 121.424 -0.797 . . . . 0.0 109.263 173.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 93.66 130.85 5.79 Favored Glycine 0 CA--C 1.532 1.098 0 N-CA-C 108.11 -1.996 . . . . 0.0 108.11 -169.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -68.66 163.33 37.43 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 122.242 1.961 . . . . 0.0 109.282 170.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.9 p -156.39 -66.68 0.11 Allowed 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -178.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 33.1 t -80.59 134.77 35.96 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 161.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.955 0 CA-C-O 117.276 -1.847 . . . . 0.0 108.606 164.709 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.923 0 CA-C-O 118.534 -1.148 . . . . 0.0 111.555 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.4 m 93.78 53.72 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 129.171 2.988 . . . . 0.0 111.406 174.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.7 m -141.35 166.36 24.99 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 126.072 1.749 . . . . 0.0 106.708 161.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 143.99 12.39 0.31 Allowed Glycine 0 CA--C 1.529 0.942 0 CA-C-O 118.533 -1.148 . . . . 0.0 113.88 -177.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.0 m -74.47 171.88 12.97 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 119.377 1.589 . . . . 0.0 109.655 170.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.7 t -72.92 -55.71 6.21 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 166.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 153.06 -176.92 30.98 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 -178.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -162.11 142.31 10.11 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.612 1.165 . . . . 0.0 108.438 172.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? 56.76 -172.29 0.08 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.702 1.601 . . . . 0.0 110.438 -161.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.2 m -84.22 167.1 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.558 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 156.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.1 t -81.57 158.3 24.46 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 122.548 1.166 . . . . 0.0 110.26 169.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -69.39 167.59 16.22 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.42 1.888 . . . . 0.0 109.019 164.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.09 -56.85 16.44 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.914 1.285 . . . . 0.0 111.934 173.156 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.0 t -53.89 -58.52 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 123.844 0.858 . . . . 0.0 108.728 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -51.47 -46.12 53.05 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-O 118.571 -1.127 . . . . 0.0 112.929 176.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 36.1 tttm -59.06 -53.04 62.83 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 118.874 1.337 . . . . 0.0 109.244 -178.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 92.6 t -62.67 -33.59 60.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 118.707 -0.663 . . . . 0.0 110.548 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 70.1 mt -66.16 -59.19 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 119.913 1.233 . . . . 0.0 108.634 176.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -51.59 -47.33 63.59 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 126.545 1.938 . . . . 0.0 110.209 -178.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -60.4 -66.34 0.54 Allowed 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.726 1.61 . . . . 0.0 109.994 174.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.16 -26.19 69.0 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-O 118.736 -1.036 . . . . 0.0 113.303 -169.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 19.2 mtm105 -58.13 -64.28 0.97 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.546 1.173 . . . . 0.0 109.045 165.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -69.41 -8.43 46.53 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.562 1.545 . . . . 0.0 113.571 -175.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.8 m -69.24 -13.77 62.59 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.877 1.271 . . . . 0.0 112.201 162.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -133.86 12.71 4.01 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.484 1.914 . . . . 0.0 111.475 172.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.41 4.43 17.58 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 125.292 1.425 . . . . 0.0 114.758 -175.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 25.3 mt -66.69 125.85 27.13 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 119.635 1.717 . . . . 0.0 109.431 -165.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 52.1 p -65.88 168.98 7.2 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.754 0.788 . . . . 0.0 110.248 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -64.42 -34.6 78.55 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.459 -0.776 . . . . 0.0 110.733 172.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.2 mtpt -61.33 -44.44 97.19 Favored 'General case' 0 CA--C 1.518 -0.271 0 O-C-N 121.737 -0.602 . . . . 0.0 110.976 171.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -66.23 -37.85 86.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 118.312 0.506 . . . . 0.0 110.419 -177.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.11 -51.95 67.81 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 171.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.76 -48.55 69.6 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.283 1.033 . . . . 0.0 110.151 -177.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.7 m -57.76 -46.1 84.99 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.282 1.033 . . . . 0.0 111.369 175.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.2 mttm -59.03 -22.28 60.43 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.41 1.004 . . . . 0.0 113.681 178.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.582 HG22 ' HB3' ' A' ' 60' ' ' LYS . 26.9 pt -113.41 6.05 7.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 119.534 1.061 . . . . 0.0 111.992 178.354 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 49.88 48.33 21.92 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.234 1.814 . . . . 0.0 111.156 -174.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.471 ' HG3' ' H ' ' A' ' 39' ' ' LYS . 3.1 tp10 -127.68 -171.06 2.35 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.618 1.967 . . . . 0.0 109.007 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.471 ' H ' ' HG3' ' A' ' 38' ' ' GLU . 11.0 mmpt? -103.87 146.18 32.04 Favored Pre-proline 0 CA--C 1.531 0.242 0 O-C-N 120.655 -1.278 . . . . 0.0 111.169 -174.426 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -73.19 -19.2 22.88 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.46 2.106 . . . . 0.0 114.161 -178.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -58.47 -52.31 66.18 Favored 'General case' 0 C--N 1.339 0.127 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 167.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.4 m -66.1 -29.04 45.49 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.532 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.808 -175.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 49.1 mm -61.62 -50.16 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 120.421 1.464 . . . . 0.0 110.251 174.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.24 -31.85 73.11 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 122.396 0.279 . . . . 0.0 111.589 178.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -77.08 -33.45 57.08 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 122.943 0.497 . . . . 0.0 110.405 177.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -57.69 -43.63 85.27 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 125.657 1.583 . . . . 0.0 110.016 170.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -60.06 -58.31 9.08 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.014 0.926 . . . . 0.0 109.451 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.46 -9.42 34.13 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 178.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.1 0.15 77.86 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-N 120.061 1.301 . . . . 0.0 113.457 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 72.4 mtt-85 -70.82 -43.9 67.63 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.896 1.279 . . . . 0.0 111.125 -176.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.19 139.25 58.75 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 173.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 50.3 mm -74.45 117.13 59.57 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 105.669 -1.975 . . . . 0.0 105.669 168.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -77.04 115.01 3.92 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 C-N-CA 121.223 1.282 . . . . 0.0 109.072 -171.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -81.38 131.18 35.27 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.892 1.677 . . . . 0.0 107.77 -174.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -54.8 -33.5 61.6 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.33 1.052 . . . . 0.0 113.137 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -60.97 -64.02 1.1 Allowed 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 122.1 0.952 . . . . 0.0 108.577 174.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.439 ' HA ' ' HD3' ' A' ' 60' ' ' LYS . 77.5 t -60.6 -41.11 86.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.816 1.247 . . . . 0.0 110.272 -174.008 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.2 mt -48.23 -46.22 35.11 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.047 0.939 . . . . 0.0 110.551 177.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.02 -33.56 62.41 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 118.6 0.637 . . . . 0.0 113.561 178.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.582 ' HB3' HG22 ' A' ' 36' ' ' ILE . 37.3 mtpt -64.46 -40.19 95.25 Favored 'General case' 0 N--CA 1.463 0.205 0 O-C-N 121.305 -1.115 . . . . 0.0 109.541 174.23 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.9 mt -63.64 -36.77 77.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 124.681 1.192 . . . . 0.0 108.746 174.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.458 ' HA ' HD23 ' A' ' 69' ' ' LEU . 54.6 mt-10 -57.19 -51.23 70.16 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 119.739 1.154 . . . . 0.0 110.241 174.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 60.6 mtt85 -63.18 -27.48 69.39 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.188 0.449 . . . . 0.0 111.545 175.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.1 -38.11 87.61 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.948 0.899 . . . . 0.0 112.187 179.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 22.9 pt -118.6 -9.04 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 119.134 0.879 . . . . 0.0 113.256 -176.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.44 36.36 93.28 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 126.555 2.026 . . . . 0.0 113.343 -176.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 84.7 mt -133.37 165.51 24.67 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.345 1.458 . . . . 0.0 108.156 169.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 53.3 mttm -76.25 141.88 41.57 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.615 1.566 . . . . 0.0 109.565 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.458 HD23 ' HA ' ' A' ' 62' ' ' GLU . 3.8 mm? -118.6 11.07 12.73 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 126.267 1.827 . . . . 0.0 110.968 178.46 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 5.8 mtt85 -140.22 167.9 21.06 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.254 1.422 . . . . 0.0 108.255 176.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 73.4 171.04 21.25 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.543 1.544 . . . . 0.0 111.158 -173.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.75 -13.08 60.06 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.359 -1.083 . . . . 0.0 110.163 165.259 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -75.01 18.5 0.18 Allowed 'General case' 0 CA--C 1.549 0.921 0 O-C-N 120.577 -1.327 . . . . 0.0 110.146 168.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.9 tt -53.85 148.04 2.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 O-C-N 120.301 -1.499 . . . . 0.0 110.62 173.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 67.62 -1.43 7.45 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 123.781 0.705 . . . . 0.0 113.504 -178.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 12.3 mmtp -73.69 155.12 89.28 Favored Pre-proline 0 N--CA 1.452 -0.367 0 CA-C-N 119.634 1.717 . . . . 0.0 106.968 160.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -57.22 156.64 24.32 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 122.792 2.328 . . . . 0.0 112.559 177.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 30.7 pt -100.86 153.94 4.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 154.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 25.02 61.25 0.06 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 128.214 2.605 . . . . 0.0 113.612 166.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -171.0 -30.48 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.539 1.936 . . . . 0.0 111.813 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -109.77 107.9 2.42 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-O 118.2 -1.333 . . . . 0.0 111.49 -169.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -73.77 68.32 4.67 Favored 'Trans proline' 0 CA--C 1.537 0.667 1 C-N-CA 125.42 4.08 . . . . 0.0 111.126 -177.515 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.11 116.03 9.78 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.404 1.482 . . . . 0.0 108.546 -173.01 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.3 140.99 43.22 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 123.914 0.886 . . . . 0.0 109.973 174.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 31.7 mttp -64.38 147.41 52.67 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.223 1.009 . . . . 0.0 109.16 178.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.5 t -71.07 -47.27 59.29 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 168.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -78.68 117.38 4.59 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-O 117.519 -1.711 . . . . 0.0 110.91 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -76.1 -175.2 2.4 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.971 2.447 . . . . 0.0 109.698 167.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 10.0 p -137.75 163.01 32.41 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 161.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 30.1 t -79.5 124.83 28.85 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 104.306 -2.479 . . . . 0.0 104.306 149.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.911 0 N-CA-C 104.308 -3.517 . . . . 0.0 104.308 -171.212 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.906 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.9 t -72.04 159.53 34.03 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.288 0.635 . . . . 0.0 111.157 -175.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 64.3 m -136.14 100.48 4.42 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.261 1.424 . . . . 0.0 109.276 169.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -131.28 168.18 22.21 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 164.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.7 t -159.26 -40.42 0.06 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 118.149 -0.929 . . . . 0.0 112.365 175.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.8 m 38.05 75.26 0.07 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.816 2.046 . . . . 0.0 112.726 178.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -138.09 179.83 17.88 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 124.82 1.2 . . . . 0.0 110.283 178.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -147.39 145.63 29.33 Favored 'General case' 0 C--O 1.238 0.459 0 O-C-N 121.681 -0.894 . . . . 0.0 109.01 -174.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -173.93 156.54 2.79 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.558 1.143 . . . . 0.0 111.568 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.7 p -66.0 162.38 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 123.521 0.728 . . . . 0.0 109.285 159.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.2 t -135.18 169.72 17.02 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.787 1.235 . . . . 0.0 108.851 165.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.1 mp -67.96 163.16 22.78 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 125.281 1.432 . . . . 0.0 109.367 174.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -58.18 -40.14 80.74 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-O 119.422 -0.323 . . . . 0.0 110.473 176.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.2 t -56.71 -58.26 6.27 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.316 0 C-N-CA 123.668 0.787 . . . . 0.0 109.67 177.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -56.57 -38.59 81.95 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 119.571 1.078 . . . . 0.0 112.363 178.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -62.05 -59.3 5.29 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.257 1.028 . . . . 0.0 110.096 175.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.4 t -61.35 -37.57 77.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 125.308 1.443 . . . . 0.0 110.347 -175.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 51.4 mt -53.47 -68.67 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 170.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -58.4 -34.05 70.32 Favored 'General case' 0 N--CA 1.445 -0.697 0 O-C-N 123.882 0.739 . . . . 0.0 110.8 -168.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -57.22 -69.69 0.15 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.093 1.757 . . . . 0.0 109.906 174.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.95 -32.1 73.14 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.776 -0.529 . . . . 0.0 111.776 -172.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -54.58 -62.01 1.93 Allowed 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 125.392 1.477 . . . . 0.0 108.798 172.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -63.19 -38.21 90.27 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 119.14 0.882 . . . . 0.0 111.449 -177.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 43.5 m -76.26 -2.31 30.79 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.377 0.99 . . . . 0.0 112.561 -177.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -115.55 12.86 16.25 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.256 1.022 . . . . 0.0 111.229 165.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.79 3.15 66.76 Favored Glycine 0 C--N 1.34 0.769 0 C-N-CA 128.03 2.729 . . . . 0.0 114.676 175.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.446 HD22 ' HE3' ' A' ' 35' ' ' LYS . 33.6 mt -72.95 130.16 39.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 118.781 1.29 . . . . 0.0 109.087 -159.167 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.0 p -68.51 170.75 8.52 Favored 'General case' 0 C--O 1.239 0.507 0 O-C-N 121.328 -0.858 . . . . 0.0 109.143 169.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -61.73 -30.1 70.55 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.64 -0.663 . . . . 0.0 110.408 168.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.4 mttt -71.24 -39.09 71.88 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.645 1.111 . . . . 0.0 112.3 175.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -64.65 -48.76 73.62 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.23 -47.63 78.08 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.789 0.836 . . . . 0.0 110.772 176.149 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.41 -50.39 73.86 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.536 0.734 . . . . 0.0 111.269 178.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.7 m -55.13 -47.72 74.67 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.068 1.347 . . . . 0.0 109.712 177.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.446 ' HE3' HD22 ' A' ' 27' ' ' LEU . 51.0 mttm -59.88 -15.45 21.47 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 125.453 1.501 . . . . 0.0 113.981 178.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.43 HD11 HD11 ' A' ' 43' ' ' ILE . 25.4 pt -122.35 15.43 5.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 118.998 0.817 . . . . 0.0 111.348 175.162 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.8 t30 57.53 13.14 1.75 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.166 1.386 . . . . 0.0 113.686 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -107.29 -170.87 1.77 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.762 2.025 . . . . 0.0 108.89 -173.206 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -102.51 149.65 36.9 Favored Pre-proline 0 N--CA 1.466 0.327 0 CA-C-N 120.024 1.284 . . . . 0.0 112.783 -175.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.71 -13.98 35.6 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 123.39 2.727 . . . . 0.0 112.919 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.9 tp60 -54.81 -60.15 3.76 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 123.588 0.755 . . . . 0.0 109.343 165.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.0 m -60.68 -41.09 86.93 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.52 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -172.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.43 HD11 HD11 ' A' ' 36' ' ' ILE . 44.0 mm -54.23 -47.28 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 119.252 0.933 . . . . 0.0 110.726 -178.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.8 -35.72 73.28 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.121 0.486 . . . . 0.0 112.134 176.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -79.18 -38.31 36.17 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.369 1.068 . . . . 0.0 110.992 -177.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -58.37 -39.7 80.28 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.216 1.407 . . . . 0.0 109.026 170.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -70.12 -33.09 71.41 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -178.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.2 t -73.85 -29.48 62.14 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.958 1.253 . . . . 0.0 109.41 167.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.55 10.84 49.48 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 124.002 0.81 . . . . 0.0 111.364 -174.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.7 mmt-85 -64.62 -60.93 2.55 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.258 1.023 . . . . 0.0 109.666 176.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.89 141.28 49.8 Favored 'General case' 0 C--O 1.239 0.543 0 O-C-N 124.787 1.304 . . . . 0.0 110.073 -172.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.402 HD12 ' N ' ' A' ' 52' ' ' ILE . 1.8 mp -74.14 123.99 89.66 Favored Pre-proline 0 CA--C 1.533 0.31 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 -177.241 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -67.18 114.86 3.37 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 121.561 1.508 . . . . 0.0 110.215 -178.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 -103.94 116.86 33.02 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 125.039 1.336 . . . . 0.0 108.418 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -47.27 -39.24 14.05 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.23 1.412 . . . . 0.0 113.472 -175.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -63.08 -52.97 60.59 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 118.416 0.553 . . . . 0.0 110.356 -178.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.525 ' HA ' ' HD3' ' A' ' 60' ' ' LYS . 23.9 t -63.66 -43.24 98.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 124.391 1.076 . . . . 0.0 108.36 -178.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 81.6 mt -53.7 -48.88 69.13 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-O 118.528 -0.748 . . . . 0.0 110.257 176.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.5 -34.4 69.0 Favored Glycine 0 CA--C 1.534 1.266 0 CA-C-N 119.24 0.927 . . . . 0.0 113.309 177.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.525 ' HD3' ' HA ' ' A' ' 57' ' ' VAL . 17.9 mtpp -70.57 -44.86 66.5 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.493 -1.004 . . . . 0.0 109.5 175.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.8 mt -59.62 -35.4 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.114 0 C-N-CA 124.862 1.265 . . . . 0.0 109.792 178.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -54.28 -51.76 63.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 119.039 0.836 . . . . 0.0 110.245 177.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 58.1 mtt180 -71.81 -8.4 54.05 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.493 -0.755 . . . . 0.0 112.804 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.37 -38.46 63.18 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.436 0.694 . . . . 0.0 110.719 173.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.429 HD11 HD21 ' A' ' 69' ' ' LEU . 25.7 pt -120.25 -10.51 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -172.363 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.26 33.69 83.38 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 126.628 2.061 . . . . 0.0 113.027 -178.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 67.8 mt -128.8 164.82 22.2 Favored 'General case' 0 CA--C 1.527 0.076 0 CA-C-N 118.126 0.963 . . . . 0.0 109.635 170.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -78.84 140.68 38.13 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 126.055 1.742 . . . . 0.0 108.738 174.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.429 HD21 HD11 ' A' ' 65' ' ' ILE . 4.3 mm? -120.01 -2.18 10.29 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 127.897 2.479 . . . . 0.0 110.462 -177.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.512 HH11 ' HG2' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -141.02 169.67 17.17 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.673 1.189 . . . . 0.0 109.136 176.935 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.53 164.51 18.96 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -169.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.9 ttmt -78.06 3.21 15.49 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.884 -0.774 . . . . 0.0 111.061 175.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -96.69 23.11 7.3 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.827 2.051 . . . . 0.0 110.499 171.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.3 tt -52.96 151.94 1.04 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-N 120.238 1.381 . . . . 0.0 110.763 177.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.83 -6.03 14.71 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 119.058 -0.857 . . . . 0.0 113.36 178.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 40.1 mmtt -76.02 150.97 83.85 Favored Pre-proline 0 N--CA 1.45 -0.441 0 CA-C-N 119.83 1.815 . . . . 0.0 107.744 166.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -69.99 157.15 60.87 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 123.253 2.636 . . . . 0.0 111.64 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.0 pt -101.45 148.43 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.093 0 C-N-CA 123.959 0.904 . . . . 0.0 108.775 177.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 35.42 68.86 0.19 Allowed 'General case' 0 C--O 1.237 0.445 0 C-N-CA 127.466 2.306 . . . . 0.0 111.707 175.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.0 ptpt -120.71 174.31 6.66 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 125.075 1.35 . . . . 0.0 109.169 170.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -57.55 168.62 4.52 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 123.467 0.556 . . . . 0.0 112.072 177.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.11 157.02 55.0 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.57 2.18 . . . . 0.0 110.884 -177.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -153.11 6.03 0.36 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.537 0.735 . . . . 0.0 112.022 165.252 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -171.66 -177.76 2.09 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 128.05 2.54 . . . . 0.0 106.359 177.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -143.49 -162.27 1.42 Allowed 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.49 1.116 . . . . 0.0 109.037 159.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 44.9 m 61.37 178.69 0.11 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.554 1.941 . . . . 0.0 113.945 174.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -129.86 178.49 17.44 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 160.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -75.16 -35.34 3.09 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.375 2.05 . . . . 0.0 111.429 172.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.6 m 57.74 166.89 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 128.26 2.624 . . . . 0.0 114.405 172.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 61.7 m -162.24 -25.72 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.457 1.903 . . . . 0.0 112.182 171.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.447 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 -176.793 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.698 0 CA-C-O 119.269 -0.74 . . . . 0.0 112.164 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.3 t 49.31 46.14 23.21 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.032 1.416 . . . . 0.0 109.26 -157.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.6 m -65.48 135.02 54.65 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.805 0.842 . . . . 0.0 109.607 -172.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.88 -95.96 0.95 Allowed Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 107.114 -2.394 . . . . 0.0 107.114 168.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.5 t -153.96 117.03 4.51 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.998 1.719 . . . . 0.0 107.573 177.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.0 p -141.15 135.86 31.28 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 164.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 158.03 -156.59 27.49 Favored Glycine 0 CA--C 1.521 0.447 0 CA-C-N 119.739 1.154 . . . . 0.0 112.505 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -145.83 108.58 4.51 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 126.116 1.766 . . . . 0.0 108.777 169.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.7 tpm_? -159.1 162.41 36.52 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 177.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.2 p -60.29 156.88 2.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 C-N-CA 123.749 0.82 . . . . 0.0 109.559 165.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.7 p -106.47 107.24 18.16 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 172.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.1 mp -65.16 154.07 39.06 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 118.602 -0.713 . . . . 0.0 109.215 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -41.07 -55.41 2.58 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.739 1.616 . . . . 0.0 112.201 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.2 t -56.91 -61.33 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 C-N-CA 123.473 0.709 . . . . 0.0 109.227 -178.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.37 -33.1 65.06 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-N 119.325 0.966 . . . . 0.0 113.562 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 59.2 tptt -65.31 -55.09 20.22 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 125.421 1.488 . . . . 0.0 109.768 176.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 76.8 t -63.3 -39.16 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 CA-C-N 118.586 0.63 . . . . 0.0 110.573 178.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 83.3 mt -58.6 -56.31 17.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -51.47 -53.48 36.78 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.15 0.98 . . . . 0.0 109.662 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -58.98 -54.92 41.75 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 123.21 0.319 . . . . 0.0 110.977 -178.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.28 -25.01 76.32 Favored Glycine 0 CA--C 1.523 0.556 0 O-C-N 120.701 -1.249 . . . . 0.0 113.033 -172.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.427 ' HB3' HH11 ' A' ' 22' ' ' ARG . 20.0 mtm105 -60.07 -60.6 3.57 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 119.2 1.5 . . . . 0.0 109.511 162.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -64.6 -29.67 70.68 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.96 0.904 . . . . 0.0 111.916 -169.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.2 m -57.3 -20.97 31.73 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.485 1.114 . . . . 0.0 111.831 171.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -120.12 9.89 11.26 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.446 1.899 . . . . 0.0 109.462 -176.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 73.34 -4.75 24.47 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 126.565 2.031 . . . . 0.0 114.739 -177.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 52.1 mt -70.61 152.95 43.36 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 118.815 1.307 . . . . 0.0 111.539 -159.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.403 HG23 ' H ' ' A' ' 31' ' ' ASP . 0.5 OUTLIER -93.53 167.75 11.49 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.72 1.208 . . . . 0.0 110.393 172.056 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 9.3 mp0 -50.48 -39.72 48.98 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.64 0.776 . . . . 0.0 111.852 163.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 43.4 mttt -62.25 -38.61 89.89 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 118.502 0.592 . . . . 0.0 110.884 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.403 ' H ' HG23 ' A' ' 28' ' ' THR . 81.4 m-20 -66.65 -40.8 88.84 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 122.753 0.421 . . . . 0.0 110.089 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.84 -53.9 49.48 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 125.258 1.423 . . . . 0.0 109.161 177.143 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -48.83 -57.22 6.74 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.652 1.581 . . . . 0.0 109.739 178.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 18.5 m -57.93 -39.12 77.24 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.237 1.015 . . . . 0.0 112.803 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.9 mttm -58.68 -39.67 81.38 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 119.457 1.026 . . . . 0.0 112.36 176.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.7 pt -103.3 10.61 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 123.624 0.77 . . . . 0.0 111.376 -173.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.8 t30 65.32 42.68 3.81 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.925 2.09 . . . . 0.0 113.674 176.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -135.64 -177.44 4.68 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.032 0.933 . . . . 0.0 113.149 -174.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -92.43 145.23 30.17 Favored Pre-proline 0 C--N 1.339 0.135 0 C-N-CA 125.314 1.445 . . . . 0.0 110.345 178.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.1 -6.07 18.39 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.73 2.287 . . . . 0.0 112.951 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.3 tp60 -61.35 -51.39 69.04 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 118.501 -0.761 . . . . 0.0 110.684 169.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.7 m -68.79 -29.97 45.41 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.305 0 CA-C-N 118.906 0.775 . . . . 0.0 109.468 -176.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.7 mm -64.84 -46.64 91.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 124.048 0.939 . . . . 0.0 109.942 177.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.33 -35.91 74.7 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.061 0.544 . . . . 0.0 111.112 175.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.94 -40.94 62.72 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 121.731 -0.606 . . . . 0.0 110.978 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -53.91 -47.43 71.17 Favored 'General case' 0 C--N 1.334 -0.081 0 C-N-CA 125.066 1.346 . . . . 0.0 110.331 172.129 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -57.41 -42.69 82.81 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.572 0.749 . . . . 0.0 112.03 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.1 t -78.45 -25.41 45.91 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.825 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.72 44.89 2.58 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 -174.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 15.9 mmt85 -129.76 -21.65 3.05 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 125.171 1.388 . . . . 0.0 112.793 -171.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.28 133.48 49.78 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 169.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 41.0 mm -68.91 109.18 3.83 Favored Pre-proline 0 C--O 1.237 0.432 0 N-CA-C 104.779 -2.304 . . . . 0.0 104.779 169.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -84.19 114.2 1.85 Allowed 'Trans proline' 0 N--CA 1.445 -1.359 0 N-CA-C 108.568 -1.358 . . . . 0.0 108.568 -159.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -80.84 140.31 35.48 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -63.02 -29.26 70.68 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.077 0.853 . . . . 0.0 110.798 173.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -57.88 -60.85 3.07 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.522 1.129 . . . . 0.0 109.593 173.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.479 ' HA ' ' HE3' ' A' ' 60' ' ' LYS . 59.8 t -64.68 -46.19 93.04 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.259 0 CA-C-O 118.38 -0.819 . . . . 0.0 110.098 -177.014 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 25.1 mt -48.88 -48.43 42.17 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 123.894 0.878 . . . . 0.0 109.501 172.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.56 -44.15 85.82 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 125.721 1.629 . . . . 0.0 113.687 176.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.479 ' HE3' ' HA ' ' A' ' 57' ' ' VAL . 44.6 mtmt -65.66 -42.47 91.33 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 117.762 0.781 . . . . 0.0 110.753 175.223 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.1 mt -60.75 -33.32 54.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.743 0.817 . . . . 0.0 109.307 175.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.413 ' HA ' HD23 ' A' ' 69' ' ' LEU . 30.2 mt-10 -59.36 -46.38 88.81 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.775 1.17 . . . . 0.0 110.656 174.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 40.4 mtt-85 -58.13 -40.24 80.76 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 118.698 0.681 . . . . 0.0 110.367 173.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.0 -25.18 67.49 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.523 1.529 . . . . 0.0 114.627 -171.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.54 HD11 HD21 ' A' ' 69' ' ' LEU . 26.3 pt -125.41 -12.98 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-N 119.264 0.938 . . . . 0.0 112.086 176.233 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.9 29.89 64.34 Favored Glycine 0 C--N 1.336 0.577 0 C-N-CA 126.369 1.938 . . . . 0.0 113.165 -178.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.2 mt -130.05 163.32 26.78 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.397 1.479 . . . . 0.0 109.35 174.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -73.45 143.55 46.63 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 125.198 1.399 . . . . 0.0 108.946 175.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.54 HD21 HD11 ' A' ' 65' ' ' ILE . 3.9 mm? -119.03 8.81 11.67 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.105 1.362 . . . . 0.0 110.472 178.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 34.6 mtm105 -141.03 127.61 20.11 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 121.549 -0.72 . . . . 0.0 109.272 -166.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.01 179.22 48.83 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 125.168 1.366 . . . . 0.0 112.038 176.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -64.41 -13.17 49.67 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -93.51 22.81 5.03 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.094 0.861 . . . . 0.0 109.745 177.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.1 tt -55.2 149.24 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 O-C-N 120.95 -1.093 . . . . 0.0 110.368 178.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.57 -14.22 7.26 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-O 117.681 -1.622 . . . . 0.0 113.148 178.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 32.4 mmtt -68.19 144.36 96.74 Favored Pre-proline 0 N--CA 1.452 -0.373 0 CA-C-N 120.459 2.13 . . . . 0.0 107.882 173.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -69.27 150.75 71.57 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.613 2.875 . . . . 0.0 111.648 -177.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.4 pt -101.59 147.03 8.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 C-N-CA 124.146 0.978 . . . . 0.0 109.663 -178.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 46.6 59.49 3.87 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.878 2.071 . . . . 0.0 112.225 177.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -125.14 108.28 11.62 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 172.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 151.58 -167.37 30.91 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 -177.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -60.54 171.71 3.23 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.153 1.902 . . . . 0.0 109.763 160.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.4 ttm180 -149.72 145.72 26.83 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 170.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.45 -45.09 69.91 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 170.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.9 tttm -162.24 -179.15 6.82 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.591 1.556 . . . . 0.0 107.579 178.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.5 m -132.36 -1.28 3.57 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.713 1.205 . . . . 0.0 112.74 172.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 150.95 -178.95 28.06 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 -172.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -62.1 145.88 96.31 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 121.748 1.632 . . . . 0.0 109.787 166.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 71.8 m -142.78 119.18 10.91 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 170.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.9 t -131.18 2.15 4.25 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.478 1.511 . . . . 0.0 111.921 -176.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.124 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 178.702 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.697 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.5 p -164.97 -37.75 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.769 1.228 . . . . 0.0 110.795 162.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.4 t -152.78 -26.17 0.16 Allowed 'General case' 0 C--O 1.236 0.342 0 C-N-CA 123.864 0.866 . . . . 0.0 111.795 -172.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.53 -142.95 20.58 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 108.256 -1.938 . . . . 0.0 108.256 -160.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 25.8 t -136.07 157.55 46.57 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.11 1.364 . . . . 0.0 108.211 -178.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.3 t -136.37 -167.91 2.14 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 122.489 1.138 . . . . 0.0 112.039 -171.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -149.55 170.86 29.73 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 126.653 2.073 . . . . 0.0 109.38 175.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -154.69 150.97 28.2 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 126.057 1.743 . . . . 0.0 107.414 179.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.5 mmt180 -139.5 156.81 46.69 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 123.972 0.909 . . . . 0.0 110.065 -169.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 t 48.2 42.05 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 124.748 1.219 . . . . 0.0 109.878 -177.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.8 m -64.96 147.52 53.28 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 123.308 0.643 . . . . 0.0 109.937 -174.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -54.95 148.85 12.63 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.821 1.248 . . . . 0.0 108.48 171.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -59.31 -30.37 68.29 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.671 0.669 . . . . 0.0 111.404 174.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.7 t -58.18 -62.06 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 124.24 1.016 . . . . 0.0 108.479 172.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.37 -40.13 60.52 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-N 119.394 0.997 . . . . 0.0 111.968 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -61.52 -58.14 9.33 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.098 0.949 . . . . 0.0 111.27 177.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.2 t -60.04 -36.98 70.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 123.955 0.902 . . . . 0.0 109.774 -178.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.444 HG13 HD11 ' A' ' 69' ' ' LEU . 75.4 mt -57.94 -62.27 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 174.435 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -56.14 -40.68 74.19 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 118.654 0.661 . . . . 0.0 111.411 -175.095 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -62.03 -43.93 97.79 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.511 1.524 . . . . 0.0 112.117 175.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -75.02 -33.29 55.21 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 124.742 1.163 . . . . 0.0 112.226 -176.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 15.4 mtm105 -65.71 -48.65 71.28 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 117.687 0.744 . . . . 0.0 110.216 169.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -55.5 -33.82 64.06 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.914 0.886 . . . . 0.0 112.485 175.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.1 t -64.08 -19.06 64.97 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.143 0.977 . . . . 0.0 111.701 -178.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.417 ' HE3' ' HA ' ' A' ' 65' ' ' ILE . 5.7 mtmm -130.57 7.22 4.85 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.785 1.234 . . . . 0.0 110.811 -175.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 48.58 47.31 29.79 Favored Glycine 0 C--N 1.337 0.614 0 C-N-CA 126.068 1.794 . . . . 0.0 113.127 -173.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.656 HD13 ' HE3' ' A' ' 35' ' ' LYS . 61.1 mt -101.81 119.52 38.91 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -177.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.464 HG23 ' H ' ' A' ' 31' ' ' ASP . 13.3 t -68.01 169.26 10.35 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.627 0.727 . . . . 0.0 109.462 176.305 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -64.38 -36.72 85.06 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.389 0.676 . . . . 0.0 109.842 178.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.423 ' HA ' ' HB3' ' A' ' 40' ' ' PRO . 7.4 mttt -57.4 -44.65 84.7 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.191 0.997 . . . . 0.0 113.434 167.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.464 ' H ' HG23 ' A' ' 28' ' ' THR . 2.3 m-20 -65.9 -43.53 87.93 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -176.316 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.87 -50.48 73.6 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.082 1.353 . . . . 0.0 111.387 176.118 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.23 -48.5 65.13 Favored 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 125.485 1.514 . . . . 0.0 109.981 177.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 20.5 m -61.42 -47.87 83.78 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.932 0.787 . . . . 0.0 111.508 175.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.656 ' HE3' HD13 ' A' ' 27' ' ' LEU . 50.5 mttm -55.56 -40.33 71.79 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 119.282 0.946 . . . . 0.0 111.98 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.3 pt -98.28 6.16 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 123.438 0.695 . . . . 0.0 112.256 -178.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 52.4 t30 44.46 63.94 1.5 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.488 2.315 . . . . 0.0 113.383 -173.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -138.93 -173.32 3.54 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.835 2.054 . . . . 0.0 110.114 174.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -82.55 148.16 57.78 Favored Pre-proline 0 N--CA 1.467 0.412 0 O-C-N 120.791 -1.193 . . . . 0.0 110.594 177.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.423 ' HB3' ' HA ' ' A' ' 30' ' ' LYS . 26.5 Cg_endo -66.39 -28.02 46.9 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.608 2.205 . . . . 0.0 111.872 169.378 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -67.67 -43.54 79.98 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 118.56 -0.733 . . . . 0.0 109.97 -178.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.9 m -68.37 -31.64 52.23 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.373 0 CA-C-O 117.827 -1.082 . . . . 0.0 110.69 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 41.5 mm -57.92 -49.82 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 120.093 1.315 . . . . 0.0 109.367 170.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.09 -22.92 65.08 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 121.541 -0.724 . . . . 0.0 112.622 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.67 -26.53 27.71 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 118.177 -0.916 . . . . 0.0 112.015 172.072 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -62.22 -59.09 5.54 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.395 1.452 . . . . 0.0 108.585 173.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.411 ' OE1' HG21 ' A' ' 18' ' ' ILE . 1.0 OUTLIER -52.66 -42.82 65.06 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 123.69 0.796 . . . . 0.0 112.859 176.521 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 27.3 m -66.68 -24.04 66.22 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 117.841 -1.076 . . . . 0.0 113.634 177.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.42 24.84 11.67 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 119.97 1.259 . . . . 0.0 113.732 -177.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -122.98 -30.85 3.72 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.015 1.407 . . . . 0.0 113.457 -170.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.7 132.94 49.19 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 170.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 39.4 mm -69.25 113.56 17.57 Favored Pre-proline 0 C--O 1.24 0.582 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 179.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.57 115.36 3.38 Favored 'Trans proline' 0 N--CA 1.445 -1.36 0 C-N-CA 122.648 2.232 . . . . 0.0 108.426 -175.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -95.77 147.8 23.25 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 174.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 59.6 t-20 -54.07 -45.02 71.62 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.913 1.285 . . . . 0.0 110.782 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -57.6 -52.01 67.17 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.513 0.725 . . . . 0.0 111.106 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.1 t -68.66 -40.48 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 O-C-N 121.748 -0.595 . . . . 0.0 110.635 -178.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 31.5 mt -51.49 -43.37 62.18 Favored 'General case' 0 C--O 1.22 -0.469 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 171.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.13 -39.59 97.35 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-N 119.169 0.895 . . . . 0.0 112.841 175.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -63.85 -44.48 93.03 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 119.185 1.492 . . . . 0.0 110.046 175.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.3 mt -64.34 -35.46 74.24 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.095 0 C-N-CA 124.984 1.314 . . . . 0.0 110.162 178.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.406 ' HA ' HD23 ' A' ' 69' ' ' LEU . 94.4 mt-10 -58.63 -51.0 71.76 Favored 'General case' 0 CA--C 1.512 -0.497 0 O-C-N 121.509 -0.744 . . . . 0.0 109.524 177.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -58.64 -40.1 82.44 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-O 118.789 -0.624 . . . . 0.0 110.804 176.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.18 -26.43 60.61 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.507 1.523 . . . . 0.0 113.895 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.424 HD11 HD21 ' A' ' 69' ' ' LEU . 16.9 pt -114.55 -15.02 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 119.74 1.155 . . . . 0.0 112.353 173.192 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.74 27.83 70.15 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 127.847 2.642 . . . . 0.0 113.597 -174.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.9 mt -136.56 158.58 44.11 Favored 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 124.842 1.257 . . . . 0.0 109.36 -179.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -66.65 139.99 57.89 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 125.598 1.559 . . . . 0.0 109.572 176.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.444 HD11 HG13 ' A' ' 18' ' ' ILE . 4.3 mm? -114.54 0.87 14.13 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.472 1.509 . . . . 0.0 109.972 171.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 53.2 mtm180 -135.42 142.39 45.61 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.863 1.265 . . . . 0.0 108.161 -169.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.62 163.03 12.34 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -173.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -73.41 -1.77 19.63 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.564 -0.962 . . . . 0.0 113.379 -175.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -77.44 16.07 0.68 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.883 0.765 . . . . 0.0 111.174 165.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.1 tt -50.3 135.54 9.3 Favored 'Isoleucine or valine' 0 C--O 1.242 0.706 0 CA-C-N 120.091 1.314 . . . . 0.0 110.699 -175.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.46 -3.85 71.29 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-O 119.541 -0.588 . . . . 0.0 113.537 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 20.0 mmtm -74.86 150.13 85.95 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 120.655 2.227 . . . . 0.0 107.202 163.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -66.14 157.96 57.04 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.951 2.434 . . . . 0.0 111.992 -174.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 17.8 pt -101.34 138.41 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 168.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 38.32 -23.78 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.736 1 C-N-CA 134.266 5.027 . . . . 0.0 120.789 178.122 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.7 mmtp -67.58 170.34 7.83 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 121.607 2.003 . . . . 0.0 109.058 176.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -55.78 142.33 37.98 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-O 119.233 -0.759 . . . . 0.0 112.282 -166.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.44 155.95 67.32 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.009 2.473 . . . . 0.0 110.437 -178.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 22.6 ttt-85 -162.82 29.75 0.1 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.532 0.733 . . . . 0.0 110.671 174.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -132.61 174.76 9.95 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.028 0.931 . . . . 0.0 109.607 176.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.49 138.52 43.54 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.541 1.136 . . . . 0.0 108.645 174.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 43.6 t 176.2 155.76 0.22 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.969 2.508 . . . . 0.0 105.957 -177.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -103.46 101.71 2.09 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 117.988 -1.451 . . . . 0.0 109.505 176.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.48 167.49 20.58 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 CA-C-N 120.736 2.268 . . . . 0.0 111.966 177.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.7 p -146.26 -178.6 6.23 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 125.493 1.517 . . . . 0.0 109.287 174.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 13.7 t -153.37 162.41 41.31 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.54 1.536 . . . . 0.0 107.793 175.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.118 0 N-CA-C 107.886 -2.085 . . . . 0.0 107.886 149.881 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.64 0 N-CA-C 107.352 -2.299 . . . . 0.0 107.352 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.9 m 52.21 169.58 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 122.052 0.93 . . . . 0.0 111.644 -133.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.8 t -150.82 -177.55 6.06 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 150.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -127.34 178.17 17.07 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 124.164 0.888 . . . . 0.0 113.072 -170.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.9 m -135.86 -51.25 0.72 Allowed 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.667 1.187 . . . . 0.0 110.019 172.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 46.3 p -148.44 159.99 43.49 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.528 0.603 . . . . 0.0 110.784 -178.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 152.15 15.6 0.07 OUTLIER Glycine 0 CA--C 1.53 0.998 0 CA-C-O 118.324 -1.264 . . . . 0.0 113.429 -166.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 81.38 136.8 0.06 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 129.66 3.184 . . . . 0.0 110.697 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 26.9 mtt-85 -160.4 171.61 18.77 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 127.377 2.271 . . . . 0.0 109.178 178.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . 0.327 0.8 OUTLIER 55.4 -153.68 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 130.796 3.638 . . . . 0.0 110.478 -175.211 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.29 1.6 p 52.57 -157.02 0.15 Allowed 'General case' 0 C--O 1.239 0.526 0 C-N-CA 126.192 1.797 . . . . 0.0 111.824 174.31 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 74.52 157.98 0.2 Allowed 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 126.845 2.058 . . . . 0.0 114.102 164.29 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -98.21 -61.99 1.3 Allowed 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.416 165.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 49.7 t -54.26 -56.73 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 120.054 1.297 . . . . 0.0 110.669 -173.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -54.71 -42.37 77.75 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-O 119.129 -0.817 . . . . 0.0 113.041 176.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.478 ' HE3' ' HA ' ' A' ' 16' ' ' LYS . 1.8 tpmt? -62.5 -48.5 79.3 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 118.599 1.199 . . . . 0.0 110.177 177.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.518 HG21 HG12 ' A' ' 74' ' ' ILE . 74.9 t -61.43 -43.09 96.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 124.536 1.134 . . . . 0.0 109.589 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.5 mt -59.51 -52.98 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 C-N-CA 124.324 1.05 . . . . 0.0 108.624 177.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -54.79 -50.18 69.13 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.267 1.427 . . . . 0.0 110.262 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -58.74 -56.2 25.32 Favored 'General case' 0 C--O 1.227 -0.109 0 C-N-CA 124.915 1.286 . . . . 0.0 111.31 178.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.5 -23.18 76.07 Favored Glycine 0 CA--C 1.52 0.403 0 CA-C-O 118.678 -1.068 . . . . 0.0 112.395 -171.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.4 mtm105 -60.6 -64.36 0.98 Allowed 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 119.178 1.489 . . . . 0.0 108.805 164.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -56.71 -37.74 71.34 Favored 'General case' 0 CA--C 1.52 -0.196 0 O-C-N 124.199 0.937 . . . . 0.0 111.098 -171.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.3 t -65.96 -13.84 60.5 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.812 -0.555 . . . . 0.0 111.52 -175.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -126.91 8.37 6.78 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.143 2.177 . . . . 0.0 110.212 -173.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.83 5.13 50.69 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 125.506 1.527 . . . . 0.0 114.221 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 19.7 mt -71.36 120.39 16.87 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 119.258 1.529 . . . . 0.0 108.882 -168.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 69.4 p -66.01 174.35 2.54 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.661 -0.65 . . . . 0.0 109.778 170.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -66.81 -41.35 87.67 Favored 'General case' 0 C--O 1.231 0.127 0 O-C-N 120.217 -1.552 . . . . 0.0 109.849 174.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.1 tttp -64.67 -25.33 67.9 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.11 0.564 . . . . 0.0 111.589 177.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -72.07 -45.37 60.98 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.437 0.695 . . . . 0.0 109.97 172.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.16 -46.85 88.27 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.374 0.534 . . . . 0.0 109.807 176.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.34 -50.37 65.15 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 125.232 1.413 . . . . 0.0 109.788 175.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.2 m -56.21 -49.63 73.56 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.367 1.067 . . . . 0.0 110.55 175.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -59.94 -16.12 27.38 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 124.935 1.294 . . . . 0.0 114.432 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.508 HD11 HD11 ' A' ' 43' ' ' ILE . 15.8 pt -126.82 9.39 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 119.807 1.185 . . . . 0.0 110.997 177.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.1 m120 54.88 30.7 14.34 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.042 1.737 . . . . 0.0 112.282 179.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -102.45 178.89 4.46 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.487 1.515 . . . . 0.0 110.318 -176.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -77.35 137.3 64.21 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 173.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -67.93 -22.47 42.21 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.488 2.125 . . . . 0.0 111.971 176.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 48.5 tp60 -61.65 -43.18 99.35 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.547 -0.721 . . . . 0.0 110.923 173.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.0 m -73.87 -28.16 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 119.013 0.824 . . . . 0.0 110.737 -176.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.508 HD11 HD11 ' A' ' 36' ' ' ILE . 37.4 mm -56.67 -48.21 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 119.298 0.954 . . . . 0.0 109.691 169.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.5 -35.53 70.34 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 123.43 0.457 . . . . 0.0 111.179 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -83.21 -23.18 32.91 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.551 0.741 . . . . 0.0 112.605 -177.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -62.23 -35.89 80.29 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.901 0.773 . . . . 0.0 109.801 166.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -70.48 -36.67 73.98 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.302 0.956 . . . . 0.0 111.627 175.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.4 m -66.73 -32.29 73.49 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.36 0.527 . . . . 0.0 111.876 173.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.46 7.28 57.05 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 124.82 1.2 . . . . 0.0 112.518 -172.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -78.52 -57.09 3.95 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.76 1.624 . . . . 0.0 110.822 -173.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.29 146.86 42.41 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 124.012 0.82 . . . . 0.0 109.078 -175.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 25.6 mm -68.84 122.06 83.62 Favored Pre-proline 0 C--O 1.237 0.406 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 -178.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.91 113.3 3.73 Favored 'Trans proline' 0 N--CA 1.444 -1.409 0 N-CA-C 106.148 -2.289 . . . . 0.0 106.148 171.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -125.56 138.78 53.96 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 118.878 -0.582 . . . . 0.0 109.721 -171.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -52.25 -46.28 65.7 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.999 1.32 . . . . 0.0 112.99 -165.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -55.39 -50.89 68.55 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -178.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.531 ' HA ' ' HD3' ' A' ' 60' ' ' LYS . 94.3 t -74.38 -47.87 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 124.785 1.234 . . . . 0.0 109.891 -174.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 42.5 mt -45.33 -49.65 12.69 Favored 'General case' 0 C--O 1.225 -0.218 0 C-N-CA 125.126 1.37 . . . . 0.0 110.378 175.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.76 -44.49 80.52 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 123.646 0.641 . . . . 0.0 113.184 176.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.531 ' HD3' ' HA ' ' A' ' 57' ' ' VAL . 17.6 mtpp -68.69 -38.24 80.16 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 121.771 -0.841 . . . . 0.0 109.125 -178.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.5 mt -62.4 -39.72 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 C-N-CA 123.777 0.831 . . . . 0.0 109.471 174.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -59.36 -48.99 79.55 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 119.649 1.113 . . . . 0.0 109.299 176.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 26.4 mtm105 -64.15 -18.58 64.58 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.371 0.668 . . . . 0.0 112.408 176.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.25 -55.74 5.7 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.727 1.211 . . . . 0.0 109.941 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.1 pt -91.76 -24.18 5.56 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 123.111 0.565 . . . . 0.0 110.746 -176.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.38 32.6 34.13 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 125.284 1.421 . . . . 0.0 112.593 -174.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.0 mt -135.72 163.41 30.25 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.057 1.743 . . . . 0.0 109.161 175.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 71.8 mttt -74.93 144.47 43.24 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 125.314 1.445 . . . . 0.0 110.776 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -118.69 16.95 13.63 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 127.323 2.249 . . . . 0.0 109.494 174.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -135.95 163.91 29.19 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 126.678 1.991 . . . . 0.0 109.449 -178.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 66.62 177.11 8.03 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 124.971 1.272 . . . . 0.0 112.11 176.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.8 tptt -72.89 -10.17 59.51 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.447 -1.031 . . . . 0.0 111.149 168.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -78.92 11.96 2.41 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.767 1.627 . . . . 0.0 111.616 172.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.518 HG12 HG21 ' A' ' 17' ' ' VAL . 5.3 tt -53.66 140.02 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 119.736 1.153 . . . . 0.0 110.704 -179.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.24 -10.79 40.46 Favored Glycine 0 CA--C 1.533 1.178 0 CA-C-O 117.743 -1.587 . . . . 0.0 114.078 -176.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 33.2 mmtt -66.53 151.76 95.82 Favored Pre-proline 0 C--N 1.345 0.373 0 CA-C-N 120.608 2.204 . . . . 0.0 107.768 166.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -58.04 158.93 19.76 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 123.76 2.973 . . . . 0.0 112.549 175.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 24.7 pt -101.87 141.96 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 165.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 37.26 72.38 0.12 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.743 2.417 . . . . 0.0 112.702 177.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 24.3 mtmm -56.04 -43.21 77.63 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 117.878 -1.058 . . . . 0.0 112.573 -176.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -131.97 -177.26 14.8 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 177.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -73.47 99.39 1.13 Allowed 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.958 2.439 . . . . 0.0 109.719 176.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.2 mmt85 -140.39 75.49 1.51 Allowed 'General case' 0 C--O 1.237 0.429 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -106.33 -179.74 4.03 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.04 1.336 . . . . 0.0 110.558 177.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 49.2 pttt -117.26 -43.17 2.85 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.798 1.239 . . . . 0.0 109.603 172.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.7 m 55.23 59.34 4.03 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.565 1.146 . . . . 0.0 111.963 166.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -123.71 69.33 0.46 Allowed Glycine 0 CA--C 1.527 0.837 0 CA-C-O 118.391 -1.227 . . . . 0.0 110.414 177.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -61.11 153.36 65.09 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 123.253 2.635 . . . . 0.0 110.988 -178.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.3 p -123.13 51.58 1.44 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.72 1.208 . . . . 0.0 109.403 -171.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.7 p -71.02 109.88 5.38 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.918 1.287 . . . . 0.0 110.49 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.847 0 N-CA-C 106.827 -2.509 . . . . 0.0 106.827 162.621 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.691 0 CA-C-O 121.661 0.59 . . . . 0.0 111.89 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.5 m -104.95 161.82 13.87 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 165.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.29 -26.27 66.45 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.465 -0.772 . . . . 0.0 112.474 -178.064 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.8 171.38 47.05 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 124.525 1.059 . . . . 0.0 110.647 -175.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 t -78.42 96.33 5.33 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.065 0.946 . . . . 0.0 108.905 -176.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.0 m -125.02 72.9 1.25 Allowed 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.252 1.421 . . . . 0.0 109.156 176.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.41 -176.55 44.71 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 -170.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -147.17 -53.3 0.22 Allowed 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.739 0.816 . . . . 0.0 108.832 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 58.04 154.5 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 130.263 3.425 . . . . 0.0 115.472 177.175 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.7 t 41.0 65.94 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 125.779 1.632 . . . . 0.0 107.716 -168.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.6 p -57.67 103.07 0.11 Allowed 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 174.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.3 mp -58.96 162.48 4.17 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 176.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 56.1 mp0 -51.46 -48.45 62.79 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 118.288 -0.863 . . . . 0.0 112.192 -174.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 55.8 t -59.12 -59.59 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 119.384 0.993 . . . . 0.0 110.138 179.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -55.52 -45.65 83.6 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-N 119.994 1.27 . . . . 0.0 113.267 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 49.7 tttp -56.75 -54.65 43.78 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 118.846 1.323 . . . . 0.0 109.462 175.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.2 t -61.94 -37.53 78.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 123.207 0.603 . . . . 0.0 110.586 -177.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 69.5 mt -61.16 -61.67 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 175.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -53.01 -45.56 67.99 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.209 1.404 . . . . 0.0 110.076 -175.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -59.9 -58.78 7.09 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.884 1.674 . . . . 0.0 111.749 175.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -52.48 -51.38 43.46 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.441 ' HB3' HH11 ' A' ' 22' ' ' ARG . 11.9 mtm105 -48.38 -61.86 1.79 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.179 0.992 . . . . 0.0 109.742 175.611 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -57.56 -33.39 68.09 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 124.344 1.057 . . . . 0.0 112.22 -177.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.89 -28.93 64.91 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.851 1.205 . . . . 0.0 111.703 -172.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -94.73 2.69 55.55 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.177 0.898 . . . . 0.0 111.832 167.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 61.51 43.7 98.96 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 110.816 -0.913 . . . . 0.0 110.816 -176.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 68.3 mt -109.97 159.58 17.15 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.163 1.385 . . . . 0.0 108.324 178.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.9 t -116.38 169.32 9.4 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.787 1.235 . . . . 0.0 110.046 -170.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -55.24 -44.25 75.34 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.527 1.131 . . . . 0.0 110.739 174.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.25 -39.67 72.95 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 118.347 -0.835 . . . . 0.0 111.769 173.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -75.76 -37.28 59.42 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 119.558 1.072 . . . . 0.0 111.158 -176.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.408 HD23 ' HG2' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -59.67 -49.05 79.23 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.78 1.232 . . . . 0.0 108.744 173.123 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.7 -49.33 73.29 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.15 1.38 . . . . 0.0 109.656 178.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.8 m -58.66 -44.87 90.27 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.812 0.733 . . . . 0.0 110.928 174.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.8 mttm -62.2 -27.29 68.87 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 117.295 -1.336 . . . . 0.0 113.263 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.53 HG22 ' HB3' ' A' ' 60' ' ' LYS . 28.0 pt -107.95 6.19 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 120.461 1.482 . . . . 0.0 112.578 176.353 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 56.5 t30 48.63 62.21 2.68 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.101 1.76 . . . . 0.0 112.738 -172.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -133.42 179.88 5.93 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 126.982 2.113 . . . . 0.0 109.242 176.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 25.0 mmtp -87.01 153.24 54.35 Favored Pre-proline 0 N--CA 1.47 0.551 0 C-N-CA 124.692 1.197 . . . . 0.0 109.796 169.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.68 -26.64 39.1 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.26 1.974 . . . . 0.0 111.391 176.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.0 tp60 -60.5 -29.81 69.31 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.01 0.924 . . . . 0.0 112.514 178.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.6 m -79.72 -35.35 16.38 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.37 0 CA-C-N 119.439 1.018 . . . . 0.0 109.81 174.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.403 HD11 HD11 ' A' ' 36' ' ' ILE . 29.8 mm -60.72 -44.74 97.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 120.273 1.397 . . . . 0.0 110.056 179.283 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.58 -30.36 65.2 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 176.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -89.09 -24.93 22.16 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.98 0.912 . . . . 0.0 111.854 178.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -62.9 -44.39 96.23 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 120.029 1.286 . . . . 0.0 108.917 166.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -59.92 -43.57 94.84 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.22 0.608 . . . . 0.0 110.582 172.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.2 m -66.3 -37.45 85.44 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.636 0.653 . . . . 0.0 111.815 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.74 29.37 8.21 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -169.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -111.11 -29.21 7.97 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.409 1.483 . . . . 0.0 111.477 -171.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.42 178.36 2.95 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.655 0.782 . . . . 0.0 110.082 170.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.4 mm -109.75 113.69 57.38 Favored Pre-proline 0 C--O 1.237 0.423 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -78.31 115.61 3.74 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 123.375 2.716 . . . . 0.0 109.298 -175.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -118.92 144.61 46.34 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.296 1.439 . . . . 0.0 108.958 -175.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.4 m-20 -48.33 -45.42 35.27 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.6 1.56 . . . . 0.0 111.942 -171.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -63.87 -52.15 61.32 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -173.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.433 ' HA ' ' HD3' ' A' ' 60' ' ' LYS . 8.9 t -64.1 -47.74 88.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-O 117.834 -1.079 . . . . 0.0 108.931 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.412 HD13 ' HD3' ' A' ' 70' ' ' ARG . 25.7 mt -46.6 -56.46 6.03 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 125.405 1.482 . . . . 0.0 109.625 174.11 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.13 -33.68 70.61 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 123.627 0.632 . . . . 0.0 113.559 178.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.53 ' HB3' HG22 ' A' ' 36' ' ' ILE . 23.8 mtpp -71.11 -46.67 61.23 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 118.746 1.273 . . . . 0.0 109.228 177.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.7 mt -61.82 -35.9 70.55 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.08 0 C-N-CA 124.542 1.137 . . . . 0.0 109.414 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -57.13 -50.52 72.55 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 176.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.457 ' HA ' HD11 ' A' ' 78' ' ' ILE . 61.0 mtt180 -58.48 -38.31 77.33 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 120.832 -1.168 . . . . 0.0 111.449 173.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.46 -25.91 60.42 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.229 1.012 . . . . 0.0 113.713 -176.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.415 HD11 HD21 ' A' ' 69' ' ' LEU . 45.5 pt -120.87 -10.73 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 124.323 1.049 . . . . 0.0 111.984 175.224 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.39 28.56 72.4 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 126.891 2.186 . . . . 0.0 113.337 -176.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.451 HD23 ' HA ' ' A' ' 77' ' ' PRO . 69.3 mt -138.27 163.18 32.42 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.419 1.488 . . . . 0.0 107.752 -178.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -86.41 143.13 27.96 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 126.778 2.031 . . . . 0.0 112.335 -170.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.415 HD21 HD11 ' A' ' 65' ' ' ILE . 4.1 mm? -118.98 6.53 11.35 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.756 1.622 . . . . 0.0 111.004 -176.167 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.412 ' HD3' HD13 ' A' ' 58' ' ' LEU . 81.5 mtm180 -141.8 156.92 45.55 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.789 1.236 . . . . 0.0 109.454 -177.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 73.98 172.39 26.3 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.505 1.05 . . . . 0.0 111.823 -174.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -65.4 -16.11 63.28 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.9 -0.765 . . . . 0.0 110.896 171.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.44 9.31 0.48 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.313 1.445 . . . . 0.0 111.913 173.335 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.5 tt -54.11 129.87 15.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 121.42 1.918 . . . . 0.0 110.009 -177.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.97 -15.44 59.39 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-O 118.743 -1.032 . . . . 0.0 114.404 -177.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.3 mtmt -68.24 152.4 96.55 Favored Pre-proline 0 N--CA 1.444 -0.748 0 CA-C-N 119.235 1.518 . . . . 0.0 107.765 170.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.451 ' HA ' HD23 ' A' ' 67' ' ' LEU . 28.2 Cg_endo -71.91 157.96 53.78 Favored 'Trans proline' 0 N--CA 1.447 -1.228 0 C-N-CA 122.724 2.283 . . . . 0.0 111.082 -174.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.457 HD11 ' HA ' ' A' ' 63' ' ' ARG . 10.5 pt -101.53 129.1 53.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 105.512 -2.032 . . . . 0.0 105.512 165.012 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 31.19 59.32 0.26 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.821 2.048 . . . . 0.0 113.114 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -60.07 140.81 56.61 Favored 'General case' 0 C--N 1.344 0.356 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -174.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -120.64 -116.98 2.53 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 107.901 -2.079 . . . . 0.0 107.901 -178.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -65.48 160.8 41.11 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 122.475 2.117 . . . . 0.0 111.262 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 61.15 83.22 0.15 Allowed 'General case' 0 C--O 1.234 0.251 0 C-N-CA 126.07 1.748 . . . . 0.0 110.813 175.347 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.36 144.42 16.56 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 114.816 -1.083 . . . . 0.0 109.025 164.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.5 tmtt? -157.0 93.49 1.35 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 178.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 26.2 p -72.66 115.02 11.43 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -175.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -156.09 73.53 0.24 Allowed Glycine 0 N--CA 1.447 -0.579 0 CA-C-O 117.682 -1.621 . . . . 0.0 111.444 -173.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -71.1 179.93 4.02 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.894 2.396 . . . . 0.0 110.709 170.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 26.1 p -114.01 -71.72 0.74 Allowed 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.47 1.108 . . . . 0.0 109.944 -177.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 49.2 m -62.0 -40.59 96.19 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 119.038 -0.506 . . . . 0.0 111.058 177.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.779 0 C-N-CA 126.326 1.917 . . . . 0.0 109.129 179.091 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.665 0 N-CA-C 112.41 -0.276 . . . . 0.0 112.41 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.9 p -55.36 136.97 48.86 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 122.159 0.981 . . . . 0.0 110.832 -176.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 56.1 m -79.01 97.54 6.12 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 176.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -64.44 91.07 0.1 OUTLIER Glycine 0 CA--C 1.523 0.545 0 N-CA-C 108.127 -1.989 . . . . 0.0 108.127 167.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.2 m 67.17 -52.81 0.48 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 129.184 2.994 . . . . 0.0 113.693 -172.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . 0.277 66.1 p 50.41 15.84 0.24 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.739 2.016 . . . . 0.0 113.62 -164.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -93.49 -161.96 35.98 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 126.607 2.051 . . . . 0.0 111.678 -171.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 61.61 159.38 0.06 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 128.378 2.671 . . . . 0.0 113.758 -178.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -130.5 -11.15 4.02 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 120.985 -1.072 . . . . 0.0 113.846 172.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.7 t -92.29 77.13 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 124.006 0.922 . . . . 0.0 109.097 -164.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.5 p -137.28 149.59 47.2 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 123.572 0.749 . . . . 0.0 110.074 177.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.9 mp -63.06 146.72 52.64 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 172.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -62.02 -36.88 82.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 118.371 -0.823 . . . . 0.0 112.797 -167.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.9 t -55.8 -61.12 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 171.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.56 -34.23 49.25 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-O 118.379 -1.234 . . . . 0.0 113.369 177.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -73.07 -48.38 36.45 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 119.405 1.603 . . . . 0.0 110.89 178.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 79.1 t -59.77 -40.01 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 118.945 0.793 . . . . 0.0 109.006 176.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.408 HG21 ' OE1' ' A' ' 47' ' ' GLU . 53.1 mt -58.17 -59.17 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 174.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -54.15 -45.9 72.14 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.151 0.58 . . . . 0.0 110.467 -177.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -54.94 -63.74 1.06 Allowed 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.071 1.349 . . . . 0.0 110.55 174.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.48 -34.95 87.67 Favored Glycine 0 CA--C 1.519 0.308 0 CA-C-N 119.002 0.819 . . . . 0.0 112.714 -172.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.518 HH21 ' HG2' ' A' ' 47' ' ' GLU . 27.1 mtm105 -62.74 -56.25 19.31 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 117.881 0.841 . . . . 0.0 109.125 173.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -54.97 -40.9 70.53 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.094 1.358 . . . . 0.0 111.467 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.7 m -66.63 -41.2 88.71 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.985 0.811 . . . . 0.0 109.484 -176.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 37.8 mtpt -84.21 -1.12 54.58 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.027 0.931 . . . . 0.0 112.682 177.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.39 16.38 64.95 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.503 1.049 . . . . 0.0 113.216 -175.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 43.1 mt -79.25 154.89 28.84 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 119.105 1.452 . . . . 0.0 109.694 -176.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 82.8 p -92.99 170.21 9.83 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.847 0.859 . . . . 0.0 110.718 175.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -60.45 -38.57 84.58 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.326 -0.859 . . . . 0.0 110.407 165.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.06 -38.59 83.27 Favored 'General case' 0 C--O 1.231 0.129 0 O-C-N 121.67 -0.644 . . . . 0.0 111.252 175.201 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -67.09 -35.1 79.07 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 117.968 0.349 . . . . 0.0 110.469 176.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.401 HD22 ' HB1' ' A' ' 64' ' ' ALA . 0.1 OUTLIER -65.24 -49.78 68.33 Favored 'General case' 0 CA--C 1.529 0.14 0 O-C-N 121.545 -0.722 . . . . 0.0 109.172 178.131 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.93 -44.9 64.09 Favored 'General case' 0 CA--C 1.522 -0.117 0 C-N-CA 124.701 1.2 . . . . 0.0 109.9 176.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 43.9 m -62.85 -52.22 63.96 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.619 1.167 . . . . 0.0 109.927 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -58.68 -20.78 51.44 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.203 1.401 . . . . 0.0 114.297 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.4 pt -115.15 2.66 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 123.809 0.844 . . . . 0.0 111.937 177.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.8 t30 50.97 55.6 9.3 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.275 1.83 . . . . 0.0 112.878 -175.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -128.11 -175.69 3.57 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 127.344 2.258 . . . . 0.0 109.725 175.106 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.75 146.55 37.25 Favored Pre-proline 0 N--CA 1.464 0.226 0 O-C-N 120.81 -1.181 . . . . 0.0 110.223 174.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -66.34 -16.86 52.93 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.57 2.18 . . . . 0.0 114.242 178.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -61.55 -43.21 99.27 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 119.413 1.006 . . . . 0.0 110.829 172.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.4 m -63.71 -32.6 57.53 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.412 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.132 -176.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 25.2 mm -63.28 -46.51 95.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 124.754 1.221 . . . . 0.0 109.648 177.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.21 -40.1 67.32 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.928 -0.483 . . . . 0.0 111.146 174.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -79.7 -28.45 40.65 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.392 0.677 . . . . 0.0 112.566 -178.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -62.91 -52.28 63.66 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.405 1.082 . . . . 0.0 108.918 171.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.518 ' HG2' HH21 ' A' ' 22' ' ' ARG . 0.7 OUTLIER -60.07 -42.71 95.15 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 175.563 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.6 t -66.97 -37.82 84.94 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 124.043 0.839 . . . . 0.0 110.713 -177.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.94 3.12 20.11 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 118.596 -1.113 . . . . 0.0 114.269 -175.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 49.4 mtm180 -102.86 -14.28 16.63 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.453 1.626 . . . . 0.0 113.764 -170.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.72 151.66 41.39 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 119.665 1.12 . . . . 0.0 108.458 174.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.2 mm -79.6 116.17 58.84 Favored Pre-proline 0 C--O 1.236 0.354 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 165.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -70.78 141.92 42.22 Favored 'Trans proline' 0 N--CA 1.448 -1.175 0 N-CA-C 108.897 -1.232 . . . . 0.0 108.897 175.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -136.34 150.33 48.8 Favored 'General case' 0 CA--C 1.513 -0.445 0 O-C-N 121.472 -0.767 . . . . 0.0 110.064 169.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -55.29 -41.65 72.59 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 125.106 1.362 . . . . 0.0 111.149 -175.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -52.98 -60.06 3.75 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.412 1.085 . . . . 0.0 110.051 175.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.578 ' HA ' ' HD3' ' A' ' 60' ' ' LYS . 41.1 t -64.87 -51.08 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-O 118.285 -0.864 . . . . 0.0 109.713 -176.205 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 71.9 mt -44.38 -50.69 9.07 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 124.922 1.289 . . . . 0.0 110.804 175.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.77 -36.07 92.19 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 118.691 0.678 . . . . 0.0 113.126 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.578 ' HD3' ' HA ' ' A' ' 57' ' ' VAL . 16.2 mtpp -68.67 -44.25 74.48 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 118.7 1.25 . . . . 0.0 108.96 175.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.428 HG21 HD13 ' A' ' 61' ' ' ILE . 61.5 mt -59.1 -35.73 58.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 123.493 0.717 . . . . 0.0 109.362 177.109 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.426 ' HA ' HD23 ' A' ' 69' ' ' LEU . 48.6 mt-10 -57.45 -44.45 84.76 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 119.642 1.11 . . . . 0.0 109.859 176.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -73.01 -13.89 61.31 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.541 1.136 . . . . 0.0 113.199 178.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.401 ' HB1' HD22 ' A' ' 32' ' ' LEU . . . -73.33 -41.61 63.29 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.294 1.038 . . . . 0.0 111.455 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 36.0 pt -116.56 -16.69 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.293 1.037 . . . . 0.0 111.552 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.44 30.22 46.08 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 125.793 1.663 . . . . 0.0 113.091 -178.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 77' ' ' PRO . 74.5 mt -123.72 163.12 21.75 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 118.486 1.143 . . . . 0.0 109.427 173.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.0 mttm -72.09 131.91 43.48 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 127.411 2.284 . . . . 0.0 108.252 172.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 62' ' ' GLU . 4.1 mm? -112.67 7.98 18.87 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 126.666 1.986 . . . . 0.0 110.206 176.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.47 161.69 39.89 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 126.832 2.053 . . . . 0.0 107.634 -175.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 70.17 160.49 3.03 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.165 0.888 . . . . 0.0 111.166 -168.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -63.73 -11.99 30.94 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 120.929 -1.336 . . . . 0.0 111.203 173.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.22 6.46 1.68 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.04 1.736 . . . . 0.0 111.35 173.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.9 tt -48.98 136.27 5.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-N 121.241 1.837 . . . . 0.0 110.909 -173.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.06 -11.62 66.67 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 124.001 0.81 . . . . 0.0 113.992 -177.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 49.7 mmtt -74.4 150.32 87.09 Favored Pre-proline 0 N--CA 1.452 -0.35 0 CA-C-N 119.271 1.536 . . . . 0.0 108.477 169.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 22.5 Cg_endo -70.8 161.99 44.15 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.309 2.672 . . . . 0.0 111.733 -177.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.7 pt -101.27 108.63 23.82 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 178.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 58.62 104.81 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 127.784 2.434 . . . . 0.0 113.883 177.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.5 mptt 70.53 -167.85 0.16 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.028 2.131 . . . . 0.0 109.425 -167.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.93 175.58 36.52 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 123.95 0.786 . . . . 0.0 114.629 169.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -66.18 105.92 0.92 Allowed 'Trans proline' 0 C--N 1.349 0.576 1 C-N-CA 126.095 4.53 . . . . 0.0 112.365 -171.524 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 46.1 ttt180 -81.36 -24.83 36.79 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.706 0.802 . . . . 0.0 112.388 -170.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -82.14 163.86 21.69 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.792 0.724 . . . . 0.0 110.074 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.8 pttp -155.1 172.42 18.17 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.752 1.221 . . . . 0.0 111.808 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 39.9 t -139.01 169.84 17.07 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 127.305 2.242 . . . . 0.0 105.786 162.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 137.38 156.47 7.27 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 170.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -82.26 48.99 2.98 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 124.489 3.46 . . . . 0.0 111.942 -173.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.6 m -119.6 104.42 10.27 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 105.747 -1.945 . . . . 0.0 105.747 177.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.6 p -81.24 92.4 6.33 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.565 0 CA-C-O 117.351 -1.805 . . . . 0.0 109.34 -175.884 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.573 0 CA-C-O 120.172 -0.238 . . . . 0.0 112.563 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.0 m -141.67 170.52 15.56 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 125.211 1.404 . . . . 0.0 109.894 175.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 71.3 m 45.71 69.71 0.43 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.773 2.029 . . . . 0.0 112.883 -177.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.25 171.01 38.04 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 110.969 -0.853 . . . . 0.0 110.969 172.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -165.43 159.73 17.26 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 125.667 1.587 . . . . 0.0 108.829 178.377 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.7 p -73.68 161.42 30.28 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.219 0.608 . . . . 0.0 109.552 163.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.26 153.4 49.46 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 170.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -137.38 141.78 41.74 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.109 0.964 . . . . 0.0 109.149 173.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.434 ' HG2' ' H ' ' A' ' 10' ' ' VAL . 16.2 ttp85 56.74 -165.45 0.14 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.836 1.254 . . . . 0.0 110.737 -174.088 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.434 ' H ' ' HG2' ' A' ' 9' ' ' ARG . 27.0 m -78.51 116.57 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -174.084 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.2 p -71.66 107.79 4.68 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.162 0.585 . . . . 0.0 109.522 -178.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -56.19 155.1 7.03 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.442 1.097 . . . . 0.0 109.916 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -44.45 -57.93 3.27 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.647 1.579 . . . . 0.0 111.925 177.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 52.5 t -58.37 -57.06 12.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -178.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.14 -35.39 77.1 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 118.885 0.766 . . . . 0.0 113.191 -178.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.2 tptt -68.59 -52.75 28.24 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 124.001 0.92 . . . . 0.0 110.011 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 67.0 t -61.61 -36.52 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 49.1 mt -57.98 -60.12 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-O 118.161 -0.923 . . . . 0.0 108.924 173.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -53.8 -50.99 64.89 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.976 0.807 . . . . 0.0 109.905 -177.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -56.45 -48.47 76.98 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 126.345 1.858 . . . . 0.0 112.283 -178.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.99 -36.73 45.79 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-O 118.668 -1.073 . . . . 0.0 111.175 -175.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.483 ' HG2' HD23 ' A' ' 32' ' ' LEU . 15.4 mtm105 -56.77 -55.85 29.07 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 118.571 1.185 . . . . 0.0 109.763 170.151 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -50.78 -49.45 58.27 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 126.284 1.833 . . . . 0.0 110.883 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.6 m -63.63 -5.75 4.43 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.562 0.745 . . . . 0.0 112.412 -174.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -130.93 4.53 4.49 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.698 1.999 . . . . 0.0 110.638 -175.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.81 15.67 60.37 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.134 1.349 . . . . 0.0 113.546 -175.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 42.1 mt -73.73 127.08 31.84 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 119.086 1.443 . . . . 0.0 109.042 -170.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.4 p -67.57 169.54 9.12 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.697 0.761 . . . . 0.0 109.79 168.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -61.68 -34.55 75.93 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 120.999 -1.063 . . . . 0.0 110.086 166.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.89 -34.53 71.67 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-O 117.485 -1.245 . . . . 0.0 111.696 176.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -57.66 -51.76 68.19 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 119.787 1.176 . . . . 0.0 108.013 176.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.483 HD23 ' HG2' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -57.88 -48.23 80.44 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.882 0.873 . . . . 0.0 110.019 -176.967 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.07 -49.71 65.83 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.157 1.383 . . . . 0.0 110.202 177.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.1 m -60.66 -44.78 96.04 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.156 0.982 . . . . 0.0 111.174 175.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.8 mttm -53.19 -28.68 27.78 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.453 1.101 . . . . 0.0 112.208 175.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.576 HG22 ' HB3' ' A' ' 60' ' ' LYS . 20.3 pt -112.66 7.71 8.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 124.202 1.001 . . . . 0.0 113.079 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.16 21.77 5.49 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 127.027 2.131 . . . . 0.0 113.311 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.78 173.23 6.66 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.547 1.139 . . . . 0.0 109.853 -173.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -71.43 139.56 84.22 Favored Pre-proline 0 CA--C 1.53 0.204 0 C-N-CA 124.182 0.993 . . . . 0.0 110.93 -173.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -74.78 -10.73 21.73 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.451 2.767 . . . . 0.0 112.373 177.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.2 tp60 -58.84 -57.64 12.16 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 163.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.0 m -67.14 -24.32 31.9 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 CA-C-O 119.077 -0.487 . . . . 0.0 111.102 -169.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 43.6 mm -63.22 -47.68 91.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 124.489 1.116 . . . . 0.0 111.475 171.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.06 -36.62 84.92 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 122.562 0.345 . . . . 0.0 110.574 176.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.45 -31.69 65.66 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.201 0.6 . . . . 0.0 111.363 177.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -58.82 -38.32 78.38 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 125.341 1.456 . . . . 0.0 111.82 170.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -60.81 -58.83 6.8 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.019 0.528 . . . . 0.0 110.361 178.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.3 p -66.63 -27.11 67.43 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -176.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.21 8.11 56.75 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-O 119.856 -0.414 . . . . 0.0 112.281 -170.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 21.0 mtm180 -69.17 -38.12 78.54 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 118.288 1.044 . . . . 0.0 110.369 172.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.67 138.29 48.5 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.8 mm -76.62 126.25 86.28 Favored Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 168.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -68.76 158.83 56.23 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 121.645 1.563 . . . . 0.0 109.851 177.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 -136.51 137.26 40.12 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 171.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -54.51 -34.42 61.66 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.446 1.099 . . . . 0.0 110.925 -179.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -61.95 -58.26 8.58 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.566 0.746 . . . . 0.0 109.773 178.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 83.9 t -66.97 -46.15 85.51 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.453 0 CA-C-O 117.402 -1.285 . . . . 0.0 109.151 -176.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 62.3 mt -44.72 -56.17 4.67 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 120.794 1.634 . . . . 0.0 110.895 169.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.18 -14.19 52.36 Favored Glycine 0 CA--C 1.536 1.39 0 CA-C-N 118.566 0.621 . . . . 0.0 114.007 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.576 ' HB3' HG22 ' A' ' 36' ' ' ILE . 22.7 mtpp -89.39 -46.74 8.5 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 125.557 1.543 . . . . 0.0 110.444 171.147 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.0 mt -53.47 -37.5 30.26 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.191 0 C-N-CA 124.532 1.133 . . . . 0.0 108.698 175.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -55.95 -54.47 44.38 Favored 'General case' 0 C--O 1.223 -0.327 0 C-N-CA 119.65 -0.82 . . . . 0.0 111.343 175.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 23.6 mtm180 -69.35 -7.58 38.63 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.977 0.808 . . . . 0.0 112.738 176.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.35 -27.1 35.06 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.264 1.025 . . . . 0.0 111.686 176.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.541 HD11 HD21 ' A' ' 69' ' ' LEU . 16.1 pt -127.71 -11.55 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.026 0.93 . . . . 0.0 112.934 -178.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 66.06 39.09 94.59 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 126.02 1.771 . . . . 0.0 112.132 -174.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 77' ' ' PRO . 61.9 mt -132.02 162.81 29.85 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 124.336 1.054 . . . . 0.0 109.311 170.085 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -74.26 140.12 44.77 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 126.013 1.725 . . . . 0.0 108.538 174.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.541 HD21 HD11 ' A' ' 65' ' ' ILE . 3.4 mm? -117.46 11.17 13.79 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.937 1.295 . . . . 0.0 109.839 178.118 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 27.2 mtm105 -140.14 161.57 37.32 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.716 1.206 . . . . 0.0 109.418 178.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.12 169.47 24.98 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 124.327 0.965 . . . . 0.0 110.874 -175.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.658 ' H ' ' HD3' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -68.42 -17.64 64.26 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 121.772 -0.84 . . . . 0.0 111.38 170.772 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -77.95 15.03 0.95 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.375 1.47 . . . . 0.0 110.792 173.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.3 tt -52.55 142.35 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 O-C-N 120.888 -1.132 . . . . 0.0 110.084 175.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.56 0.03 57.23 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-O 117.577 -1.68 . . . . 0.0 113.948 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 33.7 mmtt -77.33 154.53 81.99 Favored Pre-proline 0 N--CA 1.453 -0.321 0 CA-C-N 119.893 1.846 . . . . 0.0 107.46 157.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 18.6 Cg_endo -70.32 163.68 37.83 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 123.266 2.644 . . . . 0.0 112.852 -179.319 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.0 pt -112.15 170.34 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 C-N-CA 126.192 1.797 . . . . 0.0 108.507 172.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 67.04 161.29 0.16 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.3 1.84 . . . . 0.0 110.227 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -82.3 80.04 8.6 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 120.018 -1.676 . . . . 0.0 109.535 179.188 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -148.17 120.87 1.26 Allowed Glycine 0 CA--C 1.525 0.68 0 N-CA-C 107.357 -2.297 . . . . 0.0 107.357 161.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -76.01 66.88 6.84 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.647 2.898 . . . . 0.0 110.077 174.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.2 mmp_? -72.13 177.9 4.14 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.657 1.183 . . . . 0.0 108.269 165.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 8.39 92.47 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 128.658 2.783 . . . . 0.0 113.942 162.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -75.56 67.84 2.12 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 166.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.2 m -76.93 149.57 36.01 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 156.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -171.51 78.63 0.09 OUTLIER Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 107.268 -2.333 . . . . 0.0 107.268 -175.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -62.16 170.03 6.94 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.085 1.857 . . . . 0.0 111.175 178.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.3 t -145.96 148.84 33.19 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.45 1.1 . . . . 0.0 108.311 175.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.9 m -144.87 159.7 42.47 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.233 1.013 . . . . 0.0 110.294 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.168 0 N-CA-C 105.729 -2.948 . . . . 0.0 105.729 163.32 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 . . . . . 0 C--O 1.225 -0.199 0 CA-C-O 119.149 -0.453 . . . . 0.0 111.322 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.8 t -57.51 -54.73 27.26 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.253 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 171.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.4 -44.18 93.65 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-N 118.388 0.54 . . . . 0.0 112.372 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -59.68 -56.93 15.76 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 117.631 -1.176 . . . . 0.0 109.636 175.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 69.3 t -58.84 -36.07 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 120.357 1.435 . . . . 0.0 110.375 -178.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.6 mt -57.3 -59.24 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 174.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -57.11 -48.31 78.94 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.753 1.221 . . . . 0.0 110.784 -178.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -62.87 -46.38 88.13 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 125.123 1.369 . . . . 0.0 111.636 -176.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.39 -35.73 63.28 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-O 118.816 -0.991 . . . . 0.0 111.493 178.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.621 ' HG2' HD23 ' A' ' 32' ' ' LEU . 13.1 mtm105 -54.82 -61.61 2.2 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 118.049 0.924 . . . . 0.0 109.211 170.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -62.39 -30.82 71.47 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.131 0.972 . . . . 0.0 111.663 -172.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.8 m -63.88 -16.87 62.43 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 118.92 -0.562 . . . . 0.0 112.422 175.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -124.22 11.42 8.78 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.891 2.076 . . . . 0.0 110.314 -176.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.33 13.97 31.66 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.514 1.054 . . . . 0.0 114.678 -176.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 44.4 mt -78.36 119.95 22.42 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 119.945 1.873 . . . . 0.0 108.845 -170.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 62.1 p -64.67 168.9 5.5 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.557 0.694 . . . . 0.0 110.362 172.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -62.91 -34.51 77.58 Favored 'General case' 0 N--CA 1.464 0.258 0 O-C-N 120.424 -1.422 . . . . 0.0 110.428 174.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.93 -33.02 63.79 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.186 0.594 . . . . 0.0 109.73 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -63.65 -39.44 94.35 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.641 1.11 . . . . 0.0 109.557 171.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.621 HD23 ' HG2' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -64.89 -52.81 54.51 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 123.917 0.887 . . . . 0.0 110.312 179.848 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.93 -43.24 63.35 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 124.679 1.192 . . . . 0.0 110.403 177.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 60.7 m -60.11 -52.39 65.57 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.998 0.919 . . . . 0.0 110.379 174.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.3 mttm -57.23 -25.28 58.84 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 119.24 0.927 . . . . 0.0 113.196 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.3 pt -113.81 5.16 7.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 118.972 0.806 . . . . 0.0 112.227 -176.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.9 m120 54.5 54.94 8.62 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.524 1.529 . . . . 0.0 109.537 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -128.59 -178.6 4.65 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 126.922 2.089 . . . . 0.0 109.168 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 51.7 mmtt -81.02 149.73 67.22 Favored Pre-proline 0 C--N 1.333 -0.148 0 C-N-CA 123.853 0.861 . . . . 0.0 109.546 167.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.48 -11.5 26.46 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.668 2.245 . . . . 0.0 112.115 167.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -59.49 -57.94 10.77 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.952 1.301 . . . . 0.0 109.448 169.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.9 m -63.92 -33.27 61.02 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.556 0 CA-C-O 118.128 -0.939 . . . . 0.0 110.689 -173.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 42.8 mm -60.5 -46.51 95.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 120.166 1.348 . . . . 0.0 110.044 176.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.08 -28.91 69.95 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.169 0.587 . . . . 0.0 112.356 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -85.23 -38.46 18.9 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.846 0.858 . . . . 0.0 110.61 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -54.98 -40.98 70.64 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 126.328 1.851 . . . . 0.0 110.537 173.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -58.68 -42.94 89.66 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.82 0.848 . . . . 0.0 112.084 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 9.0 m -75.41 -35.32 61.02 Favored 'General case' 0 C--N 1.331 -0.207 0 O-C-N 122.097 -0.377 . . . . 0.0 110.222 175.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.85 46.34 3.17 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 -168.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 21.2 mtm-85 -128.42 -0.35 5.63 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 125.272 1.429 . . . . 0.0 113.309 -177.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -89.48 175.76 7.17 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 161.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 48.8 mm -93.8 112.66 57.87 Favored Pre-proline 0 C--O 1.239 0.541 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 171.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -77.49 115.51 3.91 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 123.138 2.558 . . . . 0.0 108.064 -177.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -113.84 142.5 46.01 Favored 'General case' 0 CA--C 1.517 -0.317 0 O-C-N 121.695 -0.628 . . . . 0.0 109.674 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -58.24 -26.23 62.64 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.791 0.836 . . . . 0.0 113.146 -171.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -62.91 -57.61 10.21 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.98 0.912 . . . . 0.0 110.528 173.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.2 t -68.68 -43.75 82.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 118.409 -0.805 . . . . 0.0 109.573 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 54.5 mt -49.48 -46.84 48.65 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.08 0.855 . . . . 0.0 110.337 171.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.99 -43.2 95.12 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 123.998 0.809 . . . . 0.0 112.722 176.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -61.8 -45.65 92.92 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 118.373 1.087 . . . . 0.0 110.796 174.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.0 mt -61.47 -33.69 58.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 C-N-CA 123.939 0.896 . . . . 0.0 110.324 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -56.8 -51.3 69.49 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 119.538 1.063 . . . . 0.0 110.419 176.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 52.5 mtt180 -54.12 -42.03 69.02 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.27 0.628 . . . . 0.0 109.874 177.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.04 -42.22 68.94 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.72 1.608 . . . . 0.0 113.09 -173.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 45.7 pt -114.74 -16.94 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 123.593 0.757 . . . . 0.0 112.167 -174.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.57 25.18 54.61 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 125.09 1.328 . . . . 0.0 113.052 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 77' ' ' PRO . 61.6 mt -130.59 162.95 28.18 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.081 1.352 . . . . 0.0 109.434 179.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 47.6 mttm -77.16 146.3 37.17 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 127.16 2.184 . . . . 0.0 110.312 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -121.32 5.03 10.24 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.512 1.525 . . . . 0.0 112.223 -175.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 66.3 mtm180 -139.59 163.5 32.39 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.681 1.592 . . . . 0.0 109.909 171.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.38 167.76 43.78 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 125.831 1.681 . . . . 0.0 109.538 -171.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -71.36 -9.76 58.67 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.455 -1.027 . . . . 0.0 110.137 163.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -75.09 8.17 2.78 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.547 1.939 . . . . 0.0 110.791 170.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.4 tt -52.54 141.46 6.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 O-C-N 120.275 -1.516 . . . . 0.0 110.279 175.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.3 -4.61 54.58 Favored Glycine 0 CA--C 1.537 1.428 0 CA-C-O 119.04 -0.867 . . . . 0.0 113.838 -177.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.5 mmtt -66.29 146.79 99.05 Favored Pre-proline 0 N--CA 1.454 -0.267 0 CA-C-N 119.877 1.839 . . . . 0.0 107.934 159.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.432 ' HA ' HD23 ' A' ' 67' ' ' LEU . 33.5 Cg_endo -70.43 162.11 43.59 Favored 'Trans proline' 0 N--CA 1.447 -1.262 0 C-N-CA 123.441 2.76 . . . . 0.0 111.222 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.1 pt . . . . . 0 C--N 1.332 -0.155 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 172.459 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 . . . . . 0 C--O 1.226 -0.144 0 CA-C-O 119.875 -0.107 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.5 t -55.68 -58.38 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 123.575 0.75 . . . . 0.0 109.389 173.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.31 -40.02 95.42 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 118.891 0.769 . . . . 0.0 112.666 -178.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.36 -54.44 45.66 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.563 1.145 . . . . 0.0 110.242 176.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.4 t -63.25 -38.24 81.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 C-N-CA 123.618 0.767 . . . . 0.0 110.268 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 52.0 mt -56.81 -56.71 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.065 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 175.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -52.61 -55.28 23.44 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.194 0.598 . . . . 0.0 110.115 -178.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.23 -41.94 98.87 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.138 0.575 . . . . 0.0 111.468 -174.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.34 -41.61 45.05 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-O 119.204 -0.775 . . . . 0.0 111.396 -176.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.545 ' HG2' HD23 ' A' ' 32' ' ' LEU . 14.1 mtm105 -52.5 -60.11 3.64 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 117.669 0.734 . . . . 0.0 109.514 171.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.72 -31.33 72.47 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 123.702 0.626 . . . . 0.0 110.953 -171.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.8 t -64.2 -25.03 67.89 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.029 0.532 . . . . 0.0 111.77 176.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -112.98 13.08 19.44 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.913 1.285 . . . . 0.0 111.226 178.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.31 13.4 43.16 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.221 0.915 . . . . 0.0 113.446 -178.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 54.4 mt -74.04 118.89 17.52 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -171.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 27.0 p -65.72 174.3 2.4 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.626 0.726 . . . . 0.0 109.564 171.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -68.6 -37.16 79.58 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 120.747 -1.22 . . . . 0.0 110.137 174.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -64.86 -35.3 80.67 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 119.246 0.93 . . . . 0.0 111.612 172.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.63 -51.54 69.35 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 118.973 0.806 . . . . 0.0 109.048 176.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.545 HD23 ' HG2' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -60.81 -50.76 72.15 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 124.332 1.053 . . . . 0.0 109.888 -177.024 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -49.64 -52.36 31.28 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.092 1.357 . . . . 0.0 110.2 175.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.0 m -58.25 -44.54 88.38 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.857 0.863 . . . . 0.0 112.439 175.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.3 mttp -59.71 -16.29 26.02 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.445 1.02 . . . . 0.0 112.764 176.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.485 HG22 ' HB3' ' A' ' 60' ' ' LYS . 18.9 pt -117.69 8.97 7.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 124.808 1.243 . . . . 0.0 111.886 173.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.6 t30 55.12 6.78 0.15 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 128.494 2.718 . . . . 0.0 115.609 -174.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -102.64 -171.0 1.88 Allowed 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 124.537 1.135 . . . . 0.0 109.216 -171.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.413 ' O ' HG22 ' A' ' 42' ' ' VAL . 69.6 mmtt -95.87 141.36 23.05 Favored Pre-proline 0 N--CA 1.464 0.263 0 O-C-N 120.743 -1.223 . . . . 0.0 113.359 -168.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.09 -20.82 43.59 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.175 2.583 . . . . 0.0 112.585 -177.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.4 tp60 -56.82 -44.0 81.59 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 117.74 -1.124 . . . . 0.0 110.696 167.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.413 HG22 ' O ' ' A' ' 39' ' ' LYS 0.273 12.1 m -67.15 -36.1 75.99 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.345 0 CA-C-N 120.116 1.325 . . . . 0.0 109.917 179.812 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 42.1 mm -59.3 -49.01 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 119.827 1.194 . . . . 0.0 109.931 177.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.34 -36.59 71.36 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.24 -41.61 48.63 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.738 1.615 . . . . 0.0 111.827 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -57.94 -45.96 85.81 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.103 1.361 . . . . 0.0 108.81 175.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -55.17 -38.22 68.02 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.479 0.711 . . . . 0.0 111.392 175.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.52 2.24 56.49 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -179.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.15 13.21 77.65 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-N 120.27 1.396 . . . . 0.0 113.026 174.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -87.98 -57.52 2.9 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.671 1.588 . . . . 0.0 108.082 -169.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.52 142.62 48.42 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.76 0.824 . . . . 0.0 110.136 -177.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.8 mt -69.47 119.51 71.14 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 168.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.54 135.41 24.11 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.257 1.971 . . . . 0.0 109.149 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -133.8 132.78 40.88 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.008 0.923 . . . . 0.0 109.136 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -40.39 -46.18 2.33 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.647 1.979 . . . . 0.0 112.358 176.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -51.01 -48.88 61.32 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.377 0.671 . . . . 0.0 111.22 -178.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.501 ' HA ' ' HD3' ' A' ' 60' ' ' LYS . 58.2 t -79.73 -48.05 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 125.819 1.648 . . . . 0.0 108.636 -178.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 88.6 mt -50.46 -40.01 49.59 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.497 1.044 . . . . 0.0 111.742 177.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.17 -28.75 72.49 Favored Glycine 0 CA--C 1.526 0.768 0 O-C-N 121.036 -1.04 . . . . 0.0 112.47 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.501 ' HD3' ' HA ' ' A' ' 57' ' ' VAL . 18.9 mtpp -73.51 -47.51 40.53 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 124.619 1.168 . . . . 0.0 108.213 173.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.9 mt -58.1 -39.34 72.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 123.704 0.801 . . . . 0.0 110.32 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -60.32 -42.66 96.04 Favored 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 118.869 -1.132 . . . . 0.0 110.644 -178.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -66.78 -37.04 83.8 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 118.84 0.746 . . . . 0.0 111.447 174.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.66 -36.25 64.4 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.941 1.696 . . . . 0.0 111.946 -177.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 24.5 pt -113.25 -19.1 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 118.999 0.818 . . . . 0.0 112.029 176.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.74 30.08 60.29 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 125.506 1.526 . . . . 0.0 113.061 -176.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' A' ' 77' ' ' PRO . 29.9 mt -132.56 161.45 33.79 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 124.839 1.256 . . . . 0.0 108.3 173.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -71.32 141.12 50.47 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 125.499 1.52 . . . . 0.0 109.408 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -115.88 -1.34 12.6 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.721 1.608 . . . . 0.0 109.506 175.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.4 mtm105 -132.76 142.05 48.82 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.537 1.535 . . . . 0.0 108.491 -177.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.59 167.49 36.62 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 125.135 1.35 . . . . 0.0 111.104 -178.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -70.59 -12.14 61.38 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 121.687 -0.89 . . . . 0.0 111.396 172.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -82.04 16.91 1.73 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.106 2.162 . . . . 0.0 111.267 171.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.2 tt -52.06 141.88 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 O-C-N 120.613 -1.305 . . . . 0.0 110.161 176.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.97 -10.06 10.23 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-O 118.762 -1.021 . . . . 0.0 114.065 -177.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.3 mmtt -70.78 151.06 95.29 Favored Pre-proline 0 N--CA 1.453 -0.294 0 CA-C-N 120.843 2.321 . . . . 0.0 106.016 161.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.455 ' HA ' HD23 ' A' ' 67' ' ' LEU . 14.1 Cg_endo -67.96 157.02 63.66 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.863 2.376 . . . . 0.0 111.246 -174.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 25.9 pt . . . . . 0 C--O 1.234 0.242 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 161.198 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 . . . . . 0 CA--C 1.533 0.32 0 CA-C-O 119.091 -0.48 . . . . 0.0 110.737 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 63.4 t -58.62 -66.38 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 125.028 1.331 . . . . 0.0 109.695 174.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.59 -29.41 40.07 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 119.182 0.901 . . . . 0.0 113.498 -177.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.7 tttt -72.58 -55.51 6.79 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 117.654 -1.165 . . . . 0.0 110.701 175.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.3 t -58.84 -39.26 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 120.101 1.319 . . . . 0.0 110.28 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 86.4 mt -54.96 -61.21 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 175.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -63.35 -39.9 95.81 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 -172.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -58.25 -46.82 85.26 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.688 1.595 . . . . 0.0 111.381 176.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.94 -43.74 81.46 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -178.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.9 mtm105 -54.89 -59.55 4.57 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 117.341 0.57 . . . . 0.0 110.54 173.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -58.89 -33.05 70.07 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.636 0.775 . . . . 0.0 110.885 -176.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.0 t -68.31 -8.45 39.82 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 118.23 -0.891 . . . . 0.0 113.395 177.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -132.37 7.88 4.25 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 120.363 1.438 . . . . 0.0 111.505 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 57.19 32.15 63.01 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-N 118.793 0.724 . . . . 0.0 112.174 -173.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 44.8 mt -85.38 119.78 26.13 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.7 t -73.88 171.71 12.9 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.143 0.883 . . . . 0.0 109.964 176.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -61.68 -37.64 84.87 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 120.364 -1.46 . . . . 0.0 110.841 176.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.4 mttp -59.28 -32.6 70.18 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.078 0.854 . . . . 0.0 112.684 170.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -70.32 -39.25 74.87 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 119.422 1.01 . . . . 0.0 108.604 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.68 -48.02 76.28 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -50.89 -51.2 54.15 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 126.221 1.808 . . . . 0.0 109.455 177.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 60.1 m -61.49 -47.29 86.3 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.985 1.314 . . . . 0.0 111.037 177.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.6 mttm -64.21 -20.49 66.06 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 26.6 pt -111.34 -2.33 10.25 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.356 0 CA-C-N 120.179 1.354 . . . . 0.0 111.214 174.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 53.5 t30 44.92 71.5 0.26 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.695 1.598 . . . . 0.0 112.466 -167.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -140.26 177.65 7.84 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 127.36 2.264 . . . . 0.0 109.179 166.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 28.2 mtmt -79.38 141.48 57.18 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 124.061 0.944 . . . . 0.0 111.916 177.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -66.51 -11.13 30.4 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.41 2.74 . . . . 0.0 115.227 -178.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 42.4 tp60 -75.89 -27.79 57.85 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 120.699 1.591 . . . . 0.0 111.379 169.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 m -68.1 -35.8 72.93 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.413 0 CA-C-N 120.832 1.651 . . . . 0.0 108.293 173.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 33.6 mm -59.67 -50.44 79.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 C-N-CA 124.207 1.003 . . . . 0.0 110.078 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.4 -32.11 73.45 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.928 -0.483 . . . . 0.0 112.089 176.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.82 -27.98 61.39 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 120.798 -1.189 . . . . 0.0 110.97 175.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -69.46 -37.7 77.43 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.653 1.581 . . . . 0.0 110.87 175.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -55.29 -56.8 15.93 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 167.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.5 m -66.58 -19.88 65.88 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.22 1.008 . . . . 0.0 113.46 -172.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.34 -10.31 73.37 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 123.773 0.702 . . . . 0.0 114.5 -175.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 28.9 mtt-85 -77.23 -21.21 54.13 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 118.199 1.0 . . . . 0.0 112.39 -174.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.14 115.22 19.58 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 105.264 -2.125 . . . . 0.0 105.264 168.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.2 mm -69.1 113.73 18.49 Favored Pre-proline 0 C--O 1.238 0.47 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 -171.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -77.33 114.57 3.77 Favored 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 121.783 1.655 . . . . 0.0 110.563 -163.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -110.5 144.23 39.65 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.945 0.898 . . . . 0.0 109.539 -174.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -53.41 -40.46 65.12 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -171.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -52.51 -60.63 3.0 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.052 0.941 . . . . 0.0 109.662 177.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.579 ' HA ' ' HD3' ' A' ' 60' ' ' LYS . 70.9 t -65.96 -44.8 92.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-O 118.328 -0.844 . . . . 0.0 109.49 -175.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.7 mt -51.3 -44.79 61.98 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.783 0.72 . . . . 0.0 110.2 176.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.82 -43.96 94.46 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.024 0.821 . . . . 0.0 113.068 175.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.579 ' HD3' ' HA ' ' A' ' 57' ' ' VAL . 15.8 mtpp -65.23 -42.88 92.94 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 121.304 -1.115 . . . . 0.0 109.651 178.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.2 mt -60.81 -32.99 53.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 123.563 0.745 . . . . 0.0 109.271 176.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.465 ' HA ' HD23 ' A' ' 69' ' ' LEU . 38.3 mt-10 -58.49 -49.03 78.84 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 120.078 1.308 . . . . 0.0 110.212 178.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 48.5 mtt85 -68.6 -20.91 64.52 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.606 -0.684 . . . . 0.0 112.496 175.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.27 -54.81 41.31 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.405 HD11 HD21 ' A' ' 69' ' ' LEU . 50.2 pt -100.22 -18.07 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -176.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.19 20.87 58.25 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 125.871 1.701 . . . . 0.0 113.533 -177.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 77' ' ' PRO . 60.8 mt -125.47 161.73 26.46 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 125.14 1.376 . . . . 0.0 108.913 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -72.18 139.78 48.41 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 125.244 1.418 . . . . 0.0 109.226 177.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 62' ' ' GLU . 3.2 mm? -119.72 -1.39 10.57 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.218 1.807 . . . . 0.0 110.961 177.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.3 mmm180 -125.46 155.14 40.95 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 119.496 1.044 . . . . 0.0 108.68 170.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.13 159.93 6.63 Favored Glycine 0 N--CA 1.447 -0.613 0 O-C-N 124.843 1.339 . . . . 0.0 110.573 -178.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -73.18 -4.24 31.66 Favored 'General case' 0 N--CA 1.464 0.273 0 O-C-N 121.001 -1.293 . . . . 0.0 112.131 -176.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -73.32 12.4 0.59 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.849 0.749 . . . . 0.0 110.572 162.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.7 tt -48.56 134.03 5.96 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 CA-C-N 120.269 1.395 . . . . 0.0 109.125 176.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.32 -4.76 66.15 Favored Glycine 0 CA--C 1.538 1.521 0 CA-C-O 119.155 -0.803 . . . . 0.0 114.15 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 40.9 mmtt -72.57 151.39 91.54 Favored Pre-proline 0 N--CA 1.455 -0.206 0 CA-C-N 119.989 1.895 . . . . 0.0 106.794 159.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 30.8 Cg_endo -72.47 160.75 46.02 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 123.423 2.749 . . . . 0.0 111.489 -178.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 36.8 pt . . . . . 0 C--O 1.235 0.294 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 173.518 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 69.5 mt-10 . . . . . 0 N--CA 1.462 0.155 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.5 t -57.97 -51.22 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 176.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.45 -36.5 84.63 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 118.771 -1.016 . . . . 0.0 112.895 175.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -63.19 -55.92 21.04 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 119.024 1.412 . . . . 0.0 109.235 176.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.4 t -64.12 -34.55 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-N 119.311 0.96 . . . . 0.0 110.573 -178.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.4 mt -59.18 -59.49 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 171.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -56.69 -41.28 77.09 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 118.836 0.744 . . . . 0.0 110.75 -174.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -62.79 -57.13 11.98 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.405 1.882 . . . . 0.0 110.822 176.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.69 -32.66 83.76 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 118.205 0.457 . . . . 0.0 111.995 -175.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.566 ' HG2' HD23 ' A' ' 32' ' ' LEU . 25.3 mtm105 -53.51 -61.41 2.32 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 166.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -50.55 -46.56 57.6 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.713 1.205 . . . . 0.0 111.69 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.2 m -71.11 -6.79 41.97 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.42 1.088 . . . . 0.0 113.409 -176.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.546 ' HE3' HD11 ' A' ' 27' ' ' LEU . 26.5 mtpp -120.06 8.12 10.94 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.899 1.68 . . . . 0.0 111.535 167.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.09 19.58 51.71 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.777 1.179 . . . . 0.0 113.015 -176.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.546 HD11 ' HE3' ' A' ' 25' ' ' LYS . 79.6 mt -84.34 131.87 34.66 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 118.804 1.302 . . . . 0.0 108.552 -171.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.4 p -75.75 176.57 7.61 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 171.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -68.07 -37.58 81.41 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.179 -0.951 . . . . 0.0 110.73 172.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.6 tmtp? -63.26 -39.23 94.01 Favored 'General case' 0 N--CA 1.462 0.125 0 C-N-CA 123.107 0.563 . . . . 0.0 110.873 174.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.55 -42.22 83.01 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 177.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.566 HD23 ' HG2' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -58.04 -50.67 72.65 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 123.744 0.817 . . . . 0.0 110.089 176.35 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -48.54 -53.47 18.1 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 125.269 1.428 . . . . 0.0 109.978 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 35.1 m -63.09 -40.74 98.56 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.647 0.779 . . . . 0.0 111.933 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.7 mttp -61.81 -12.19 16.08 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 119.719 1.145 . . . . 0.0 113.81 174.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 24.8 pt -123.6 10.38 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 119.99 1.268 . . . . 0.0 111.583 175.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 37.09 68.85 0.25 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 128.453 2.701 . . . . 0.0 112.067 -168.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -131.35 -178.67 4.95 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 127.44 2.296 . . . . 0.0 107.437 173.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -93.67 151.57 40.11 Favored Pre-proline 0 CA--C 1.531 0.233 0 C-N-CA 124.362 1.065 . . . . 0.0 110.595 171.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -67.03 -17.27 51.03 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 123.676 2.917 . . . . 0.0 113.697 -178.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 -65.51 -52.24 54.08 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 118.502 0.592 . . . . 0.0 110.398 177.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.1 m -63.55 -27.61 43.33 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 C-N-CA 120.5 -0.48 . . . . 0.0 109.965 -175.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 38.0 mm -61.38 -53.32 50.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 123.084 0.554 . . . . 0.0 110.574 174.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.17 -39.9 73.07 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 118.957 0.798 . . . . 0.0 111.485 177.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.88 -31.15 67.72 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 118.678 -0.677 . . . . 0.0 111.086 -178.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -63.06 -45.63 91.28 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 125.288 1.435 . . . . 0.0 111.342 172.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.415 ' CD ' HH21 ' A' ' 22' ' ' ARG . 4.7 mt-10 -58.86 -32.96 69.92 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.292 0.637 . . . . 0.0 111.328 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 43.7 m -82.8 -23.15 33.96 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 174.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.2 0.15 80.72 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 119.624 1.102 . . . . 0.0 114.218 -169.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.8 mtt85 -69.49 -47.12 64.9 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 117.867 0.834 . . . . 0.0 109.561 -177.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.39 134.82 57.35 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 171.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 34.0 mm -68.95 120.39 76.02 Favored Pre-proline 0 C--O 1.237 0.416 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -71.44 115.54 4.33 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.503 2.135 . . . . 0.0 110.5 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -106.2 122.2 45.74 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 126.509 1.923 . . . . 0.0 107.697 -178.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -55.73 -24.8 37.08 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 119.813 1.188 . . . . 0.0 113.221 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -61.55 -55.93 25.53 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.491 0.716 . . . . 0.0 109.284 174.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.0 t -71.26 -38.76 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.4 -177.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.4 mt -50.44 -46.39 56.53 Favored 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 169.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.61 -46.89 91.6 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 124.138 0.875 . . . . 0.0 112.036 177.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -57.85 -43.7 86.05 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 117.935 0.867 . . . . 0.0 110.828 175.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.0 mt -65.24 -35.77 76.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 124.685 1.194 . . . . 0.0 110.325 178.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.488 ' HB3' HG21 ' A' ' 78' ' ' ILE . 69.9 mt-10 -59.93 -49.91 75.82 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 119.495 1.043 . . . . 0.0 108.616 176.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.8 mtm105 -57.59 -31.32 66.06 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 122.871 0.468 . . . . 0.0 111.288 175.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.47 -53.7 26.55 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.011 0.924 . . . . 0.0 112.227 -177.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 35.6 pt -90.05 -16.5 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 122.418 0.287 . . . . 0.0 111.269 -177.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.92 27.28 58.77 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 125.871 1.701 . . . . 0.0 113.186 -175.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 77' ' ' PRO . 24.2 mt -143.37 161.38 38.51 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.727 1.764 . . . . 0.0 109.887 179.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -68.28 142.83 55.46 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 126.163 1.785 . . . . 0.0 110.746 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 62' ' ' GLU . 4.2 mm? -118.17 10.33 12.89 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.467 1.107 . . . . 0.0 110.398 173.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 25.1 mtm105 -139.8 157.27 46.0 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 121.32 -0.863 . . . . 0.0 109.711 -178.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.96 167.91 21.04 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -170.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 43.2 tttp -68.94 -14.08 62.82 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.363 -1.08 . . . . 0.0 110.642 172.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -64.93 8.23 0.13 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.695 1.998 . . . . 0.0 112.426 168.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.7 tt -50.24 135.9 8.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-N 120.552 1.524 . . . . 0.0 110.283 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.28 -4.68 62.18 Favored Glycine 0 CA--C 1.533 1.204 0 CA-C-O 119.045 -0.864 . . . . 0.0 114.406 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 44.7 mmtt -70.07 153.14 95.57 Favored Pre-proline 0 N--CA 1.453 -0.314 0 CA-C-N 119.808 1.804 . . . . 0.0 107.101 161.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.42 ' HA ' HD23 ' A' ' 67' ' ' LEU . 11.5 Cg_endo -67.18 168.78 16.67 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.062 2.508 . . . . 0.0 112.53 -176.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.488 HG21 ' HB3' ' A' ' 62' ' ' GLU . 34.4 pt . . . . . 0 N--CA 1.453 -0.302 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 175.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 . . . . . 0 CA--C 1.54 0.596 0 CA-C-O 119.238 -0.41 . . . . 0.0 111.235 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.0 t -57.58 -57.37 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 125.742 1.617 . . . . 0.0 109.8 178.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -49.12 -46.7 33.79 Favored Glycine 0 C--O 1.223 -0.537 0 C-N-CA 124.849 1.214 . . . . 0.0 112.246 177.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -62.1 -49.08 77.36 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 119.008 1.404 . . . . 0.0 110.958 178.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 63.6 t -60.63 -41.99 90.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-N 119.482 1.037 . . . . 0.0 110.983 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.402 HG13 HD11 ' A' ' 69' ' ' LEU . 21.2 mt -54.15 -68.19 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 106.209 -1.775 . . . . 0.0 106.209 173.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -57.87 -30.37 65.77 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 125.079 1.352 . . . . 0.0 110.413 -167.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -64.55 -69.38 0.29 Allowed 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.715 1.606 . . . . 0.0 110.924 171.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.58 -29.34 74.62 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-N 119.413 1.006 . . . . 0.0 111.765 -171.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.4 ttp85 -53.74 -60.45 3.3 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 126.218 1.807 . . . . 0.0 108.76 168.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -67.42 -28.94 68.33 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 119.809 1.186 . . . . 0.0 113.334 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 59.0 m -61.03 -20.42 62.5 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.187 0.903 . . . . 0.0 111.99 172.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.456 ' HE3' HD11 ' A' ' 27' ' ' LEU . 25.7 mtpp -109.67 5.9 23.29 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.915 1.686 . . . . 0.0 111.073 175.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.06 9.75 54.66 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 126.442 1.972 . . . . 0.0 113.68 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.456 HD11 ' HE3' ' A' ' 25' ' ' LYS . 34.7 mt -74.15 130.78 40.43 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 118.559 1.179 . . . . 0.0 109.231 -163.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 32.1 p -66.02 162.35 19.61 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 166.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -55.19 -37.24 66.8 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 121.469 -0.77 . . . . 0.0 109.863 169.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -63.85 -43.46 96.05 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.05 0.54 . . . . 0.0 111.298 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -70.02 -35.55 74.41 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 118.853 -0.594 . . . . 0.0 110.628 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.63 -46.05 90.15 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.747 0.703 . . . . 0.0 109.937 173.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.61 -54.44 45.98 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 124.722 1.209 . . . . 0.0 108.978 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 52.0 m -68.01 -31.4 71.06 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 117.962 -1.018 . . . . 0.0 111.608 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.1 mttp -52.75 -50.58 63.19 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 119.945 1.248 . . . . 0.0 110.47 173.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.9 pt -88.13 2.42 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 123.174 0.59 . . . . 0.0 112.383 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 62.3 t-20 45.02 74.21 0.14 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 128.973 2.909 . . . . 0.0 111.716 -170.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -139.35 173.6 11.37 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 128.612 2.765 . . . . 0.0 109.906 178.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.8 mmpt? -81.44 144.21 52.93 Favored Pre-proline 0 CA--C 1.534 0.341 0 O-C-N 121.505 -0.747 . . . . 0.0 109.882 173.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.32 -16.52 13.64 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.334 2.022 . . . . 0.0 114.452 -172.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 -68.04 -34.16 75.95 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 120.331 1.423 . . . . 0.0 110.782 173.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.6 m -72.22 -27.81 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 119.686 1.13 . . . . 0.0 110.155 177.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 36.3 mm -63.92 -50.51 77.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 C-N-CA 123.221 0.609 . . . . 0.0 109.414 172.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.17 -35.58 71.77 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.126 0.489 . . . . 0.0 110.462 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -72.94 -31.03 64.33 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 117.974 -1.012 . . . . 0.0 112.462 176.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -57.08 -50.84 71.54 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-N 120.019 1.281 . . . . 0.0 109.958 170.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -67.55 -29.68 69.12 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 119.188 -0.434 . . . . 0.0 110.965 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.6 m -71.11 -37.1 72.37 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.299 0.954 . . . . 0.0 111.716 176.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 113.85 9.37 16.45 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 124.943 1.259 . . . . 0.0 113.441 -176.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.5 mmt85 -101.29 -42.63 6.24 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 124.546 1.138 . . . . 0.0 110.955 -163.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.85 130.02 42.45 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 174.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 30.1 mm -68.3 124.9 90.89 Favored Pre-proline 0 C--O 1.238 0.456 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 -177.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -76.58 111.81 3.33 Favored 'Trans proline' 0 N--CA 1.442 -1.525 0 N-CA-C 106.836 -2.024 . . . . 0.0 106.836 -175.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -104.9 130.65 53.01 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 -174.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -50.54 -31.51 15.85 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 117.85 -1.071 . . . . 0.0 113.64 -178.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -65.24 -59.55 3.95 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 120.838 1.654 . . . . 0.0 110.673 172.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.1 t -59.7 -47.46 91.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 124.143 0.977 . . . . 0.0 110.034 -176.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 78.8 mt -47.68 -51.03 23.23 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 124.432 1.093 . . . . 0.0 109.538 169.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.72 -43.44 69.32 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 123.718 0.675 . . . . 0.0 112.576 177.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt -66.45 -44.04 83.88 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.14 0.97 . . . . 0.0 109.946 177.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.3 mt -60.01 -37.22 71.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 124.76 1.224 . . . . 0.0 109.903 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -58.35 -47.37 84.01 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 119.229 0.922 . . . . 0.0 109.564 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 26.1 mtt-85 -69.75 -27.22 64.76 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 118.296 -0.859 . . . . 0.0 112.326 176.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.75 -40.15 79.02 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.818 0.847 . . . . 0.0 112.056 176.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 22.1 pt -117.2 -16.07 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -174.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.1 30.88 62.4 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 125.225 1.393 . . . . 0.0 112.813 -176.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 77' ' ' PRO . 69.7 mt -124.11 164.32 19.68 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 118.631 1.216 . . . . 0.0 109.489 169.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -78.76 140.85 38.2 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 126.033 1.733 . . . . 0.0 108.22 176.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.402 HD11 HG13 ' A' ' 18' ' ' ILE . 3.0 mm? -120.07 7.84 10.9 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.563 1.145 . . . . 0.0 108.985 -179.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 22.8 mtm105 -141.63 168.61 19.35 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 127.208 2.203 . . . . 0.0 108.461 177.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 68.91 158.26 1.45 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -162.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 24.3 mtmt -64.63 -15.6 61.46 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 120.876 -1.367 . . . . 0.0 111.387 164.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -66.62 11.69 0.09 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.323 2.249 . . . . 0.0 111.906 168.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.1 tt -51.84 144.52 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 O-C-N 120.485 -1.384 . . . . 0.0 110.532 177.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.79 -4.03 24.29 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-O 118.911 -0.938 . . . . 0.0 113.152 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 39.6 mmtt -69.51 150.79 96.87 Favored Pre-proline 0 N--CA 1.446 -0.667 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 157.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.459 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 14.8 Cg_endo -69.33 158.5 57.28 Favored 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 122.448 2.099 . . . . 0.0 111.365 -177.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 27.8 pt . . . . . 0 C--O 1.238 0.474 0 N-CA-C 105.796 -1.928 . . . . 0.0 105.796 158.876 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 . . . . . 0 CA--C 1.532 0.254 0 N-CA-C 111.132 0.049 . . . . 0.0 111.132 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.5 t -57.9 -56.94 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 124.07 0.948 . . . . 0.0 109.094 177.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -55.21 -39.82 72.68 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-O 118.947 -0.918 . . . . 0.0 112.745 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 48.8 tptt -60.2 -57.7 11.69 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.633 1.216 . . . . 0.0 109.733 176.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.4 t -61.81 -31.9 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 118.662 0.665 . . . . 0.0 110.029 -177.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.1 mt -65.76 -56.41 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 CA-C-N 119.809 1.186 . . . . 0.0 109.061 176.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -51.88 -49.38 63.09 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.599 1.16 . . . . 0.0 110.404 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -66.39 -53.06 40.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.104 1.762 . . . . 0.0 111.958 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.23 -34.24 89.39 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 124.413 1.006 . . . . 0.0 111.519 -174.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.9 mtm105 -64.69 -51.31 63.13 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 118.531 -0.747 . . . . 0.0 111.28 168.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -51.8 -37.76 52.92 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.751 0.82 . . . . 0.0 111.399 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.2 m -73.92 -2.39 23.72 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.621 1.968 . . . . 0.0 112.493 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 21.0 mtpp -136.54 6.72 3.0 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.448 2.299 . . . . 0.0 111.314 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.26 21.04 69.9 Favored Glycine 0 CA--C 1.536 1.399 0 CA-C-O 118.681 -1.066 . . . . 0.0 114.742 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 20.8 mt -93.44 135.4 34.72 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.271 1.536 . . . . 0.0 110.964 -169.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 61.7 p -74.98 170.52 15.82 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.262 -0.899 . . . . 0.0 109.515 163.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -63.44 -29.01 70.37 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.237 -0.914 . . . . 0.0 111.568 166.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.53 -36.81 73.92 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.836 0.855 . . . . 0.0 110.8 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -66.13 -37.39 85.59 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 171.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.408 HD22 ' HA ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -67.9 -48.42 66.08 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 118.207 0.458 . . . . 0.0 111.267 -175.236 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -48.24 -48.85 34.97 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 125.43 1.492 . . . . 0.0 109.209 172.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 63.0 m -60.91 -48.74 80.44 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.796 0.838 . . . . 0.0 111.528 175.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.3 mttm -58.4 -11.68 3.08 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 127.175 2.19 . . . . 0.0 114.233 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.9 pt -128.64 0.07 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 119.26 0.937 . . . . 0.0 112.273 177.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 53.2 t30 42.27 76.31 0.08 Allowed 'General case' 0 C--O 1.235 0.301 0 C-N-CA 126.768 2.027 . . . . 0.0 112.103 -163.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -137.6 -179.51 5.79 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 128.03 2.532 . . . . 0.0 107.567 168.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -88.01 141.71 31.54 Favored Pre-proline 0 C--N 1.335 -0.05 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 175.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -64.36 -18.82 64.47 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.587 2.192 . . . . 0.0 112.029 170.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.5 tp60 -62.23 -52.19 64.76 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 123.93 0.892 . . . . 0.0 110.429 171.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.1 m -69.88 -34.68 61.36 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.431 0 CA-C-N 119.36 0.982 . . . . 0.0 110.094 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 42.1 mm -56.57 -48.96 79.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 O-C-N 121.227 -0.921 . . . . 0.0 110.244 174.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.81 -20.91 66.65 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 178.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.16 -54.05 12.38 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 118.822 -0.608 . . . . 0.0 110.45 167.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -42.81 -50.65 5.62 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 124.535 1.134 . . . . 0.0 112.35 176.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.79 -29.35 68.51 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 120.897 1.68 . . . . 0.0 113.223 -171.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 12.8 m -69.85 -37.16 76.06 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.874 166.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.63 28.58 18.69 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -177.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -79.16 -50.8 10.42 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 117.494 0.647 . . . . 0.0 109.373 -174.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.35 167.32 18.38 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 127.366 2.266 . . . . 0.0 110.433 171.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 23.9 mm -89.73 127.34 54.61 Favored Pre-proline 0 C--O 1.235 0.333 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 174.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -72.75 115.07 4.2 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 N-CA-C 108.645 -1.329 . . . . 0.0 108.645 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -99.14 135.99 39.75 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.664 0.786 . . . . 0.0 110.795 -169.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -52.4 -36.95 55.4 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.365 1.066 . . . . 0.0 113.275 -170.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -57.59 -64.91 0.74 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.072 0.949 . . . . 0.0 109.226 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 92.4 t -63.3 -40.44 89.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 125.574 1.549 . . . . 0.0 109.844 -178.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.6 mt -49.61 -52.82 27.75 Favored 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 124.354 1.062 . . . . 0.0 110.223 175.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.76 -31.5 78.34 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-N 118.679 0.672 . . . . 0.0 112.523 -178.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -67.59 -43.55 80.27 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 121.401 -1.058 . . . . 0.0 110.371 173.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.0 mt -63.51 -37.12 78.74 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.091 0 C-N-CA 124.337 1.055 . . . . 0.0 109.843 176.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.475 ' HA ' HD23 ' A' ' 69' ' ' LEU . 42.6 mt-10 -56.39 -50.86 70.37 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.386 0.994 . . . . 0.0 109.227 176.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 23.2 mtm180 -64.95 -19.04 65.75 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 175.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.59 -44.76 73.67 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 118.426 -0.797 . . . . 0.0 111.264 177.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.482 HD11 HD21 ' A' ' 69' ' ' LEU . 21.5 pt -114.45 -10.13 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -173.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.51 23.36 78.13 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 127.561 2.505 . . . . 0.0 114.031 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.0 mt -121.94 161.59 22.59 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 118.453 1.126 . . . . 0.0 108.793 172.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -74.36 140.26 44.68 Favored 'General case' 0 CA--C 1.512 -0.51 0 C-N-CA 124.984 1.314 . . . . 0.0 108.753 176.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.482 HD21 HD11 ' A' ' 65' ' ' ILE . 4.0 mm? -119.56 9.92 11.64 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 125.087 1.355 . . . . 0.0 111.201 176.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.5 mtm180 -130.85 166.79 20.12 Favored 'General case' 0 C--O 1.233 0.209 0 O-C-N 121.023 -1.048 . . . . 0.0 109.04 174.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.63 176.91 43.56 Favored Glycine 0 N--CA 1.449 -0.495 0 O-C-N 124.233 0.958 . . . . 0.0 110.89 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -83.2 11.74 6.13 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.643 0.777 . . . . 0.0 111.114 171.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -102.91 16.25 27.14 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.381 1.472 . . . . 0.0 110.359 177.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.5 tt -54.68 142.98 7.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 O-C-N 121.219 -0.925 . . . . 0.0 110.545 -168.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.55 -4.48 59.9 Favored Glycine 0 CA--C 1.536 1.4 0 CA-C-O 119.307 -0.718 . . . . 0.0 114.257 -178.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -71.74 149.15 92.9 Favored Pre-proline 0 C--N 1.341 0.212 0 CA-C-N 119.938 1.869 . . . . 0.0 107.974 163.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.34 151.22 29.43 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 123.896 3.064 . . . . 0.0 112.85 -171.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.0 pt . . . . . 0 N--CA 1.454 -0.232 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 175.541 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 . . . . . 0 N--CA 1.456 -0.154 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 53.5 t -57.31 -64.53 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.098 0 C-N-CA 125.41 1.484 . . . . 0.0 109.287 -178.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -49.16 -42.99 32.58 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-N 119.425 1.011 . . . . 0.0 112.998 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -67.44 -52.6 37.6 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 117.843 -1.075 . . . . 0.0 112.564 177.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 66.7 t -59.27 -31.34 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 119.805 1.184 . . . . 0.0 110.242 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 52.9 mt -61.32 -58.38 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 175.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -60.03 -47.0 87.65 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 123.608 0.568 . . . . 0.0 110.47 -177.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -60.3 -49.75 76.36 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.841 1.256 . . . . 0.0 110.734 178.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.17 -32.14 75.9 Favored Glycine 0 CA--C 1.52 0.377 0 O-C-N 120.535 -1.353 . . . . 0.0 112.663 -177.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 15.1 mtm105 -59.6 -61.42 2.63 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 118.145 0.973 . . . . 0.0 110.777 167.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.27 -22.95 67.2 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.169 0.988 . . . . 0.0 112.692 -174.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.4 t -61.4 -16.59 48.05 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.662 1.585 . . . . 0.0 111.303 171.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -126.98 2.12 6.57 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.413 1.885 . . . . 0.0 110.986 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 71.67 0.24 39.29 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 126.022 1.772 . . . . 0.0 113.024 -175.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.6 mt -78.63 145.32 34.74 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 119.034 1.417 . . . . 0.0 110.619 -162.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.1 p -83.86 174.61 10.25 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.656 0.782 . . . . 0.0 110.013 -173.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -69.09 -38.49 78.99 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 121.432 -0.793 . . . . 0.0 109.743 171.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.3 mtpm? -58.91 -41.99 88.57 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.82 0.848 . . . . 0.0 110.911 171.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -63.43 -43.46 97.4 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 118.832 0.742 . . . . 0.0 109.388 177.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.32 -49.3 77.56 Favored 'General case' 0 C--O 1.228 -0.069 0 C-N-CA 124.205 1.002 . . . . 0.0 110.091 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.15 -45.24 71.98 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.856 0.862 . . . . 0.0 109.919 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.7 m -61.82 -48.45 80.53 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.287 1.035 . . . . 0.0 110.576 177.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.2 mttm -54.48 -27.66 39.21 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.764 1.226 . . . . 0.0 113.274 176.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.6 pt -111.93 10.05 8.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 123.928 0.891 . . . . 0.0 112.13 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.5 m120 45.25 48.68 10.2 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.594 2.358 . . . . 0.0 111.421 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -132.27 -171.49 2.65 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.241 1.416 . . . . 0.0 109.224 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.6 mmmm -91.61 142.0 26.36 Favored Pre-proline 0 N--CA 1.466 0.355 0 O-C-N 121.015 -1.053 . . . . 0.0 109.713 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.52 -10.18 28.24 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.715 2.277 . . . . 0.0 112.123 169.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 30.0 tp60 -50.92 -61.68 2.07 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.901 1.28 . . . . 0.0 109.361 163.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.4 m -66.42 -29.5 46.77 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.677 0 C-N-CA 119.741 -0.783 . . . . 0.0 110.419 -175.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 51.4 mm -62.77 -45.08 99.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 119.686 1.13 . . . . 0.0 109.952 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.82 -39.64 92.48 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 121.496 -0.082 . . . . 0.0 111.09 172.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -63.62 -40.28 96.51 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.512 0.725 . . . . 0.0 110.68 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -63.25 -44.73 94.34 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 126.183 1.793 . . . . 0.0 108.867 176.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -60.73 -30.41 69.97 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.277 1.031 . . . . 0.0 113.164 176.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.7 m -90.49 -19.64 23.61 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 177.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.97 42.45 7.62 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 119.56 1.073 . . . . 0.0 111.188 -173.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -114.36 -47.83 2.91 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 124.941 1.297 . . . . 0.0 108.856 -176.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.21 150.11 11.5 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.31 0.644 . . . . 0.0 109.874 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 36.3 mm -68.98 117.32 50.51 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 167.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -69.76 115.6 4.17 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 N-CA-C 106.892 -2.003 . . . . 0.0 106.892 171.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -127.67 123.91 36.64 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 -172.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.2 p-10 -51.74 -29.59 19.25 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.909 1.684 . . . . 0.0 112.998 -174.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -58.54 -47.6 83.67 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.741 1.616 . . . . 0.0 111.205 173.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.2 t -91.66 -36.5 7.99 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-O 117.778 -1.106 . . . . 0.0 109.971 -175.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 14.1 mt -47.8 -45.63 29.83 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.56 1.073 . . . . 0.0 109.518 170.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.65 -40.31 94.57 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-O 119.492 -0.616 . . . . 0.0 112.813 176.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -64.99 -47.63 76.86 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 118.836 1.318 . . . . 0.0 109.683 177.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.3 mt -61.41 -36.1 70.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 123.226 0.611 . . . . 0.0 110.117 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -58.3 -50.19 74.49 Favored 'General case' 0 C--N 1.33 -0.255 0 O-C-N 121.583 -0.698 . . . . 0.0 109.862 176.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 36.5 mtt180 -65.91 -24.77 66.9 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.301 -0.874 . . . . 0.0 112.807 174.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.85 -55.88 28.73 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 118.771 0.714 . . . . 0.0 109.525 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.427 HD11 HD21 ' A' ' 69' ' ' LEU . 45.9 pt -93.34 -15.92 7.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 123.548 0.739 . . . . 0.0 112.002 -177.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.18 39.67 92.48 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 125.337 1.446 . . . . 0.0 111.682 -173.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 47.5 mt -135.45 166.14 23.88 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.4 1.08 . . . . 0.0 109.057 169.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -73.54 141.52 46.7 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 126.336 1.854 . . . . 0.0 109.52 176.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.427 HD21 HD11 ' A' ' 65' ' ' ILE . 3.4 mm? -119.36 5.25 11.18 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.425 1.89 . . . . 0.0 110.302 176.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 56.1 mtm180 -142.1 147.08 36.16 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.924 0.783 . . . . 0.0 110.009 -172.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.25 167.58 21.4 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 125.193 1.378 . . . . 0.0 109.931 -170.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.2 mttp -68.84 -11.57 60.62 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.119 -1.224 . . . . 0.0 111.667 176.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.98 13.74 0.49 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.924 1.69 . . . . 0.0 110.704 172.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.8 tt -52.65 150.45 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 O-C-N 120.843 -1.161 . . . . 0.0 110.761 176.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.53 -12.49 7.78 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-O 118.871 -0.96 . . . . 0.0 113.749 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 33.9 mmtt -70.77 150.57 95.27 Favored Pre-proline 0 N--CA 1.449 -0.515 0 CA-C-N 119.671 1.736 . . . . 0.0 107.784 166.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -73.16 162.44 40.67 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 123.575 2.85 . . . . 0.0 110.856 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 42.3 pt . . . . . 0 N--CA 1.465 0.296 0 C-N-CA 124.364 1.065 . . . . 0.0 108.535 -178.858 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 . . . . . 0 N--CA 1.465 0.31 0 CA-C-O 119.616 -0.23 . . . . 0.0 111.066 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.1 t -56.13 -61.7 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 123.506 0.722 . . . . 0.0 109.464 176.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -56.67 -38.08 80.15 Favored Glycine 0 C--N 1.335 0.527 0 CA-C-N 119.523 1.056 . . . . 0.0 112.523 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.4 -56.35 21.24 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.276 1.038 . . . . 0.0 109.86 177.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.3 t -60.13 -37.88 74.87 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.128 0 C-N-CA 123.808 0.843 . . . . 0.0 110.298 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 64.4 mt -59.98 -57.74 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 176.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -55.68 -49.0 74.11 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.142 0.577 . . . . 0.0 110.125 -176.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -56.67 -60.61 3.3 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 123.362 0.665 . . . . 0.0 110.801 176.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.38 -30.84 78.96 Favored Glycine 0 CA--C 1.521 0.442 0 CA-C-N 119.914 1.234 . . . . 0.0 112.719 -171.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.487 HH11 ' HB3' ' A' ' 22' ' ' ARG . 16.7 mtm105 -57.12 -65.72 0.57 Allowed 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 118.272 1.036 . . . . 0.0 109.782 166.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -61.52 -29.88 70.28 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.806 1.242 . . . . 0.0 112.161 -173.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.7 m -72.6 -4.73 32.58 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.984 1.314 . . . . 0.0 112.295 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp -127.72 12.35 6.82 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.465 1.906 . . . . 0.0 110.16 176.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.21 17.56 66.11 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.297 0.951 . . . . 0.0 113.725 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 59.4 mt -88.62 144.77 26.08 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 118.652 1.226 . . . . 0.0 111.505 -168.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 81.9 p -84.18 168.75 15.48 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.305 173.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -58.91 -43.38 91.04 Favored 'General case' 0 N--CA 1.464 0.267 0 O-C-N 121.321 -0.862 . . . . 0.0 110.216 166.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.5 mttt -57.1 -36.27 70.43 Favored 'General case' 0 CA--C 1.521 -0.136 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 176.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -64.13 -38.37 90.83 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 118.244 0.474 . . . . 0.0 110.232 176.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.59 -48.68 71.5 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 123.34 0.656 . . . . 0.0 109.256 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -50.16 -56.42 11.05 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.48 1.512 . . . . 0.0 108.643 178.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 95.9 m -59.59 -44.14 93.47 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.491 0.717 . . . . 0.0 112.299 177.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -58.86 -32.83 69.81 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 119.595 1.089 . . . . 0.0 112.137 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.2 pt -103.39 1.44 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 119.12 0.873 . . . . 0.0 112.073 176.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 63.3 t30 54.11 44.38 29.3 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 128.236 2.614 . . . . 0.0 113.709 -175.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -113.76 177.85 4.49 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.788 2.035 . . . . 0.0 110.907 176.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -75.93 147.99 81.26 Favored Pre-proline 0 C--N 1.342 0.26 0 CA-C-N 118.991 0.814 . . . . 0.0 109.542 168.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.0 -7.48 20.94 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 123.023 2.482 . . . . 0.0 112.616 170.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.4 tp60 -55.63 -63.44 1.17 Allowed 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 123.278 0.631 . . . . 0.0 109.551 166.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.8 m -67.98 -22.92 28.39 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.339 0 C-N-CA 119.954 -0.698 . . . . 0.0 111.014 -169.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 44.1 mm -61.63 -46.93 95.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 123.98 0.912 . . . . 0.0 110.298 171.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.31 -27.13 68.39 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 123.259 0.623 . . . . 0.0 112.287 177.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -79.75 -39.11 31.79 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.214 1.006 . . . . 0.0 110.789 176.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -55.0 -40.15 69.82 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 125.92 1.688 . . . . 0.0 111.054 175.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -61.14 -39.9 91.81 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 119.177 -0.44 . . . . 0.0 111.895 -177.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.5 m -80.87 -23.89 38.73 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 118.478 -0.772 . . . . 0.0 112.954 172.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.05 7.2 62.65 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-O 119.286 -0.73 . . . . 0.0 112.8 -171.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 45.8 mtt180 -67.44 -37.55 83.17 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.062 1.431 . . . . 0.0 110.195 177.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.63 115.1 7.62 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 167.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.6 mm -70.04 117.42 53.91 Favored Pre-proline 0 C--O 1.236 0.364 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 170.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -80.75 154.48 20.31 Favored 'Trans proline' 0 N--CA 1.446 -1.28 0 C-N-CA 122.188 1.925 . . . . 0.0 110.238 -173.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -127.47 153.92 45.72 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.526 1.13 . . . . 0.0 108.506 174.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 72.9 m-80 -62.12 -31.84 72.35 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.883 0.765 . . . . 0.0 112.309 -172.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -56.61 -61.37 2.47 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.004 0.922 . . . . 0.0 109.381 174.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.0 t -66.15 -48.94 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-O 118.087 -0.959 . . . . 0.0 109.69 -176.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 51.9 mt -44.91 -48.4 11.27 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 119.366 0.985 . . . . 0.0 110.164 170.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.14 -47.45 73.83 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 125.236 1.398 . . . . 0.0 112.562 176.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -61.73 -41.95 98.32 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 121.732 -0.863 . . . . 0.0 110.425 175.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 77.5 mt -63.68 -34.63 69.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 118.755 0.707 . . . . 0.0 109.651 176.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -62.11 -43.5 98.69 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 120.957 -1.089 . . . . 0.0 109.873 174.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 84.8 mtt-85 -59.22 -39.01 81.36 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.453 -0.78 . . . . 0.0 111.004 173.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.74 -55.36 31.1 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.619 1.568 . . . . 0.0 111.453 -175.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.0 pt -91.02 -26.51 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 118.673 0.669 . . . . 0.0 110.942 -178.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.59 28.08 36.82 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 125.614 1.578 . . . . 0.0 112.215 -178.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 77' ' ' PRO . 19.6 mt -133.65 165.09 25.74 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.542 1.537 . . . . 0.0 108.572 173.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.2 mttm -69.41 140.96 54.19 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 126.236 1.814 . . . . 0.0 109.947 176.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -119.75 8.02 11.11 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.429 1.892 . . . . 0.0 109.791 174.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -133.42 154.93 50.36 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.578 1.551 . . . . 0.0 108.082 -175.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 65.51 174.18 4.7 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.627 1.584 . . . . 0.0 112.624 -178.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 72.1 mttt -69.15 -16.83 63.73 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 121.883 -0.775 . . . . 0.0 111.867 178.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -76.82 16.04 0.58 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.391 0.996 . . . . 0.0 111.362 176.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.6 tt -52.15 139.51 8.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 O-C-N 120.718 -1.239 . . . . 0.0 110.78 -176.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.27 -8.05 41.96 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 118.79 -1.006 . . . . 0.0 113.386 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 16.5 mmtt -72.55 154.38 91.57 Favored Pre-proline 0 N--CA 1.451 -0.411 0 CA-C-N 120.546 2.173 . . . . 0.0 106.672 161.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.47 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 14.7 Cg_endo -67.8 170.67 13.57 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 123.388 2.725 . . . . 0.0 112.204 -175.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 25.2 pt . . . . . 0 C--O 1.236 0.353 0 C-N-CA 124.637 1.175 . . . . 0.0 108.679 171.822 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 . . . . . 0 CA--C 1.536 0.411 0 CA-C-O 118.906 -0.568 . . . . 0.0 110.034 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 37.1 t -60.95 -57.44 12.12 Favored 'Isoleucine or valine' 0 C--N 1.344 0.329 0 CA-C-N 119.372 0.987 . . . . 0.0 109.14 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.91 -40.9 66.38 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 119.677 -0.513 . . . . 0.0 112.1 177.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.8 tptt -57.85 -61.22 2.68 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 117.827 0.814 . . . . 0.0 110.826 173.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 78.6 t -58.49 -31.85 44.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 118.994 0.816 . . . . 0.0 110.068 -176.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 52.3 mt -64.74 -59.19 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-O 117.799 -1.096 . . . . 0.0 108.753 175.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -54.23 -50.03 68.1 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.706 0.803 . . . . 0.0 109.839 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.85 -52.22 63.96 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 123.786 0.835 . . . . 0.0 110.394 -177.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.99 -33.87 88.4 Favored Glycine 0 CA--C 1.524 0.618 0 CA-C-O 118.862 -0.966 . . . . 0.0 112.098 -177.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.679 ' HG2' HD23 ' A' ' 32' ' ' LEU . 17.3 mtm105 -59.68 -58.14 9.89 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 118.321 1.061 . . . . 0.0 109.7 170.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.9 mm100 -64.36 -17.68 63.95 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.753 1.621 . . . . 0.0 113.216 -176.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 65.3 m -72.15 -11.33 60.69 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.144 0.978 . . . . 0.0 112.941 168.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -135.66 23.06 3.38 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 120.399 1.454 . . . . 0.0 111.993 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 61.2 14.19 38.92 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.477 1.037 . . . . 0.0 113.924 -178.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 44.5 mt -73.09 125.27 27.28 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 118.67 1.235 . . . . 0.0 108.898 -167.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 67.2 p -66.7 170.42 6.44 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 165.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -63.04 -32.39 73.75 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.098 -1.001 . . . . 0.0 110.399 169.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -72.15 -36.32 69.3 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.481 0.712 . . . . 0.0 111.058 178.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -59.91 -40.54 89.19 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.96 0.8 . . . . 0.0 109.129 174.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.679 HD23 ' HG2' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -65.82 -47.5 74.81 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.406 0.682 . . . . 0.0 110.803 177.003 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.64 -47.4 67.1 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.485 1.114 . . . . 0.0 110.487 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 95.3 m -58.89 -49.12 78.98 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 125.03 1.332 . . . . 0.0 111.081 172.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.6 mttp -57.88 -22.55 48.86 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 117.837 -1.078 . . . . 0.0 113.563 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.487 HG22 ' HB3' ' A' ' 60' ' ' LYS . 25.6 pt -115.3 8.15 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 120.021 1.282 . . . . 0.0 112.096 173.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 42.1 t30 36.74 72.15 0.12 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.424 1.889 . . . . 0.0 112.015 -170.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.77 -179.69 6.48 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.691 1.596 . . . . 0.0 109.706 171.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -68.54 143.51 95.33 Favored Pre-proline 0 N--CA 1.455 -0.203 0 O-C-N 121.347 -0.846 . . . . 0.0 109.797 172.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -69.72 -10.33 28.34 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 122.599 2.199 . . . . 0.0 112.123 170.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -61.29 -42.22 98.28 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.897 1.279 . . . . 0.0 110.73 170.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.3 m -76.39 -27.27 17.35 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.382 0 C-N-CA 119.687 -0.805 . . . . 0.0 110.294 -176.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.3 mm -62.99 -47.47 92.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 119.44 1.018 . . . . 0.0 109.226 176.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.68 -42.38 71.32 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 122.885 0.474 . . . . 0.0 110.834 175.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -78.58 -32.9 47.87 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 118.608 -0.71 . . . . 0.0 111.263 -173.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -58.8 -43.72 90.59 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.33 1.052 . . . . 0.0 109.533 168.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.418 ' CD ' HH21 ' A' ' 22' ' ' ARG . 7.0 mt-10 -62.43 -40.55 96.93 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 118.44 -0.79 . . . . 0.0 112.501 -178.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.3 m -82.11 -25.62 34.29 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 119.145 0.884 . . . . 0.0 112.657 175.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 108.84 3.33 32.07 Favored Glycine 0 CA--C 1.523 0.538 0 C-N-CA 123.464 0.554 . . . . 0.0 113.052 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 55.0 mmt-85 -67.3 -58.34 4.98 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.32 1.448 . . . . 0.0 109.416 -175.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.11 142.71 53.75 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.438 0.563 . . . . 0.0 109.894 -175.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 mt -68.43 126.86 93.15 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 174.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.15 116.86 4.79 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 122.72 2.28 . . . . 0.0 108.192 175.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -114.67 126.72 55.2 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 178.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -44.69 -38.19 4.2 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.767 1.627 . . . . 0.0 114.103 175.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -58.18 -33.15 68.94 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 123.245 0.618 . . . . 0.0 111.979 177.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 75.3 t -94.19 -46.8 13.58 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 C-N-CA 124.898 1.279 . . . . 0.0 109.425 176.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 78.0 mt -47.97 -49.35 30.91 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 120.463 1.483 . . . . 0.0 111.115 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.78 -31.47 71.75 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 118.459 0.572 . . . . 0.0 113.131 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.487 ' HB3' HG22 ' A' ' 36' ' ' ILE . 9.9 mtpp -74.31 -43.39 56.95 Favored 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 125.071 1.348 . . . . 0.0 109.419 175.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.0 mt -59.17 -36.79 64.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 175.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -59.12 -46.16 89.05 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.426 1.012 . . . . 0.0 109.995 176.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 48.0 mtt180 -67.57 -23.31 65.39 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.329 -0.857 . . . . 0.0 112.713 174.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.95 -37.09 81.16 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.614 1.166 . . . . 0.0 111.893 -178.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 29.7 pt -119.25 -20.38 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.021 0.929 . . . . 0.0 112.544 -177.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.61 29.43 52.43 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 125.476 1.512 . . . . 0.0 113.345 -177.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.473 HD23 ' HA ' ' A' ' 77' ' ' PRO . 81.1 mt -124.92 166.09 16.92 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 118.267 1.033 . . . . 0.0 108.569 170.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.7 mttm -74.59 143.27 44.48 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 125.357 1.463 . . . . 0.0 109.738 175.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -121.26 9.71 10.47 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.56 1.544 . . . . 0.0 110.387 176.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 33.9 mtt-85 -137.64 163.06 32.16 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 119.371 0.987 . . . . 0.0 110.951 175.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.82 177.95 49.94 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 125.413 1.483 . . . . 0.0 110.811 -174.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -69.75 -20.91 63.49 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 121.694 -0.886 . . . . 0.0 110.741 163.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.34 15.71 0.09 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 128.755 2.822 . . . . 0.0 111.382 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.3 tt -56.86 150.89 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 O-C-N 121.106 -0.997 . . . . 0.0 109.334 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.73 -7.15 7.42 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-O 118.533 -1.148 . . . . 0.0 114.13 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.401 ' HB3' ' HE3' ' A' ' 76' ' ' LYS . 24.9 mmmt -61.47 149.79 82.65 Favored Pre-proline 0 C--N 1.342 0.242 0 CA-C-N 120.04 1.92 . . . . 0.0 107.137 158.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.473 ' HA ' HD23 ' A' ' 67' ' ' LEU . 19.6 Cg_endo -67.73 154.79 72.28 Favored 'Trans proline' 0 N--CA 1.445 -1.337 0 C-N-CA 123.139 2.56 . . . . 0.0 110.462 170.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.7 pt . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 164.489 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 . . . . . 0 N--CA 1.466 0.334 0 N-CA-C 111.207 0.077 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.1 t -56.3 -53.88 34.59 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.15 0 C-N-CA 124.044 0.938 . . . . 0.0 109.498 173.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -56.63 -39.7 86.32 Favored Glycine 0 CA--C 1.529 0.924 0 CA-C-N 119.363 0.983 . . . . 0.0 112.719 178.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -63.63 -55.44 23.58 Favored 'General case' 0 N--CA 1.46 0.048 0 CA-C-N 118.51 1.155 . . . . 0.0 109.943 176.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.3 t -58.71 -38.47 72.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 123.465 0.706 . . . . 0.0 110.443 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 57.0 mt -58.64 -59.48 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 176.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -61.93 -37.15 83.6 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 118.073 0.397 . . . . 0.0 111.229 -173.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.88 -53.98 50.66 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 121.418 -0.801 . . . . 0.0 111.914 171.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.64 -37.12 93.24 Favored Glycine 0 CA--C 1.521 0.457 0 CA-C-O 119.177 -0.79 . . . . 0.0 111.899 -173.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 17.6 mtm105 -57.3 -61.33 2.55 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 117.69 0.745 . . . . 0.0 109.407 173.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -60.74 -29.91 69.68 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.132 0.973 . . . . 0.0 112.347 -177.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.4 m -65.05 -12.95 56.27 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.285 0.948 . . . . 0.0 112.959 177.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 41.6 mttm -121.69 8.83 10.07 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.484 1.513 . . . . 0.0 110.295 171.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.12 24.86 61.42 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 126.014 1.769 . . . . 0.0 113.249 -177.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 57.6 mt -87.55 139.89 30.08 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.264 1.532 . . . . 0.0 111.536 -171.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.55 HG23 ' H ' ' A' ' 31' ' ' ASP . 14.1 t -78.88 163.68 25.09 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.613 1.165 . . . . 0.0 110.156 177.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -59.21 -40.84 87.08 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 121.015 -1.053 . . . . 0.0 110.086 175.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.47 -34.85 76.15 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 118.512 -0.756 . . . . 0.0 111.972 178.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.55 ' H ' HG23 ' A' ' 28' ' ' THR . 0.5 OUTLIER -67.39 -36.53 81.51 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.354 0.979 . . . . 0.0 110.787 175.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.78 -47.21 84.49 Favored 'General case' 0 C--N 1.338 0.108 0 O-C-N 121.896 -0.503 . . . . 0.0 109.875 178.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.23 -53.31 36.38 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 125.859 1.664 . . . . 0.0 108.738 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 29.3 m -58.09 -49.58 76.44 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.851 0.861 . . . . 0.0 111.55 174.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 49.1 mttm -57.53 -20.52 32.29 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.6 pt -116.6 5.2 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 119.399 1.0 . . . . 0.0 112.009 176.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 46.6 t30 48.01 64.42 1.65 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 127.04 2.136 . . . . 0.0 110.821 -175.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -137.9 174.88 10.11 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 127.38 2.272 . . . . 0.0 109.862 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.1 mmmm -73.72 143.07 81.22 Favored Pre-proline 0 CA--C 1.53 0.175 0 C-N-CA 124.448 1.099 . . . . 0.0 109.647 172.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -71.99 -12.22 28.07 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.678 2.252 . . . . 0.0 112.829 175.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 44.4 tp60 -73.83 -28.24 61.51 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 117.626 -1.178 . . . . 0.0 111.752 173.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.0 m -75.71 -34.29 28.24 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 CA-C-N 120.544 1.52 . . . . 0.0 109.984 174.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 35.9 mm -59.96 -52.72 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 119.579 1.081 . . . . 0.0 109.893 178.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.67 -31.78 71.92 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.252 -177.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -78.32 -36.26 46.65 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.769 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -54.73 -46.79 74.31 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 126.087 1.755 . . . . 0.0 110.147 173.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -59.65 -48.61 80.97 Favored 'General case' 0 C--N 1.34 0.152 0 C-N-CA 124.011 0.924 . . . . 0.0 110.854 177.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.9 -19.88 61.19 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 107.75 -3.21 34.07 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 125.1 1.333 . . . . 0.0 113.723 176.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 13.0 mmt180 -71.77 -52.87 15.41 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.895 1.347 . . . . 0.0 111.896 -170.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.56 129.23 40.92 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -175.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 35.4 mm -70.11 120.1 75.97 Favored Pre-proline 0 C--O 1.236 0.375 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 174.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -84.39 113.6 1.74 Allowed 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 121.093 1.195 . . . . 0.0 110.216 -171.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -81.24 142.12 33.47 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 177.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -55.54 -38.59 69.46 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.899 0.88 . . . . 0.0 111.849 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -67.19 -50.76 59.82 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.288 0.635 . . . . 0.0 111.351 174.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.6 t -64.42 -43.62 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 119.543 1.065 . . . . 0.0 109.962 -176.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 22.4 mt -45.36 -51.95 10.52 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 125.172 1.389 . . . . 0.0 109.447 165.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.98 -32.66 76.07 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 123.683 0.659 . . . . 0.0 114.105 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -71.71 -48.07 49.74 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 118.984 1.392 . . . . 0.0 109.522 174.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.1 mt -54.8 -36.12 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.104 0 C-N-CA 124.128 0.971 . . . . 0.0 109.923 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -56.27 -50.82 70.28 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 121.884 -0.51 . . . . 0.0 111.081 176.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 65.9 mtt85 -65.58 -24.9 67.19 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.678 0.672 . . . . 0.0 111.954 177.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.36 -33.96 77.2 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.97 0.908 . . . . 0.0 112.95 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.4 HD11 HD21 ' A' ' 69' ' ' LEU . 44.6 pt -117.41 -11.78 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.815 0.846 . . . . 0.0 112.174 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.0 36.18 72.64 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 126.078 1.799 . . . . 0.0 113.294 -175.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 48.7 mt -134.88 164.58 27.27 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 118.589 1.195 . . . . 0.0 109.894 171.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -69.99 141.29 52.98 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 127.404 2.281 . . . . 0.0 109.086 172.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.4 HD21 HD11 ' A' ' 65' ' ' ILE . 3.1 mm? -118.64 6.12 11.62 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.874 1.67 . . . . 0.0 110.005 176.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -138.88 162.23 35.32 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 125.01 1.324 . . . . 0.0 108.647 -175.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 67.27 170.65 4.7 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 -165.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -69.38 -15.72 63.37 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 123.472 0.709 . . . . 0.0 110.774 168.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -69.91 16.73 0.06 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.635 1.574 . . . . 0.0 111.71 172.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.0 tt -55.66 146.76 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 O-C-N 120.699 -1.251 . . . . 0.0 110.108 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.69 -1.4 53.11 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-O 119.664 -0.52 . . . . 0.0 113.63 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 20.1 mmtm -85.6 151.03 55.08 Favored Pre-proline 0 N--CA 1.45 -0.455 0 CA-C-N 119.447 1.624 . . . . 0.0 108.469 171.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -70.31 161.65 45.22 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 124.271 3.314 . . . . 0.0 113.191 -173.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 32.7 pt . . . . . 0 C--O 1.234 0.247 0 C-N-CA 125.56 1.544 . . . . 0.0 110.961 -175.55 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.0 mp0 . . . . . 0 N--CA 1.451 -0.424 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.6 t -53.8 -62.32 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 C-N-CA 125.299 1.44 . . . . 0.0 109.949 -178.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -52.36 -51.47 42.25 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-N 119.759 1.163 . . . . 0.0 112.678 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.03 -41.01 86.78 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 118.352 1.076 . . . . 0.0 111.923 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 68.1 t -70.99 -37.72 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 119.358 0.981 . . . . 0.0 110.913 176.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 40.5 mt -57.34 -56.98 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 176.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -54.17 -54.63 37.14 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 125.191 1.396 . . . . 0.0 109.512 -176.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -51.61 -60.72 2.83 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.788 1.235 . . . . 0.0 111.137 177.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.84 -27.35 72.44 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-O 118.692 -1.06 . . . . 0.0 113.042 -170.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.421 ' HG2' HD23 ' A' ' 32' ' ' LEU . 18.9 mtm105 -59.39 -59.42 5.48 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 118.314 1.057 . . . . 0.0 108.324 167.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -57.19 -39.55 75.61 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 125.547 1.539 . . . . 0.0 112.5 -175.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 56.7 m -58.91 -40.41 84.42 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 120.004 1.274 . . . . 0.0 110.529 177.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -81.27 -2.89 50.7 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.042 0.937 . . . . 0.0 111.568 176.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.31 7.9 69.11 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 126.393 1.949 . . . . 0.0 113.207 -176.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.2 mt -83.99 147.13 27.61 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 118.033 0.917 . . . . 0.0 110.408 -165.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 62.7 p -80.43 176.16 10.02 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.265 0.626 . . . . 0.0 110.344 177.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -63.6 -42.19 98.28 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 118.799 -0.62 . . . . 0.0 110.081 168.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -55.63 -42.35 74.84 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.245 1.018 . . . . 0.0 111.661 174.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -65.34 -40.08 93.21 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.421 HD23 ' HG2' ' A' ' 22' ' ' ARG . 0.3 OUTLIER -62.52 -49.5 75.08 Favored 'General case' 0 C--N 1.344 0.336 0 C-N-CA 123.578 0.751 . . . . 0.0 109.105 176.723 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.83 -57.25 10.84 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 124.947 1.299 . . . . 0.0 108.363 -177.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 85.7 m -61.71 -34.16 75.3 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.466 0.707 . . . . 0.0 112.229 176.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.5 mttm -63.35 -15.31 57.02 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 120.832 1.651 . . . . 0.0 112.817 173.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.0 pt -120.41 6.4 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 124.731 1.212 . . . . 0.0 111.072 175.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 40.8 t30 55.65 31.09 16.64 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 128.131 2.573 . . . . 0.0 114.53 -173.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -105.68 -177.01 3.24 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 125.424 1.49 . . . . 0.0 110.918 177.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -84.81 145.66 44.49 Favored Pre-proline 0 C--O 1.228 -0.059 0 C-N-CA 126.458 1.903 . . . . 0.0 111.359 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.03 -19.76 63.69 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.798 2.332 . . . . 0.0 111.961 171.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 28.5 tp60 -64.45 -46.93 81.0 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.87 175.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.6 m -69.6 -31.56 49.3 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.731 0 O-C-N 123.766 0.666 . . . . 0.0 110.244 -173.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 23.7 mm -64.8 -44.44 96.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 O-C-N 119.953 -1.717 . . . . 0.0 110.241 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.59 -32.52 72.62 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 174.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.43 -57.32 10.64 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.765 170.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -52.02 -35.61 47.5 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 126.236 1.815 . . . . 0.0 112.48 -178.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.42 ' CD ' HH21 ' A' ' 22' ' ' ARG . 22.6 mt-10 -67.89 -24.47 65.23 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.076 0.853 . . . . 0.0 112.036 176.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.42 -32.84 28.87 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.874 1.27 . . . . 0.0 110.419 164.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.95 33.74 32.43 Favored Glycine 0 CA--C 1.525 0.694 0 O-C-N 121.185 -0.947 . . . . 0.0 112.573 -173.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.5 mtt85 -71.69 -60.02 2.45 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 118.29 1.045 . . . . 0.0 109.56 177.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.71 137.87 43.19 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 128.081 2.553 . . . . 0.0 108.918 173.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.9 mt -73.53 116.77 54.69 Favored Pre-proline 0 C--O 1.236 0.386 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 175.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -67.35 115.64 3.79 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 122.489 2.126 . . . . 0.0 107.29 -172.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -97.13 142.6 28.86 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -173.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -60.72 -39.26 87.94 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 119.039 -0.505 . . . . 0.0 110.357 -171.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -59.91 -26.55 66.02 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 175.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 73.2 t -93.44 -43.92 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 119.997 1.271 . . . . 0.0 109.085 177.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 26.9 mt -50.0 -46.73 53.0 Favored 'General case' 0 C--O 1.227 -0.086 0 C-N-CA 124.244 1.018 . . . . 0.0 110.105 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.98 -40.1 95.03 Favored Glycine 0 CA--C 1.535 1.336 0 CA-C-N 118.207 0.458 . . . . 0.0 113.009 176.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.6 mtmm -60.67 -42.78 97.76 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 118.794 1.297 . . . . 0.0 110.803 175.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.8 mt -67.31 -35.79 74.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 123.759 0.824 . . . . 0.0 109.515 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -58.77 -47.66 83.94 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 119.43 1.014 . . . . 0.0 109.519 175.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 16.5 mtm-85 -64.4 -20.69 66.3 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 175.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.92 -52.41 24.78 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.872 0.869 . . . . 0.0 111.478 -179.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.426 HD11 HD21 ' A' ' 69' ' ' LEU . 47.8 pt -99.96 -15.7 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.762 0.825 . . . . 0.0 111.828 -177.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.38 27.77 61.02 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 126.011 1.767 . . . . 0.0 113.563 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 77' ' ' PRO . 58.9 mt -129.38 165.42 21.55 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.883 0.873 . . . . 0.0 108.973 173.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -70.32 145.05 51.48 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 125.326 1.451 . . . . 0.0 109.382 175.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.426 HD21 HD11 ' A' ' 65' ' ' ILE . 3.8 mm? -118.83 16.39 13.49 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.255 1.822 . . . . 0.0 109.462 175.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -144.92 162.18 37.5 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 125.364 1.466 . . . . 0.0 108.826 -171.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 70.44 171.63 10.27 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 124.633 1.111 . . . . 0.0 110.855 -174.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -67.54 -24.7 65.57 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.351 -1.088 . . . . 0.0 109.447 165.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -73.52 21.33 0.08 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.729 2.012 . . . . 0.0 112.126 175.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.7 tt -53.54 151.68 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 O-C-N 120.734 -1.229 . . . . 0.0 110.233 172.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.61 -6.83 10.31 Favored Glycine 0 CA--C 1.536 1.397 0 O-C-N 121.118 -0.989 . . . . 0.0 114.108 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 52.9 mmtt -71.01 148.5 94.47 Favored Pre-proline 0 N--CA 1.453 -0.313 0 CA-C-N 120.022 1.911 . . . . 0.0 107.529 163.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.412 ' HA ' HD23 ' A' ' 67' ' ' LEU . 27.9 Cg_endo -71.05 158.78 54.3 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.419 2.746 . . . . 0.0 111.609 -175.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 17.8 pt . . . . . 0 C--O 1.234 0.25 0 C-N-CA 123.589 0.756 . . . . 0.0 109.187 177.069 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 . . . . . 0 C--O 1.235 0.318 0 N-CA-C 111.385 0.143 . . . . 0.0 111.385 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.7 t -52.23 -63.84 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 C-N-CA 126.433 1.893 . . . . 0.0 109.141 176.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -51.56 -41.26 49.07 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-N 118.493 0.588 . . . . 0.0 112.998 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -64.94 -51.02 64.1 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 117.287 0.544 . . . . 0.0 110.299 -178.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.7 t -66.83 -33.77 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.104 0 C-N-CA 123.299 0.639 . . . . 0.0 110.149 -178.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 59.0 mt -56.03 -58.0 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 173.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -58.61 -47.61 83.76 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 123.898 0.879 . . . . 0.0 110.806 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -60.17 -53.29 59.5 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 118.899 0.772 . . . . 0.0 111.827 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.1 -25.45 74.62 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-O 118.48 -1.178 . . . . 0.0 112.966 -174.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.617 ' HG2' HD23 ' A' ' 32' ' ' LEU . 7.8 mtm105 -54.54 -67.71 0.24 Allowed 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 119.214 1.507 . . . . 0.0 110.482 160.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -61.46 -34.2 75.04 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 123.933 0.77 . . . . 0.0 110.527 -167.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.2 t -69.7 -10.39 58.1 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.031 0.932 . . . . 0.0 111.546 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -118.46 7.41 11.88 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.933 1.693 . . . . 0.0 110.308 173.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.15 2.44 40.05 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 126.308 1.908 . . . . 0.0 114.148 -177.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 21.4 mt -67.09 119.69 12.45 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 124.779 1.231 . . . . 0.0 107.71 -176.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.2 t -71.53 173.5 7.91 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.911 168.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -53.07 -55.33 24.69 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.51 -0.744 . . . . 0.0 109.754 174.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -58.58 -27.28 64.48 Favored 'General case' 0 C--O 1.227 -0.103 0 CA-C-N 118.515 0.598 . . . . 0.0 112.239 178.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -69.13 -36.07 77.07 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.125 -0.984 . . . . 0.0 111.109 173.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.617 HD23 ' HG2' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -68.77 -48.72 62.96 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.526 0.731 . . . . 0.0 110.943 -179.634 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.56 -51.95 57.28 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.854 0.862 . . . . 0.0 109.664 174.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 83.5 m -67.6 -30.07 69.57 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 118.734 -0.65 . . . . 0.0 111.592 -179.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.8 mttm -59.98 -49.55 77.24 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 120.279 1.399 . . . . 0.0 111.138 170.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.7 pt -86.53 -6.03 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 119.302 0.955 . . . . 0.0 112.731 -176.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.7 t30 59.15 65.16 1.24 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 128.851 2.861 . . . . 0.0 112.561 -171.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -133.86 178.78 6.68 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 126.913 2.085 . . . . 0.0 110.089 176.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -79.29 151.93 75.69 Favored Pre-proline 0 N--CA 1.463 0.18 0 C-N-CA 124.73 1.212 . . . . 0.0 109.116 169.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -79.78 -11.96 13.74 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.192 1.928 . . . . 0.0 115.306 -179.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -71.82 -43.85 64.89 Favored 'General case' 0 CA--C 1.515 -0.368 0 O-C-N 120.981 -1.075 . . . . 0.0 110.075 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.6 m -67.32 -38.22 80.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 -172.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 27.6 mm -55.82 -50.66 66.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 125.796 1.639 . . . . 0.0 110.821 170.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.11 -30.73 68.33 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 122.244 -0.285 . . . . 0.0 111.36 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.2 -30.93 49.19 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 118.418 -0.801 . . . . 0.0 111.382 177.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -59.11 -43.97 91.96 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 120.026 1.285 . . . . 0.0 110.231 169.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -56.23 -40.84 74.73 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -171.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.2 m -105.2 9.27 34.14 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.66 -0.92 58.14 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.144 -1.027 . . . . 0.0 114.258 163.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 19.5 mtm180 -91.91 -21.52 20.54 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 118.941 1.371 . . . . 0.0 114.367 -174.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.72 145.81 55.56 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 166.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 26.9 mm -72.79 116.77 53.47 Favored Pre-proline 0 C--O 1.238 0.49 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 171.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.42 123.26 9.37 Favored 'Trans proline' 0 N--CA 1.445 -1.324 0 N-CA-C 108.21 -1.496 . . . . 0.0 108.21 -178.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 63.3 t-20 -131.8 122.46 25.82 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 -171.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -48.99 -34.09 12.35 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.842 1.257 . . . . 0.0 113.522 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -57.27 -35.19 69.45 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 65.6 t -93.98 -41.97 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 126.968 2.107 . . . . 0.0 109.937 176.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 76.9 mt -56.81 -39.73 74.7 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 120.457 1.48 . . . . 0.0 110.753 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.02 -38.66 93.26 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-N 118.922 0.783 . . . . 0.0 112.573 175.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 24.0 mtmm -65.39 -47.54 75.97 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 117.627 0.714 . . . . 0.0 110.574 173.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 78.1 mt -60.64 -34.6 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 123.86 0.864 . . . . 0.0 110.331 -178.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -56.57 -50.31 72.31 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.654 -0.654 . . . . 0.0 110.396 175.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.4 mtt85 -59.42 -35.37 73.87 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 118.763 0.71 . . . . 0.0 110.72 176.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.72 -32.86 70.94 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.006 1.323 . . . . 0.0 112.929 -174.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 44.4 pt -115.57 -12.15 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 123.755 0.822 . . . . 0.0 112.172 177.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.79 40.0 98.0 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 126.516 2.008 . . . . 0.0 112.648 -174.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 41.0 mt -142.78 164.31 30.44 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.711 1.256 . . . . 0.0 109.33 173.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -68.72 142.99 54.85 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 126.442 1.897 . . . . 0.0 110.902 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -117.54 4.28 12.41 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.865 2.066 . . . . 0.0 111.226 177.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 37.1 mtt-85 -138.44 163.29 32.31 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.258 1.023 . . . . 0.0 110.804 176.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.76 166.56 16.94 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 125.581 1.562 . . . . 0.0 110.09 -170.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -73.63 -7.41 51.84 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.036 -1.273 . . . . 0.0 110.296 168.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -67.53 6.94 0.54 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.729 1.612 . . . . 0.0 112.286 164.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.7 tt -51.36 142.4 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 120.151 1.342 . . . . 0.0 110.983 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.14 3.6 53.02 Favored Glycine 0 CA--C 1.537 1.452 0 O-C-N 121.637 -0.664 . . . . 0.0 114.002 -178.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 20.3 mmtt -81.46 155.09 71.67 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 120.709 2.255 . . . . 0.0 105.959 159.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -70.92 158.25 55.93 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.803 2.335 . . . . 0.0 113.072 -171.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 28.5 pt . . . . . 0 C--N 1.332 -0.184 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 171.273 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.465 0.276 0 CA-C-O 118.979 -0.534 . . . . 0.0 111.934 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.0 t -53.89 -58.52 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 123.844 0.858 . . . . 0.0 108.728 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -51.47 -46.12 53.05 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-O 118.571 -1.127 . . . . 0.0 112.929 176.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 36.1 tttm -59.06 -53.04 62.83 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 118.874 1.337 . . . . 0.0 109.244 -178.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 92.6 t -62.67 -33.59 60.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 118.707 -0.663 . . . . 0.0 110.548 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 70.1 mt -66.16 -59.19 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 119.913 1.233 . . . . 0.0 108.634 176.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -51.59 -47.33 63.59 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 126.545 1.938 . . . . 0.0 110.209 -178.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -60.4 -66.34 0.54 Allowed 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.726 1.61 . . . . 0.0 109.994 174.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.16 -26.19 69.0 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-O 118.736 -1.036 . . . . 0.0 113.303 -169.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 19.2 mtm105 -58.13 -64.28 0.97 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.546 1.173 . . . . 0.0 109.045 165.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -69.41 -8.43 46.53 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.562 1.545 . . . . 0.0 113.571 -175.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.8 m -69.24 -13.77 62.59 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.877 1.271 . . . . 0.0 112.201 162.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -133.86 12.71 4.01 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.484 1.914 . . . . 0.0 111.475 172.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.41 4.43 17.58 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 125.292 1.425 . . . . 0.0 114.758 -175.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 25.3 mt -66.69 125.85 27.13 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 119.635 1.717 . . . . 0.0 109.431 -165.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 52.1 p -65.88 168.98 7.2 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.754 0.788 . . . . 0.0 110.248 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -64.42 -34.6 78.55 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.459 -0.776 . . . . 0.0 110.733 172.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.2 mtpt -61.33 -44.44 97.19 Favored 'General case' 0 CA--C 1.518 -0.271 0 O-C-N 121.737 -0.602 . . . . 0.0 110.976 171.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -66.23 -37.85 86.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 118.312 0.506 . . . . 0.0 110.419 -177.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.11 -51.95 67.81 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 171.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.76 -48.55 69.6 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.283 1.033 . . . . 0.0 110.151 -177.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.7 m -57.76 -46.1 84.99 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.282 1.033 . . . . 0.0 111.369 175.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.2 mttm -59.03 -22.28 60.43 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.41 1.004 . . . . 0.0 113.681 178.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.582 HG22 ' HB3' ' A' ' 60' ' ' LYS . 26.9 pt -113.41 6.05 7.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 119.534 1.061 . . . . 0.0 111.992 178.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 49.88 48.33 21.92 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.234 1.814 . . . . 0.0 111.156 -174.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.471 ' HG3' ' H ' ' A' ' 39' ' ' LYS . 3.1 tp10 -127.68 -171.06 2.35 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.618 1.967 . . . . 0.0 109.007 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.471 ' H ' ' HG3' ' A' ' 38' ' ' GLU . 11.0 mmpt? -103.87 146.18 32.04 Favored Pre-proline 0 CA--C 1.531 0.242 0 O-C-N 120.655 -1.278 . . . . 0.0 111.169 -174.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -73.19 -19.2 22.88 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.46 2.106 . . . . 0.0 114.161 -178.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -58.47 -52.31 66.18 Favored 'General case' 0 C--N 1.339 0.127 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 167.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.4 m -66.1 -29.04 45.49 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.532 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.808 -175.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 49.1 mm -61.62 -50.16 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 120.421 1.464 . . . . 0.0 110.251 174.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.24 -31.85 73.11 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 122.396 0.279 . . . . 0.0 111.589 178.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -77.08 -33.45 57.08 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 122.943 0.497 . . . . 0.0 110.405 177.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -57.69 -43.63 85.27 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 125.657 1.583 . . . . 0.0 110.016 170.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -60.06 -58.31 9.08 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.014 0.926 . . . . 0.0 109.451 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.46 -9.42 34.13 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 178.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.1 0.15 77.86 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-N 120.061 1.301 . . . . 0.0 113.457 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 72.4 mtt-85 -70.82 -43.9 67.63 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.896 1.279 . . . . 0.0 111.125 -176.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.19 139.25 58.75 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 173.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 50.3 mm -74.45 117.13 59.57 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 105.669 -1.975 . . . . 0.0 105.669 168.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -77.04 115.01 3.92 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 C-N-CA 121.223 1.282 . . . . 0.0 109.072 -171.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -81.38 131.18 35.27 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.892 1.677 . . . . 0.0 107.77 -174.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -54.8 -33.5 61.6 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.33 1.052 . . . . 0.0 113.137 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -60.97 -64.02 1.1 Allowed 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 122.1 0.952 . . . . 0.0 108.577 174.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.439 ' HA ' ' HD3' ' A' ' 60' ' ' LYS . 77.5 t -60.6 -41.11 86.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.816 1.247 . . . . 0.0 110.272 -174.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.2 mt -48.23 -46.22 35.11 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.047 0.939 . . . . 0.0 110.551 177.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.02 -33.56 62.41 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 118.6 0.637 . . . . 0.0 113.561 178.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.582 ' HB3' HG22 ' A' ' 36' ' ' ILE . 37.3 mtpt -64.46 -40.19 95.25 Favored 'General case' 0 N--CA 1.463 0.205 0 O-C-N 121.305 -1.115 . . . . 0.0 109.541 174.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.9 mt -63.64 -36.77 77.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 124.681 1.192 . . . . 0.0 108.746 174.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.458 ' HA ' HD23 ' A' ' 69' ' ' LEU . 54.6 mt-10 -57.19 -51.23 70.16 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 119.739 1.154 . . . . 0.0 110.241 174.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 60.6 mtt85 -63.18 -27.48 69.39 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.188 0.449 . . . . 0.0 111.545 175.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.1 -38.11 87.61 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.948 0.899 . . . . 0.0 112.187 179.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 22.9 pt -118.6 -9.04 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 119.134 0.879 . . . . 0.0 113.256 -176.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.44 36.36 93.28 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 126.555 2.026 . . . . 0.0 113.343 -176.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 84.7 mt -133.37 165.51 24.67 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.345 1.458 . . . . 0.0 108.156 169.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 53.3 mttm -76.25 141.88 41.57 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.615 1.566 . . . . 0.0 109.565 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.458 HD23 ' HA ' ' A' ' 62' ' ' GLU . 3.8 mm? -118.6 11.07 12.73 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 126.267 1.827 . . . . 0.0 110.968 178.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 5.8 mtt85 -140.22 167.9 21.06 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.254 1.422 . . . . 0.0 108.255 176.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 73.4 171.04 21.25 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.543 1.544 . . . . 0.0 111.158 -173.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.75 -13.08 60.06 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.359 -1.083 . . . . 0.0 110.163 165.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -75.01 18.5 0.18 Allowed 'General case' 0 CA--C 1.549 0.921 0 O-C-N 120.577 -1.327 . . . . 0.0 110.146 168.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.9 tt -53.85 148.04 2.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 O-C-N 120.301 -1.499 . . . . 0.0 110.62 173.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 67.62 -1.43 7.45 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 123.781 0.705 . . . . 0.0 113.504 -178.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 12.3 mmtp -73.69 155.12 89.28 Favored Pre-proline 0 N--CA 1.452 -0.367 0 CA-C-N 119.634 1.717 . . . . 0.0 106.968 160.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -57.22 156.64 24.32 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 122.792 2.328 . . . . 0.0 112.559 177.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 30.7 pt . . . . . 0 C--O 1.236 0.369 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 154.134 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 . . . . . 0 C--O 1.221 -0.4 0 CA-C-O 119.422 -0.323 . . . . 0.0 110.473 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.2 t -56.71 -58.26 6.27 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.316 0 C-N-CA 123.668 0.787 . . . . 0.0 109.67 177.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -56.57 -38.59 81.95 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 119.571 1.078 . . . . 0.0 112.363 178.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -62.05 -59.3 5.29 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.257 1.028 . . . . 0.0 110.096 175.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.4 t -61.35 -37.57 77.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 125.308 1.443 . . . . 0.0 110.347 -175.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 51.4 mt -53.47 -68.67 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 170.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -58.4 -34.05 70.32 Favored 'General case' 0 N--CA 1.445 -0.697 0 O-C-N 123.882 0.739 . . . . 0.0 110.8 -168.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -57.22 -69.69 0.15 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.093 1.757 . . . . 0.0 109.906 174.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.95 -32.1 73.14 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.776 -0.529 . . . . 0.0 111.776 -172.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -54.58 -62.01 1.93 Allowed 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 125.392 1.477 . . . . 0.0 108.798 172.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -63.19 -38.21 90.27 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 119.14 0.882 . . . . 0.0 111.449 -177.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 43.5 m -76.26 -2.31 30.79 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.377 0.99 . . . . 0.0 112.561 -177.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -115.55 12.86 16.25 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.256 1.022 . . . . 0.0 111.229 165.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.79 3.15 66.76 Favored Glycine 0 C--N 1.34 0.769 0 C-N-CA 128.03 2.729 . . . . 0.0 114.676 175.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.446 HD22 ' HE3' ' A' ' 35' ' ' LYS . 33.6 mt -72.95 130.16 39.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 118.781 1.29 . . . . 0.0 109.087 -159.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.0 p -68.51 170.75 8.52 Favored 'General case' 0 C--O 1.239 0.507 0 O-C-N 121.328 -0.858 . . . . 0.0 109.143 169.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -61.73 -30.1 70.55 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.64 -0.663 . . . . 0.0 110.408 168.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.4 mttt -71.24 -39.09 71.88 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.645 1.111 . . . . 0.0 112.3 175.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -64.65 -48.76 73.62 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.23 -47.63 78.08 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.789 0.836 . . . . 0.0 110.772 176.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.41 -50.39 73.86 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.536 0.734 . . . . 0.0 111.269 178.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.7 m -55.13 -47.72 74.67 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.068 1.347 . . . . 0.0 109.712 177.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.446 ' HE3' HD22 ' A' ' 27' ' ' LEU . 51.0 mttm -59.88 -15.45 21.47 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 125.453 1.501 . . . . 0.0 113.981 178.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.43 HD11 HD11 ' A' ' 43' ' ' ILE . 25.4 pt -122.35 15.43 5.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 118.998 0.817 . . . . 0.0 111.348 175.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.8 t30 57.53 13.14 1.75 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.166 1.386 . . . . 0.0 113.686 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -107.29 -170.87 1.77 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.762 2.025 . . . . 0.0 108.89 -173.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -102.51 149.65 36.9 Favored Pre-proline 0 N--CA 1.466 0.327 0 CA-C-N 120.024 1.284 . . . . 0.0 112.783 -175.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.71 -13.98 35.6 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 123.39 2.727 . . . . 0.0 112.919 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.9 tp60 -54.81 -60.15 3.76 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 123.588 0.755 . . . . 0.0 109.343 165.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.0 m -60.68 -41.09 86.93 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.52 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -172.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.43 HD11 HD11 ' A' ' 36' ' ' ILE . 44.0 mm -54.23 -47.28 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 119.252 0.933 . . . . 0.0 110.726 -178.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.8 -35.72 73.28 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.121 0.486 . . . . 0.0 112.134 176.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -79.18 -38.31 36.17 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.369 1.068 . . . . 0.0 110.992 -177.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -58.37 -39.7 80.28 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.216 1.407 . . . . 0.0 109.026 170.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -70.12 -33.09 71.41 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -178.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.2 t -73.85 -29.48 62.14 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.958 1.253 . . . . 0.0 109.41 167.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.55 10.84 49.48 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 124.002 0.81 . . . . 0.0 111.364 -174.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.7 mmt-85 -64.62 -60.93 2.55 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.258 1.023 . . . . 0.0 109.666 176.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.89 141.28 49.8 Favored 'General case' 0 C--O 1.239 0.543 0 O-C-N 124.787 1.304 . . . . 0.0 110.073 -172.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.402 HD12 ' N ' ' A' ' 52' ' ' ILE . 1.8 mp -74.14 123.99 89.66 Favored Pre-proline 0 CA--C 1.533 0.31 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 -177.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -67.18 114.86 3.37 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 121.561 1.508 . . . . 0.0 110.215 -178.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 -103.94 116.86 33.02 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 125.039 1.336 . . . . 0.0 108.418 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -47.27 -39.24 14.05 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.23 1.412 . . . . 0.0 113.472 -175.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -63.08 -52.97 60.59 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 118.416 0.553 . . . . 0.0 110.356 -178.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.525 ' HA ' ' HD3' ' A' ' 60' ' ' LYS . 23.9 t -63.66 -43.24 98.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 124.391 1.076 . . . . 0.0 108.36 -178.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 81.6 mt -53.7 -48.88 69.13 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-O 118.528 -0.748 . . . . 0.0 110.257 176.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.5 -34.4 69.0 Favored Glycine 0 CA--C 1.534 1.266 0 CA-C-N 119.24 0.927 . . . . 0.0 113.309 177.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.525 ' HD3' ' HA ' ' A' ' 57' ' ' VAL . 17.9 mtpp -70.57 -44.86 66.5 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.493 -1.004 . . . . 0.0 109.5 175.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.8 mt -59.62 -35.4 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.114 0 C-N-CA 124.862 1.265 . . . . 0.0 109.792 178.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -54.28 -51.76 63.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 119.039 0.836 . . . . 0.0 110.245 177.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 58.1 mtt180 -71.81 -8.4 54.05 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.493 -0.755 . . . . 0.0 112.804 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.37 -38.46 63.18 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.436 0.694 . . . . 0.0 110.719 173.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.429 HD11 HD21 ' A' ' 69' ' ' LEU . 25.7 pt -120.25 -10.51 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -172.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.26 33.69 83.38 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 126.628 2.061 . . . . 0.0 113.027 -178.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 67.8 mt -128.8 164.82 22.2 Favored 'General case' 0 CA--C 1.527 0.076 0 CA-C-N 118.126 0.963 . . . . 0.0 109.635 170.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -78.84 140.68 38.13 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 126.055 1.742 . . . . 0.0 108.738 174.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.429 HD21 HD11 ' A' ' 65' ' ' ILE . 4.3 mm? -120.01 -2.18 10.29 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 127.897 2.479 . . . . 0.0 110.462 -177.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.512 HH11 ' HG2' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -141.02 169.67 17.17 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.673 1.189 . . . . 0.0 109.136 176.935 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.53 164.51 18.96 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -169.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.9 ttmt -78.06 3.21 15.49 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.884 -0.774 . . . . 0.0 111.061 175.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -96.69 23.11 7.3 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.827 2.051 . . . . 0.0 110.499 171.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.3 tt -52.96 151.94 1.04 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-N 120.238 1.381 . . . . 0.0 110.763 177.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.83 -6.03 14.71 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 119.058 -0.857 . . . . 0.0 113.36 178.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 40.1 mmtt -76.02 150.97 83.85 Favored Pre-proline 0 N--CA 1.45 -0.441 0 CA-C-N 119.83 1.815 . . . . 0.0 107.744 166.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -69.99 157.15 60.87 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 123.253 2.636 . . . . 0.0 111.64 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.0 pt . . . . . 0 N--CA 1.461 0.093 0 C-N-CA 123.959 0.904 . . . . 0.0 108.775 177.069 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 . . . . . 0 N--CA 1.471 0.616 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.2 t -56.91 -61.33 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 C-N-CA 123.473 0.709 . . . . 0.0 109.227 -178.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.37 -33.1 65.06 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-N 119.325 0.966 . . . . 0.0 113.562 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 59.2 tptt -65.31 -55.09 20.22 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 125.421 1.488 . . . . 0.0 109.768 176.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 76.8 t -63.3 -39.16 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 CA-C-N 118.586 0.63 . . . . 0.0 110.573 178.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 83.3 mt -58.6 -56.31 17.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -51.47 -53.48 36.78 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.15 0.98 . . . . 0.0 109.662 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -58.98 -54.92 41.75 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 123.21 0.319 . . . . 0.0 110.977 -178.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.28 -25.01 76.32 Favored Glycine 0 CA--C 1.523 0.556 0 O-C-N 120.701 -1.249 . . . . 0.0 113.033 -172.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.427 HH11 ' HB3' ' A' ' 22' ' ' ARG . 20.0 mtm105 -60.07 -60.6 3.57 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 119.2 1.5 . . . . 0.0 109.511 162.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -64.6 -29.67 70.68 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.96 0.904 . . . . 0.0 111.916 -169.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.2 m -57.3 -20.97 31.73 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.485 1.114 . . . . 0.0 111.831 171.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -120.12 9.89 11.26 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.446 1.899 . . . . 0.0 109.462 -176.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 73.34 -4.75 24.47 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 126.565 2.031 . . . . 0.0 114.739 -177.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 52.1 mt -70.61 152.95 43.36 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 118.815 1.307 . . . . 0.0 111.539 -159.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.403 HG23 ' H ' ' A' ' 31' ' ' ASP . 0.5 OUTLIER -93.53 167.75 11.49 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.72 1.208 . . . . 0.0 110.393 172.056 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 9.3 mp0 -50.48 -39.72 48.98 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.64 0.776 . . . . 0.0 111.852 163.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 43.4 mttt -62.25 -38.61 89.89 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 118.502 0.592 . . . . 0.0 110.884 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.403 ' H ' HG23 ' A' ' 28' ' ' THR . 81.4 m-20 -66.65 -40.8 88.84 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 122.753 0.421 . . . . 0.0 110.089 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.84 -53.9 49.48 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 125.258 1.423 . . . . 0.0 109.161 177.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -48.83 -57.22 6.74 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.652 1.581 . . . . 0.0 109.739 178.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 18.5 m -57.93 -39.12 77.24 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.237 1.015 . . . . 0.0 112.803 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.9 mttm -58.68 -39.67 81.38 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 119.457 1.026 . . . . 0.0 112.36 176.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.7 pt -103.3 10.61 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 123.624 0.77 . . . . 0.0 111.376 -173.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.8 t30 65.32 42.68 3.81 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.925 2.09 . . . . 0.0 113.674 176.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -135.64 -177.44 4.68 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.032 0.933 . . . . 0.0 113.149 -174.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -92.43 145.23 30.17 Favored Pre-proline 0 C--N 1.339 0.135 0 C-N-CA 125.314 1.445 . . . . 0.0 110.345 178.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.1 -6.07 18.39 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.73 2.287 . . . . 0.0 112.951 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.3 tp60 -61.35 -51.39 69.04 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 118.501 -0.761 . . . . 0.0 110.684 169.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.7 m -68.79 -29.97 45.41 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.305 0 CA-C-N 118.906 0.775 . . . . 0.0 109.468 -176.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.7 mm -64.84 -46.64 91.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 124.048 0.939 . . . . 0.0 109.942 177.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.33 -35.91 74.7 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.061 0.544 . . . . 0.0 111.112 175.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.94 -40.94 62.72 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 121.731 -0.606 . . . . 0.0 110.978 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -53.91 -47.43 71.17 Favored 'General case' 0 C--N 1.334 -0.081 0 C-N-CA 125.066 1.346 . . . . 0.0 110.331 172.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -57.41 -42.69 82.81 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.572 0.749 . . . . 0.0 112.03 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.1 t -78.45 -25.41 45.91 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.825 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.72 44.89 2.58 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 -174.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 15.9 mmt85 -129.76 -21.65 3.05 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 125.171 1.388 . . . . 0.0 112.793 -171.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.28 133.48 49.78 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 169.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 41.0 mm -68.91 109.18 3.83 Favored Pre-proline 0 C--O 1.237 0.432 0 N-CA-C 104.779 -2.304 . . . . 0.0 104.779 169.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -84.19 114.2 1.85 Allowed 'Trans proline' 0 N--CA 1.445 -1.359 0 N-CA-C 108.568 -1.358 . . . . 0.0 108.568 -159.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -80.84 140.31 35.48 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -63.02 -29.26 70.68 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.077 0.853 . . . . 0.0 110.798 173.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -57.88 -60.85 3.07 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.522 1.129 . . . . 0.0 109.593 173.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.479 ' HA ' ' HE3' ' A' ' 60' ' ' LYS . 59.8 t -64.68 -46.19 93.04 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.259 0 CA-C-O 118.38 -0.819 . . . . 0.0 110.098 -177.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 25.1 mt -48.88 -48.43 42.17 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 123.894 0.878 . . . . 0.0 109.501 172.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.56 -44.15 85.82 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 125.721 1.629 . . . . 0.0 113.687 176.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.479 ' HE3' ' HA ' ' A' ' 57' ' ' VAL . 44.6 mtmt -65.66 -42.47 91.33 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 117.762 0.781 . . . . 0.0 110.753 175.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.1 mt -60.75 -33.32 54.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.743 0.817 . . . . 0.0 109.307 175.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.413 ' HA ' HD23 ' A' ' 69' ' ' LEU . 30.2 mt-10 -59.36 -46.38 88.81 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.775 1.17 . . . . 0.0 110.656 174.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 40.4 mtt-85 -58.13 -40.24 80.76 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 118.698 0.681 . . . . 0.0 110.367 173.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.0 -25.18 67.49 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.523 1.529 . . . . 0.0 114.627 -171.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.54 HD11 HD21 ' A' ' 69' ' ' LEU . 26.3 pt -125.41 -12.98 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-N 119.264 0.938 . . . . 0.0 112.086 176.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.9 29.89 64.34 Favored Glycine 0 C--N 1.336 0.577 0 C-N-CA 126.369 1.938 . . . . 0.0 113.165 -178.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.2 mt -130.05 163.32 26.78 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.397 1.479 . . . . 0.0 109.35 174.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -73.45 143.55 46.63 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 125.198 1.399 . . . . 0.0 108.946 175.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.54 HD21 HD11 ' A' ' 65' ' ' ILE . 3.9 mm? -119.03 8.81 11.67 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.105 1.362 . . . . 0.0 110.472 178.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 34.6 mtm105 -141.03 127.61 20.11 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 121.549 -0.72 . . . . 0.0 109.272 -166.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.01 179.22 48.83 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 125.168 1.366 . . . . 0.0 112.038 176.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -64.41 -13.17 49.67 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -93.51 22.81 5.03 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.094 0.861 . . . . 0.0 109.745 177.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.1 tt -55.2 149.24 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 O-C-N 120.95 -1.093 . . . . 0.0 110.368 178.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.57 -14.22 7.26 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-O 117.681 -1.622 . . . . 0.0 113.148 178.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 32.4 mmtt -68.19 144.36 96.74 Favored Pre-proline 0 N--CA 1.452 -0.373 0 CA-C-N 120.459 2.13 . . . . 0.0 107.882 173.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -69.27 150.75 71.57 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.613 2.875 . . . . 0.0 111.648 -177.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.4 pt . . . . . 0 C--O 1.235 0.298 0 C-N-CA 124.146 0.978 . . . . 0.0 109.663 -178.153 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 . . . . . 0 N--CA 1.465 0.283 0 CA-C-O 119.357 -0.354 . . . . 0.0 111.404 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.7 t -58.18 -62.06 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 124.24 1.016 . . . . 0.0 108.479 172.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.37 -40.13 60.52 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-N 119.394 0.997 . . . . 0.0 111.968 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -61.52 -58.14 9.33 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.098 0.949 . . . . 0.0 111.27 177.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.2 t -60.04 -36.98 70.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 123.955 0.902 . . . . 0.0 109.774 -178.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.444 HG13 HD11 ' A' ' 69' ' ' LEU . 75.4 mt -57.94 -62.27 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 174.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -56.14 -40.68 74.19 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 118.654 0.661 . . . . 0.0 111.411 -175.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -62.03 -43.93 97.79 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.511 1.524 . . . . 0.0 112.117 175.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -75.02 -33.29 55.21 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 124.742 1.163 . . . . 0.0 112.226 -176.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 15.4 mtm105 -65.71 -48.65 71.28 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 117.687 0.744 . . . . 0.0 110.216 169.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -55.5 -33.82 64.06 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.914 0.886 . . . . 0.0 112.485 175.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.1 t -64.08 -19.06 64.97 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.143 0.977 . . . . 0.0 111.701 -178.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.417 ' HE3' ' HA ' ' A' ' 65' ' ' ILE . 5.7 mtmm -130.57 7.22 4.85 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.785 1.234 . . . . 0.0 110.811 -175.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 48.58 47.31 29.79 Favored Glycine 0 C--N 1.337 0.614 0 C-N-CA 126.068 1.794 . . . . 0.0 113.127 -173.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.656 HD13 ' HE3' ' A' ' 35' ' ' LYS . 61.1 mt -101.81 119.52 38.91 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -177.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.464 HG23 ' H ' ' A' ' 31' ' ' ASP . 13.3 t -68.01 169.26 10.35 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.627 0.727 . . . . 0.0 109.462 176.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -64.38 -36.72 85.06 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.389 0.676 . . . . 0.0 109.842 178.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.423 ' HA ' ' HB3' ' A' ' 40' ' ' PRO . 7.4 mttt -57.4 -44.65 84.7 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.191 0.997 . . . . 0.0 113.434 167.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.464 ' H ' HG23 ' A' ' 28' ' ' THR . 2.3 m-20 -65.9 -43.53 87.93 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -176.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.87 -50.48 73.6 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.082 1.353 . . . . 0.0 111.387 176.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.23 -48.5 65.13 Favored 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 125.485 1.514 . . . . 0.0 109.981 177.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 20.5 m -61.42 -47.87 83.78 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.932 0.787 . . . . 0.0 111.508 175.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.656 ' HE3' HD13 ' A' ' 27' ' ' LEU . 50.5 mttm -55.56 -40.33 71.79 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 119.282 0.946 . . . . 0.0 111.98 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.3 pt -98.28 6.16 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 123.438 0.695 . . . . 0.0 112.256 -178.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 52.4 t30 44.46 63.94 1.5 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.488 2.315 . . . . 0.0 113.383 -173.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -138.93 -173.32 3.54 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.835 2.054 . . . . 0.0 110.114 174.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -82.55 148.16 57.78 Favored Pre-proline 0 N--CA 1.467 0.412 0 O-C-N 120.791 -1.193 . . . . 0.0 110.594 177.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.423 ' HB3' ' HA ' ' A' ' 30' ' ' LYS . 26.5 Cg_endo -66.39 -28.02 46.9 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.608 2.205 . . . . 0.0 111.872 169.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -67.67 -43.54 79.98 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 118.56 -0.733 . . . . 0.0 109.97 -178.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.9 m -68.37 -31.64 52.23 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.373 0 CA-C-O 117.827 -1.082 . . . . 0.0 110.69 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 41.5 mm -57.92 -49.82 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 120.093 1.315 . . . . 0.0 109.367 170.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.09 -22.92 65.08 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 121.541 -0.724 . . . . 0.0 112.622 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.67 -26.53 27.71 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 118.177 -0.916 . . . . 0.0 112.015 172.072 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -62.22 -59.09 5.54 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.395 1.452 . . . . 0.0 108.585 173.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.411 ' OE1' HG21 ' A' ' 18' ' ' ILE . 1.0 OUTLIER -52.66 -42.82 65.06 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 123.69 0.796 . . . . 0.0 112.859 176.521 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 27.3 m -66.68 -24.04 66.22 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 117.841 -1.076 . . . . 0.0 113.634 177.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.42 24.84 11.67 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 119.97 1.259 . . . . 0.0 113.732 -177.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -122.98 -30.85 3.72 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.015 1.407 . . . . 0.0 113.457 -170.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.7 132.94 49.19 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 170.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 39.4 mm -69.25 113.56 17.57 Favored Pre-proline 0 C--O 1.24 0.582 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 179.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.57 115.36 3.38 Favored 'Trans proline' 0 N--CA 1.445 -1.36 0 C-N-CA 122.648 2.232 . . . . 0.0 108.426 -175.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -95.77 147.8 23.25 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 174.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 59.6 t-20 -54.07 -45.02 71.62 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.913 1.285 . . . . 0.0 110.782 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -57.6 -52.01 67.17 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.513 0.725 . . . . 0.0 111.106 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.1 t -68.66 -40.48 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 O-C-N 121.748 -0.595 . . . . 0.0 110.635 -178.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 31.5 mt -51.49 -43.37 62.18 Favored 'General case' 0 C--O 1.22 -0.469 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 171.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.13 -39.59 97.35 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-N 119.169 0.895 . . . . 0.0 112.841 175.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -63.85 -44.48 93.03 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 119.185 1.492 . . . . 0.0 110.046 175.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.3 mt -64.34 -35.46 74.24 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.095 0 C-N-CA 124.984 1.314 . . . . 0.0 110.162 178.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.406 ' HA ' HD23 ' A' ' 69' ' ' LEU . 94.4 mt-10 -58.63 -51.0 71.76 Favored 'General case' 0 CA--C 1.512 -0.497 0 O-C-N 121.509 -0.744 . . . . 0.0 109.524 177.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -58.64 -40.1 82.44 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-O 118.789 -0.624 . . . . 0.0 110.804 176.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.18 -26.43 60.61 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.507 1.523 . . . . 0.0 113.895 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.424 HD11 HD21 ' A' ' 69' ' ' LEU . 16.9 pt -114.55 -15.02 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 119.74 1.155 . . . . 0.0 112.353 173.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.74 27.83 70.15 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 127.847 2.642 . . . . 0.0 113.597 -174.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.9 mt -136.56 158.58 44.11 Favored 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 124.842 1.257 . . . . 0.0 109.36 -179.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -66.65 139.99 57.89 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 125.598 1.559 . . . . 0.0 109.572 176.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.444 HD11 HG13 ' A' ' 18' ' ' ILE . 4.3 mm? -114.54 0.87 14.13 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.472 1.509 . . . . 0.0 109.972 171.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 53.2 mtm180 -135.42 142.39 45.61 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.863 1.265 . . . . 0.0 108.161 -169.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.62 163.03 12.34 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -173.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -73.41 -1.77 19.63 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.564 -0.962 . . . . 0.0 113.379 -175.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -77.44 16.07 0.68 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.883 0.765 . . . . 0.0 111.174 165.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.1 tt -50.3 135.54 9.3 Favored 'Isoleucine or valine' 0 C--O 1.242 0.706 0 CA-C-N 120.091 1.314 . . . . 0.0 110.699 -175.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.46 -3.85 71.29 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-O 119.541 -0.588 . . . . 0.0 113.537 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 20.0 mmtm -74.86 150.13 85.95 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 120.655 2.227 . . . . 0.0 107.202 163.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -66.14 157.96 57.04 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.951 2.434 . . . . 0.0 111.992 -174.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 17.8 pt . . . . . 0 N--CA 1.466 0.325 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 168.165 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 118.369 -0.824 . . . . 0.0 110.416 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 49.7 t -54.26 -56.73 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 120.054 1.297 . . . . 0.0 110.669 -173.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -54.71 -42.37 77.75 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-O 119.129 -0.817 . . . . 0.0 113.041 176.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.478 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 1.8 tpmt? -62.5 -48.5 79.3 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 118.599 1.199 . . . . 0.0 110.177 177.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.518 HG21 HG12 ' A' ' 74' ' ' ILE . 74.9 t -61.43 -43.09 96.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 124.536 1.134 . . . . 0.0 109.589 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.5 mt -59.51 -52.98 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 C-N-CA 124.324 1.05 . . . . 0.0 108.624 177.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -54.79 -50.18 69.13 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.267 1.427 . . . . 0.0 110.262 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -58.74 -56.2 25.32 Favored 'General case' 0 C--O 1.227 -0.109 0 C-N-CA 124.915 1.286 . . . . 0.0 111.31 178.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.5 -23.18 76.07 Favored Glycine 0 CA--C 1.52 0.403 0 CA-C-O 118.678 -1.068 . . . . 0.0 112.395 -171.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.4 mtm105 -60.6 -64.36 0.98 Allowed 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 119.178 1.489 . . . . 0.0 108.805 164.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -56.71 -37.74 71.34 Favored 'General case' 0 CA--C 1.52 -0.196 0 O-C-N 124.199 0.937 . . . . 0.0 111.098 -171.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.3 t -65.96 -13.84 60.5 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.812 -0.555 . . . . 0.0 111.52 -175.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -126.91 8.37 6.78 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.143 2.177 . . . . 0.0 110.212 -173.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.83 5.13 50.69 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 125.506 1.527 . . . . 0.0 114.221 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 19.7 mt -71.36 120.39 16.87 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 119.258 1.529 . . . . 0.0 108.882 -168.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 69.4 p -66.01 174.35 2.54 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.661 -0.65 . . . . 0.0 109.778 170.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -66.81 -41.35 87.67 Favored 'General case' 0 C--O 1.231 0.127 0 O-C-N 120.217 -1.552 . . . . 0.0 109.849 174.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.1 tttp -64.67 -25.33 67.9 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.11 0.564 . . . . 0.0 111.589 177.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -72.07 -45.37 60.98 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.437 0.695 . . . . 0.0 109.97 172.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.16 -46.85 88.27 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.374 0.534 . . . . 0.0 109.807 176.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.34 -50.37 65.15 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 125.232 1.413 . . . . 0.0 109.788 175.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.2 m -56.21 -49.63 73.56 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.367 1.067 . . . . 0.0 110.55 175.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -59.94 -16.12 27.38 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 124.935 1.294 . . . . 0.0 114.432 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.508 HD11 HD11 ' A' ' 43' ' ' ILE . 15.8 pt -126.82 9.39 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 119.807 1.185 . . . . 0.0 110.997 177.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.1 m120 54.88 30.7 14.34 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.042 1.737 . . . . 0.0 112.282 179.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -102.45 178.89 4.46 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.487 1.515 . . . . 0.0 110.318 -176.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -77.35 137.3 64.21 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 173.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -67.93 -22.47 42.21 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.488 2.125 . . . . 0.0 111.971 176.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 48.5 tp60 -61.65 -43.18 99.35 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.547 -0.721 . . . . 0.0 110.923 173.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.0 m -73.87 -28.16 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 119.013 0.824 . . . . 0.0 110.737 -176.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.508 HD11 HD11 ' A' ' 36' ' ' ILE . 37.4 mm -56.67 -48.21 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 119.298 0.954 . . . . 0.0 109.691 169.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.5 -35.53 70.34 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 123.43 0.457 . . . . 0.0 111.179 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -83.21 -23.18 32.91 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.551 0.741 . . . . 0.0 112.605 -177.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -62.23 -35.89 80.29 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.901 0.773 . . . . 0.0 109.801 166.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -70.48 -36.67 73.98 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.302 0.956 . . . . 0.0 111.627 175.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.4 m -66.73 -32.29 73.49 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.36 0.527 . . . . 0.0 111.876 173.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.46 7.28 57.05 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 124.82 1.2 . . . . 0.0 112.518 -172.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -78.52 -57.09 3.95 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.76 1.624 . . . . 0.0 110.822 -173.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.29 146.86 42.41 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 124.012 0.82 . . . . 0.0 109.078 -175.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 25.6 mm -68.84 122.06 83.62 Favored Pre-proline 0 C--O 1.237 0.406 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 -178.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.91 113.3 3.73 Favored 'Trans proline' 0 N--CA 1.444 -1.409 0 N-CA-C 106.148 -2.289 . . . . 0.0 106.148 171.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -125.56 138.78 53.96 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 118.878 -0.582 . . . . 0.0 109.721 -171.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -52.25 -46.28 65.7 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.999 1.32 . . . . 0.0 112.99 -165.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -55.39 -50.89 68.55 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -178.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.531 ' HA ' ' HD3' ' A' ' 60' ' ' LYS . 94.3 t -74.38 -47.87 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 124.785 1.234 . . . . 0.0 109.891 -174.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 42.5 mt -45.33 -49.65 12.69 Favored 'General case' 0 C--O 1.225 -0.218 0 C-N-CA 125.126 1.37 . . . . 0.0 110.378 175.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.76 -44.49 80.52 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 123.646 0.641 . . . . 0.0 113.184 176.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.531 ' HD3' ' HA ' ' A' ' 57' ' ' VAL . 17.6 mtpp -68.69 -38.24 80.16 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 121.771 -0.841 . . . . 0.0 109.125 -178.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.5 mt -62.4 -39.72 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 C-N-CA 123.777 0.831 . . . . 0.0 109.471 174.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -59.36 -48.99 79.55 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 119.649 1.113 . . . . 0.0 109.299 176.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 26.4 mtm105 -64.15 -18.58 64.58 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.371 0.668 . . . . 0.0 112.408 176.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.25 -55.74 5.7 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.727 1.211 . . . . 0.0 109.941 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.1 pt -91.76 -24.18 5.56 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 123.111 0.565 . . . . 0.0 110.746 -176.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.38 32.6 34.13 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 125.284 1.421 . . . . 0.0 112.593 -174.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.0 mt -135.72 163.41 30.25 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.057 1.743 . . . . 0.0 109.161 175.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 71.8 mttt -74.93 144.47 43.24 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 125.314 1.445 . . . . 0.0 110.776 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -118.69 16.95 13.63 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 127.323 2.249 . . . . 0.0 109.494 174.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -135.95 163.91 29.19 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 126.678 1.991 . . . . 0.0 109.449 -178.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 66.62 177.11 8.03 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 124.971 1.272 . . . . 0.0 112.11 176.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.8 tptt -72.89 -10.17 59.51 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.447 -1.031 . . . . 0.0 111.149 168.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -78.92 11.96 2.41 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.767 1.627 . . . . 0.0 111.616 172.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.518 HG12 HG21 ' A' ' 17' ' ' VAL . 5.3 tt -53.66 140.02 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 119.736 1.153 . . . . 0.0 110.704 -179.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.24 -10.79 40.46 Favored Glycine 0 CA--C 1.533 1.178 0 CA-C-O 117.743 -1.587 . . . . 0.0 114.078 -176.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 33.2 mmtt -66.53 151.76 95.82 Favored Pre-proline 0 C--N 1.345 0.373 0 CA-C-N 120.608 2.204 . . . . 0.0 107.768 166.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -58.04 158.93 19.76 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 123.76 2.973 . . . . 0.0 112.549 175.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 24.7 pt . . . . . 0 N--CA 1.466 0.332 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 165.841 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 56.1 mp0 . . . . . 0 CA--C 1.53 0.193 0 CA-C-O 118.288 -0.863 . . . . 0.0 112.192 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 55.8 t -59.12 -59.59 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 119.384 0.993 . . . . 0.0 110.138 179.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -55.52 -45.65 83.6 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-N 119.994 1.27 . . . . 0.0 113.267 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 49.7 tttp -56.75 -54.65 43.78 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 118.846 1.323 . . . . 0.0 109.462 175.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.2 t -61.94 -37.53 78.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 123.207 0.603 . . . . 0.0 110.586 -177.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 69.5 mt -61.16 -61.67 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 175.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -53.01 -45.56 67.99 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.209 1.404 . . . . 0.0 110.076 -175.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -59.9 -58.78 7.09 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.884 1.674 . . . . 0.0 111.749 175.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -52.48 -51.38 43.46 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.441 HH11 ' HB3' ' A' ' 22' ' ' ARG . 11.9 mtm105 -48.38 -61.86 1.79 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.179 0.992 . . . . 0.0 109.742 175.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -57.56 -33.39 68.09 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 124.344 1.057 . . . . 0.0 112.22 -177.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.89 -28.93 64.91 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.851 1.205 . . . . 0.0 111.703 -172.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -94.73 2.69 55.55 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.177 0.898 . . . . 0.0 111.832 167.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 61.51 43.7 98.96 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 110.816 -0.913 . . . . 0.0 110.816 -176.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 68.3 mt -109.97 159.58 17.15 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.163 1.385 . . . . 0.0 108.324 178.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.9 t -116.38 169.32 9.4 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.787 1.235 . . . . 0.0 110.046 -170.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -55.24 -44.25 75.34 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.527 1.131 . . . . 0.0 110.739 174.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.25 -39.67 72.95 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 118.347 -0.835 . . . . 0.0 111.769 173.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -75.76 -37.28 59.42 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 119.558 1.072 . . . . 0.0 111.158 -176.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.408 HD23 ' HG2' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -59.67 -49.05 79.23 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.78 1.232 . . . . 0.0 108.744 173.123 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.7 -49.33 73.29 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.15 1.38 . . . . 0.0 109.656 178.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.8 m -58.66 -44.87 90.27 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.812 0.733 . . . . 0.0 110.928 174.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.8 mttm -62.2 -27.29 68.87 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 117.295 -1.336 . . . . 0.0 113.263 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.53 HG22 ' HB3' ' A' ' 60' ' ' LYS . 28.0 pt -107.95 6.19 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 120.461 1.482 . . . . 0.0 112.578 176.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 56.5 t30 48.63 62.21 2.68 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.101 1.76 . . . . 0.0 112.738 -172.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -133.42 179.88 5.93 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 126.982 2.113 . . . . 0.0 109.242 176.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 25.0 mmtp -87.01 153.24 54.35 Favored Pre-proline 0 N--CA 1.47 0.551 0 C-N-CA 124.692 1.197 . . . . 0.0 109.796 169.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.68 -26.64 39.1 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.26 1.974 . . . . 0.0 111.391 176.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.0 tp60 -60.5 -29.81 69.31 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.01 0.924 . . . . 0.0 112.514 178.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.6 m -79.72 -35.35 16.38 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.37 0 CA-C-N 119.439 1.018 . . . . 0.0 109.81 174.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.403 HD11 HD11 ' A' ' 36' ' ' ILE . 29.8 mm -60.72 -44.74 97.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 120.273 1.397 . . . . 0.0 110.056 179.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.58 -30.36 65.2 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 176.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -89.09 -24.93 22.16 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.98 0.912 . . . . 0.0 111.854 178.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -62.9 -44.39 96.23 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 120.029 1.286 . . . . 0.0 108.917 166.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -59.92 -43.57 94.84 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.22 0.608 . . . . 0.0 110.582 172.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.2 m -66.3 -37.45 85.44 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.636 0.653 . . . . 0.0 111.815 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.74 29.37 8.21 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -169.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -111.11 -29.21 7.97 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.409 1.483 . . . . 0.0 111.477 -171.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.42 178.36 2.95 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.655 0.782 . . . . 0.0 110.082 170.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.4 mm -109.75 113.69 57.38 Favored Pre-proline 0 C--O 1.237 0.423 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -78.31 115.61 3.74 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 123.375 2.716 . . . . 0.0 109.298 -175.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -118.92 144.61 46.34 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.296 1.439 . . . . 0.0 108.958 -175.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.4 m-20 -48.33 -45.42 35.27 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.6 1.56 . . . . 0.0 111.942 -171.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -63.87 -52.15 61.32 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -173.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.433 ' HA ' ' HD3' ' A' ' 60' ' ' LYS . 8.9 t -64.1 -47.74 88.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-O 117.834 -1.079 . . . . 0.0 108.931 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.412 HD13 ' HD3' ' A' ' 70' ' ' ARG . 25.7 mt -46.6 -56.46 6.03 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 125.405 1.482 . . . . 0.0 109.625 174.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.13 -33.68 70.61 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 123.627 0.632 . . . . 0.0 113.559 178.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.53 ' HB3' HG22 ' A' ' 36' ' ' ILE . 23.8 mtpp -71.11 -46.67 61.23 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 118.746 1.273 . . . . 0.0 109.228 177.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.7 mt -61.82 -35.9 70.55 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.08 0 C-N-CA 124.542 1.137 . . . . 0.0 109.414 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -57.13 -50.52 72.55 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 176.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.457 ' HA ' HD11 ' A' ' 78' ' ' ILE . 61.0 mtt180 -58.48 -38.31 77.33 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 120.832 -1.168 . . . . 0.0 111.449 173.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.46 -25.91 60.42 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.229 1.012 . . . . 0.0 113.713 -176.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.415 HD11 HD21 ' A' ' 69' ' ' LEU . 45.5 pt -120.87 -10.73 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 124.323 1.049 . . . . 0.0 111.984 175.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.39 28.56 72.4 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 126.891 2.186 . . . . 0.0 113.337 -176.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.451 HD23 ' HA ' ' A' ' 77' ' ' PRO . 69.3 mt -138.27 163.18 32.42 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.419 1.488 . . . . 0.0 107.752 -178.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -86.41 143.13 27.96 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 126.778 2.031 . . . . 0.0 112.335 -170.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.415 HD21 HD11 ' A' ' 65' ' ' ILE . 4.1 mm? -118.98 6.53 11.35 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.756 1.622 . . . . 0.0 111.004 -176.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.412 ' HD3' HD13 ' A' ' 58' ' ' LEU . 81.5 mtm180 -141.8 156.92 45.55 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.789 1.236 . . . . 0.0 109.454 -177.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 73.98 172.39 26.3 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.505 1.05 . . . . 0.0 111.823 -174.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -65.4 -16.11 63.28 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.9 -0.765 . . . . 0.0 110.896 171.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.44 9.31 0.48 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.313 1.445 . . . . 0.0 111.913 173.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.5 tt -54.11 129.87 15.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 121.42 1.918 . . . . 0.0 110.009 -177.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.97 -15.44 59.39 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-O 118.743 -1.032 . . . . 0.0 114.404 -177.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.3 mtmt -68.24 152.4 96.55 Favored Pre-proline 0 N--CA 1.444 -0.748 0 CA-C-N 119.235 1.518 . . . . 0.0 107.765 170.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.451 ' HA ' HD23 ' A' ' 67' ' ' LEU . 28.2 Cg_endo -71.91 157.96 53.78 Favored 'Trans proline' 0 N--CA 1.447 -1.228 0 C-N-CA 122.724 2.283 . . . . 0.0 111.082 -174.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.457 HD11 ' HA ' ' A' ' 63' ' ' ARG . 10.5 pt . . . . . 0 C--O 1.235 0.322 0 N-CA-C 105.512 -2.032 . . . . 0.0 105.512 165.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 . . . . . 0 C--O 1.227 -0.122 0 CA-C-O 118.371 -0.823 . . . . 0.0 112.797 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.9 t -55.8 -61.12 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 171.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.56 -34.23 49.25 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-O 118.379 -1.234 . . . . 0.0 113.369 177.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -73.07 -48.38 36.45 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 119.405 1.603 . . . . 0.0 110.89 178.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 79.1 t -59.77 -40.01 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 118.945 0.793 . . . . 0.0 109.006 176.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.408 HG21 ' OE1' ' A' ' 47' ' ' GLU . 53.1 mt -58.17 -59.17 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 174.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -54.15 -45.9 72.14 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.151 0.58 . . . . 0.0 110.467 -177.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -54.94 -63.74 1.06 Allowed 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.071 1.349 . . . . 0.0 110.55 174.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.48 -34.95 87.67 Favored Glycine 0 CA--C 1.519 0.308 0 CA-C-N 119.002 0.819 . . . . 0.0 112.714 -172.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.518 HH21 ' HG2' ' A' ' 47' ' ' GLU . 27.1 mtm105 -62.74 -56.25 19.31 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 117.881 0.841 . . . . 0.0 109.125 173.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -54.97 -40.9 70.53 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.094 1.358 . . . . 0.0 111.467 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.7 m -66.63 -41.2 88.71 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.985 0.811 . . . . 0.0 109.484 -176.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 37.8 mtpt -84.21 -1.12 54.58 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.027 0.931 . . . . 0.0 112.682 177.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.39 16.38 64.95 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.503 1.049 . . . . 0.0 113.216 -175.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 43.1 mt -79.25 154.89 28.84 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 119.105 1.452 . . . . 0.0 109.694 -176.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 82.8 p -92.99 170.21 9.83 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.847 0.859 . . . . 0.0 110.718 175.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -60.45 -38.57 84.58 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.326 -0.859 . . . . 0.0 110.407 165.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.06 -38.59 83.27 Favored 'General case' 0 C--O 1.231 0.129 0 O-C-N 121.67 -0.644 . . . . 0.0 111.252 175.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -67.09 -35.1 79.07 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 117.968 0.349 . . . . 0.0 110.469 176.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.401 HD22 ' HB1' ' A' ' 64' ' ' ALA . 0.1 OUTLIER -65.24 -49.78 68.33 Favored 'General case' 0 CA--C 1.529 0.14 0 O-C-N 121.545 -0.722 . . . . 0.0 109.172 178.131 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.93 -44.9 64.09 Favored 'General case' 0 CA--C 1.522 -0.117 0 C-N-CA 124.701 1.2 . . . . 0.0 109.9 176.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 43.9 m -62.85 -52.22 63.96 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.619 1.167 . . . . 0.0 109.927 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -58.68 -20.78 51.44 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.203 1.401 . . . . 0.0 114.297 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.4 pt -115.15 2.66 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 123.809 0.844 . . . . 0.0 111.937 177.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.8 t30 50.97 55.6 9.3 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.275 1.83 . . . . 0.0 112.878 -175.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -128.11 -175.69 3.57 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 127.344 2.258 . . . . 0.0 109.725 175.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.75 146.55 37.25 Favored Pre-proline 0 N--CA 1.464 0.226 0 O-C-N 120.81 -1.181 . . . . 0.0 110.223 174.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -66.34 -16.86 52.93 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.57 2.18 . . . . 0.0 114.242 178.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -61.55 -43.21 99.27 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 119.413 1.006 . . . . 0.0 110.829 172.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.4 m -63.71 -32.6 57.53 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.412 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.132 -176.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 25.2 mm -63.28 -46.51 95.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 124.754 1.221 . . . . 0.0 109.648 177.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.21 -40.1 67.32 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.928 -0.483 . . . . 0.0 111.146 174.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -79.7 -28.45 40.65 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.392 0.677 . . . . 0.0 112.566 -178.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -62.91 -52.28 63.66 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.405 1.082 . . . . 0.0 108.918 171.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.518 ' HG2' HH21 ' A' ' 22' ' ' ARG . 0.7 OUTLIER -60.07 -42.71 95.15 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 175.563 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.6 t -66.97 -37.82 84.94 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 124.043 0.839 . . . . 0.0 110.713 -177.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.94 3.12 20.11 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 118.596 -1.113 . . . . 0.0 114.269 -175.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 49.4 mtm180 -102.86 -14.28 16.63 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.453 1.626 . . . . 0.0 113.764 -170.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.72 151.66 41.39 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 119.665 1.12 . . . . 0.0 108.458 174.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.2 mm -79.6 116.17 58.84 Favored Pre-proline 0 C--O 1.236 0.354 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 165.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -70.78 141.92 42.22 Favored 'Trans proline' 0 N--CA 1.448 -1.175 0 N-CA-C 108.897 -1.232 . . . . 0.0 108.897 175.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -136.34 150.33 48.8 Favored 'General case' 0 CA--C 1.513 -0.445 0 O-C-N 121.472 -0.767 . . . . 0.0 110.064 169.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -55.29 -41.65 72.59 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 125.106 1.362 . . . . 0.0 111.149 -175.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -52.98 -60.06 3.75 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.412 1.085 . . . . 0.0 110.051 175.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.578 ' HA ' ' HD3' ' A' ' 60' ' ' LYS . 41.1 t -64.87 -51.08 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-O 118.285 -0.864 . . . . 0.0 109.713 -176.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 71.9 mt -44.38 -50.69 9.07 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 124.922 1.289 . . . . 0.0 110.804 175.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.77 -36.07 92.19 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 118.691 0.678 . . . . 0.0 113.126 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.578 ' HD3' ' HA ' ' A' ' 57' ' ' VAL . 16.2 mtpp -68.67 -44.25 74.48 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 118.7 1.25 . . . . 0.0 108.96 175.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.428 HG21 HD13 ' A' ' 61' ' ' ILE . 61.5 mt -59.1 -35.73 58.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 123.493 0.717 . . . . 0.0 109.362 177.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.426 ' HA ' HD23 ' A' ' 69' ' ' LEU . 48.6 mt-10 -57.45 -44.45 84.76 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 119.642 1.11 . . . . 0.0 109.859 176.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -73.01 -13.89 61.31 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.541 1.136 . . . . 0.0 113.199 178.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.401 ' HB1' HD22 ' A' ' 32' ' ' LEU . . . -73.33 -41.61 63.29 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.294 1.038 . . . . 0.0 111.455 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 36.0 pt -116.56 -16.69 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.293 1.037 . . . . 0.0 111.552 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.44 30.22 46.08 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 125.793 1.663 . . . . 0.0 113.091 -178.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 77' ' ' PRO . 74.5 mt -123.72 163.12 21.75 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 118.486 1.143 . . . . 0.0 109.427 173.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.0 mttm -72.09 131.91 43.48 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 127.411 2.284 . . . . 0.0 108.252 172.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 62' ' ' GLU . 4.1 mm? -112.67 7.98 18.87 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 126.666 1.986 . . . . 0.0 110.206 176.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.47 161.69 39.89 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 126.832 2.053 . . . . 0.0 107.634 -175.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 70.17 160.49 3.03 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.165 0.888 . . . . 0.0 111.166 -168.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -63.73 -11.99 30.94 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 120.929 -1.336 . . . . 0.0 111.203 173.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.22 6.46 1.68 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.04 1.736 . . . . 0.0 111.35 173.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.9 tt -48.98 136.27 5.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-N 121.241 1.837 . . . . 0.0 110.909 -173.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.06 -11.62 66.67 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 124.001 0.81 . . . . 0.0 113.992 -177.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 49.7 mmtt -74.4 150.32 87.09 Favored Pre-proline 0 N--CA 1.452 -0.35 0 CA-C-N 119.271 1.536 . . . . 0.0 108.477 169.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 22.5 Cg_endo -70.8 161.99 44.15 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.309 2.672 . . . . 0.0 111.733 -177.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.7 pt . . . . . 0 C--N 1.339 0.148 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 178.464 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 . . . . . 0 CA--C 1.531 0.221 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 52.5 t -58.37 -57.06 12.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -178.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.14 -35.39 77.1 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 118.885 0.766 . . . . 0.0 113.191 -178.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.2 tptt -68.59 -52.75 28.24 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 124.001 0.92 . . . . 0.0 110.011 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 67.0 t -61.61 -36.52 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 49.1 mt -57.98 -60.12 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-O 118.161 -0.923 . . . . 0.0 108.924 173.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -53.8 -50.99 64.89 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.976 0.807 . . . . 0.0 109.905 -177.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -56.45 -48.47 76.98 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 126.345 1.858 . . . . 0.0 112.283 -178.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.99 -36.73 45.79 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-O 118.668 -1.073 . . . . 0.0 111.175 -175.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.483 ' HG2' HD23 ' A' ' 32' ' ' LEU . 15.4 mtm105 -56.77 -55.85 29.07 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 118.571 1.185 . . . . 0.0 109.763 170.151 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -50.78 -49.45 58.27 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 126.284 1.833 . . . . 0.0 110.883 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.6 m -63.63 -5.75 4.43 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.562 0.745 . . . . 0.0 112.412 -174.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -130.93 4.53 4.49 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.698 1.999 . . . . 0.0 110.638 -175.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.81 15.67 60.37 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.134 1.349 . . . . 0.0 113.546 -175.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 42.1 mt -73.73 127.08 31.84 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 119.086 1.443 . . . . 0.0 109.042 -170.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.4 p -67.57 169.54 9.12 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.697 0.761 . . . . 0.0 109.79 168.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -61.68 -34.55 75.93 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 120.999 -1.063 . . . . 0.0 110.086 166.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.89 -34.53 71.67 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-O 117.485 -1.245 . . . . 0.0 111.696 176.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -57.66 -51.76 68.19 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 119.787 1.176 . . . . 0.0 108.013 176.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.483 HD23 ' HG2' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -57.88 -48.23 80.44 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.882 0.873 . . . . 0.0 110.019 -176.967 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.07 -49.71 65.83 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.157 1.383 . . . . 0.0 110.202 177.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.1 m -60.66 -44.78 96.04 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.156 0.982 . . . . 0.0 111.174 175.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.8 mttm -53.19 -28.68 27.78 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.453 1.101 . . . . 0.0 112.208 175.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.576 HG22 ' HB3' ' A' ' 60' ' ' LYS . 20.3 pt -112.66 7.71 8.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 124.202 1.001 . . . . 0.0 113.079 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.16 21.77 5.49 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 127.027 2.131 . . . . 0.0 113.311 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.78 173.23 6.66 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.547 1.139 . . . . 0.0 109.853 -173.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -71.43 139.56 84.22 Favored Pre-proline 0 CA--C 1.53 0.204 0 C-N-CA 124.182 0.993 . . . . 0.0 110.93 -173.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -74.78 -10.73 21.73 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.451 2.767 . . . . 0.0 112.373 177.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.2 tp60 -58.84 -57.64 12.16 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 163.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.0 m -67.14 -24.32 31.9 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 CA-C-O 119.077 -0.487 . . . . 0.0 111.102 -169.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 43.6 mm -63.22 -47.68 91.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 124.489 1.116 . . . . 0.0 111.475 171.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.06 -36.62 84.92 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 122.562 0.345 . . . . 0.0 110.574 176.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.45 -31.69 65.66 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.201 0.6 . . . . 0.0 111.363 177.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -58.82 -38.32 78.38 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 125.341 1.456 . . . . 0.0 111.82 170.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -60.81 -58.83 6.8 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.019 0.528 . . . . 0.0 110.361 178.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.3 p -66.63 -27.11 67.43 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -176.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.21 8.11 56.75 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-O 119.856 -0.414 . . . . 0.0 112.281 -170.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 21.0 mtm180 -69.17 -38.12 78.54 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 118.288 1.044 . . . . 0.0 110.369 172.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.67 138.29 48.5 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.8 mm -76.62 126.25 86.28 Favored Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 168.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -68.76 158.83 56.23 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 121.645 1.563 . . . . 0.0 109.851 177.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 -136.51 137.26 40.12 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 171.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -54.51 -34.42 61.66 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.446 1.099 . . . . 0.0 110.925 -179.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -61.95 -58.26 8.58 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.566 0.746 . . . . 0.0 109.773 178.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 83.9 t -66.97 -46.15 85.51 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.453 0 CA-C-O 117.402 -1.285 . . . . 0.0 109.151 -176.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 62.3 mt -44.72 -56.17 4.67 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 120.794 1.634 . . . . 0.0 110.895 169.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.18 -14.19 52.36 Favored Glycine 0 CA--C 1.536 1.39 0 CA-C-N 118.566 0.621 . . . . 0.0 114.007 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.576 ' HB3' HG22 ' A' ' 36' ' ' ILE . 22.7 mtpp -89.39 -46.74 8.5 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 125.557 1.543 . . . . 0.0 110.444 171.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.0 mt -53.47 -37.5 30.26 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.191 0 C-N-CA 124.532 1.133 . . . . 0.0 108.698 175.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -55.95 -54.47 44.38 Favored 'General case' 0 C--O 1.223 -0.327 0 C-N-CA 119.65 -0.82 . . . . 0.0 111.343 175.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 23.6 mtm180 -69.35 -7.58 38.63 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.977 0.808 . . . . 0.0 112.738 176.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.35 -27.1 35.06 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.264 1.025 . . . . 0.0 111.686 176.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.541 HD11 HD21 ' A' ' 69' ' ' LEU . 16.1 pt -127.71 -11.55 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.026 0.93 . . . . 0.0 112.934 -178.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 66.06 39.09 94.59 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 126.02 1.771 . . . . 0.0 112.132 -174.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 77' ' ' PRO . 61.9 mt -132.02 162.81 29.85 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 124.336 1.054 . . . . 0.0 109.311 170.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -74.26 140.12 44.77 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 126.013 1.725 . . . . 0.0 108.538 174.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.541 HD21 HD11 ' A' ' 65' ' ' ILE . 3.4 mm? -117.46 11.17 13.79 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.937 1.295 . . . . 0.0 109.839 178.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 27.2 mtm105 -140.14 161.57 37.32 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.716 1.206 . . . . 0.0 109.418 178.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.12 169.47 24.98 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 124.327 0.965 . . . . 0.0 110.874 -175.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.658 ' H ' ' HD3' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -68.42 -17.64 64.26 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 121.772 -0.84 . . . . 0.0 111.38 170.772 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -77.95 15.03 0.95 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.375 1.47 . . . . 0.0 110.792 173.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.3 tt -52.55 142.35 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 O-C-N 120.888 -1.132 . . . . 0.0 110.084 175.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.56 0.03 57.23 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-O 117.577 -1.68 . . . . 0.0 113.948 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 33.7 mmtt -77.33 154.53 81.99 Favored Pre-proline 0 N--CA 1.453 -0.321 0 CA-C-N 119.893 1.846 . . . . 0.0 107.46 157.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 18.6 Cg_endo -70.32 163.68 37.83 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 123.266 2.644 . . . . 0.0 112.852 -179.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.0 pt . . . . . 0 N--CA 1.464 0.258 0 C-N-CA 126.192 1.797 . . . . 0.0 108.507 172.59 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.55 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 t -61.17 138.8 58.21 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.181 0.992 . . . . 0.0 109.42 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.3 p -152.27 174.58 13.61 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 167.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 135.0 -149.32 19.87 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 108.511 -1.836 . . . . 0.0 108.511 -175.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.3 m 76.6 72.68 0.07 Allowed 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.636 1.974 . . . . 0.0 108.655 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.9 p -122.38 118.74 29.14 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 127.24 2.216 . . . . 0.0 108.188 176.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -164.71 79.6 0.13 Allowed Glycine 0 C--N 1.331 0.286 0 N-CA-C 108.008 -2.037 . . . . 0.0 108.008 -177.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 50.28 93.12 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 127.81 2.444 . . . . 0.0 113.422 175.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.62 176.65 8.87 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 125.647 1.579 . . . . 0.0 108.572 168.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.7 t -77.86 160.85 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 175.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 65.1 p -133.46 121.6 22.46 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 105.231 -2.137 . . . . 0.0 105.231 173.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.7 mp -59.25 162.46 4.56 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 118.473 0.578 . . . . 0.0 109.574 174.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -61.14 -33.18 72.98 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-O 119.149 -0.453 . . . . 0.0 111.322 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.8 t -57.51 -54.73 27.26 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.253 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 171.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.4 -44.18 93.65 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-N 118.388 0.54 . . . . 0.0 112.372 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -59.68 -56.93 15.76 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 117.631 -1.176 . . . . 0.0 109.636 175.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 69.3 t -58.84 -36.07 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 120.357 1.435 . . . . 0.0 110.375 -178.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.6 mt -57.3 -59.24 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 174.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -57.11 -48.31 78.94 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.753 1.221 . . . . 0.0 110.784 -178.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -62.87 -46.38 88.13 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 125.123 1.369 . . . . 0.0 111.636 -176.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.39 -35.73 63.28 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-O 118.816 -0.991 . . . . 0.0 111.493 178.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.621 ' HG2' HD23 ' A' ' 32' ' ' LEU . 13.1 mtm105 -54.82 -61.61 2.2 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 118.049 0.924 . . . . 0.0 109.211 170.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -62.39 -30.82 71.47 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.131 0.972 . . . . 0.0 111.663 -172.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.8 m -63.88 -16.87 62.43 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 118.92 -0.562 . . . . 0.0 112.422 175.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -124.22 11.42 8.78 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.891 2.076 . . . . 0.0 110.314 -176.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.33 13.97 31.66 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.514 1.054 . . . . 0.0 114.678 -176.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 44.4 mt -78.36 119.95 22.42 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 119.945 1.873 . . . . 0.0 108.845 -170.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 62.1 p -64.67 168.9 5.5 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.557 0.694 . . . . 0.0 110.362 172.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -62.91 -34.51 77.58 Favored 'General case' 0 N--CA 1.464 0.258 0 O-C-N 120.424 -1.422 . . . . 0.0 110.428 174.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.93 -33.02 63.79 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.186 0.594 . . . . 0.0 109.73 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -63.65 -39.44 94.35 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.641 1.11 . . . . 0.0 109.557 171.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.621 HD23 ' HG2' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -64.89 -52.81 54.51 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 123.917 0.887 . . . . 0.0 110.312 179.848 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.93 -43.24 63.35 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 124.679 1.192 . . . . 0.0 110.403 177.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 60.7 m -60.11 -52.39 65.57 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.998 0.919 . . . . 0.0 110.379 174.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.3 mttm -57.23 -25.28 58.84 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 119.24 0.927 . . . . 0.0 113.196 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.3 pt -113.81 5.16 7.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 118.972 0.806 . . . . 0.0 112.227 -176.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.9 m120 54.5 54.94 8.62 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.524 1.529 . . . . 0.0 109.537 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -128.59 -178.6 4.65 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 126.922 2.089 . . . . 0.0 109.168 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 51.7 mmtt -81.02 149.73 67.22 Favored Pre-proline 0 C--N 1.333 -0.148 0 C-N-CA 123.853 0.861 . . . . 0.0 109.546 167.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.48 -11.5 26.46 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.668 2.245 . . . . 0.0 112.115 167.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -59.49 -57.94 10.77 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.952 1.301 . . . . 0.0 109.448 169.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.9 m -63.92 -33.27 61.02 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.556 0 CA-C-O 118.128 -0.939 . . . . 0.0 110.689 -173.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 42.8 mm -60.5 -46.51 95.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 120.166 1.348 . . . . 0.0 110.044 176.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.08 -28.91 69.95 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.169 0.587 . . . . 0.0 112.356 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -85.23 -38.46 18.9 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.846 0.858 . . . . 0.0 110.61 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -54.98 -40.98 70.64 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 126.328 1.851 . . . . 0.0 110.537 173.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -58.68 -42.94 89.66 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.82 0.848 . . . . 0.0 112.084 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 9.0 m -75.41 -35.32 61.02 Favored 'General case' 0 C--N 1.331 -0.207 0 O-C-N 122.097 -0.377 . . . . 0.0 110.222 175.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.85 46.34 3.17 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 -168.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 21.2 mtm-85 -128.42 -0.35 5.63 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 125.272 1.429 . . . . 0.0 113.309 -177.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -89.48 175.76 7.17 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 161.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 48.8 mm -93.8 112.66 57.87 Favored Pre-proline 0 C--O 1.239 0.541 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 171.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -77.49 115.51 3.91 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 123.138 2.558 . . . . 0.0 108.064 -177.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -113.84 142.5 46.01 Favored 'General case' 0 CA--C 1.517 -0.317 0 O-C-N 121.695 -0.628 . . . . 0.0 109.674 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -58.24 -26.23 62.64 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.791 0.836 . . . . 0.0 113.146 -171.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -62.91 -57.61 10.21 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.98 0.912 . . . . 0.0 110.528 173.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.2 t -68.68 -43.75 82.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 118.409 -0.805 . . . . 0.0 109.573 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 54.5 mt -49.48 -46.84 48.65 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.08 0.855 . . . . 0.0 110.337 171.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.99 -43.2 95.12 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 123.998 0.809 . . . . 0.0 112.722 176.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -61.8 -45.65 92.92 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 118.373 1.087 . . . . 0.0 110.796 174.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.0 mt -61.47 -33.69 58.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 C-N-CA 123.939 0.896 . . . . 0.0 110.324 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -56.8 -51.3 69.49 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 119.538 1.063 . . . . 0.0 110.419 176.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 52.5 mtt180 -54.12 -42.03 69.02 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.27 0.628 . . . . 0.0 109.874 177.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.04 -42.22 68.94 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.72 1.608 . . . . 0.0 113.09 -173.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 45.7 pt -114.74 -16.94 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 123.593 0.757 . . . . 0.0 112.167 -174.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.57 25.18 54.61 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 125.09 1.328 . . . . 0.0 113.052 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 77' ' ' PRO . 61.6 mt -130.59 162.95 28.18 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.081 1.352 . . . . 0.0 109.434 179.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 47.6 mttm -77.16 146.3 37.17 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 127.16 2.184 . . . . 0.0 110.312 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -121.32 5.03 10.24 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.512 1.525 . . . . 0.0 112.223 -175.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 66.3 mtm180 -139.59 163.5 32.39 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.681 1.592 . . . . 0.0 109.909 171.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 85.38 167.76 43.78 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 125.831 1.681 . . . . 0.0 109.538 -171.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -71.36 -9.76 58.67 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.455 -1.027 . . . . 0.0 110.137 163.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -75.09 8.17 2.78 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.547 1.939 . . . . 0.0 110.791 170.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.4 tt -52.54 141.46 6.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 O-C-N 120.275 -1.516 . . . . 0.0 110.279 175.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.3 -4.61 54.58 Favored Glycine 0 CA--C 1.537 1.428 0 CA-C-O 119.04 -0.867 . . . . 0.0 113.838 -177.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.5 mmtt -66.29 146.79 99.05 Favored Pre-proline 0 N--CA 1.454 -0.267 0 CA-C-N 119.877 1.839 . . . . 0.0 107.934 159.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.432 ' HA ' HD23 ' A' ' 67' ' ' LEU . 33.5 Cg_endo -70.43 162.11 43.59 Favored 'Trans proline' 0 N--CA 1.447 -1.262 0 C-N-CA 123.441 2.76 . . . . 0.0 111.222 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 19.1 pt -101.19 109.82 26.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 172.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 70.48 -72.15 0.12 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.638 2.375 . . . . 0.0 111.994 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -129.07 142.79 50.78 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 126.378 1.871 . . . . 0.0 107.886 175.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 167.64 166.28 26.46 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 126.789 2.138 . . . . 0.0 108.486 174.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -71.5 166.13 30.34 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.886 2.39 . . . . 0.0 111.283 -178.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 19.8 ptt180 -65.73 163.19 17.07 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.093 0.473 . . . . 0.0 111.33 173.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -141.63 161.32 38.21 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 125.785 1.634 . . . . 0.0 108.993 163.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 16.7 tttt -78.33 176.49 9.27 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.218 1.407 . . . . 0.0 108.065 174.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 36.4 p -136.73 -172.28 3.13 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.656 1.182 . . . . 0.0 109.151 173.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 174.92 170.24 37.75 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.736 1.16 . . . . 0.0 110.477 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -77.04 -175.62 2.75 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.953 2.435 . . . . 0.0 110.467 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.4 p -123.91 -165.14 1.31 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 125.685 1.594 . . . . 0.0 106.995 168.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.9 t -152.09 -173.51 4.56 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 157.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.748 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 178.443 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.575 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.2 m -135.67 -52.34 0.75 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.37 1.068 . . . . 0.0 110.458 -176.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.3 m -152.29 129.34 11.09 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 123.943 0.897 . . . . 0.0 108.738 -175.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -65.68 84.38 0.09 OUTLIER Glycine 0 CA--C 1.526 0.76 0 C-N-CA 124.99 1.281 . . . . 0.0 111.582 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 76.87 -12.77 1.01 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 128.923 2.889 . . . . 0.0 113.992 171.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 78.1 p -90.78 166.25 13.21 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 120.495 1.498 . . . . 0.0 110.442 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 165.74 68.28 0.03 OUTLIER Glycine 0 C--N 1.333 0.414 0 O-C-N 121.569 -0.707 . . . . 0.0 112.17 173.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -152.67 108.37 3.32 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 117.909 0.855 . . . . 0.0 108.752 178.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.57 174.97 4.85 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.531 1.933 . . . . 0.0 109.346 169.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.7 p -73.56 171.28 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 CA-C-N 118.667 0.667 . . . . 0.0 109.505 170.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.4 p -102.7 162.89 12.56 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.015 1.326 . . . . 0.0 111.017 174.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.9 mp -69.38 155.64 40.11 Favored 'General case' 0 N--CA 1.456 -0.125 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 169.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -61.6 -40.2 93.95 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 123.61 0.764 . . . . 0.0 111.018 -172.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.5 t -55.68 -58.38 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 123.575 0.75 . . . . 0.0 109.389 173.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.31 -40.02 95.42 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 118.891 0.769 . . . . 0.0 112.666 -178.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.36 -54.44 45.66 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.563 1.145 . . . . 0.0 110.242 176.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.4 t -63.25 -38.24 81.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 C-N-CA 123.618 0.767 . . . . 0.0 110.268 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 52.0 mt -56.81 -56.71 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.065 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 175.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -52.61 -55.28 23.44 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.194 0.598 . . . . 0.0 110.115 -178.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.23 -41.94 98.87 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 123.138 0.575 . . . . 0.0 111.468 -174.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.34 -41.61 45.05 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-O 119.204 -0.775 . . . . 0.0 111.396 -176.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.545 ' HG2' HD23 ' A' ' 32' ' ' LEU . 14.1 mtm105 -52.5 -60.11 3.64 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 117.669 0.734 . . . . 0.0 109.514 171.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.72 -31.33 72.47 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 123.702 0.626 . . . . 0.0 110.953 -171.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.8 t -64.2 -25.03 67.89 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.029 0.532 . . . . 0.0 111.77 176.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -112.98 13.08 19.44 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.913 1.285 . . . . 0.0 111.226 178.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.31 13.4 43.16 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.221 0.915 . . . . 0.0 113.446 -178.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 54.4 mt -74.04 118.89 17.52 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -171.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 27.0 p -65.72 174.3 2.4 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.626 0.726 . . . . 0.0 109.564 171.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -68.6 -37.16 79.58 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 120.747 -1.22 . . . . 0.0 110.137 174.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -64.86 -35.3 80.67 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 119.246 0.93 . . . . 0.0 111.612 172.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.63 -51.54 69.35 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 118.973 0.806 . . . . 0.0 109.048 176.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.545 HD23 ' HG2' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -60.81 -50.76 72.15 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 124.332 1.053 . . . . 0.0 109.888 -177.024 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -49.64 -52.36 31.28 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.092 1.357 . . . . 0.0 110.2 175.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.0 m -58.25 -44.54 88.38 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.857 0.863 . . . . 0.0 112.439 175.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.3 mttp -59.71 -16.29 26.02 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.445 1.02 . . . . 0.0 112.764 176.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.485 HG22 ' HB3' ' A' ' 60' ' ' LYS . 18.9 pt -117.69 8.97 7.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 124.808 1.243 . . . . 0.0 111.886 173.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.6 t30 55.12 6.78 0.15 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 128.494 2.718 . . . . 0.0 115.609 -174.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -102.64 -171.0 1.88 Allowed 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 124.537 1.135 . . . . 0.0 109.216 -171.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.413 ' O ' HG22 ' A' ' 42' ' ' VAL . 69.6 mmtt -95.87 141.36 23.05 Favored Pre-proline 0 N--CA 1.464 0.263 0 O-C-N 120.743 -1.223 . . . . 0.0 113.359 -168.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.09 -20.82 43.59 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.175 2.583 . . . . 0.0 112.585 -177.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.4 tp60 -56.82 -44.0 81.59 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 117.74 -1.124 . . . . 0.0 110.696 167.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.413 HG22 ' O ' ' A' ' 39' ' ' LYS 0.273 12.1 m -67.15 -36.1 75.99 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.345 0 CA-C-N 120.116 1.325 . . . . 0.0 109.917 179.812 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 42.1 mm -59.3 -49.01 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 119.827 1.194 . . . . 0.0 109.931 177.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.34 -36.59 71.36 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.24 -41.61 48.63 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.738 1.615 . . . . 0.0 111.827 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -57.94 -45.96 85.81 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.103 1.361 . . . . 0.0 108.81 175.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -55.17 -38.22 68.02 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.479 0.711 . . . . 0.0 111.392 175.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.52 2.24 56.49 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -179.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.15 13.21 77.65 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-N 120.27 1.396 . . . . 0.0 113.026 174.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -87.98 -57.52 2.9 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.671 1.588 . . . . 0.0 108.082 -169.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.52 142.62 48.42 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.76 0.824 . . . . 0.0 110.136 -177.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.8 mt -69.47 119.51 71.14 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 168.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.54 135.41 24.11 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.257 1.971 . . . . 0.0 109.149 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -133.8 132.78 40.88 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.008 0.923 . . . . 0.0 109.136 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -40.39 -46.18 2.33 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.647 1.979 . . . . 0.0 112.358 176.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -51.01 -48.88 61.32 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.377 0.671 . . . . 0.0 111.22 -178.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.501 ' HA ' ' HD3' ' A' ' 60' ' ' LYS . 58.2 t -79.73 -48.05 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 125.819 1.648 . . . . 0.0 108.636 -178.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 88.6 mt -50.46 -40.01 49.59 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.497 1.044 . . . . 0.0 111.742 177.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.17 -28.75 72.49 Favored Glycine 0 CA--C 1.526 0.768 0 O-C-N 121.036 -1.04 . . . . 0.0 112.47 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.501 ' HD3' ' HA ' ' A' ' 57' ' ' VAL . 18.9 mtpp -73.51 -47.51 40.53 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 124.619 1.168 . . . . 0.0 108.213 173.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.9 mt -58.1 -39.34 72.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 123.704 0.801 . . . . 0.0 110.32 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -60.32 -42.66 96.04 Favored 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 118.869 -1.132 . . . . 0.0 110.644 -178.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -66.78 -37.04 83.8 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 118.84 0.746 . . . . 0.0 111.447 174.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -54.66 -36.25 64.4 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.941 1.696 . . . . 0.0 111.946 -177.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 24.5 pt -113.25 -19.1 7.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 118.999 0.818 . . . . 0.0 112.029 176.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.74 30.08 60.29 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 125.506 1.526 . . . . 0.0 113.061 -176.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' A' ' 77' ' ' PRO . 29.9 mt -132.56 161.45 33.79 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 124.839 1.256 . . . . 0.0 108.3 173.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -71.32 141.12 50.47 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 125.499 1.52 . . . . 0.0 109.408 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -115.88 -1.34 12.6 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.721 1.608 . . . . 0.0 109.506 175.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.4 mtm105 -132.76 142.05 48.82 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.537 1.535 . . . . 0.0 108.491 -177.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.59 167.49 36.62 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 125.135 1.35 . . . . 0.0 111.104 -178.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -70.59 -12.14 61.38 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 121.687 -0.89 . . . . 0.0 111.396 172.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -82.04 16.91 1.73 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.106 2.162 . . . . 0.0 111.267 171.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.2 tt -52.06 141.88 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 O-C-N 120.613 -1.305 . . . . 0.0 110.161 176.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.97 -10.06 10.23 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-O 118.762 -1.021 . . . . 0.0 114.065 -177.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.3 mmtt -70.78 151.06 95.29 Favored Pre-proline 0 N--CA 1.453 -0.294 0 CA-C-N 120.843 2.321 . . . . 0.0 106.016 161.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.455 ' HA ' HD23 ' A' ' 67' ' ' LEU . 14.1 Cg_endo -67.96 157.02 63.66 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.863 2.376 . . . . 0.0 111.246 -174.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 25.9 pt -101.02 160.1 3.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 161.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 44.36 80.17 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.616 1.566 . . . . 0.0 112.197 167.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -62.93 84.56 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.585 1.154 . . . . 0.0 112.132 -175.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.68 -151.35 16.22 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 125.292 1.425 . . . . 0.0 110.216 166.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.53 125.23 14.04 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.771 2.981 . . . . 0.0 111.745 -168.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 57.3 mtp180 37.59 53.37 1.41 Allowed 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.357 1.863 . . . . 0.0 111.692 -173.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.7 67.25 0.78 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.345 1.058 . . . . 0.0 109.655 172.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -68.95 166.34 18.11 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 127.567 2.347 . . . . 0.0 111.21 -176.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.5 t -146.9 -63.72 0.29 Allowed 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 121.303 -0.873 . . . . 0.0 109.105 167.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 129.76 94.7 0.73 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 106.647 -2.581 . . . . 0.0 106.647 -168.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -81.02 -7.68 13.16 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 122.526 2.15 . . . . 0.0 114.034 -165.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.6 t -86.31 -50.43 6.94 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 172.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.3 m 52.48 -179.08 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.02 1.328 . . . . 0.0 110.984 -157.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.629 0 N-CA-C 106.427 -2.669 . . . . 0.0 106.427 -159.572 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.802 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -105.6 82.46 1.81 Allowed 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 105.534 -2.025 . . . . 0.0 105.534 154.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.1 m -121.52 96.22 4.99 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -167.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 62.89 79.76 0.14 Allowed Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.788 1.185 . . . . 0.0 113.233 175.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.1 t -77.25 128.41 34.3 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.867 1.267 . . . . 0.0 108.997 173.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.7 m 47.55 48.15 17.06 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.118 1.367 . . . . 0.0 112.875 171.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.83 29.21 0.63 Allowed Glycine 0 CA--C 1.529 0.91 0 C-N-CA 126.397 1.951 . . . . 0.0 113.966 178.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -157.18 157.84 35.15 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 126.083 1.753 . . . . 0.0 108.113 -177.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -96.23 8.11 44.71 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.83 0.852 . . . . 0.0 113.062 -170.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 p -139.86 78.67 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 120.662 1.574 . . . . 0.0 108.595 -176.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -61.51 133.77 56.09 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.959 176.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -58.63 153.49 16.32 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 171.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -57.93 -42.13 84.21 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 119.091 -0.48 . . . . 0.0 110.737 -175.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 63.4 t -58.62 -66.38 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 125.028 1.331 . . . . 0.0 109.695 174.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.59 -29.41 40.07 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 119.182 0.901 . . . . 0.0 113.498 -177.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.7 tttt -72.58 -55.51 6.79 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 117.654 -1.165 . . . . 0.0 110.701 175.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.3 t -58.84 -39.26 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 120.101 1.319 . . . . 0.0 110.28 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 86.4 mt -54.96 -61.21 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 175.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -63.35 -39.9 95.81 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 -172.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -58.25 -46.82 85.26 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.688 1.595 . . . . 0.0 111.381 176.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.94 -43.74 81.46 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -178.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.9 mtm105 -54.89 -59.55 4.57 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 117.341 0.57 . . . . 0.0 110.54 173.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -58.89 -33.05 70.07 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.636 0.775 . . . . 0.0 110.885 -176.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.0 t -68.31 -8.45 39.82 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 118.23 -0.891 . . . . 0.0 113.395 177.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -132.37 7.88 4.25 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 120.363 1.438 . . . . 0.0 111.505 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 57.19 32.15 63.01 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-N 118.793 0.724 . . . . 0.0 112.174 -173.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 44.8 mt -85.38 119.78 26.13 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.7 t -73.88 171.71 12.9 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.143 0.883 . . . . 0.0 109.964 176.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -61.68 -37.64 84.87 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 120.364 -1.46 . . . . 0.0 110.841 176.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.4 mttp -59.28 -32.6 70.18 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.078 0.854 . . . . 0.0 112.684 170.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -70.32 -39.25 74.87 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 119.422 1.01 . . . . 0.0 108.604 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.68 -48.02 76.28 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -50.89 -51.2 54.15 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 126.221 1.808 . . . . 0.0 109.455 177.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 60.1 m -61.49 -47.29 86.3 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.985 1.314 . . . . 0.0 111.037 177.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.6 mttm -64.21 -20.49 66.06 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 26.6 pt -111.34 -2.33 10.25 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.356 0 CA-C-N 120.179 1.354 . . . . 0.0 111.214 174.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 53.5 t30 44.92 71.5 0.26 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.695 1.598 . . . . 0.0 112.466 -167.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -140.26 177.65 7.84 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 127.36 2.264 . . . . 0.0 109.179 166.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 28.2 mtmt -79.38 141.48 57.18 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 124.061 0.944 . . . . 0.0 111.916 177.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -66.51 -11.13 30.4 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.41 2.74 . . . . 0.0 115.227 -178.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 42.4 tp60 -75.89 -27.79 57.85 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 120.699 1.591 . . . . 0.0 111.379 169.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 m -68.1 -35.8 72.93 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.413 0 CA-C-N 120.832 1.651 . . . . 0.0 108.293 173.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 33.6 mm -59.67 -50.44 79.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 C-N-CA 124.207 1.003 . . . . 0.0 110.078 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.4 -32.11 73.45 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.928 -0.483 . . . . 0.0 112.089 176.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.82 -27.98 61.39 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 120.798 -1.189 . . . . 0.0 110.97 175.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -69.46 -37.7 77.43 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.653 1.581 . . . . 0.0 110.87 175.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -55.29 -56.8 15.93 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 167.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.5 m -66.58 -19.88 65.88 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.22 1.008 . . . . 0.0 113.46 -172.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.34 -10.31 73.37 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 123.773 0.702 . . . . 0.0 114.5 -175.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 28.9 mtt-85 -77.23 -21.21 54.13 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 118.199 1.0 . . . . 0.0 112.39 -174.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.14 115.22 19.58 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 105.264 -2.125 . . . . 0.0 105.264 168.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.2 mm -69.1 113.73 18.49 Favored Pre-proline 0 C--O 1.238 0.47 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 -171.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -77.33 114.57 3.77 Favored 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 121.783 1.655 . . . . 0.0 110.563 -163.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -110.5 144.23 39.65 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.945 0.898 . . . . 0.0 109.539 -174.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -53.41 -40.46 65.12 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -171.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -52.51 -60.63 3.0 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.052 0.941 . . . . 0.0 109.662 177.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.579 ' HA ' ' HD3' ' A' ' 60' ' ' LYS . 70.9 t -65.96 -44.8 92.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-O 118.328 -0.844 . . . . 0.0 109.49 -175.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.7 mt -51.3 -44.79 61.98 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.783 0.72 . . . . 0.0 110.2 176.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.82 -43.96 94.46 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.024 0.821 . . . . 0.0 113.068 175.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.579 ' HD3' ' HA ' ' A' ' 57' ' ' VAL . 15.8 mtpp -65.23 -42.88 92.94 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 121.304 -1.115 . . . . 0.0 109.651 178.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.2 mt -60.81 -32.99 53.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 123.563 0.745 . . . . 0.0 109.271 176.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.465 ' HA ' HD23 ' A' ' 69' ' ' LEU . 38.3 mt-10 -58.49 -49.03 78.84 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 120.078 1.308 . . . . 0.0 110.212 178.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 48.5 mtt85 -68.6 -20.91 64.52 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.606 -0.684 . . . . 0.0 112.496 175.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.27 -54.81 41.31 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.405 HD11 HD21 ' A' ' 69' ' ' LEU . 50.2 pt -100.22 -18.07 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -176.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.19 20.87 58.25 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 125.871 1.701 . . . . 0.0 113.533 -177.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 77' ' ' PRO . 60.8 mt -125.47 161.73 26.46 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 125.14 1.376 . . . . 0.0 108.913 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -72.18 139.78 48.41 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 125.244 1.418 . . . . 0.0 109.226 177.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 62' ' ' GLU . 3.2 mm? -119.72 -1.39 10.57 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.218 1.807 . . . . 0.0 110.961 177.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.3 mmm180 -125.46 155.14 40.95 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 119.496 1.044 . . . . 0.0 108.68 170.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.13 159.93 6.63 Favored Glycine 0 N--CA 1.447 -0.613 0 O-C-N 124.843 1.339 . . . . 0.0 110.573 -178.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -73.18 -4.24 31.66 Favored 'General case' 0 N--CA 1.464 0.273 0 O-C-N 121.001 -1.293 . . . . 0.0 112.131 -176.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -73.32 12.4 0.59 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.849 0.749 . . . . 0.0 110.572 162.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.7 tt -48.56 134.03 5.96 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 CA-C-N 120.269 1.395 . . . . 0.0 109.125 176.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.32 -4.76 66.15 Favored Glycine 0 CA--C 1.538 1.521 0 CA-C-O 119.155 -0.803 . . . . 0.0 114.15 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 40.9 mmtt -72.57 151.39 91.54 Favored Pre-proline 0 N--CA 1.455 -0.206 0 CA-C-N 119.989 1.895 . . . . 0.0 106.794 159.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 30.8 Cg_endo -72.47 160.75 46.02 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 123.423 2.749 . . . . 0.0 111.489 -178.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 36.8 pt -101.11 138.49 25.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 173.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 49.12 23.16 0.71 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.3 1.84 . . . . 0.0 114.187 170.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.1 pttp -22.82 85.46 0.0 OUTLIER 'General case' 0 C--O 1.236 0.358 0 C-N-CA 130.923 3.689 . . . . 0.0 115.257 -168.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.66 -164.49 39.15 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.898 1.713 . . . . 0.0 112.142 -174.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -62.02 95.06 0.14 Allowed 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 124.819 3.679 . . . . 0.0 111.148 176.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 65.0 ttt-85 -140.75 121.08 13.96 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 170.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 41.01 75.55 0.08 Allowed 'General case' 0 C--O 1.234 0.284 0 C-N-CA 126.886 2.074 . . . . 0.0 111.212 -175.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -152.21 -46.89 0.1 Allowed 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 118.545 -0.74 . . . . 0.0 111.055 -173.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.5 m 48.0 72.51 0.26 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.526 1.13 . . . . 0.0 111.544 -171.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -66.52 -163.37 1.5 Allowed Glycine 0 CA--C 1.538 1.523 0 C-N-CA 125.515 1.531 . . . . 0.0 112.572 173.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -61.3 -19.17 62.84 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 123.078 2.519 . . . . 0.0 114.341 -168.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.3 p -136.45 -69.75 0.47 Allowed 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 154.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.2 t -154.68 -67.61 0.13 Allowed 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 171.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.857 0 CA-C-O 117.857 -1.524 . . . . 0.0 109.317 -172.984 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.729 0 CA-C-O 118.648 -1.084 . . . . 0.0 110.716 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.2 m -166.33 167.6 15.77 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.496 1.519 . . . . 0.0 108.84 172.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.5 m -135.6 -53.1 0.76 Allowed 'General case' 0 C--N 1.334 -0.098 0 C-N-CA 124.293 1.037 . . . . 0.0 108.404 162.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 68.19 170.19 5.53 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -165.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.09 119.38 4.69 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 171.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.6 m 48.06 -160.53 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.962 1.705 . . . . 0.0 113.315 -176.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.17 129.98 2.91 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 126.376 1.941 . . . . 0.0 109.79 -177.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -61.29 119.6 8.78 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 125.019 1.328 . . . . 0.0 113.143 -166.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -98.49 175.19 6.11 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.522 1.129 . . . . 0.0 110.869 178.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.8 p -145.19 155.64 13.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 125.574 1.55 . . . . 0.0 108.36 -175.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 70.5 p -85.29 78.91 9.68 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 122.876 1.322 . . . . 0.0 108.563 166.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.0 tp -53.67 130.97 38.19 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 126.026 1.73 . . . . 0.0 107.928 178.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 69.5 mt-10 -55.76 -47.81 76.37 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 126.002 1.721 . . . . 0.0 112.856 -167.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.5 t -57.97 -51.22 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 176.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.45 -36.5 84.63 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 118.771 -1.016 . . . . 0.0 112.895 175.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -63.19 -55.92 21.04 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 119.024 1.412 . . . . 0.0 109.235 176.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.4 t -64.12 -34.55 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-N 119.311 0.96 . . . . 0.0 110.573 -178.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.4 mt -59.18 -59.49 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 171.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -56.69 -41.28 77.09 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 118.836 0.744 . . . . 0.0 110.75 -174.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -62.79 -57.13 11.98 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.405 1.882 . . . . 0.0 110.822 176.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.69 -32.66 83.76 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 118.205 0.457 . . . . 0.0 111.995 -175.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.566 ' HG2' HD23 ' A' ' 32' ' ' LEU . 25.3 mtm105 -53.51 -61.41 2.32 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 166.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -50.55 -46.56 57.6 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.713 1.205 . . . . 0.0 111.69 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.2 m -71.11 -6.79 41.97 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.42 1.088 . . . . 0.0 113.409 -176.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.546 ' HE3' HD11 ' A' ' 27' ' ' LEU . 26.5 mtpp -120.06 8.12 10.94 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.899 1.68 . . . . 0.0 111.535 167.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.09 19.58 51.71 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.777 1.179 . . . . 0.0 113.015 -176.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.546 HD11 ' HE3' ' A' ' 25' ' ' LYS . 79.6 mt -84.34 131.87 34.66 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 118.804 1.302 . . . . 0.0 108.552 -171.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.4 p -75.75 176.57 7.61 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 171.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -68.07 -37.58 81.41 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.179 -0.951 . . . . 0.0 110.73 172.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.6 tmtp? -63.26 -39.23 94.01 Favored 'General case' 0 N--CA 1.462 0.125 0 C-N-CA 123.107 0.563 . . . . 0.0 110.873 174.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -67.55 -42.22 83.01 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 177.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.566 HD23 ' HG2' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -58.04 -50.67 72.65 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 123.744 0.817 . . . . 0.0 110.089 176.35 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -48.54 -53.47 18.1 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 125.269 1.428 . . . . 0.0 109.978 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 35.1 m -63.09 -40.74 98.56 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.647 0.779 . . . . 0.0 111.933 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.7 mttp -61.81 -12.19 16.08 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 119.719 1.145 . . . . 0.0 113.81 174.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 24.8 pt -123.6 10.38 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 119.99 1.268 . . . . 0.0 111.583 175.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 37.09 68.85 0.25 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 128.453 2.701 . . . . 0.0 112.067 -168.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -131.35 -178.67 4.95 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 127.44 2.296 . . . . 0.0 107.437 173.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -93.67 151.57 40.11 Favored Pre-proline 0 CA--C 1.531 0.233 0 C-N-CA 124.362 1.065 . . . . 0.0 110.595 171.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -67.03 -17.27 51.03 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 123.676 2.917 . . . . 0.0 113.697 -178.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 -65.51 -52.24 54.08 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 118.502 0.592 . . . . 0.0 110.398 177.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.1 m -63.55 -27.61 43.33 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.378 0 C-N-CA 120.5 -0.48 . . . . 0.0 109.965 -175.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 38.0 mm -61.38 -53.32 50.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 123.084 0.554 . . . . 0.0 110.574 174.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.17 -39.9 73.07 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 118.957 0.798 . . . . 0.0 111.485 177.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.88 -31.15 67.72 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 118.678 -0.677 . . . . 0.0 111.086 -178.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -63.06 -45.63 91.28 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 125.288 1.435 . . . . 0.0 111.342 172.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.415 ' CD ' HH21 ' A' ' 22' ' ' ARG . 4.7 mt-10 -58.86 -32.96 69.92 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.292 0.637 . . . . 0.0 111.328 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 43.7 m -82.8 -23.15 33.96 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 174.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.2 0.15 80.72 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 119.624 1.102 . . . . 0.0 114.218 -169.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.8 mtt85 -69.49 -47.12 64.9 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 117.867 0.834 . . . . 0.0 109.561 -177.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.39 134.82 57.35 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 171.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 34.0 mm -68.95 120.39 76.02 Favored Pre-proline 0 C--O 1.237 0.416 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -71.44 115.54 4.33 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.503 2.135 . . . . 0.0 110.5 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -106.2 122.2 45.74 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 126.509 1.923 . . . . 0.0 107.697 -178.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -55.73 -24.8 37.08 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 119.813 1.188 . . . . 0.0 113.221 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -61.55 -55.93 25.53 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.491 0.716 . . . . 0.0 109.284 174.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.0 t -71.26 -38.76 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.4 -177.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.4 mt -50.44 -46.39 56.53 Favored 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 169.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.61 -46.89 91.6 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 124.138 0.875 . . . . 0.0 112.036 177.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -57.85 -43.7 86.05 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 117.935 0.867 . . . . 0.0 110.828 175.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.0 mt -65.24 -35.77 76.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 124.685 1.194 . . . . 0.0 110.325 178.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.488 ' HB3' HG21 ' A' ' 78' ' ' ILE . 69.9 mt-10 -59.93 -49.91 75.82 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 119.495 1.043 . . . . 0.0 108.616 176.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.8 mtm105 -57.59 -31.32 66.06 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 122.871 0.468 . . . . 0.0 111.288 175.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.47 -53.7 26.55 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.011 0.924 . . . . 0.0 112.227 -177.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 35.6 pt -90.05 -16.5 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 122.418 0.287 . . . . 0.0 111.269 -177.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.92 27.28 58.77 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 125.871 1.701 . . . . 0.0 113.186 -175.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 77' ' ' PRO . 24.2 mt -143.37 161.38 38.51 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.727 1.764 . . . . 0.0 109.887 179.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -68.28 142.83 55.46 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 126.163 1.785 . . . . 0.0 110.746 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 62' ' ' GLU . 4.2 mm? -118.17 10.33 12.89 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.467 1.107 . . . . 0.0 110.398 173.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 25.1 mtm105 -139.8 157.27 46.0 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 121.32 -0.863 . . . . 0.0 109.711 -178.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.96 167.91 21.04 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -170.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 43.2 tttp -68.94 -14.08 62.82 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.363 -1.08 . . . . 0.0 110.642 172.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -64.93 8.23 0.13 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.695 1.998 . . . . 0.0 112.426 168.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.7 tt -50.24 135.9 8.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-N 120.552 1.524 . . . . 0.0 110.283 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.28 -4.68 62.18 Favored Glycine 0 CA--C 1.533 1.204 0 CA-C-O 119.045 -0.864 . . . . 0.0 114.406 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 44.7 mmtt -70.07 153.14 95.57 Favored Pre-proline 0 N--CA 1.453 -0.314 0 CA-C-N 119.808 1.804 . . . . 0.0 107.101 161.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.42 ' HA ' HD23 ' A' ' 67' ' ' LEU . 11.5 Cg_endo -67.18 168.78 16.67 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.062 2.508 . . . . 0.0 112.53 -176.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.488 HG21 ' HB3' ' A' ' 62' ' ' GLU . 34.4 pt -107.55 115.57 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 175.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 61.59 -171.15 0.15 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.667 1.187 . . . . 0.0 110.213 177.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? 46.96 53.53 10.38 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.368 1.067 . . . . 0.0 110.413 177.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 178.67 -167.35 37.7 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 108.453 -1.859 . . . . 0.0 108.453 -158.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -69.43 100.79 0.8 Allowed 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.245 2.63 . . . . 0.0 109.609 -171.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.51 141.62 23.08 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 -173.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -133.67 138.11 45.7 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.728 1.211 . . . . 0.0 108.167 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 40.2 mttm -145.08 113.57 6.67 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 160.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 59.1 m -138.88 29.52 2.3 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.634 1.173 . . . . 0.0 110.243 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -157.67 162.82 32.28 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 108.287 -1.925 . . . . 0.0 108.287 168.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.28 150.83 71.61 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.51 2.14 . . . . 0.0 109.845 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.8 t -72.0 132.21 43.97 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 157.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.2 m -60.23 148.63 35.79 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.55 0.74 . . . . 0.0 111.205 -172.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.412 -1.215 . . . . 0.0 110.85 176.976 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.282 0 CA-C-O 118.577 -1.124 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 83.4 p 49.47 30.51 3.44 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 162.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.7 t -75.44 117.46 17.25 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 121.029 -1.044 . . . . 0.0 109.085 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -100.48 -83.25 1.72 Allowed Glycine 0 CA--C 1.523 0.554 0 N-CA-C 108.299 -1.92 . . . . 0.0 108.299 167.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 62.9 m 60.25 -67.56 0.04 OUTLIER 'General case' 0 C--O 1.235 0.309 0 C-N-CA 129.018 2.927 . . . . 0.0 113.807 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 55.21 177.0 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.965 1.706 . . . . 0.0 111.911 -163.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 120.83 52.45 0.25 Allowed Glycine 0 C--N 1.333 0.415 0 C-N-CA 125.015 1.293 . . . . 0.0 110.42 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -158.67 175.71 13.29 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.149 1.38 . . . . 0.0 108.549 174.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -137.05 15.87 3.04 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.525 0.73 . . . . 0.0 112.225 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.8 m -70.77 154.61 7.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.9 p -148.94 93.54 2.12 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -171.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 18.1 tp -67.98 136.85 54.56 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 173.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -61.75 -58.12 9.25 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 119.238 -0.41 . . . . 0.0 111.235 -173.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.0 t -57.58 -57.37 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 125.742 1.617 . . . . 0.0 109.8 178.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -49.12 -46.7 33.79 Favored Glycine 0 C--O 1.223 -0.537 0 C-N-CA 124.849 1.214 . . . . 0.0 112.246 177.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -62.1 -49.08 77.36 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 119.008 1.404 . . . . 0.0 110.958 178.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 63.6 t -60.63 -41.99 90.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-N 119.482 1.037 . . . . 0.0 110.983 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.402 HG13 HD11 ' A' ' 69' ' ' LEU . 21.2 mt -54.15 -68.19 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 106.209 -1.775 . . . . 0.0 106.209 173.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -57.87 -30.37 65.77 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 125.079 1.352 . . . . 0.0 110.413 -167.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -64.55 -69.38 0.29 Allowed 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.715 1.606 . . . . 0.0 110.924 171.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.58 -29.34 74.62 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-N 119.413 1.006 . . . . 0.0 111.765 -171.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.4 ttp85 -53.74 -60.45 3.3 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 126.218 1.807 . . . . 0.0 108.76 168.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -67.42 -28.94 68.33 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 119.809 1.186 . . . . 0.0 113.334 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 59.0 m -61.03 -20.42 62.5 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.187 0.903 . . . . 0.0 111.99 172.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.456 ' HE3' HD11 ' A' ' 27' ' ' LEU . 25.7 mtpp -109.67 5.9 23.29 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.915 1.686 . . . . 0.0 111.073 175.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.06 9.75 54.66 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 126.442 1.972 . . . . 0.0 113.68 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.456 HD11 ' HE3' ' A' ' 25' ' ' LYS . 34.7 mt -74.15 130.78 40.43 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 118.559 1.179 . . . . 0.0 109.231 -163.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 32.1 p -66.02 162.35 19.61 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 166.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -55.19 -37.24 66.8 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 121.469 -0.77 . . . . 0.0 109.863 169.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -63.85 -43.46 96.05 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.05 0.54 . . . . 0.0 111.298 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -70.02 -35.55 74.41 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 118.853 -0.594 . . . . 0.0 110.628 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.63 -46.05 90.15 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.747 0.703 . . . . 0.0 109.937 173.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.61 -54.44 45.98 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 124.722 1.209 . . . . 0.0 108.978 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 52.0 m -68.01 -31.4 71.06 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 117.962 -1.018 . . . . 0.0 111.608 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.1 mttp -52.75 -50.58 63.19 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 119.945 1.248 . . . . 0.0 110.47 173.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.9 pt -88.13 2.42 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 123.174 0.59 . . . . 0.0 112.383 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 62.3 t-20 45.02 74.21 0.14 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 128.973 2.909 . . . . 0.0 111.716 -170.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -139.35 173.6 11.37 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 128.612 2.765 . . . . 0.0 109.906 178.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.8 mmpt? -81.44 144.21 52.93 Favored Pre-proline 0 CA--C 1.534 0.341 0 O-C-N 121.505 -0.747 . . . . 0.0 109.882 173.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.32 -16.52 13.64 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.334 2.022 . . . . 0.0 114.452 -172.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 -68.04 -34.16 75.95 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 120.331 1.423 . . . . 0.0 110.782 173.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.6 m -72.22 -27.81 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 119.686 1.13 . . . . 0.0 110.155 177.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 36.3 mm -63.92 -50.51 77.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 C-N-CA 123.221 0.609 . . . . 0.0 109.414 172.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.17 -35.58 71.77 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.126 0.489 . . . . 0.0 110.462 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -72.94 -31.03 64.33 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 117.974 -1.012 . . . . 0.0 112.462 176.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -57.08 -50.84 71.54 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-N 120.019 1.281 . . . . 0.0 109.958 170.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -67.55 -29.68 69.12 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 119.188 -0.434 . . . . 0.0 110.965 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.6 m -71.11 -37.1 72.37 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.299 0.954 . . . . 0.0 111.716 176.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 113.85 9.37 16.45 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 124.943 1.259 . . . . 0.0 113.441 -176.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.5 mmt85 -101.29 -42.63 6.24 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 124.546 1.138 . . . . 0.0 110.955 -163.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.85 130.02 42.45 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 174.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 30.1 mm -68.3 124.9 90.89 Favored Pre-proline 0 C--O 1.238 0.456 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 -177.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -76.58 111.81 3.33 Favored 'Trans proline' 0 N--CA 1.442 -1.525 0 N-CA-C 106.836 -2.024 . . . . 0.0 106.836 -175.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -104.9 130.65 53.01 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 -174.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -50.54 -31.51 15.85 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 117.85 -1.071 . . . . 0.0 113.64 -178.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -65.24 -59.55 3.95 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 120.838 1.654 . . . . 0.0 110.673 172.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.1 t -59.7 -47.46 91.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 124.143 0.977 . . . . 0.0 110.034 -176.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 78.8 mt -47.68 -51.03 23.23 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 124.432 1.093 . . . . 0.0 109.538 169.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.72 -43.44 69.32 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 123.718 0.675 . . . . 0.0 112.576 177.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt -66.45 -44.04 83.88 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.14 0.97 . . . . 0.0 109.946 177.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.3 mt -60.01 -37.22 71.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 124.76 1.224 . . . . 0.0 109.903 178.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -58.35 -47.37 84.01 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 119.229 0.922 . . . . 0.0 109.564 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 26.1 mtt-85 -69.75 -27.22 64.76 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 118.296 -0.859 . . . . 0.0 112.326 176.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.75 -40.15 79.02 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.818 0.847 . . . . 0.0 112.056 176.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 22.1 pt -117.2 -16.07 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -174.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.1 30.88 62.4 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 125.225 1.393 . . . . 0.0 112.813 -176.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 77' ' ' PRO . 69.7 mt -124.11 164.32 19.68 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 118.631 1.216 . . . . 0.0 109.489 169.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -78.76 140.85 38.2 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 126.033 1.733 . . . . 0.0 108.22 176.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.402 HD11 HG13 ' A' ' 18' ' ' ILE . 3.0 mm? -120.07 7.84 10.9 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.563 1.145 . . . . 0.0 108.985 -179.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 22.8 mtm105 -141.63 168.61 19.35 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 127.208 2.203 . . . . 0.0 108.461 177.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 68.91 158.26 1.45 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -162.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 24.3 mtmt -64.63 -15.6 61.46 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 120.876 -1.367 . . . . 0.0 111.387 164.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -66.62 11.69 0.09 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.323 2.249 . . . . 0.0 111.906 168.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.1 tt -51.84 144.52 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 O-C-N 120.485 -1.384 . . . . 0.0 110.532 177.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.79 -4.03 24.29 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-O 118.911 -0.938 . . . . 0.0 113.152 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 39.6 mmtt -69.51 150.79 96.87 Favored Pre-proline 0 N--CA 1.446 -0.667 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 157.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.459 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 14.8 Cg_endo -69.33 158.5 57.28 Favored 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 122.448 2.099 . . . . 0.0 111.365 -177.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 27.8 pt -101.53 150.19 6.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 105.796 -1.928 . . . . 0.0 105.796 158.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 63.5 -77.27 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.487 1.915 . . . . 0.0 112.568 170.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.7 tttm -65.58 94.04 0.18 Allowed 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.786 1.234 . . . . 0.0 108.911 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -56.37 151.82 22.22 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.524 -0.631 . . . . 0.0 111.524 -170.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -62.04 125.39 16.35 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.739 2.293 . . . . 0.0 109.083 -167.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 35.7 mtt180 53.18 33.49 15.4 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.007 0.523 . . . . 0.0 111.705 175.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.76 113.9 1.12 Allowed 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.511 1.125 . . . . 0.0 108.118 167.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.0 tptm -74.21 -36.12 63.96 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -153.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 35.8 m -70.53 176.5 4.05 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.32 0.648 . . . . 0.0 112.037 -174.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 38.65 57.75 1.87 Allowed Glycine 0 CA--C 1.527 0.793 0 C-N-CA 127.111 2.291 . . . . 0.0 114.633 171.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -67.33 -18.19 49.95 Favored 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 122.336 2.024 . . . . 0.0 113.114 -177.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 70.5 m 36.67 79.96 0.03 OUTLIER 'General case' 0 C--O 1.236 0.347 0 C-N-CA 126.881 2.072 . . . . 0.0 112.339 178.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 70.0 m -58.94 154.24 15.73 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 154.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.924 0 CA-C-O 116.905 -2.053 . . . . 0.0 109.093 -165.817 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.66 0 N-CA-C 111.658 -0.577 . . . . 0.0 111.658 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.4 m 57.13 -172.07 0.09 Allowed 'General case' 0 C--O 1.241 0.649 0 C-N-CA 125.828 1.651 . . . . 0.0 112.391 -173.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.9 p -148.4 -169.62 3.4 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.284 1.834 . . . . 0.0 108.703 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 98.35 79.85 1.49 Allowed Glycine 0 C--N 1.335 0.524 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 171.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.1 m -161.81 84.24 0.6 Allowed 'General case' 0 C--O 1.24 0.602 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 165.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.1 m -58.48 -41.34 85.07 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.373 1.069 . . . . 0.0 110.716 -174.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.29 171.35 43.12 Favored Glycine 0 C--N 1.337 0.585 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -176.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -166.71 111.74 0.78 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 124.748 1.219 . . . . 0.0 108.252 172.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 62.5 mtt85 -152.05 159.0 43.81 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 124.786 1.234 . . . . 0.0 111.62 177.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.7 m -79.02 150.44 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 123.384 0.674 . . . . 0.0 110.078 155.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.1 t -172.36 172.06 4.55 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 127.92 2.488 . . . . 0.0 107.438 167.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.1 mp -58.09 152.61 16.38 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.223 1.409 . . . . 0.0 109.768 173.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -58.62 -43.96 89.84 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.467 0.307 . . . . 0.0 111.132 -178.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.5 t -57.9 -56.94 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 124.07 0.948 . . . . 0.0 109.094 177.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -55.21 -39.82 72.68 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-O 118.947 -0.918 . . . . 0.0 112.745 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 48.8 tptt -60.2 -57.7 11.69 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.633 1.216 . . . . 0.0 109.733 176.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.4 t -61.81 -31.9 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 118.662 0.665 . . . . 0.0 110.029 -177.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.1 mt -65.76 -56.41 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 CA-C-N 119.809 1.186 . . . . 0.0 109.061 176.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -51.88 -49.38 63.09 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.599 1.16 . . . . 0.0 110.404 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -66.39 -53.06 40.21 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.104 1.762 . . . . 0.0 111.958 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.23 -34.24 89.39 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 124.413 1.006 . . . . 0.0 111.519 -174.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 18.9 mtm105 -64.69 -51.31 63.13 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 118.531 -0.747 . . . . 0.0 111.28 168.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -51.8 -37.76 52.92 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.751 0.82 . . . . 0.0 111.399 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.2 m -73.92 -2.39 23.72 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.621 1.968 . . . . 0.0 112.493 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 21.0 mtpp -136.54 6.72 3.0 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.448 2.299 . . . . 0.0 111.314 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.26 21.04 69.9 Favored Glycine 0 CA--C 1.536 1.399 0 CA-C-O 118.681 -1.066 . . . . 0.0 114.742 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 20.8 mt -93.44 135.4 34.72 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.271 1.536 . . . . 0.0 110.964 -169.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 61.7 p -74.98 170.52 15.82 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.262 -0.899 . . . . 0.0 109.515 163.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -63.44 -29.01 70.37 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.237 -0.914 . . . . 0.0 111.568 166.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.53 -36.81 73.92 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.836 0.855 . . . . 0.0 110.8 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -66.13 -37.39 85.59 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 171.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.408 HD22 ' HA ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -67.9 -48.42 66.08 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 118.207 0.458 . . . . 0.0 111.267 -175.236 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -48.24 -48.85 34.97 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 125.43 1.492 . . . . 0.0 109.209 172.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 63.0 m -60.91 -48.74 80.44 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.796 0.838 . . . . 0.0 111.528 175.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.3 mttm -58.4 -11.68 3.08 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 127.175 2.19 . . . . 0.0 114.233 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.9 pt -128.64 0.07 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 119.26 0.937 . . . . 0.0 112.273 177.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 53.2 t30 42.27 76.31 0.08 Allowed 'General case' 0 C--O 1.235 0.301 0 C-N-CA 126.768 2.027 . . . . 0.0 112.103 -163.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -137.6 -179.51 5.79 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 128.03 2.532 . . . . 0.0 107.567 168.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -88.01 141.71 31.54 Favored Pre-proline 0 C--N 1.335 -0.05 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 175.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -64.36 -18.82 64.47 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.587 2.192 . . . . 0.0 112.029 170.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.5 tp60 -62.23 -52.19 64.76 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 123.93 0.892 . . . . 0.0 110.429 171.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.1 m -69.88 -34.68 61.36 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.431 0 CA-C-N 119.36 0.982 . . . . 0.0 110.094 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 42.1 mm -56.57 -48.96 79.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 O-C-N 121.227 -0.921 . . . . 0.0 110.244 174.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.81 -20.91 66.65 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 178.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.16 -54.05 12.38 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 118.822 -0.608 . . . . 0.0 110.45 167.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -42.81 -50.65 5.62 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 124.535 1.134 . . . . 0.0 112.35 176.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.79 -29.35 68.51 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 120.897 1.68 . . . . 0.0 113.223 -171.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 12.8 m -69.85 -37.16 76.06 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.874 166.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.63 28.58 18.69 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -177.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -79.16 -50.8 10.42 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 117.494 0.647 . . . . 0.0 109.373 -174.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.35 167.32 18.38 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 127.366 2.266 . . . . 0.0 110.433 171.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 23.9 mm -89.73 127.34 54.61 Favored Pre-proline 0 C--O 1.235 0.333 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 174.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -72.75 115.07 4.2 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 N-CA-C 108.645 -1.329 . . . . 0.0 108.645 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -99.14 135.99 39.75 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.664 0.786 . . . . 0.0 110.795 -169.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -52.4 -36.95 55.4 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.365 1.066 . . . . 0.0 113.275 -170.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -57.59 -64.91 0.74 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.072 0.949 . . . . 0.0 109.226 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 92.4 t -63.3 -40.44 89.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 125.574 1.549 . . . . 0.0 109.844 -178.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.6 mt -49.61 -52.82 27.75 Favored 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 124.354 1.062 . . . . 0.0 110.223 175.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.76 -31.5 78.34 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-N 118.679 0.672 . . . . 0.0 112.523 -178.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -67.59 -43.55 80.27 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 121.401 -1.058 . . . . 0.0 110.371 173.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.0 mt -63.51 -37.12 78.74 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.091 0 C-N-CA 124.337 1.055 . . . . 0.0 109.843 176.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.475 ' HA ' HD23 ' A' ' 69' ' ' LEU . 42.6 mt-10 -56.39 -50.86 70.37 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.386 0.994 . . . . 0.0 109.227 176.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 23.2 mtm180 -64.95 -19.04 65.75 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 175.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.59 -44.76 73.67 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 118.426 -0.797 . . . . 0.0 111.264 177.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.482 HD11 HD21 ' A' ' 69' ' ' LEU . 21.5 pt -114.45 -10.13 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -173.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.51 23.36 78.13 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 127.561 2.505 . . . . 0.0 114.031 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.0 mt -121.94 161.59 22.59 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 118.453 1.126 . . . . 0.0 108.793 172.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -74.36 140.26 44.68 Favored 'General case' 0 CA--C 1.512 -0.51 0 C-N-CA 124.984 1.314 . . . . 0.0 108.753 176.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.482 HD21 HD11 ' A' ' 65' ' ' ILE . 4.0 mm? -119.56 9.92 11.64 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 125.087 1.355 . . . . 0.0 111.201 176.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.5 mtm180 -130.85 166.79 20.12 Favored 'General case' 0 C--O 1.233 0.209 0 O-C-N 121.023 -1.048 . . . . 0.0 109.04 174.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.63 176.91 43.56 Favored Glycine 0 N--CA 1.449 -0.495 0 O-C-N 124.233 0.958 . . . . 0.0 110.89 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -83.2 11.74 6.13 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.643 0.777 . . . . 0.0 111.114 171.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -102.91 16.25 27.14 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.381 1.472 . . . . 0.0 110.359 177.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.5 tt -54.68 142.98 7.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 O-C-N 121.219 -0.925 . . . . 0.0 110.545 -168.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.55 -4.48 59.9 Favored Glycine 0 CA--C 1.536 1.4 0 CA-C-O 119.307 -0.718 . . . . 0.0 114.257 -178.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -71.74 149.15 92.9 Favored Pre-proline 0 C--N 1.341 0.212 0 CA-C-N 119.938 1.869 . . . . 0.0 107.974 163.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.34 151.22 29.43 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 123.896 3.064 . . . . 0.0 112.85 -171.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.0 pt -101.36 127.87 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 175.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 41.22 55.72 3.22 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.561 1.544 . . . . 0.0 114.088 176.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 48.2 mttp 59.51 41.53 19.01 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.789 1.636 . . . . 0.0 112.891 -175.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -57.29 176.08 1.46 Allowed Glycine 0 CA--C 1.536 1.383 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.832 153.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.91 153.85 58.31 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.611 2.207 . . . . 0.0 113.468 -169.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 30.0 mtp180 -69.82 175.97 3.96 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.779 167.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.57 163.68 33.18 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 126.138 1.775 . . . . 0.0 108.569 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 52.9 mttp 71.03 -35.86 0.34 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 128.226 2.61 . . . . 0.0 112.522 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.7 p -66.12 -177.66 0.54 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.315 1.446 . . . . 0.0 110.662 162.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 102.76 100.33 2.55 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 176.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -66.06 168.19 16.23 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.533 2.155 . . . . 0.0 110.543 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.2 t -133.53 112.87 11.86 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.18 0.992 . . . . 0.0 108.528 -161.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.9 t -70.8 142.42 51.33 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.735 0.814 . . . . 0.0 108.933 176.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.929 0 N-CA-C 108.085 -2.006 . . . . 0.0 108.085 176.675 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.751 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.0 t 53.32 75.6 0.25 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.9 1.28 . . . . 0.0 110.466 -177.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.9 t -66.74 146.02 54.9 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 169.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -93.63 76.49 1.09 Allowed Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 108.051 -2.019 . . . . 0.0 108.051 172.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -172.39 158.15 4.25 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.217 1.407 . . . . 0.0 109.414 169.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.7 p -148.67 -4.78 0.43 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.798 1.239 . . . . 0.0 112.771 174.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 95.32 -106.51 3.41 Favored Glycine 0 C--N 1.337 0.602 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -153.22 -177.12 6.11 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.503 1.121 . . . . 0.0 108.357 -173.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.2 163.77 1.51 Allowed 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.142 -0.974 . . . . 0.0 109.749 160.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.8 m -133.36 178.59 5.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.605 0 C-N-CA 124.812 1.245 . . . . 0.0 109.466 -176.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.6 p -71.81 160.47 32.53 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.646 1.178 . . . . 0.0 111.953 174.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.4 mp 62.06 155.12 0.04 OUTLIER 'General case' 0 C--N 1.341 0.202 0 C-N-CA 128.658 2.783 . . . . 0.0 112.983 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -70.36 -48.83 54.56 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 120.574 -1.329 . . . . 0.0 107.501 171.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 53.5 t -57.31 -64.53 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.098 0 C-N-CA 125.41 1.484 . . . . 0.0 109.287 -178.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -49.16 -42.99 32.58 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-N 119.425 1.011 . . . . 0.0 112.998 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -67.44 -52.6 37.6 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 117.843 -1.075 . . . . 0.0 112.564 177.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 66.7 t -59.27 -31.34 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 119.805 1.184 . . . . 0.0 110.242 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 52.9 mt -61.32 -58.38 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 175.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -60.03 -47.0 87.65 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 123.608 0.568 . . . . 0.0 110.47 -177.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -60.3 -49.75 76.36 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.841 1.256 . . . . 0.0 110.734 178.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.17 -32.14 75.9 Favored Glycine 0 CA--C 1.52 0.377 0 O-C-N 120.535 -1.353 . . . . 0.0 112.663 -177.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 15.1 mtm105 -59.6 -61.42 2.63 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 118.145 0.973 . . . . 0.0 110.777 167.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.27 -22.95 67.2 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.169 0.988 . . . . 0.0 112.692 -174.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.4 t -61.4 -16.59 48.05 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.662 1.585 . . . . 0.0 111.303 171.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -126.98 2.12 6.57 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.413 1.885 . . . . 0.0 110.986 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 71.67 0.24 39.29 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 126.022 1.772 . . . . 0.0 113.024 -175.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.6 mt -78.63 145.32 34.74 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 119.034 1.417 . . . . 0.0 110.619 -162.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.1 p -83.86 174.61 10.25 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.656 0.782 . . . . 0.0 110.013 -173.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -69.09 -38.49 78.99 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 121.432 -0.793 . . . . 0.0 109.743 171.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.3 mtpm? -58.91 -41.99 88.57 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.82 0.848 . . . . 0.0 110.911 171.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -63.43 -43.46 97.4 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 118.832 0.742 . . . . 0.0 109.388 177.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.32 -49.3 77.56 Favored 'General case' 0 C--O 1.228 -0.069 0 C-N-CA 124.205 1.002 . . . . 0.0 110.091 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.15 -45.24 71.98 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.856 0.862 . . . . 0.0 109.919 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.7 m -61.82 -48.45 80.53 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.287 1.035 . . . . 0.0 110.576 177.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.2 mttm -54.48 -27.66 39.21 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.764 1.226 . . . . 0.0 113.274 176.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.6 pt -111.93 10.05 8.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 123.928 0.891 . . . . 0.0 112.13 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.5 m120 45.25 48.68 10.2 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.594 2.358 . . . . 0.0 111.421 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -132.27 -171.49 2.65 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.241 1.416 . . . . 0.0 109.224 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.6 mmmm -91.61 142.0 26.36 Favored Pre-proline 0 N--CA 1.466 0.355 0 O-C-N 121.015 -1.053 . . . . 0.0 109.713 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.52 -10.18 28.24 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.715 2.277 . . . . 0.0 112.123 169.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 30.0 tp60 -50.92 -61.68 2.07 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.901 1.28 . . . . 0.0 109.361 163.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.4 m -66.42 -29.5 46.77 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.677 0 C-N-CA 119.741 -0.783 . . . . 0.0 110.419 -175.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 51.4 mm -62.77 -45.08 99.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 119.686 1.13 . . . . 0.0 109.952 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.82 -39.64 92.48 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 121.496 -0.082 . . . . 0.0 111.09 172.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -63.62 -40.28 96.51 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.512 0.725 . . . . 0.0 110.68 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -63.25 -44.73 94.34 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 126.183 1.793 . . . . 0.0 108.867 176.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -60.73 -30.41 69.97 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.277 1.031 . . . . 0.0 113.164 176.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.7 m -90.49 -19.64 23.61 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 177.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.97 42.45 7.62 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 119.56 1.073 . . . . 0.0 111.188 -173.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -114.36 -47.83 2.91 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 124.941 1.297 . . . . 0.0 108.856 -176.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.21 150.11 11.5 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.31 0.644 . . . . 0.0 109.874 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 36.3 mm -68.98 117.32 50.51 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 167.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -69.76 115.6 4.17 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 N-CA-C 106.892 -2.003 . . . . 0.0 106.892 171.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -127.67 123.91 36.64 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 -172.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.2 p-10 -51.74 -29.59 19.25 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.909 1.684 . . . . 0.0 112.998 -174.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -58.54 -47.6 83.67 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.741 1.616 . . . . 0.0 111.205 173.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.2 t -91.66 -36.5 7.99 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-O 117.778 -1.106 . . . . 0.0 109.971 -175.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 14.1 mt -47.8 -45.63 29.83 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.56 1.073 . . . . 0.0 109.518 170.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.65 -40.31 94.57 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-O 119.492 -0.616 . . . . 0.0 112.813 176.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -64.99 -47.63 76.86 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 118.836 1.318 . . . . 0.0 109.683 177.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.3 mt -61.41 -36.1 70.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 123.226 0.611 . . . . 0.0 110.117 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -58.3 -50.19 74.49 Favored 'General case' 0 C--N 1.33 -0.255 0 O-C-N 121.583 -0.698 . . . . 0.0 109.862 176.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 36.5 mtt180 -65.91 -24.77 66.9 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.301 -0.874 . . . . 0.0 112.807 174.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.85 -55.88 28.73 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 118.771 0.714 . . . . 0.0 109.525 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.427 HD11 HD21 ' A' ' 69' ' ' LEU . 45.9 pt -93.34 -15.92 7.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 123.548 0.739 . . . . 0.0 112.002 -177.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.18 39.67 92.48 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 125.337 1.446 . . . . 0.0 111.682 -173.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 47.5 mt -135.45 166.14 23.88 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.4 1.08 . . . . 0.0 109.057 169.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -73.54 141.52 46.7 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 126.336 1.854 . . . . 0.0 109.52 176.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.427 HD21 HD11 ' A' ' 65' ' ' ILE . 3.4 mm? -119.36 5.25 11.18 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.425 1.89 . . . . 0.0 110.302 176.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 56.1 mtm180 -142.1 147.08 36.16 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.924 0.783 . . . . 0.0 110.009 -172.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.25 167.58 21.4 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 125.193 1.378 . . . . 0.0 109.931 -170.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.2 mttp -68.84 -11.57 60.62 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.119 -1.224 . . . . 0.0 111.667 176.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.98 13.74 0.49 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.924 1.69 . . . . 0.0 110.704 172.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.8 tt -52.65 150.45 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 O-C-N 120.843 -1.161 . . . . 0.0 110.761 176.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.53 -12.49 7.78 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-O 118.871 -0.96 . . . . 0.0 113.749 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 33.9 mmtt -70.77 150.57 95.27 Favored Pre-proline 0 N--CA 1.449 -0.515 0 CA-C-N 119.671 1.736 . . . . 0.0 107.784 166.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -73.16 162.44 40.67 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 123.575 2.85 . . . . 0.0 110.856 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 42.3 pt -110.69 141.24 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 124.364 1.065 . . . . 0.0 108.535 -178.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 53.19 23.64 3.23 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.783 2.033 . . . . 0.0 114.324 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -83.23 59.1 4.81 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 120.04 -1.662 . . . . 0.0 110.691 -171.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 145.24 -170.6 26.58 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 123.623 0.63 . . . . 0.0 112.706 172.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -75.55 -175.58 2.52 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 124.26 3.307 . . . . 0.0 111.409 169.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? 55.05 47.88 21.01 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.396 1.478 . . . . 0.0 109.141 -178.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.57 172.73 3.15 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.227 168.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt 53.12 -160.07 0.13 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.63 1.572 . . . . 0.0 111.709 170.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 11.8 t -153.77 -66.08 0.14 Allowed 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -81.29 -175.56 50.19 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 172.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -71.72 167.61 26.05 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.829 3.019 . . . . 0.0 111.164 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.3 m 176.53 164.04 0.43 Allowed 'General case' 0 C--O 1.237 0.408 0 C-N-CA 127.596 2.358 . . . . 0.0 109.293 168.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 13.4 m -72.78 -60.72 2.09 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 164.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.92 0 CA-C-O 117.762 -1.577 . . . . 0.0 110.993 173.18 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.81 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.2 m -76.63 -58.67 3.15 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 118.563 1.181 . . . . 0.0 111.722 -170.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.4 m 52.55 166.84 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 127.455 2.302 . . . . 0.0 113.539 -166.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 159.17 -165.99 34.48 Favored Glycine 0 CA--C 1.521 0.413 0 O-C-N 120.139 -1.6 . . . . 0.0 112.951 -172.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.0 t -146.69 167.74 23.06 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.561 1.544 . . . . 0.0 108.397 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.5 p -153.74 48.82 0.66 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.591 0.71 . . . . 0.0 109.538 -173.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.43 131.8 5.68 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 107.796 -2.122 . . . . 0.0 107.796 -167.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -46.51 -45.39 18.44 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 127.551 2.34 . . . . 0.0 112.398 -174.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 91.2 mtm-85 59.2 162.6 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 127.843 2.457 . . . . 0.0 113.333 -176.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.1 m -76.07 160.43 5.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 170.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.2 p -139.26 165.48 27.07 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.969 1.308 . . . . 0.0 108.467 -174.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.8 mp -78.72 154.58 29.95 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 163.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -56.07 -38.24 70.39 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 122.37 0.268 . . . . 0.0 111.066 -177.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.1 t -56.13 -61.7 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 123.506 0.722 . . . . 0.0 109.464 176.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -56.67 -38.08 80.15 Favored Glycine 0 C--N 1.335 0.527 0 CA-C-N 119.523 1.056 . . . . 0.0 112.523 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.4 -56.35 21.24 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.276 1.038 . . . . 0.0 109.86 177.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.3 t -60.13 -37.88 74.87 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.128 0 C-N-CA 123.808 0.843 . . . . 0.0 110.298 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 64.4 mt -59.98 -57.74 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 176.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -55.68 -49.0 74.11 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.142 0.577 . . . . 0.0 110.125 -176.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -56.67 -60.61 3.3 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 123.362 0.665 . . . . 0.0 110.801 176.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.38 -30.84 78.96 Favored Glycine 0 CA--C 1.521 0.442 0 CA-C-N 119.914 1.234 . . . . 0.0 112.719 -171.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.487 HH11 ' HB3' ' A' ' 22' ' ' ARG . 16.7 mtm105 -57.12 -65.72 0.57 Allowed 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 118.272 1.036 . . . . 0.0 109.782 166.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -61.52 -29.88 70.28 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.806 1.242 . . . . 0.0 112.161 -173.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.7 m -72.6 -4.73 32.58 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.984 1.314 . . . . 0.0 112.295 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp -127.72 12.35 6.82 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.465 1.906 . . . . 0.0 110.16 176.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.21 17.56 66.11 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.297 0.951 . . . . 0.0 113.725 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 59.4 mt -88.62 144.77 26.08 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 118.652 1.226 . . . . 0.0 111.505 -168.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 81.9 p -84.18 168.75 15.48 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.305 173.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -58.91 -43.38 91.04 Favored 'General case' 0 N--CA 1.464 0.267 0 O-C-N 121.321 -0.862 . . . . 0.0 110.216 166.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.5 mttt -57.1 -36.27 70.43 Favored 'General case' 0 CA--C 1.521 -0.136 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 176.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -64.13 -38.37 90.83 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 118.244 0.474 . . . . 0.0 110.232 176.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.59 -48.68 71.5 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 123.34 0.656 . . . . 0.0 109.256 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -50.16 -56.42 11.05 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.48 1.512 . . . . 0.0 108.643 178.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 95.9 m -59.59 -44.14 93.47 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.491 0.717 . . . . 0.0 112.299 177.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -58.86 -32.83 69.81 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 119.595 1.089 . . . . 0.0 112.137 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.2 pt -103.39 1.44 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 119.12 0.873 . . . . 0.0 112.073 176.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 63.3 t30 54.11 44.38 29.3 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 128.236 2.614 . . . . 0.0 113.709 -175.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -113.76 177.85 4.49 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.788 2.035 . . . . 0.0 110.907 176.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -75.93 147.99 81.26 Favored Pre-proline 0 C--N 1.342 0.26 0 CA-C-N 118.991 0.814 . . . . 0.0 109.542 168.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.0 -7.48 20.94 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 123.023 2.482 . . . . 0.0 112.616 170.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.4 tp60 -55.63 -63.44 1.17 Allowed 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 123.278 0.631 . . . . 0.0 109.551 166.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.8 m -67.98 -22.92 28.39 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.339 0 C-N-CA 119.954 -0.698 . . . . 0.0 111.014 -169.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 44.1 mm -61.63 -46.93 95.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 123.98 0.912 . . . . 0.0 110.298 171.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.31 -27.13 68.39 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 123.259 0.623 . . . . 0.0 112.287 177.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -79.75 -39.11 31.79 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.214 1.006 . . . . 0.0 110.789 176.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -55.0 -40.15 69.82 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 125.92 1.688 . . . . 0.0 111.054 175.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -61.14 -39.9 91.81 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 119.177 -0.44 . . . . 0.0 111.895 -177.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.5 m -80.87 -23.89 38.73 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 118.478 -0.772 . . . . 0.0 112.954 172.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.05 7.2 62.65 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-O 119.286 -0.73 . . . . 0.0 112.8 -171.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 45.8 mtt180 -67.44 -37.55 83.17 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.062 1.431 . . . . 0.0 110.195 177.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.63 115.1 7.62 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 167.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.6 mm -70.04 117.42 53.91 Favored Pre-proline 0 C--O 1.236 0.364 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 170.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -80.75 154.48 20.31 Favored 'Trans proline' 0 N--CA 1.446 -1.28 0 C-N-CA 122.188 1.925 . . . . 0.0 110.238 -173.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -127.47 153.92 45.72 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.526 1.13 . . . . 0.0 108.506 174.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 72.9 m-80 -62.12 -31.84 72.35 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.883 0.765 . . . . 0.0 112.309 -172.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -56.61 -61.37 2.47 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.004 0.922 . . . . 0.0 109.381 174.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.0 t -66.15 -48.94 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-O 118.087 -0.959 . . . . 0.0 109.69 -176.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 51.9 mt -44.91 -48.4 11.27 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 119.366 0.985 . . . . 0.0 110.164 170.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.14 -47.45 73.83 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 125.236 1.398 . . . . 0.0 112.562 176.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -61.73 -41.95 98.32 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 121.732 -0.863 . . . . 0.0 110.425 175.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 77.5 mt -63.68 -34.63 69.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 118.755 0.707 . . . . 0.0 109.651 176.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -62.11 -43.5 98.69 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 120.957 -1.089 . . . . 0.0 109.873 174.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 84.8 mtt-85 -59.22 -39.01 81.36 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.453 -0.78 . . . . 0.0 111.004 173.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.74 -55.36 31.1 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.619 1.568 . . . . 0.0 111.453 -175.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.0 pt -91.02 -26.51 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 118.673 0.669 . . . . 0.0 110.942 -178.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.59 28.08 36.82 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 125.614 1.578 . . . . 0.0 112.215 -178.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 77' ' ' PRO . 19.6 mt -133.65 165.09 25.74 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.542 1.537 . . . . 0.0 108.572 173.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 41.2 mttm -69.41 140.96 54.19 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 126.236 1.814 . . . . 0.0 109.947 176.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -119.75 8.02 11.11 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.429 1.892 . . . . 0.0 109.791 174.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -133.42 154.93 50.36 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.578 1.551 . . . . 0.0 108.082 -175.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 65.51 174.18 4.7 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.627 1.584 . . . . 0.0 112.624 -178.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 72.1 mttt -69.15 -16.83 63.73 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 121.883 -0.775 . . . . 0.0 111.867 178.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -76.82 16.04 0.58 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.391 0.996 . . . . 0.0 111.362 176.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.6 tt -52.15 139.51 8.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 O-C-N 120.718 -1.239 . . . . 0.0 110.78 -176.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.27 -8.05 41.96 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 118.79 -1.006 . . . . 0.0 113.386 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 16.5 mmtt -72.55 154.38 91.57 Favored Pre-proline 0 N--CA 1.451 -0.411 0 CA-C-N 120.546 2.173 . . . . 0.0 106.672 161.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.47 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 14.7 Cg_endo -67.8 170.67 13.57 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 123.388 2.725 . . . . 0.0 112.204 -175.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 25.2 pt -109.04 164.45 5.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 124.637 1.175 . . . . 0.0 108.679 171.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -72.81 135.05 45.16 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 174.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 35.5 mttt -152.37 158.83 43.26 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.733 1.613 . . . . 0.0 108.095 161.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 43.22 -114.42 0.85 Allowed Glycine 0 CA--C 1.534 1.275 0 C-N-CA 125.126 1.346 . . . . 0.0 112.486 174.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.95 104.17 1.31 Allowed 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 123.901 3.067 . . . . 0.0 111.304 -176.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 42.1 ttt180 95.08 121.63 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 130.46 3.504 . . . . 0.0 110.22 168.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.6 -61.49 0.37 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.027 1.731 . . . . 0.0 109.108 177.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.5 mtmt 61.26 163.21 0.07 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 127.675 2.39 . . . . 0.0 112.186 -173.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 43.9 m 30.8 77.29 0.03 OUTLIER 'General case' 0 C--O 1.234 0.25 0 C-N-CA 126.901 2.08 . . . . 0.0 113.205 -170.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 165.98 66.29 0.03 OUTLIER Glycine 0 CA--C 1.523 0.576 0 N-CA-C 106.318 -2.713 . . . . 0.0 106.318 174.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -64.73 149.42 89.74 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 121.757 1.638 . . . . 0.0 110.023 -174.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.8 m -157.3 165.57 35.47 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.729 1.211 . . . . 0.0 109.155 176.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.6 p -128.01 171.41 11.87 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.0 1.32 . . . . 0.0 108.47 171.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.852 0 N-CA-C 104.735 -3.346 . . . . 0.0 104.735 167.981 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.853 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.3 t -145.95 -37.85 0.25 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.454 0.702 . . . . 0.0 111.148 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.1 m 33.96 49.38 0.28 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.419 2.287 . . . . 0.0 115.591 172.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -61.1 152.79 39.79 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.825 -0.51 . . . . 0.0 111.825 -176.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.0 p -162.87 74.88 0.4 Allowed 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.6 0.76 . . . . 0.0 109.13 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.9 m -143.81 154.17 43.13 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 122.655 0.382 . . . . 0.0 110.804 176.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -81.04 -105.08 0.32 Allowed Glycine 0 CA--C 1.522 0.48 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 173.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -137.3 97.48 3.49 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.026 1.33 . . . . 0.0 109.218 -168.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 24.7 mmt85 -134.55 6.02 3.48 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.748 0.819 . . . . 0.0 113.104 -173.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.1 p -62.72 149.92 9.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-N 118.726 0.694 . . . . 0.0 110.859 177.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.2 p -127.5 180.0 5.2 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 127.038 2.135 . . . . 0.0 108.907 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.4 mp 66.3 -177.12 0.19 Allowed 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.044 1.338 . . . . 0.0 113.158 165.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -97.85 -44.85 6.54 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.808 0.843 . . . . 0.0 110.034 158.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 37.1 t -60.95 -57.44 12.12 Favored 'Isoleucine or valine' 0 C--N 1.344 0.329 0 CA-C-N 119.372 0.987 . . . . 0.0 109.14 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.91 -40.9 66.38 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 119.677 -0.513 . . . . 0.0 112.1 177.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.8 tptt -57.85 -61.22 2.68 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 117.827 0.814 . . . . 0.0 110.826 173.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 78.6 t -58.49 -31.85 44.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 118.994 0.816 . . . . 0.0 110.068 -176.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 52.3 mt -64.74 -59.19 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-O 117.799 -1.096 . . . . 0.0 108.753 175.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -54.23 -50.03 68.1 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.706 0.803 . . . . 0.0 109.839 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.85 -52.22 63.96 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 123.786 0.835 . . . . 0.0 110.394 -177.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.99 -33.87 88.4 Favored Glycine 0 CA--C 1.524 0.618 0 CA-C-O 118.862 -0.966 . . . . 0.0 112.098 -177.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.679 ' HG2' HD23 ' A' ' 32' ' ' LEU . 17.3 mtm105 -59.68 -58.14 9.89 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 118.321 1.061 . . . . 0.0 109.7 170.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.9 mm100 -64.36 -17.68 63.95 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.753 1.621 . . . . 0.0 113.216 -176.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 65.3 m -72.15 -11.33 60.69 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.144 0.978 . . . . 0.0 112.941 168.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -135.66 23.06 3.38 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 120.399 1.454 . . . . 0.0 111.993 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 61.2 14.19 38.92 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.477 1.037 . . . . 0.0 113.924 -178.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 44.5 mt -73.09 125.27 27.28 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 118.67 1.235 . . . . 0.0 108.898 -167.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 67.2 p -66.7 170.42 6.44 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 165.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -63.04 -32.39 73.75 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.098 -1.001 . . . . 0.0 110.399 169.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -72.15 -36.32 69.3 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.481 0.712 . . . . 0.0 111.058 178.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -59.91 -40.54 89.19 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.96 0.8 . . . . 0.0 109.129 174.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.679 HD23 ' HG2' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -65.82 -47.5 74.81 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.406 0.682 . . . . 0.0 110.803 177.003 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.64 -47.4 67.1 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.485 1.114 . . . . 0.0 110.487 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 95.3 m -58.89 -49.12 78.98 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 125.03 1.332 . . . . 0.0 111.081 172.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.6 mttp -57.88 -22.55 48.86 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 117.837 -1.078 . . . . 0.0 113.563 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.487 HG22 ' HB3' ' A' ' 60' ' ' LYS . 25.6 pt -115.3 8.15 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 120.021 1.282 . . . . 0.0 112.096 173.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 42.1 t30 36.74 72.15 0.12 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.424 1.889 . . . . 0.0 112.015 -170.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.77 -179.69 6.48 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.691 1.596 . . . . 0.0 109.706 171.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -68.54 143.51 95.33 Favored Pre-proline 0 N--CA 1.455 -0.203 0 O-C-N 121.347 -0.846 . . . . 0.0 109.797 172.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -69.72 -10.33 28.34 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 122.599 2.199 . . . . 0.0 112.123 170.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -61.29 -42.22 98.28 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.897 1.279 . . . . 0.0 110.73 170.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.3 m -76.39 -27.27 17.35 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.382 0 C-N-CA 119.687 -0.805 . . . . 0.0 110.294 -176.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.3 mm -62.99 -47.47 92.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 119.44 1.018 . . . . 0.0 109.226 176.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.68 -42.38 71.32 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 122.885 0.474 . . . . 0.0 110.834 175.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -78.58 -32.9 47.87 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 118.608 -0.71 . . . . 0.0 111.263 -173.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -58.8 -43.72 90.59 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.33 1.052 . . . . 0.0 109.533 168.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.418 ' CD ' HH21 ' A' ' 22' ' ' ARG . 7.0 mt-10 -62.43 -40.55 96.93 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 118.44 -0.79 . . . . 0.0 112.501 -178.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.3 m -82.11 -25.62 34.29 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 119.145 0.884 . . . . 0.0 112.657 175.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 108.84 3.33 32.07 Favored Glycine 0 CA--C 1.523 0.538 0 C-N-CA 123.464 0.554 . . . . 0.0 113.052 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 55.0 mmt-85 -67.3 -58.34 4.98 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.32 1.448 . . . . 0.0 109.416 -175.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.11 142.71 53.75 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.438 0.563 . . . . 0.0 109.894 -175.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 mt -68.43 126.86 93.15 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 174.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.15 116.86 4.79 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 122.72 2.28 . . . . 0.0 108.192 175.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -114.67 126.72 55.2 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 178.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -44.69 -38.19 4.2 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.767 1.627 . . . . 0.0 114.103 175.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -58.18 -33.15 68.94 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 123.245 0.618 . . . . 0.0 111.979 177.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 75.3 t -94.19 -46.8 13.58 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.315 0 C-N-CA 124.898 1.279 . . . . 0.0 109.425 176.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 78.0 mt -47.97 -49.35 30.91 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 120.463 1.483 . . . . 0.0 111.115 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.78 -31.47 71.75 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 118.459 0.572 . . . . 0.0 113.131 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.487 ' HB3' HG22 ' A' ' 36' ' ' ILE . 9.9 mtpp -74.31 -43.39 56.95 Favored 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 125.071 1.348 . . . . 0.0 109.419 175.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.0 mt -59.17 -36.79 64.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 175.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -59.12 -46.16 89.05 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.426 1.012 . . . . 0.0 109.995 176.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 48.0 mtt180 -67.57 -23.31 65.39 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.329 -0.857 . . . . 0.0 112.713 174.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.95 -37.09 81.16 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.614 1.166 . . . . 0.0 111.893 -178.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 29.7 pt -119.25 -20.38 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.021 0.929 . . . . 0.0 112.544 -177.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.61 29.43 52.43 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 125.476 1.512 . . . . 0.0 113.345 -177.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.473 HD23 ' HA ' ' A' ' 77' ' ' PRO . 81.1 mt -124.92 166.09 16.92 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 118.267 1.033 . . . . 0.0 108.569 170.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.7 mttm -74.59 143.27 44.48 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 125.357 1.463 . . . . 0.0 109.738 175.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -121.26 9.71 10.47 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.56 1.544 . . . . 0.0 110.387 176.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 33.9 mtt-85 -137.64 163.06 32.16 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 119.371 0.987 . . . . 0.0 110.951 175.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.82 177.95 49.94 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 125.413 1.483 . . . . 0.0 110.811 -174.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -69.75 -20.91 63.49 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 121.694 -0.886 . . . . 0.0 110.741 163.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.34 15.71 0.09 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 128.755 2.822 . . . . 0.0 111.382 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.3 tt -56.86 150.89 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 O-C-N 121.106 -0.997 . . . . 0.0 109.334 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.73 -7.15 7.42 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-O 118.533 -1.148 . . . . 0.0 114.13 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.401 ' HB3' ' HE3' ' A' ' 76' ' ' LYS . 24.9 mmmt -61.47 149.79 82.65 Favored Pre-proline 0 C--N 1.342 0.242 0 CA-C-N 120.04 1.92 . . . . 0.0 107.137 158.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.473 ' HA ' HD23 ' A' ' 67' ' ' LEU . 19.6 Cg_endo -67.73 154.79 72.28 Favored 'Trans proline' 0 N--CA 1.445 -1.337 0 C-N-CA 123.139 2.56 . . . . 0.0 110.462 170.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.7 pt -101.94 144.56 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 164.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 51.39 34.83 12.65 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.077 1.351 . . . . 0.0 113.603 164.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -116.65 66.95 0.72 Allowed 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 176.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 154.87 171.62 21.79 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 125.259 1.409 . . . . 0.0 110.112 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.44 94.72 0.98 Allowed 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.824 3.016 . . . . 0.0 110.908 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.5 ttm180 -159.92 141.78 12.99 Favored 'General case' 0 C--O 1.234 0.243 0 O-C-N 121.104 -0.998 . . . . 0.0 109.881 170.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -140.09 135.23 32.36 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 149.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 11.6 ptpt -73.98 173.09 10.49 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 118.282 0.492 . . . . 0.0 110.651 172.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.0 m -121.63 176.62 5.62 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 124.359 1.064 . . . . 0.0 108.469 159.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 163.45 -81.92 0.12 Allowed Glycine 0 CA--C 1.518 0.257 0 N-CA-C 107.853 -2.099 . . . . 0.0 107.853 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -70.05 97.78 0.68 Allowed 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.462 2.108 . . . . 0.0 108.241 173.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.3 m -61.48 108.53 0.97 Allowed 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 173.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 63.44 170.2 0.16 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.373 1.469 . . . . 0.0 112.425 -168.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.426 0 N-CA-C 106.606 -2.597 . . . . 0.0 106.606 167.675 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.313 0 CA-C-O 118.846 -0.974 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.5 m -151.89 159.96 43.67 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.592 1.557 . . . . 0.0 107.54 166.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.8 t -140.47 1.89 1.79 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.969 1.308 . . . . 0.0 111.335 172.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 75.38 -174.36 52.25 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 -164.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.9 p -156.2 26.56 0.36 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.332 1.053 . . . . 0.0 111.223 176.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.4 m -132.32 128.27 37.36 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.291 1.436 . . . . 0.0 109.827 -168.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -97.38 -123.61 4.65 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 107.781 -2.128 . . . . 0.0 107.781 165.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 45.84 68.92 0.52 Allowed 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.512 1.925 . . . . 0.0 111.595 175.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.24 163.75 35.37 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 123.843 0.857 . . . . 0.0 110.337 -173.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.2 m -65.77 163.42 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 123.764 0.826 . . . . 0.0 109.22 165.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 40.2 p -131.81 91.14 2.93 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 175.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.4 mp -61.83 150.43 37.23 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 172.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -57.89 -43.7 86.25 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 117.99 0.359 . . . . 0.0 111.207 -175.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.1 t -56.3 -53.88 34.59 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.15 0 C-N-CA 124.044 0.938 . . . . 0.0 109.498 173.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -56.63 -39.7 86.32 Favored Glycine 0 CA--C 1.529 0.924 0 CA-C-N 119.363 0.983 . . . . 0.0 112.719 178.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -63.63 -55.44 23.58 Favored 'General case' 0 N--CA 1.46 0.048 0 CA-C-N 118.51 1.155 . . . . 0.0 109.943 176.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.3 t -58.71 -38.47 72.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 123.465 0.706 . . . . 0.0 110.443 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 57.0 mt -58.64 -59.48 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 176.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -61.93 -37.15 83.6 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 118.073 0.397 . . . . 0.0 111.229 -173.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.88 -53.98 50.66 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 121.418 -0.801 . . . . 0.0 111.914 171.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.64 -37.12 93.24 Favored Glycine 0 CA--C 1.521 0.457 0 CA-C-O 119.177 -0.79 . . . . 0.0 111.899 -173.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 17.6 mtm105 -57.3 -61.33 2.55 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 117.69 0.745 . . . . 0.0 109.407 173.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -60.74 -29.91 69.68 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.132 0.973 . . . . 0.0 112.347 -177.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.4 m -65.05 -12.95 56.27 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.285 0.948 . . . . 0.0 112.959 177.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 41.6 mttm -121.69 8.83 10.07 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.484 1.513 . . . . 0.0 110.295 171.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.12 24.86 61.42 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 126.014 1.769 . . . . 0.0 113.249 -177.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 57.6 mt -87.55 139.89 30.08 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.264 1.532 . . . . 0.0 111.536 -171.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.55 HG23 ' H ' ' A' ' 31' ' ' ASP . 14.1 t -78.88 163.68 25.09 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.613 1.165 . . . . 0.0 110.156 177.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -59.21 -40.84 87.08 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 121.015 -1.053 . . . . 0.0 110.086 175.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.47 -34.85 76.15 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 118.512 -0.756 . . . . 0.0 111.972 178.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.55 ' H ' HG23 ' A' ' 28' ' ' THR . 0.5 OUTLIER -67.39 -36.53 81.51 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.354 0.979 . . . . 0.0 110.787 175.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.78 -47.21 84.49 Favored 'General case' 0 C--N 1.338 0.108 0 O-C-N 121.896 -0.503 . . . . 0.0 109.875 178.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.23 -53.31 36.38 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 125.859 1.664 . . . . 0.0 108.738 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 29.3 m -58.09 -49.58 76.44 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.851 0.861 . . . . 0.0 111.55 174.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 49.1 mttm -57.53 -20.52 32.29 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.6 pt -116.6 5.2 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 119.399 1.0 . . . . 0.0 112.009 176.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 46.6 t30 48.01 64.42 1.65 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 127.04 2.136 . . . . 0.0 110.821 -175.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -137.9 174.88 10.11 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 127.38 2.272 . . . . 0.0 109.862 178.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.1 mmmm -73.72 143.07 81.22 Favored Pre-proline 0 CA--C 1.53 0.175 0 C-N-CA 124.448 1.099 . . . . 0.0 109.647 172.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -71.99 -12.22 28.07 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.678 2.252 . . . . 0.0 112.829 175.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 44.4 tp60 -73.83 -28.24 61.51 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 117.626 -1.178 . . . . 0.0 111.752 173.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.0 m -75.71 -34.29 28.24 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 CA-C-N 120.544 1.52 . . . . 0.0 109.984 174.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 35.9 mm -59.96 -52.72 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 119.579 1.081 . . . . 0.0 109.893 178.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.67 -31.78 71.92 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.252 -177.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -78.32 -36.26 46.65 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.769 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -54.73 -46.79 74.31 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 126.087 1.755 . . . . 0.0 110.147 173.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -59.65 -48.61 80.97 Favored 'General case' 0 C--N 1.34 0.152 0 C-N-CA 124.011 0.924 . . . . 0.0 110.854 177.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.9 -19.88 61.19 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 107.75 -3.21 34.07 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 125.1 1.333 . . . . 0.0 113.723 176.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 13.0 mmt180 -71.77 -52.87 15.41 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.895 1.347 . . . . 0.0 111.896 -170.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.56 129.23 40.92 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -175.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 35.4 mm -70.11 120.1 75.97 Favored Pre-proline 0 C--O 1.236 0.375 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 174.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -84.39 113.6 1.74 Allowed 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 121.093 1.195 . . . . 0.0 110.216 -171.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -81.24 142.12 33.47 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 177.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -55.54 -38.59 69.46 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.899 0.88 . . . . 0.0 111.849 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -67.19 -50.76 59.82 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.288 0.635 . . . . 0.0 111.351 174.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.6 t -64.42 -43.62 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 119.543 1.065 . . . . 0.0 109.962 -176.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 22.4 mt -45.36 -51.95 10.52 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 125.172 1.389 . . . . 0.0 109.447 165.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.98 -32.66 76.07 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 123.683 0.659 . . . . 0.0 114.105 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -71.71 -48.07 49.74 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 118.984 1.392 . . . . 0.0 109.522 174.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.1 mt -54.8 -36.12 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.104 0 C-N-CA 124.128 0.971 . . . . 0.0 109.923 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -56.27 -50.82 70.28 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 121.884 -0.51 . . . . 0.0 111.081 176.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 65.9 mtt85 -65.58 -24.9 67.19 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.678 0.672 . . . . 0.0 111.954 177.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.36 -33.96 77.2 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.97 0.908 . . . . 0.0 112.95 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.4 HD11 HD21 ' A' ' 69' ' ' LEU . 44.6 pt -117.41 -11.78 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.815 0.846 . . . . 0.0 112.174 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.0 36.18 72.64 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 126.078 1.799 . . . . 0.0 113.294 -175.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 48.7 mt -134.88 164.58 27.27 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 118.589 1.195 . . . . 0.0 109.894 171.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -69.99 141.29 52.98 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 127.404 2.281 . . . . 0.0 109.086 172.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.4 HD21 HD11 ' A' ' 65' ' ' ILE . 3.1 mm? -118.64 6.12 11.62 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.874 1.67 . . . . 0.0 110.005 176.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -138.88 162.23 35.32 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 125.01 1.324 . . . . 0.0 108.647 -175.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 67.27 170.65 4.7 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.644 -0.982 . . . . 0.0 110.644 -165.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -69.38 -15.72 63.37 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 123.472 0.709 . . . . 0.0 110.774 168.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -69.91 16.73 0.06 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.635 1.574 . . . . 0.0 111.71 172.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.0 tt -55.66 146.76 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 O-C-N 120.699 -1.251 . . . . 0.0 110.108 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.69 -1.4 53.11 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-O 119.664 -0.52 . . . . 0.0 113.63 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 20.1 mmtm -85.6 151.03 55.08 Favored Pre-proline 0 N--CA 1.45 -0.455 0 CA-C-N 119.447 1.624 . . . . 0.0 108.469 171.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -70.31 161.65 45.22 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 124.271 3.314 . . . . 0.0 113.191 -173.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 32.7 pt -113.16 158.9 13.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 125.56 1.544 . . . . 0.0 110.961 -175.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 59.43 -178.33 0.09 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.829 2.452 . . . . 0.0 111.17 -171.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -67.57 128.29 35.89 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 120.654 -1.278 . . . . 0.0 109.758 176.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -160.8 166.1 35.4 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 108.148 -1.981 . . . . 0.0 108.148 169.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.12 123.39 9.94 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.979 2.452 . . . . 0.0 110.445 -177.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 17.7 ptt-85 -152.45 -48.91 0.1 Allowed 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 177.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 53.39 -176.46 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.848 1.259 . . . . 0.0 111.889 -164.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 38.0 mmtt 29.1 83.55 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 128.092 2.557 . . . . 0.0 114.136 -178.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.4 m -146.05 -175.09 4.61 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.882 1.273 . . . . 0.0 109.653 170.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -65.11 154.83 49.61 Favored Glycine 0 CA--C 1.533 1.172 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 173.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -65.06 154.71 72.08 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.151 1.9 . . . . 0.0 110.064 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 58.0 m -159.48 138.85 11.3 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.036 0.934 . . . . 0.0 109.327 175.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.0 m -61.4 171.77 1.34 Allowed 'General case' 0 C--O 1.241 0.627 0 C-N-CA 125.52 1.528 . . . . 0.0 109.01 164.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.832 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 178.065 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.541 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.48 -64.09 0.36 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 167.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.1 m 51.99 -165.48 0.06 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.891 1.276 . . . . 0.0 111.953 -177.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 179.47 -148.16 7.98 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 106.332 -2.707 . . . . 0.0 106.332 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.4 p -63.59 152.81 37.73 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.414 0.686 . . . . 0.0 110.81 168.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.7 m -140.88 -179.18 5.92 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.645 1.578 . . . . 0.0 107.825 169.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -146.9 37.35 1.18 Allowed Glycine 0 CA--C 1.519 0.326 0 N-CA-C 110.074 -1.21 . . . . 0.0 110.074 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.18 166.39 14.16 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 122.37 -0.488 . . . . 0.0 111.002 -174.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -136.99 123.29 20.61 Favored 'General case' 0 CA--C 1.512 -0.512 0 O-C-N 121.597 -0.689 . . . . 0.0 109.36 -170.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.543 HG22 HE22 ' A' ' 19' ' ' GLN . 22.0 t -69.87 115.68 9.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 177.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.0 m -136.28 157.96 45.55 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.484 0.714 . . . . 0.0 109.199 -168.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 64.94 172.18 0.2 Allowed 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 127.117 2.167 . . . . 0.0 113.222 168.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.0 mp0 -66.52 -55.14 16.93 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 168.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.6 t -53.8 -62.32 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 C-N-CA 125.299 1.44 . . . . 0.0 109.949 -178.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -52.36 -51.47 42.25 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-N 119.759 1.163 . . . . 0.0 112.678 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.03 -41.01 86.78 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 118.352 1.076 . . . . 0.0 111.923 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 68.1 t -70.99 -37.72 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 119.358 0.981 . . . . 0.0 110.913 176.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 40.5 mt -57.34 -56.98 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 176.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.543 HE22 HG22 ' A' ' 10' ' ' VAL . 18.0 tt0 -54.17 -54.63 37.14 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 125.191 1.396 . . . . 0.0 109.512 -176.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -51.61 -60.72 2.83 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.788 1.235 . . . . 0.0 111.137 177.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.84 -27.35 72.44 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-O 118.692 -1.06 . . . . 0.0 113.042 -170.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.421 ' HG2' HD23 ' A' ' 32' ' ' LEU . 18.9 mtm105 -59.39 -59.42 5.48 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 118.314 1.057 . . . . 0.0 108.324 167.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -57.19 -39.55 75.61 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 125.547 1.539 . . . . 0.0 112.5 -175.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 56.7 m -58.91 -40.41 84.42 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 120.004 1.274 . . . . 0.0 110.529 177.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -81.27 -2.89 50.7 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.042 0.937 . . . . 0.0 111.568 176.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.31 7.9 69.11 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 126.393 1.949 . . . . 0.0 113.207 -176.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.2 mt -83.99 147.13 27.61 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 118.033 0.917 . . . . 0.0 110.408 -165.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 62.7 p -80.43 176.16 10.02 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.265 0.626 . . . . 0.0 110.344 177.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -63.6 -42.19 98.28 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 118.799 -0.62 . . . . 0.0 110.081 168.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -55.63 -42.35 74.84 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.245 1.018 . . . . 0.0 111.661 174.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -65.34 -40.08 93.21 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.421 HD23 ' HG2' ' A' ' 22' ' ' ARG . 0.3 OUTLIER -62.52 -49.5 75.08 Favored 'General case' 0 C--N 1.344 0.336 0 C-N-CA 123.578 0.751 . . . . 0.0 109.105 176.723 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.83 -57.25 10.84 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 124.947 1.299 . . . . 0.0 108.363 -177.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 85.7 m -61.71 -34.16 75.3 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.466 0.707 . . . . 0.0 112.229 176.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.5 mttm -63.35 -15.31 57.02 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 120.832 1.651 . . . . 0.0 112.817 173.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.0 pt -120.41 6.4 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 124.731 1.212 . . . . 0.0 111.072 175.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 40.8 t30 55.65 31.09 16.64 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 128.131 2.573 . . . . 0.0 114.53 -173.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -105.68 -177.01 3.24 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 125.424 1.49 . . . . 0.0 110.918 177.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -84.81 145.66 44.49 Favored Pre-proline 0 C--O 1.228 -0.059 0 C-N-CA 126.458 1.903 . . . . 0.0 111.359 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.03 -19.76 63.69 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.798 2.332 . . . . 0.0 111.961 171.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 28.5 tp60 -64.45 -46.93 81.0 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.87 175.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.6 m -69.6 -31.56 49.3 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.731 0 O-C-N 123.766 0.666 . . . . 0.0 110.244 -173.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 23.7 mm -64.8 -44.44 96.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 O-C-N 119.953 -1.717 . . . . 0.0 110.241 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.59 -32.52 72.62 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 174.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.43 -57.32 10.64 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.765 170.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -52.02 -35.61 47.5 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 126.236 1.815 . . . . 0.0 112.48 -178.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.42 ' CD ' HH21 ' A' ' 22' ' ' ARG . 22.6 mt-10 -67.89 -24.47 65.23 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.076 0.853 . . . . 0.0 112.036 176.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.42 -32.84 28.87 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.874 1.27 . . . . 0.0 110.419 164.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.95 33.74 32.43 Favored Glycine 0 CA--C 1.525 0.694 0 O-C-N 121.185 -0.947 . . . . 0.0 112.573 -173.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.5 mtt85 -71.69 -60.02 2.45 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 118.29 1.045 . . . . 0.0 109.56 177.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -54.71 137.87 43.19 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 128.081 2.553 . . . . 0.0 108.918 173.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.9 mt -73.53 116.77 54.69 Favored Pre-proline 0 C--O 1.236 0.386 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 175.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -67.35 115.64 3.79 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 122.489 2.126 . . . . 0.0 107.29 -172.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -97.13 142.6 28.86 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -173.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -60.72 -39.26 87.94 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 119.039 -0.505 . . . . 0.0 110.357 -171.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -59.91 -26.55 66.02 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 175.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 73.2 t -93.44 -43.92 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 119.997 1.271 . . . . 0.0 109.085 177.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 26.9 mt -50.0 -46.73 53.0 Favored 'General case' 0 C--O 1.227 -0.086 0 C-N-CA 124.244 1.018 . . . . 0.0 110.105 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.98 -40.1 95.03 Favored Glycine 0 CA--C 1.535 1.336 0 CA-C-N 118.207 0.458 . . . . 0.0 113.009 176.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.6 mtmm -60.67 -42.78 97.76 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 118.794 1.297 . . . . 0.0 110.803 175.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.8 mt -67.31 -35.79 74.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 123.759 0.824 . . . . 0.0 109.515 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -58.77 -47.66 83.94 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 119.43 1.014 . . . . 0.0 109.519 175.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 16.5 mtm-85 -64.4 -20.69 66.3 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 175.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.92 -52.41 24.78 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.872 0.869 . . . . 0.0 111.478 -179.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.426 HD11 HD21 ' A' ' 69' ' ' LEU . 47.8 pt -99.96 -15.7 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.762 0.825 . . . . 0.0 111.828 -177.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.38 27.77 61.02 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 126.011 1.767 . . . . 0.0 113.563 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 77' ' ' PRO . 58.9 mt -129.38 165.42 21.55 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.883 0.873 . . . . 0.0 108.973 173.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -70.32 145.05 51.48 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 125.326 1.451 . . . . 0.0 109.382 175.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.426 HD21 HD11 ' A' ' 65' ' ' ILE . 3.8 mm? -118.83 16.39 13.49 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.255 1.822 . . . . 0.0 109.462 175.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -144.92 162.18 37.5 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 125.364 1.466 . . . . 0.0 108.826 -171.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 70.44 171.63 10.27 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 124.633 1.111 . . . . 0.0 110.855 -174.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -67.54 -24.7 65.57 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.351 -1.088 . . . . 0.0 109.447 165.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -73.52 21.33 0.08 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.729 2.012 . . . . 0.0 112.126 175.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.7 tt -53.54 151.68 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 O-C-N 120.734 -1.229 . . . . 0.0 110.233 172.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.61 -6.83 10.31 Favored Glycine 0 CA--C 1.536 1.397 0 O-C-N 121.118 -0.989 . . . . 0.0 114.108 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 52.9 mmtt -71.01 148.5 94.47 Favored Pre-proline 0 N--CA 1.453 -0.313 0 CA-C-N 120.022 1.911 . . . . 0.0 107.529 163.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.412 ' HA ' HD23 ' A' ' 67' ' ' LEU . 27.9 Cg_endo -71.05 158.78 54.3 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.419 2.746 . . . . 0.0 111.609 -175.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 17.8 pt -105.66 139.67 26.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 C-N-CA 123.589 0.756 . . . . 0.0 109.187 177.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 49.32 54.16 11.43 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.211 1.804 . . . . 0.0 110.769 176.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.3 tmtm? -127.84 107.23 9.69 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -171.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 119.53 -173.61 15.15 Favored Glycine 0 CA--C 1.533 1.156 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -177.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.19 79.87 2.83 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 125.266 3.977 . . . . 0.0 110.167 -169.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -163.3 88.51 0.58 Allowed 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 178.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -153.94 168.12 27.44 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 125.212 1.405 . . . . 0.0 107.973 173.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.49 10.1 9.11 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.837 0.855 . . . . 0.0 113.283 -175.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.8 t -130.89 170.0 15.01 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 -178.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 114.85 82.81 1.08 Allowed Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.813 1.673 . . . . 0.0 109.815 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -72.59 177.49 7.42 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.5 2.133 . . . . 0.0 112.35 -177.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.8 167.71 21.44 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.951 2.101 . . . . 0.0 106.517 161.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 25.0 t -148.15 20.7 1.1 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.458 1.903 . . . . 0.0 108.694 174.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.519 0 N-CA-C 106.405 -2.678 . . . . 0.0 106.405 -129.522 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.685 0 N-CA-C 108.842 -1.703 . . . . 0.0 108.842 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.7 m 64.06 -66.79 0.11 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.997 1.319 . . . . 0.0 109.777 -162.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.6 p -60.46 166.68 2.96 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.81 1.244 . . . . 0.0 111.016 158.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.97 -80.08 1.5 Allowed Glycine 0 C--N 1.333 0.386 0 N-CA-C 108.919 -1.673 . . . . 0.0 108.919 171.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.9 m 52.8 94.01 0.02 OUTLIER 'General case' 0 C--O 1.232 0.179 0 C-N-CA 127.262 2.225 . . . . 0.0 112.465 -176.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 88.0 p -142.97 140.69 31.17 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.286 1.034 . . . . 0.0 109.683 168.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 72.59 168.74 12.26 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.315 1.436 . . . . 0.0 113.069 -177.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -81.66 48.44 1.19 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.685 1.594 . . . . 0.0 110.938 -173.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -64.31 132.76 51.13 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 120.899 -1.126 . . . . 0.0 110.306 -176.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.0 m -61.94 163.89 1.24 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 123.923 0.889 . . . . 0.0 109.809 162.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.9 t -116.76 174.9 5.83 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 158.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.9 mp -65.09 160.94 19.96 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.314 1.046 . . . . 0.0 109.898 177.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -52.44 -50.74 62.0 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.289 0.636 . . . . 0.0 111.385 -173.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.7 t -52.23 -63.84 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 C-N-CA 126.433 1.893 . . . . 0.0 109.141 176.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -51.56 -41.26 49.07 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-N 118.493 0.588 . . . . 0.0 112.998 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -64.94 -51.02 64.1 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 117.287 0.544 . . . . 0.0 110.299 -178.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.7 t -66.83 -33.77 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.104 0 C-N-CA 123.299 0.639 . . . . 0.0 110.149 -178.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 59.0 mt -56.03 -58.0 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 173.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -58.61 -47.61 83.76 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 123.898 0.879 . . . . 0.0 110.806 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -60.17 -53.29 59.5 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 118.899 0.772 . . . . 0.0 111.827 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -72.1 -25.45 74.62 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-O 118.48 -1.178 . . . . 0.0 112.966 -174.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.617 ' HG2' HD23 ' A' ' 32' ' ' LEU . 7.8 mtm105 -54.54 -67.71 0.24 Allowed 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 119.214 1.507 . . . . 0.0 110.482 160.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -61.46 -34.2 75.04 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 123.933 0.77 . . . . 0.0 110.527 -167.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.2 t -69.7 -10.39 58.1 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.031 0.932 . . . . 0.0 111.546 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -118.46 7.41 11.88 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.933 1.693 . . . . 0.0 110.308 173.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.15 2.44 40.05 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 126.308 1.908 . . . . 0.0 114.148 -177.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 21.4 mt -67.09 119.69 12.45 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 124.779 1.231 . . . . 0.0 107.71 -176.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.2 t -71.53 173.5 7.91 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.911 168.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -53.07 -55.33 24.69 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.51 -0.744 . . . . 0.0 109.754 174.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -58.58 -27.28 64.48 Favored 'General case' 0 C--O 1.227 -0.103 0 CA-C-N 118.515 0.598 . . . . 0.0 112.239 178.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -69.13 -36.07 77.07 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.125 -0.984 . . . . 0.0 111.109 173.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.617 HD23 ' HG2' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -68.77 -48.72 62.96 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.526 0.731 . . . . 0.0 110.943 -179.634 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.56 -51.95 57.28 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.854 0.862 . . . . 0.0 109.664 174.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 83.5 m -67.6 -30.07 69.57 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 118.734 -0.65 . . . . 0.0 111.592 -179.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.8 mttm -59.98 -49.55 77.24 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 120.279 1.399 . . . . 0.0 111.138 170.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.7 pt -86.53 -6.03 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 119.302 0.955 . . . . 0.0 112.731 -176.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.7 t30 59.15 65.16 1.24 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 128.851 2.861 . . . . 0.0 112.561 -171.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -133.86 178.78 6.68 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 126.913 2.085 . . . . 0.0 110.089 176.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -79.29 151.93 75.69 Favored Pre-proline 0 N--CA 1.463 0.18 0 C-N-CA 124.73 1.212 . . . . 0.0 109.116 169.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -79.78 -11.96 13.74 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.192 1.928 . . . . 0.0 115.306 -179.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -71.82 -43.85 64.89 Favored 'General case' 0 CA--C 1.515 -0.368 0 O-C-N 120.981 -1.075 . . . . 0.0 110.075 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.6 m -67.32 -38.22 80.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 -172.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 27.6 mm -55.82 -50.66 66.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 125.796 1.639 . . . . 0.0 110.821 170.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.11 -30.73 68.33 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 122.244 -0.285 . . . . 0.0 111.36 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.2 -30.93 49.19 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 118.418 -0.801 . . . . 0.0 111.382 177.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -59.11 -43.97 91.96 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 120.026 1.285 . . . . 0.0 110.231 169.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -56.23 -40.84 74.73 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -171.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.2 m -105.2 9.27 34.14 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.66 -0.92 58.14 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.144 -1.027 . . . . 0.0 114.258 163.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 19.5 mtm180 -91.91 -21.52 20.54 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 118.941 1.371 . . . . 0.0 114.367 -174.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.72 145.81 55.56 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 166.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 26.9 mm -72.79 116.77 53.47 Favored Pre-proline 0 C--O 1.238 0.49 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 171.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.42 123.26 9.37 Favored 'Trans proline' 0 N--CA 1.445 -1.324 0 N-CA-C 108.21 -1.496 . . . . 0.0 108.21 -178.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 63.3 t-20 -131.8 122.46 25.82 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 -171.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -48.99 -34.09 12.35 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.842 1.257 . . . . 0.0 113.522 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -57.27 -35.19 69.45 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 65.6 t -93.98 -41.97 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 126.968 2.107 . . . . 0.0 109.937 176.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 76.9 mt -56.81 -39.73 74.7 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 120.457 1.48 . . . . 0.0 110.753 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.02 -38.66 93.26 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-N 118.922 0.783 . . . . 0.0 112.573 175.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 24.0 mtmm -65.39 -47.54 75.97 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 117.627 0.714 . . . . 0.0 110.574 173.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 78.1 mt -60.64 -34.6 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 123.86 0.864 . . . . 0.0 110.331 -178.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -56.57 -50.31 72.31 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.654 -0.654 . . . . 0.0 110.396 175.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.4 mtt85 -59.42 -35.37 73.87 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 118.763 0.71 . . . . 0.0 110.72 176.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.72 -32.86 70.94 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.006 1.323 . . . . 0.0 112.929 -174.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 44.4 pt -115.57 -12.15 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 123.755 0.822 . . . . 0.0 112.172 177.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.79 40.0 98.0 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 126.516 2.008 . . . . 0.0 112.648 -174.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 41.0 mt -142.78 164.31 30.44 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.711 1.256 . . . . 0.0 109.33 173.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -68.72 142.99 54.85 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 126.442 1.897 . . . . 0.0 110.902 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -117.54 4.28 12.41 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.865 2.066 . . . . 0.0 111.226 177.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 37.1 mtt-85 -138.44 163.29 32.31 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.258 1.023 . . . . 0.0 110.804 176.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.76 166.56 16.94 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 125.581 1.562 . . . . 0.0 110.09 -170.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -73.63 -7.41 51.84 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.036 -1.273 . . . . 0.0 110.296 168.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -67.53 6.94 0.54 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.729 1.612 . . . . 0.0 112.286 164.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.7 tt -51.36 142.4 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 120.151 1.342 . . . . 0.0 110.983 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.14 3.6 53.02 Favored Glycine 0 CA--C 1.537 1.452 0 O-C-N 121.637 -0.664 . . . . 0.0 114.002 -178.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 20.3 mmtt -81.46 155.09 71.67 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 120.709 2.255 . . . . 0.0 105.959 159.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -70.92 158.25 55.93 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.803 2.335 . . . . 0.0 113.072 -171.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 28.5 pt -100.96 145.98 10.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 171.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 23.83 58.97 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 127.506 2.322 . . . . 0.0 114.305 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 24.0 ttpt -61.7 -40.21 94.21 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-O 119.024 -0.512 . . . . 0.0 110.421 -164.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -142.13 171.38 24.6 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 123.802 0.715 . . . . 0.0 111.498 172.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -63.63 101.3 0.31 Allowed 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 124.746 3.631 . . . . 0.0 111.086 178.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 80.8 mtt85 47.43 -119.03 0.98 Allowed 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 125.974 1.71 . . . . 0.0 109.486 -171.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 21.3 76.76 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 128.746 2.818 . . . . 0.0 113.544 173.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -56.78 -33.33 66.53 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.279 0.631 . . . . 0.0 112.557 -172.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.8 p -148.24 174.03 12.41 Favored 'General case' 0 C--O 1.237 0.436 0 O-C-N 121.424 -0.797 . . . . 0.0 109.263 173.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 93.66 130.85 5.79 Favored Glycine 0 CA--C 1.532 1.098 0 N-CA-C 108.11 -1.996 . . . . 0.0 108.11 -169.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -68.66 163.33 37.43 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 122.242 1.961 . . . . 0.0 109.282 170.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.9 p -156.39 -66.68 0.11 Allowed 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -178.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 33.1 t -80.59 134.77 35.96 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 161.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.955 0 CA-C-O 117.276 -1.847 . . . . 0.0 108.606 164.709 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.923 0 CA-C-O 118.534 -1.148 . . . . 0.0 111.555 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.4 m 93.78 53.72 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 129.171 2.988 . . . . 0.0 111.406 174.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.7 m -141.35 166.36 24.99 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 126.072 1.749 . . . . 0.0 106.708 161.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 143.99 12.39 0.31 Allowed Glycine 0 CA--C 1.529 0.942 0 CA-C-O 118.533 -1.148 . . . . 0.0 113.88 -177.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.0 m -74.47 171.88 12.97 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 119.377 1.589 . . . . 0.0 109.655 170.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.7 t -72.92 -55.71 6.21 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 166.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 153.06 -176.92 30.98 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 -178.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -162.11 142.31 10.11 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.612 1.165 . . . . 0.0 108.438 172.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? 56.76 -172.29 0.08 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.702 1.601 . . . . 0.0 110.438 -161.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.2 m -84.22 167.1 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.558 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 156.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.1 t -81.57 158.3 24.46 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 122.548 1.166 . . . . 0.0 110.26 169.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -69.39 167.59 16.22 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.42 1.888 . . . . 0.0 109.019 164.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.09 -56.85 16.44 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.914 1.285 . . . . 0.0 111.934 173.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.0 t -53.89 -58.52 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 123.844 0.858 . . . . 0.0 108.728 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -51.47 -46.12 53.05 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-O 118.571 -1.127 . . . . 0.0 112.929 176.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 36.1 tttm -59.06 -53.04 62.83 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 118.874 1.337 . . . . 0.0 109.244 -178.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 92.6 t -62.67 -33.59 60.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 118.707 -0.663 . . . . 0.0 110.548 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 70.1 mt -66.16 -59.19 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 119.913 1.233 . . . . 0.0 108.634 176.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -51.59 -47.33 63.59 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 126.545 1.938 . . . . 0.0 110.209 -178.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -60.4 -66.34 0.54 Allowed 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.726 1.61 . . . . 0.0 109.994 174.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.16 -26.19 69.0 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-O 118.736 -1.036 . . . . 0.0 113.303 -169.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 19.2 mtm105 -58.13 -64.28 0.97 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.546 1.173 . . . . 0.0 109.045 165.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -69.41 -8.43 46.53 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.562 1.545 . . . . 0.0 113.571 -175.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.8 m -69.24 -13.77 62.59 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.877 1.271 . . . . 0.0 112.201 162.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -133.86 12.71 4.01 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.484 1.914 . . . . 0.0 111.475 172.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.41 4.43 17.58 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 125.292 1.425 . . . . 0.0 114.758 -175.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 25.3 mt -66.69 125.85 27.13 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 119.635 1.717 . . . . 0.0 109.431 -165.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 52.1 p -65.88 168.98 7.2 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.754 0.788 . . . . 0.0 110.248 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -64.42 -34.6 78.55 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.459 -0.776 . . . . 0.0 110.733 172.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.2 mtpt -61.33 -44.44 97.19 Favored 'General case' 0 CA--C 1.518 -0.271 0 O-C-N 121.737 -0.602 . . . . 0.0 110.976 171.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -66.23 -37.85 86.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 118.312 0.506 . . . . 0.0 110.419 -177.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.11 -51.95 67.81 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 171.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.76 -48.55 69.6 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.283 1.033 . . . . 0.0 110.151 -177.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.7 m -57.76 -46.1 84.99 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.282 1.033 . . . . 0.0 111.369 175.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.2 mttm -59.03 -22.28 60.43 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.41 1.004 . . . . 0.0 113.681 178.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.582 HG22 ' HB3' ' A' ' 60' ' ' LYS . 26.9 pt -113.41 6.05 7.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 119.534 1.061 . . . . 0.0 111.992 178.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 49.88 48.33 21.92 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.234 1.814 . . . . 0.0 111.156 -174.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.471 ' HG3' ' H ' ' A' ' 39' ' ' LYS . 3.1 tp10 -127.68 -171.06 2.35 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.618 1.967 . . . . 0.0 109.007 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.471 ' H ' ' HG3' ' A' ' 38' ' ' GLU . 11.0 mmpt? -103.87 146.18 32.04 Favored Pre-proline 0 CA--C 1.531 0.242 0 O-C-N 120.655 -1.278 . . . . 0.0 111.169 -174.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -73.19 -19.2 22.88 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.46 2.106 . . . . 0.0 114.161 -178.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -58.47 -52.31 66.18 Favored 'General case' 0 C--N 1.339 0.127 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 167.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.4 m -66.1 -29.04 45.49 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.532 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.808 -175.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 49.1 mm -61.62 -50.16 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 120.421 1.464 . . . . 0.0 110.251 174.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.24 -31.85 73.11 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 122.396 0.279 . . . . 0.0 111.589 178.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -77.08 -33.45 57.08 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 122.943 0.497 . . . . 0.0 110.405 177.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -57.69 -43.63 85.27 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 125.657 1.583 . . . . 0.0 110.016 170.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -60.06 -58.31 9.08 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.014 0.926 . . . . 0.0 109.451 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.46 -9.42 34.13 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 178.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.1 0.15 77.86 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-N 120.061 1.301 . . . . 0.0 113.457 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 72.4 mtt-85 -70.82 -43.9 67.63 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.896 1.279 . . . . 0.0 111.125 -176.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.19 139.25 58.75 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 173.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 50.3 mm -74.45 117.13 59.57 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 105.669 -1.975 . . . . 0.0 105.669 168.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -77.04 115.01 3.92 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 C-N-CA 121.223 1.282 . . . . 0.0 109.072 -171.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -81.38 131.18 35.27 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.892 1.677 . . . . 0.0 107.77 -174.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -54.8 -33.5 61.6 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.33 1.052 . . . . 0.0 113.137 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -60.97 -64.02 1.1 Allowed 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 122.1 0.952 . . . . 0.0 108.577 174.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.439 ' HA ' ' HD3' ' A' ' 60' ' ' LYS . 77.5 t -60.6 -41.11 86.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.816 1.247 . . . . 0.0 110.272 -174.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.2 mt -48.23 -46.22 35.11 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.047 0.939 . . . . 0.0 110.551 177.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.02 -33.56 62.41 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 118.6 0.637 . . . . 0.0 113.561 178.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.582 ' HB3' HG22 ' A' ' 36' ' ' ILE . 37.3 mtpt -64.46 -40.19 95.25 Favored 'General case' 0 N--CA 1.463 0.205 0 O-C-N 121.305 -1.115 . . . . 0.0 109.541 174.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.9 mt -63.64 -36.77 77.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 124.681 1.192 . . . . 0.0 108.746 174.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.458 ' HA ' HD23 ' A' ' 69' ' ' LEU . 54.6 mt-10 -57.19 -51.23 70.16 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 119.739 1.154 . . . . 0.0 110.241 174.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 60.6 mtt85 -63.18 -27.48 69.39 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.188 0.449 . . . . 0.0 111.545 175.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.1 -38.11 87.61 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.948 0.899 . . . . 0.0 112.187 179.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 22.9 pt -118.6 -9.04 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 119.134 0.879 . . . . 0.0 113.256 -176.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.44 36.36 93.28 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 126.555 2.026 . . . . 0.0 113.343 -176.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 84.7 mt -133.37 165.51 24.67 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.345 1.458 . . . . 0.0 108.156 169.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 53.3 mttm -76.25 141.88 41.57 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.615 1.566 . . . . 0.0 109.565 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.458 HD23 ' HA ' ' A' ' 62' ' ' GLU . 3.8 mm? -118.6 11.07 12.73 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 126.267 1.827 . . . . 0.0 110.968 178.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 5.8 mtt85 -140.22 167.9 21.06 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.254 1.422 . . . . 0.0 108.255 176.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 73.4 171.04 21.25 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.543 1.544 . . . . 0.0 111.158 -173.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.75 -13.08 60.06 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.359 -1.083 . . . . 0.0 110.163 165.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -75.01 18.5 0.18 Allowed 'General case' 0 CA--C 1.549 0.921 0 O-C-N 120.577 -1.327 . . . . 0.0 110.146 168.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.9 tt -53.85 148.04 2.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 O-C-N 120.301 -1.499 . . . . 0.0 110.62 173.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 67.62 -1.43 7.45 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 123.781 0.705 . . . . 0.0 113.504 -178.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 12.3 mmtp -73.69 155.12 89.28 Favored Pre-proline 0 N--CA 1.452 -0.367 0 CA-C-N 119.634 1.717 . . . . 0.0 106.968 160.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -57.22 156.64 24.32 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 122.792 2.328 . . . . 0.0 112.559 177.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 30.7 pt -100.86 153.94 4.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 154.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 25.02 61.25 0.06 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 128.214 2.605 . . . . 0.0 113.612 166.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -171.0 -30.48 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.539 1.936 . . . . 0.0 111.813 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -109.77 107.9 2.42 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-O 118.2 -1.333 . . . . 0.0 111.49 -169.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -73.77 68.32 4.67 Favored 'Trans proline' 0 CA--C 1.537 0.667 1 C-N-CA 125.42 4.08 . . . . 0.0 111.126 -177.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.11 116.03 9.78 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.404 1.482 . . . . 0.0 108.546 -173.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.3 140.99 43.22 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 123.914 0.886 . . . . 0.0 109.973 174.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 31.7 mttp -64.38 147.41 52.67 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.223 1.009 . . . . 0.0 109.16 178.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.5 t -71.07 -47.27 59.29 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 168.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -78.68 117.38 4.59 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-O 117.519 -1.711 . . . . 0.0 110.91 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -76.1 -175.2 2.4 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.971 2.447 . . . . 0.0 109.698 167.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 10.0 p -137.75 163.01 32.41 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 161.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 30.1 t -79.5 124.83 28.85 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 104.306 -2.479 . . . . 0.0 104.306 149.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.911 0 N-CA-C 104.308 -3.517 . . . . 0.0 104.308 -171.212 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.906 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.9 t -72.04 159.53 34.03 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.288 0.635 . . . . 0.0 111.157 -175.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 64.3 m -136.14 100.48 4.42 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.261 1.424 . . . . 0.0 109.276 169.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -131.28 168.18 22.21 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 164.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.7 t -159.26 -40.42 0.06 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 118.149 -0.929 . . . . 0.0 112.365 175.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.8 m 38.05 75.26 0.07 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.816 2.046 . . . . 0.0 112.726 178.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -138.09 179.83 17.88 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 124.82 1.2 . . . . 0.0 110.283 178.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -147.39 145.63 29.33 Favored 'General case' 0 C--O 1.238 0.459 0 O-C-N 121.681 -0.894 . . . . 0.0 109.01 -174.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -173.93 156.54 2.79 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.558 1.143 . . . . 0.0 111.568 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.7 p -66.0 162.38 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 123.521 0.728 . . . . 0.0 109.285 159.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.2 t -135.18 169.72 17.02 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.787 1.235 . . . . 0.0 108.851 165.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.1 mp -67.96 163.16 22.78 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 125.281 1.432 . . . . 0.0 109.367 174.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -58.18 -40.14 80.74 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-O 119.422 -0.323 . . . . 0.0 110.473 176.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.2 t -56.71 -58.26 6.27 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.316 0 C-N-CA 123.668 0.787 . . . . 0.0 109.67 177.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -56.57 -38.59 81.95 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 119.571 1.078 . . . . 0.0 112.363 178.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -62.05 -59.3 5.29 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.257 1.028 . . . . 0.0 110.096 175.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.4 t -61.35 -37.57 77.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 125.308 1.443 . . . . 0.0 110.347 -175.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 51.4 mt -53.47 -68.67 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 170.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -58.4 -34.05 70.32 Favored 'General case' 0 N--CA 1.445 -0.697 0 O-C-N 123.882 0.739 . . . . 0.0 110.8 -168.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -57.22 -69.69 0.15 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.093 1.757 . . . . 0.0 109.906 174.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.95 -32.1 73.14 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.776 -0.529 . . . . 0.0 111.776 -172.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -54.58 -62.01 1.93 Allowed 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 125.392 1.477 . . . . 0.0 108.798 172.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -63.19 -38.21 90.27 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 119.14 0.882 . . . . 0.0 111.449 -177.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 43.5 m -76.26 -2.31 30.79 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.377 0.99 . . . . 0.0 112.561 -177.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -115.55 12.86 16.25 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.256 1.022 . . . . 0.0 111.229 165.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 74.79 3.15 66.76 Favored Glycine 0 C--N 1.34 0.769 0 C-N-CA 128.03 2.729 . . . . 0.0 114.676 175.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.446 HD22 ' HE3' ' A' ' 35' ' ' LYS . 33.6 mt -72.95 130.16 39.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 118.781 1.29 . . . . 0.0 109.087 -159.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.0 p -68.51 170.75 8.52 Favored 'General case' 0 C--O 1.239 0.507 0 O-C-N 121.328 -0.858 . . . . 0.0 109.143 169.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -61.73 -30.1 70.55 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.64 -0.663 . . . . 0.0 110.408 168.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.4 mttt -71.24 -39.09 71.88 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.645 1.111 . . . . 0.0 112.3 175.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -64.65 -48.76 73.62 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.23 -47.63 78.08 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.789 0.836 . . . . 0.0 110.772 176.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.41 -50.39 73.86 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.536 0.734 . . . . 0.0 111.269 178.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.7 m -55.13 -47.72 74.67 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.068 1.347 . . . . 0.0 109.712 177.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.446 ' HE3' HD22 ' A' ' 27' ' ' LEU . 51.0 mttm -59.88 -15.45 21.47 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 125.453 1.501 . . . . 0.0 113.981 178.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.43 HD11 HD11 ' A' ' 43' ' ' ILE . 25.4 pt -122.35 15.43 5.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 118.998 0.817 . . . . 0.0 111.348 175.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.8 t30 57.53 13.14 1.75 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.166 1.386 . . . . 0.0 113.686 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -107.29 -170.87 1.77 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.762 2.025 . . . . 0.0 108.89 -173.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -102.51 149.65 36.9 Favored Pre-proline 0 N--CA 1.466 0.327 0 CA-C-N 120.024 1.284 . . . . 0.0 112.783 -175.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.71 -13.98 35.6 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 123.39 2.727 . . . . 0.0 112.919 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.9 tp60 -54.81 -60.15 3.76 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 123.588 0.755 . . . . 0.0 109.343 165.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.0 m -60.68 -41.09 86.93 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.52 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -172.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.43 HD11 HD11 ' A' ' 36' ' ' ILE . 44.0 mm -54.23 -47.28 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 119.252 0.933 . . . . 0.0 110.726 -178.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.8 -35.72 73.28 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.121 0.486 . . . . 0.0 112.134 176.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -79.18 -38.31 36.17 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.369 1.068 . . . . 0.0 110.992 -177.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -58.37 -39.7 80.28 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.216 1.407 . . . . 0.0 109.026 170.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -70.12 -33.09 71.41 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -178.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.2 t -73.85 -29.48 62.14 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.958 1.253 . . . . 0.0 109.41 167.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.55 10.84 49.48 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 124.002 0.81 . . . . 0.0 111.364 -174.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.7 mmt-85 -64.62 -60.93 2.55 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.258 1.023 . . . . 0.0 109.666 176.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.89 141.28 49.8 Favored 'General case' 0 C--O 1.239 0.543 0 O-C-N 124.787 1.304 . . . . 0.0 110.073 -172.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.402 HD12 ' N ' ' A' ' 52' ' ' ILE . 1.8 mp -74.14 123.99 89.66 Favored Pre-proline 0 CA--C 1.533 0.31 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 -177.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -67.18 114.86 3.37 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 121.561 1.508 . . . . 0.0 110.215 -178.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 -103.94 116.86 33.02 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 125.039 1.336 . . . . 0.0 108.418 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -47.27 -39.24 14.05 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.23 1.412 . . . . 0.0 113.472 -175.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -63.08 -52.97 60.59 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 118.416 0.553 . . . . 0.0 110.356 -178.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.525 ' HA ' ' HD3' ' A' ' 60' ' ' LYS . 23.9 t -63.66 -43.24 98.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 124.391 1.076 . . . . 0.0 108.36 -178.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 81.6 mt -53.7 -48.88 69.13 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-O 118.528 -0.748 . . . . 0.0 110.257 176.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -57.5 -34.4 69.0 Favored Glycine 0 CA--C 1.534 1.266 0 CA-C-N 119.24 0.927 . . . . 0.0 113.309 177.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.525 ' HD3' ' HA ' ' A' ' 57' ' ' VAL . 17.9 mtpp -70.57 -44.86 66.5 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.493 -1.004 . . . . 0.0 109.5 175.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.8 mt -59.62 -35.4 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.114 0 C-N-CA 124.862 1.265 . . . . 0.0 109.792 178.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -54.28 -51.76 63.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 119.039 0.836 . . . . 0.0 110.245 177.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 58.1 mtt180 -71.81 -8.4 54.05 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.493 -0.755 . . . . 0.0 112.804 179.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.37 -38.46 63.18 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.436 0.694 . . . . 0.0 110.719 173.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.429 HD11 HD21 ' A' ' 69' ' ' LEU . 25.7 pt -120.25 -10.51 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -172.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.26 33.69 83.38 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 126.628 2.061 . . . . 0.0 113.027 -178.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 67.8 mt -128.8 164.82 22.2 Favored 'General case' 0 CA--C 1.527 0.076 0 CA-C-N 118.126 0.963 . . . . 0.0 109.635 170.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -78.84 140.68 38.13 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 126.055 1.742 . . . . 0.0 108.738 174.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.429 HD21 HD11 ' A' ' 65' ' ' ILE . 4.3 mm? -120.01 -2.18 10.29 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 127.897 2.479 . . . . 0.0 110.462 -177.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.512 HH11 ' HG2' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -141.02 169.67 17.17 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.673 1.189 . . . . 0.0 109.136 176.935 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.53 164.51 18.96 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -169.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.9 ttmt -78.06 3.21 15.49 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.884 -0.774 . . . . 0.0 111.061 175.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -96.69 23.11 7.3 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.827 2.051 . . . . 0.0 110.499 171.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.3 tt -52.96 151.94 1.04 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-N 120.238 1.381 . . . . 0.0 110.763 177.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.83 -6.03 14.71 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 119.058 -0.857 . . . . 0.0 113.36 178.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 40.1 mmtt -76.02 150.97 83.85 Favored Pre-proline 0 N--CA 1.45 -0.441 0 CA-C-N 119.83 1.815 . . . . 0.0 107.744 166.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -69.99 157.15 60.87 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 123.253 2.636 . . . . 0.0 111.64 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.0 pt -101.45 148.43 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.093 0 C-N-CA 123.959 0.904 . . . . 0.0 108.775 177.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 35.42 68.86 0.19 Allowed 'General case' 0 C--O 1.237 0.445 0 C-N-CA 127.466 2.306 . . . . 0.0 111.707 175.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.0 ptpt -120.71 174.31 6.66 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 125.075 1.35 . . . . 0.0 109.169 170.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -57.55 168.62 4.52 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 123.467 0.556 . . . . 0.0 112.072 177.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.11 157.02 55.0 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.57 2.18 . . . . 0.0 110.884 -177.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -153.11 6.03 0.36 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.537 0.735 . . . . 0.0 112.022 165.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -171.66 -177.76 2.09 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 128.05 2.54 . . . . 0.0 106.359 177.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -143.49 -162.27 1.42 Allowed 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.49 1.116 . . . . 0.0 109.037 159.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 44.9 m 61.37 178.69 0.11 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.554 1.941 . . . . 0.0 113.945 174.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -129.86 178.49 17.44 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 160.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -75.16 -35.34 3.09 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.375 2.05 . . . . 0.0 111.429 172.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.6 m 57.74 166.89 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 128.26 2.624 . . . . 0.0 114.405 172.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 61.7 m -162.24 -25.72 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.457 1.903 . . . . 0.0 112.182 171.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.447 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 -176.793 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.698 0 CA-C-O 119.269 -0.74 . . . . 0.0 112.164 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.3 t 49.31 46.14 23.21 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.032 1.416 . . . . 0.0 109.26 -157.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.6 m -65.48 135.02 54.65 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.805 0.842 . . . . 0.0 109.607 -172.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.88 -95.96 0.95 Allowed Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 107.114 -2.394 . . . . 0.0 107.114 168.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.5 t -153.96 117.03 4.51 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.998 1.719 . . . . 0.0 107.573 177.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.0 p -141.15 135.86 31.28 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 164.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 158.03 -156.59 27.49 Favored Glycine 0 CA--C 1.521 0.447 0 CA-C-N 119.739 1.154 . . . . 0.0 112.505 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -145.83 108.58 4.51 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 126.116 1.766 . . . . 0.0 108.777 169.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.7 tpm_? -159.1 162.41 36.52 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 177.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.2 p -60.29 156.88 2.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 C-N-CA 123.749 0.82 . . . . 0.0 109.559 165.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.7 p -106.47 107.24 18.16 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 106.935 -1.505 . . . . 0.0 106.935 172.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.1 mp -65.16 154.07 39.06 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 118.602 -0.713 . . . . 0.0 109.215 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -41.07 -55.41 2.58 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.739 1.616 . . . . 0.0 112.201 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.2 t -56.91 -61.33 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 C-N-CA 123.473 0.709 . . . . 0.0 109.227 -178.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.37 -33.1 65.06 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-N 119.325 0.966 . . . . 0.0 113.562 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 59.2 tptt -65.31 -55.09 20.22 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 125.421 1.488 . . . . 0.0 109.768 176.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 76.8 t -63.3 -39.16 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 CA-C-N 118.586 0.63 . . . . 0.0 110.573 178.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 83.3 mt -58.6 -56.31 17.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 177.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -51.47 -53.48 36.78 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.15 0.98 . . . . 0.0 109.662 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -58.98 -54.92 41.75 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 123.21 0.319 . . . . 0.0 110.977 -178.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.28 -25.01 76.32 Favored Glycine 0 CA--C 1.523 0.556 0 O-C-N 120.701 -1.249 . . . . 0.0 113.033 -172.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.427 HH11 ' HB3' ' A' ' 22' ' ' ARG . 20.0 mtm105 -60.07 -60.6 3.57 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 119.2 1.5 . . . . 0.0 109.511 162.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -64.6 -29.67 70.68 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.96 0.904 . . . . 0.0 111.916 -169.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.2 m -57.3 -20.97 31.73 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.485 1.114 . . . . 0.0 111.831 171.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -120.12 9.89 11.26 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.446 1.899 . . . . 0.0 109.462 -176.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 73.34 -4.75 24.47 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 126.565 2.031 . . . . 0.0 114.739 -177.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 52.1 mt -70.61 152.95 43.36 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 118.815 1.307 . . . . 0.0 111.539 -159.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.403 HG23 ' H ' ' A' ' 31' ' ' ASP . 0.5 OUTLIER -93.53 167.75 11.49 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.72 1.208 . . . . 0.0 110.393 172.056 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 9.3 mp0 -50.48 -39.72 48.98 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.64 0.776 . . . . 0.0 111.852 163.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 43.4 mttt -62.25 -38.61 89.89 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 118.502 0.592 . . . . 0.0 110.884 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.403 ' H ' HG23 ' A' ' 28' ' ' THR . 81.4 m-20 -66.65 -40.8 88.84 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 122.753 0.421 . . . . 0.0 110.089 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.84 -53.9 49.48 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 125.258 1.423 . . . . 0.0 109.161 177.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -48.83 -57.22 6.74 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.652 1.581 . . . . 0.0 109.739 178.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 18.5 m -57.93 -39.12 77.24 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.237 1.015 . . . . 0.0 112.803 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.9 mttm -58.68 -39.67 81.38 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 119.457 1.026 . . . . 0.0 112.36 176.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.7 pt -103.3 10.61 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 123.624 0.77 . . . . 0.0 111.376 -173.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.8 t30 65.32 42.68 3.81 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.925 2.09 . . . . 0.0 113.674 176.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -135.64 -177.44 4.68 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.032 0.933 . . . . 0.0 113.149 -174.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -92.43 145.23 30.17 Favored Pre-proline 0 C--N 1.339 0.135 0 C-N-CA 125.314 1.445 . . . . 0.0 110.345 178.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.1 -6.07 18.39 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.73 2.287 . . . . 0.0 112.951 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.3 tp60 -61.35 -51.39 69.04 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 118.501 -0.761 . . . . 0.0 110.684 169.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.7 m -68.79 -29.97 45.41 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.305 0 CA-C-N 118.906 0.775 . . . . 0.0 109.468 -176.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.7 mm -64.84 -46.64 91.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 124.048 0.939 . . . . 0.0 109.942 177.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.33 -35.91 74.7 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.061 0.544 . . . . 0.0 111.112 175.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.94 -40.94 62.72 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 121.731 -0.606 . . . . 0.0 110.978 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -53.91 -47.43 71.17 Favored 'General case' 0 C--N 1.334 -0.081 0 C-N-CA 125.066 1.346 . . . . 0.0 110.331 172.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -57.41 -42.69 82.81 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.572 0.749 . . . . 0.0 112.03 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.1 t -78.45 -25.41 45.91 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.825 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.72 44.89 2.58 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 -174.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 15.9 mmt85 -129.76 -21.65 3.05 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 125.171 1.388 . . . . 0.0 112.793 -171.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.28 133.48 49.78 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 169.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 41.0 mm -68.91 109.18 3.83 Favored Pre-proline 0 C--O 1.237 0.432 0 N-CA-C 104.779 -2.304 . . . . 0.0 104.779 169.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -84.19 114.2 1.85 Allowed 'Trans proline' 0 N--CA 1.445 -1.359 0 N-CA-C 108.568 -1.358 . . . . 0.0 108.568 -159.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -80.84 140.31 35.48 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -63.02 -29.26 70.68 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.077 0.853 . . . . 0.0 110.798 173.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -57.88 -60.85 3.07 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.522 1.129 . . . . 0.0 109.593 173.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.479 ' HA ' ' HE3' ' A' ' 60' ' ' LYS . 59.8 t -64.68 -46.19 93.04 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.259 0 CA-C-O 118.38 -0.819 . . . . 0.0 110.098 -177.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 25.1 mt -48.88 -48.43 42.17 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 123.894 0.878 . . . . 0.0 109.501 172.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -55.56 -44.15 85.82 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 125.721 1.629 . . . . 0.0 113.687 176.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.479 ' HE3' ' HA ' ' A' ' 57' ' ' VAL . 44.6 mtmt -65.66 -42.47 91.33 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 117.762 0.781 . . . . 0.0 110.753 175.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.1 mt -60.75 -33.32 54.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.743 0.817 . . . . 0.0 109.307 175.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.413 ' HA ' HD23 ' A' ' 69' ' ' LEU . 30.2 mt-10 -59.36 -46.38 88.81 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.775 1.17 . . . . 0.0 110.656 174.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 40.4 mtt-85 -58.13 -40.24 80.76 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 118.698 0.681 . . . . 0.0 110.367 173.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.0 -25.18 67.49 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.523 1.529 . . . . 0.0 114.627 -171.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.54 HD11 HD21 ' A' ' 69' ' ' LEU . 26.3 pt -125.41 -12.98 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-N 119.264 0.938 . . . . 0.0 112.086 176.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.9 29.89 64.34 Favored Glycine 0 C--N 1.336 0.577 0 C-N-CA 126.369 1.938 . . . . 0.0 113.165 -178.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.2 mt -130.05 163.32 26.78 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.397 1.479 . . . . 0.0 109.35 174.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 52.4 mttm -73.45 143.55 46.63 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 125.198 1.399 . . . . 0.0 108.946 175.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.54 HD21 HD11 ' A' ' 65' ' ' ILE . 3.9 mm? -119.03 8.81 11.67 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.105 1.362 . . . . 0.0 110.472 178.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 34.6 mtm105 -141.03 127.61 20.11 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 121.549 -0.72 . . . . 0.0 109.272 -166.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.01 179.22 48.83 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 125.168 1.366 . . . . 0.0 112.038 176.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -64.41 -13.17 49.67 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 114.136 1.161 . . . . 0.0 114.136 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -93.51 22.81 5.03 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.094 0.861 . . . . 0.0 109.745 177.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.1 tt -55.2 149.24 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 O-C-N 120.95 -1.093 . . . . 0.0 110.368 178.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.57 -14.22 7.26 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-O 117.681 -1.622 . . . . 0.0 113.148 178.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 32.4 mmtt -68.19 144.36 96.74 Favored Pre-proline 0 N--CA 1.452 -0.373 0 CA-C-N 120.459 2.13 . . . . 0.0 107.882 173.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -69.27 150.75 71.57 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.613 2.875 . . . . 0.0 111.648 -177.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.4 pt -101.59 147.03 8.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 C-N-CA 124.146 0.978 . . . . 0.0 109.663 -178.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 46.6 59.49 3.87 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.878 2.071 . . . . 0.0 112.225 177.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -125.14 108.28 11.62 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 172.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 151.58 -167.37 30.91 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 -177.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -60.54 171.71 3.23 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.153 1.902 . . . . 0.0 109.763 160.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.4 ttm180 -149.72 145.72 26.83 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 170.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.45 -45.09 69.91 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 170.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.9 tttm -162.24 -179.15 6.82 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.591 1.556 . . . . 0.0 107.579 178.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.5 m -132.36 -1.28 3.57 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.713 1.205 . . . . 0.0 112.74 172.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 150.95 -178.95 28.06 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 -172.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -62.1 145.88 96.31 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 121.748 1.632 . . . . 0.0 109.787 166.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 71.8 m -142.78 119.18 10.91 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 170.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.9 t -131.18 2.15 4.25 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.478 1.511 . . . . 0.0 111.921 -176.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.124 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 178.702 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.697 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.5 p -164.97 -37.75 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 124.769 1.228 . . . . 0.0 110.795 162.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.4 t -152.78 -26.17 0.16 Allowed 'General case' 0 C--O 1.236 0.342 0 C-N-CA 123.864 0.866 . . . . 0.0 111.795 -172.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.53 -142.95 20.58 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 108.256 -1.938 . . . . 0.0 108.256 -160.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 25.8 t -136.07 157.55 46.57 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.11 1.364 . . . . 0.0 108.211 -178.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.3 t -136.37 -167.91 2.14 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 122.489 1.138 . . . . 0.0 112.039 -171.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -149.55 170.86 29.73 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 126.653 2.073 . . . . 0.0 109.38 175.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -154.69 150.97 28.2 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 126.057 1.743 . . . . 0.0 107.414 179.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.5 mmt180 -139.5 156.81 46.69 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 123.972 0.909 . . . . 0.0 110.065 -169.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 t 48.2 42.05 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 124.748 1.219 . . . . 0.0 109.878 -177.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.8 m -64.96 147.52 53.28 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 123.308 0.643 . . . . 0.0 109.937 -174.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -54.95 148.85 12.63 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.821 1.248 . . . . 0.0 108.48 171.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -59.31 -30.37 68.29 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.671 0.669 . . . . 0.0 111.404 174.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.7 t -58.18 -62.06 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 124.24 1.016 . . . . 0.0 108.479 172.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.37 -40.13 60.52 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-N 119.394 0.997 . . . . 0.0 111.968 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -61.52 -58.14 9.33 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.098 0.949 . . . . 0.0 111.27 177.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.2 t -60.04 -36.98 70.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 123.955 0.902 . . . . 0.0 109.774 -178.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.444 HG13 HD11 ' A' ' 69' ' ' LEU . 75.4 mt -57.94 -62.27 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 174.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -56.14 -40.68 74.19 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 118.654 0.661 . . . . 0.0 111.411 -175.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -62.03 -43.93 97.79 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.511 1.524 . . . . 0.0 112.117 175.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -75.02 -33.29 55.21 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 124.742 1.163 . . . . 0.0 112.226 -176.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 15.4 mtm105 -65.71 -48.65 71.28 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 117.687 0.744 . . . . 0.0 110.216 169.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -55.5 -33.82 64.06 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.914 0.886 . . . . 0.0 112.485 175.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.1 t -64.08 -19.06 64.97 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.143 0.977 . . . . 0.0 111.701 -178.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.417 ' HE3' ' HA ' ' A' ' 65' ' ' ILE . 5.7 mtmm -130.57 7.22 4.85 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.785 1.234 . . . . 0.0 110.811 -175.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 48.58 47.31 29.79 Favored Glycine 0 C--N 1.337 0.614 0 C-N-CA 126.068 1.794 . . . . 0.0 113.127 -173.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.656 HD13 ' HE3' ' A' ' 35' ' ' LYS . 61.1 mt -101.81 119.52 38.91 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -177.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.464 HG23 ' H ' ' A' ' 31' ' ' ASP . 13.3 t -68.01 169.26 10.35 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.627 0.727 . . . . 0.0 109.462 176.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -64.38 -36.72 85.06 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.389 0.676 . . . . 0.0 109.842 178.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.423 ' HA ' ' HB3' ' A' ' 40' ' ' PRO . 7.4 mttt -57.4 -44.65 84.7 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.191 0.997 . . . . 0.0 113.434 167.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.464 ' H ' HG23 ' A' ' 28' ' ' THR . 2.3 m-20 -65.9 -43.53 87.93 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -176.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.87 -50.48 73.6 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.082 1.353 . . . . 0.0 111.387 176.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.23 -48.5 65.13 Favored 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 125.485 1.514 . . . . 0.0 109.981 177.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 20.5 m -61.42 -47.87 83.78 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.932 0.787 . . . . 0.0 111.508 175.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.656 ' HE3' HD13 ' A' ' 27' ' ' LEU . 50.5 mttm -55.56 -40.33 71.79 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 119.282 0.946 . . . . 0.0 111.98 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.3 pt -98.28 6.16 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 123.438 0.695 . . . . 0.0 112.256 -178.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 52.4 t30 44.46 63.94 1.5 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.488 2.315 . . . . 0.0 113.383 -173.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -138.93 -173.32 3.54 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.835 2.054 . . . . 0.0 110.114 174.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -82.55 148.16 57.78 Favored Pre-proline 0 N--CA 1.467 0.412 0 O-C-N 120.791 -1.193 . . . . 0.0 110.594 177.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.423 ' HB3' ' HA ' ' A' ' 30' ' ' LYS . 26.5 Cg_endo -66.39 -28.02 46.9 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.608 2.205 . . . . 0.0 111.872 169.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -67.67 -43.54 79.98 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 118.56 -0.733 . . . . 0.0 109.97 -178.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.9 m -68.37 -31.64 52.23 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.373 0 CA-C-O 117.827 -1.082 . . . . 0.0 110.69 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 41.5 mm -57.92 -49.82 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 120.093 1.315 . . . . 0.0 109.367 170.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.09 -22.92 65.08 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 121.541 -0.724 . . . . 0.0 112.622 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.67 -26.53 27.71 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 118.177 -0.916 . . . . 0.0 112.015 172.072 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -62.22 -59.09 5.54 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.395 1.452 . . . . 0.0 108.585 173.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.411 ' OE1' HG21 ' A' ' 18' ' ' ILE . 1.0 OUTLIER -52.66 -42.82 65.06 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 123.69 0.796 . . . . 0.0 112.859 176.521 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 27.3 m -66.68 -24.04 66.22 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 117.841 -1.076 . . . . 0.0 113.634 177.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.42 24.84 11.67 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 119.97 1.259 . . . . 0.0 113.732 -177.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -122.98 -30.85 3.72 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.015 1.407 . . . . 0.0 113.457 -170.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.7 132.94 49.19 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 170.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 39.4 mm -69.25 113.56 17.57 Favored Pre-proline 0 C--O 1.24 0.582 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 179.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.57 115.36 3.38 Favored 'Trans proline' 0 N--CA 1.445 -1.36 0 C-N-CA 122.648 2.232 . . . . 0.0 108.426 -175.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -95.77 147.8 23.25 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 174.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 59.6 t-20 -54.07 -45.02 71.62 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.913 1.285 . . . . 0.0 110.782 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -57.6 -52.01 67.17 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.513 0.725 . . . . 0.0 111.106 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.1 t -68.66 -40.48 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 O-C-N 121.748 -0.595 . . . . 0.0 110.635 -178.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 31.5 mt -51.49 -43.37 62.18 Favored 'General case' 0 C--O 1.22 -0.469 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 171.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.13 -39.59 97.35 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-N 119.169 0.895 . . . . 0.0 112.841 175.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -63.85 -44.48 93.03 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 119.185 1.492 . . . . 0.0 110.046 175.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.3 mt -64.34 -35.46 74.24 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.095 0 C-N-CA 124.984 1.314 . . . . 0.0 110.162 178.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.406 ' HA ' HD23 ' A' ' 69' ' ' LEU . 94.4 mt-10 -58.63 -51.0 71.76 Favored 'General case' 0 CA--C 1.512 -0.497 0 O-C-N 121.509 -0.744 . . . . 0.0 109.524 177.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -58.64 -40.1 82.44 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-O 118.789 -0.624 . . . . 0.0 110.804 176.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.18 -26.43 60.61 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.507 1.523 . . . . 0.0 113.895 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.424 HD11 HD21 ' A' ' 69' ' ' LEU . 16.9 pt -114.55 -15.02 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 119.74 1.155 . . . . 0.0 112.353 173.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.74 27.83 70.15 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 127.847 2.642 . . . . 0.0 113.597 -174.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.9 mt -136.56 158.58 44.11 Favored 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 124.842 1.257 . . . . 0.0 109.36 -179.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -66.65 139.99 57.89 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 125.598 1.559 . . . . 0.0 109.572 176.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.444 HD11 HG13 ' A' ' 18' ' ' ILE . 4.3 mm? -114.54 0.87 14.13 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.472 1.509 . . . . 0.0 109.972 171.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 53.2 mtm180 -135.42 142.39 45.61 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.863 1.265 . . . . 0.0 108.161 -169.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.62 163.03 12.34 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -173.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -73.41 -1.77 19.63 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.564 -0.962 . . . . 0.0 113.379 -175.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -77.44 16.07 0.68 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.883 0.765 . . . . 0.0 111.174 165.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.1 tt -50.3 135.54 9.3 Favored 'Isoleucine or valine' 0 C--O 1.242 0.706 0 CA-C-N 120.091 1.314 . . . . 0.0 110.699 -175.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.46 -3.85 71.29 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-O 119.541 -0.588 . . . . 0.0 113.537 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 20.0 mmtm -74.86 150.13 85.95 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 120.655 2.227 . . . . 0.0 107.202 163.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -66.14 157.96 57.04 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.951 2.434 . . . . 0.0 111.992 -174.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 17.8 pt -101.34 138.41 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 168.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 38.32 -23.78 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.736 1 C-N-CA 134.266 5.027 . . . . 0.0 120.789 178.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.7 mmtp -67.58 170.34 7.83 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 121.607 2.003 . . . . 0.0 109.058 176.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -55.78 142.33 37.98 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-O 119.233 -0.759 . . . . 0.0 112.282 -166.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.44 155.95 67.32 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.009 2.473 . . . . 0.0 110.437 -178.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 22.6 ttt-85 -162.82 29.75 0.1 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.532 0.733 . . . . 0.0 110.671 174.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -132.61 174.76 9.95 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.028 0.931 . . . . 0.0 109.607 176.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.49 138.52 43.54 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.541 1.136 . . . . 0.0 108.645 174.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 43.6 t 176.2 155.76 0.22 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.969 2.508 . . . . 0.0 105.957 -177.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -103.46 101.71 2.09 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 117.988 -1.451 . . . . 0.0 109.505 176.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.48 167.49 20.58 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 CA-C-N 120.736 2.268 . . . . 0.0 111.966 177.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.7 p -146.26 -178.6 6.23 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 125.493 1.517 . . . . 0.0 109.287 174.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 13.7 t -153.37 162.41 41.31 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.54 1.536 . . . . 0.0 107.793 175.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.118 0 N-CA-C 107.886 -2.085 . . . . 0.0 107.886 149.881 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.64 0 N-CA-C 107.352 -2.299 . . . . 0.0 107.352 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.9 m 52.21 169.58 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 122.052 0.93 . . . . 0.0 111.644 -133.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.8 t -150.82 -177.55 6.06 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 150.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -127.34 178.17 17.07 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 124.164 0.888 . . . . 0.0 113.072 -170.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.9 m -135.86 -51.25 0.72 Allowed 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.667 1.187 . . . . 0.0 110.019 172.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 46.3 p -148.44 159.99 43.49 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.528 0.603 . . . . 0.0 110.784 -178.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 152.15 15.6 0.07 OUTLIER Glycine 0 CA--C 1.53 0.998 0 CA-C-O 118.324 -1.264 . . . . 0.0 113.429 -166.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 81.38 136.8 0.06 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 129.66 3.184 . . . . 0.0 110.697 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 26.9 mtt-85 -160.4 171.61 18.77 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 127.377 2.271 . . . . 0.0 109.178 178.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . 0.327 0.8 OUTLIER 55.4 -153.68 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 130.796 3.638 . . . . 0.0 110.478 -175.211 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . 0.29 1.6 p 52.57 -157.02 0.15 Allowed 'General case' 0 C--O 1.239 0.526 0 C-N-CA 126.192 1.797 . . . . 0.0 111.824 174.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 74.52 157.98 0.2 Allowed 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 126.845 2.058 . . . . 0.0 114.102 164.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -98.21 -61.99 1.3 Allowed 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.416 165.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 49.7 t -54.26 -56.73 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 120.054 1.297 . . . . 0.0 110.669 -173.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -54.71 -42.37 77.75 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-O 119.129 -0.817 . . . . 0.0 113.041 176.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.478 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 1.8 tpmt? -62.5 -48.5 79.3 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 118.599 1.199 . . . . 0.0 110.177 177.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.518 HG21 HG12 ' A' ' 74' ' ' ILE . 74.9 t -61.43 -43.09 96.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 124.536 1.134 . . . . 0.0 109.589 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.5 mt -59.51 -52.98 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 C-N-CA 124.324 1.05 . . . . 0.0 108.624 177.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -54.79 -50.18 69.13 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.267 1.427 . . . . 0.0 110.262 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -58.74 -56.2 25.32 Favored 'General case' 0 C--O 1.227 -0.109 0 C-N-CA 124.915 1.286 . . . . 0.0 111.31 178.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.5 -23.18 76.07 Favored Glycine 0 CA--C 1.52 0.403 0 CA-C-O 118.678 -1.068 . . . . 0.0 112.395 -171.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.4 mtm105 -60.6 -64.36 0.98 Allowed 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 119.178 1.489 . . . . 0.0 108.805 164.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -56.71 -37.74 71.34 Favored 'General case' 0 CA--C 1.52 -0.196 0 O-C-N 124.199 0.937 . . . . 0.0 111.098 -171.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.3 t -65.96 -13.84 60.5 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.812 -0.555 . . . . 0.0 111.52 -175.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -126.91 8.37 6.78 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.143 2.177 . . . . 0.0 110.212 -173.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.83 5.13 50.69 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 125.506 1.527 . . . . 0.0 114.221 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 19.7 mt -71.36 120.39 16.87 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 119.258 1.529 . . . . 0.0 108.882 -168.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 69.4 p -66.01 174.35 2.54 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.661 -0.65 . . . . 0.0 109.778 170.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -66.81 -41.35 87.67 Favored 'General case' 0 C--O 1.231 0.127 0 O-C-N 120.217 -1.552 . . . . 0.0 109.849 174.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.1 tttp -64.67 -25.33 67.9 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.11 0.564 . . . . 0.0 111.589 177.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -72.07 -45.37 60.98 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.437 0.695 . . . . 0.0 109.97 172.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.16 -46.85 88.27 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.374 0.534 . . . . 0.0 109.807 176.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.34 -50.37 65.15 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 125.232 1.413 . . . . 0.0 109.788 175.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.2 m -56.21 -49.63 73.56 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.367 1.067 . . . . 0.0 110.55 175.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -59.94 -16.12 27.38 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 124.935 1.294 . . . . 0.0 114.432 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.508 HD11 HD11 ' A' ' 43' ' ' ILE . 15.8 pt -126.82 9.39 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 119.807 1.185 . . . . 0.0 110.997 177.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.1 m120 54.88 30.7 14.34 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.042 1.737 . . . . 0.0 112.282 179.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -102.45 178.89 4.46 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.487 1.515 . . . . 0.0 110.318 -176.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -77.35 137.3 64.21 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 173.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -67.93 -22.47 42.21 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.488 2.125 . . . . 0.0 111.971 176.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 48.5 tp60 -61.65 -43.18 99.35 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.547 -0.721 . . . . 0.0 110.923 173.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.0 m -73.87 -28.16 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 119.013 0.824 . . . . 0.0 110.737 -176.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.508 HD11 HD11 ' A' ' 36' ' ' ILE . 37.4 mm -56.67 -48.21 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 119.298 0.954 . . . . 0.0 109.691 169.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.5 -35.53 70.34 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 123.43 0.457 . . . . 0.0 111.179 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -83.21 -23.18 32.91 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.551 0.741 . . . . 0.0 112.605 -177.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -62.23 -35.89 80.29 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.901 0.773 . . . . 0.0 109.801 166.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -70.48 -36.67 73.98 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.302 0.956 . . . . 0.0 111.627 175.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.4 m -66.73 -32.29 73.49 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.36 0.527 . . . . 0.0 111.876 173.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.46 7.28 57.05 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 124.82 1.2 . . . . 0.0 112.518 -172.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -78.52 -57.09 3.95 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.76 1.624 . . . . 0.0 110.822 -173.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.29 146.86 42.41 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 124.012 0.82 . . . . 0.0 109.078 -175.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 25.6 mm -68.84 122.06 83.62 Favored Pre-proline 0 C--O 1.237 0.406 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 -178.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.91 113.3 3.73 Favored 'Trans proline' 0 N--CA 1.444 -1.409 0 N-CA-C 106.148 -2.289 . . . . 0.0 106.148 171.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -125.56 138.78 53.96 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 118.878 -0.582 . . . . 0.0 109.721 -171.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -52.25 -46.28 65.7 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.999 1.32 . . . . 0.0 112.99 -165.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -55.39 -50.89 68.55 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -178.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.531 ' HA ' ' HD3' ' A' ' 60' ' ' LYS . 94.3 t -74.38 -47.87 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 124.785 1.234 . . . . 0.0 109.891 -174.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 42.5 mt -45.33 -49.65 12.69 Favored 'General case' 0 C--O 1.225 -0.218 0 C-N-CA 125.126 1.37 . . . . 0.0 110.378 175.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -54.76 -44.49 80.52 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 123.646 0.641 . . . . 0.0 113.184 176.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.531 ' HD3' ' HA ' ' A' ' 57' ' ' VAL . 17.6 mtpp -68.69 -38.24 80.16 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 121.771 -0.841 . . . . 0.0 109.125 -178.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.5 mt -62.4 -39.72 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 C-N-CA 123.777 0.831 . . . . 0.0 109.471 174.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -59.36 -48.99 79.55 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 119.649 1.113 . . . . 0.0 109.299 176.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 26.4 mtm105 -64.15 -18.58 64.58 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.371 0.668 . . . . 0.0 112.408 176.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.25 -55.74 5.7 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.727 1.211 . . . . 0.0 109.941 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.1 pt -91.76 -24.18 5.56 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 123.111 0.565 . . . . 0.0 110.746 -176.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.38 32.6 34.13 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 125.284 1.421 . . . . 0.0 112.593 -174.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.0 mt -135.72 163.41 30.25 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.057 1.743 . . . . 0.0 109.161 175.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 71.8 mttt -74.93 144.47 43.24 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 125.314 1.445 . . . . 0.0 110.776 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -118.69 16.95 13.63 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 127.323 2.249 . . . . 0.0 109.494 174.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -135.95 163.91 29.19 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 126.678 1.991 . . . . 0.0 109.449 -178.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 66.62 177.11 8.03 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 124.971 1.272 . . . . 0.0 112.11 176.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.8 tptt -72.89 -10.17 59.51 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.447 -1.031 . . . . 0.0 111.149 168.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -78.92 11.96 2.41 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.767 1.627 . . . . 0.0 111.616 172.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.518 HG12 HG21 ' A' ' 17' ' ' VAL . 5.3 tt -53.66 140.02 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 119.736 1.153 . . . . 0.0 110.704 -179.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.24 -10.79 40.46 Favored Glycine 0 CA--C 1.533 1.178 0 CA-C-O 117.743 -1.587 . . . . 0.0 114.078 -176.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 33.2 mmtt -66.53 151.76 95.82 Favored Pre-proline 0 C--N 1.345 0.373 0 CA-C-N 120.608 2.204 . . . . 0.0 107.768 166.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -58.04 158.93 19.76 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 123.76 2.973 . . . . 0.0 112.549 175.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 24.7 pt -101.87 141.96 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 165.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 37.26 72.38 0.12 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.743 2.417 . . . . 0.0 112.702 177.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 24.3 mtmm -56.04 -43.21 77.63 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 117.878 -1.058 . . . . 0.0 112.573 -176.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -131.97 -177.26 14.8 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 177.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -73.47 99.39 1.13 Allowed 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.958 2.439 . . . . 0.0 109.719 176.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.2 mmt85 -140.39 75.49 1.51 Allowed 'General case' 0 C--O 1.237 0.429 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -106.33 -179.74 4.03 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.04 1.336 . . . . 0.0 110.558 177.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 49.2 pttt -117.26 -43.17 2.85 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.798 1.239 . . . . 0.0 109.603 172.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.7 m 55.23 59.34 4.03 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.565 1.146 . . . . 0.0 111.963 166.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -123.71 69.33 0.46 Allowed Glycine 0 CA--C 1.527 0.837 0 CA-C-O 118.391 -1.227 . . . . 0.0 110.414 177.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -61.11 153.36 65.09 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 123.253 2.635 . . . . 0.0 110.988 -178.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.3 p -123.13 51.58 1.44 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.72 1.208 . . . . 0.0 109.403 -171.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.7 p -71.02 109.88 5.38 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.918 1.287 . . . . 0.0 110.49 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.847 0 N-CA-C 106.827 -2.509 . . . . 0.0 106.827 162.621 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.691 0 CA-C-O 121.661 0.59 . . . . 0.0 111.89 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.5 m -104.95 161.82 13.87 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 165.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.29 -26.27 66.45 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.465 -0.772 . . . . 0.0 112.474 -178.064 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.8 171.38 47.05 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 124.525 1.059 . . . . 0.0 110.647 -175.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 t -78.42 96.33 5.33 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.065 0.946 . . . . 0.0 108.905 -176.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.0 m -125.02 72.9 1.25 Allowed 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.252 1.421 . . . . 0.0 109.156 176.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 73.41 -176.55 44.71 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 -170.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -147.17 -53.3 0.22 Allowed 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.739 0.816 . . . . 0.0 108.832 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 58.04 154.5 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 130.263 3.425 . . . . 0.0 115.472 177.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.7 t 41.0 65.94 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 125.779 1.632 . . . . 0.0 107.716 -168.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.6 p -57.67 103.07 0.11 Allowed 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 174.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.3 mp -58.96 162.48 4.17 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 176.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 56.1 mp0 -51.46 -48.45 62.79 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 118.288 -0.863 . . . . 0.0 112.192 -174.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 55.8 t -59.12 -59.59 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 119.384 0.993 . . . . 0.0 110.138 179.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -55.52 -45.65 83.6 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-N 119.994 1.27 . . . . 0.0 113.267 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 49.7 tttp -56.75 -54.65 43.78 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 118.846 1.323 . . . . 0.0 109.462 175.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.2 t -61.94 -37.53 78.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 123.207 0.603 . . . . 0.0 110.586 -177.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 69.5 mt -61.16 -61.67 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 175.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -53.01 -45.56 67.99 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.209 1.404 . . . . 0.0 110.076 -175.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -59.9 -58.78 7.09 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.884 1.674 . . . . 0.0 111.749 175.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -52.48 -51.38 43.46 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.441 HH11 ' HB3' ' A' ' 22' ' ' ARG . 11.9 mtm105 -48.38 -61.86 1.79 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.179 0.992 . . . . 0.0 109.742 175.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -57.56 -33.39 68.09 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 124.344 1.057 . . . . 0.0 112.22 -177.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.89 -28.93 64.91 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.851 1.205 . . . . 0.0 111.703 -172.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -94.73 2.69 55.55 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.177 0.898 . . . . 0.0 111.832 167.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 61.51 43.7 98.96 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 110.816 -0.913 . . . . 0.0 110.816 -176.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 68.3 mt -109.97 159.58 17.15 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.163 1.385 . . . . 0.0 108.324 178.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.9 t -116.38 169.32 9.4 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.787 1.235 . . . . 0.0 110.046 -170.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -55.24 -44.25 75.34 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.527 1.131 . . . . 0.0 110.739 174.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.25 -39.67 72.95 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 118.347 -0.835 . . . . 0.0 111.769 173.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -75.76 -37.28 59.42 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 119.558 1.072 . . . . 0.0 111.158 -176.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.408 HD23 ' HG2' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -59.67 -49.05 79.23 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.78 1.232 . . . . 0.0 108.744 173.123 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.7 -49.33 73.29 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.15 1.38 . . . . 0.0 109.656 178.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.8 m -58.66 -44.87 90.27 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.812 0.733 . . . . 0.0 110.928 174.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.8 mttm -62.2 -27.29 68.87 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 117.295 -1.336 . . . . 0.0 113.263 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.53 HG22 ' HB3' ' A' ' 60' ' ' LYS . 28.0 pt -107.95 6.19 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 120.461 1.482 . . . . 0.0 112.578 176.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 56.5 t30 48.63 62.21 2.68 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.101 1.76 . . . . 0.0 112.738 -172.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -133.42 179.88 5.93 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 126.982 2.113 . . . . 0.0 109.242 176.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 25.0 mmtp -87.01 153.24 54.35 Favored Pre-proline 0 N--CA 1.47 0.551 0 C-N-CA 124.692 1.197 . . . . 0.0 109.796 169.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.68 -26.64 39.1 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.26 1.974 . . . . 0.0 111.391 176.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.0 tp60 -60.5 -29.81 69.31 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.01 0.924 . . . . 0.0 112.514 178.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.6 m -79.72 -35.35 16.38 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.37 0 CA-C-N 119.439 1.018 . . . . 0.0 109.81 174.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.403 HD11 HD11 ' A' ' 36' ' ' ILE . 29.8 mm -60.72 -44.74 97.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 120.273 1.397 . . . . 0.0 110.056 179.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.58 -30.36 65.2 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 176.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -89.09 -24.93 22.16 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.98 0.912 . . . . 0.0 111.854 178.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -62.9 -44.39 96.23 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 120.029 1.286 . . . . 0.0 108.917 166.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -59.92 -43.57 94.84 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.22 0.608 . . . . 0.0 110.582 172.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.2 m -66.3 -37.45 85.44 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.636 0.653 . . . . 0.0 111.815 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.74 29.37 8.21 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -169.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -111.11 -29.21 7.97 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.409 1.483 . . . . 0.0 111.477 -171.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.42 178.36 2.95 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.655 0.782 . . . . 0.0 110.082 170.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.4 mm -109.75 113.69 57.38 Favored Pre-proline 0 C--O 1.237 0.423 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -78.31 115.61 3.74 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 123.375 2.716 . . . . 0.0 109.298 -175.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -118.92 144.61 46.34 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.296 1.439 . . . . 0.0 108.958 -175.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.4 m-20 -48.33 -45.42 35.27 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.6 1.56 . . . . 0.0 111.942 -171.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -63.87 -52.15 61.32 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -173.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.433 ' HA ' ' HD3' ' A' ' 60' ' ' LYS . 8.9 t -64.1 -47.74 88.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-O 117.834 -1.079 . . . . 0.0 108.931 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.412 HD13 ' HD3' ' A' ' 70' ' ' ARG . 25.7 mt -46.6 -56.46 6.03 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 125.405 1.482 . . . . 0.0 109.625 174.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.13 -33.68 70.61 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 123.627 0.632 . . . . 0.0 113.559 178.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.53 ' HB3' HG22 ' A' ' 36' ' ' ILE . 23.8 mtpp -71.11 -46.67 61.23 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 118.746 1.273 . . . . 0.0 109.228 177.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.7 mt -61.82 -35.9 70.55 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.08 0 C-N-CA 124.542 1.137 . . . . 0.0 109.414 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -57.13 -50.52 72.55 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 176.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.457 ' HA ' HD11 ' A' ' 78' ' ' ILE . 61.0 mtt180 -58.48 -38.31 77.33 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 120.832 -1.168 . . . . 0.0 111.449 173.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.46 -25.91 60.42 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.229 1.012 . . . . 0.0 113.713 -176.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.415 HD11 HD21 ' A' ' 69' ' ' LEU . 45.5 pt -120.87 -10.73 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 124.323 1.049 . . . . 0.0 111.984 175.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.39 28.56 72.4 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 126.891 2.186 . . . . 0.0 113.337 -176.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.451 HD23 ' HA ' ' A' ' 77' ' ' PRO . 69.3 mt -138.27 163.18 32.42 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.419 1.488 . . . . 0.0 107.752 -178.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -86.41 143.13 27.96 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 126.778 2.031 . . . . 0.0 112.335 -170.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.415 HD21 HD11 ' A' ' 65' ' ' ILE . 4.1 mm? -118.98 6.53 11.35 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.756 1.622 . . . . 0.0 111.004 -176.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.412 ' HD3' HD13 ' A' ' 58' ' ' LEU . 81.5 mtm180 -141.8 156.92 45.55 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.789 1.236 . . . . 0.0 109.454 -177.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 73.98 172.39 26.3 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.505 1.05 . . . . 0.0 111.823 -174.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -65.4 -16.11 63.28 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.9 -0.765 . . . . 0.0 110.896 171.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.44 9.31 0.48 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.313 1.445 . . . . 0.0 111.913 173.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.5 tt -54.11 129.87 15.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 121.42 1.918 . . . . 0.0 110.009 -177.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.97 -15.44 59.39 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-O 118.743 -1.032 . . . . 0.0 114.404 -177.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.3 mtmt -68.24 152.4 96.55 Favored Pre-proline 0 N--CA 1.444 -0.748 0 CA-C-N 119.235 1.518 . . . . 0.0 107.765 170.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.451 ' HA ' HD23 ' A' ' 67' ' ' LEU . 28.2 Cg_endo -71.91 157.96 53.78 Favored 'Trans proline' 0 N--CA 1.447 -1.228 0 C-N-CA 122.724 2.283 . . . . 0.0 111.082 -174.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.457 HD11 ' HA ' ' A' ' 63' ' ' ARG . 10.5 pt -101.53 129.1 53.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 105.512 -2.032 . . . . 0.0 105.512 165.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 31.19 59.32 0.26 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.821 2.048 . . . . 0.0 113.114 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -60.07 140.81 56.61 Favored 'General case' 0 C--N 1.344 0.356 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -174.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -120.64 -116.98 2.53 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 107.901 -2.079 . . . . 0.0 107.901 -178.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -65.48 160.8 41.11 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 122.475 2.117 . . . . 0.0 111.262 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 61.15 83.22 0.15 Allowed 'General case' 0 C--O 1.234 0.251 0 C-N-CA 126.07 1.748 . . . . 0.0 110.813 175.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.36 144.42 16.56 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 114.816 -1.083 . . . . 0.0 109.025 164.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.5 tmtt? -157.0 93.49 1.35 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 178.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 26.2 p -72.66 115.02 11.43 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -175.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -156.09 73.53 0.24 Allowed Glycine 0 N--CA 1.447 -0.579 0 CA-C-O 117.682 -1.621 . . . . 0.0 111.444 -173.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -71.1 179.93 4.02 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.894 2.396 . . . . 0.0 110.709 170.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 26.1 p -114.01 -71.72 0.74 Allowed 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.47 1.108 . . . . 0.0 109.944 -177.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 49.2 m -62.0 -40.59 96.19 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 119.038 -0.506 . . . . 0.0 111.058 177.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.779 0 C-N-CA 126.326 1.917 . . . . 0.0 109.129 179.091 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.665 0 N-CA-C 112.41 -0.276 . . . . 0.0 112.41 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.9 p -55.36 136.97 48.86 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 122.159 0.981 . . . . 0.0 110.832 -176.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 56.1 m -79.01 97.54 6.12 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 176.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -64.44 91.07 0.1 OUTLIER Glycine 0 CA--C 1.523 0.545 0 N-CA-C 108.127 -1.989 . . . . 0.0 108.127 167.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.2 m 67.17 -52.81 0.48 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 129.184 2.994 . . . . 0.0 113.693 -172.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . 0.277 66.1 p 50.41 15.84 0.24 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.739 2.016 . . . . 0.0 113.62 -164.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -93.49 -161.96 35.98 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 126.607 2.051 . . . . 0.0 111.678 -171.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 61.61 159.38 0.06 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 128.378 2.671 . . . . 0.0 113.758 -178.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -130.5 -11.15 4.02 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 120.985 -1.072 . . . . 0.0 113.846 172.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.7 t -92.29 77.13 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 124.006 0.922 . . . . 0.0 109.097 -164.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.5 p -137.28 149.59 47.2 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 123.572 0.749 . . . . 0.0 110.074 177.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.9 mp -63.06 146.72 52.64 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 172.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -62.02 -36.88 82.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 118.371 -0.823 . . . . 0.0 112.797 -167.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.9 t -55.8 -61.12 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 171.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -53.56 -34.23 49.25 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-O 118.379 -1.234 . . . . 0.0 113.369 177.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -73.07 -48.38 36.45 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 119.405 1.603 . . . . 0.0 110.89 178.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 79.1 t -59.77 -40.01 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 118.945 0.793 . . . . 0.0 109.006 176.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.408 HG21 ' OE1' ' A' ' 47' ' ' GLU . 53.1 mt -58.17 -59.17 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 174.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -54.15 -45.9 72.14 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.151 0.58 . . . . 0.0 110.467 -177.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -54.94 -63.74 1.06 Allowed 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.071 1.349 . . . . 0.0 110.55 174.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.48 -34.95 87.67 Favored Glycine 0 CA--C 1.519 0.308 0 CA-C-N 119.002 0.819 . . . . 0.0 112.714 -172.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.518 HH21 ' HG2' ' A' ' 47' ' ' GLU . 27.1 mtm105 -62.74 -56.25 19.31 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 117.881 0.841 . . . . 0.0 109.125 173.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -54.97 -40.9 70.53 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.094 1.358 . . . . 0.0 111.467 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.7 m -66.63 -41.2 88.71 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.985 0.811 . . . . 0.0 109.484 -176.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 37.8 mtpt -84.21 -1.12 54.58 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.027 0.931 . . . . 0.0 112.682 177.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.39 16.38 64.95 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.503 1.049 . . . . 0.0 113.216 -175.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 43.1 mt -79.25 154.89 28.84 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 119.105 1.452 . . . . 0.0 109.694 -176.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 82.8 p -92.99 170.21 9.83 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.847 0.859 . . . . 0.0 110.718 175.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -60.45 -38.57 84.58 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 121.326 -0.859 . . . . 0.0 110.407 165.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.06 -38.59 83.27 Favored 'General case' 0 C--O 1.231 0.129 0 O-C-N 121.67 -0.644 . . . . 0.0 111.252 175.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -67.09 -35.1 79.07 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 117.968 0.349 . . . . 0.0 110.469 176.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.401 HD22 ' HB1' ' A' ' 64' ' ' ALA . 0.1 OUTLIER -65.24 -49.78 68.33 Favored 'General case' 0 CA--C 1.529 0.14 0 O-C-N 121.545 -0.722 . . . . 0.0 109.172 178.131 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -51.93 -44.9 64.09 Favored 'General case' 0 CA--C 1.522 -0.117 0 C-N-CA 124.701 1.2 . . . . 0.0 109.9 176.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 43.9 m -62.85 -52.22 63.96 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.619 1.167 . . . . 0.0 109.927 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -58.68 -20.78 51.44 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.203 1.401 . . . . 0.0 114.297 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.4 pt -115.15 2.66 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 123.809 0.844 . . . . 0.0 111.937 177.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.8 t30 50.97 55.6 9.3 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.275 1.83 . . . . 0.0 112.878 -175.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -128.11 -175.69 3.57 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 127.344 2.258 . . . . 0.0 109.725 175.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.75 146.55 37.25 Favored Pre-proline 0 N--CA 1.464 0.226 0 O-C-N 120.81 -1.181 . . . . 0.0 110.223 174.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -66.34 -16.86 52.93 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.57 2.18 . . . . 0.0 114.242 178.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -61.55 -43.21 99.27 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 119.413 1.006 . . . . 0.0 110.829 172.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.4 m -63.71 -32.6 57.53 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.412 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.132 -176.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 25.2 mm -63.28 -46.51 95.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 124.754 1.221 . . . . 0.0 109.648 177.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.21 -40.1 67.32 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.928 -0.483 . . . . 0.0 111.146 174.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -79.7 -28.45 40.65 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.392 0.677 . . . . 0.0 112.566 -178.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -62.91 -52.28 63.66 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.405 1.082 . . . . 0.0 108.918 171.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.518 ' HG2' HH21 ' A' ' 22' ' ' ARG . 0.7 OUTLIER -60.07 -42.71 95.15 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 175.563 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.6 t -66.97 -37.82 84.94 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 124.043 0.839 . . . . 0.0 110.713 -177.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.94 3.12 20.11 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 118.596 -1.113 . . . . 0.0 114.269 -175.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 49.4 mtm180 -102.86 -14.28 16.63 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.453 1.626 . . . . 0.0 113.764 -170.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.72 151.66 41.39 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 119.665 1.12 . . . . 0.0 108.458 174.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.2 mm -79.6 116.17 58.84 Favored Pre-proline 0 C--O 1.236 0.354 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 165.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -70.78 141.92 42.22 Favored 'Trans proline' 0 N--CA 1.448 -1.175 0 N-CA-C 108.897 -1.232 . . . . 0.0 108.897 175.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -136.34 150.33 48.8 Favored 'General case' 0 CA--C 1.513 -0.445 0 O-C-N 121.472 -0.767 . . . . 0.0 110.064 169.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -55.29 -41.65 72.59 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 125.106 1.362 . . . . 0.0 111.149 -175.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -52.98 -60.06 3.75 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.412 1.085 . . . . 0.0 110.051 175.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.578 ' HA ' ' HD3' ' A' ' 60' ' ' LYS . 41.1 t -64.87 -51.08 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-O 118.285 -0.864 . . . . 0.0 109.713 -176.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 71.9 mt -44.38 -50.69 9.07 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 124.922 1.289 . . . . 0.0 110.804 175.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.77 -36.07 92.19 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 118.691 0.678 . . . . 0.0 113.126 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.578 ' HD3' ' HA ' ' A' ' 57' ' ' VAL . 16.2 mtpp -68.67 -44.25 74.48 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 118.7 1.25 . . . . 0.0 108.96 175.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.428 HG21 HD13 ' A' ' 61' ' ' ILE . 61.5 mt -59.1 -35.73 58.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 123.493 0.717 . . . . 0.0 109.362 177.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.426 ' HA ' HD23 ' A' ' 69' ' ' LEU . 48.6 mt-10 -57.45 -44.45 84.76 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 119.642 1.11 . . . . 0.0 109.859 176.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -73.01 -13.89 61.31 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.541 1.136 . . . . 0.0 113.199 178.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.401 ' HB1' HD22 ' A' ' 32' ' ' LEU . . . -73.33 -41.61 63.29 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.294 1.038 . . . . 0.0 111.455 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 36.0 pt -116.56 -16.69 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.293 1.037 . . . . 0.0 111.552 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.44 30.22 46.08 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 125.793 1.663 . . . . 0.0 113.091 -178.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 77' ' ' PRO . 74.5 mt -123.72 163.12 21.75 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 118.486 1.143 . . . . 0.0 109.427 173.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.0 mttm -72.09 131.91 43.48 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 127.411 2.284 . . . . 0.0 108.252 172.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 62' ' ' GLU . 4.1 mm? -112.67 7.98 18.87 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 126.666 1.986 . . . . 0.0 110.206 176.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.47 161.69 39.89 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 126.832 2.053 . . . . 0.0 107.634 -175.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 70.17 160.49 3.03 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.165 0.888 . . . . 0.0 111.166 -168.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -63.73 -11.99 30.94 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 120.929 -1.336 . . . . 0.0 111.203 173.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.22 6.46 1.68 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.04 1.736 . . . . 0.0 111.35 173.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.9 tt -48.98 136.27 5.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-N 121.241 1.837 . . . . 0.0 110.909 -173.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.06 -11.62 66.67 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 124.001 0.81 . . . . 0.0 113.992 -177.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 49.7 mmtt -74.4 150.32 87.09 Favored Pre-proline 0 N--CA 1.452 -0.35 0 CA-C-N 119.271 1.536 . . . . 0.0 108.477 169.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 22.5 Cg_endo -70.8 161.99 44.15 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.309 2.672 . . . . 0.0 111.733 -177.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.7 pt -101.27 108.63 23.82 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 178.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 58.62 104.81 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 127.784 2.434 . . . . 0.0 113.883 177.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.5 mptt 70.53 -167.85 0.16 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.028 2.131 . . . . 0.0 109.425 -167.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.93 175.58 36.52 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 123.95 0.786 . . . . 0.0 114.629 169.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -66.18 105.92 0.92 Allowed 'Trans proline' 0 C--N 1.349 0.576 1 C-N-CA 126.095 4.53 . . . . 0.0 112.365 -171.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 46.1 ttt180 -81.36 -24.83 36.79 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.706 0.802 . . . . 0.0 112.388 -170.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -82.14 163.86 21.69 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.792 0.724 . . . . 0.0 110.074 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.8 pttp -155.1 172.42 18.17 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.752 1.221 . . . . 0.0 111.808 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 39.9 t -139.01 169.84 17.07 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 127.305 2.242 . . . . 0.0 105.786 162.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 137.38 156.47 7.27 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 170.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -82.26 48.99 2.98 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 124.489 3.46 . . . . 0.0 111.942 -173.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.6 m -119.6 104.42 10.27 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 105.747 -1.945 . . . . 0.0 105.747 177.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.6 p -81.24 92.4 6.33 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.565 0 CA-C-O 117.351 -1.805 . . . . 0.0 109.34 -175.884 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.573 0 CA-C-O 120.172 -0.238 . . . . 0.0 112.563 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.0 m -141.67 170.52 15.56 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 125.211 1.404 . . . . 0.0 109.894 175.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 71.3 m 45.71 69.71 0.43 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.773 2.029 . . . . 0.0 112.883 -177.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.25 171.01 38.04 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 110.969 -0.853 . . . . 0.0 110.969 172.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -165.43 159.73 17.26 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 125.667 1.587 . . . . 0.0 108.829 178.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.7 p -73.68 161.42 30.28 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.219 0.608 . . . . 0.0 109.552 163.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.26 153.4 49.46 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 170.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -137.38 141.78 41.74 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.109 0.964 . . . . 0.0 109.149 173.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.434 ' HG2' ' H ' ' A' ' 10' ' ' VAL . 16.2 ttp85 56.74 -165.45 0.14 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.836 1.254 . . . . 0.0 110.737 -174.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.434 ' H ' ' HG2' ' A' ' 9' ' ' ARG . 27.0 m -78.51 116.57 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -174.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.2 p -71.66 107.79 4.68 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.162 0.585 . . . . 0.0 109.522 -178.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -56.19 155.1 7.03 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.442 1.097 . . . . 0.0 109.916 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -44.45 -57.93 3.27 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.647 1.579 . . . . 0.0 111.925 177.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 52.5 t -58.37 -57.06 12.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -178.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.14 -35.39 77.1 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 118.885 0.766 . . . . 0.0 113.191 -178.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.2 tptt -68.59 -52.75 28.24 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 124.001 0.92 . . . . 0.0 110.011 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 67.0 t -61.61 -36.52 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 49.1 mt -57.98 -60.12 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-O 118.161 -0.923 . . . . 0.0 108.924 173.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -53.8 -50.99 64.89 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.976 0.807 . . . . 0.0 109.905 -177.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -56.45 -48.47 76.98 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 126.345 1.858 . . . . 0.0 112.283 -178.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -74.99 -36.73 45.79 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-O 118.668 -1.073 . . . . 0.0 111.175 -175.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.483 ' HG2' HD23 ' A' ' 32' ' ' LEU . 15.4 mtm105 -56.77 -55.85 29.07 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 118.571 1.185 . . . . 0.0 109.763 170.151 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -50.78 -49.45 58.27 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 126.284 1.833 . . . . 0.0 110.883 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 50.6 m -63.63 -5.75 4.43 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.562 0.745 . . . . 0.0 112.412 -174.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -130.93 4.53 4.49 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.698 1.999 . . . . 0.0 110.638 -175.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.81 15.67 60.37 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.134 1.349 . . . . 0.0 113.546 -175.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 42.1 mt -73.73 127.08 31.84 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 119.086 1.443 . . . . 0.0 109.042 -170.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.4 p -67.57 169.54 9.12 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.697 0.761 . . . . 0.0 109.79 168.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -61.68 -34.55 75.93 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 120.999 -1.063 . . . . 0.0 110.086 166.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.89 -34.53 71.67 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-O 117.485 -1.245 . . . . 0.0 111.696 176.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -57.66 -51.76 68.19 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 119.787 1.176 . . . . 0.0 108.013 176.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.483 HD23 ' HG2' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -57.88 -48.23 80.44 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.882 0.873 . . . . 0.0 110.019 -176.967 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.07 -49.71 65.83 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.157 1.383 . . . . 0.0 110.202 177.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.1 m -60.66 -44.78 96.04 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.156 0.982 . . . . 0.0 111.174 175.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.8 mttm -53.19 -28.68 27.78 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.453 1.101 . . . . 0.0 112.208 175.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.576 HG22 ' HB3' ' A' ' 60' ' ' LYS . 20.3 pt -112.66 7.71 8.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 124.202 1.001 . . . . 0.0 113.079 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.16 21.77 5.49 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 127.027 2.131 . . . . 0.0 113.311 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.78 173.23 6.66 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.547 1.139 . . . . 0.0 109.853 -173.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -71.43 139.56 84.22 Favored Pre-proline 0 CA--C 1.53 0.204 0 C-N-CA 124.182 0.993 . . . . 0.0 110.93 -173.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -74.78 -10.73 21.73 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.451 2.767 . . . . 0.0 112.373 177.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.2 tp60 -58.84 -57.64 12.16 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 163.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.0 m -67.14 -24.32 31.9 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 CA-C-O 119.077 -0.487 . . . . 0.0 111.102 -169.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 43.6 mm -63.22 -47.68 91.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 124.489 1.116 . . . . 0.0 111.475 171.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.06 -36.62 84.92 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 122.562 0.345 . . . . 0.0 110.574 176.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.45 -31.69 65.66 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.201 0.6 . . . . 0.0 111.363 177.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -58.82 -38.32 78.38 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 125.341 1.456 . . . . 0.0 111.82 170.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -60.81 -58.83 6.8 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.019 0.528 . . . . 0.0 110.361 178.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.3 p -66.63 -27.11 67.43 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -176.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.21 8.11 56.75 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-O 119.856 -0.414 . . . . 0.0 112.281 -170.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 21.0 mtm180 -69.17 -38.12 78.54 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 118.288 1.044 . . . . 0.0 110.369 172.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.67 138.29 48.5 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.8 mm -76.62 126.25 86.28 Favored Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 168.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -68.76 158.83 56.23 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 121.645 1.563 . . . . 0.0 109.851 177.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 -136.51 137.26 40.12 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 171.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -54.51 -34.42 61.66 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.446 1.099 . . . . 0.0 110.925 -179.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -61.95 -58.26 8.58 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.566 0.746 . . . . 0.0 109.773 178.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 83.9 t -66.97 -46.15 85.51 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.453 0 CA-C-O 117.402 -1.285 . . . . 0.0 109.151 -176.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 62.3 mt -44.72 -56.17 4.67 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 120.794 1.634 . . . . 0.0 110.895 169.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.18 -14.19 52.36 Favored Glycine 0 CA--C 1.536 1.39 0 CA-C-N 118.566 0.621 . . . . 0.0 114.007 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.576 ' HB3' HG22 ' A' ' 36' ' ' ILE . 22.7 mtpp -89.39 -46.74 8.5 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 125.557 1.543 . . . . 0.0 110.444 171.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.0 mt -53.47 -37.5 30.26 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.191 0 C-N-CA 124.532 1.133 . . . . 0.0 108.698 175.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -55.95 -54.47 44.38 Favored 'General case' 0 C--O 1.223 -0.327 0 C-N-CA 119.65 -0.82 . . . . 0.0 111.343 175.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 23.6 mtm180 -69.35 -7.58 38.63 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.977 0.808 . . . . 0.0 112.738 176.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.35 -27.1 35.06 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.264 1.025 . . . . 0.0 111.686 176.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.541 HD11 HD21 ' A' ' 69' ' ' LEU . 16.1 pt -127.71 -11.55 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.026 0.93 . . . . 0.0 112.934 -178.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 66.06 39.09 94.59 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 126.02 1.771 . . . . 0.0 112.132 -174.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 77' ' ' PRO . 61.9 mt -132.02 162.81 29.85 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 124.336 1.054 . . . . 0.0 109.311 170.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -74.26 140.12 44.77 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 126.013 1.725 . . . . 0.0 108.538 174.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.541 HD21 HD11 ' A' ' 65' ' ' ILE . 3.4 mm? -117.46 11.17 13.79 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.937 1.295 . . . . 0.0 109.839 178.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 27.2 mtm105 -140.14 161.57 37.32 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.716 1.206 . . . . 0.0 109.418 178.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.12 169.47 24.98 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 124.327 0.965 . . . . 0.0 110.874 -175.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.658 ' H ' ' HD3' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -68.42 -17.64 64.26 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 121.772 -0.84 . . . . 0.0 111.38 170.772 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -77.95 15.03 0.95 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.375 1.47 . . . . 0.0 110.792 173.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.3 tt -52.55 142.35 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 O-C-N 120.888 -1.132 . . . . 0.0 110.084 175.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.56 0.03 57.23 Favored Glycine 0 CA--C 1.528 0.891 0 CA-C-O 117.577 -1.68 . . . . 0.0 113.948 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 33.7 mmtt -77.33 154.53 81.99 Favored Pre-proline 0 N--CA 1.453 -0.321 0 CA-C-N 119.893 1.846 . . . . 0.0 107.46 157.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 18.6 Cg_endo -70.32 163.68 37.83 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 123.266 2.644 . . . . 0.0 112.852 -179.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.0 pt -112.15 170.34 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 C-N-CA 126.192 1.797 . . . . 0.0 108.507 172.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 67.04 161.29 0.16 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.3 1.84 . . . . 0.0 110.227 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -82.3 80.04 8.6 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 120.018 -1.676 . . . . 0.0 109.535 179.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -148.17 120.87 1.26 Allowed Glycine 0 CA--C 1.525 0.68 0 N-CA-C 107.357 -2.297 . . . . 0.0 107.357 161.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -76.01 66.88 6.84 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.647 2.898 . . . . 0.0 110.077 174.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.2 mmp_? -72.13 177.9 4.14 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.657 1.183 . . . . 0.0 108.269 165.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 8.39 92.47 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 128.658 2.783 . . . . 0.0 113.942 162.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -75.56 67.84 2.12 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 166.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.2 m -76.93 149.57 36.01 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 156.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -171.51 78.63 0.09 OUTLIER Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 107.268 -2.333 . . . . 0.0 107.268 -175.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -62.16 170.03 6.94 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.085 1.857 . . . . 0.0 111.175 178.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.3 t -145.96 148.84 33.19 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.45 1.1 . . . . 0.0 108.311 175.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.9 m -144.87 159.7 42.47 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.233 1.013 . . . . 0.0 110.294 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.168 0 N-CA-C 105.729 -2.948 . . . . 0.0 105.729 163.32 . . . . . . . . 0 0 . 1 stop_ save_